note_id
stringlengths
13
15
subject_id
int64
10M
20M
hadm_id
int64
20M
30M
note_type
stringclasses
1 value
note_seq
int64
2
133
charttime
stringlengths
19
19
storetime
stringlengths
19
19
text
stringlengths
1.56k
52.7k
10757689-DS-21
10,757,689
24,715,669
DS
21
2115-06-26 00:00:00
2115-06-26 15:43:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Dilantin / contrast CT dye Attending: ___ Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: ___ cardiac catheterization History of Present Illness: Ms. ___ is a ___ F hx R posterior ICA aneurysm repair in ___, who presented to the ___ ER for headache and cough. In the ER she was noted to have 5 days of occasional fever, chills, sweats, cough, sinus congestion, as well as wheezing. The past 3 days she has noticed constant headache similar to her migraines prior to her aneurysm coiling. The headache was R>L and extended from occiput to forehead, worse with coughing. Of note, these symptoms are in the setting of recent intervention. She was seen by neurosurgery here and underwent a cerebral angiogram on ___, started taking aspirin and Plavix 3 days ago per neurosurgery, with plan to recannalize R ICA aneurysm on ___. Neurosurgery was consulted in the ER, recommended CTA head and neck, which did not show any acute findings. Of note, she was pre-medicated for the CT given her contrast allergy. However, in light of her ongoing cough and significant wheezing on exam, there was concern for a COPD exacerbation. She has a distant smoking history. In the ED, initial vitals were: T 98.2 HR 84 BP 156/65 RR 16 O2 99% RA - Exam notable for: lung wheezing - Labs notable for: CBC, BMP within normal limits; Flu negative - Imaging was notable for: CXR: No acute intrathoracic process. Noncontrast head CT: No acute intracranial process. CTA neck: No evidence of occlusion, dissection, or flow limiting stenosis. CTA head: Status post coiling of a supraclinoid right ICA aneurysm. Left MCA is either extremely diminutive or completely occluded. Numerous collateral vessels are seen in the expected location of the M1 segment of the left MCA. This is similar compared to report from recent angiogram. - Patient was given: Acetaminophen, Metoclopramide, Diphenhydramine, Benzonatate, Guaifenesin Albuterol, ipratropium nebs x6 Methylprednisolone 50 mg x1, 125 mg x1 Azithromycin 500 mg x1 Aspirin 324 mg, Clopidogrel 75 mg Upon arrival to the floor, patient reports again that earlier last week she began having URI/allergic type symptoms with congestion, cough. Started taking Claritin but symptoms progressed. Cough incited a headache, bilateral, frontal. Had also a 20 min episode of very tight breathing. Never had COPD exacerbation. Had 15 pack year history but quit many years ago. Living a very active life in ___ now without limitations such as SOB. Currently endorses some SOB. Past Medical History: -Right ICA aneurysm s/p coil (___) -left frontal meningioma -Schwanomatosis -Multiple back surgeries, complicated by L foot drop -MCA dissection -GERD Social History: ___ Family History: NC Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VITAL SIGNS: T 98.0 PO BP 163/70 HR 81 RR 18 O2 97 RA GENERAL: NAD, sitting comfortably in chair HEENT: OP clear, sclera anicteric NECK: supple CARDIAC: RRR, soft systolic murmur best heard over RUSB LUNGS: Very poor air movement bilaterally, minimal expiratory wheezing, no crackles ABDOMEN: non-tender, non-distended EXTREMITIES: WWP NEUROLOGIC: L foot drop, baseline. DISCHARGE PHYSICAL EXAM: ======================== VITAL SIGNS: ___ 0750 Temp: 97.5 PO BP: 105/69 HR: 71 RR: 18 O2 sat: 97% O2 delivery: Ra GENERAL: NAD, sitting comfortably in chair HEENT: OP clear, sclera anicteric, resolving hoarse voice, tender cervical LAD NECK: supple CARDIAC: RRR, no MRG LUNGS: moderate air movement bilaterally, mild wheezes intermittently ABDOMEN: non-tender, non-distended EXTREMITIES: WWP, neg edema Pertinent Results: ADMISSION LABS: =============== ___ 06:40PM BLOOD WBC-9.5 RBC-4.26 Hgb-13.0 Hct-39.0 MCV-92 MCH-30.5 MCHC-33.3 RDW-13.2 RDWSD-43.8 Plt ___ ___ 06:40PM BLOOD Neuts-67.3 ___ Monos-5.7 Eos-2.1 Baso-0.5 Im ___ AbsNeut-6.42* AbsLymp-2.30 AbsMono-0.54 AbsEos-0.20 AbsBaso-0.05 ___ 06:40PM BLOOD Glucose-124* UreaN-21* Creat-0.9 Na-147 K-4.1 Cl-107 HCO3-25 AnGap-15 PERTINENT/ DISCHARGE LABS: ========================== ___ 05:35AM BLOOD WBC-11.5* RBC-3.63* Hgb-11.2 Hct-33.1* MCV-91 MCH-30.9 MCHC-33.8 RDW-13.0 RDWSD-43.2 Plt ___ ___ 08:10AM BLOOD ___ PTT-24.8* ___ ___ 07:05AM BLOOD Glucose-95 UreaN-16 Creat-0.9 Na-147 K-4.3 Cl-108 HCO3-26 AnGap-13 ___ 11:25PM BLOOD CK-MB-6 cTropnT-<0.01 ___ 08:10AM BLOOD CK-MB-6 cTropnT-<0.01 ___ 05:48PM BLOOD CK-MB-6 cTropnT-<0.01 ___ 11:15PM BLOOD CK-MB-7 cTropnT-<0.01 ___ 08:10AM BLOOD %HbA1c-6.1* eAG-128* ___ 08:10AM BLOOD Triglyc-92 HDL-49 CHOL/HD-3.9 LDLcalc-123 ___ 08:10AM BLOOD ADP-DONE Collage-DONE Arach A-DONE IMAGING REPORTS: ================ CXR ___: No acute intrathoracic process. CTA HEAD AND NECK ___: IMPRESSION: No acute intracranial infarct, hemorrhage or mass. The patient is status post prior coiled right paraclinoid ICA posterior wall aneurysm. The coil results in beam hardening artifact which obscures the immediate surroundings and reference is made to prior angiography report of ___ which suggested recanalization of the neck of the aneurysm. There is severe stenosis/occlusion of the proximal left M1 segment with reconstitution of the distal left MCA branches by collaterals. Slightly decreased arborization of the distal left MCA branches compared to the right. Small basilar artery with fetal type origins of the PCAs bilateral. No proximal ICA stenosis by NASCET criteria. Dominant left vertebral artery. Diminutive right vertebral artery which essentially terminates as the ___. STRESS TEST ___: IMPRESSION: Good exercise tolerance. Atypical symptoms with borderline ischemic ST segment changes. Appropriate hemodynamic response to exercise. CATH REPORT ___: Coronary Anatomy Dominance: Right * Left Main Coronary Artery The LMCA is short, without angiographically apparent disease. * Left Anterior Descending The LAD is without angiographically apparent disease. * Circumflex The Circumflex is without angiographically apparent disease. * Right Coronary Artery The RCA is without angiographically apparent disease. Intra-procedural Complications: None Impressions: No angiographically apparent coronary artery disease Normal left ventricular filling pressure V/Q SCAN ___: IMPRESSION: Normal lung scan. CT SINUS ___: IMPRESSION: 1. Study is limited by streak artifact from dental amalgam and right ICA coil mass. 2. No evidence of fracture or soft tissue fluid collection. 3. Within limits of this noncontrast study, no definite evidence of maxillofacial mass. If continued concern for maxillofacial or skullbase mass, consider dedicated contrast facial or skullbase MRI for further evaluation 4. Paranasal sinus disease with findings concerning for acute, chronic and/or fungal sinusitis, as described. Mild systemic arterial hypertension CT CHEST W/O CONTRAST: IMPRESSION: 1. No evidence of interstitial lung disease or intrathoracic malignancy. 2. Findings of reactive small airways disease. 3. Indeterminate 1.3 cm left adrenal nodule, statistically likely an adenoma. 4. 2.9 x 1.1 cm lobular density within the superior medial left breast, likely representing patchy parenchymal tissue, although appearing slightly asymmetric. Recommend correlation with prior screening mammograms. RECOMMENDATION(S): Correlation with prior screening mammograms. MICRO STUDIES: ============== ___ 1:16 pm Rapid Respiratory Viral Screen & Culture Source: Nasopharyngeal swab. **FINAL REPORT ___ Respiratory Viral Culture (Final ___: NO UTM RECEIVED, UNABLE TO PERFORM VIRAL CULTURE. NOTIFIED ___ 3.50P ___. Brief Hospital Course: Ms. ___ is a ___ female with past medical history MCA dissection, right posterior ICA aneurysm status post coiling, who presents with headache, shortness of breath. She had a negative head CT in the ER. Although she lacked a history of COPD or reactive airway disease, her exam and clinical picture fit a post-viral COPD/asthma exacerbation. Her symptoms were refractory to steroids, and pulmonology was consulted, who recommended CT imaging of her sinus and chest which were consistent with a reactive small airway disease and sinusitis. Her course was also complicated by chest pain, with a borderline positive exercise tolerance test. She was taken for cardiac catheterization, which showed clean coronaries, it was presumed that her chest pain was related to her upper respiratory infection. #Shortness of breath Patient initially presented with approximately 1 week of URI type symptoms with sinusitis, progressing to worsening cough with episodic wheezing. Her exam showed very poor air movement, concerning for reactive airway disease. She has no history of asthma, a distant 15-pack-year smoking history without formal diagnosis of COPD or prior exacerbation, and no cardiac history. She received IV steroids in the ER, then continued on duonebs, albuterol nebs, transitioned to PO steroids and to complete a 6 day taper after discharge (20 mg x3 days, 10 mg x3 days). VQ scan negative for PE. Given that her symptoms were refractory to steroids, with minimal improvement, pulmonology was consulted. CT chest and sinus were obtained, notable for reactive small airway disease and sinusitis. Cough was managed by ___ ___. She was discharged with albuterol, albuterol-ipratropium inhalers, prednisone taper, and hypertonic saline nebs (neb machine delivered to bedside), and return precautions. It was communicated to her ___ team that pulmonary team recommended delaying her procedure until resolution of her broncospastic symptoms, and for formal anesthesia pre-operative evaluation. She will follow up with ___ Pulmonology for further PFT testing. # Chest Pressure Had chest pressure, palpitations, and diaphoresis during albuterol administration, resolved with SL nitro. Troponin and CK-MB negative x2 and EKG without any ST elevations/depressions. ETT with ST depressions inferiorly, anteriorly and chest pressure symptoms; brought to cath on ___ with clean coronaries. Chest pressure likely related to ongoing respiratory pathology. Chronic Problems: ------------------ #Right ICA aneurysm Patient followed by neurosurgery here, CTA in the emergency department was unremarkable for bleed. Planning for pipeline stent placement on ___. Patient had a platelet aggregation test which showed borderline Plavix response. After discussion with neurosurgery, she was switched to aspirin 81 mg and ticagrelor 90 mg twice daily. Of note ticagrelor is known to cause worsening dyspnea as a side effect. #GERD. Patient usually takes omeprazole, but switched recently given recent initiation of clopidogrel. We continued home ranitidine 150 mg twice daily #Constipation - Senna daily TRANSITIONAL ISSUES: ==================== [] Please ensure patient follows up with ___ Pulmonology [] Follow up PFT testing recommended [] Indeterminate 1.3 cm left adrenal nodule, statistically likely an adenoma [] 2.9 x 1.1 cm lobular density within the superior medial left breast, likely representing patchy parenchymal tissue, although appearing slightly asymmetric. Recommend correlation with prior screening mammograms. [] If sinusitis does not improve, consider repeating sinus imaging, given CT read which raised possibility of fungal sinusitis (though this was felt clinically unlikely) [] Please discuss with patient re: initiating statin given ASCVD ~11% [] Ensure patient follows up with neurosurgery for planned procedure on aneurysm # CODE: full (presumed) # CONTACT: ___ (Cell) ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 325 mg PO DAILY 2. Senna 17.2 mg PO DAILY 3. Clopidogrel 75 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Ranitidine 150 mg PO BID 6. Vagifem (estradiol) 10 mcg vaginal 2X/WEEK Discharge Medications: 1. Albuterol 0.083% Neb Soln 0.63 mg NEB Q4H:PRN dyspnea RX *albuterol sulfate 2.5 mg/3 mL (0.083 %) 3 mL neb q4h PRN Disp #*30 Vial Refills:*0 2. Albuterol Inhaler ___ PUFF IH Q4H:PRN wheeze, shortness of breath RX *albuterol sulfate [ProAir HFA] 90 mcg ___ puff IH q4H PRN Disp #*1 Inhaler Refills:*0 3. Benzonatate 100 mg PO TID RX *benzonatate 100 mg 1 capsule(s) by mouth TID PRN Disp #*30 Capsule Refills:*0 4. Dextromethorphan-Guaifenesin (Sugar Free) ___ mL PO Q6H:PRN cough RX *dextromethorphan-guaifenesin [Diabetic Tussin DM] 100 mg-10 mg/5 mL ___ mL by mouth q6h PRN Refills:*0 5. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID RX *fluticasone-salmeterol [Advair Diskus] 250 mcg-50 mcg/dose 1 puff IH twice a day Disp #*1 Disk Refills:*0 6. Ipratropium-Albuterol Inhalation Spray 1 INH IH Q6H RX *ipratropium-albuterol [Combivent Respimat] 20 mcg-100 mcg/actuation 1 puff IH every six (6) hours Disp #*1 Inhaler Refills:*0 7. PredniSONE 20 mg PO DAILY Duration: 2 Doses This is dose # 1 of 2 tapered doses RX *prednisone 10 mg 2 tablet(s) by mouth once a day Disp #*7 Tablet Refills:*0 8. PredniSONE 10 mg PO DAILY Duration: 3 Doses This is dose # 2 of 2 tapered doses 9. Sodium Chloride 3% Inhalation Soln 15 mL NEB Q6H RX *sodium chloride 3 % 15 mL IH q6h PRN Disp #*30 Vial Refills:*0 10. Sodium Chloride Nasal ___ SPRY NU BID RX *sodium chloride [Saline Nasal] 0.65 % ___ spray in each nostril twice a day Disp #*1 Spray Refills:*0 11. TiCAGRELOR 90 mg PO BID RX *ticagrelor [Brilinta] 90 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 12. TraZODone 50 mg PO QHS:PRN insomnia RX *trazodone 50 mg 1 tablet(s) by mouth QHS PRN Disp #*14 Tablet Refills:*0 13. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 14. Multivitamins 1 TAB PO DAILY 15. Ranitidine 150 mg PO BID 16. Senna 17.2 mg PO DAILY 17. Vagifem (estradiol) 10 mcg vaginal 2X/WEEK 18.Nebulizer Machine Diagnosis: Asthma, Bronchitis ICD Code ___ Length of Need: Indefinite ___ ___ Limited ___ ___ Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS =============== SHORTNESS OF BREATH REACTIVE AIRWAY DISEASE SECONDARY DIAGNOSIS ================== RIGHT INTERNAL CAROTID ARTERY ANEURYSM Discharge Condition: Activity Status: Ambulatory - Independent. Level of Consciousness: Alert and interactive. Mental Status: Clear and coherent. Discharge Instructions: Dear ___, It was a pleasure to care for you during your admission here Why was I admitted to the hospital? - You were admitted for concern of your breathing status What happened while I was admitted? - You had CT scans of your brain and neck, which showed no changes. - You were given IV and oral steroids, and nebulizer treatments. - You were having chest pain, and had a borderline positive stress test. He had a cardiac catheterization, which did not show any significant coronary artery disease. - You were seen by our pulmonologist, who recommended CT imaging. Your CT imaging did not show any new concerning findings. What should I do when I leave the hospital? - Please follow up with your neurosurgery team about delaying your surgery while you recover from this bronchitis. - Continue taking your medications as listed - Follow up with your doctor appointments below We wish you all the best, ___ Followup Instructions: ___
10757690-DS-17
10,757,690
23,721,517
DS
17
2146-05-04 00:00:00
2146-05-04 17:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: ___ left thoracentesis History of Present Illness: Mr ___ is a ___ male with hx of HCV cirrhosis (genotype 2), decompensated with acites, lower extremity edema, esophageal varices and pleural effusions requiring thoracentesis (last on ___, with recent admission on ___ for decompensated cirrhosis, now transferred to ___ from ___ ___ for worsening dyspnea on exertion and cough, and abdominal fullness, over the past several days. His cough has been non-productive of mucus or blood. He has felt some chest heaviness with deep breathing, but denies rank chest pain, palpitations, or lightheadedness. Denies fevers, chills, or sweats. Has some worsening of his chronic leg swelling. His abdomen feels more full than usual, but he denies abdominal pain, nausea, vomiting, diarrhea, constipation, dysuria, or hematuria. OSH labs notable for TBili/DBili 2.5/0.9, albumin 2.5, Hct 34. CXR showed large L pleural effusion. He was transferred to ___ as this is where he receives his usual hepatology care. . In the ED, initial vitals were 98.9, 100, 126/68, 16, 95% RA. Exam notable for soft abdomen. Labs revealed hct 32, INR 1.6, normal chem panel, Bili 2.6, albumin 2.5. CXR showed large L pleural effusion. His case was discussed with hepatology, who recommended admission for diuretic therapy. VS prior to transfer were: 97, 109/74, 23, 100%2L. . ROS: per HPI. Also denies headache, vision changes, congestion, sore throat, BRBPR, melena, or hematochezia. Past Medical History: -- Hepatitis C Genotype 2, cirrhosis, decompensated ascites, varices, and edema -- BPH -- Hypertension -- Status post cholecystectomy -- Ataxia of unknown origin currently uses a wheelchair and a walker -- Right inguinal hernia s/p repair and now recurrent and inoperable per pt Social History: ___ Family History: uncle with cirrhosis (likely etoh) Physical Exam: ADMISSION PHYSICAL EXAM: VS: 97.9, 118/53, 94, 18, 98% 3L GENERAL: Cachectic adult male in NAD, speaking in abbreviated sentences due to dyspnea. Otherwise appears comfortable and appropriate HEENT: Sclera anicteric. PERRL, EOMI. MMM NECK: Thin, supple, no JVD or LAD CARDIAC: Tachycardic, regular, non-displaced PMI, S1 S2 without murmurs, rubs or gallops. No S3 or S4 appreciated LUNGS: Minimal breath sounds halfway up left lung. + expiratory wheeze throughout. No chest wall deformities but ribs clearly visualized. Resp mildly labored but no accessory muscle use, moving ABDOMEN: Soft, full, non-distended, non-tender to palpation. Dullness to percussion over dependent areas but tympanic anteriorly EXTREMITIES: Symmetric 3+ edema of ___ to thighs bilaterally. Warm, with palpable DP/radial pulses bilaterally. No asterixis . DISCHARGE PHYSICAL EXAM: VS: 99.6, 92/56, 82, 18, 97% 3L GENERAL: Cachectic NAD, Appears comfortable and appropriate HEENT: Sclera anicteric. PERRL, EOMI. MMM NECK: Thin, supple, no JVD or LAD CARDIAC: RRR, S1 S2 without murmurs, rubs or gallops. LUNGS: Comfortable on supplemental O2. Breath sounds decreased in lower left lung field. Faint wheezing throughout. ABDOMEN: Soft, mildly distended, non-tender to palpation. Dullness to percussion over dependent areas but tympanic anteriorly. EXTREMITIES: Symmetric 2+ edema of ___ to thighs bilaterally. NEURO: Strength preserved in all limbs. No gross sensory loss. CNIII-XII grossly intact. Dysmmetric finger to nose. No asterixis. Pertinent Results: ADMISSION LABS: ___ 10:04PM BLOOD WBC-3.1* RBC-3.03* Hgb-11.3* Hct-32.1* MCV-106* MCH-37.5* MCHC-35.3* RDW-15.6* Plt Ct-72* ___ 10:04PM BLOOD Neuts-63.8 Lymphs-15.6* Monos-16.1* Eos-4.0 Baso-0.5 ___ 10:04PM BLOOD ___ PTT-32.5 ___ ___ 10:04PM BLOOD UreaN-19 Creat-1.0 Na-135 K-4.0 Cl-100 HCO3-31 AnGap-8 ___ 10:04PM BLOOD ALT-32 AST-37 LD(LDH)-204 AlkPhos-79 TotBili-2.6* DirBili-1.0* IndBili-1.6 ___ 10:04PM BLOOD Albumin-2.5* . PLEURAL FLUID: ___ 02:19PM PLEURAL WBC-150* RBC-1638* Polys-5* Lymphs-47* Monos-5* Atyps-5* Meso-17* Macro-21* ___ 02:19PM PLEURAL TotProt-1.2 Glucose-123 LD(LDH)-63 Albumin-LESS THAN Cholest-PND Triglyc-PND . MICRO: ___ PLEURAL FLUID CULTURE NO GROWTH TO DATE . DISCHARGE LABS: ___ 06:30AM BLOOD WBC-3.3* RBC-2.94* Hgb-10.7* Hct-31.5* MCV-107* MCH-36.4* MCHC-34.1 RDW-15.4 Plt Ct-62* ___ 06:30AM BLOOD ___ PTT-34.3 ___ ___ 06:30AM BLOOD Glucose-83 UreaN-19 Creat-1.0 Na-136 K-3.8 Cl-98 HCO3-33* AnGap-9 ___ 06:30AM BLOOD ALT-30 AST-35 LD(LDH)-194 AlkPhos-69 TotBili-2.1* ___ 06:30AM BLOOD Albumin-2.1* Calcium-8.5 Phos-3.0 Mg-2.0 . IMAGING: ___ CXR: COMPARISON: Radiograph available from ___. FRONTAL AND LATERAL CHEST RADIOGRAPHS: There is a large left pleural effusion, new since ___ examination, obscuring the left hemidiaphragm and left cardiac border. The upper mediastinal border is within normal limits. The right lung volume is low. There is no right pleural effusion or right consolidation. There is no pneumothorax. The hepatic flexure is gas-filled, also seen on prior chest radiograph from ___. IMPRESSION: New large left pleural effusion. . ___ CT CHEST INDICATION: ___ man with hepatitis C cirrhosis and recurrent pleural effusion status post thoracentesis, now with cough. Please evaluate for source of cough. COMPARISON: Multiple prior chest radiographs, most recent performed approximately two hours prior. TECHNIQUE: MDCT-acquired images were obtained through the chest without contrast. Coronal and sagittal reformatted images were also displayed. FINDINGS: A large, nonhemorrhagic, layering, left pleural effusion has substantially reaccumulated when compared to the chest radiograph two hours earlier, responsible for adjacent compressive atelectasis. Septal thickening and ground-glass opacities in the left lower lobe and along the fissure in the left upper lobe are most likely re-expansion pulmonary edema. The lungs are otherwise clear. The airways are patent. There is no mediastinal, hilar, or axillary lymphadenopathy. The heart size is normal. This examination is not tailored for subdiaphragmatic evaluation. The liver is shrunken and nodular in contour, consistent with patient's known cirrhosis. The patient is status post cholecystectomy. The spleen is enlarged. Large volume ascites, nearly isodense with the left pleural effusion elevates the right hemidiaphragm as seen on prior chest radiographs. Stranding throughout the subcutaneous fat is consistent with anasarca. BONE WINDOWS: Nondisplaced rib fractures are noted of the right lateral seventh through ninth ribs and anterior right sixth rib and the anterolateral aspects of the left eighth through tenth ribs. There are no osseous lesions concerning for metastatic disease. Loose bodies are present posterior to the right humeral head. IMPRESSION: 1. No evidence of pneumonia. Left lung abnormality is best explained by re-expansion pulmonary edema. 2. Substantial reaccumulation of large left pleural effusion. 3. Cirrhotic liver, splenomegaly, and a large amount of ascites. 4. Multiple nondisplaced bilateral rib fractures as detailed above. Brief Hospital Course: Mr. ___ is a ___ year old male with hepatitis c (HCV) cirrhosis, decompensated with ascites, lower extremity edema, pleural effusions, admitted with worsening dyspnea in setting of new large left pleural effusion. ACTIVE ISSUES BY PROBLEM: # Dyspnea: His chest xray was consistent with a new large left sided pleural effusion. This was felt to be the likely cause of his dyspnea, with a possible contribution from ascites. He has recently required drainage of other pleural effusions. He underwent thoracentesis and his dyspnea improved following the procedure. The thoracentisis fluid analysis indicated a transudative process, most likely from his decompensated cirrhosis/hepatic hydrothorax. He was maintained on nasal cannula to maintain O2 sat > 93%. His home torsemide dose was increased from 20 mg two times a day to 40 mg two times a day. Home spironolactone was continued. Additionally, since he had some wheezing on exam originally, he was given nebulizers as needed. -Has lab script for ___ to check electrolytes. . # Decompensated HCV cirrhosis: Genotype 2. As above, with pleural effusions, ascites, and possible encephalopathy. Was not worked up for transplant during this admission. Continued lactulose 30 mg tid, not on rifaximin currently. No need for SBP prophylaxis. No need for nadalol as no documented varices. He did not have a significant elevation of his liver function tests during this admission, although his total bilirubin did rise slightly with a direct bilirubin predominance. . # Deconditioning: Patient is cachectic and lives alone. Prior social worker notes indicate he has had ___ in past. He was started on Ensure supplements with meals and physical therapy was consulted. However, patient declined working with physical therapy secondary to fatigue. . INACTIVE ISSUES BY PROBLEM: # Hypertension: Normotensive during admission. Continued home diuretics. . # BPH: Not an active issue during admission. Did not require medications. . . TRANSITIONAL ISSUES: PROPHYLAXIS: Received SC heparin in house CODE: Full (confirmed) CONTACT: Patient, ___ (sister; ___ *Living situation as above, social work is aware and are assisting *Regarding patient's HCV, will need follow up in the liver clinic for evaluation for treatment. *CT of the chest final read showed multple right sided rib fractures not concerning for malignant disease. Calcium and phoshorus levels were normal. Should receive outpatient workup including bone mineral density scan and possible PTH level. Medications on Admission: -spironolactone 100 mg daily -camphor-menthol 0.5-0.5 % Lotion QID PRN pruritis -lactulose 10 gram/15 mL ___ MLs PO TID -torsemide 40 mg daily -phytonadione 5 mg daily -vit D 1000u daily Discharge Medications: 1. spironolactone 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day). 3. phytonadione 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 5. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) Inhalation Q6H (every 6 hours) as needed for dyspnea, wheeze. 6. torsemide 20 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 7. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day): Please use if patient is bed bound/non ambulatory. Otherwise, can hold if exercising/walking. 8. Vitamin D 1,000 unit Tablet Sig: One (1) Tablet PO once a day. 9. Outpatient Lab Work Please get a complete metabolic panel drawn on ___ and fax results to PCP and hepatologist. Dr. ___ PCP phone number: ___ Hepatologist ___ MD/ ___ PA phone number: ___ Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS Recurrent pleural effusion Cirrhosis due to hepatitis C infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, . You were admitted to the hospital because you were having difficulty breathing. This is because you had an accumulation of fluid around your lung--called a pleural effusion. This was drained with a needle but will likely return due to your liver disease. We have increased the amount of water pills (aka "Diuretics") to try to keep this fluid away from the lungs. We have arranged for you to see ___, the physician ___ for Dr. ___, in the liver department to help you with your liver disease. . The following changes were made to your medications: Increased Torsemide dose to 40 mg two times a day. Albuterol as needed for wheezing. . It is very important that you keep all of the follow-up appointments listed below. It is also important that you weigh yourself everyday and call your doctor if your weight goes up more than 3 lbs. . It was a pleasure taking care of you in the hospital! Followup Instructions: ___
10757690-DS-18
10,757,690
27,649,555
DS
18
2146-05-31 00:00:00
2146-05-31 15:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: confusion Major Surgical or Invasive Procedure: thoracentesis (___) Dobhoff feeding tube placement (___) and advancement by endoscopy (___/??) History of Present Illness: Patient is a ___ w/HCV cirrhosis c/b esophageal varices and recurrent hydrothorax as well as ascites but no h/o SBP, not on transplant list who was sent in from ALF w/increased confusion. He was oriented to ___. He was feeling ___ last night per sister. He has had poor po intake. Pt reported slight epigastric pain earlier today was painfree on arrival. He reports an episode of vomiting at his ALF yesterday. He denied F/CP/SOB but has had anorexia and weight loss lately. Of note, patient was recently admitted in ___ with dyspnea due to a left sided transudative pleural effusion. This was drained, and torsemide dose was doubled. Pt's sister reports he is more confused than normal. . In the ED, initial VS: 97.9 100 110/60 16 97%, pt was abdominal pain-free, labs were significant for UA with 14 WBC and few bacteria, trace leuk esterace positive, as well as ammonia of 63, ___ with Cr of 1.6 over baseline of 0.9-1.0. Transaminases to 50's slightly above baseline. CXR demonstrated left pleural effusion. RUQ US was performed which demonstrated patent portal vasculature and no tappable pocket. Hepatology saw the patient in the ED and recommended treatment for UTI. He received ceftriaxone 1 gm iv x 1 ___s lactulose 10 ml x 1. VS on transfer were: : 98.8 110/64 88 16 96%RA. . Overnight, the patient had no complaints. He states that he feels back to his baseline and is not confused. Past Medical History: -- Hepatitis C Genotype 2, cirrhosis, decompensated ascites, varices, and edema -- BPH -- Hypertension -- Status post cholecystectomy -- Ataxia of unknown origin currently uses a wheelchair and a walker -- Right inguinal hernia s/p repair and now recurrent and inoperable per pt Social History: ___ Family History: uncle with cirrhosis (likely etoh) Physical Exam: ADMISSION PHYSICAL EXAM: VS - Temp 97.3 F, BP 101/57, HR 93, R 16, O2-sat 97% RA GENERAL - wasted, chronically ill appearing man in NAD, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae icteric, sl dry MM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/ND, minimally TTP in periumbilical area with, no rebound/guarding, no masses or HSM EXTREMITIES - 2+ pedal edema 2+ peripheral pulses (radials, DPs) NEURO - awake, A&Ox3, CNs II-XII intact, muscle strength ___ throughout, sensation grossly intact throughout. no asterixis . DISCHARGE PHYSICAL EXAM: VS: 97.6 88/48 95 20 99% RA GENERAL: chronically ill appearing man in NAD, comfortable, appropriate HEENT: NC/AT, PERRLA, EOMI, sclerae icteric, MMM, OP clear. Dobhoff in place. NECK: supple, no JVD LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART: RRR, no MRG, nl S1-S2 ABDOMEN: NABS, soft, non-tender, mild distension, no masses or HSM EXTREMITIES: trace pedal edema, 2+ peripheral pulses (DPs) NEURO: awake, A&Ox3, no asterixis Pertinent Results: Admission Labs: ___ 05:45PM BLOOD WBC-4.8 RBC-3.32* Hgb-11.9* Hct-34.7* MCV-104* MCH-35.9* MCHC-34.4 RDW-14.4 Plt Ct-92* ___ 05:45PM BLOOD Neuts-69.6 Lymphs-11.5* Monos-15.8* Eos-2.7 Baso-0.4 ___ 05:45PM BLOOD Glucose-106* UreaN-30* Creat-1.6* Na-134 K-4.7 Cl-99 HCO3-28 AnGap-12 ___ 05:45PM BLOOD ALT-59* AST-58* AlkPhos-72 TotBili-2.3* DirBili-0.9* IndBili-1.4 ___ 05:45PM BLOOD Albumin-2.6* ___ 05:45PM BLOOD Ammonia-63* ___ 05:45PM BLOOD Lipase-37 Interim Labs: ___ 06:08AM BLOOD VitB12-909* Folate-9.3 ___ 05:45AM BLOOD TSH-4.3* ___ 06:50AM BLOOD Free T4-1.3 ___ 11:05AM BLOOD HIV Ab-PND Urine: ___ 07:55PM URINE Color-Yellow Appear-Clear Sp ___ ___ 07:55PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-TR ___ 07:55PM URINE RBC-<1 WBC-14* Bacteri-FEW Yeast-NONE Epi-0 ___ 07:55PM URINE CastHy-37* ___ 07:55PM URINE Mucous-OCC ___ 07:55PM URINE Hours-RANDOM UreaN-451 Creat-86 Na-58 K-64 Cl-42 ___ 07:55PM URINE Osmolal-382 ___ 06:32PM URINE Eos-PND ___ 06:32PM URINE Hours-RANDOM UreaN-954 Creat-111 Na-10 K-GREATER TH Cl-LESS THAN Pleural fluid: ___ 04:45PM PLEURAL WBC-600* ___ Polys-6* Lymphs-77* ___ Meso-2* Macro-15* ___ 04:45PM PLEURAL TotProt-1.7 Glucose-137 LD(LDH)-83 Albumin-LESS THAN Cholest-24 Discharge Labs: ___ 06:05AM BLOOD WBC-3.0* RBC-2.69* Hgb-9.9* Hct-28.6* MCV-106* MCH-36.7* MCHC-34.5 RDW-14.7 Plt Ct-71* ___ 06:05AM BLOOD ___ PTT-36.6* ___ ___ 06:05AM BLOOD Glucose-94 UreaN-61* Creat-1.3* Na-133 K-4.8 Cl-100 HCO3-30 AnGap-8 ___ 06:05AM BLOOD ALT-70* AST-85* AlkPhos-78 TotBili-1.2 ___ 06:05AM BLOOD Calcium-8.8 Phos-3.4 Mg-2.5 Microbiology: ___ 7:55 pm URINE Site: CLEAN CATCH URINE CULTURE (Final ___: ENTEROCOCCUS SP.. >100,000 ORGANISMS/ML.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROCOCCUS SP. | AMPICILLIN------------ <=2 S NITROFURANTOIN-------- <=16 S TETRACYCLINE---------- =>16 R VANCOMYCIN------------ 1 S ___ CULTURE - NO GROWTH ___ CULTURE - NO GROWTH ___ 4:45 pm PLEURAL FLUID PLEURAL FLUID. GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE (Preliminary): NO GROWTH. ANAEROBIC CULTURE (Preliminary): NO GROWTH. ___ 2:30 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final ___: Feces negative for C.difficile toxin A & B by EIA. (Reference Range-Negative). Brief Hospital Course: ___ year old man with a history of HCV cirrhosis c/b esophageal varices and recurrent hydrothorax as well as ascites who presents with AMS in the setting of decreased po intake and likely UTI with improved MS after antibiotics and lactulose. . # AMS: The patient was altered at the time of admission. This was thought to be a combination of hepatic encephalopathy and infection. Urine culture consistent with UTI. Thoracentesis revealed transudate without sign of infection. Lactulose returned mental status to baseline within the first day of admission. . # UTI: The patient was initially treated with Cipro. Urine culture showed enterococcus sensitive to ampicillin. Antibiotic coverage was changed to Augmentin for a planned 7 day course (___). The patient denied urinary symptoms. . # ___: Baseline 1.0, elevated to 1.6 on admission. This was thought to be pre-renal due to poor PO intake. Diuretics were held and the patient was hydrated with good effect. His Cr did not return to baseline, however, and was at 1.3 the day of discharge. His diuretics were held on discharge to allow renal recovery. He was scheduled for an appointment in the Liver clinic two days following discharge to potentially restart his diuretics to avoid volume overload. . # Weight loss: Patient reported substantial weight loss over the last month, concerning for systemic cause (endocrine, malignancy) in addition to poor appetite. Last colonoscopy normal (per report). TSH was elevated but free T4 normal. A Dobhoff feeding tube was placed ___ and tube feeding initiated. HIV test pending on discharge. . # Shortness of breath: Pleural effusion drained ___ for over 1 L of fluid. Analysis consistent with transudate, no sign of infection, likely ___ ascites. Patient experienced shortness of breath after this procedure, but CXR showed no pneumothorax. The patient rapidly recovered and had no further oxygen requirement. His diuretics were held for renal impairment, but may be restarted by the outpatient clinic. . # Hyponatremia: Baseline ___, likely hypovolemic hyponatremia due to liver disease. Fluid restriction to 1.5L was effective to maintain sodium level. . # Hyperkalemia: K 5.6 ___, received 30g kayexelate with improvement to 4.8. . # Anemia: Hct 28.5, down from 34 on admission. No active bleeding, near baseline. Macrocytic, normal folate and B12. Resolved with treatment of UTI, no transfusion necessary. . # Cirrhosis: ___ HCV and EtOH. Lactulose was continued with good effect. . # CODE: Full (confirmed with pt) # CONTACT: Patient and sister . ___ Issues: - HIV test pending - Consider restarting diuretics later this week - 1 day Augmentin course remaining Medications on Admission: -spironolactone 100 mg BID -lactulose 30 gram TID -phytonadione 5 mg daily -docusate sodium 100 mg BID -albuterol sulfate neb q6h PRN dyspnea -torsemide 40 mg daily -Vitamin D 1,000 unit daily -heparin SC TID if not ambulatory -Zofran 4 mg po q6h prn nausea -Hydroxyzine 12.5 mg po TID prn pruritis Discharge Medications: 1. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO TID (3 times a day): titrate to ___ BMs/day . 2. phytonadione 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 4. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1) nebulizer Inhalation Q6H (every 6 hours) as needed for wheezing, sob. 5. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO once a day. 6. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) injection Injection TID (3 times a day): if not ambulatory. 7. Zofran 4 mg Tablet Sig: One (1) Tablet PO every six (6) hours as needed for nausea. 8. hydroxyzine HCl 25 mg Tablet Sig: 0.5 Tablet PO three times a day as needed for itching. 9. amoxicillin-pot clavulanate 875-125 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 1 days: through ___. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: primary: acute renal failure urinary tract infection pleural effusion malnutrition . secondary: cirrhosis complicated by ascites, varices, pleural effusion, and edema ataxia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: It was a pleasure taking care of you at ___ ___. You came to the hospital with confusion and shortness of breath. You were found to have a recurrence of your pleural effusion (fluid in the lung) and to have a urinary tract infection. You were treated with a thoracentesis, a procedure in which fluid is removed from the space around the lung. You received antibiotics for the infection. Your mental status rapidly improved to normal and your breathing improved. On admission, you noted that you had lost weight over the last month. A feeding tube was placed and was advanced with an endoscope. You were started on tube feeding to improve your nutrition. We made the following changes to your medications: - START augmentin for one more day (through ___ to complete treatment for a UTI). - STOP spironolactone, torsemide. Dr. ___ restart these at a later time. Please follow-up with your treating physicians as listed below. You will need labwork done on ___ at your appointment with Dr. ___. Followup Instructions: ___
10757917-DS-14
10,757,917
21,853,414
DS
14
2183-09-24 00:00:00
2183-11-13 04:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Ace Inhibitors / codeine Attending: ___. Chief Complaint: Elective Ileostomy Takedown Major Surgical or Invasive Procedure: ___ Ileostomy Takedown History of Present Illness: Ms. ___ is a ___ woman with locally advanced rectal cancer who underwent a robotic low anterior resection with diverting loop ileostomy ___ after neoadjuvant chemoradiation. Her postop course was uneventful. She came to the ___ ED today due to approximately ___ weeks of progressively worsening fatigue and lethargy. She reports sleeping more than is typical for her, including during the day. She denies any nausea, vomiting, or abdominal pain. She reports "normal" output from her ostomy, but is unable to quantify how much she has been emptying from her bag every day. She says she took a single dose of lomotil yesterday, but prior to that had taken no lomotil, psyllium, wafers, metamucil, or any other stool-bulking or anti-motility agents for at least ___ weeks. She says her urine color and quantity has been normal, and she denies any dysuria or hematuria. She passed the pouch study. Risks and benefits including, but not limited to, infection, bleeding, leak, need for more procedures, were discussed. Patient understood and agreed to the procedure. Past Medical History: Atrial Fibrillation Hyperlipidemia Hypertension Mild aortic stenosis Gout DM2 w/ diabetic neuropathy. Social History: ___ Family History: Myocardial infarction in both father and mother. She had colon cancer in her distant relatives. Physical Exam: GEN: Alert and oriented, no acute distress, conversant and interactive. HEENT: Sclerae anicteric, mucous membranes moist, oropharynx is clear. NECK: Trachea is midline, thyroid unremarkable, no palpable cervical lymphadenopathy, no visible JVD. CV: Regular rate and rhythm, no audible murmurs. PULM/CHEST: Clear to auscultation bilaterally, respirations are unlabored on room air. ABD: Soft, nondistended, nontender, no rebound or guarding, nontympanitic, no palpable masses, no hernias, well-healed incisions, ostomy is pink and patent with both stool and gas in bag. Ext: Mild bilateral lower extremity edema, distal extremities feel warm. On Discharge, Incision C/D/I without erythema, edema, or drainage Brief Hospital Course: The patient presented to ___ for elective ileostomy takedown. For full details of the procedure please see the separately dictated operative reports. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia, including extubation, was transferred to the floor. Her postoperative course was complicated by low blood pressure and low urine output . The patient's home medications were continued throughout this hospitalization. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atenolol 100 mg PO DAILY 2. Acetaminophen 650 mg PO Q6H:PRN Pain 3. Losartan Potassium 100 mg PO DAILY 4. LOPERamide 2 mg PO TID:PRN ostomy output is >1200cc/day 5. MetFORMIN XR (Glucophage XR) 1000 mg PO DAILY 6. Psyllium Wafer 1 WAF PO TID 7. Lancets,Thin (lancets) 28 gauge miscellaneous BID Use with glucometer 8. Rivaroxaban 20 mg PO DAILY 9. Rosuvastatin Calcium 20 mg PO QPM 10. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN Pain Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain 2. Atenolol 100 mg PO DAILY 3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*45 Tablet Refills:*0 4. Rivaroxaban 20 mg PO DAILY 5. GlipiZIDE 2.5 mg PO DAILY RX *glipizide 2.5 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*0 6. Lancets,Thin (lancets) 28 gauge miscellaneous BID Use with glucometer 7. Rosuvastatin Calcium 20 mg PO QPM Discharge Disposition: Home With Service Facility: ___ ___: Acute Renal Failure now s/p ileostomy takedown Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital after an ileostomy takedown. You have recovered from this procedure well and you are now ready to return home. You have tolerated a regular diet, passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. After anesthesia it is not uncommon for patient’s to have some decrease in bowel function but your should not have prolonged constipation. Some loose stool and passing of small amounts of dark, old appearing blood are expected however, if you notice that you are passing bright red blood with bowel your please seek medical attention. If you are passing loose stool without improvement please call the office or go to the emergency room if the symptoms are severe. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms does not improve call the office. It is also not uncommon after an ileostomy takedown to have frequent loose stools until you are taking more regular food however this should improve. The muscles of the sphincters have not been used in quite some time and you may experience urgency or small amounts of incontinence however this should improve. If you do not show improvement in these symptoms within ___ days please call the office for advice. Occasionally, patients will need to take a medication to slow their bowel movements as their bodies adjust to the new normal without an ileostomy, you should consult with our office for advice. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or constipation. You have a small wound where the old ileostomy once was. This should be covered with a dry sterile gauze dressing. The wound should continue to be packed with a gauze packing strip by the visiting nurses. ___ monitor the incision for signs and symptoms of infection including: increasing redness at the incision, opening of the incision, increased pain at the incision line, draining of white/green/yellow/foul smelling drainage, or if you develop a fever. Please call the office if you develop these symptoms or go to the emergency room if the symptoms are severe. You may shower, let the warm water run over the wound line and pat the area dry with a towel, do not rub. Please apply a new gauze dressing after showering. No heavy lifting for at least 6 weeks after surgery unless instructed otherwise by Dr. ___ Dr. ___. You may gradually increase your activity as tolerated but clear heavy exercise with Dr. ___ Dr. ___. You will be prescribed a small amount of the pain medication Oxycodone. Please take this medication exactly as prescribed. You may take Tylenol as recommended for pain. Please do not take more than 4000mg of Tylenol daily. Do not drink alcohol while taking narcotic pain medication or Tylenol. Please do not drive a car while taking narcotic pain medication. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Followup Instructions: ___
10758024-DS-12
10,758,024
24,707,558
DS
12
2166-10-10 00:00:00
2166-10-10 16:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: Hypotension Major Surgical or Invasive Procedure: None History of Present Illness: ___ ___ male w/ HTN, DM, CAD (s/p ___ CABG), carotid stenosis s/p ___ stroke, cognitive impairment, bipolar d/o, and urinary retention s/p recent indwelling Foley and E coli UTI, sent from ___ living with hypotension. The patient was recently admitted ___ for urinary retention that resolved with foley placement. He failed a voiding trial so he was discharged with a foley. He was supposed to have urology follow up but was hospitalized prior to this appointment. At that admission, he also had an elevated BNP and pulmonary vascular congestion thought likely due to renal failure. Patient was discharged with a Foley, but insisted on being switched to a straight cath. Patient was getting straight cathed 3 times a day at ___. On ___, he started to become hypotensive, delirious, and with pyuria. On ___, he had a fever to ___. Blood pressures were as low as 66/42. He had a urine culture on ___ that resulted ___ with E coli sensitive to cefepime so he was started on 2g IV cefepime (2 doses, last given ___ am). He was also given 2L NS. He had one fall ___ and one again on ___ if these were witnessed. He was confused with poor oral intake and on ___, he developed coffee ground emesis and bilious emesis x2. He complained of fatigue, thirst, and nausea. Due to concern for delirium and sepsis, he was sent to ___. In the ED, initial vitals: 98.5 ___ 16 95% RA Exam notable for: Alert and oriented ×2 Negative rush and fast exam Benign cardiopulmonary exam Benign abdomen No spinal tenderness Trauma survey negative Labs notable for: WBC 10.5, hgb 9.4, plt 211 INR 1.3 LFTs unremarkable BMP notable for Na 136, K 4.5, HCO3 23, BUN 46, Cr 1.9 CK 177, MB 1, trop 0.04 lactate 2.4 ___ UA with large leuks, negative nitrites, few bacteria, moderate blood, WBC 167, protein 100 Imaging: CT-Spine without contrast No acute fracture or traumatic malalignment. CT Head without contrast No acute intracranial process CXR Mild to moderate pulmonary edema, similar to prior study. Patient received: IV CefePIME 2 g IV LORazepam .5 mg IV Vancomycin 1000 mg IV Acetaminophen IV 1000 mg IV OLANZapine 5 mg IVF NS 3000 mL Patient had femoral central line placed. Vitals on transfer: ___ 19 96% RA Upon arrival to ___, the patient wants to wear clothes and move his arms. He denies chest pain, shortness of breath, abdominal pain, or diarrhea. REVIEW OF SYSTEMS: (+) Per HPI (-) Otherwise Past Medical History: CAD - CABG ___ Stroke - ___ (80-90s% stenosis R MCA CVA , treated TPA) Cognitive impairment - alzheimers/vascular ___ edema Urinary incontinence Visual impairment Cataracts (s/p lens replacement on R) Tremor DM2 cholecystectomy ___ history of cholangitis HL bipolar HTN constipation insomnia Social History: ___ Family History: None noted. Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: Reviewed in Metavision GENERAL: confused, agitated HEENT: Sclera anicteric, dry MM, oropharynx clear NECK: JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis, 2+ bilateral ___ edema SKIN: No rashes NEURO: intact strength on handgrip, able to move all 4 extremities, ACCESS: Right femoral line c/d/I DISCHARGE PHYSICAL EXAM GEN: elderly man in NAD HEENT: EOMI, sclerae anicteric, MMM, OP clear NECK: No LAD, no JVD CARDIAC: RRR, no M/R/G. +presacral edema PULM: normal effort, no accessory muscle use, LCAB GI: soft, NT, ND, NABS MSK: No visible joint effusions or deformities. DERM: No visible rash. No jaundice. NEURO: AAOx2 but repeats himself and is a tangential historian. No facial droop, moving all extremities. PSYCH: Full range of affect EXTREMITIES: WWP, no edema Pertinent Results: ADMISSION LABS: =============== ___ 12:13PM BLOOD WBC-10.5* (94% polys) RBC-3.10* Hgb-9.4* Hct-29.6* MCV-96 MCH-30.3 MCHC-31.8* RDW-15.6* RDWSD-53.6* Plt ___ ___ 12:13PM BLOOD ___ PTT-30.8 ___ ___ 12:13PM BLOOD Glucose-183* UreaN-46* Creat-1.9* Na-136 K-4.5 Cl-100 HCO3-23 AnGap-13 ___ 12:13PM BLOOD ALT-15 AST-24 CK(CPK)-177 AlkPhos-92 TotBili-1.3 ___ 12:13PM BLOOD CK-MB-1 ___ 12:13PM BLOOD cTropnT-0.04* ___ 12:13PM BLOOD Albumin-2.9* ___ 09:02PM BLOOD TIBC-190* VitB12-946* Folate-6 Ferritn-729* Iron 49 ___ 09:02PM BLOOD TSH-2.1 ___ 12:28PM BLOOD Lactate-2.4* DISCHARGE LABS: =============== ___ 09:30AM BLOOD WBC-9.0 RBC-2.94* Hgb-8.8* Hct-27.6* MCV-94 MCH-29.9 MCHC-31.9* RDW-16.3* RDWSD-56.1* Plt ___ ___ 09:30AM BLOOD Glucose-124* UreaN-18 Creat-1.1 Na-143 K-3.8 Cl-104 HCO3-28 AnGap-11 MICRO: =============== Blood culture ___: ESCHERICHIA COLI AMPICILLIN------------ 8 S AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ 2 S TRIMETHOPRIM/SULFA---- <=1 S Blood cultures ___: NEGATIVE IMAGING: =============== ___ CT Head without contrast 1. No acute intracranial process. 2. Chronic right basal ganglia infarct. ___: CT C spine without contrast 1. No acute fracture or traumatic malalignment. 2. Multilevel degenerative changes. ___: CXR Mild to moderate pulmonary edema, similar to prior study. Brief Hospital Course: ___ ___ male w/ HTN, DM, CAD (s/p ___ CABG), carotid stenosis s/p ___ stroke, cognitive impairment, bipolar d/o, and urinary retention s/p recent indwelling Foley and E coli UTI,, now admitted with gram-negative bacteremia and sepsis. #SEPSIS #URINARY TRACT INFECTION #E COLI BACTEREMIA #METABOLIC ENCEPHALOPATHY Blood culture from the ED grew E coli, resistant to fluoroquinolones. This matches the culture results on the urine from ___, so likely this is of a urinary source. He was septic on arrival with hypotension and confusion, but blood pressure responded to fluids and antibiotics. He was treated with cefepime, then converted to ceftriaxone based on final susceptibilities. He will complete a fourteen-day course of antibiotics via his midline. #URINARY RETENTION #PRESUMED BPH His tamsulosis was reduced from 0.8 mg to 0.4 mg due to orthostatic hypotension. He was started on finasteride. He is discharged with a Foley in place but is encouraged to go back to intermittent straight cath as he prefers (and if this can be accommodated by staff at the rehab). The patient has follow up with Urology booked and he should have a voiding trial at that time. #ACUTE KIDNEY INJURY Mix of pre-renal from sepsis/hypovolemia and probable obstructive ___ from ongoing retention. Improving after IVF and placement of foley in ED. Creatinine 1.1 on day of discharge. #SCROTAL PAIN Patient complained of acute pain in his scrotum. Large hydrocele limited exam, so obtained a scrotal ultrasound, which was fairly normal. Symptom seemed to be self-limited. #RECENT FALLS Patient had falls prior to arrival, presumably in setting of infection/hypotension, with orthostasis and delirium. Trauma series imaging negative on arrival. #COFFEE GROUND EMESIS Coffee-ground emesis was documented in ___ notes. Patient has stable HCT and is tolerating po intake. Will continue PPI and not investigate further. Continue iron supplementation #CAD/carotid stenosis: Right MCA ischemic stroke in ___. Continued on ASA. A statin should be considered, but this was deferred for now. #Bipolar He continues on his home Zyprexa 7.5mg daily. #Essential tremor and Hypertension On propranolol 10mg daily at home; this is a small enough dose that it likely is not really helping. Have stopped this medication. ___ edema: Restart home furosemide 20 mg daily at discharge. He has mild edema from IV fluids for sepsis. #DM Continue home metformin. #insomnia: Switched trazodone to ramelteon, as trazodone seemed to cause some delirium. #vitamin D deficiency: Continue vitamin D 1000 U daily PO #Code: full code per MOLST #HCP: granddaughter ___ ___ TRANSITIONAL ISSUES: =================== [ ] 11 more days of CTX for UTI and bacteremia (his E coli is resistant to Cipro and Levaquin). [ ] voiding trial at his urology follow up (or earlier if desired, although note that he was started on finasteride on ___, and is being treated for UTI, so he is unlikely to succeed for a week or two). [ ] suggest starting statin given CAD and history of stroke. This was deferred on the assumption that it may have been tried before. Family were unsure. [ ] consider elective EGD for reported coffee-ground emesis prior to arrival, as true UGI bleeding in this age group could be a sign of upper GI malignancy Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO QID:PRN GI distress 3. Aspirin 81 mg PO DAILY 4. Bengay Cream 1 Appl TP BID:PRN neck pain 5. Bisacodyl 10 mg PO DAILY 6. Bisacodyl 10 mg PR QHS:PRN constipation 7. Propranolol 10 mg PO DAILY 8. Senna 17.2 mg PO BID 9. Tamsulosin 0.8 mg PO QHS 10. TraZODone 25 mg PO BID:PRN anxiety 11. TraZODone 25 mg PO QHS 12. Ciprofloxacin 0.3% Ophth Soln ___ DROP LEFT EYE 5X/D 13. Vitamin D 1000 UNIT PO DAILY 14. MetFORMIN (Glucophage) 500 mg PO BID 15. Furosemide 20 mg PO DAILY 16. Polyethylene Glycol 17 g PO TID:PRN constipation 17. Lactulose 30 mL PO QPM 18. cyanocobalamin (vitamin B-12) 1,000 mcg/mL injection q2months 19. Ferrous GLUCONATE 324 mg PO Q2DAYS 20. Ascorbic Acid ___ mg PO DAILY 21. OLANZapine 7.5 mg PO DAILY Discharge Medications: 1. CefTRIAXone 2 gm IV Q 24H Duration: 11 Days 2. Finasteride 5 mg PO DAILY 3. Ramelteon 8 mg PO QHS 4. Senna 8.6 mg PO BID:PRN Constipation 5. Tamsulosin 0.4 mg PO QHS 6. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 7. Aluminum-Magnesium Hydrox.-Simethicone 30 mL PO QID:PRN GI distress 8. Aspirin 81 mg PO DAILY 9. Bengay Cream 1 Appl TP BID:PRN neck pain 10. Bisacodyl 10 mg PR QHS:PRN constipation 11. cyanocobalamin (vitamin B-12) 1,000 mcg/mL injection q2months 12. Ferrous GLUCONATE 324 mg PO Q2DAYS 13. Furosemide 20 mg PO DAILY 14. Lactulose 30 mL PO QPM 15. MetFORMIN (Glucophage) 500 mg PO BID 16. OLANZapine 7.5 mg PO DAILY 17. Polyethylene Glycol 17 g PO TID:PRN constipation 18. TraZODone 25 mg PO BID:PRN anxiety 19. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Sepsis due to E coli UTI Bacteremia Metabolic encephalopathy Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: You were admitted to the hospital with a UTI where the bacteria (E coli) spread to your bloodstream. You will need two weeks of IV antibiotics for this serious infection. Your low blood pressure and your confusion were due to sepsis in the setting of your infection; both have improved with antibiotic treatment. Followup Instructions: ___
10758024-DS-14
10,758,024
28,955,647
DS
14
2167-12-29 00:00:00
2168-01-01 17:28:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Penicillins Attending: ___. Chief Complaint: Nausea, vomiting, constipation Major Surgical or Invasive Procedure: ___: Sigmoidoscopy, colonic stent placement ___: 1. Laparoscopic loop sigmoid colostomy. 2. Flexible sigmoidoscopy with aborted stent retrieval. History of Present Illness: Mr. ___ is a ___ y/o M w/ HTN, DM, CAD (s/p ___ CABG), carotid stenosis s/p ___ stroke, cognitive impairment, bipolar d/o, invasive urologic mass, and urinary retention ___ BPH, presenting now for N/V and constipation, found to have a large bowel obstruction. Unfortunately, most of the history is obtained from report as patient is a poor historian, and further history could not be collaborated. Per report, patient developed multiple episodes of nausea and vomiting, as well as noted a prolonged course without having a bowel movement. He also had significant abdominal pain, prompted the assisted living facility he resides at to call EMS. In the ED, vital signs were stable. He had a guaiac positive stool on rectal exam. In the setting of prolonged QTc, Ativan was given for Ativan. A CT abd/pelvis w/ contrast was obtained, which showed redemonstration of invasive ill-defined mass, however now with worsening invasion into the rectal/anal area, resulting in a large bowel obstruction and diffuse dilation of the colon. ACS differed management given the mass originates from a urologic origin. Urology was also consulted, but also differed to ACS for management of bowel obstruction. Thus, patient was admitted to medicine for further management of bowel obstruction. ED course was also complicated by mild hyperkalemia to 5.9 for which patient received insulin/dextrose and calcium, with appropriate improvement. On arrival to the floor, patient is fairly somnolent and soft spoken, but states that overall he feels much better. His N/V has resolved, and his abdominal pain, though still present, is better. He denies passing any gas. He is unable to provide me with further history about what led him to being admitted. REVIEW OF SYSTEMS: ================== Per HPI, otherwise, 10-point review of systems was within normal limits. Past Medical History: CAD - CABG Stroke - ___ (80-90s% stenosis R MCA CVA , treated TPA) Cognitive impairment - alzheimers/vascular ___ edema Urinary incontinence Visual impairment Cataracts (s/p lens replacement on R) Tremor DM2 cholecystectomy ___ history of cholangitis HL bipolar HTN constipation insomnia ***Urologic mass of unclear etiology: Was first noted in ___, with evidence of invasion into and around the prostate/bladder. Per report, at that time patient was referred to a urologist at an outside institution, where after discussion with the physician and his family, he differed further management/evaluation, and has only been monitored since. Social History: ___ Family History: Reviewed and non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VITALS: Reviewed in OMR GENERAL: Somnolent, but in no acute distress HEENT: Mucus membranes dry. Soft spoken. CARDIAC: RRR, no murmurs, rubs, or gallops LUNGS: CTAB ABDOMEN: Soft, but distended. Mildly tender to palpation in all quadrants. Ventral hernia present. EXTREMITIES: No clubbing, cyanosis, or edema. NEUROLOGIC: Difficult to ascertain as translator was having difficulty hearing patient, and he was often repeating the same statements over and over again. Discharge Physical Exam: VS: T: 97.7 PO BP: 174/80 R Sitting HR: 78 RR: 16 O2: 97% Ra GEN: A+Ox3, NAD HEENT: atraumatic CV: RRR PULM: CTA b/l ABD: soft, non-distended, non-tender to palpation. Lap sites with no s/s infection. Colostomy with flatus and stool in bag. EXT: no edema b/l Pertinent Results: IMAGING: ___: CT Chest: Multiple pulmonary nodules bilaterally measuring up to 1.3 cm, concerning for metastatic disease. ___: CT Head: 1. No acute intracranial process. 2. No intracranial masses, within the limitations of noncontrast CT. ___: KUB: 1. Mild fecal loading in the ascending colon. Visualized air-filled loops of large bowel appear improved from CT scan dated ___. 2. No free air. ___: CXR: Interval mild worsening of pulmonary edema and dependent atelectasis within the lung bases, however aspiration pneumonia cannot be excluded. Recommend following with serial chest x-rays. ___: KUB: 1. Nonspecific bowel gas pattern. No evidence of obstruction. 2. Rectal stent in unchanged position from prior radiograph dated ___. ___: Right knee x-ray: Moderate degenerative changes with evidence of tricompartmental narrowing and chondrocalcinosis. Small joint effusion. Extensive vascular calcifications. No discrete lytic or sclerotic lesions concerning for metastasis. Multiple surgical clips in the soft tissues of the lower leg. Bone mineralization is preserved. LABS: ___ 05:41PM K+-3.8 ___ 01:09PM LACTATE-1.6 K+-5.9* ___ 12:50PM GLUCOSE-127* UREA N-39* CREAT-1.7* SODIUM-133* POTASSIUM-8.0* CHLORIDE-101 TOTAL CO2-19* ANION GAP-13 ___ 12:50PM ALT(SGPT)-17 AST(SGOT)-70* ALK PHOS-101 TOT BILI-0.6 ___ 12:50PM LIPASE-19 ___ 12:50PM ALBUMIN-3.5 CALCIUM-9.0 PHOSPHATE-4.1 MAGNESIUM-2.0 ___ 12:50PM WBC-8.3 RBC-3.56* HGB-10.4* HCT-33.3* MCV-94 MCH-29.2 MCHC-31.2* RDW-15.3 RDWSD-52.5* ___ 12:50PM NEUTS-77.1* LYMPHS-15.1* MONOS-6.3 EOS-0.7* BASOS-0.4 IM ___ AbsNeut-6.39* AbsLymp-1.25 AbsMono-0.52 AbsEos-0.06 AbsBaso-0.03 ___ 12:50PM PLT COUNT-254 ___ 12:50PM ___ PTT-30.7 ___ Brief Hospital Course: BRIEF HOSPITAL COURSE: ====================== Mr. ___ is a ___ year old man w/ PMHx HTN, DM, CAD (s/p ___ CABG), carotid stenosis s/p ___ stroke, cognitive impairment, bipolar d/o, invasive urologic mass (likely prostate cancer), and urinary retention, who initially presented with large bowel obstruction ___ mass effect from likely prostate cancer. Conservative management of obstruction was attempted with rectal tube and then colonic stenting, both unsuccessfuly. He ultimately underwent diverting colostomy for definitive management on ___. This procedure went well (reader, please refer to operative report for further details). While admitted he was also treated for infection/sepsis with a 7 day course of broad spectrum antibiotics. Infectious source somewhat unclear but was likely either pulmonary or urinary. The antibiotics were discontinued as they were no longer needed. Post-operatively, discussion was had with Gastroenterology regarding attempting removal of the stent. The decision was made to leave the stent in place given the fact that it had most likely already epithelialized and removal would likely require an operation which would not be beneficial to the patient. The patient had return of bowel function via the ostomy and he was started on a regular diet which he tolerated. Pain was well-controlled with acetaminophen. The malecot drain was removed from the ostomy prior to discharge. ACUTE/ACTIVE ISSUES: ==================== #. Large Bowel Obstruction Felt to be related to mass effect from likely prostate cancer, see below). Failed trial of rectal tube, rectal stent w/ GI. After family meetings pt underwent plan for diverting colostomy. Also started on bicalutamide, as below, for palliative pharmacologic treatment of mass. The stent migrated a few centimeters proximal to the desirable place, and after weighing risk and benefits for its removal, the decision to leave it there was made. # Invasive Urologic Mass # Likely Metastatic Prostate Cancer Per report, patient is followed by urology outpatient, and has differed work-up for mass previously. Suspect this mass likely represents prostate cancer, especially w/ highly elevated PSA. CT revealing likely mets to lung. Heme/Onc was consulted for palliatve therapy and recommended bicalutamide to shrink mass. #Sepsis #Likely Pneumonia vs UTI Admission CXR w/ concern for pneumonia. Patient started on levofloxacin which was switched to doxycycline in the setting of long QTc. Patient was again febrile on ___ after transition to doxy w/ concurrent hypotension raising concern for sepsis. However, notably patient was without leukocytosis and BPs improved prior to fluid resuscitation or broadening of abx. Meropenem was started and then discontinued as it was no longer needed. #Dysphagia: #Malnutiriton SLP was consulted for assistance w/ palliative diet that reduces aspiration risk. CHRONIC/STABLE ISSUES: ====================== #T2DM Provided sliding scale insulin with humalog #H/o Stroke #CAD s/p CABG Continued home ASA 81mg #Urinary Retention Chronic, likely related to known urologic mass (likely prostate cancer). Foley catheter continued. Continued home Finasteride. Bicalutamide was started as above. #Normocytic Hypochromic Anemia Chronic and stable with previous lab values. Suspect likely secondary to mass and inflammation. #Chronic Kidney Disease Renal function at baseline for patient. #Rash: Erythematous rash noted on patient's chest on admission. Felt to possibly represent drug allergy from cephalosporin administration. Received one dose of prednisone and symptoms were treated with saran lotion. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Aspirin 81 mg PO DAILY 3. cyanocobalamin (vitamin B-12) 1,000 mcg/mL injection q2months 4. Finasteride 5 mg PO DAILY 5. Ondansetron 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 6. Polyethylene Glycol 17 g PO TID:PRN constipation 7. Ramelteon 8 mg PO QHS 8. Senna 8.6 mg PO BID:PRN Constipation 9. TraZODone 50 mg PO BID:PRN anxiety 10. Vitamin D 1000 UNIT PO DAILY 11. TraMADol 25 mg PO Q8H:PRN Pain - Moderate 12. Bisacodyl 10 mg PO DAILY:PRN Constipation - Second Line 13. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 14. Lidocaine 5% Patch 1 PTCH TD QPM 15. Ferrous Sulfate 325 mg PO Q2DAYS Discharge Medications: 1. bicalutamide 50 mg oral DAILY 2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 3. Aspirin 81 mg PO DAILY 4. Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line 5. Bisacodyl 10 mg PO DAILY:PRN Constipation - Second Line 6. cyanocobalamin (vitamin B-12) 1,000 mcg/mL injection q2months 7. Ferrous Sulfate 325 mg PO Q2DAYS 8. Finasteride 5 mg PO DAILY 9. Lidocaine 5% Patch 1 PTCH TD QPM 10. Ondansetron 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 11. Polyethylene Glycol 17 g PO TID:PRN constipation 12. Ramelteon 8 mg PO QHS Should be given 30 minutes before bedtime 13. Senna 8.6 mg PO BID:PRN Constipation 14. TraMADol 25 mg PO Q8H:PRN Pain - Moderate 15. TraZODone 50 mg PO BID:PRN anxiety 16. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary: Partial large bowel obstruction. Secondary: Large pelvic mass involving the bladder, prostate and rectum with extension into right ureter. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid. Discharge Instructions: Dear Mr. ___, You were admitted to ___ for evaluation following your bowel obstruction and underwent a colonic stent placement on ___ followed by a laparoscopic diverting loop sigmoid colostomy on ___. The colonic stent migrated upwards, and it will be left in place as the benefit of leaving the stent outweighs the risk of surgically removing the stent. You are recovering well and are now ready for discharge. Please follow the instructions below to continue your recovery: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Monitoring Ostomy output/ Prevention of Dehydration: *Keep well hydrated. *Replace fluid loss from ostomy daily. *Avoid only drinking plain water. Include Gatorade and/or other vitamin drinks to replace fluid. *Try to maintain ostomy output between 1000mL to 1500mL per day. *If Ostomy output >1 liter, take 4mg of Imodium, repeat 2mg with each episode of loose stool. Do not exceed 16mg/24 hours. Followup Instructions: ___
10758241-DS-6
10,758,241
29,964,421
DS
6
2130-09-08 00:00:00
2130-09-08 15:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: S/p fall Major Surgical or Invasive Procedure: ___: Right burr hole for ___ evacuation History of Present Illness: ___ is a ___ male who presents to ___ on ___ with a mild TBI. Patient states that he fell yesterday and hit his head on the nightstand, this was witnessed by his daughter. His other daughter and son in law are at the bedside, and state that over the past couple of months he has had a decline in his mental status, including confusion, dizziness and new difficulty with balance and gait. He takes care of his dying wife at home, and over the past two months has had difficulty with his memory and organizing her daily medications. His daughter brought him to his PCP today, that ordered a MRI brain. This showed a right sided subdural hematoma with midline shift. He was sent to ___ for further neurosurgical evaluation. Past Medical History: Glaucoma Bilateral hip replacements - ___ years ago Bilateral cataract removal Social History: ___ Family History: Non-contributory Physical Exam: ON ADMISSION: ___ ============ Physical Exam: O: T: 97.7 BP: 137/95 HR: 77 RR: 17 O2 Sat: 99% on RA GCS at the scene: unknown GCS upon Neurosurgery Evaluation: 15 Time of evaluation: 1515 Airway: [ ]Intubated [x]Not intubated Eye Opening: [ ]1 Does not open eyes [ ]2 Opens eyes to painful stimuli [ ]3 Opens eyes to voice [x]4 Opens eyes spontaneously Verbal: [ ]1 Makes no sounds [ ]2 Incomprehensible sounds [ ]3 Inappropriate words [ ]4 Confused, disoriented [x]5 Oriented Motor: [ ]1 No movement [ ]2 Extension to painful stimuli (decerebrate response) [ ]3 Abnormal flexion to painful stimuli (decorticate response) [ ___ Flexion/ withdrawal to painful stimuli [ ]5 Localizes to painful stimuli [x]6 Obeys commands Exam: Gen: WD/WN, comfortable, NAD. HEENT: 3-2mm bilaterally - oblong d/t bilateral cataract removal Wearing glasses Extrem: warm and well perfused Neuro: Mental Status: Awake, alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech is fluent with good comprehension. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 3mm to 2mm bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue with slight left deviation Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Left downward drift without pronation LUE 4+/5 RUE ___ BLE ___ Sensation: Intact to light touch ------------ ON DISCHARGE ============ Exam: Opens eyes: [x]spontaneous [ ]to voice [ ]to noxious Orientation: [x]Person [x]Place [x]Time Follows commands: [ ]Simple [x]Complex [ ]None Pupils: PERRL EOMs: [x]Full [ ]Restricted Face Symmetric: [x]Yes [ ]No Pronator Drift: [ ]Yes [x]No Speech Fluent: [x]Yes [ ]No Comprehension Intact: [x]Yes [ ]No Motor: TrapDeltoidBicepTricepGrip IPQuadHamATEHLGast [x]Sensation intact to light touch in all four extremities. Wound: [x]Clean, dry, intact Pertinent Results: See OMR for pertinent imaging & labs Brief Hospital Course: #Right Subdural Hematoma On ___, Mr. ___ presented to the ED per his PCP after mRI revealed a right sided mixed density SDH. HE was admitted to ___ for pre-op planning where he remained neurologically stable. Patient was started on Keppra 500mg BID for a total of 7 days post admission for his traumatic SDH. On ___, the patient went to the OR for right sided burr holes for evacuation of SDH. Please see dedicated operative note for further detail. OR was uncomplicated. Postoperatively, the patient recovered from anesthesia in the PACU. He was transferred back to the NIMU on POD 0. NCHCT was obtained on POD 1 that showed improvement in midline shift and reduction of SDH. Subdural JP drain was left in place intraoperatively which was removed on POD2. Patient was transferred to the floor on ___ where he continued to be monitored frequently. Patient remained neurologically intact, intermittent headaches treated with PRN analgesics. Patient initially with a decrease in H&H, however this was monitored closely, remained stable and continued to increase to WNL. Patient also developed bilateral eye irritation and was ordered for artificial tears daily which helped improve his eye irritation. Patient was resumed on his daily, home dose aspirin on ___. Staples from burr hole incisions were removed on ___. Patient continued to do well on ___. Was ambulating, tolerating a diet and remained neurologically intact and was cleared for discharge to a SNF on ___. #Afib The patient was noted to be in afib, rate controlled since he went to the operating room on ___. On ___, a medicine consult was obtained who recommended he follow-up with his PCP to discus the risks and benefits of starting anticoagulation in the setting of an intracranial hemorrhage. On ___ Medicine recommended Patient is not a candidate for anticoagulation in the short-term given SDH and does not appear to be a good candidate for long-term anticoagulation given history of severe falls. His HR remained controlled throughout his hospitalization. He will follow-up with his PCP upon discharge to further discuss. #Disposition Physical and occupational therapy evaluated patient on ___ AM and recommended discharge to ___ rehab. Patient was discharged on ___. Medications on Admission: Atorvastatin 20mg QHS, Timolol 0.5% gtt - 1 drop both eyes daily, Calcium, ASA 81mg daily (last taken ___ Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever Do not take more than 4 grams per day. 2. Artificial Tears ___ DROP BOTH EYES Q4H:PRN dry eye/irritation 3. Bisacodyl 10 mg PO/PR DAILY 4. Docusate Sodium 100 mg PO BID 5. Milk of Magnesia 30 mL PO Q6H:PRN Constipation - First Line 6. Polyethylene Glycol 17 g PO DAILY 7. Senna 8.6 mg PO BID 8. Aspirin 81 mg PO DAILY 9. Atorvastatin 20 mg PO QPM 10. Timolol Maleate 0.5% 1 DROP BOTH EYES BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Subdural hematoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Discharge Instructions Brain Hemorrhage with Surgery Surgery • You underwent a surgery called a burr hole evacuation to have blood removed from your brain. • The staples in your incision were removed while you were inpatient. • It is best to keep your incision open to air but it is ok to cover it when outside. • Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity • We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. • You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. • No driving while taking any narcotic or sedating medication. • If you experienced a seizure while admitted, you are NOT allowed to drive by law. • No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications • Please do NOT take any blood thinning medication (Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. • You have been restarted on your daily Aspirin. - You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: • You may have difficulty paying attention, concentrating, and remembering new information. • Emotional and/or behavioral difficulties are common. • Feeling more tired, restlessness, irritability, and mood swings are also common. •You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. •You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. •Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. Headaches: •Headache is one of the most common symptoms after a brain bleed. •Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache. •Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor. •There are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/ meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for: •Severe pain, swelling, redness or drainage from the incision site. •Fever greater than 101.5 degrees Fahrenheit •Nausea and/or vomiting •Extreme sleepiness and not being able to stay awake •Severe headaches not relieved by pain relievers •Seizures •Any new problems with your vision or ability to speak •Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: •Sudden numbness or weakness in the face, arm, or leg •Sudden confusion or trouble speaking or understanding •Sudden trouble walking, dizziness, or loss of balance or coordination •Sudden severe headaches with no known reason Followup Instructions: ___
10758378-DS-6
10,758,378
26,107,082
DS
6
2142-08-16 00:00:00
2142-08-16 17:07:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: Penicillins Attending: ___. Chief Complaint: epilepsy with increased seizure frequency Major Surgical or Invasive Procedure: none History of Present Illness: ___ year old right handed woman with a seizure disoder who presents after having 2 seizures this morning. She reports that since her discharge on ___ she had 1 seizure 2 weeks ago on a ___, and then 2 this morning. The seizure 2 weeks ago was slightly different in that she had an "aura," which she describes as foggy thinking and feeling "not right" prior to the start of the convulsions, which were witnessed by her roommate. This morning she awoke around 6:30am, was still in her bed, when she again had a similar aura, followed by a pulling of her head to the left with left hemibody tingling. She was still aware of what was going on, but unable to speak. She had called out to her roommate, who came in to look over her during this. After about 20 minutes her roommate tried to give her a glass of water, but the patient was unable to swallow it correctly and it dribbled all over her front. As she was beginning to have a typical headache and tiredness that follows her seizures, she went back to sleep. Around 9am she had a second seizure, this time generallized convulsions with no preceeding symptoms that her roommate witnessed. This lasted only a few seconds to minutes, after which she had a headache and was sleepy. She tried to call Dr. ___ was unable to reach him. She then called her PCP who reached Dr. ___ asked her to come in to the ED. She reports that she increased her Lamictal to 50mg BID per Dr. ___ yesterday. She continues on Depakote 750mg BID and had a level drawn yesterday, indicating a level near 100. She takes Xanax occasionally for anxiety, none in the past 3 days. She reports no recent infectious symptoms or head trauma. She reports her sleep has been improved recently, currently getting ___ hours per night. No clear new sources of stress in her life, she did return to work last ___, but does not consider this stressful. She reports that her mood has been euthymic recently with no thoughts of hurting herself. In regard to her seizure history, her first event was ___ when she had a seizure vs choking spell on the couch. She then had a similar event that night from sleep. After having her lamotrigine (for mood) was weaned in ___, she had a third event/seizure in her kitchen ___. After this event she went to ___, where she had a normal work up including MRI brain, EEG, LP. She had an event during this stay that was labeled as "nonepileptic" as well. She was admitted here ___ for EEG monitoring and Keppra wean as Keppra had worsened her mood/suicideal ideation. At that time she was started back on Depakote and Lamictal, currently on a very slow uptitration of the Lamictal. She was on LTM EEG during this admission, which showed mostly generalized, frontally predominant 13 Hz spikes and generalized, frontally predominant rhythmic ___ Hz spike or polyspike and wave discharges occasionally with a left hemisphere predominance. It was suspected from the EEG recordings that she has either a primary generalized epilepsy or less likely, partial complex epilepsy with a frontal focus with rapid spread. As of the possible etiology of her seizure disorder, she does reports that she had staring spells and was a daydreamer in school. She reports she feels that she still has staring spells. Despite this she did well in school. She also has a history of head trauma during a car accident in childhood, as well as hitting her head this past ___ when she slipped on black ice. She has not had any CNS infections. Her mother had seizures ___ years ago controlled on Depakene and has some "lesion in the brain." She did well in school and had no developmental delay. She denies early morning jerks, sudden episodes of fear, strange smells, rising sensations, ___. On neuro ROS, the pt reports headache, typical of her post-seizure headaches. She denies loss of vision, blurred vision, diplopia, dysphagia, lightheadedness, vertigo, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. Denies focal weakness, numbness, parasthesiae. Denies difficulty with gait. . On general review of systems, the pt denies recent fever or chills. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies vomiting, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: -IBS -Seizure disorder - per HPI -C section at ___ years of age -tonsilectomy in ___ -cyst removal in ___ Social History: ___ Family History: Mother with seizure disorder, seizure free x ___ years. No other seizure/neurologic history in the family Physical Exam: Vitals: T:97 P:88 R:18 BP: 115/83 SaO2:99% RA General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions or tongue lacs in oropharynx Neck: Supple. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted Abdomen: soft, NT/ND, no masses or organomegaly noted. Extremities:warm and well perfused Skin: no rashes or lesions noted. . Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Speech was not dysarthric. Able to follow both midline and appendicular commands. The pt. had good knowledge of current events. There was no evidence of apraxia or neglect. Calculation was intact. -Cranial Nerves: I: Olfaction not tested. II: PERRL, 5mm to 4mm bilaterall. VFF to confrontation. Fundoscopic exam shows sharp optic discs with venous pulsations. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. . -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements. No asterixis. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 5 . -Sensory: No deficits to light touch, cold, vibration, proprioception throughout. . -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 2 R 2 2 2 2 2 Plantar response was flexor bilaterally. . -Coordination: No dysmetria on FNF or HKS bilaterally. . -Gait: Good initiation. Narrow-based, normal stride and arm swing. Able to walk on toes, heels, and in tandem with only a little unsteadiness. Pertinent Results: BASIC BLOOD WORK ___ 06:00AM BLOOD WBC-9.1 RBC-4.21 Hgb-14.1 Hct-39.7 MCV-94 MCH-33.4* MCHC-35.5* RDW-12.7 Plt ___ ___ 02:15PM BLOOD Neuts-68.4 ___ Monos-6.3 Eos-2.4 Baso-0.6 ___ 12:45PM BLOOD Glucose-99 UreaN-9 Creat-0.7 Na-138 K-4.3 Cl-101 HCO3-26 AnGap-15 ___ 12:45PM BLOOD Calcium-9.3 Phos-3.3 Mg-1.9 ___ 02:15PM BLOOD ALT-14 AST-22 AlkPhos-57 TotBili-0.2 LAMICTAL LEVEL LAMOTRIGINE 3.5 L 4.0-18.0 mcg/mL URINE TOX & URINALYSIS ___ 02:15PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 02:15PM URINE Color-Yellow Appear-Clear Sp ___ ___ 02:15PM URINE Blood-MOD Nitrite-NEG Protein-TR Glucose-NEG Ketone-10 Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-SM ___ 02:15PM URINE RBC-44* WBC-3 Bacteri-FEW Yeast-NONE Epi-1 ___ 02:15PM URINE UCG-NEGATIVE ___ 02:15PM URINE bnzodzp-POS barbitr-POS opiates-NEG cocaine-NEG amphetm-NEG mthdone-NEG PRELIMINAR MRI (___): There is slight asymmetry of the occipital horns, left greater than right, but within normal physiologic limits. There is no shift of normally midline structures. The ventricles and sulci are otherwise normal in size. The gray-white matter differentiation is preserved. There is no acute infarct or hemorrhage. Major vascular flow voids are present. There is slight asymmetry of the occipital horns, left greater than right, but within normal physiologic limits. There is no shift of normally midline structures. The ventricles and sulci are otherwise normal in size. The gray-white matter differentiation is preserved. There is no acute infarct or hemorrhage. Major vascular flow voids are present. The hippocampal formation and signal intensity are normal and symmetric. There is no evidence of mesial temporal sclerosis. There is an incidental 1.1 x 1.0 x 1.3 cm pineal gland cyst, without suspicious post-contrast enhancement. There is no abnormal post-contrast enhancement. The visualized paranasal sinuses and mastoid air cells are clear. The globes are symmetric and normal. IMPRESSION: 1. No acute intracranial process. No acute infarct, hemorrhage, or abnormal post-contrast enhancement. 2. No evidence of cortical malformation and gray matter heterotopia. No evidence of mesial temporal sclerosis. 3. Incidental finding of a 1.2 cm pineal gland cyst. In the absence of prior studies, consider long-term follow-up to establish stability if clinically indicated. ROUTINE EEG (___): read pending; per Dr. ___ is fine. Brief Hospital Course: Ms. ___ is a ___ RH woman with seizure d/o previously thought to be generalized based on prior seizure semiology (GTCs) and EEG (generalized ___ Spikes on interictal EEG) who presented with increased seizure frequency (3 since last discharge, two of which occurred on day of admission). Two of these events were described as being concerning for partial onset seizures, as they started with left head turning and left sensory symptoms. Her exam on admisison was notable for clumsiness of the left hand on RAM and FNF as well as mild weakness of the L triceps and IP. Given this, we were concerned both that there was actually a focal source of her epilepsy that had not been picked up on prior MRI. We were also concerned that even though she is currently uptitrating on Lamictal with a VPA bridge (and reportedly had a VPA level of 100 earlier this week), she was not well covered so started an Ativan bridge and additionally initiated Lacosamide 50mg BID (with plans to increase as an outpatient). We initially planned to monitor for 24 hours and then plan for MRI as an outpatient. Unfortunately, the patient was found confused and seeming post-ictal on hospital day 2 after starting Ativan and Lacosamide. Therefore, we increased Lacosamide more quickly (to 100mg BID) and got a routine EEG to look for obvious focality. This EEG was normal per preliminary report. While she was here, we obtained an MRI with epilepsy protocol which did not show any concerning findings. She did not have any further events concerning for seizures, so she was discharged with an Ativan bridge for ___s a plan to increase Lacosamide to a goal of 200mg BID over 6 days (by ___. She will follow-up with her outpatient neurologist, Dr. ___ in the next few weeks. In addition, while here, ___ had significant headaches which improved with Fioricet and IVF. At discharge, she did not have headache. Medications on Admission: -Fiorcet PRN for headache -Lamictal 50 mg BID (increased yesterday) -Depakote 750mg BID -Fluoxetine 60 mg daily -Magnesium oxide 400 mg BID -Xanax 0.5 mg tabs 1.5 tablets q 4 hours Discharge Medications: 1. Divalproex (DELayed Release) 750 mg PO BID 2. Fluoxetine 60 mg PO DAILY 3. LaMOTrigine 50 mg PO BID 4. LACOSamide 200 mg PO BID ___: 100mg BID ___: 150mg BID ___: 200mg BID RX *lacosamide [Vimpat] 100 mg see instructions tablet(s) by mouth twice a day Disp #*120 Tablet Refills:*1 5. Lorazepam 0.5 mg PO QID ___: 0.5mg q6hr ___: 0.5mg q8hr ___: 0.5mg BID ___: 0.5mg QD then stop. RX *lorazepam 0.5 mg see instructionse n by mouth see instructions Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Seizures Discharge Condition: 98, 101/64, HR 64, RR 18, 100%RA Gen: NAD HEENT: MMM, anicteric CV: RRR, no murmurs Resp: CTAB GI: +BS, soft, NTND Ext: WWP Neuro MS: Awake, alert, appropriate attention and memory, speech fluent CN: PERRL, EOMI, no nystagmus, face symmetric Motor: normal bulk and tone; strength ___ bilaterally ___: intact to light touch, vibration, proprioception distally Coord: dysmetria on FNF, with slower more clumsy movements on the left Gait: narrow based and stable Discharge Instructions: Dear Ms. ___, You were admitted to the neurology service for a cluster of seizures and then had an additional seizure while you were here. We decided to add a third medication called Vimpat to protect you against seizures while your Lamictal dose is being increased. You will take Vimpat 100 mg (two pills) twice a day for two more days ___ & ___ and then increase to 150mg (3pills) for three days (___) and then increase to 200mg (4 pills) twice a day on ___. I addition, you will take some scheduled Ativan doses at home while you are increasing the Vimpat. You will take 0.5mg every 6 hours for two days (___), then decrease to 0.5mg every 8hours for 3 days (___), then decrease to 0.5mg twice a day for 3 days (___), then take 0.5mg once a day for three days (___) and then stop. Do not take the Xanax while you are taking Ativan. Please continue to take your Depakote and increase your Lamictal as previously planned. You may feel quite sleepy while you are taking the Vimpat and Ativan, but you should become more tolerant of these medications over time. If you are having significant side effects, please speak with Dr. ___. Do not stop the medications abruptly. Please continue to follow seizure precautions as discussed during this and the prior admission. Do not drive cars until you have been seizure free for at least 6 months. Do not operate heavy machinery, go into unguarded bodies of water (including bathtubs), climb to heights greater than you are tall, or be around hot surfaces or open flames. Thank you. Followup Instructions: ___
10758378-DS-7
10,758,378
25,098,108
DS
7
2142-09-13 00:00:00
2142-09-13 17:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: Penicillins Attending: ___. Chief Complaint: gait difficulties Major Surgical or Invasive Procedure: none History of Present Illness: Briefly Mrs. ___ is a ___ with hx of epilepsy with two recent admissions with vEEG monitoring who presented to the ED last ___ with 2 events that were concerning for seizures. She was observed in the ED and did not have further events and was continuing to improve and other than mild gait difficulty that appear somewhat inconsistent she was close to her baseline and was therefore discharged to outpatient follow up with Dr. ___. She was told by phone yesterday to increase her vimpat to 100mg qAM and 125mg QPM (was supposed to be on 200mg BID but did not reach this titrated amount and reportedly continued taking 100 mg BID). She saw him in clinic today and continued to be ataxic and lethargic and was refered back to the ED for further management and likely admission. She has not had repeat seizures since ___ but continues to feel sluggish as is "she is post-ictal". Otherwise, she denies recent symptoms of infectious illness but does report that she is in close proximity to sick contacts at ___. She denies falls or trauma to the head. She continues to be compliant with her medications. Past Medical History: -IBS -Seizure disorder - per HPI -C section at ___ years of age -tonsilectomy in ___ -cyst removal in ___ Social History: ___ Family History: Mother with seizure disorder, seizure free x ___ years. No other seizure/neurologic history in the family Physical Exam: Physical exam: AFVSS GEN: NAD, sitting in bed comfortable HEENT: neck supple, normocephalic and atraumatic, CV: RRR Lungs: CTA Abd: soft, nt nd Ext wwp, no edema Neuro -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. Pt. was able to register 3 objects and recall ___ at 5 minutes. The pt. had good knowledge of current events. There was no evidence of apraxia or neglect. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm and brisk. VFF to confrontation. Funduscopic exam revealed no papilledema, exudates, or hemorrhages. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. Mild intention tremor noted L>R. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 3 2 (no clonus) R 2 2 2 3 2 (no clonus) Plantar response was flexor bilaterally. -Coordination: Slight intention tremor worse on the left, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. Mild orbiting of left hand. -Gait: Good initiation. Romberg with sway that attenuates when she is distracted (for instance writting on her forehead), gait is varied with large amplitude swaying without falls, able to stand on each foot with falling, able to balance on her toes and heels,. Upon discharge: Exam was unchanged with the exception that her gait had normalized, she was able to walk steadily and had a negative Romberg without sway. Pertinent Results: ___ 06:15AM BLOOD WBC-7.4 RBC-4.25 Hgb-13.9 Hct-41.1 MCV-97 MCH-32.8* MCHC-33.9 RDW-12.9 Plt ___ ___ 04:00PM BLOOD Neuts-64.8 ___ Monos-5.1 Eos-3.5 Baso-0.9 ___ 06:15AM BLOOD Plt ___ ___ 06:15AM BLOOD Glucose-75 UreaN-8 Creat-0.7 Na-139 K-4.3 Cl-101 HCO3-29 AnGap-13 ___ 06:15AM BLOOD ALT-8 AST-13 LD(LDH)-144 AlkPhos-38 TotBili-0.2 ___ 06:15AM BLOOD Albumin-4.3 Calcium-9.5 Phos-3.5# Mg-2.1 U/A negative/normal Brief Hospital Course: Patient was admitted from outpatient Neurology Clinic for EEG monitoring in the setting of ataxia/unsteady gait. She was unsure of exact medication dosing upon admisison and so got less medication than usual (what we had in our system- only 100mg Vimpat, and only 50mg of Lamictal). Despite this, there was no seizure activity and her preliminary EEG read was at her baseline: "IMPRESSION: This is an abnormal continuous EMU monitoring study because of sleep related paroxysmal interictal epileptic activity that appears to be generalized. There were however no sustained events during this recording session." The EEG read from the last 12 hours of admission is pending at the time of discharge. The morning following admission, ___, she felt completely better and her walking was back to baseline. She remained neurologically at her baseline and received the extra dose of medications when her correct dosage was figured out (Vimpat 200mg BID and Lamictal 100mg qAM and 125mg qPM). She was discharged on all of her home medications and will touch base with her outpatient neurologist Dr. ___ thing on ___ morning ___. Medications on Admission: Divalproex (DELayed Release) 750 mg PO BID Fluoxetine 60 mg PO DAILY LaMOTrigine 50 mg PO BID **DOSE INCORRECT LACOSamide 200 mg PO BID **DOSE INCORRECT Discharge Medications: 1. Divalproex (DELayed Release) 750 mg PO BID 2. Fluoxetine 60 mg PO DAILY 3. LACOSamide 200 mg PO BID 4. LaMOTrigine 100 mg PO QAM **DOSE TO BE INCREASED BY OUTPATIENT NEUROLOGIST 5. LaMOTrigine 125 mg PO QPM **DOSE TO BE INCREASED BY OUTPATIENT NEUROLOGIST Discharge Disposition: Home Discharge Diagnosis: Epilepsy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital because of difficulty walking and concern for seizure activity. You EEG did not show seizure activity and your walking was back to normal by the following day. You are back to baseline so you are safe to go home. Please take it easy this weekend, drink plenty of fluids and get plenty of rest. You may return to your normal activities on ___. Please call Dr. ___ first thing ___ morning to touch base and see when he would like to follow up with you next. Please return to the nearest emergency room for any persistent worsening of your symptoms or new concerns for seizure. There was some confusion regarding the dose of your home medications upon your admission to the hospital. We recommend that you make an up to date list of your current home medications, including doses and how many times a day you take each medication, and keep a copy of this in your purse or wallet to help prevent this confusion from happening in the future. Followup Instructions: ___
10758594-DS-9
10,758,594
28,635,205
DS
9
2112-05-24 00:00:00
2112-05-28 00:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ hx of pancreas divisum and chronic pancreatitis since last ___ p/w worsening epigastric pain x5 days, no inciting event. States was admitted here 6 weeks ago and found to have a large pseudocyst. No fever. + nausea and some vomiting, unable to keep food down. No diarrhea. No dysuria. Feels like his pancreatitis. Does not drink alcohol since last ___. Drinks ___ as well as marijuana. Denies other illicits. Of note he was admitted in ___ for pancreatitis. At that time lipase was 143. He denied ETOH use at that time. ERCP was unsuccessful at draining pseudocyst due to abnormal pancreatic anatomy (divisum confirmed by MRCP). It was thought this was the cause of his recurrent pancreatitis. He was treated with aggressive IVF, bowel rest, IV to PO dilaudid. GI recommended conservative treatment at that time. In the ED, initial vitals were: 97.8 F, BP 140/80s, HR ___, RR 17, 98% RA - Exam notable for: a&o, RRR, CTAB, abd soft, nd, tender in epigastrum no ___ edema - Labs notable for: lactate 1.6, bland UA, Na 139, K 4, Cr 0.7, lipase 140, WBC 9 - Imaging was notable for: RUS u/s that showed 1. No evidence of cholelithiasis or cholecystitis. 2. There is partial visualization of a heterogeneous well circumscribed complex cystic collection measuring approximately 5.7 x 3.8 cm, likely related to the known wallled off necrotic collection, better seen on a prior MRCP from ___. - Patient was given: IV morphine x1, IV dilaudid 1 mg x3, multiple liters of NS Upon arrival to the floor, patient reports that his pain never really stopped since his last admission. He felt like he needed to come in yesterday because "it was flaring up bad." He denies fever, diarrhea, bloody stool, endorses 60 lb weight loss over the past 6 months, nausea, vomiting. REVIEW OF SYSTEMS: (+) Per HPI (-) 10 point ROS reviewed and negative unless stated above in HPI Past Medical History: Asthma pancreatitis hypertension Anxiety Social History: ___ Family History: Father died age ___ alcohol related causes. Mother alive and no issues he knows of. Family history of Breast and Rectal cancer. Physical Exam: ADMISSION PHYSICAL EXAM VITAL SIGNS: afebrile, 124/82, HR 62, 18, 97 RA GENERAL: visibly uncomfortable, pleasant, NAD HEENT: pupils 4-5 mm, reactive, EOMI, MMM NECK: supple CARDIAC: RRR LUNGS: CTAB ABDOMEN: +BS, very tender to palpation and auscultation in the epigastric and RUQ area. EXTREMITIES: WWP without edema NEUROLOGIC: grossly intact SKIN: no rashes DISCHARGE PHYSICAL EXAM Vitals- Tm 98.4 ___ 18 95-97RA General- Alert, oriented, slightly distressed but conversational HEENT- Sclera anicteric, MMM Lungs- CTAB, no R/R/W CARDIO - RRR, nl S1 S2, no M/R/G Abdomen- soft, minimal epigastric tenderness (improvement from prior days), non-distended, bowel sounds present, no ecchymoses. Ext- warm, well perfused. no clubbing, cyanosis or edema Neuro- motor function grossly normal Pertinent Results: ADMISSION LABS ------------------ ___ 06:50PM BLOOD WBC-9.0# RBC-5.04 Hgb-15.3 Hct-45.9 MCV-91 MCH-30.4 MCHC-33.3 RDW-13.6 RDWSD-46.1 Plt ___ ___ 06:50PM BLOOD Neuts-63.7 ___ Monos-8.8 Eos-1.4 Baso-0.6 Im ___ AbsNeut-5.72# AbsLymp-2.27 AbsMono-0.79 AbsEos-0.13 AbsBaso-0.05 ___ 06:50PM BLOOD Glucose-93 UreaN-10 Creat-0.7 Na-139 K-4.0 Cl-100 HCO3-25 AnGap-18 ___ 06:50PM BLOOD Albumin-4.5 ___ 08:00AM BLOOD Calcium-8.7 Phos-3.9 Mg-1.7 ___ 06:50PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 07:50PM BLOOD Lactate-1.6 ___ 07:50PM URINE Color-Yellow Appear-Clear Sp ___ ___ 07:50PM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG ___ 07:50PM URINE RBC-3* WBC-1 Bacteri-NONE Yeast-NONE Epi-0 MICROBIOLOGY ---------------- ___ 2:34 am URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ 7:50 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. IMAGING ---------- RUQ ULTRASOUND ___: 1. No evidence of cholelithiasis or cholecystitis. 2. Partial visualization of a complex cystic collection compatible with the previously seen walled-off necrotic collection, better evaluated on prior MRCP from ___. MRCP ___: 1. Known pseudocyst is slightly smaller in this patient with known chronic pancreatitis. 2. Pancreas divisum. G-TUBE POSITIONING ___: Successful post-pyloric advancement of a Dobhoff feeding tube. The tube is ready to use. DISCHARGE/INTERVAL LABS ___ 07:40AM BLOOD WBC-4.9 RBC-4.69 Hgb-14.7 Hct-43.1 MCV-92 MCH-31.3 MCHC-34.1 RDW-13.8 RDWSD-46.9* Plt ___ ___ 06:10AM BLOOD Glucose-110* UreaN-9 Creat-0.7 Na-139 K-4.1 Cl-98 HCO3-27 AnGap-18 ___ 08:00AM BLOOD ALT-19 AST-14 AlkPhos-56 TotBili-0.6 ___ 06:10AM BLOOD Calcium-8.6 Phos-3.1 Mg-2.2 Brief Hospital Course: Key Information for Outpatient Providers:Mr. ___ is a ___ y/o M with history of alcoholic pancreatitis and symptomatic pseudocyst s/p ERCP drainage attempt in the past, complicated by pancreas divisum, who presents with persistent epigastric pain. # Abdominal pain # Pancreatic pseudocyst. He has a history of alcoholic pancreatitis. Although he no longer drinks alcohol, his current presentation for abdominal pain is an acute exacerbation of his chronic pain likely related to his pseudocyst, which has extended into the mediastinum. Given past workup and imaging, the ERCP team does not feel that his pseudocyst is amenable to drainage. MRI on this admission reveals that his pseudocyst has been decreasing in size. Patient was evaluated by ERCP while hospitalized who recommended bowel rest with post-pyloric feeding through an NJ tube to improve pseudocyst decompression. He was maintained on his home Creon and Pantoprazole. For pain relief, patient was treated with home Gabapentin, Tylenol and Dilaudid as needed. He was evaluated by the Chronic Pain service who recommended up-titration of his Gabapentin regimen. He will be discharged with follow-up with Dr. ___. # Fever. Developed a temperature to 101.4F on ___. Patient did not endorse focal infectious symptoms, specifically denying cough, diarrhea, or dysuria at that time. Blood and urine cultures were sent off and are without growth to date. CHRONIC ISSUES: =============== # Anxiety: Continue home Xanax, Clonazepam, and Trazodone. TRANSITIONAL ISSUES =================== [ ] Will require NJ-tube post-pyloric tube feeds after discharge and require additional management with Dr. ___ (appointment on ___ at 9:20 am) [ ] Pain is likely to be a chronic issue for the patient. Advise close follow-up with the Chronic Pain clinic after discharge and weaning off opioids [ ] 1. Acetaminophen 1 gram every 8 hours as needed (DO NOT take more than 3 grams in one day). 2. Dilaudid 2 mg every four hours as needed. 3. Gabapentin 300 mg three times per day as needed. If this medication is making you more sleepy, please reduce how much you are taking. # Code: FULL CODE # Communication: ___ ___ (wife) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q4H sob, wheezing 2. ALPRAZolam 0.5 mg PO TID:PRN anxiety 3. ClonazePAM 2 mg PO QHS 4. Creon 12 3 CAP PO TID W/MEALS 5. Ipratropium Bromide MDI 2 PUFF IH Q6H:PRN shortness of breath, wheezing 6. Propranolol 20 mg PO BID 7. TraZODone 200 mg PO QHS:PRN insomnia 8. Polyethylene Glycol 17 g PO DAILY:PRN constipation 9. Pantoprazole 40 mg PO QAM 10. Acetaminophen 1000 mg PO TID 11. Senna 8.6 mg PO BID 12. OxyCODONE--Acetaminophen (5mg-325mg) ___ TAB PO Q8H PRN BREAKTHROUGH PAIN 13. terbinafine HCl 250 mg oral DAILY 14. Gabapentin 100 mg PO BID 15. Gabapentin 200 mg PO QHS Discharge Medications: 1. Cepacol (Sore Throat Lozenge) 1 LOZ PO Q2H:PRN sore throat RX *dextromethorphan-benzocaine [Cepacol Sorethroat-Cough] 5 mg-7.5 mg 1 lozenge(s) by mouth q2H Disp #*16 Lozenge Refills:*0 2. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN Pain - Mild RX *hydromorphone [Dilaudid] 2 mg 1 tablet(s) by mouth every four (4) hours Disp #*21 Tablet Refills:*0 3. Gabapentin 100 mg PO TID RX *gabapentin 100 mg 3 capsule(s) by mouth three times a day Disp #*60 Capsule Refills:*2 4. Acetaminophen 1000 mg PO TID 5. Albuterol Inhaler 2 PUFF IH Q4H sob, wheezing 6. ALPRAZolam 0.5 mg PO TID:PRN anxiety 7. ClonazePAM 2 mg PO QHS 8. Creon 12 3 CAP PO TID W/MEALS 9. Ipratropium Bromide MDI 2 PUFF IH Q6H:PRN shortness of breath, wheezing 10. Pantoprazole 40 mg PO QAM 11. Polyethylene Glycol 17 g PO DAILY:PRN constipation 12. Propranolol 20 mg PO BID 13. Senna 8.6 mg PO BID 14. terbinafine HCl 250 mg oral DAILY 15. TraZODone 200 mg PO QHS:PRN insomnia Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnosis: Acute on chronic abdominal pain Pancreatic pseudocyst Pancreatic divisum Secondary Diagnoses: Anxiety Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear. Mr. ___, You were hospitalized at ___ due to an acute flare of your abdominal pain. We believe that your pain is related to this pancreatic pseudocyst. As you have been informed of in the past, this cyst cannot be drained and this is partly complicated by the anatomy of your pancreas. Repeat imaging of the cyst does show that it has decreased in size. We have started you on tube feeds which have been redirected to a separate part of your GI tract. Our hope is that this will avoid activation of your pancreas, allowing it to rest and therefore promoting decompression of the pseudocyst. Given your abdominal findings, pain is likely to be a chronic rather than acute issue. You have been treated with a variety of pain medications and have been seen by our chronic pain service. You will be seen by the Pain Clinic after discharge for ongoing management of your pain. Your pain regimen on discharge: - Acetaminophen 1 gram every 8 hours as needed (DO NOT take more than 3 grams in one day) - Dilaudid 2 mg every four hours as needed - Gabapentin 300 mg three times per day as needed. If this medication is making you more sleepy, please reduce how much you are taking. It is very important that you attend your appointments listed below. It was a pleasure taking care of you! We wish you the best! Your ___ Team Followup Instructions: ___
10758777-DS-23
10,758,777
25,035,558
DS
23
2186-09-06 00:00:00
2186-09-07 08:47:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: L shoulder pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old woman with JAK2 positive essential thrombocythemia, anemia ___ beta thalassemia trait, transfusion dependent MDS, DM2, htn, HL who presents to the ED with acute onset left shoulder pain. Patient reports doing vigorous yoga today at the ___ followed by lunch and then bingo. While at ___, she raised her hand and then developed intense pain in her left shoulder. The pain began at ~ 1:30PM. She denies any trauma. The pain was worse with any movement and got better keeping the arm still. She denied any associated chest pressure, palpitations, SOB, or radiation. It persisted for more than 4 hours despite tylenol. She has never had pain like this before in the left shoulder although she does have arthritis and has had pain in the right shoulder in the past. She also noted LUQ pain after her shoulder pain began. She does not feel the two are related. Her abdominal pain is pleuritic. She initially thought it was due to constipation but the pain did not get better after a BM. She was worried it was related to her known splenomegaly. She could not say clearly when this pain started. She was scheduled to have a transfusion tomorrow as an outpatient and feels that she is due for a transfusion. She called the Heme/Onc fellow to report her symptoms when they did not resolve and she was referred to the ED. Of note, she was recently seen in the ED for syncope which was thought to be vasovagal in origin. She was treated with 7 days of Bactrim for a UTI at that time. She had no symptoms of UTI prior to diagnosis and she denies any current dysuria, fevers, or chills. . In ED, 97.7, 150/48, 71, 16, 96% RA. Exam notable for LUQ tenderness. Labs revealed severe anemia with Hct of 18.3 from 25 on ___ and platelets of 71 down from 106. Differential with 18% bands with multiple atypical cells but this is not inconsistent with prior draws. Cr was 1.8 close to her usual baseline. ALT/AST elevated compared to prior but last checked ___. CXR was without free air under diaphragm nor acute cardiopulmonary process. CT abdomen/pelvis was performed given her abdominal pain which revealed splenomegaly without splenic rupture. She was given tylenol ___ mg x 1 and morphine 4 mg IV x 2 with improved pain control. PRBC transfusion was initiated and she was given 10 mg IV lasix in the ED given patient reports of prior pulmonary edema with transfusions. . Currently, her shoulder pain has improved. She has more range of motion now with less pain. Her left sided abdominal pain persistsbut is improving as well. Of note, she has not passed any urine since 4 pm today despite IV lasix in the ED. She does think she has been drinking less than usual today. She denies any fevers, chills, cough, melena, hematochezia. All other ROS negative except as noted above. Past Medical History: -diabetes type II -peripheral neuropathy -laparoscopic cholecystectomy ___ -Anemia ___ beta thalassemia trait -MDS -___ thrombocytosis -___ s/p treatment -Type 2 diabetes diagnosed ___. -Asthma. -Hypertension. -osteoporosis. -lumbar spinal stenosis. -hypercholesterolemia. -s/p appendectomy at age ___. Social History: ___ Family History: Mother had thalassemia as well, unable to obtain additional history Physical Exam: T: 97.9 BP: 142/50 HR: 58 RR: 18 O2 100% 2LNC Gen: Pleasant, pale appearing, NAD HEENT: (+) conjunctival pallor. No icterus. MMM. OP clear. NECK: Supple, JVP low. CV: RRR. nl S1, S2. ___ holosys murmur LUNGS: CTAB. No wheezes, rales, or rhonchi. ABD: NABS. Soft. TTP in L abdomen with fullness. Cannot due complete assessment of spleen as patient requests only light palpation. No rebound or guarding. No CVA tenderness. No suprapubic tenderness. (+) periumbilical hernia easily reducible. EXT: WWP, NO CCE. Full distal pulses bilaterally. L shoulder tender to palpation around joint with minimal pain on active and passive range of motion. SKIN: No rashes/lesions, ecchymoses. NEURO: A&Ox3. Appropriate. CN ___ grossly intact. Moving all extremities. Physical Exam unchanged upon discharge. Patient with less conjunctival pallor Pertinent Results: ___ 07:55PM BLOOD WBC-6.6 RBC-2.23* Hgb-6.3* Hct-18.3*# MCV-82 MCH-28.1 MCHC-34.1 RDW-16.9* Plt Ct-71* ___ 08:36AM BLOOD WBC-7.2 RBC-2.82*# Hgb-8.0*# Hct-23.1*# MCV-82 MCH-28.5 MCHC-34.9 RDW-16.4* Plt Ct-73* ___ 05:20PM BLOOD WBC-11.3*# RBC-3.04* Hgb-8.7* Hct-25.0* MCV-82 MCH-28.8 MCHC-35.0 RDW-16.8* Plt Ct-79* ___ 06:15AM BLOOD WBC-7.2 RBC-2.84* Hgb-8.0* Hct-23.4* MCV-82 MCH-28.0 MCHC-34.1 RDW-16.7* Plt Ct-81* ___ 06:15AM BLOOD Glucose-104* UreaN-40* Creat-1.6* Na-138 K-3.7 Cl-103 HCO3-28 AnGap-11 ___:36AM BLOOD Glucose-111* UreaN-45* Creat-1.7* Na-140 K-3.9 Cl-104 HCO3-28 AnGap-12 ___ 07:55PM BLOOD Glucose-236* UreaN-49* Creat-1.8* Na-136 K-4.0 Cl-100 HCO3-23 AnGap-17 ___ 06:15AM BLOOD ALT-45* AST-54* LD(___)-846* AlkPhos-33* TotBili-1.4 ___ 05:20PM BLOOD LD(___)-869* TotBili-1.4 DirBili-0.6* IndBili-0.8 ___ 08:36AM BLOOD ALT-49* AST-57* AlkPhos-32* TotBili-1.3 ___ 07:55PM BLOOD ALT-50* AST-58* LD(___)-800* AlkPhos-29* TotBili-1.2 ___ 06:15AM BLOOD Albumin-3.6 Calcium-8.2* Phos-5.0*# Mg-1.4* ___ 05:20PM BLOOD calTIBC-267 Hapto-<5* Ferritn-5948* TRF-205 ___. ___ F ___ ___BDOMEN W/O CONTRAST Study Date of ___ 10:02 ___ ___ ___ 10:___BDOMEN W/O CONTRAST Clip # ___ Reason: eval for splenic lac/rupture, other acute pathology Field of view: 36 UNDERLYING MEDICAL CONDITION: ___ year old woman with myelodysplastic syndrome now with LUQ and left shoulder pain REASON FOR THIS EXAMINATION: eval for splenic lac/rupture, other acute pathology CONTRAINDICATIONS FOR IV CONTRAST: renal failure Wet Read: ___ ___ 11:00 ___ Splenomegaly but no splenic rupture. Left lower renal pole cyst. Wet Read Audit # 1 Final Report INDICATION: ___ woman with myelodysplastic syndrome, now with left upper quadrant and left shoulder pain. Evaluate for splenic laceration or rupture. COMPARISON: CT torso with contrast, ___. TECHNIQUE: MDCT axial images were obtained through the abdomen without the administration of IV contrast. Multiplanar reformats were generated and reviewed. CT OF THE ABDOMEN: The visualized lung bases show mild atelectasis, prominently at the right lung base (2, 3). The visualized heart and pericardium are unremarkable. Trace physiologic pericardial effusion is noted. Evaluation of solid organs and intra-abdominal vasculature is limited by non-contrast technique. Within this limitation, the liver and bilateral adrenal glands appear unremarkable. The patient is status post cholecystectomy. The pancreas appears mildly atrophic. Calcification is noted within the splenic vessels. The right kidney appears unremarkable. The left kidney demonstrates a 15 mm x 12 mm hypodensity in the lower pole of the left kidney, likely cyst. Trace left subdiaphragmatic fluid appears simple in appearance, overall decreased from prior. Retroperitoneal and mesenteric lymph nodes do not meet size criteria for pathologic enlargement. Intra-abdominal loops of large and small bowel are within normal limits. The spleen is again noted to be massively enlarged measuring approximately 20.1 cm in length. There is no evidence of splenic laceration. Visualized osseous structures show no focal lytic or sclerotic lesion suspicious for malignancy. Multilevel degenerative changes are noted within the visualized thoracolumbar spine. IMPRESSION: Massive splenomegaly with no evidence of splenic rupture. Trace left subdiaphragmatic fluid appears simple in appearance. The study and the report were reviewed by the staff radiologist. ___. ___ ___. ___ ___: WED ___ 12:02 ___ Imaging Lab Brief Hospital Course: Ms. ___ is a ___ year old woman with JAK2 positive essential thrombocythemia, anemia secondary to beta thalassemia trait, transfusion dependent MDS, DM2, HTN, HL who presented with left shoulder pain and splenomegaly. # LUQ pain: Likely secondary to massive splenomegaly. Differential on admission also included UTI/Pyelonephritis and nephrolitiasis. Urinalysis was negative for UTI or PRBC making nephrolithaisis or pyelonephritis unlikely. Pain control was achieved with PRN oxycodone. After consultation with Dr. ___, ___ was initiated to diminish extramedullary hematopoiesis in the spleen. No immediate effect on massive splenectomy on exam was appreciated, but a rapid response was not expected. # anemia: Secondary to underlying beta thalassemia trait and transfusion dependent MDS. ___ dependent. Generally requires 2 units PRBCs for Hct<23. No evidence of active bleeding during this admission. Hct remained stable at 23 after 2 PRBC transfusions. # shoulder pain: Likely musculoskeletal given physical exam findings and 3 view shoulder films which demonstrate arthritic changes. MI was ruled out with normal EKG and negative troponins. Also likely a component of referred pain from splenic irritation of the diaphragm. Outpatient physical therapy evaluation may be indicated if the pain does not resolve with treatment of hypersplenism. Medications on Admission: acyclovir 400 mg BID albuterol 90 ug 2 p prior to pentamidine norvasc 5 mg daily atenolol 50 mg daily budesonide 3 mg tid flexeril 5 mg tid PRN pain cyclosporine 75 mg QAM, 50 mg Q ___ (Gengraf) Vitamin D2 50000u Q1wk Fluconazole 400 mg Q24 hours Folic acid - 4 mg daily loperamide 2 mg 4x/day PRN diarreha ativan ___ mg QHS PRN insomnia mycophenolate 500 mg BID oxycodone ___ mg q6hour pentamidine 300 mg inhaled Q6 months Prednisone 5 mg QD Zantac 150 mg BID PRN MgOxide 266 mg BID MVI 1 tab Daily Discharge Medications: 1. amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 2. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 3. fenofibrate 160 mg Tablet Sig: One (1) Tablet PO once a day. 4. folic acid 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 5. furosemide 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 6. glyburide 5 mg Tablet Sig: One (1) Tablet PO once a day. 7. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 8. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 9. pravastatin 40 mg Tablet Sig: One (1) Tablet PO once a day. 10. Calcium 600 + D(3) 600 mg(1,500mg) -400 unit Tablet Sig: One (1) Tablet PO once a day. 11. multivitamin Tablet Sig: One (1) Tablet PO once a day. 12. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for severe pain. Disp:*90 Tablet(s)* Refills:*0* 13. hydroxyurea 500 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). Disp:*30 Capsule(s)* Refills:*2* 14. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). Disp:*60 Capsule(s)* Refills:*2* 15. senna 8.6 mg Tablet Sig: ___ Tablets PO BID (2 times a day). Disp:*90 Tablet(s)* Refills:*2* Discharge Disposition: Home Discharge Diagnosis: Myelodysplastic syndrome Essential Thrombocythemia Chronic Kidney Disease Diastolic congestive Heart Failure Type II Diabetes Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___. You were admitted with abdominal pain which is likely due to an enlarged spleen. While you were here, we treated you with oral pain medications, gave you 3 units of blood, and obtained an X ray of your shoulder which ruled out a fracture. We were able to rule out dangerous causes of pain such as a heart attack or ruptured spleen. We also gave you a chemotherapeutic agent known as hydroxyurea. The following medication changes have been made: START Oxycodone ___ every 3 hours as needed for pain START Hydroxyurea 500mg daily START Colace twice daily START Senna twice daily (as needed for constipation) Please take all other medications as directed. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
10758777-DS-24
10,758,777
22,988,680
DS
24
2187-04-16 00:00:00
2187-04-20 16:48:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Weakness Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old woman with JAK2 positive essential thrombocythemia, anemia ___ beta thalassemia trait, transfusion dependent MDS, DM2, hypertensive heart disease with heart failure, diabetes, recurrent UTI, atrial fibrillation not on anticoagulation presenting with weakness x 2 days. She had a scheduled transfusion in ___ clinic ___ and felt weak with difficulty standing up the following day as well as nauseated, vomiting and inability to tolerate PO. She also noticed shortness of breath that began last night when she woke up to use the toilet. Patient denies ever having dyspnea in the past. Temp 100.4 at home. Denied any CP, cough, abdominal pain, diarrhea, orthopnea, dysuria, skin changes, or lower ext edema. In ED initial vitals were 98.3 88 130/70 16 98% Labs were significant for UA with mod leuk, lg blood, >182 WBC, few bact, 44 RBC, <1 epi; LDH 844, Tbili 1.7, Dbili 1.0, ALT 47, AST 51 Patient was given ceftriaxone for possible UTI Final vitals prior to transfer were 98.3, 116/35, 16, 69, 100% ra Access 18g R fa IVF 1 L of NS Review of Systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies blurry vision, diplopia, loss of vision, photophobia. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies chest pain or tightness, palpitations, lower extremity edema. Denies cough, shortness of breath, or wheezes. Denies nausea, vomiting, diarrhea, constipation, abdominal pain, melena, hematemesis, hematochezia. Denies dysuria, stool or urine incontinence. Denies arthralgias or myalgias. Denies rashes or skin breakdown. No numbness/tingling in extremities. All other systems negative. Past Medical History: -diabetes type II -peripheral neuropathy -laparoscopic cholecystectomy ___ -Anemia ___ beta thalassemia trait -MDS -___ thrombocytosis -___ s/p treatment -Type 2 diabetes diagnosed ___. -Asthma. -Hypertension. -osteoporosis. -lumbar spinal stenosis. -hypercholesterolemia. -s/p appendectomy at age ___. Social History: ___ Family History: Mother had thalassemia as well, unable to obtain additional history Physical Exam: GENERAL: NAD SKIN: warm and well perfused, no excoriations or lesions, no rashes HEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, patent nares, MMM, good dentition, nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, no mrg LUNG: few diffuse crackles and expiratory wheezes ABDOMEN: LUQ tenderness to palpation, nondistended, +BS, no rebound/guarding EXTREMITIES: moving all extremities well, no cyanosis, clubbing or edema, no obvious deformities PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact Discharge: GENERAL: NAD, sitting up in chair SKIN: warm and well perfused, no excoriations or lesions, no rashes HEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, patent nares, MMM, good dentition, nontender supple neck, no LAD, no JVD CARDIAC: RRR, S1/S2, no mrg LUNG: diffuse crackles in all lung fields b/l. ABDOMEN: mild tenderness in LLQ, splenomegaly, nondistended, +BS, no rebound/guarding EXTREMITIES: trace b/l pedal edema, moving all extremities well, no cyanosis, no obvious deformities PULSES: 2+ DP pulses bilaterally NEURO: CN II-XII intact Pertinent Results: ___ 05:00PM CK-MB-1 cTropnT-0.03* ___ 08:43AM LACTATE-1.0 ___ 08:37AM GLUCOSE-288* UREA N-57* CREAT-2.5* SODIUM-135 POTASSIUM-4.1 CHLORIDE-99 TOTAL CO2-21* ANION GAP-19 ___ 08:37AM ALT(SGPT)-47* AST(SGOT)-51* LD(LDH)-844* CK(CPK)-34 ALK PHOS-31* TOT BILI-1.7* DIR BILI-1.0* INDIR BIL-0.7 ___ 08:37AM LIPASE-28 ___ 08:37AM cTropnT-0.02* ___ 08:37AM WBC-7.3# RBC-2.91*# HGB-7.9*# HCT-24.2*# MCV-83 MCH-27.1 MCHC-32.5 RDW-19.3* ___ 08:37AM NEUTS-68 BANDS-9* LYMPHS-16* MONOS-4 EOS-0 BASOS-0 ___ METAS-2* MYELOS-1* NUC RBCS-11* ___ 08:37AM URINE BLOOD-LG NITRITE-NEG PROTEIN-100 GLUCOSE-TR KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-MOD ___ 08:37AM URINE RBC-44* WBC->182* BACTERIA-FEW YEAST-NONE EPI-<1 TRANS EPI-<1 ___ 08:10AM BLOOD WBC-7.5 RBC-2.94* Hgb-8.1* Hct-24.7* MCV-84 MCH-27.4 MCHC-32.7 RDW-19.4* Plt ___ ___ 08:10AM BLOOD Neuts-67 Bands-10* Lymphs-10* Monos-4 Eos-1 Baso-2 ___ Metas-4* Myelos-2* NRBC-10* ___ 08:10AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-2+ Macrocy-OCCASIONAL Microcy-1+ Polychr-OCCASIONAL Tear Dr-1+ Ellipto-OCCASIONAL ___ 08:10AM BLOOD Glucose-123* UreaN-30* Creat-1.5* Na-137 K-5.6* Cl-105 HCO3-19* AnGap-19 ___ 01:10PM BLOOD LD(LDH)-766* ___ 06:35AM BLOOD CK-MB-1 cTropnT-0.02* proBNP-2271* ___ 01:10PM BLOOD B-GLUCAN-PND **FINAL REPORT ___ Blood Culture, Routine (Final ___: ESCHERICHIA COLI. FINAL SENSITIVITIES. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. ESCHERICHIA COLI. SECOND MORPHOLOGY. FINAL SENSITIVITIES. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | ESCHERICHIA COLI | | AMPICILLIN------------ =>32 R =>32 R AMPICILLIN/SULBACTAM-- 8 S 8 S CEFAZOLIN------------- <=4 S <=4 S CEFEPIME-------------- <=1 S <=1 S CEFTAZIDIME----------- <=1 S <=1 S CEFTRIAXONE----------- <=1 S <=1 S CIPROFLOXACIN---------<=0.25 S <=0.25 S GENTAMICIN------------ <=1 S <=1 S MEROPENEM-------------<=0.25 S <=0.25 S PIPERACILLIN/TAZO----- S S TOBRAMYCIN------------ <=1 S <=1 S TRIMETHOPRIM/SULFA---- =>16 R =>16 R Anaerobic Bottle Gram Stain (Final ___: Reported to and read back by ___ @ 2152 ON ___ - ___. GRAM NEGATIVE ROD(S). Aerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). CXR ___: IMPRESSION: 1. New multifocal pneumonia. 2. Increase in small left greater than right pleural effusions, and mild pulmonary edema from ___ 06:10AM BLOOD WBC-7.4 RBC-3.15* Hgb-8.8* Hct-26.6* MCV-84 MCH-27.9 MCHC-33.1 RDW-19.1* Plt ___ ___ 06:10AM BLOOD Glucose-191* UreaN-24* Creat-1.2* Na-134 K-4.3 Cl-104 HCO3-23 AnGap-11 Brief Hospital Course: Ms. ___ is a ___ year old woman with JAK2 positive essential thrombocythemia, anemia ___ beta thalassemia trait, transfusion dependent MDS, DM2, hypertensive heart disease with heart failure, diabetes, recurrent UTI, atrial fibrillation not on anticoagulation who presented with weakness and vomiting secondary to anaerobic GNR urosepsis. She was found to have multifocal pneumonia on ___ which was believed to be community acquired based on her dyspnea on admission and became apparent on CXR after rehydration. ACUTE CONDITIONS MANAGED: #Pyelonephritis: Diagnosed on positive e.coli blood cultures and clinical CVA tenderness. Pt had been started on broad spectrum coverage with Zosyn and switched to levaquin when sensitivity panel came back. Bilateral renal ultrasound ruled out hydronephrosis. Cr trended down to baseline of 1.3 at discharge from 2.8. #Pneumonia: Diagnosed on CXR on ___ which showed multifocal pneumonia. The PNA only showed up on cxr following hydration. Since she was SOB on admission, she was treated for CAP with Levaquin on ___. She was continued on scheduled Duoneb, with PRN albuterol.Pt did not require steroids. After falling improve for several days and an elevated LDH, a chest CT and b-glucgan were ordered. CT showed some ground glass opacities but b-glucgan was negative. Pt's O2 sats eventually rebounded and here WBC trended down to baseline. #LUQ abdominal pain: we believe this pain is due to her known splenomegaly. It may be possible that the bacteremia allowed for seeding of the spleen and an infarct. The pain responded well to tylenol with codeine. Loose stools: starting ___ and were most likely secondary to ABX. C.diff ws negative. Pt's loose stools resolved several days prior to discharge. CHRONIC CONDITIONS MANAGED: CKD Stage III: Creatinine improved to below her baseline of 2.1 CHF: was stable throughout admission. She continued her home meds Metoprolol Succinate XL 25 mg and Amiodarone 200 mg. Lasix was held on admission due to dehydrated status. Several doses were given throughout admission for slightly elevated K+ and increased fluid in lungs. Diabetes Mellitus: stable DM: Pt was put on ISS due to highly variable renal function. Hypertension: stable on home meds Metoprolol Succinate XL 25 mg and Amlodipine 10 mg. MDS/Anemia: Pt was continued on Folic Acid 1 mg PO BID throughout admission. She received roughly 4 units of pRBC throughout admission to keep her her Hct >21 Hyperlipidemia: stable on statin throughout admission. TRANSITIONS OF CARE: 1. CODE: FULL CODE 2. Pt will follow-up with Dr. ___ on ___ and her primary doctors 4. Medications: Pt will finish treatment with levaquin and is also given albuterol and spiriva prn. Medications on Admission: AMIODARONE - (Prescribed by Other Provider) - 200 mg Tablet - 1 Tablet(s) by mouth one daily AMLODIPINE - 10 mg Tablet - one Tablet(s) by mouth once daily FENOFIBRATE - 160 mg Tablet - 1 Tablet(s) by mouth once a day FOLIC ACID - 1 mg Tablet - one Tablet(s) by mouth twice a day FUROSEMIDE - (Prescribed by Other Provider; Dose adjustment - no new Rx) - 20 mg Tablet - 1 (One) Tablet(s) by mouth twice a day GLIMEPIRIDE - (Prescribed by Other Provider) - 1 mg Tablet - 1 Tablet(s) by mouth once a day METOPROLOL SUCCINATE - 25 mg Tablet Extended Release 24 hr - 1 Tablet(s) by mouth once a day OMEPRAZOLE - (converting) - 20 mg Capsule, Delayed Release(E.C.) - 1 Capsule(s) by mouth once a day PRAVASTATIN [PRAVACHOL] - 40 mg Tablet - 1 Tablet(s) by mouth once a day TRIMETHOPRIM - 100 mg Tablet - 1 Tablet(s) by mouth once a day CALCIUM CARBONATE-VITAMIN D3 - (Prescribed by Other Provider; ___; Dose adjustment - no new Rx) - 600 mg-400 unit Tablet - 1 Tablet(s) by mouth 1.5 tablet by mouth in the morning, 1 tablet by mouth in the evening MULTIVITAMIN-MINERALS-LUTEIN [CENTRUM SILVER] - (OTC) - Tablet - 1 Tablet(s) by mouth daily No IRON Discharge Medications: 1. amlodipine 10 mg Tablet Sig: One (1) Tablet PO once a day. 2. folic acid 1 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 3. furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day. Tablet(s) 4. glimepiride 1 mg Tablet Sig: One (1) Tablet PO twice a day. 5. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 7. pravastatin 40 mg Tablet Sig: One (1) Tablet PO once a day. 8. calcium carbonate-vitamin D3 600 mg(1,500mg) -400 unit Tablet Sig: 1.5 Tablets PO twice a day: 1.5 qam, 1 tablet in the evening. 9. amiodarone 200 mg Tablet Sig: One (1) Tablet PO once a day. 10. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: ___ puffs Inhalation every ___ hours as needed for shortness of breath or wheezing: Please f/u with PCP if wheezing and SOB persists longer than 1 week. Disp:*1 inhaler* Refills:*2* 11. Spiriva with HandiHaler 18 mcg Capsule, w/Inhalation Device Sig: One (1) pump Inhalation once a day for 1 weeks: Please contact pcp if SOB and wheezing persist over a week. Disp:*1 device* Refills:*2* 12. Centrum Silver Tablet Sig: One (1) Tablet PO once a day. 13. fenofibrate 160 mg Tablet Sig: One (1) Tablet PO once a day. 14. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO every other day for 3 days: last day = ___. Disp:*3 Tablet(s)* Refills:*0* Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Pyelonephritis, community-acquired pneumonia Secondary: myelodysplastic syndrome Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you during this admission. You were admitted for feeling weak, and found to have a urinary infection and pneumonia. You were placed on antibiotics and improved. You had some diarrhea, but there was no evidence of infection, and this may have been from the antibiotics. The following medications were STARTED: - Albuterol ___ puffs every ___ hours as needed for wheezing - Spiriva inhaled once daily - Levofloxacin for 3 more days The following medications were changed during this admission: - Decrease Furosemide to 20mg daily (from twice daily) - STOP Trimethoprim PLEASE continue all other medications you were taking prior to this admission. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
10759281-DS-16
10,759,281
21,880,481
DS
16
2177-08-07 00:00:00
2177-08-07 15:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Laparoscopic cholecystectomy History of Present Illness: ___ year old female with PMH cholelithiasis is admitted with abdominal pain and pancreatitis. The day after ___ (5 days ago) she developed bloating and dyspepsia and epigastric discomfort which she attributed to gas. The symptoms worsened and she presented to her PCP on the day prior to admission and was given omeprazole for possible gastritis. She denies nausea, vomiting or intolareance to PO intake. reported lack of appetite over the last 4 days. Labs checked in clinc were remarkable for ___, AST/ALT ___, Amylase 2870, tBili: 2.2, WBC 10. She was referred to the ___ ED. In the ED, initial VS were: T98.2 P60 BP109/64 RR18 SaO296% Exam was remarkable for epigastric and RUQ tenderness. RUQ U/S showed gall bladder filled with stones, CBD 4mm and normal, pancreatic head could not be evaluated due to bowel gas. Labs had downtrended to Lipase:537, AST/ALT 267/769. Tbili had normalized at 0.8, WBC unchanged at 10. EKG showed sinus rhythm with TWI in III avF and V1 apparently new from EKG ___. On arrival to the floor, she reports no abdominal pain or discomfort, no nausea or vomiting, asking for po intake. REVIEW OF SYSTEMS: (+) as in HPI (-) fever, chills, night sweats, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: - Cholelithiasis - Hyperlipidemia - Obesity - Depression - GERD - Familial tremor (on Nadolol) Social History: ___ Family History: Father: deceased age ___ of liver cancer. Mother: living in her ___, asthma, tremor. Physical Exam: VS - Temp 98.1F, BP 137/58 , HR 61 , R 13, O2-sat 100% RA GENERAL - well-appearing woman in NAD, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no JVD, no carotid bruits LUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact, steady gait Physical examination upon discharge: ___ vital signs: t=97.9, hr=55, bp=114/54, rr=18, oxygen sat= 95% General: NAD CV: ns1, s2, -s3, -s4, no murmurs LUNGS: clear ABDOMEN: soft, tender at port sites, port dressings clean and dry EXT: + dp bil., no pedal edema bil., no calf tenderness bil NEURO: alert and oriented x 3, speech clear, no tremors Pertinent Results: ___ 03:52PM PLT COUNT-382 ___ 03:52PM WBC-10.2 RBC-4.24 HGB-13.2 HCT-39.9 MCV-94 MCH-31.2 MCHC-33.2 RDW-13.5 ___ 03:52PM ___ ___ 03:52PM ALT(SGPT)-1017* AST(SGOT)-425* ALK PHOS-231* AMYLASE-2870* TOT BILI-2.2* ___ 03:10PM PLT COUNT-394 ___ 03:10PM NEUTS-72.3* LYMPHS-16.9* MONOS-7.0 EOS-3.3 BASOS-0.6 ___ 03:10PM WBC-10.5 RBC-4.24 HGB-13.2 HCT-39.8 MCV-94 MCH-31.1 MCHC-33.1 RDW-13.1 ___ 03:10PM ALBUMIN-4.5 CALCIUM-9.7 PHOSPHATE-3.6 MAGNESIUM-2.2 ___ 03:10PM cTropnT-<0.01 ___ 03:10PM ALT(SGPT)-769* AST(SGOT)-267* ALK PHOS-247* TOT BILI-0.8 ___ 03:10PM GLUCOSE-94 UREA N-12 CREAT-1.0 SODIUM-136 POTASSIUM-4.3 CHLORIDE-99 TOTAL CO2-27 ANION GAP-14 ___ 05:30PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG ___ 05:30PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 11:02PM ___ PTT-31.9 ___ ___ 11:02PM CK-MB-2 cTropnT-<0.01 ___ 11:02PM CK(CPK)-63 RUQ US: 1. Cholelithiasis without evidence of acute cholecystitis. 2. No biliary ductal dilatation. CBD measures 4 mm. 3. Mild intrahepatic pneumobilia 4. Normal appearance of the pancreatic head and neck. Limited evaluation of the body and tail. ___: EKG: Sinus rhythm. Non-specific anterior and inferior ST-T wave changes. Compared to the previous tracing of ___ the axis is less rightward and the rate has slowed. There are ST-T wave changes. Otherwise, no diagnostic interim change. TRACING #1 ___: EKG: Sinus rhythm. Compared to the previous tracing of ___ there are new T wave inversions in leads V1-V4 raising the question of active anterior ischemia. Followup and clinical correlation are suggested. TRACING #2 Brief Hospital Course: The patient was admitted to the acute care service with abdominal pain. Blood work drawn prior to admission showed elevated LFT's, lipase and amylase suggestive of gallstone pancreatitis. The patient was instructed to report to the emergency room. Upon admission, she was made NPO, given intravenous fluids, and underwent imaging. She was reported on ultrasound to have a gallbladder filled with stones, but with no wall thickening. Her EKG on admission was remarkable for T wave inversion in III, avF and V1 apparently new from an EKG in ___. Cardiac enzymes were negative x 3 which raised a low suspicion for myocardidal infarction. She was monitered on telemetry for one night without events. Her vital signs and liver enzymes were closely monitored. On HD #4,she was taken to the operating room where she underwent a laparoscopic cholecystectomy. She also underwent a intraoperative cholangiogram which showed filling of the duodenum and the right and left hepatic ducts, with no filling defects. The operative course was stable with minimal blood loss. She was extubated after the procedure and monitored in the recovery room. Her post-operative course has been stable. The patient was started on clear liquids and transitioned to a regular diet. She has been voiding without difficulty. Her incisional pain is controlled with oral analgesia. On POD #1, the patient was discharged home with stable vital signs. An appointment for follow-up was made with the acute care service. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. econazole *NF* 1 % Topical BID 2. Fluoxetine 40 mg PO DAILY 3. Fluticasone Propionate NASAL 2 SPRY NU DAILY 4. Nadolol 20 mg PO DAILY For tremor 5. Omeprazole 20 mg PO DAILY 6. Loratadine *NF* 10 mg Oral Daily Discharge Medications: 1. nadolol 20 mg tablet Sig: One (1) tablet PO DAILY (Daily). 2. fluoxetine 40 mg capsule Sig: One (1) capsule PO DAILY (Daily). 3. omeprazole 20 mg capsule,delayed ___ Sig: One (1) capsule,delayed ___ PO DAILY (Daily). 4. Colace 100 mg capsule Sig: One (1) capsule PO twice a day: hold for loose stool. 5. Percocet ___ mg tablet Sig: ___ tablets PO every ___ hours as needed for pain: may cause increased drowsiness, avoid driving while on this medicaiton. Disp:*25 tablet(s)* Refills:*0* 6. senna 8.6 mg tablet Sig: One (1) tablet PO twice a day as needed for constipation. Discharge Disposition: Home Discharge Diagnosis: cholelithiasis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hosptial with abdominal pain. You underwent an ultrasound of your abdomen which showed gallstones. You were taken to the operating room where you had your gallbladder removed. You are slowly recovering from your surgery and you are preparing for discharge home: You were admitted to the hospital with acute cholecystitis. You were taken to the operating room and had your gallbladder removed laparoscopically. You tolerated the procedure well and are now being discharged home to continue your recovery with the following instructions. Please follow up in the Acute Care Surgery clinic at the appointment listed below. ACTIVITY: Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. You may climb stairs. You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. You may start some light exercise when you feel comfortable. You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: You may feel weak or "washed out" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. You may have a sore throat because of a tube that was in your throat during surgery. You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. You could have a poor appetite for a while. Food may seem unappealing. All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: Tomorrow you may shower and remove the gauzes over your incisions. Under these dressing you have small plastic bandages called steristrips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay). Your incisions may be slightly red around the stitches. This is normal. You may gently wash away dried material around your incision. Avoid direct sun exposure to the incision area. Do not use any ointments on the incision unless you were told otherwise. You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: Constipation is a common side effect of narcotic pain medicaitons. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. Your pain medicine will work better if you take it before your pain gets too severe. Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. If you are experiencing no pain, it is okay to skip a dose of pain medicine. Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: Take all the medicines you were on before the operation just as you did before, unless you have been told differently. If you have any questions about what medicine to take or not to take, please call your surgeon. DANGER SIGNS: Please call your surgeon if you develop: - worsening abdominal pain - sharp or severe pain that lasts several hours - temperature of 101 degrees or higher - severe diarrhea - vomiting - redness around the incision that is spreading - increased swelling around the incision - excessive bruising around the incision - cloudy fluid coming from the wound - bright red blood or foul smelling discharge coming from the wound - an increase in drainage from the wound Followup Instructions: ___
10759357-DS-10
10,759,357
20,248,614
DS
10
2139-08-27 00:00:00
2139-08-27 11:15:00
Name: ___ ___ No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: simvastatin / Bactrim / Linzess / Sulfa (Sulfonamide Antibiotics) / Macrodantin / Rosophin in Dextrose Attending: ___. Chief Complaint: Right Femur fx Major Surgical or Invasive Procedure: R femur retrograde IMN (___) History of Present Illness: ___ w/hx of MS and HTN presenting from rehab with a fall from her wheelchair between ___, presents to ED with distal right femur fx. Patient reports that she was bending down and slipped out of her wheelchair, landing on her right leg. No head strike, no LOC. Patient has pain in right leg, no pain elsewhere. No CP, no SOB. Reports DVT in RLE right on coumadin. Head CT and Cspine were negative per report. Trauma consulted given fall hx, noted abd bruising, planning to obtian abd CT scan. Past Medical History: MS, obesity, and HTN Social History: ___ Family History: NC Physical Exam: RLE - foot drop, no motor in foot, SILT SSSPDPPT, WWP. inc cdi with staples Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have R distal femur frx and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for R femur retrograde IMN, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The patient was transfused 1u pRBCs on ___ for low Hct 21.8 that responded appropriately. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is NWB in the RL extremity, and will be discharged on coumadin (bridged from lovenox) for DVT prophylaxis. The patient will follow up with Dr. ___ trauma team per routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Modafinil 200 mg PO DAILY 2. Sertraline 50 mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Baclofen 20 mg PO QID 5. methenamine hippurate 1 gram oral BID 6. Tamsulosin 0.4 mg PO QHS 7. Tizanidine 4 mg PO QHS 8. Topiramate (Topamax) 50 mg PO QHS:PRN weight loss Discharge Medications: 1. Atorvastatin 20 mg PO QPM 2. Baclofen 20 mg PO QID 3. methenamine hippurate 1 gram oral BID 4. Modafinil 200 mg PO DAILY 5. Sertraline 50 mg PO DAILY 6. Tamsulosin 0.4 mg PO QHS 7. Tizanidine 4 mg PO QHS 8. Topiramate (Topamax) 50 mg PO QHS:PRN weight loss 9. Acetaminophen 500 mg PO Q4H 10. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 11. Docusate Sodium 100 mg PO BID 12. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN Pain RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*10 Tablet Refills:*0 13. Senna 8.6 mg PO BID 14. Warfarin 5 mg PO DAILY RX *warfarin [Coumadin] 3 mg 1 tablet(s) by mouth once a day Disp #*10 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: R distal femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - touch down bearing right lower extremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take your Coumadin as prescribed and monitored WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. Physical Therapy: Activity: Activity: Activity as tolerated Right lower extremity: touch down weight bearing Encourage turn, cough and deep breathe q2h when awake Treatments Frequency: Wound care: Site: Incision Type: Surgical Dressing: Gauze - dry Comment: To be changed DAILY by ___ starting POD ___. RN - please overwrap any dressing bleedthrough with ABDs and ACE Followup Instructions: ___
10760019-DS-6
10,760,019
20,606,838
DS
6
2138-06-05 00:00:00
2138-07-23 15:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: ___: Laparoscopic appendectomy History of Present Illness: Ms. ___ is an ___ otherwise healthy who presents with RLQ adbominal for ~20 hours duration. Briefly, she states that she began developing vague midline abdominal pain late yesterday evening that has progressively worsened with migration/localization to the RLQ at this time. She also reports subjective chills, nausea and three episodes of emesis. She has anorexia and has not taken any PO since yesterday evening. She otherwise denies CP/SOB, diarrhea/constipation, bleeding. Past Medical History: None Social History: ___ Family History: No h/o colon cancer/GI malignancy Physical Exam: Physical Exam on admission: Vitals: 98.1 50 130/82 18 99% RA Gen: A&Ox3, fatiguedl-appearing female, in NAD HEENT: No scleral icterus, no palpable LAD Pulm: comfortable on room air CV: NRRR, no m/r/g Abd: soft, nondistended, TTP in RLQ without rebound/guarding, no palpable masses Ext: WWP bilaterally, no c/c/e, no ulcerations Neuro: moves all limbs spontaneously, no focal deficits Physical Exam on discharge: VS: 98.3 PO 112 / 74 L Lying 70 20 98 Ra GEN: Awake, alert, pleasant and interactive. CV: RRR PULM: Clear to auscultation bilaterally ABD: Soft, non-distended, tender to palp incisionally. active bowel sounds. EXT: Warm and dry. 2+ ___ pulse. NEURO: A&Ox3. Follows commands and moves all extremities equal and strong. Speech is clear and fluent. Pertinent Results: ___ 02:07PM BLOOD WBC-11.0* RBC-4.77 Hgb-12.9 Hct-41.3 MCV-87 MCH-27.0 MCHC-31.2* RDW-14.0 RDWSD-44.0 Plt ___ ___ 02:07PM BLOOD Neuts-78.3* Lymphs-15.3* Monos-5.2 Eos-0.5* Baso-0.3 Im ___ AbsNeut-8.58* AbsLymp-1.68 AbsMono-0.57 AbsEos-0.06 AbsBaso-0.03 ___ 02:07PM BLOOD ___ PTT-31.8 ___ ___ 02:07PM BLOOD Glucose-101* UreaN-9 Creat-0.6 Na-139 K-4.2 Cl-102 HCO3-23 AnGap-14 ___ 02:12PM BLOOD Lactate-1.1 CT ABD & PELVIS WITH CONTRAST ___: IMPRESSION: 1. Acute uncomplicated appendicitis. High-density intraluminal material throughout a large portion of the appendix likely appendicoliths. 2. Heterogeneous enhancement of the liver is likely secondary to contrast timing. Correlation with LFTs is recommended. Brief Hospital Course: P.___. is a ___ year old female, who was admitted to ___ on ___ for evaluation and treatment of abdominal pain. Admission abdominal/pelvic CT revealed acute uncomplicated appendicitis. The patient underwent laparoscopic appendectomy on ___, which went well without complication (reader referred to the Operative Note for details). After a brief, uneventful stay in the PACU, the patient arrived on the floor hemodynamically stable. The patient was advanced to a regular diet, which she was tolerating. She was converted to oral pain medication with continued good effect. The patient voided without problem. During this hospitalization, the patient ambulated early and was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: None Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H Do not exceed 4gm in a 24 hour period. 2. Docusate Sodium 100 mg PO BID 3. Ibuprofen 600 mg PO Q6H:PRN Pain - Mild Please take with food. 4. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Moderate Please take lowest effective dose. Wean as tolerated. RX *oxycodone 5 mg 1 tablet(s) by mouth every eight (8) hours Disp #*4 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Acute appendicitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the hospital because of abdominal pain. CT imaging showed an infection in your appendix. You had your appendix removed laparoscopically. You are doing well, tolerating a regular diet, and your pain is well-controlled, so you are ready to go home. Please follow the discharge instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. ACTIVITY: o Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. o You may climb stairs. o You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. o Don't lift more than ___ lbs for 4 weeks. (This is about the weight of a briefcase or a bag of groceries.) This applies to lifting children, but they may sit on your lap. o You may start some light exercise when you feel comfortable. o You will need to stay out of bathtubs or swimming pools for a time while your incision is healing. Ask your doctor when you can resume tub baths or swimming. HOW YOU MAY FEEL: o You may feel weak or "washed out" for a couple of weeks. You might want to nap often. Simple tasks may exhaust you. o You may have a sore throat because of a tube that was in your throat during surgery. o You might have trouble concentrating or difficulty sleeping. You might feel somewhat depressed. o You could have a poor appetite for a while. Food may seem unappealing. o All of these feelings and reactions are normal and should go away in a short time. If they do not, tell your surgeon. YOUR INCISION: o Tomorrow you may shower and remove the gauzes over your incisions. Under these dressing you have small plastic bandages called steri-strips. Do not remove steri-strips for 2 weeks. (These are the thin paper strips that might be on your incision.) But if they fall off before that that's okay). o Your incisions may be slightly red around the stitches. This is normal. o You may gently wash away dried material around your incision. o Avoid direct sun exposure to the incision area. o Do not use any ointments on the incision unless you were told otherwise. o You may see a small amount of clear or light red fluid staining your dressing or clothes. If the staining is severe, please call your surgeon. o You may shower. As noted above, ask your doctor when you may resume tub baths or swimming. YOUR BOWELS: o Constipation is a common side effect of narcotic pain medications. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. o If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. PAIN MANAGEMENT: o It is normal to feel some discomfort/pain following abdominal surgery. This pain is often described as "soreness". o Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. o You will receive a prescription for pain medicine to take by mouth. It is important to take this medicine as directed. o Do not take it more frequently than prescribed. Do not take more medicine at one time than prescribed. o Your pain medicine will work better if you take it before your pain gets too severe. o Talk with your surgeon about how long you will need to take prescription pain medicine. Please don't take any other pain medicine, including non-prescription pain medicine, unless your surgeon has said its okay. o If you are experiencing no pain, it is okay to skip a dose of pain medicine. o Remember to use your "cough pillow" for splinting when you cough or when you are doing your deep breathing exercises. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain Followup Instructions: ___
10760122-DS-12
10,760,122
25,305,407
DS
12
2118-05-04 00:00:00
2118-05-04 15:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest and back pain Major Surgical or Invasive Procedure: ___: Thoracic endograft repair for penetrating thoracic aortic ulcer of the descending thoracic aorta History of Present Illness: ___ gentleman with an intramural hematoma and penetrating aotic ulceration of the descending thoracic aorta presents with symptoms of persistant lower chest and epigastric pain radiating to the back depite normal BP. Past Medical History: Past Medical History: Hypertension, PTSD, mood disorder Past Surgical History: lipoma removal, facial reconstruction s/p MVA Social History: ___ Family History: Mother had MI, no marfans or connective tissue disorder Physical Exam: Vitals: GEN: A&O, NAD, interactive and cooperative HEENT: No scleral icterus CV: RRR PULM: Clear to auscultation b/l ABD: Soft, nondistended, tender with deep palpation in lower-mid abdomen, no pulsatile mass Ext: No ___ edema, ___ warm and well perfused, palpable bilateral pedal pulses, no wounds or ulcers Pulses: R: p/p/p/p L: p/p/p/p Pertinent Results: ___ 03:20AM BLOOD WBC-7.4 RBC-3.82* Hgb-13.0* Hct-36.0* MCV-94 MCH-33.9* MCHC-36.0* RDW-13.7 Plt ___ ___ 03:20AM BLOOD ___ PTT-44.9* ___ ___ 03:20AM BLOOD Glucose-102* UreaN-15 Creat-0.7 Na-134 K-4.4 Cl-104 HCO3-28 AnGap-___ 03:20AM BLOOD ALT-79* AST-94* CK(CPK)-131 AlkPhos-130 TotBili-0.8 ___ 03:20AM BLOOD Calcium-8.3* Phos-3.2 Mg-2.2 CTA (___): Intramural hematoma extending from the level of the left subclavian artery and terminating at the level of the renal arteries, not significantly changed from ___. Intramural ulcers ulcer of the level of the descending thoracic aorta, also unchanged (series 2, image 74, series 2, image 78). There may be intramural hematoma extending into the proximal left subclavian artery (series 2, image 6). Descending thoracic aorta measuring up to approximately 4.4 cm, not significantly changed. All vessels off of the abdominal aorta appear patent. Brief Hospital Course: Mr ___ presented to ___ on ___ for evaluation of persistent symptoms of chest and abdominal pain radiating to the back presumed to be secondary to a known intramural aortic hematoma. He was admitted to the vascular surgery service. He was initially admitted to the CVICU for close monitoring fo his blood pressure with esmolol drip. On ___ he was weaned off the esmolol drip and his blood pressure was adequately controlled with PO medication. On ___ a CTA was done which revealed an unchanged intramural hematoma but continued to have pain. As such, was taken to the OR on ___ for TEVAR. He tolerated the procedure well without complications. After a brief and uneventful stay in the PACU, the patient was transferred to the floor for further post-operative management. Neuro: Intact with no focal deficiet. CV: The patient remained stable from a cardiovascular standpoint on lisinopril and metoprolol. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI: Post-operatively, the patient was made NPO with IV fluids. Diet was advanced when appropriate, which was well tolerated. Patient's intake and output were closely monitored, and IV fluid was adjusted when necessary. Electrolytes were routinely followed, and repleted when necessary. GU: The patient had a foley catheter placed in the OR, which was removed on midnight of POD#. After the foley was removed, the patient voided without difficulty. ID: The patient's white blood count and fever curves were closely watched for signs of infection, of which there were none. Hematology: The patient's complete blood count was examined routinely. EXtremities: Groin puncture sites are well healed without hematoma or ecchymosis. Distal pulses are intact. Prophylaxis: The patient received subcutaneous heparin. Patient wore venodyne boots and was encouraged to get up and ambulate as early as possible following surgery. On POD 2, the patient was discharged to home. At discharge, he was tolerating a regular diet, passing flatus, stooling, voiding, and ambulating independently. He will follow-up in clinic in 4 weeks. This information was communicated to the patient directly prior to discharge with verbalized understanding and agreement. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY Discharge Medications: 1. Lisinopril 5 mg PO DAILY RX *lisinopril 5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Aspirin EC 81 mg PO DAILY RX *aspirin [Aspirin Childrens] 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Ibuprofen 800 mg PO Q8H:PRN pain RX *ibuprofen 800 mg 1 tablet(s) by mouth three times daily as needed. Disp #*90 Tablet Refills:*0 4. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Penetrating descending thoracic aortic ulcer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Division of Vascular and Endovascular Surgery Endovascular Abdominal Aortic Aneurysm (AAA) Discharge Instructions MEDICATIONS: •Take Aspirin 81mg (enteric coated) once daily •Continue all other medications you were taking before surgery, unless otherwise directed •You make take Tylenol or prescribed pain medications for any post procedure pain or discomfort WHAT TO EXPECT AT HOME: It is normal to have slight swelling of the legs: •Elevate your leg above the level of your heart (use ___ pillows or a recliner) every ___ hours throughout the day and at night •Avoid prolonged periods of standing or sitting without your legs elevated It is normal to feel tired and have a decreased appetite, your appetite will return with time •Drink plenty of fluids and eat small frequent meals •It is important to eat nutritious food options (high fiber, lean meats, vegetables/fruits, low fat, low cholesterol) to maintain your strength and assist in wound healing •To avoid constipation: eat a high fiber diet and use stool softener while taking pain medication ACTIVITIES: •When you go home, you may walk and go up and down stairs •You may shower (let the soapy water run over groin incision, rinse and pat dry) •Your incision may be left uncovered, unless you have small amounts of drainage from the wound, then place a dry dressing or band aid over the area that is draining, as needed •No heavy lifting, pushing or pulling (greater than 5 lbs) for 1 week (to allow groin puncture to heal) •After 1 week, gradually increase your activities and distance walked as you can tolerate Followup Instructions: ___
10760122-DS-19
10,760,122
23,490,086
DS
19
2120-08-24 00:00:00
2120-08-24 17:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / epidural injection / tramadol / Tylenol Attending: ___. Chief Complaint: abdominal pain, volume overload Major Surgical or Invasive Procedure: EGD ___ History of Present Illness: Mr. ___ is a ___ yo M w/medical history notable for HCV/EtOH cirrhosis (Child B) c/b ___ s/p RFA ___, ascites, varices/PHG, HIV (most recent CD4 ___ with multiple recent admissions for abdominal pain and volume overload, presenting today with abd pain and volume overload. In the ED complained of worsening abd pain over last 5 days, not relieved by his standing oxycodone. He endorses lethargy, inability to sleep. He also reports a 7 pound weight gain x2 days, denies missing medication doses, change in diet. Reports has abdominal pain straight down the middle of his abdomen from epigastrium down to umbilicus; denies radiation, association with eating, vomiting, changes in bowel movements. Given worsening of his pain and volume overload, he was referred to the ED for further evaluation. In the ED initial vitals: T97.6, HR91, BP156/82, RR18, PO2 96 - Exam notable for: Tender to palpation throughout the most notably in the epigastrium and around the umbilicus, no rebound, no guarding, no fluid wave - Imaging notable for: RUQ with no ascites; patent portal vein - Labs notable for WBC 10.7 left shift, INR 1.5, K 5.1, ALT 100, AST 176, Alkphos 205, Tbili 3.3, lipase 63, albumin 3.2 - Patient was given: oxycodone 5mg x2 - Vitals prior to transfer: 97.8 71 131/90 15 94% RA On the floor, patient reports ongoing pain. Patient was admitted ___ at ___ and received work-up for transaminitis and diffuse abdominal pain revealing acalculous cholecystitis and LLL PNA. He was treated with IV amp/sulbactam, that was then transitioned to vanc/zosyn, and then to augmentin+azithromycin to complete as an outpatient. He was then admitted 24 hours later to ___ for volume overload. Paracentesis with 0.9L fluid out, no SBP. Was diuresed with IV lasix. On discharge, Lasix 10mg was stopped, and he was started on Torsemide 20mg, and Spironolactone increased from 25mg to 50mg. Presented to BI again ___ for dizziness and fatigue, likely ___ overdiuresis. addition of Torsemide at OSH. Received IV Albumin for 3 days, and although orthostatics normalized, his dizziness did not completely resolve. Meclizine started ___ with moderate effect. Started back on prior home doses of Lasix 10mg and Spironolactone 25mg daily. Given rising potassium (5.3) on day of discharge, Spironolactone was stopped on discharge (___). Past Medical History: PAST MEDICAL HISTORY: - HCV/EtOH cirrhosis (Child B), c/b HCC s/p RFA - HIV well controlled - HTN - PTSD - Mood disorder - Penetrating thoracic aortic ulcer of the descending thoracic aorta s/p TEVAR ___ - Cervical disk herniation - GIB - ?COPD PAST SURGICAL HX: - Lipoma removal L upper arm - Facial reconstruction s/p MVA (wire mesh) after accident ___ y/o (bicycle accident) - ___: Thoracic endograft repair for penetrating thoracic aortic ulcer of the descending thoracic aorta - b/l ___ metacarpal injuries s/p repair Social History: ___ Family History: CAD in mother Physical ___: ADMISSION EXAM ============== VS: 98.0 PO 158 / 98 70 18 96 Ra GENERAL: well appearing, no NAD HEENT: AT/NC, PERRL, EOMI. OP clear, adentulous NECK: supple, no LAD, no elevated JVP CARDIAC: RRR, (+)S1, S2, no m/r/g PULMONARY: prolonged expiratory phase, no wheeze/rales/rhonchi ABDOMEN: soft, mild distended, diffuse TTP, negative ___ sign, (+)BS EXTREMITIES: WWP, no edema SKIN: few red patches, excoriations NEUROLOGIC: AAOx3, moves all extremities spontaneously, no asterixis PSYCHIATRIC: appropriate, interactive DISCHARGE EXAM ============== VS: T 97.9, BP 138 / 87, P79, RR18, PO2 97 Ra GENERAL: well appearing, no NAD HEENT: AT/NC, PERRL, EOMI. OP clear; scleral icterus CARDIAC: RRR, (+)S1, S2, no murmurs PULMONARY: distant lung sound, no crackles or rhonchi ABDOMEN: soft, mild distension, negative Murphys; epigastric TTP EXTREMITIES: WWP, trace edema bilaterally NEUROLOGIC: AAOx3, no asterixis Pertinent Results: ADMISSION LABS =============== ___ 09:05AM BLOOD WBC-10.7* RBC-3.95* Hgb-14.2 Hct-41.8 MCV-106* MCH-35.9* MCHC-34.0 RDW-17.3* RDWSD-68.1* Plt ___ ___ 09:05AM BLOOD Neuts-80* Bands-1 Lymphs-9* Monos-6 Eos-4 Baso-0 ___ Myelos-0 AbsNeut-8.67* AbsLymp-0.96* AbsMono-0.64 AbsEos-0.43 AbsBaso-0.00* ___ 09:05AM BLOOD Plt Smr-LOW* Plt ___ ___:16AM BLOOD ___ PTT-29.5 ___ ___ 09:05AM BLOOD Glucose-133* UreaN-16 Creat-0.7 Na-139 K-5.1 Cl-106 HCO3-21* AnGap-12 ___ 09:05AM BLOOD ALT-100* AST-176* AlkPhos-205* TotBili-3.3* ___ 09:05AM BLOOD Lipase-63* ___ 09:05AM BLOOD Albumin-3.2* Calcium-8.5 Phos-3.5 Mg-2.1 MICRO/OTHER PERTINENT LABS =========================== ___ 9:17 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: < 10,000 CFU/mL. DISCHARGE LABS ============== ___ 06:50AM BLOOD WBC-8.8 RBC-3.56* Hgb-12.9* Hct-38.5* MCV-108* MCH-36.2* MCHC-33.5 RDW-17.2* RDWSD-69.2* Plt Ct-86* ___ 06:50AM BLOOD ___ PTT-66.4* ___ ___ 06:50AM BLOOD Glucose-88 UreaN-14 Creat-0.7 Na-142 K-4.7 Cl-105 HCO3-24 AnGap-13 ___ 06:50AM BLOOD ALT-100* AST-158* AlkPhos-160* TotBili-3.0* ___ 06:50AM BLOOD Calcium-8.6 Phos-3.5 Mg-2.2 Brief Hospital Course: Outpatient Providers: ___ yo M w/medical history notable for HCV/EtOH cirrhosis (Child B) c/b ___ s/p RFA ___, ascites, varices/PHG, HIV (most recent CD4 ___ with multiple recent admissions (last discharge ___, presenting with abd pain/volume overload. # Abdominal pain: in the setting of cirrhosis, there was initial concern for decompensation with volume overload and acutely worsened abd pain. No PVT on RUQ US, no ascites (on CT and bedside US). HCC lesion in right lobe appeared stable in size but with enhancement on recent MRI and CT, with concern for recurrence in the setting of rapidly rising AFP levels. However, multiphase CT did not show evidence of infiltrative HCC. CT thorax was done showing no metastatic lesions. LFTs and Tbili were elevated but near baseline. Lipase was normal with low concern for pancreatitis. Had new penetrating atheroma seen on CT, but vascular surgery said it was stable and no intervention was appropriate at this time. Abdominal pain thought to be secondary to GERD and PPI was increased to BID dosing. Patient to follow with vascular surgery outpatient. # Volume overload: discharged ___ on Lasix 10mg, and was taken off spironolactone due to hyperK. Weight 185 on ___, admission 192 (up 7 lbs). Likely ___ to suboptimal diuretic regimen. Received IV Lasix with improvement of weight and euvolemic on exam. Transitioned to lasix 40mg po. Will need close monitoring of electrolytes on increased dose. Discharge Cr 1.3. Discharge weight 185.6 lb. #New Penetrating atheroma on CT: patient with hx of penetrating descending thoracic aortic ulcers s/p TEVAR ___ here w/ abdominal pain. As per vascular surgery, there are several scans within the past year that look very similar to the most recent and there has not been any recent change in the aneurysm size over the past 6 months. There is perhaps 1-2mm growth compared to the scan from 16 months ago but this is consistent with normal progression. He is a poor candidate for open surgery. Given apparent stability on imaging, treatment deferred unless there is significant growth or convincing symptoms attributable to the aorta. Patient has had stable vital signs, and with inconsistent description of pain. Vascular will follow and monitor outpatient. #Coagulopathy: INR up from baseline 1.5-->1.8 on admission. Likely ___ liver disease, but could also be secondary to inadequate po. s/p po vitK 5mg, back down to 1.5. # EtOH/HCV Cirrhosis MELD 16(Child B) - HE: hx in the past. Continued on rifaxmin 550 BID and lactulose 30ml QID. Patent portal vein on US ___ - GIB/VARICES: last EGD in ___ showed 2 small cords of varices and PHG, no banding, not on nadolol. Repeat EGD ___ with no varices - ASCITES: h/o ascites in the past requiring paracentesis. No ascites on US ___. Now on Lasix 40mg (home dose 10mg daily and off spirono last admission). - SBP: No hx, no need for ppx at this time - HCV status: untreated; genotype 3A, VL 256,000 (diagnosed ?___ ago, thinks it was a from car accident when he was ___ old with blood transfusion) - ___: history of ___ s/p RFA ___, and of note, review of his recent labs shows a persistently rising AFP level of AFP 491.8 from 278.3. US ___ with stable lesion in right lobe 2.1 x 1.9 x 1.7 cm at the site of prior ablation. MR abd ___ with mild enhancement at inferior aspect of ablation cavity unchanged from ___. Multiphase CT with same intensity around ablated region, no infiltrative cancer. CT chest without metastases. Will follow with liver clinic and liver tumor clinic outpatient. - Transplant list: was to be listed again. Original concern for ___ met to left acromion but diagnosed as subchondral cyst by ortho - MELD at discharge: 15. # HIV: His HIV is well controlled. His most recent CD4 was ___, and his VL was less than assay. Continued on home descovy and dolutegravir. # HLD - continued home atorvastatin # Supplementation - continued home calcium. # Insomnia - continued ramelteon # COPD- continued home albuterol and ipratropium PRN TRANSITIONAL ISSUES ================== #Discharge weight: 185.6 lb [ ] f/u PCP in ___ week to monitor electrolyes and Cr [ ] can decrease PPI back to once daily from BID if no improvement in abdominal pain [ ] f/u liver clinic for transplant workup [ [ f/u liver tumor clinic for ___ s/p RFA now with rising AFP (no infiltrative HCC on multiphase CT and no mets in the chest) [ ] f/u vascular surgery outpatient for monitoring of atheroma. #Code status: full #Contact: ___, ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 10 mg PO QPM 2. Calcium Carbonate 500 mg PO BID 3. Descovy (emtricitabine-tenofovir alafen) 200-25 mg oral DAILY 4. Dolutegravir 50 mg PO DAILY 5. Lactulose 30 mL PO TID 6. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Mild 7. Rifaximin 550 mg PO BID 8. TraZODone 100 mg PO QHS:PRN insomnia 9. Multivitamins 1 TAB PO DAILY 10. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN 11. ipratropium-albuterol ___ mcg/actuation inhalation Q6H:PRN 12. Ondansetron 4 mg PO Q8H:PRN nausea 13. Furosemide 10 mg PO DAILY Discharge Medications: 1. Furosemide 40 mg PO DAILY RX *furosemide 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 3. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN 4. Atorvastatin 10 mg PO QPM 5. Calcium Carbonate 500 mg PO BID 6. Descovy (emtricitabine-tenofovir alafen) 200-25 mg oral DAILY 7. Dolutegravir 50 mg PO DAILY 8. ipratropium-albuterol ___ mcg/actuation inhalation Q6H:PRN 9. Lactulose 30 mL PO TID 10. Multivitamins 1 TAB PO DAILY 11. Ondansetron 4 mg PO Q8H:PRN nausea 12. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Mild 13. Rifaximin 550 mg PO BID 14. TraZODone 100 mg PO QHS:PRN insomnia 15.Outpatient Lab Work 571.5 CMP with LFTs, ___, CBC on ___ and fax results to liver center ATTN Dr. ___: ___ Discharge Disposition: Home Discharge Diagnosis: PRIMARY: Abdominal pain HCV Cirrhosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, WHY WAS I ADMITTED TO THE HOSPITAL? -You had worsening of your abdominal pain and your weight went up. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? -You received IV Lasix to remove the extra fluid. -You had imaging of your abdomen which did not show any concerning findings. We think reflux might be causing your abdominal pain. - You had imaging of your liver that did not show any progression of the cancer. - You had imaging of your chest that showed no spread of cancer. - You had imaging of your aorta that showed a plaque/ballooning of the vessel that is common after surgery, but will need to be monitored closely by vascular surgery. WHAT SHOULD I DO WHEN I GO HOME? -Please weigh yourself every morning, before you eat or take your medications. Please call your doctor if your weight changes by more than 3 pounds in one day or more than 5 pounds in three days. -Please continue to make your medications as prescribed. You will now take your pantoprazole twice a day to help with the abdominal pain. You are now on lasix 40mg daily for your swelling. -Please keep your appointments with your team of doctors. -___ will need to call ___ to confirm appointment with Dr. ___ (vascular surgery. This is VERY important. WHEN SHOULD I COME BACK TO THE HOSPITAL? - If you have fevers, chills, confusion, worsening abdominal pain, diarrhea, vomiting, or blood or black in your stool. - If you have any symptoms that concern you. Thank you for letting us be a part of your care! Your ___ Team Followup Instructions: ___
10760122-DS-20
10,760,122
29,707,276
DS
20
2120-09-15 00:00:00
2120-09-15 15:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / epidural injection / tramadol / Tylenol Attending: ___ Chief Complaint: Abdominal Pain Major Surgical or Invasive Procedure: EGD History of Present Illness: ___ with history of Hep C cirrhosis (Childs B), HIV (CD4 1106 ___ who presents from home with abdominal pain. Patient has many recent admissions for abdominal pain with some equivocal imaging for cholecystitis, however surgical teams have not considered him to have acute cholecystitis and so no intervention pursued. Patient states he was recently hospitalized at ___ ___ for severe lower R-sided abd pain. He says they mostly just monitored him, no procedures were pursued, and he was discharged on ___ mostly because he wanted to leave. This morning he was at home and had recurrent severe R-sided lower abd pain. This radiates up to his RUQ. No associated n/v/d. No diaphoresis. He then presented to the ED. Past Medical History: PAST MEDICAL HISTORY: - HCV/EtOH cirrhosis (Child B), c/b HCC s/p RFA - HIV well controlled - HTN - PTSD - Mood disorder - Penetrating thoracic aortic ulcer of the descending thoracic aorta s/p TEVAR ___ - Cervical disk herniation - GIB - ?COPD PAST SURGICAL HX: - Lipoma removal L upper arm - Facial reconstruction s/p MVA (wire mesh) after accident ___ y/o (bicycle accident) - ___: Thoracic endograft repair for penetrating thoracic aortic ulcer of the descending thoracic aorta - b/l ___ metacarpal injuries s/p repair Social History: ___ Family History: CAD in mother Physical ___: ADMISSION PHYSICAL EXAM: ======================== VITALS: T 97.8 BP 128/70 HR 82 RR 14 O2 94% RA General: Alert, oriented, no acute distress HEENT: slight scleral icterus CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: severe TTP diffusely, most notable in RUQ and RLQ GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Warm, dry, no rashes or notable lesions. Neuro: no asterixis DISCHARGE PHYSICAL EXAM: ======================== VS: T 97.7 BP 107 / 68 HR 62 RR 16 O2 95% RA Weight: (188 lb admission) 192.31 lb GENERAL: Tired appearing, NAD, AAOx3 HEENT: NCAT, MMM, anicteric sclera NECK: Neck supple, no JVD HEART: RRR, no MRG, 2+ radial pulses LUNGS: CTAB, no increased work of breathing ABDOMEN: Soft, nondistended, tenderness to palpation throughout abdomen, particularly RUQ/RLQ. EXTREMITIES: Warm and well-perfused, no edema or cyanosis. Clubbing of the fingernails. NEURO: AAOx3, CN II-XII grossly intact. Asterixis not present SKIN: no jaundice Pertinent Results: ADMISSION LABS: ================ ___ 03:15PM BLOOD WBC-9.6 RBC-3.66* Hgb-13.7 Hct-40.0 MCV-109* MCH-37.4* MCHC-34.3 RDW-17.2* RDWSD-69.7* Plt Ct-79* ___ 03:15PM BLOOD Neuts-71.8* Lymphs-16.4* Monos-7.7 Eos-3.1 Baso-0.2 Im ___ AbsNeut-6.84* AbsLymp-1.57 AbsMono-0.74 AbsEos-0.30 AbsBaso-0.02 ___ 03:15PM BLOOD ___ PTT-41.4* ___ ___ 03:15PM BLOOD Glucose-101* UreaN-9 Creat-0.7 Na-138 K-4.7 Cl-104 HCO3-26 AnGap-8* ___ 03:15PM BLOOD ALT-176* AST-304* AlkPhos-193* TotBili-4.1* ___ 05:25AM BLOOD Albumin-2.6* Calcium-8.1* Phos-2.9 Mg-1.5* ___ 03:22PM BLOOD Lactate-1.5 IMAGING: ======== ___ LIVER/GALLBLADDER ULTRASOUND IMPRESSION: 1. Cirrhotic liver with moderate perihepatic ascites. 2. Gallbladder is distended with wall thickening, similar to multiple prior studies. 3. Patent portal vein. ___ MRCP IMPRESSION: 1. Cirrhotic liver morphology. Unable to evaluate for hepatocellular carcinoma given extensive artifact from thoracic vascular stent graft. Screening examinations should be done with multiphasic CT. 2. Decreased gallbladder distension with persistent mild wall edema, findings are most likely related to background liver disease especially in the setting of a normal HIDA scan. 3. Normal biliary tree. ___ CTA ABDOMEN Cirrhotic liver morphology with evidence of portal hypertension and new trace ascites. Findings are again concerning for recurrence inferior to the treatment segment VII cavity, stable from prior exam. DISCHARGE LABS: =============== ___ 05:48AM BLOOD WBC-7.1 RBC-3.37* Hgb-12.3* Hct-36.3* MCV-108* MCH-36.5* MCHC-33.9 RDW-17.5* RDWSD-70.4* Plt Ct-81* ___ 05:48AM BLOOD ___ PTT-72.6* ___ ___ 05:48AM BLOOD Glucose-108* UreaN-13 Creat-0.7 Na-141 K-4.5 Cl-109* HCO3-26 AnGap-6* ___ 05:48AM BLOOD ALT-123* AST-217* AlkPhos-155* TotBili-3.4* ___ 05:48AM BLOOD Albumin-2.0* Mg-1.7 Brief Hospital Course: PATIENT SUMMARY ___ with history of Hep C cirrhosis who presents from home with severe acute on chronic abdominal pain, with a hepatocellular and cholestatic liver injury pattern, but with negative workup including HIDA scan and MRCP. CTA Liver showed recurrence of his known HCC, s/p RFA in the past. The patient had persistent pain, and his course was complicated by one day of axillary fevers. He was discharged with plan for follow up of his recurrent HCC for radiofrequency ablation, which may help his pain. ACTIVE ISSUES ================ #Acute on chronic Abdominal pain: Patient has been in and out of hospitals for months due to abdominal pain, which has been steadily worsening. There was no ascites pocket seen on ultrasound for ___ to tap, thus making SBP less likely as a potential cause. On prior admission, his CT A/P was not consistent with any acute abdominal process, per surgery. His RUQUS showed gallbladder wall distension and a patent portal vein. Subsequent imaging was also unremarkable, including an MRCP and a HIDA scan. However, there is still no identified etiology for his persistent transaminitis and bilirubin elevation over past several months. His case was discussed at the ___ Surgery Conference. They suggested a CTA liver, which showed interval recurrence of his known HCC inferior to the treatment segment VII cavity, which could be contributing to his pain. and it was suggested that outpatient Radiofrequency Ablation be performed, in the setting of recurrent tumor seen on CT with rising AFP. His pain was controlled with Oxycodone (7.5 mg q6h PRN initially, weaned back to 5mg q6h PRN). Amytriptiline was started to help with a possible component of somatic symptom disorder, which seemed to help. He was discharged with close outpatient follow up. #Fever: Patient was febrile by axillary temperature on ___, but never by PO measurement. He was pancultured (Blood and urine cultures were all negative). CXR was also negative. He was given IV Fluids, and his fever curve was trended with no further fevers. #Hep C cirrhosis: #Coagulopathy #HCC s/p radiofrequency ablation Childs C on admission, MELD-Na 19 with history HE and ___ s/p RFA, but no history ascites or varices. Last EGD on ___ showed no varices. INR was 1.8 on ___, for which he was given Vitamin K. HIDA scan was normal. MRCP was unremarkable except for mild gallbladder wall edema. CTA liver with interval recurrence inferior to the treatment segment VII cavity, stable from prior imaging. His last EGD was on ___, with no evidence varices. His home Spironolactone and Lasix were continued, as were Lactulose and Rifaximin. Plan for outpatient RFA in the setting of recurrence with rising AFP, although patient is very worried that this will jeopardize his position on the transplant list. STABLE ISSUES: ================ #HIV: Stable on Dolutegravir + Emtricitabine + Tenofovir, well controlled with CD4 count of 1,106 and Viral Load of 1.4 on ___. #Penetrating thoracic aortic ulcer of the descending thoracic Aorta s/p TEVAR ___. No intervention per recent vascular note. Continue outpatient follow up with vascular. #HTN: Continued diuresis with Lasix, ___ as above. #HLD: Continued Atorvastatin 10. #COPD: Continued Duonebs q6h prn. ======================= TRANSITIONAL ISSUES ======================= [ ] Continue ___ RFA, scheduled for ___. [ ] Follow up with transplant clinic on ___. [ ] Can consider up titrating amitriptyline for pain control. [ ] Continue to follow with vascular for penetrating thoracic aorta. [ ] Consider metoclopramide for functional pain if Amitriptyline does not help. #Discharge Stats -INR at discharge: 1.7 -Cr at discharge: 0.7 -Weight at discharge: 87.14 kg (192.11 lb) #New meds: - Acetaminophen 1000mg BID - Amitriptyline 25mg QHS - Maalox/Diphenhydramine/Lidocaine 15 mL PO TID - Miralax and Senna #Changed meds: - Oxycodone 5 mg q6h prn pain (prescribed 15 tabs) #Code status: Full (confirmed) #Health care proxy/emergency contact: ___ (son) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN 2. Atorvastatin 10 mg PO QPM 3. Calcium Carbonate 500 mg PO BID 4. Descovy (emtricitabine-tenofovir alafen) 200-25 mg oral DAILY 5. Dolutegravir 50 mg PO DAILY 6. Lactulose 30 mL PO QID 7. Multivitamins 1 TAB PO DAILY 8. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Mild 9. Rifaximin 550 mg PO BID 10. ipratropium-albuterol ___ mcg/actuation inhalation Q6H:PRN 11. Ondansetron 4 mg PO Q8H:PRN nausea 12. TraZODone 100 mg PO QHS:PRN insomnia 13. Pantoprazole 40 mg PO Q12H 14. Furosemide 40 mg PO DAILY 15. Spironolactone 25 mg PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO BID RX *acetaminophen 500 mg 2 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 2. Amitriptyline 25 mg PO QHS RX *amitriptyline 25 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills:*0 3. Maalox/Diphenhydramine/Lidocaine 15 mL PO TID RX *alum-mag hydroxide-simeth [Maalox Maximum Strength] 400 mg-400 mg-40 mg/5 mL 15 mL by mouth three times a day Refills:*0 4. Polyethylene Glycol 17 g PO DAILY:PRN constipation RX *polyethylene glycol 3350 17 gram/dose 1 powder(s) by mouth daily Refills:*0 5. Senna 8.6 mg PO BID RX *sennosides [senna] 8.6 mg 1 tab by mouth twice a day Disp #*30 Tablet Refills:*0 6. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Severe RX *oxycodone 5 mg 1 tablet(s) by mouth every eight (8) hours Disp #*15 Tablet Refills:*0 7. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN 8. Atorvastatin 10 mg PO QPM 9. Calcium Carbonate 500 mg PO BID 10. Descovy (emtricitabine-tenofovir alafen) 200-25 mg oral DAILY 11. Dolutegravir 50 mg PO DAILY 12. Furosemide 40 mg PO DAILY 13. ipratropium-albuterol ___ inh inhalation Q6H:PRN dyspnea 14. Lactulose 30 mL PO QID 15. Multivitamins 1 TAB PO DAILY 16. Ondansetron 4 mg PO Q8H:PRN nausea 17. Pantoprazole 40 mg PO Q12H 18. Rifaximin 550 mg PO BID 19. Spironolactone 25 mg PO DAILY 20. TraZODone 100 mg PO QHS:PRN insomnia Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS Acute on chronic Abdominal Pain SECONDARY DIAGNOSES Hepatocellular Carcinoma Hep C Cirrhosis HIV HTN Known Thoracic Aorta Ulcer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking part in your care at ___. WHY WAS I ADMITTED TO THE HOSPITAL? ==================================== - You were having belly pain. WHAT HAPPENED TO ME WHILE I WAS IN THE HOSPITAL? ================================================== - Your HIDA scan and MRCP (abdominal MRI) were all negative and did not reveal a cause for the belly pain. - Your CT scan was the same as before, and we felt it best for you to continue the microwave RFA treatments. - Your pain was controlled with medications and you were able to eat. WHAT SHOULD I DO WHEN I LEAVE THE HOSPITAL? ============================================ - Your medications have changed. See the list below. - Your follow up appointments are below. - Continue the microwave RFA treatments. WHEN SHOULD I RETURN TO THE HOSPITAL? ====================================== - If you are having more severe pain that is not controlled by the medications. - If you are unable to eat, or having severe nausea and vomiting. Sincerely, Your ___ Treatment Team Followup Instructions: ___
10760122-DS-25
10,760,122
21,187,951
DS
25
2120-12-28 00:00:00
2120-12-28 14:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / epidural injection / tramadol / Tylenol Attending: ___ Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Large volume paracentesis ___ History of Present Illness: Mr. ___ is a ___ year old gentleman with history of HCV cirrhosis (Child C/___, MELD 24) in the setting of HIV coinfection, complicated by portal hypertension (rectal varices, ascites, hepatic encephalopathy), and metastatic HCC with mets to shoulder s/p resection and palliative XRT, with plan to start sorafenib who presents with abdominal pain and worsening volume overload. Patient was recently seen in ___ clinic, with increased abdominal ascites and weight increase from 180s to 204 pounds. At that time he denied any other fevers or chills, but did complain of new RUQ abdominal pain. He received a diagnostic and therapeutic paracentesis on ___, with no evidence of SBP, but only 210 mL of ascites fluid was able to be removed per radiology note and per patient. Patient notes he isn't quite sure why they were unable to remove more fluid, but that the person doing the procedure was communicating with an attending 2 doors away. For his new RUQ abdominal pain, he received ultrasound, which did not demonstrate any new lesions, only old radiofrequency ablation site in right hepatic lobe, and increased ascites. Portal venous system was unable to be well assessed. His home furosemide and spironolactone dosing were increased, per notes to spironolactone 150 mg daily and furosemide 60 mg daily, but patient reports taking spironolactone 100 mg and furosemide 100 mg daily. Patient also notes new onset of epigastric abdominal pain for the past week, described as like someone stabbing him with needle, with oxycodone as the only thing that helps. He notes minimal urine output to increased dose of diuretics, with persistent weight gain, now to 210 lbs. He notes increased shortness of breath with exertion, such that he is unable to cook/clean for himself now and his sister is helping him. Although his legs are swollen, he does not think they are more edematous than usual. No fevers, chills, confusion, black or bloody stools. On ___, due to concern for worsening abdominal pain/distension and jaundice, he was advised to present to ED for labs and attempt at another large volume paracentesis. In the ED, initial VS were: 95.9 98 ___ 97% RA Exam notable for: severe abdominal ttp, trace pedal edema Labs showed: WBC 7.0 Hgb 12.6 Plt 109 133 | 98 | 9 ------------- 3.8 | 25 | 0.8 ALT 37 AST 82 AlkPhos 243 Tbili 5.0 Alb 2.5 Lactate 1.5 Ascites: WBC 294, 6% poly, RBC 64, protein 0.5, glucose 101 U/A 7 WBC, mod leuk, neg nitr Imaging showed: ___ CT A/P with contrast 1. No free intraperitoneal air. No evidence of liver bowel injury. 2. Cirrhotic liver with moderate ascites, minimally increased from prior. Overall slight decrease in size of prior ablation site in segment 7 of the liver. 3. Distal descending thoracic aortic aneurysm measuring up to 4.0 Cm superior to the stent and suprarenal aortic aneurysm measuring up to 4.0 cm in greatest diameter just inferior to the endovascular stent are unchanged compared to prior. ___ CXR Subsegmental atelectasis in the lung bases. No pneumothorax. Small left pleural effusion. Consults: Hepatology "Given worsening pain not controlled after recent outpatient clinic visit and attempt at large volume para, I suspect he will require admission for re-attempt at LVP +/- pain control. Labs ordered, not yet pending. Vitals with HR 98 and BP 110/73. Diagnostic para if labs worse, if febrile, or abdominal pain is worse than 2 days ago. Admit to ___ if stable for the floor. Patient received: ___ 20:44 IV Morphine Sulfate 4 mg ___ ___ 22:46 PO/NG Amitriptyline 25 mg ___ ___ 22:46 PO/NG Lactulose 30 mL ___ ___ 22:46 PO/NG Magnesium Oxide 800 mg ___ ___ 22:46 PO/NG OxyCODONE (Immediate Release) 10 mg ___ ___ 22:46 PO OxyCODONE SR (OxyconTIN) 10 mg ___ Past Medical History: 1. Penetrating thoracic aortic aneurysm of the descending aorta status post TAVR on ___ 2. Cirrhosis ___ chronic genotype hepatitis C, ETOH 3. Hypertension 4. PTSD 5. Cervical disc herniations 6. Gastritis with bleeding 7. Lipoma 8. HIV on ART Social History: ___ Family History: Mom with CAD. Multiple prior family malignancies. The patient is unsure of the type. Physical Exam: ADMISSION EXAM: =============== VS: ___ 0020 Temp: 97.9 PO BP: 119/83 L Lying HR: 104 RR: 20 O2 sat: 94% O2 delivery: Ra GENERAL: NAD, lying in bed with 2 pillows HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Distended and tense, + fluid wave, TTP most markedly in RUQ and epigastrium without rebound or guarding, paracentesis site in L flank c/d/i EXTREMITIES: +clubbing (per patient chronic), 2+ edema to level of knee PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose, + asterixis SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE EXAM: =============== VS: 97.4 123/85 97 18 99%RA GENERAL: NAD, ambulating independently HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, JVP at 8 cm H2O HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Soft, + fluid wave, TTP in RUQ without rebound or guarding, paracentesis site in L flank c/d/I. EXTREMITIES: +clubbing (per patient chronic), 2+ edema to level of knee. Difficulty lifting left arm/shoulder due to "cancer" in the bone. PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, no asterixis noted. SKIN: Pale lower extremities, warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LABS: =============== ___ 10:00PM ASCITES TOT PROT-0.5 GLUCOSE-101 ___ 10:00PM ASCITES TNC-294* RBC-64* POLYS-6* LYMPHS-26* ___ MESOTHELI-4* MACROPHAG-62* OTHER-2* ___ 05:52PM LACTATE-1.5 ___ 05:40PM GLUCOSE-84 UREA N-9 CREAT-0.8 SODIUM-133* POTASSIUM-3.8 CHLORIDE-98 TOTAL CO2-25 ANION GAP-10 ___ 05:40PM ALT(SGPT)-37 AST(SGOT)-82* ALK PHOS-243* TOT BILI-5.9* DIR BILI-2.9* INDIR BIL-3.0 ___ 05:40PM LIPASE-29 ___ 05:40PM ALBUMIN-2.5* ___ 05:40PM WBC-7.0 RBC-3.54* HGB-12.6* HCT-36.4* MCV-103* MCH-35.6* MCHC-34.6 RDW-19.7* RDWSD-74.6* ___ 05:40PM NEUTS-66.6 LYMPHS-17.8* MONOS-11.1 EOS-2.7 BASOS-0.7 IM ___ AbsNeut-4.63 AbsLymp-1.24 AbsMono-0.77 AbsEos-0.19 AbsBaso-0.05 ___ 05:40PM PLT COUNT-109* ___ 05:40PM ___ PTT-42.7* ___ ___ 04:06PM URINE HOURS-RANDOM ___ 04:06PM URINE HOURS-RANDOM ___ 04:06PM URINE UHOLD-HOLD ___ 04:06PM URINE GR HOLD-HOLD ___ 04:06PM URINE COLOR-Yellow APPEAR-Hazy* SP ___ ___ 04:06PM URINE BLOOD-TR* NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-MOD* ___ 04:06PM URINE RBC-2 WBC-7* BACTERIA-FEW* YEAST-NONE EPI-0 ___ 04:06PM URINE HYALINE-4* ___ 04:06PM URINE MUCOUS-OCC* DISCHARGE LABS: =============== MICRO: ====== ___ 10:00 pm PERITONEAL FLUID PERITONEAL FLUID. GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. This is a concentrated smear made by cytospin method, please refer to hematology for a quantitative white blood cell count.. FLUID CULTURE (Preliminary): ANAEROBIC CULTURE (Preliminary): IMAGING: ======== Chest PA/Lateral ___: FINDINGS: Heart size is normal. The aorta remains tortuous. Mediastinal and hilar contours are unremarkable. Pulmonary vasculature is not engorged. Subsegmental atelectasis is seen in the lung bases. Small left pleural effusion is noted. No right-sided pleural effusion or pneumothorax is detected. No subdiaphragmatic free air is present. Stent graft is seen within the distal descending thoracic/proximal abdominal aorta. IMPRESSION: Subsegmental atelectasis in the lung bases. No pneumothorax. Small left pleural effusion. CT ABDOMEN/PELVIS ___: IMPRESSION: 1. No free intraperitoneal air. No evidence of liver bowel injury. 2. Cirrhotic liver with moderate ascites, minimally increased from prior. Overall slight decrease in size of prior ablation site in segment 7 of the liver. 3. Distal descending thoracic aortic aneurysm measuring up to 4.0 Cm superior to the stent and suprarenal aortic aneurysm measuring up to 4.0 cm in greatest diameter just inferior to the endovascular stent are unchanged compared to prior. Brief Hospital Course: PATIENT SUMMARY: ================ Mr. ___ is a ___ year old gentleman with history of HCV cirrhosis (Child ___, MELD ___) in the setting of HIV coinfection, complicated by portal hypertension (rectal varices, ascites, hepatic encephalopathy), and metastatic HCC with metastatic disease to left shoulder s/p resection and palliative XRT, who presented with RUQ/epigastric abdominal pain and volume overload. # HCV Cirrhosis (Child ___, MELD 24) Patient presented with worsening volume overload despite increasing outpatient diuretics. Outpatient hepatologist believed patient would benefit from repeat attempt at large volume paracentesis, unclear why only 210 mL was able to be removed during last attempt. SAAG > 1.1, consistent with portal hypertension, no evidence of SBP on diagnostic paracentesis. He does have asterixis on exam at this time. Continued home spironolactone 150 mg and furosemide 60 mg daily. Patient underwent therapeutic paracentesis with 1.5 L of ascitic fluid removed. Patient's abdominal pain improved after the paracentesis. Continued Lactulose 30 mL QID, titrated to ___ BM daily and home rifaxamin 550 mg daily. # Hyperbilirubinemia # RUQ/epigastric abdominal pain Etiology of abdominal pain is unclear with no evidence of complication from recent paracentesis on CT A/P, as well as no evidence of intrahepatic or extrahepatic biliary dilation. No new liver lesions identified, and gallbladder appeared WNL. Lipase WNL, making pancreatitis unlikely. Certainly worsening ascites can contribute to pain, although focal nature is unusual. Pain improved following large volume paracentesis. Pain controlled with oxycodone 5 mg q4H and oxycontin 10 mg BID. # HCC with known bony metastases to L shoulder Per most recent oncology notes, patient planned to start on sorafenib at reduced dose of 200 mg BID after risk/benefit discussion, though this is a regimen that may be contraindicated with child ___ class C cirrhosis or poor liver function. He has yet to start this medication pending delivery. He is otherwise s/p RFA x 2 and palliative XRT to the shoulder. Pain controlled with above oxycodone regimen. CHRONIC ISSUES: =============== # HIV on ART: Last CD4 count ___ Continued home dolutegravir 50 mg daily and descovy 1 tab daily. # Hyperlipidemia Continued home atorvastatin 10 mg daily. # PTSD/insomnia Continued amitriptyline 25 mg PO QHS. # Supplements Continued home magnesium oxide 800 mg BID and Vitamin D 800 UNITP O DAILY. # Macrocytic anemia Chronic, improved from prior. Hgb 12.1 on admission. TRANSITIONAL ISSUES: ==================== [ ] Please schedule follow up with Dr. ___ in next week or two as you may need repeat large volume paracentesis. [ ] Would consult with your liver doctor prior to travel. [ ] Would consider further up-titrating outpatient diuretic regimen #CODE: DNR/DNI (on MOLST from ___ and confirmed with pt) #CONTACT: ___ (son/HCP) ___ ___ (friend) ___ Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Lactulose 30 mL PO QID 2. Magnesium Oxide 800 mg PO BID 3. Sorafenib 200 mg PO Q12H 4. Bisacodyl 10 mg PO DAILY:PRN constipation 5. Dolutegravir 50 mg PO DAILY 6. Atorvastatin 10 mg PO QPM 7. Furosemide 60 mg PO DAILY 8. Spironolactone 150 mg PO DAILY 9. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 10. Rifaximin 550 mg PO DAILY 11. Amitriptyline 25 mg PO QHS 12. Vitamin D 800 UNIT PO DAILY 13. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 14. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB PO DAILY Discharge Medications: 1. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 3. Amitriptyline 25 mg PO QHS 4. Atorvastatin 10 mg PO QPM 5. Bisacodyl 10 mg PO DAILY:PRN constipation 6. Dolutegravir 50 mg PO DAILY 7. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB PO DAILY 8. Furosemide 60 mg PO DAILY 9. Lactulose 30 mL PO QID 10. Magnesium Oxide 800 mg PO BID 11. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 12. Rifaximin 550 mg PO DAILY 13. Sorafenib 200 mg PO Q12H 14. Spironolactone 150 mg PO DAILY 15. Vitamin D 800 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY: ======== HCV cirrhosis HCC HIV Refractory ascites SECONDARY: ========== Hypertension PTSD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. WHY WERE YOU IN THE HOSPITAL? - You were referred to the hospital by Dr. ___ in order to help remove extra fluid that had accumulated in your abdomen. We think this caused your belly pain. WHAT HAPPENED IN THE HOSPITAL? - You had a CT scan of the abdomen which was overall unchanged when compared to prior. - You had a large volume paracentesis performed. - This showed that you did not have an infection. - 1.5 liters of fluid was removed from your abdomen. WHAT SHOULD YOU DO AFTER LEAVING THE HOSPITAL? - You should continue to take all of your medications as prescribed. - You should follow up with your doctors as ___ below. - IF you notice the size of your belly increasing, call your liver doctor to discuss increasing the frequency of your Lasix or scheduling an appointment to have fluid taken off. We wish you the best, Your ___ Care Team Followup Instructions: ___
10760122-DS-26
10,760,122
22,048,195
DS
26
2121-01-04 00:00:00
2121-01-05 17:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / epidural injection / tramadol / Tylenol Attending: ___ Chief Complaint: Abdominal pain Major Surgical or Invasive Procedure: Ultrasound-guided diagnostic paracentesis ___ ___ diagnostic paracentesis ___ History of Present Illness: This is a ___ year old gentleman with PMH of HCV cirrhosis (Child C/___, MELD 24), HIV co-infection, portal hypertension (c/b rectal varices, ascites, hepatic encephalopathy), and HCC with metastatic disease to the left shoulder s/p resection and palliative XRT recently admitted for refractory ascites and abdominal pain s/p therapeutic paracentesis now re-presenting with worsening RLQ abdominal pain. Patient was admitted to the liver service at ___ (___) for large volume paracentesis and pain control. The patient underwent diagnostic/therapeutic paracentesis on ___ with 1.5 L ascites removed and subjective improvement in abdominal pain. Ascites fluid without evidence of SBP at that time. The patient's pain was controlled with PO oxycodone and he was discharge home ___ with the plan for outpatient follow up. The patient returned home without any abdominal pain. That night, at approximately 3 AM, he awoke suddenly with a "stabbing" pain in the RLQ of his abdomen. He states that it felt as if his abdomen had popped. The patient was ultimately able to fall back asleep after taking his oxycodone. He then represented to ___ ___ with persistent RLQ abdominal pain. The patient was then transferred back to ___ for further management. In the ED, initial vitals were: Temp 97.6, HR 97, BP 128/75, RR 19, Sa 92% 4L NC. Exam notable for: RLQ tenderness, 2+ pitting edema bilaterally Labs notable for: Na 130, AST 72, ALT 32, AP 180, Tbili 5.8, Dbili 3.0, Alb 2.3, WBC 10.1, H/H 11.4/33.2, Plt 97. Imaging was notable for: - CXR: Mild bilateral pulmonary vascular congestion. - Liver U/S: 1. Cirrhotic liver with moderate ascites. No splenomegaly. Radiofrequency ablation site again demonstrated in the right hepatic lobe. No ___ lesions. 2. Poor visualization of the main portal vein. Patient was given: PO/NG OxyCODONE (Immediate Release) 5 mg PO OxyCODONE SR (OxyconTIN) 10 mg PO/NG Furosemide 60 mg PO/NG Lactulose 30 mL PO/NG Spironolactone 200 mg PO/NG Rifaximin 550 mg PO/NG OxyCODONE (Immediate Release) 5 mg PO/NG Lactulose 30 mL IV Morphine Sulfate 4 mg Hepatology evaluated the patient in ED and recommended: - If stable for floor can admit to ___ under Dr. ___ - Would consider non-contrast imaging for LQG pain since although his Cr is normal now, he just got a CT with contrast a few days ago, a LVP, likely to get another LVP this week, and diuretic-dependent. - Repeat diagnostic para to look for secondary bacterial peritonitis after his recent para. Upon arrival to the floor, patient reports "rebound" tenderness in his lower abdomen. Also states that he feels like he has "gained back all the weight they took off" while he was admitted despite being compliant with his medications. The patient endorses decreased UOP since returning home. He also had some palpitations during the worst of the pain. He also notes that the "inside" of his abdomen feels "hot." He otherwise denies fevers, chills, SOB. Past Medical History: 1. Penetrating thoracic aortic aneurysm of the descending aorta status post TAVR on ___ 2. Cirrhosis ___ chronic genotype hepatitis C, ETOH 3. Hypertension 4. PTSD 5. Cervical disc herniations 6. Gastritis with bleeding 7. Lipoma 8. HIV on ART Social History: ___ Family History: Mom with CAD. Multiple prior family malignancies. The patient is unsure of the type. Physical Exam: ADMISSION EXAM: =============== Temp: 98.3 (Tm 98.3), BP: 116/76, HR: 94, RR: 18, O2 sat: 95%, O2 delivery: Ra, Wt: 197 lb/89.36 kg GENERAL: NAD, lying in bed with shirt lifted up so as not to make contact with abdomen. HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Distended and tense, + fluid wave, TTP most markedly in RLQ and suprapubic region with minimal rebound and voluntary guarding, paracentesis site in R lower flank c/d/i with minimal ecchymosis surrounding puncture site. Sporadic ecchymoses ___. EXTREMITIES: + clubbing (per patient chronic), 2+ pitting edema to level of knee PULSES: 2+ ___ pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose, NO asterixis, pleasant and interactive. SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE EXAM: =============== VITAL SIGNS: 98.1 111/70 96 18 96%RA GENERAL: NAD, lying in bed HEENT: AT/NC, EOMI, PERRL, slightly icteric sclera, pink conjunctiva, MMM NECK: Supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: Slightly distended and tense, TTP most markedly in RLQ and suprapubic region without rebound. EXTREMITIES: + clubbing (per patient chronic), 2+ pitting edema to level of mid-shin PULSES: 2+ ___ pulses bilaterally NEURO: A&Ox3, moving all 4 extremities with purpose, no asterixis, pleasant and interactive. SKIN: warm and well perfused, no excoriations or lesions, no rashes Pertinent Results: ADMISSION LABS: =============== ___ 07:20PM GLUCOSE-88 UREA N-8 CREAT-0.8 SODIUM-129* POTASSIUM-4.0 CHLORIDE-94* TOTAL CO2-29 ANION GAP-6* ___ 07:20PM ALT(SGPT)-34 AST(SGOT)-76* LD(LDH)-310* ALK PHOS-184* TOT BILI-6.6* ___ 07:20PM ALBUMIN-2.2* CALCIUM-8.0* PHOSPHATE-2.4* MAGNESIUM-1.7 ___ 07:20PM ___ ___ 07:20PM HAPTOGLOB-<10* ___ 07:20PM WBC-7.8 RBC-3.27* HGB-11.6* HCT-34.0* MCV-104* MCH-35.5* MCHC-34.1 RDW-19.2* RDWSD-74.0* ___ 07:20PM NEUTS-61.1 ___ MONOS-11.9 EOS-3.3 BASOS-0.5 IM ___ AbsNeut-4.78 AbsLymp-1.71 AbsMono-0.93* AbsEos-0.26 AbsBaso-0.04 ___ 07:20PM PLT COUNT-116* ___ 07:20PM ___ PTT-47.5* ___ ___ 07:20PM ___ ___ 06:33PM ASCITES TNC-1187* RBC-350* POLYS-47* LYMPHS-8* ___ MESOTHELI-2* MACROPHAG-43* ___ 09:10AM ___ PTT-35.2 ___ ___ 03:50AM GLUCOSE-81 UREA N-8 CREAT-0.7 SODIUM-132* POTASSIUM-4.2 CHLORIDE-99 TOTAL CO2-24 ANION GAP-9* ___ 03:50AM ALT(SGPT)-33 AST(SGOT)-73* ALK PHOS-191* TOT BILI-6.3* DIR BILI-3.0* INDIR BIL-3.3 ___ 03:50AM ALBUMIN-2.4* ___ 03:50AM URINE HOURS-RANDOM ___ 03:50AM URINE UHOLD-HOLD ___ 03:50AM WBC-9.4 RBC-3.40* HGB-12.0* HCT-35.0* MCV-103* MCH-35.3* MCHC-34.3 RDW-19.5* RDWSD-73.8* ___ 03:50AM NEUTS-61.5 ___ MONOS-10.9 EOS-2.5 BASOS-0.3 IM ___ AbsNeut-5.77 AbsLymp-2.20 AbsMono-1.02* AbsEos-0.23 AbsBaso-0.03 ___ 03:50AM PLT COUNT-114* ___ 03:50AM URINE COLOR-Yellow APPEAR-Hazy* SP ___ ___ 03:50AM URINE BLOOD-TR* NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-SM* UROBILNGN-NEG PH-6.0 LEUK-SM* ___ 03:50AM URINE RBC-9* WBC-5 BACTERIA-FEW* YEAST-NONE EPI-0 ___ 03:50AM URINE MUCOUS-RARE* ___ 02:00AM GLUCOSE-85 UREA N-8 CREAT-0.7 SODIUM-130* POTASSIUM-4.4 CHLORIDE-98 TOTAL CO2-23 ANION GAP-9* ___ 02:00AM ALT(SGPT)-32 AST(SGOT)-72* ALK PHOS-180* TOT BILI-5.8* ___ 02:00AM ALBUMIN-2.3* ___ 02:00AM WBC-10.1*# RBC-3.22* HGB-11.4* HCT-33.2* MCV-103* MCH-35.4* MCHC-34.3 RDW-19.2* RDWSD-72.8* ___ 02:00AM NEUTS-62.1 ___ MONOS-11.6 EOS-2.3 BASOS-0.6 IM ___ AbsNeut-6.24* AbsLymp-2.23 AbsMono-1.17* AbsEos-0.23 AbsBaso-0.06 ___ 02:00AM PLT COUNT-97* PARACENTESIS LABS: ================== ___ 06:33PM ASCITES TNC-1187* RBC-350* Polys-47* Lymphs-8* ___ Mesothe-2* Macroph-43* ___ 06:33PM ASCITES TNC-918* RBC-263* Polys-12* Lymphs-53* ___ Mesothe-2* Macroph-33* DISCHARGE LABS: =============== ___ 07:59AM BLOOD WBC-6.0 RBC-2.79* Hgb-10.3* Hct-30.1* MCV-108* MCH-36.9* MCHC-34.2 RDW-19.6* RDWSD-78.5* Plt Ct-92* ___ 07:59AM BLOOD ___ ___ 07:59AM BLOOD Glucose-94 UreaN-7 Creat-0.8 Na-138 K-4.2 Cl-99 HCO3-28 AnGap-11 ___ 05:23AM BLOOD FacVIII-139 ___ 07:59AM BLOOD ALT-20 AST-45* LD(LDH)-230 AlkPhos-137* TotBili-5.4* ___ 07:59AM BLOOD Calcium-8.9 Phos-3.1 Mg-1.8 ___ 07:20PM BLOOD ___ ___ 05:04AM BLOOD AFP-182.2* IMAGING: ======== CXR ___: FINDINGS: Vascular stent noted in the descending aorta is similar in position compared to prior.There is mild bilateral pulmonary vascular congestion. No focal consolidation. No pleural effusion or pneumothorax is seen. The cardiac and mediastinal silhouettes are unchanged. IMPRESSION: Mild bilateral pulmonary vascular congestion. Liver ultrasound ___: IMPRESSION: 1. Cirrhotic liver with moderate ascites. No splenomegaly. Radiofrequency ablation site again demonstrated in the right hepatic lobe. No ___ lesions. 2. Poor visualization of the main portal vein. KUB ___: FINDINGS: There are multiple air-filled loops of small bowel with air-fluid levels, several which may be minimally dilated. Air is seen within the colon and within the rectum. There is no free air. There is no free intraperitoneal air. An aortic stent is re-demonstrated. There are no unexplained soft tissue calcifications or radiopaque foreign bodies. IMPRESSION: Air in multiple loops of small bowel, several of which may be minimally dilated. Air seen within the colon and rectum. Findings are most compatible with ileus. Left shoulder X-ray ___: FINDINGS: Again seen is aggressive osteolysis of the acromion. Compared to ___, the degree of osteolysis posteriorly may have increased and the associated lucent area traverses the entire craniocaudad diameter of the bone, compatible with a nondisplaced pathologic fracture of the acromion. Bulbous enlargement of the distal clavicle is similar to prior, compatible with degenerative changes. There is also suggestion of osteolysis along the distal edge of the clavicle, similar to prior, though this area is not well depicted on these views. There are moderate degenerative changes of glenohumeral joint, with superior subluxation of the humerus with respect to the glenoid, that is more pronounced on today's examination, question due to differences in positioning versus differential differences in function of the rotator cuff. There is diffuse osteopenia. However, no other focal lytic or sclerotic lesions and no other areas of fracture are identified. Abutting portion of the left lung is grossly clear. IMPRESSION: Apparent interval progression of lytic lesion in the acromion. Extent of the osteolysis is compatible with a nondisplaced pathologic fracture. Suspected osteolysis of the distal edge of the clavicle, not well depicted on these views. Elsewhere, no focal lytic or sclerotic lesion is detected. No other evidence of fracture. No dislocation. Osteopenia and glenohumeral joint degenerative changes again noted. Brief Hospital Course: PATIENT SUMMARY: ================ Mr. ___ is a ___ year old gentleman with history of HCV cirrhosis (Child C/___, MELD 24) in the setting of HIV coinfection, complicated by portal hypertension (rectal varices, ascites, hepatic encephalopathy), and metastatic HCC with mets to shoulder s/p resection and palliative XRT, who presented with recurrent abdominal pain following recent admission for RUQ/epigastric abdominal pain and refractory ascites s/p LVP. ACUTE ISSUES: ============= # HCV Cirrhosis (Child C/___, MELD ___) # Refractory Ascites # Abdominal Pain # SBP Patient presented with RLQ abdominal pain following a very similar presentation over the prior weekend. Initial differential included SBP (though no evidence of this on multiple recent diagnostic paracenteses), secondary bacterial peritonitis following recent paracentesis, and portal vein thrombosis given poor visualization of the main portal vein. Repeat paracentesis performed on admission was consistent with SBP (TNC 1187, RBC 350, Polys 47, Lymphs 8, Monos 0, Mesothe 2, Macroph 43). Cultures with no growth. Patient was thus started on IV ceftriaxone and MetroNIDAZOLE 500 mg PO. Repeat paracentesis performed on ___ showed resolution of SBP (TNC 918, RBC 263, Polys 12, Lymphs 53, Monos 0, Mesothe 2, Macroph 33). His abdominal pain improved and the patient was transitioned to an oral regimen of ciprofloxacin at a dose of 500 mg Q12h prior to discharge. His oral diuretics were initially held in the setting of SBP. They were resumed at reduced doses of 100 mg spironolactone and 40 mg PO Lasix. Upon discharge, Lasix and spironolactone ***were/were not*** resumed at home doses. # HCC with Metastases to Left Shoulder # Non-displaced pathologic fracture of acromion Per most recent oncology notes, patient planned to start on sorafenib at reduced dose of 200 mg BID after risk/benefit discussion, though this is a regimen that may be contraindicated with Child ___ Class C cirrhosis or poor liver function. He has yet to start this medication. He is otherwise s/p RFA x 2 and palliative XRT to the shoulder. He had repeat shoulder imaging with X-ray this admission which showed "apparent interval progression of lytic lesion in the acromion. Extent of the osteolysis is compatible with a nondisplaced pathologic fracture. Suspected osteolysis of the distal edge of the clavicle, not well depicted on these views. Elsewhere, no focal lytic or sclerotic lesion is detected. No other evidence of fracture. No dislocation." The acute pain service was consulted for help with pain management. They recommended increasing the oxycodone and oxycontin to ___ mg q4H and oxycontin 10 mg TID. Orthopedics was also consulted given the non-displaced pathologic fracture. The patient's orthopedic oncologic surgeons were contacted; updates will be provided in the event there are further recommendations regarding this patient's care. The patient will follow-up with Dr. ___ in clinic following discharge. Per discussion with Dr. ___ oncologist, the patient was advised to start sorafenib upon discharge given resolution of SBP. CHRONIC ISSUES: =============== # HIV on ART Last CD4 count ___. Continued home dolutegravir 50 mg daily and descovy 1 tab daily. # Hyperlipidemia Continued home atorvastatin 10 mg daily. # PTSD/insomnia Continued amitriptyline 25 mg PO QHS. # Supplements Continued home magnesium oxide 800 mg BID and Vitamin D 800 UNIT PO DAILY # Macrocytic anemia Monitored in house. Hgb 10.1 on discharge. TRANSITIONAL ISSUES: ==================== # Advised to start sorafenib on discharge given progression of HCC. # Palliative care consulted in house. They recommended minor upward adjustments in his oxycodone as recommended by the chronic pain service. # The patient's orthopedic oncologic surgeons were contacted during this admission due to progression of left shoulder lesion; updates will be provided in the event there are further recommendations regarding this patient's care. The patient will follow-up with Dr. ___ in clinic following discharge. # Patient will need long-term antibiotic therapy with Ciprofloxacin given SBP this admission. [ ] Outpatient lab work to be obtained ___ and faxed to Dr. ___ Dr. ___ ___ MEDICATIONS: - Ciprofloxacin at a dose of 500 mg PO Q12h for 2 days followed by 500 mg daily - Sorafenib 200 mg PO Q12H CHANGED MEDICATIONS: - OxyCODONE (Immediate Release) increased to ___ mg PO/NG Q4H:PRN - OxyCODONE SR (OxyconTIN) increased to 10 mg PO Q8H HELD MEDICATIONS: NONE #CODE: DNR/DNI (on MOLST from ___ and confirmed with patient) #CONTACT: ___ (son/HCP) ___ ___ (friend) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 2. Amitriptyline 25 mg PO QHS 3. Atorvastatin 10 mg PO QPM 4. Dolutegravir 50 mg PO DAILY 5. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB PO DAILY 6. Furosemide 60 mg PO DAILY 7. Lactulose 30 mL PO QID 8. Magnesium Oxide 800 mg PO BID 9. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate 10. Rifaximin 550 mg PO DAILY 11. Spironolactone 150 mg PO DAILY 12. Vitamin D 800 UNIT PO DAILY 13. OxyCODONE SR (OxyconTIN) 10 mg PO Q12H 14. Bisacodyl 10 mg PO DAILY:PRN constipation 15. Sorafenib 200 mg PO Q12H Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*2 2. Sorafenib 200 mg PO Q12H 3. Furosemide 40 mg PO DAILY 4. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate 5. OxyCODONE SR (OxyconTIN) 10 mg PO Q8H 6. Spironolactone 100 mg PO DAILY 7. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 8. Amitriptyline 25 mg PO QHS 9. Atorvastatin 10 mg PO QPM 10. Bisacodyl 10 mg PO DAILY:PRN constipation 11. Dolutegravir 50 mg PO DAILY 12. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB PO DAILY 13. Lactulose 30 mL PO QID 14. Magnesium Oxide 800 mg PO BID 15. Rifaximin 550 mg PO DAILY 16. Vitamin D 800 UNIT PO DAILY 17.Outpatient Lab Work Obtain CBC, chemistry and transaminases with total bilirubin. ICD ___ Please fax to ___ at ___ and Dr. ___ ___ Discharge Disposition: Home Discharge Diagnosis: PRIMARY: ======== Spontaneous bacterial peritonitis HCV cirrhosis Metastatic HCC c/b left acromion fracture HIV Refractory ascites SECONDARY: ========== Hypertension PTSD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. WHY WERE YOU IN THE HOSPITAL? - You were transferred to ___ because of worsening abdominal pain. The pain was severe enough to wake you from sleep. WHAT HAPPENED IN THE HOSPITAL? - You had another diagnostic paracentesis performed which showed an infection in your abdomen. - You were given antibiotics to treat the infection and your pain improved. - You had a shoulder X-ray which showed that there was some progression of the lytic lesion in the acromion of your left shoulder. - Your pain medications were increased to better control your pain. - You had another paracentesis performed to make sure that the infection in your abdomen got better. This showed that the infection is gone. WHAT SHOULD YOU DO AFTER LEAVING THE HOSPITAL? - You should continue to take all of your medications as prescribed. - You can now start the chemotherapy medicine that was prescribed previously. - You should follow up with your doctors as ___ below. - IF you notice the size of your belly increasing, call your liver doctor to discuss increasing the frequency of your Lasix or scheduling an appointment to have fluid taken off. We wish you the best, Your ___ Care Team Followup Instructions: ___
10760122-DS-27
10,760,122
21,234,042
DS
27
2121-01-31 00:00:00
2121-01-31 14:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / epidural injection / tramadol / Tylenol Attending: ___. Chief Complaint: Body Aches Major Surgical or Invasive Procedure: ERCP common bile duct stent placement History of Present Illness: Mr ___ is a pleasant ___ w/ HCV cirrhosis (Child C/___, MELD ___), HIV co-infection, portal HTN (c/b rectal varices, ascites, hepatic encephalopathy), and HCC with metastatic disease to the left shoulder s/p resection and palliative XRT then w. pathologic fx, who presents with body aches. Body aches began ___, relatively sudden onset. No associated respiratory symptoms or fevers. No associated specific abdominal pain or chest pain. He states that his "whole body aches" and that he has intermittent sharp pains of lightening. He has not noted any swelling in any of his extremities. He has never had pain like this before. He is on oral oxycodone and OxyContin at home which has not been able to control his pain In the ED, VS unremarkable. Found to have icterus and diffusely tender abd w/o fluid wave or pocket on POCUS. Received morphine and IV NS and transferred to 11R. On arrival to 11R, pt noted no changes in his symptoms, feeling "horrible," admitting to poor PO intake since ___, sleeping around the clock. HE admits to RLQ pain that has been stable x 2 months. Past Medical History: 1. Penetrating thoracic aortic aneurysm of the descending aorta status post TAVR on ___ 2. Cirrhosis ___ chronic genotype hepatitis C, ETOH 3. Hypertension 4. PTSD 5. Cervical disc herniations 6. Gastritis with bleeding 7. Lipoma 8. HIV on ART Social History: ___ Family History: Multiple prior family malignancies. The patient is unsure of the type. Physical Exam: ADMISSION PHYSICAL EXAM: General: NAD VITAL SIGNS: 99 Axillary 124 / 87 R Lying 90 16 95 RA HEENT: MMM, notable icterus CV: RR, NL S1S2 no S3S4 MRG PULM: CTAB ABD: BS+, soft, TTP in RLQ LIMBS: + b/l pedal edema, +clubbing, +asterixis SKIN: No rashes or skin breakdown NEURO: Cranial nerves III-XII intact, no nystagmus; strength is ___ of the proximal and distal upper and lower extremities DISCHARGE PHYSICAL EXAM: Pertinent Results: ADMISSION LABS: ___ 11:30PM URINE COLOR-Yellow APPEAR-Hazy* SP ___ ___ 11:30PM URINE BLOOD-MOD* NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-SM* UROBILNGN-NEG PH-6.5 LEUK-MOD* ___ 11:30PM URINE RBC-10* WBC-11* BACTERIA-FEW* YEAST-NONE EPI-0 ___ 11:30PM URINE MUCOUS-RARE* ___ 03:01PM LACTATE-2.4* ___ 02:45PM GLUCOSE-124* UREA N-9 CREAT-0.8 SODIUM-130* POTASSIUM-5.2* CHLORIDE-96 TOTAL CO2-20* ANION GAP-14 ___ 02:45PM estGFR-Using this ___ 02:45PM ALT(SGPT)-40 AST(SGOT)-99* CK(CPK)-126 ALK PHOS-173* TOT BILI-8.6* DIR BILI-3.0* INDIR BIL-5.6 ___ 02:45PM LIPASE-29 ___ 02:45PM ALBUMIN-3.2* CALCIUM-7.9* PHOSPHATE-2.0* MAGNESIUM-1.6 ___ 02:45PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 02:45PM WBC-9.6 RBC-3.68* HGB-13.2* HCT-37.7* MCV-102* MCH-35.9* MCHC-35.0 RDW-17.7* RDWSD-67.1* ___ 02:45PM NEUTS-74.2* LYMPHS-16.6* MONOS-7.0 EOS-1.0 BASOS-0.4 IM ___ AbsNeut-7.09* AbsLymp-1.59 AbsMono-0.67 AbsEos-0.10 AbsBaso-0.04 ___ 02:45PM PLT COUNT-97* ___ 02:45PM ___ PTT-50.8* ___ DISCHARGE LABS: ___ 07:50AM BLOOD WBC-8.7 RBC-3.01* Hgb-11.3* Hct-31.7* MCV-105* MCH-37.5* MCHC-35.6 RDW-18.6* RDWSD-71.9* Plt Ct-93* ___ 07:50AM BLOOD Plt Ct-93* ___ 05:00AM BLOOD Neuts-61.9 ___ Monos-8.4 Eos-4.1 Baso-0.4 Im ___ AbsNeut-4.67 AbsLymp-1.84 AbsMono-0.63 AbsEos-0.31 AbsBaso-0.03 ___ 07:50AM BLOOD Glucose-106* UreaN-9 Creat-0.7 Na-127* K-4.5 Cl-93* HCO3-26 AnGap-8* ___ 07:50AM BLOOD ALT-44* AST-100* LD(LDH)-283* AlkPhos-188* TotBili-7.9* ___ 07:50AM BLOOD Calcium-8.0* Phos-2.0* Mg-1.8 ___:50AM BLOOD Osmolal-265* IMAGING: ___ Abdominal Duplex: 1. Cirrhotic liver with grossly unchanged ablation cavity in segment VII. No new focal hepatic lesion. No ascites. 2. Distended gallbladder without wall thickening or gallstone to suggest acute cholecystitis. 3. The portal veins are not well visualized as on prior study from ___. ___ RUQ U/S: 1. Cirrhotic liver with grossly unchanged ablation cavity in segment VII. No new focal hepatic lesion. No ascites. 2. Distended gallbladder without wall thickening or gallstone to suggest acute cholecystitis. 3. The portal veins are not well visualized as on prior study from ___. ___ Renal U/S: Unremarkable renal ultrasound. No hydronephrosis. ___ CT a/p w/ con: 1. No evidence of bowel ischemia or diverticulitis. 2. Moderate extrahepatic biliary and distal main pancreatic ductal dilatation. Although stable compared to recent CT from ___, this is significantly increased from the prior CT from ___. Correlation with lab findings and further assessment with ERCP/MRCP (biliary) is recommended for further assessment of the distal CBD/ampullary region. MICRO: ___ Blood Cx x2: No growth ___ Urine Cx: No growth ___ Urine Cx: No growth ___ 7:00 am Blood (CMV AB) CMVP,EBVP ADDED ___. **FINAL REPORT ___ CMV IgG ANTIBODY (Final ___: POSITIVE FOR CMV IgG ANTIBODY BY EIA. 332 AU/ML. Reference Range: Negative < 4 AU/ml, Positive >= 6 AU/ml. CMV IgM ANTIBODY (Final ___: NEGATIVE FOR CMV IgM ANTIBODY BY EIA. INTERPRETATION: INFECTION AT UNDETERMINED TIME. A positive IgG result generally indicates past exposure. Infection with CMV once contracted remains latent and may reactivate when immunity is compromised. Greatly elevated serum protein with IgG levels ___ mg/dl may cause interference with CMV IgM results. If current infection is suspected, submit follow-up serum in ___ weeks. ___ 7:00 am Blood (EBV) CMVP,EBVP ADDED ___. **FINAL REPORT ___ ___ VIRUS VCA-IgG AB (Final ___: Test canceled and patient credited due to a prior EBV panel sent on ___ indicating evidence of past infection (EBV VCA-IgG positive, EBNA IgG positive and EBV VCA-IgM negative). A repeat panel is unlikely to detect EBV reactivation. Serum will be held for 3 months. For any questions, contact the Microbiology Medical Director. ___ VIRUS EBNA IgG AB (Final ___: TEST CANCELLED, PATIENT CREDITED. ___ VIRUS VCA-IgM AB (Final ___: TEST CANCELLED, PATIENT CREDITED. Brief Hospital Course: SUMMARY ======== ___ w/ HCV cirrhosis (Child ___, MELD 24), HIV co-infection, portal HTN (c/b rectal varices, ascites, hepatic encephalopathy), and HCC with metastatic disease to the left shoulder s/p resection and palliative XRT then w. pathologic fx, who presents with diffuse myalgias and malaise likely ___ his sorafenib medication which was held. He also received a common bile duct stent w/ ERCP during his in house stay and had control of his abdominal pains via liquid Dilaudid. He underwent a GOC discussion with alteration of his code status to DNR/DNI and plan for transition to home hospice. ACUTE ISSUES: # Severe Abdominal pain: Pt had episodes of severe, gripping abdominal pain - focused in RuQ. These usually responded to IV hydromorphone. Pain was carefully assessed and monitored. Opioids adjusted. By time of discharge, the pain was better controlled and he was able to manage it with PO prn medications. # Hyperbilirubinemia: Diffuse abdominal pain likely multifactorial in the setting of known HCC, concern for possible biliary obstruction based on obstructive pattern on labs and biliary dilatation on CT scan. No associated nausea/vomiting, no correlation with exertion or eating, no ischemia or obstruction seen on CT scan reassuring. Now s/p ERCP on ___ with temporary stent placement. Repeat LFTs displaying down-trend following stenting. Attempts to identify a fluid pocket for potential abdominal drainage unsuccessful on ___ given bowel contiguous with abdominal wall. Following ___ discussion on ___ was understanding of disease state and opted to transition to DNR/DNI status with transition to home hospice. Pain well controlled with dilaudid liquid given more rapid onset phase covering his acute episodes while Oxycontin coverage of baseline pain. Will need repeat ERCP in 2 weeks from ___ for possible stent removal, and outpatient apt w/ Dr ___. # Myalgias: Most likely deriving from viral illness or his sorafenib medication in the context of potential decreased liver clearance with dysfunction. Myalgias improved prior to discharge. # UTI: Positive UA on admission, treated with 5 days CTX, urine culture negative. Renal US without abnormality. Asymptomatic. # HCC w/ metastatic osseous lesions: Admitted on outpatient sorafenib. This was held during admission and decision was made to hold on discharge given preference to pursue palliative hospice care. Outpatient oncologist Dr. ___ was aware and involved during admission. # HCV cirrhosis # Coagulopathy # Peripheral Edema # Acute Hepatic Encephalopathy He presented with decompensated w/ hepatic encephalopathy on admission (overt lethargy, asterixis). Treated for possible UTI, and s/p ERCP to relieve possible biliary obstruction. He was maintained on home Lasix, spironolactone, lactulose and rifaximin. He improved and was clinically stable with improved mental status. He was placed on ciprofloxacin daily for SBP prophylaxis following UTI tx completion. Unfortunately, liver function never returned to ___ prior baseline. TB remained above 7 and MELD score was ___. Decision was made to pursue hospice care given underlying medical conditions. Sorafenib was held on discharge as above and in the setting of worsened liver failure. CHRONIC ISSUES: # HIV: VL < 1.3. Continued Descovy # COPD: Quiescent, albuterol prn # Hypomagnesemia: Continued home mag ox # HTN: Home spironolactone and Lasix diuretics TRANSITIONAL ISSUES: []Repeat ERCP in 2 weeks for stent pull and re-evaluation. []Follow-up with Dr. ___ as previously scheduled. []Discharged to home with hospice services. Elected to discontinue sorafenib. CODE STATUS: DNR/DNI on MOLST HCP: Health Care Proxy: ___ (son/HCP) ___ ___ (friend) ___ PCP: ___, MD, ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 2. Amitriptyline 25 mg PO QHS 3. Bisacodyl 10 mg PO DAILY:PRN constipation 4. Dolutegravir 50 mg PO DAILY 5. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB PO DAILY 6. Lactulose 30 mL PO QID 7. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate 8. OxyCODONE SR (OxyconTIN) 10 mg PO Q8H 9. Rifaximin 550 mg PO DAILY 10. Vitamin D 800 UNIT PO DAILY 11. Atorvastatin 10 mg PO QPM 12. Magnesium Oxide 800 mg PO BID 13. Furosemide 40 mg PO DAILY 14. Spironolactone 100 mg PO DAILY 15. Ciprofloxacin HCl 500 mg PO Q12H Discharge Medications: 1. Benzonatate 100 mg PO TID RX *benzonatate 100 mg 1 capsule(s) by mouth three times a day Disp #*90 Capsule Refills:*2 2. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity RX *hydromorphone 1 mg/mL ___ mL by mouth every 4 hours Refills:*0 3. Metoclopramide 5 mg PO QIDACHS RX *metoclopramide HCl 5 mg 1 tablet by mouth 3 times a day before meals Disp #*15 Tablet Refills:*0 4. OxyCODONE SR (OxyconTIN) 20 mg PO Q8H RX *oxycodone 20 mg 1 tablet(s) by mouth every 8 hours Disp #*15 Tablet Refills:*0 5. Rifaximin 550 mg PO BID 6. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob 7. Bisacodyl 10 mg PO DAILY:PRN constipation 8. Ciprofloxacin HCl 500 mg PO Q12H 9. Dolutegravir 50 mg PO DAILY 10. Emtricitabine-Tenofovir alafen (200mg-25mg) *DESCOVY* 1 TAB PO DAILY 11. Furosemide 40 mg PO DAILY 12. Lactulose 30 mL PO QID 13. Magnesium Oxide 800 mg PO BID 14. Spironolactone 100 mg PO DAILY 15. Vitamin D 800 UNIT PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY: Metastatic hepatocellular carcinoma Urinary tract infection Cirrhosis Diffuse myalgia SECONDARY: Human immunodeficiency virus Hepatitis C Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. Why was I in the hospital? - You were hospitalized because you presented with generalized body aches and pains which you have not experienced before in addition to decreased food and drink intake, and there was concern for possible worsening of your liver disease. What was done while I was in the hospital? - Picutres were taken that showed you did not have acute disease of your kidney, and intestines which caused either your generalized pains or your sudden sharp pains in the hospital. - Liver pictures did show you had some increases in the size of the ducts that run in the liver which could be from disease in those ducts. - You were taken with our liver specialists to receive a stent to open the obstruction which may have been causing your ducts to increase in size and had successful implantation of this stent. - Your chemotherapy medication sorafenib was held and your generalized pains subsequently resovled. - Your sudden pains were treated with liquid Dilaudid as well as your long acting Oxycontin which you were stabilized on. What should I do when I go home? - It is very important that you take your medications as prescribed. - Please go to your scheduled appointment with your primary doctor. - If you have vomiting of blood, increased swelling in your belly or legs, please tell your primary doctor or go to the emergency room. Best wishes, Your ___ team Followup Instructions: ___
10760830-DS-3
10,760,830
24,084,952
DS
3
2156-03-01 00:00:00
2156-03-01 17:32:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ s/p laparoscopic appendectomy ___ who reports all was well post-operatively until 1 week ago, when she noted abdominal pain similar to her appendicitis pain. It slowly worsened, and she noted decreased oral intake as well. She has been having bowel movements, including one on the day of presentation to the ED. She had a fever to 102 at home. Denies nausea, emesis, rigors, chest pain or shortness of breath. CT scan in the ED revealed 6 x 2cm collection at the staple line in RLQ. Incidental finding of LLL PE on CT abd/pelvis, asymptomatic. Past Medical History: Past medical history: HLD, asthma, anxiety PSH: laparoscopic appendectomy ___ Social History: ___ Family History: Mother with colon cancer at age ___ but lived until age ___. Physical Exam: Admission Physical Exam: Vitals: 100.9 103 140/70 16 97% RA GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, nondistended, tender to palpation in the RLQ without rebound or guarding, no palpable masses DRE: deferred Ext: No ___ edema, ___ warm and well perfused Discharge Physical Exam: Vitals: T:99 HR: 78 BP: 103/63 RR: 16 O2sat: 96% RA GEN: A&O, NAD HEENT: normocephalic, atraumatic, no scleral icterus, MMM CV: warm and well perfused Pulm: breathing comfortably on room air Abd: soft, nondistended, no palpable masses, mildly tender to palpation in RLQ without rebound or guarding Ext: warm and well perfused, no edema or tenderness Pertinent Results: ___ 09:50PM BLOOD WBC-14.3* RBC-3.61* Hgb-11.0* Hct-33.7* MCV-93 MCH-30.5 MCHC-32.6 RDW-12.8 RDWSD-44.2 Plt ___ ___ 09:50PM BLOOD Neuts-77.4* Lymphs-13.1* Monos-7.9 Eos-0.6* Baso-0.4 Im ___ AbsNeut-11.05* AbsLymp-1.86 AbsMono-1.12* AbsEos-0.08 AbsBaso-0.06 ___ 11:52PM BLOOD ___ PTT-25.4 ___ ___ 09:50PM BLOOD Glucose-107* UreaN-16 Creat-0.7 Na-142 K-4.7 Cl-103 HCO3-26 AnGap-13 ___ 09:50PM BLOOD ALT-27 AST-27 CK(CPK)-34 AlkPhos-84 TotBili-0.6 ___ 09:50PM BLOOD Lipase-42 ___ 09:50PM BLOOD CK-MB-<1 cTropnT-<0.01 proBNP-151 ___ 09:50PM BLOOD Albumin-3.9 ___ 09:53PM BLOOD Lactate-0.8 ___ 05:26AM BLOOD WBC-10.7* RBC-3.31* Hgb-10.2* Hct-31.0* MCV-94 MCH-30.8 MCHC-32.9 RDW-12.8 RDWSD-44.3 Plt ___ ___ 05:26AM BLOOD ___ PTT-65.7* ___ ___ 07:13AM BLOOD Glucose-132* UreaN-6 Creat-0.7 Na-141 K-4.6 Cl-103 HCO3-26 AnGap-12 IMAGING: ========= ___ CHEST (PA & LAT) No evidence of pneumonia. ___ CT ABD & PELVIS WITH CONTRAST 1. Status post appendectomy with a tubular collection tracking along the suture line measuring approximately 5 cc. This could represent small amount of hemorrhage, though superinfection cannot be excluded. 2. Questioned filling defect in the left lower lobe segmental pulmonary artery concerning for pulmonary embolism. CTA chest for evaluation of pulmonary embolism is recommended. ___ CTA CHEST 1. Segmental pulmonary embolism involving the bifurcation of the anteromedial and lateral basal segmental arteries of the left lower lobe. No evidence of right heart strain or pulmonary infarction. 2. Tubular opacity in the right upper lobe anterior segment, decreased in size compared to ___, with surrounding hyperlucency likely representing an impacted bronchus with air trapping. 3. Please see separate report performed on the same day for detailed evaluation of the abdomen pelvis. ___ BILAT LOWER EXT VEINS No evidence of deep venous thrombosis in the right or left lower extremity veins. Brief Hospital Course: Brief Hospital Course: The patient presented to the emergency room on ___ with 1 week of abdominal pain after recent laparoscopic appendectomy ___. Upon arrival to ED, she was found to be febrile to 100.9 with WBC elevated to 14.3. CT abdomen/pelvis scan was performed in the ED and revealed 6 x 2cm collection at the staple line in RLQ. There was also an incidental finding of LLL PE on CT abd/pelvis, which was completely asymptomatic. She was breathing well on room air. Further CTA chest confirmed this, although bilateral LENIs showed no DVTs. Given findings, the patient was admitted to the Acute Care Service. For her RLQ collection, she was started on IV antibiotics (cipro/flagyl). ___ drainage of collection was felt to not indicated. Her white count downtrended throughout her stay and she was transitioned to oral antibiotics. For her incidental and asymptomatic PE, she was started on a heparin drip per PE protocol with goal PTT of 60-80, which was achieved. Her pulmonary/cardiovascular function was stable throughout this admission. Neuro: The patient was alert and oriented throughout hospitalization. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. GI/GU/FEN: The patient was initially kept NPO for possible procedure, but was advanced to a Regular diet when no interventions were felt to be indicated, which was well tolerated. Patient's intake and output were closely monitored ID: The patient's fever curves were closely watched for infection improvment. She was afebrile at the time of discharge. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Her ultimately WBC trended down during her stay. Prophylaxis: The patient received a heparin drip for her PE, and ___ dyne boots were used during this stay and she was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. She was breathing comfortably on room air and abdominal exam was reassuring. The patient was tolerating a diet, ambulating, voiding without assistance, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. She was discharged on Pradaxa for anticoagulation as well as 10 day course of antibiotics. Medications on Admission: Active Medication list as of ___: Medications - Prescription ALBUTEROL SULFATE [PROAIR HFA] - ProAir HFA 90 mcg/actuation aerosol inhaler. 2 puffs(s) inhaled four times a day as needed for shortness of breath or wheeze CITALOPRAM - citalopram 40 mg tablet. TAKE 1 TABLET BY MOUTH EVERY MORNING FLUTICASONE - fluticasone 50 mcg/actuation nasal spray,suspension. Instill 1 to 2 sprays into each nostril once to twice daily FLUTICASONE [FLOVENT HFA] - Flovent HFA 110 mcg/actuation aerosol inhaler. 1 inhalation by mouth twice a day Rinse mouth after use, (call if not covered) HYDROCORTISONE ACETATE [ANUSOL-HC] - Anusol-HC 25 mg rectal suppository. apply rectally twice a day as needed for hemorroidal flare PRAVASTATIN - pravastatin 20 mg tablet. TAKE 1 TABLET NIGHTLY AT BEDTIME Medications - OTC ASPIRIN - aspirin 81 mg chewable tablet. 1 Tablet(s) by mouth once a day - (OTC) CALCIUM CARBONATE-VITAMIN D3 [CALCARB 600 WITH VITAMIN D] - Calcarb 600 With Vitamin D 600 mg (1,500 mg)-400 unit tablet. 1 tablet(s) by mouth prn dietary calcium intake <1200mg LACTOBACILLUS COMBINATION NO.4 [PROBIOTIC] - Dosage uncertain - (Prescribed by Other Provider; 1 qod) MELATONIN - Dosage uncertain - (OTC; 1 qhs) MULTIVITAMIN - Dosage uncertain - (Prescribed by Other Provider; OTC) --------------- --------------- --------------- --------------- Discharge Medications: NEW MEDICATIONS 1. Acetaminophen 650 mg PO TID 2. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*20 Tablet Refills:*0 3. Dabigatran Etexilate 75 mg PO BID Pulmonary Emoblism RX *dabigatran etexilate [Pradaxa] 75 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 4. MetroNIDAZOLE 500 mg PO TID RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day Disp #*31 Tablet Refills:*0 5. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing 6. Pravastatin 20 mg PO QPM Discharge Disposition: Home Discharge Diagnosis: Pulmonary Embolism Right Lower Quadrant Abscess Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, You were admitted to ___ for abdominal pain. You were found to have a small abscess in your abdomen and clot in your lungs. You are recovering well and are now ready for discharge. Please follow the instructions below to continue your recovery: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Followup Instructions: ___
10760967-DS-11
10,760,967
21,854,787
DS
11
2122-11-20 00:00:00
2122-12-12 13:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: ___ Major Surgical or Invasive Procedure: None History of Present Illness: ___ with no known past medical history who presents after motor vehicle crash. The patient speaks ___ only. He was reportedly being chased by the cops and flipped his car. Was reportedly wearing a seatbelt with no airbag deployment. Denies any LOC. Reportedly self extricated. Has an abrasion on his nose but was brought to the hospital for evaluation. No pain in his extremities. No chest pain, shortness of breath, abdominal pain, nausea, vomiting, diarrhea. Physical exam shows a minor abrasion over his nasal bridge in between his eyebrows but no other deficits. He is intoxicated. Past Medical History: Unknown Social History: ___ Family History: Non-contributory Physical Exam: Temp: 97.7 HR: 120 BP: 146/84 Resp: 19 O2 Sat: 98 Constitutional: Intoxicated Head / Eyes: Mild abrasions over the bridge of his nose, Pupils equal, round and reactive to light, no hemotympanum ENT / Neck: Oropharynx within normal limits Chest/Resp: Clear to auscultation Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds GI / Abdominal: Soft, Nontender, Nondistended Musc/Extr/Back: No spinal tenderness or back tenderness. No tenderness in any of his extremities with full mobility. Skin: No rash, Warm and dry Neuro: No focal neurological deficits. Psych: Normal mood, Normal mentation but intoxicated Discharge Physical Exam: VS: T: 97.8 PO BP: 124/72 HR: 79 RR: 18 O2: 99% RA GEN: A+Ox3, NAD HEENT: MMM CV: RRR PULM: CTA b/l ABD: soft, non-distended, non-tender to palpation EXT: wwp, no edema b/l Pertinent Results: IMAGING: ___: CXR: No acute cardiopulmonary process. ___: CT Head: 1. No acute intracranial process. 2. Soft tissue swelling overlying the bridge of the nose without underlying fracture. ___: CT Chest: 1. Mildly displaced acute left posterolateral seventh rib fracture. Subtle cortical irregularities of the anterior superior T5, T6, and T7 vertebral bodies are consistent with compression fractures. No additional acute fractures are identified. 2. No traumatic organ injury in the chest, abdomen, or pelvis. ___: CT C-spine: No acute fracture or traumatic malalignment. ___: T Spine x-ray: Unchanged mild compression deformities of the superior endplates of 3 mid thoracic vertebral bodies corresponding to T5, T6 and T7 as previously characterized on the CT scan of the torso. LABS: ___ 09:30AM GLUCOSE-107* UREA N-5* CREAT-0.6 SODIUM-145 POTASSIUM-4.2 CHLORIDE-106 TOTAL CO2-23 ANION GAP-16 ___ 09:30AM CALCIUM-9.9 PHOSPHATE-2.6* MAGNESIUM-2.2 ___ 09:30AM WBC-11.3* RBC-4.90 HGB-15.1 HCT-43.8 MCV-89 MCH-30.8 MCHC-34.5 RDW-12.4 RDWSD-40.5 ___ 09:30AM PLT COUNT-306 ___ 10:39PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 10:39PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 10:06PM ___ PO2-104 PCO2-37 PH-7.35 TOTAL CO2-21 BASE XS--4 ___ 10:06PM GLUCOSE-115* LACTATE-3.2* NA+-140 K+-3.4 CL--104 ___ 10:06PM HGB-16.5 calcHCT-50 O2 SAT-91 CARBOXYHB-7* MET HGB-0 ___ 10:06PM freeCa-1.09* ___ 09:51PM UREA N-6 CREAT-0.7 ___ 09:51PM LIPASE-31 ___ 09:51PM ASA-NEG ___ ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 09:51PM WBC-12.5* RBC-5.16 HGB-16.0 HCT-45.7 MCV-89 MCH-31.0 MCHC-35.0 RDW-11.9 RDWSD-38.8 ___ 09:51PM PLT COUNT-330 ___ 09:51PM ___ PTT-25.5 ___ ___ 09:51PM ___ Brief Hospital Course: Mr. ___ is a ___ with no known past medical history who presented to ___ on ___ after motor vehicle crash, +EtOH. He was found on imaging to have compression fractures of T5, T6 and T7 and a left 2nd rib fracture. He also had soft tissue swelling of the nose with no underlying fracture, and tertiary exam was otherwise negative. The patient was admitted to the Acute Care Surgery service. Orthopedic Spine Surgery was consulted for the thoracic fractures and no surgical intervention was warranted. They recommended consulting physical therapy and the patient may ambulate as tolerated. The patient ambulated independently and pain was well controlled on acetaminophen prn. Occupational Therapy was consulted and he was cleared for discharge home without services. Social Work provided alcohol counseling to the patient. The patient was started on thiamine, folate and a multivitamin in the hospital, but these medications were later discontinued as the patient states he normally has 1 beer every 3 days and denies excessive alcohol consumption. The patient remained stable from a cardiovascular and pulmonary standpoint; vital signs were routinely monitored. Incentive spirometry was encouraged. The patient tolerated a regular diet, intake and output were monitored. The patient received subcutaneous heparin for DVT prophylaxis. At the time of discharge, the patient was hemodynamically stable, alert and oriented x 3 and ambulating independently and he was cleared for discharge home without services. Medications on Admission: None Discharge Medications: 1. Acetaminophen ___ mg PO Q6H:PRN Pain - Mild 2. Docusate Sodium 100 mg PO BID:PRN constipation 3. Senna 8.6 mg PO BID:PRN constipation Discharge Disposition: Home Discharge Diagnosis: -Left posterolateral 7th rib fractures -Compression fractures T5, T6, T7 Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ after a motor vehicle crash. You sustained a left-sided rib fracture as well as thoracic spine compression fractures. For your spine fractures, you were followed by the Orthopaedic Spine service and your injuries will heal on their own. You worked with Physical and Occupational Therapy and were cleared for discharge home. You have now recovered and are ready to be discharged. Please follow the instructions below to continue your recovery: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. * Your injury caused a left 7th rib fracture which can cause severe pain and subsequently cause you to take shallow breaths because of the pain. * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Pneumonia is a complication of rib fractures. In order to decrease your risk you must use your incentive spirometer 4 times every hour while awake. This will help expand the small airways in your lungs and assist in coughing up secretions that pool in the lungs. * You will be more comfortable if you use a cough pillow to hold against your chest and guard your rib cage while coughing and deep breathing. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Narcotic pain medication can cause constipation therefore you should take a stool softener twice daily and increase your fluid and fiber intake if possible. * Do NOT smoke * If your doctor allows, non-steroidal ___ drugs are very effective in controlling pain ( ie, Ibuprofen, Motrin, Advil, Aleve, Naprosyn) but they have their own set of side effects so make sure your doctor approves. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs (crepitus). Followup Instructions: ___
10761087-DS-19
10,761,087
22,552,310
DS
19
2182-06-11 00:00:00
2182-06-13 14:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Decadron Attending: ___. Chief Complaint: weakness, fatigue Major Surgical or Invasive Procedure: None History of Present Illness: Primary ___. MD Primary Care Physician: ___. MD Primary Oncologic Diagnosis: lung adenoca, lll mass, small brain metastasis ___ y/o female with a history of adenocarcinoma of the lung with brain metastasis, last dose of maintenance Altima chemotherapy ___ presents to the ER with weakness, nausea, and malaise. She was admitted to ___ from ___ for dyspnea and Hct of 18 and was given 3 units PRBCs. Hemolysis ahd GI bleeding were ruled-out and the anemia was attributed to chemotherapy. She also had ___ (Cr 1.7 from 0.9) with FeNa 1.03%. Her Cr did not improve on IVF and Renal Ultrasound was normal. Since her last chemotherapy, she states she has felt weak, nauseous, tired, and has had poor appetite. She has been able to drink fluids but has not noticed any bloody stools. These symptoms have been chronic for the past 3 weeks, but last night she experienced mild chest pain at rest that resolved spontaneously. She went to her outpatient oncology office for a regular appointment where Cr was elevated to 3.3 and HCt was 16.2. Vitals in the ER: 97.9 91 130/77 16 94% ra. Repeat Hct was 36. The patient received 1 unit PRBCs. REVIEW OF SYSTEMS: (+) Per HPI (-) Denies fever, chills, headache. Denies change in cough or cough, shortness of breath. Denies nausea, vomiting, diarrhea, constipation, abdominal pain. Denies dysuria, frequency, or urgency. Denies rashes or skin changes. All other ROS negative Past Medical History: ONCOLOGIC HISTORY: Mrs. ___ is a ___ retired ___, lifelong smoker who underwent preoperative chest x-ray on ___ prior to cataract surgery. Her chest x-ray demonstrated a mass in the left lung. ___: CT scan of the chest on revealed a 6 cm left lower lobe mass extending from the hilum to the posterior medial pleural surface. ___: The patient was seen on an urgent basis in oncology. ___: She was referred to the ___ ___ a PET which revealed the known left lower lobe mass measuring 4.7 cm, SUV of 12. There is a small rounded nodule that may be contiguous with the dominant lesion or may be a small satellite. The mass was not invading through the chest wall or into her rib. There were no FDG-avid axillary, mediastinal, or hilar lymph odes. There was no evidence of distant metastatic disease, however, the patient went on to have an MRI of the brain. ___: Brain MRI which demonstrated a possible metastasis, a rounded right cerebellar lesion about 5 mm. The initial MRI was done without gadolinium so a repeat MRI with gadolinium was advised and performed on ___, which demonstrated that the 5 mm right cerebellar lesion was ring enhancing consistent with metastasis. There were no other enhancing lesions or abnormal leptomeningeal enhancement. ___: The patient underwent CT-guided biopsy of the lung lesion, which demonstrated adenocarcinoma of the lung positive for CK7 and TTF-1 and negative for CK20. ___: EGFR and ALK negative ___: The patient was referred for consultation with Dr. ___ radiation oncology and also Dr. ___ thoracic surgery. ___: Mediastinoscopy was performed and remarkably cytology from 2L, 4L, 2R, 4R, and level 7 were all negative for tumor. ___: The patient endorsed being quite sore after the mediastinoscopy, and on ___ en route to her CyberKnife treatment of the small cerebellar met, the patient became quite dyspneic. Oxygen saturation was 77%, she was sent to the ___ Emergency Department and the brain lesion was not treated. She was sent to the emergency department where a chest x-ray revealed a new right pleural effusion, thoracentesis was performed, and approximately 600 mL of bloody fluid was drained. Cytology is pending. Her post-procedure chest x-ray showed improved aeration of the lung without pneumothorax. ___: Cytology of pleural fluid negative for malignant cells. See below for full report. ___: Cyberknife(2200cGy) to right cerebellar lesion at ___ ___: C1 ___, consent signed. Will be given Prednisone instead of Dexamethasone ___: post radiation Brain MRI planned: no growth ___: C#2 carboplatin & pemetrexed. ___: C#3 carboplatin and pemetrexed ___: re-staging PET/CT: LLL tumor decreased (4.7x4.2cm ___ but still FDG avid SUV 13.3. Necrosis present. ___ C#4 carboplatin and pemetrexed ___ ___ neuro onc follow up MRI brain improved ___ C#5 carboplatin and pemetrexed ___ HCT 23.8% repeat 24%, txfuse ___, C#6 ___ AUC 5 pemetrexed, order restaging PET prior to next appt ___ PET stable disease LLL no new lesions ___ C#1 maintenance ___ MEDICAL HISTORY: Hypercholesterolemia DIVERTICULOSIS TOBACCO DEPENDENCE OBESITY UNSPEC Hyperlipidemia LDL goal <160 Impaired glucose tolerance Non-small cell lung cancer Brain metastasis Anemia Seizures, last grand mal seizure was about ___ years ago. Impaired hearing. Social History: ___ Family History: Father committed suicide. Mother died of abdominal aortic aneurysm. She has one sister and two half sisters. Her one sister had early stage colon cancer. Physical Exam: Vitals: T T 98.1 bp 110/70 HR 75 RR 18 SaO2 98 RA GEN: NAD, awake, alert HEENT: supple neck, dry mucous membranes, no oropharyngeal lesions PULM: normal effort, CTAB CV: RRR, no r/m/g/heaves ABD: soft, NT, ND, bowel sounds present EXT: normal perfusion SKIN: warm, dry NEURO: AOx3, no focal sensory or motor deficits PSYCH: calm, cooperative Pertinent Results: ___ 04:48PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 04:48PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG ___ 04:48PM URINE RBC-1 WBC-1 BACTERIA-NONE YEAST-NONE EPI-2 ___ 03:13PM LACTATE-3.1* K+-4.3 ___ 03:13PM HGB-12.1 calcHCT-36 ___ 02:55PM GLUCOSE-215* UREA N-53* CREAT-3.0*# SODIUM-138 POTASSIUM-4.3 CHLORIDE-99 TOTAL CO2-26 ANION GAP-17 ___ 02:55PM ALT(SGPT)-12 AST(SGOT)-16 ALK PHOS-82 TOT BILI-0.2 ___ 02:55PM LIPASE-40 ___ 02:55PM ALBUMIN-3.6 CALCIUM-8.1* PHOSPHATE-3.5 MAGNESIUM-2.2 ___ 02:55PM WBC-4.1 RBC-1.49*# HGB-5.2*# HCT-15.1*# MCV-101* MCH-35.2* MCHC-34.9 RDW-19.2* ___ 02:55PM NEUTS-59 BANDS-0 ___ MONOS-11 EOS-1 BASOS-0 ___ MYELOS-0 ___ 02:55PM HYPOCHROM-3+ ANISOCYT-2+ POIKILOCY-NORMAL MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-OCCASIONAL ___ 02:55PM PLT COUNT-53* ___ 02:55PM ___ PTT-28.4 ___ ___ 03:44PM BLOOD Lactate-1.7 ___ 02:55PM BLOOD calTIBC-247 Hapto-259* Ferritn-2262* TRF-190* DISCHARGE LABS: ___ 06:15AM BLOOD WBC-5.1 RBC-2.93* Hgb-9.5* Hct-27.0* MCV-92 MCH-32.3* MCHC-35.1* RDW-19.9* Plt Ct-64* ___ 06:05AM BLOOD Ret Aut-0.6* ___ 06:15AM BLOOD Glucose-92 UreaN-46* Creat-2.8* Na-143 K-4.6 Cl-107 HCO3-28 AnGap-13 ___ 06:15AM BLOOD Calcium-7.4* Phos-3.5 Mg-2.1 IMAGING: CT Abd & Pelvis W/O Contrast ___ IMPRESSION: 1. No evidence of retroperitoneal or intra-abdominal hemorrhage. 2. Diverticulosis without evidence of diverticulitis. 3. Partially imaged left lower lobe opacity which is most likely focal atelectasis. Renal U/S ___ IMPRESSION: Symmetric, normal size kidneys with no hydronephrosis or nephrolithiasis. Preserved cortical thickness. Brief Hospital Course: Ms. ___ is a ___ y/o female with a history of adenocarcinoma of the lung with brain metastasis, last dose of maintenance Altima chemotherapy ___ presents to the ER with weakness, nausea, dyspnea on exertion and malaise due to anemia and progressive ___. # Anemia, Normocytic - Likely due to chemo. Labs do not suggest any hemolysis. Iron & Ferritin rule out Fe deficiency. Transfused 3 units overnight on ___ with appropriate Hct bump from 15.1 to 23.9. patient has a history of significant anemia of unclear etiology. Last admission in mid ___, she was not hemolyzing or having GI bleeding, and is not on this admission either. CT abd/pelv on ___ ruled out RP bleed. Reticulocyte count <1%. Transfused 1 unit RBC on ___ with appropriate bump to Hgb 9.5. Held Pemetrexed. Guaiac stools: negative. # ___ - Patient has had progressive ___ over the past 2 months which is likely related to Dehydration +/- ATN. FENA 1.9% suggesting not prerenal. Creatinine 3.0 on admission and was 1.87 on ___, 1.25 on ___, and 1.06 on ___. Renal Ultrasound in ___ was normal. Good UOP. IVF. Nephrology consult: UPEP neg, SPEP neg, renal ultrasound neg, hold Pemetrexed. Instructed to try to have about 2L of fluid daily. Please f/u creatinine at outpatient appt # Dizziness, chronic: Mild with standing since starting chemotherapy. Orthostatics: negative. ___ concerned for cerebellar dysfunction, especially given mets; Patient refused to go to rehab. Plans to use walker and shower seat at home. Home ___. # Lung Adenocarcinoma, NSCLC: Metastatic disease to bone and brain. Followed by Dr. ___. Holding Pemetrexed maintenance chemotherapy, last dose on ___. # Cerebellar Metastases: Patient is s/p treatment ___ stable MRI ___. She presented on last admission with worsening balance and cerebellar exam concerning for increasing size of met. MRI head done on ___ showed stable cerebellar met. Likely source of her dizziness as above. # Bony metastatic disease. Will continue Zometa as outpatient. # Seizures, last grand mal seizure was ___ ___ontinued on phenytoin. # Hypercholesterolemia: Diet controlled. CONTACT: ___ HCP CODE: DNR/DNI ### TRANSITIONAL ISSUES ### -Instructed to try to have about 2L of fluid daily -Please f/u creatinine at outpatient appt -Will f/u w/ Hem/Onc Dr. ___ home walker use and home ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Calcium Carbonate 400 mg PO DAILY 2. FoLIC Acid 1 mg PO DAILY 3. Lorazepam 0.5-1 mg PO Q4H:PRN nausea, anxiety 4. Multivitamins 1 TAB PO DAILY 5. Ondansetron 8 mg PO Q8H:PRN nausea 6. Phenytoin Sodium Extended 100 mg PO QAM 7. Phenytoin Sodium Extended 300 mg PO QPM 8. Prochlorperazine 10 mg PO Q6H:PRN nausea 9. Timolol Maleate 0.25% 1 DROP BOTH EYES BID Discharge Medications: 1. Calcium Carbonate 400 mg PO DAILY 2. FoLIC Acid 1 mg PO DAILY 3. Lorazepam 0.5-1 mg PO Q4H:PRN nausea, anxiety 4. Multivitamins 1 TAB PO DAILY 5. Phenytoin Sodium Extended 100 mg PO QAM 6. Phenytoin Sodium Extended 300 mg PO QPM 7. Prochlorperazine 10 mg PO Q6H:PRN nausea 8. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 9. Ondansetron 8 mg PO Q8H:PRN nausea Discharge Disposition: Home With Service Facility: ___ ___ Diagnosis: Anemia Renal Failure Lung cancer, metatstatic Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were admitted to our hospital with weakness and nausea. We found you to have a low blood count (anemia) as well as kidney failure. We gave you blood and fluids through your IV. It is important that you follow up with Dr. ___. Followup Instructions: ___
10761742-DS-15
10,761,742
21,706,431
DS
15
2136-12-04 00:00:00
2136-12-04 18:18:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Haldol / quetiapine / Motrin Attending: ___. Chief Complaint: Unwitnessed fall Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ with past medical history notable for severe dementia who presents from her nursing home after an unwitnessed fall. Per the facility, patient was found on the ground, in no acute distress, without obvious signs of trauma. At baseline, she is minimally communicative; staff reports no recent change in her mental status or behavior. They deny recent fevers, chills, or medication changes. Patient's daughter was called and also reported concern over recent 15lb. weight loss secondary to inability to take in PO's. On arrival to the ED, initial vitals T 97.3 HR 105 BP 149/72 RR 16 O2 100% RA Exam notable for: - In no acute distress, not answering questions, follows most commands appropriately Labs notable for: - WBC 9.9, Hgb 12.1, plts 138 - LFTs unremarkable - K 3.3, BUN 26, Cr 0.9 - UA 23 WBCs, few bacteria, sml leuks, pos nitrites, tr protein Imaging notable for: - CT C-spine: No acute fracture or traumatic subluxation. - CT head w/o contrast: No acute intracranial abnormality. - CXR: No acute cardiopulmonary abnormality. Possible right ninth posterior rib fracture. Patient received: IV ceftriaxone 1g, 1L NS with 40meQ KCl at 250cc/hr Transfer vitals: T 98.6 HR 94 BP 139/82 RR 16 O2 99% RA Past Medical History: Dementia (mixed vascular/Alzheimer) Hypertension Hypothyroidism Anxiety Social History: ___ Family History: Per prior notes, heart disease in both parents. Otherwise negative. Physical Exam: Admission Physical Exam ======================= VS: T 97.6 BP 161/75 HR 97 RR 20 O2 100 Ra GENERAL: Well-appearing elderly woman, laying in bed comforatably, in NAD HEENT: NC/AT, EOMI, anicteric sclera, MMM NECK: Supple, no LAD HEART: RRR, normal S1/S2, no m/r/g LUNGS: CTAB, breathing comfortably on RA without use of accessory muscles ABDOMEN: Soft, mild TTP above bladder with voluntary guarding, no rebound, non-distended, hyperactive bowel sounds EXTREMITIES: No c/c/e SKIN: Warm, well-perfused, no rashes NEURO: Alert, unable to assess orientation due to being non-verbal, not following commands, moving all extremities with purpose, no facial asymmetry Discharge Physical Exam ======================= GENERAL: Well-appearing elderly woman, laying in bed comforatably, in NAD HEENT: NC/AT, EOMI, anicteric sclera, MMM NECK: Supple, no LAD HEART: RRR, normal S1/S2, no m/r/g LUNGS: CTAB, breathing comfortably on RA without use of accessory muscles ABDOMEN: Soft, non-tender, non-distended EXTREMITIES: No c/c/e SKIN: Warm, well-perfused, no rashes NEURO: Alert, unable to assess orientation due to being non-verbal, not following commands, moving all extremities with purpose, no facial asymmetry Pertinent Results: Admission Labs ============== ___ 09:07PM BLOOD WBC-9.9 RBC-4.13 Hgb-12.1 Hct-36.7 MCV-89 MCH-29.3 MCHC-33.0 RDW-15.6* RDWSD-51.0* Plt ___ ___ 09:07PM BLOOD Glucose-147* UreaN-26* Creat-0.9 Na-143 K-3.3* Cl-105 HCO3-24 AnGap-14 ___ 09:07PM BLOOD ALT-21 AST-17 CK(CPK)-116 AlkPhos-100 TotBili-0.7 ___ 09:07PM BLOOD Albumin-4.2 Calcium-10.7* Phos-2.1* Mg-2.1 Pertinent Labs ============== ___ 06:29AM BLOOD VitB12-___ ___ 06:29AM BLOOD TSH-4.9* Discharge Labs ============== ___ 06:42AM BLOOD WBC-9.8 RBC-3.88* Hgb-11.5 Hct-34.4 MCV-89 MCH-29.6 MCHC-33.4 RDW-15.9* RDWSD-51.2* Plt ___ ___ 06:42AM BLOOD Glucose-130* UreaN-8 Creat-0.5 Na-141 K-3.4* Cl-102 HCO3-22 AnGap-17 ___ 06:42AM BLOOD Calcium-9.3 Phos-2.6* Mg-1.8 Imaging ======= CXR (___): No definite displaced rib fractures. The previously seen cortical discontinuity in the right posterior ninth rib is not well seen and may have been artifactual on the prior study or healed since previous. Non-con head CT (___): 1. No evidence for an acute intracranial abnormality. 2. Stable 10 mm ossified extradural lesion along the left frontal lobe, consistent with a meningioma Non-con CT spine (___): 1. No evidence for an acute fracture or acute subluxation. 2. Multilevel degenerative disease. Brief Hospital Course: Ms. ___ is a ___ with history of mixed vascular/Alzheimers dementia, hypothyroidism, HTN, generalized anxiety disorder who presents from her nursing home after an unwitnessed fall, found to have orthostatic hypotension and asymptomatic bacteruria. # Fall Patient with unwitnessed fall at assisted living. C-spine/NCHCT negative, CXR with possible right ninth posterior rib fx but on repeat rib series this is not seen. Deferred further neuroimaging as unlikely to change management. Fall is likely multifactorial in setting of gait imbalance, decreased PO intake, orthostasis, underlying dementia. Unclear if patient has vision or hearing impairment. No report of new environmental hazards. No history of valvular dysfunction and no murmur heard on exam, no history of arrhythmia, low suspicion for syncope at this time, deferred TTE. Note that she saw PCP ___ ___ with concern for TIA, deferred MRI/MRA at that time. No clear risk factors for neuropathy, vit B12 WNL. She was noted to be orthostatic, for which she was given IV NS 500 mL x 2 and amlodipine was discontinued. # Weight loss # Failure to thrive # Advanced stage Dementia Patient with mixed vascular/Alzhiemer dementia, minimally verbal at this time. Patient has lost ___ pounds over the past few months with decreased PO intake and refusing meds. This is likely secondary to progression of her underlying dementia. There is no indication for feeding tube placement in patients in advanced stage dementia. Note that previously levothyroxine d/c'd by PCP ___ ___ in setting of weight loss, at that time TSH 6.29; repeat TSH 4.9 here, hence we continued to hold levothyroxine. Mammogram in ___ without concerning findings, unsure about colonoscopy history, although this is likely not within goals of care and unlikely to change management given advanced dementia. Nutrition was consulted and we repleted her K and phos. We deferred trials of megace (risks: death, VTE, edema) or dronabinol given low likelihood of efficacy and potential harms. Per discussion with family, they will be hiring ___ care following this admission, which is appropriate. In future ___ consider whether family would like to bring a hospice benefit into her home in the dementia unit. # Asymptomatic bacteriuria Prelim urine culture growing >100,000 CFU GNR, UA with 23 WBCs, few bacteria, pos nitrites. Per health aid, no change in urinary patterns, does not note pain on urination; pt is non-tender on abdominal exam. Got CTX x 1 in ED, but in setting of no symptoms suggesting UTI, this was discontinued. CHRONIC ISSUES ============== # Hypertension Amlodipine was discontinued for orthostasis (Lying BP 155/78 HR 84 -> standing 132/70 HR 90) and recent fall. We will plan to tolerate SBP<180. # Hypothyroidism TSH 4.9; PCP discontinued levothyroxine in ___ (TSH 6.8 then) due to weight loss and age. We continued to hold this medication. # Anxiety Continued mirtazapine 7.5mg qHS, also for appetite stimulation. TRANSITIONAL ISSUES =================== # Fall [] Please recheck orhostatics at next PCP ___ [] Discontinued amlodipine; please reassess need for this medication should SBP>180 [] Given risk/benefit of aspirin 325 mg (which patient was taking per daughter but not on medication list from assisted living facility), opted to discontinue this medication in context of progressive dementia and desire to decrease pill burden # Weight loss/Failure to thrive/Progressive dementia [] Monitor weekly weights at assisted living [] Continue goals of care discussion as an outpatient with Dr. ___ consider whether family is interested in palliative care # Asymptomatic bacteriuria [] F/u urine cx # Hypothyroidism - TSH 4.9 in ___, did not restart levothyroxine # Code status: DNR/DNI (MOLST in OMR) # Name of health care proxy: ___ Phone number: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 5 mg PO DAILY 2. Multivitamins 1 TAB PO DAILY 3. Vitamin B Complex w/C 1 TAB PO DAILY 4. Calcium Carbonate 750 mg PO BID 5. Acetaminophen 1300 mg PO BID 6. Mirtazapine 7.5 mg PO QHS 7. Vitamin D 1000 UNIT PO QHS 8. Ibuprofen Suspension 200 mg PO Q12H:PRN Pain - Moderate 9. melatonin 1 mg oral QHS Discharge Medications: 1. Acetaminophen 1300 mg PO BID 2. Calcium Carbonate 750 mg PO BID 3. Ibuprofen Suspension 200 mg PO Q12H:PRN Pain - Moderate 4. melatonin 1 mg oral QHS 5. Mirtazapine 7.5 mg PO QHS 6. Multivitamins 1 TAB PO DAILY 7. Vitamin B Complex w/C 1 TAB PO DAILY 8. Vitamin D 1000 UNIT PO QHS 9. HELD- amLODIPine 5 mg PO DAILY This medication was held. Do not restart amLODIPine until your doctor tells ___ to Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Fall Mixed Alzheimer/vascular Dementia Failure to thrive Asymptomatic bacteriuria Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Lethargic but arousable. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ were admitted to the hospital after having an unwitnessed fall at your assisted living facility. Your head and spine imaging did not show anything concerning. Your blood pressure was noted to be lower on standing ("orthostatic hypotension"), so we gave ___ IV fluids and discontinued your amlodipine, as dehydration and medications can both contribute. The low blood pressure may contribute to your risk of fall. Your family and assisted living facility told us that ___ have been eating less in the past few months and that ___ have had weight loss. Your potassium and phosphate levels were low, so we gave ___ IV supplementation to replete this. When ___ arrived, ___ were found to have a few bacteria in your urine and got a single dose of antibiotics. However, since ___ were not symptomatic and have not had changes in urinary patterns, we stopped your antibiotics on ___. Your thyroid levels still showed ___ had hypothyroidism, but we did not re-start levothyroxine as your PCP had stopped this in ___ due to concerns with weight loss and age. After ___ leave the hospital, - Please follow up with your PCP. - Please discontinue aspirin, statin, amlodipine, and levothyroxine. It was a pleasure taking care of ___! Your ___ team Followup Instructions: ___
10761750-DS-10
10,761,750
28,486,191
DS
10
2177-10-17 00:00:00
2177-10-28 11:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Back pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ with hx of chronic back pain recently had spinal stimulator placed here last ___ who awoke after the surgery with pressure like lower abdominal pain that has steadily been worsening. Has been inpatient at ___ with 2 negative CTs, negative TVUS whose mother drove her to ___ for further evaluation since no cause has been found. No fevers. No n/v. No cp, sob, cough. Has pressure w/ urination. No diarrhea. No groin anesthesia. No difficulty controlling urine/stool. Back pain controlled. Denies ___ weakness. In the ED, initial vitals were: 97.9 86 164/90 16 100% RA Exam notable for: alert, uncomfortable, lying on left side; RRR; CTAB abd soft, nd, diffusely tender; back: 2 incision c/d/I, mild tenderness at baseline per patient; sensation/motor intact in lower extremities Labs notable for: negative U/A Imaging notable for: Abd supine/upright which showed nonobstructive bowel gas pattern with very little colonic stool burden. Patient was given: Morphine sulfate 4mg IV x 4 Patient was seen by neurosurgery who recommended no further neurosurgical intervention or spinal imaging. Decision was made to admit for pain control Vitals notable for 98.1 74 129/77 16 99% RA On the floor, the patient complains of ___ abdominal pain which does not resolve with change in position. She states she has the same lower extremity pain as before her stimulator was placed, and that she has not passed bowel movements or flatus since before her procedure on ___. She reports her abdominal pain worsens when her bladder is full, and that she gets some relief from emptying her bladder. Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, or diarrhea. No dysuria. Denies arthralgias or myalgias. Past Medical History: - chronic low back pain - DJD of lumbar spine - autoimmune thyroiditis - hypertension - s/p spinal cord stimulator (placed at ___ ___ Social History: ___ Family History: - non-contributory Physical Exam: ADMISSION EXAM: GEN: NAD, lying in bed with blankets on HEENT: AT/NC; EOMI, PERRL, sclera anicteric CV: RRR, no M/R/G, +S1/S2 PULM: CTAB anteriorly and laterally, no W/R/R ABD: no scars visualized, mildly distended appearing, tender to palpation in left periumbilical area; +BS, tympanitic to percussion GU: no Foley in place EXT: nontender to palpation, nonedematous SKIN: no rashes or ecchymoses NEURO: A/Ox3, CNII-XII grossly intact, intact sensation in ___ without saddle anesthesia; motor exam deferred due to patient discomfort, but able to ambulate PSYCH: depressed mood, flat affect DISCHARGE EXAM: VS: 98.7 144/86 69 18 98RA GEN: NAD, lying in bed with blankets on HEENT: AT/NC; EOMI, PERRL, sclera anicteric CV: RRR, no M/R/G, +S1/S2 PULM: CTAB anteriorly and laterally, no W/R/R ABD: no scars visualized, less distended appearing, tender to palpation in right periumbilical area; +BS, tympanitic to percussion GU: no Foley in place EXT: nontender to palpation, nonedematous SKIN: no rashes or ecchymoses NEURO: A/Ox3, CNII-XII grossly intact, intact sensation in ___ without saddle anesthesia; patient ambulating daily PSYCH: depressed mood, flat affect Pertinent Results: ADMISISON LABS: ___ 10:44AM BLOOD WBC-6.0 RBC-4.26 Hgb-12.9 Hct-37.9 MCV-89 MCH-30.3 MCHC-34.0 RDW-11.3 RDWSD-36.1 Plt ___ ___ 10:44AM BLOOD Glucose-82 UreaN-8 Creat-0.8 Na-139 K-3.9 Cl-100 HCO3-29 AnGap-14 ___ 07:42AM BLOOD ALT-118* AST-103* LD(LDH)-338* AlkPhos-123* TotBili-1.1 ___ 10:44AM BLOOD Calcium-9.0 Phos-3.9 Mg-1.9 ___ 11:09PM URINE Color-Yellow Appear-Clear Sp ___ ___ 11:09PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG ___ 11:09PM URINE UCG-NEGATIVE DISCHARGE LABS: ___ 07:49AM BLOOD WBC-4.3 RBC-4.31 Hgb-12.9 Hct-37.6 MCV-87 MCH-29.9 MCHC-34.3 RDW-11.3 RDWSD-35.8 Plt ___ ___ 07:49AM BLOOD ___ PTT-34.7 ___ ___ 07:49AM BLOOD Glucose-100 UreaN-9 Creat-0.8 Na-137 K-3.9 Cl-99 HCO3-25 AnGap-17 ___ 07:49AM BLOOD ALT-68* AST-36 LD(LDH)-190 AlkPhos-100 TotBili-0.8 ___ 07:49AM BLOOD Albumin-3.7 Calcium-9.0 Phos-3.5 Mg-1.9 MICRO: ___ UCx: NG Final STUDIES: None IMAGING: ___ Abdomen (supine/erect) film: IMPRESSION:  N o n o b s t ructive bowel gas pattern with very little colonic stool burden. P a t c h y   opacities at both lung bases, best assessed by chest radiograph. ___ TVUS: IMPRESSION: 1 . Unremarkable sonographic appearance of the uterus and ovaries. 2 .   1 . 8   c m   s i m ple appearing right paraovarian cyst.  Recommend ___ year followup pelvic ultrasound. ___ CT T-spine w/o contrast: IMPRESSION: 1 .   S p i n e   s t i m u lator in place terminating at T8 level.  No paraspinal hematoma. No CT evidence of central canal abnormality. 2 .   I n d eterminate 1.4 cm sclerotic lesion involving T11 vertebral body, possibly hemangioma ___ Abdominal U/S: Normal abdominal ultrasound. Brief Hospital Course: This is a ___ year old woman with medical history notable for chronic low back pain and radicular leg pain with recent spinal stimulator implantation (___) who presented with low abdominal pain after having OSH negative workup concerning for ileus or other postoperative complication. At the outside hospital she was ruled out for bowel obstruction or any complications from the device placement. She came to ___ to be seen by her neurosurgeon and for pain control. She was evaluated and thought to have postoperative ileus in the setting of receiving copious IV morphine at OSH as well as in the ___ ED. # Abdominal pain: The patient presented after AMA from OSH after having spinal stimulator surgically implanted on ___ at ___. At the time of admission, she was ambulating, and had intact neurological examination in lower extremities. She was seen by the neurosurgery team in the ED, who initially deemed her symptoms not related to her recent procedure The patient had multiple studies in OSH which ruled out intra-abdominal process with CT A/P and TVUS. She had an abdominal film and repeat TVUS which showed no acute intra-abdominal process, but an incidental finding of ovarian cyst was noted. As the patient had received significant amounts of opioid pain medication (morphine) post-operatively, at OSH, and in ___ ED, ileus was the favored diagnosis, however there question as to whether her pain was a result of her recent procedure. Her pain was much improved after initiation of a bowel regimen (senna/docusate/PEG) and simethicone and all opioids stopped; she had multiple bowel movements with reduction in pain. Neurosurgery formally re-evaluated the patient and determined her pain might be a rare adverse event related to stimulator placement, which typically resolves without intervention. They recommend typical post device placement follow-up. The patient was discharged home with close follow-up with neurosurgery and her PCP. # low back pain: Present at baseline, reason for spinal stimulator placement. The patient had an unchanged lower extremity neurological examination. Initially, her home tizanidine and cyclobenzaprine were held, but they were restarted once she had less abdominal pain. During her stay, she activated her spinal stimulator with moderate relief in her back pain. She will follow up with the neurosurgery device clinic for further adjustment in her treatment. # hypothyroidism: The patient's levothyroxine was continued on home schedule, which is ___ 125mcg and ___ 112mcg. # hypertension: Stable on home amlodipine, which was continued during her stay. # encephalomalacia: Reportedly secondary to thyroid disease. Her home dextroamphetamine (Adderall) was continued during the stay. TRANSITIONAL ISSUES: - new medications: docusate sodium, senna, simethicone, polyethylene glycol - Patient should follow up with neurosurgical NP ___ days post-operatively for suture/staple removal and Dr. ___ ___ weeks post-operatively for evaluation. - Avoid opioid pain medications given potential ileus postoperatively. - Assist with activation and utilization of spinal stimulator. - 1.8 cm simple appearing right paraovarian cyst on TVUS will require ___ year f/u ultrasound - Contact: ___mother) ___ ___ (___) ___ - Code: Full Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 2.5 mg PO DAILY 2. Amphetamine-Dextroamphetamine XR 20 mg PO DAILY 3. Levothyroxine Sodium 112 mcg PO 4X/WEEK (___) 4. Levothyroxine Sodium 125 mcg PO 3X/WEEK (___) 5. Vitamin D ___ UNIT PO DAILY 6. Tizanidine 2 mg PO QAM 7. Cyclobenzaprine 10 mg PO QHS Discharge Medications: 1. Docusate Sodium 100 mg PO BID 2. Polyethylene Glycol 17 g PO DAILY 3. Senna 8.6 mg PO BID:PRN constipation 4. Simethicone 40-80 mg PO QID:PRN abdominal pain 5. amLODIPine 2.5 mg PO DAILY 6. Amphetamine-Dextroamphetamine XR 20 mg PO DAILY 7. Cyclobenzaprine 10 mg PO QHS 8. Levothyroxine Sodium 112 mcg PO 4X/WEEK (___) 9. Levothyroxine Sodium 125 mcg PO 3X/WEEK (___) 10. Tizanidine 2 mg PO QAM 11. Vitamin D ___ UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: - Abdominal pain due to surgery and ileus Secondary Diagnosis: - Low back pain - Hypothyroidism - Hypertension - Encephalomalacia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, Thank you for allowing us to participate in your care while at ___. Why did I come to the hospital? - You were having severe abdominal pain after having surgery to implant a spinal stimulator in your back on ___. What was done for me while I was in the hospital? - You were given medication to help make your bowels more active, which was thought to be part of the reason for your pain. - You were seen by your surgeon who believes the pain might have been a side effect from the surgery, but that it should go away on its own within a week or so. - You turned on your spinal stimulator to see if you would get some pain relief. What should I do when I leave the hospital? - Continue to take your medications as instructed. - Keep your follow up appointments with your doctor and surgeon. - Contact your surgeon if you feel the pain is not improving or getting worse. It was a pleasure caring for you while you were here. Best regards, Your ___ Care Team Followup Instructions: ___
10761861-DS-8
10,761,861
21,687,459
DS
8
2116-02-20 00:00:00
2116-02-21 09:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: shortness of breath, lower extremity swelling Major Surgical or Invasive Procedure: Cardiac Cath Study Date of ___: Hemodynamic Measurements (mmHg) Baseline Site ___ ___ End Mean A Wave V Wave HR ___ Coronary angiography: right dominant LMCA: normal LAD: 50% distal. 70% very distal in small caliber trans-apical segments. LCX: 60% in large OM1 RCA: 40% ___, 40% distal. 40% in PDA, 60% in small PL-1, 60% in large PL-2 History of Present Illness: The patient is a ___ y/o M with PMHx significant for HTN and IDDM who presents with dyspnea on exertion, wheezing for the past several weeks as well as ___ edema for 5 weeks. He's been sleeping in a recliner, and feeling short of breath when walking short distances. No chest pain, but has felt his heart racing intermittently over the last several months. He did have a cold ~ 5 weeks ago, but no other viral illnessess. No cough, no fevers, no tick exposure, no ETOH abuse. He went to his PCP's office today for these symptoms, and was sent to the ED. O2 sat at the PCP's office was noted to be 88% on RA.He has no known history of CHF and has never seen a cardiologist. In the ED intial vitals were: 97.3 112 143/99 22 96% on RA but felt tachypneic so was placed on 4L nasal cannula for comfort. Labs were significant for Cr of 1.3 (baseline 1.1) as well as proBNP of 4367. Troponin x1 was negative. EKG was significant for sinus tachycardia to 114. CXR was notable for pulmonary edema. Given that CXR could not r/o PNA, patient was given Azithromycin 500mg PO. He was also given ASA 325mg PO x1 as well as lasix 40mg IV x1. Past Medical History: IDDM HTN HLD Gout Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: ADMISSION PHYSICAL EXAMINATION: VS: 97.7 BP 127/98 P ___ R 20 O2 Sat 94 RA GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: atraumatic, anicteric sclera. PERRL. MMM. NECK: Supple, JVP difficult to assess. Non-tender non-enlarged thyroid. CARDIAC: tachycardic, regular with frequent skipped beats, no murmurs heard LUNGS: mildly dyspnic when speaking multiple sentences and with movement. Crackles bilaterally at bases. Dullness to percussion on RLL. No wheezes. ABDOMEN: Soft, non-tender, non-distended. EXTREMITIES: WWP, pitting edema almost to knees. SKIN: no rashes DISCHARGE PHYSICAL EXAMINATION: VS: T 98.3 97.9 119/81 (94-119/60-81) 95 (76-101) 20 100% ra I/O: 8hr -- / 400 24 hr 1600/1695; glucose 100-195 Wt: 106.9 on discharge <-- 107.4 <-- 109.7 <-- 110.2 <-- 111.7 <-- 111.5 <-- 112.0 GENERAL: Energetic, cheerful, NAD. Oriented x3. HEENT: atraumatic, anicteric sclera. PERRL. MMM. NECK: Supple, JVP difficult to assess. Non-tender non-enlarged thyroid. CARDIAC: regular rate with frequent skipped beats, no murmurs heard LUNGS: Breathing comfortably. CTAB. No wheezes. ABDOMEN: Soft, non-tender, non-distended. EXTREMITIES: WWP, 1+ pitting edema to mid shin SKIN: no rashes Pertinent Results: ON ADMISSION ============== ___ 04:30PM BLOOD WBC-8.8 RBC-5.99 Hgb-15.1 Hct-51.1 MCV-85 MCH-25.2* MCHC-29.5* RDW-17.4* Plt ___ ___ 04:30PM BLOOD Neuts-62.0 ___ Monos-7.6 Eos-1.2 Baso-0.3 ___ 04:30PM BLOOD Plt ___ ___ 06:08PM BLOOD ___ PTT-31.3 ___ ___ 04:30PM BLOOD Glucose-110* UreaN-14 Creat-1.3* Na-138 K-4.6 Cl-104 HCO3-26 AnGap-13 ___ 04:30PM BLOOD proBNP-4647* ___ 04:30PM BLOOD cTropnT-0.01 ___ 06:50AM BLOOD TotProt-6.0* Calcium-8.9 Phos-2.8 Mg-1.7 ___ 06:50AM BLOOD Ferritn-35 ___ 06:50AM BLOOD TSH-1.4 ___ 06:50AM BLOOD CRP-17.8* ___ 06:50AM BLOOD PEP-NO SPECIFI ___ 03:00PM BLOOD HIV Ab-NEGATIVE ___ 06:50AM BLOOD HCV Ab-NEGATIVE ___ 07:03PM BLOOD Lactate-1.3 ANGIOTENSIN 1 - CONVERTING ___ Test Result Reference Range/Units ACE, SERUM 17 ___ U/L ON DISCHARGE ================ ___ 06:25AM BLOOD WBC-6.2 RBC-5.78 Hgb-14.8 Hct-49.6 MCV-86 MCH-25.5* MCHC-29.8* RDW-17.0* Plt ___ ___ 06:40AM BLOOD Neuts-55.8 ___ Monos-8.3 Eos-3.3 Baso-0.8 ___ 06:25AM BLOOD Plt ___ ___ 06:25AM BLOOD Glucose-110* UreaN-19 Creat-1.2 Na-140 K-4.1 Cl-98 HCO3-35* AnGap-11 ___ 06:25AM BLOOD Calcium-9.1 Phos-3.3 Mg-1.9 MICRO ___ 6:53 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. PERTINENT RESULTS: ====================== ___ Creat-1.3* ___ Creat-1.2 ___ proBNP-4647* ___ cTropnT-0.01 ___ Ferritn-35 ___ TSH-1.4 ___ CRP-17.8* ___ PEP-NO SPECIFI ___ HIV Ab-NEGATIVE IMAGING =============== C.cath ___: prelim read at time of discharge ECHO ___: The left atrium is moderately dilated. The right atrium is markedly dilated. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is at least 15 mmHg. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity is moderately dilated. There is severe global left ventricular hypokinesis (LVEF = ___ %). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). The right ventricular cavity is moderately dilated with mild global free wall hypokinesis. The aortic root is mildly dilated at the sinus level. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is a trivial/physiologic pericardial effusion. IMPRESSION: Moderate left ventricular cavity dilation with severe global hypokinesis. Elevated PCWP. Moderate right ventricular cavity dilatation with mild global Moderate pulmonary hypertension. Mild mitral regurgitation. Aortic root dilatation. Biatrial dilatation. Chest pa/lat ___: Cardiomegaly with mild pulmonary edema. Possible pneumonia at the right medial lung base. ECG ___: Sinus tachycardia. Premture ventricular complexes. Left atrial abnormality. Non-diagnostic Q waves inferiorly. Delayed R wave transition. Non-specific ST segment flattening. Low voltage in the limb leads. No previous tracing available for comparison. Brief Hospital Course: Hospital course: ___ y/o M with PMHx significant for HTN and IDDM who presented with dyspnea on exertion and ___ edema for 5 weeks. Active issues: # New onset acute CHF exacerbation: Admission chest x-ray with pulmonary edema, BNP 4367. Troponin x 1 negative, no ischemic changes on EKG. On ECHO he was found to have severe global left ventricular hypokinesis on ECHO with LVEF ___. C cath on ___ with moderate diffuse CAD as well as markedly elevated left and right heart filling pressures. Cardiac MRI showed severe biventricular dysfunction with early and late gadolinium enhancement of the septal mid-myocardium, consistent with idiopathic, post-viral, or perhaps cardiac sarcoid. Unclear etiology at this time for his CHF: Hep C, HIV negative. ACE, ferritin, and SPEP/UPEP not elevated. CRP elevated at 17.8. Less likely HTN-induced cardiomyopathy given non-thickened LV. Less likely ischemic given global hypokinesis and cath results without significant stenoses. For his CHF, he was started on Spironolactone 12.5 mg PO/NG DAILY; Metoprolol Succinate was increased to 37.5 daily; he was continued on Amlodipine 10 mg PO/NG DAILY and Lisinopril 40 mg PO/NG DAILY. Moderate CAD also seen on C Cath: for this he was started on ASA 81 daily and Atorvastatin 40 daily. He did have some short runs of asymptomatic ventricular tachycardia: EP was consulted, who recommended discharge with a LifeVest pending follow-up ECHO. Unclear ideal dry weight given that patient is actively dieting/loosing weight. Last documented weights at PCP: 108.8 kg ___ 117 kg ___. Admission weight: 112 kg, discharge weight: 106.9 kg. # ___: Creatinine of 1.3 on admission and 1.2 on discharge: 1.1 on ___, 0.9 on ___. Mild elevation likely cardio-renal in the setting of CHF. Improved with diuresis. Chronic issues: # Hypertension: on metoprolol succintate, amlodipine, lisinopril at home, which were continued during admission. # Type 2 Diabetes: HbA1c 7.3 ___. Albumin/Cre ration 62.4. On Insulin, glipizide, and metformin at home. On home dose lantus and insulin SSI during admission. # Hyperlipidemia: has been on rosuvastatin 20 in the past; PCP ___ several months ago. Restarted on - have restarted high potency statin given moderate CAD on cath # Gout: continued on home dose allopurinol. TRANSITIONAL ISSUES: ============================ - Followup final read of cardiac MRI - consider outpatient FDG-PET to evaluate for cardiac sarcoid - EP consulted ___ for 38 beats of aysmptomatic VT; this was likely provoked in the setting of decompensated heart failure. He was discharged with a Life Vest and may require an ICD - torsemide was started at a dose of 40 mg daily, which may be managed as an outpatient - potassium 10 mg and magnesium 400 mg daily supplementation was initiated - check electrolytes in one week - Needs to be scheduled in ___ EP and general cardiology clinics Medications on Admission: The Preadmission Medication list is accurate and complete. 1. GlipiZIDE 5 mg PO DAILY 2. Allopurinol ___ mg PO BID 3. Lisinopril 40 mg PO DAILY 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Amlodipine 10 mg PO DAILY 6. MetFORMIN (Glucophage) 1000 mg PO BID 7. Viagra (sildenafil) 100 mg oral PRN ED 8. Glargine 12 Units Bedtime 9. Rosuvastatin Calcium 20 mg PO DAILY Discharge Medications: 1. Allopurinol ___ mg PO BID 2. Amlodipine 10 mg PO DAILY 3. Glargine 12 Units Bedtime 4. Lisinopril 40 mg PO DAILY 5. Aspirin 81 mg PO DAILY RX *aspirin [Adult Low Dose Aspirin] 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Atorvastatin 40 mg PO DAILY RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 7. Spironolactone 12.5 mg PO DAILY RX *spironolactone 25 mg 0.5 (One half) tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 8. GlipiZIDE 5 mg PO DAILY 9. MetFORMIN (Glucophage) 1000 mg PO BID 10. Metoprolol Succinate XL 37.5 mg PO DAILY RX *metoprolol succinate 25 mg 1.5 tablet(s) by mouth daily Disp #*45 Tablet Refills:*0 11. Torsemide 40 mg PO DAILY RX *torsemide 20 mg 2 tablet(s) by mouth daily Disp #*60 Tablet Refills:*0 12. Potassium Chloride 10 mEq PO DAILY RX *potassium chloride 10 mEq 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 13. Magnesium Oxide 400 mg PO DAILY Duration: 1 Dose RX *magnesium oxide 400 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary New onset systolic congestive heart failure Coronary artery disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your recent hospitalization. You were admitted because you were having trouble breathing and because your legs had become swollen. These symptoms are from fluid backing up into your lungs/legs because your heart is not working as well as it used to. We studied your heart with an ultrasound and an MRI to get a better sense of why this is happening. We were able to rule out some causes, but we still do not know exactly what's causing your heart failure and will continue to monitor this in the outpatient setting. You may require additional tests after being discharged, which will be coordinated by your outpatient cardiologists. We have started you on several medications as detailed in your discharge packet. It's important for you to wear the LifeVest over the next several weeks. Please also take your medications as prescribed, and follow-up with your doctors as ___ below. Weight yourself every morning, and call your doctor if your weight increases by more than 3 pounds. Please take your potassium and magnesium supplements. Avoid foods that are high in potassium, such as potatoes and bananas. Sincerely, Your ___ Care Team Followup Instructions: ___
10762097-DS-7
10,762,097
22,527,538
DS
7
2125-11-22 00:00:00
2125-11-22 11:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: ___: exploratory laparotomy, lysis of adhesions, small bowel resection, hernia repair History of Present Illness: ___ h/o open hiatal hernia repair (___), multiple ventral hernia repairs, s/p LBR for incarcerated hernia w perforation (___), now p/w abd pain of approximately 1 week duration. With this pain, he has transitioned his diet from solids to mainly liquids. He noted a baseball sized mass ___ his L periumbilical area. He presented to ___ where a CT scan showed incarcerated hernia and free air concerning for perforation. He continues to pass stool, althought it is less than his usual amount. Today, he passed a small liquid bowel movement. He has not passed gas ___ the past week. He denies nausea/ vomiting, fevers. Past Medical History: ventral hernias, incarcerated ventral hernia HTN GERD Social History: ___ Family History: noncontributory Physical Exam: PE: upon admission: ___ Vitals: AVSS Gen: morbidly obese, NAD CV: RRR, S1S2, no m/r/g Pulm: CTAB Abd: morbidle obese, multiple well healed surgical scars, softball sized firm bulge ___ L mid-abdomen, TTP throughout, mostly ___ area of bulge, no rebound or guarding, +peritoneal signs ___: no edema Pertinent Results: ___ 07:46AM HCT-43.0 ___ 01:06AM LACTATE-1.2 ___ 12:38AM COMMENTS-GREEN TOP ___ 12:25AM GLUCOSE-88 UREA N-19 CREAT-1.0 SODIUM-134 POTASSIUM-3.7 CHLORIDE-101 TOTAL CO2-19* ANION GAP-18 ___ 12:25AM estGFR-Using this ___ 12:25AM WBC-15.7* RBC-4.90 HGB-14.6 HCT-43.0 MCV-88 MCH-29.8 MCHC-33.9 RDW-15.6* ___ 12:25AM PLT COUNT-241 ___ 12:25AM ___ PTT-29.1 ___ ___ 06:00AM BLOOD WBC-11.0 RBC-4.35* Hgb-13.6* Hct-39.9* MCV-92 MCH-31.2 MCHC-34.0 RDW-15.1 Plt ___ ___ 05:12AM BLOOD WBC-10.4 RBC-4.24* Hgb-12.9* Hct-37.9* MCV-89 MCH-30.5 MCHC-34.2 RDW-15.4 Plt ___ ___ 04:44AM BLOOD WBC-9.0 RBC-4.23* Hgb-12.8* Hct-38.6* MCV-91 MCH-30.2 MCHC-33.1 RDW-15.7* Plt ___ ___ 04:54AM BLOOD WBC-8.3 RBC-4.03* Hgb-12.0* Hct-36.8* MCV-91 MCH-29.8 MCHC-32.6 RDW-15.5 Plt ___ ___ 05:24AM BLOOD WBC-8.1 RBC-4.08* Hgb-12.2* Hct-37.0* MCV-91 MCH-30.0 MCHC-33.0 RDW-15.7* Plt ___ ___ 04:42AM BLOOD WBC-8.2 RBC-4.09* Hgb-12.2* Hct-37.0* MCV-90 MCH-29.9 MCHC-33.1 RDW-15.5 Plt ___ ___ 07:46AM BLOOD Na-135 K-3.9 Cl-102 ___ 06:00AM BLOOD Glucose-103* UreaN-22* Creat-0.9 Na-136 K-4.5 Cl-102 HCO3-26 AnGap-13 ___ 06:00AM BLOOD Glucose-94 UreaN-20 Creat-0.7 Na-138 K-3.8 Cl-103 HCO3-26 AnGap-13 ___ 05:12AM BLOOD Glucose-80 UreaN-21* Creat-0.6 Na-137 K-4.1 Cl-105 HCO3-22 AnGap-14 ___ 04:44AM BLOOD Glucose-98 UreaN-21* Creat-0.7 Na-136 K-3.9 Cl-102 HCO3-29 AnGap-9 ___ 04:54AM BLOOD Glucose-112* UreaN-17 Creat-0.7 Na-138 K-4.0 Cl-103 HCO3-26 AnGap-13 ___ 05:24AM BLOOD Glucose-91 UreaN-13 Creat-0.7 Na-139 K-3.7 Cl-102 HCO3-26 AnGap-15 ___ 04:42AM BLOOD Glucose-105* UreaN-11 Creat-0.6 Na-135 K-3.6 Cl-102 HCO3-27 AnGap-10 ___ 06:00AM BLOOD ALT-23 AST-31 AlkPhos-89 TotBili-7.4* ___ 05:12AM BLOOD ALT-25 AST-37 AlkPhos-85 Amylase-46 TotBili-6.0* DirBili-4.6* IndBili-1.4 ___ 04:44AM BLOOD ALT-37 AST-65* AlkPhos-94 Amylase-37 TotBili-5.3* DirBili-4.4* IndBili-0.9 ___ 04:54AM BLOOD ALT-42* AST-70* AlkPhos-140* Amylase-46 TotBili-4.9* DirBili-4.0* IndBili-0.9 ___ 05:24AM BLOOD ALT-46* AST-62* AlkPhos-218* Amylase-64 TotBili-4.2* DirBili-3.0* IndBili-1.2 ___ 04:42AM BLOOD ALT-41* AST-52* AlkPhos-260* TotBili-2.7* ___ 07:46AM BLOOD Mg-1.8 ___ 06:00AM BLOOD Calcium-8.1* Phos-2.2* Mg-2.4 ___ 06:00AM BLOOD Calcium-8.5 Phos-2.3* Mg-2.3 ___ 05:12AM BLOOD Albumin-2.5* Calcium-8.1* Phos-3.9# ___ 04:44AM BLOOD Calcium-8.4 Phos-3.0 Mg-2.2 ___ 04:54AM BLOOD Calcium-8.3* Phos-3.0 Mg-2.1 ___ 05:24AM BLOOD Calcium-8.3* Phos-3.2 Mg-2.1 ___ 04:42AM BLOOD Calcium-8.1* Phos-3.4 Mg-2.1 ___: EKG: Atrial fibrillation with rapid ventricular response. No previous tracing available for comparison ___: chest x-ray: Subject to technical limitations ___ imaging a patient this size, NG tube can be traced only as far as the gastroesophageal junction. Moderate cardiomegaly and mediastinal vascular engorgement have increased. Soft tissue obscures the lower lungs. There could be a small right pleural effusion. ___: liver/gallbladder US: Cholelithiasis as seen on prior CT. No biliary dilatation visualized. 2. Limited exam of the liver due to the patient body habitus. ___: x-ray of the abdomen: An enteric tube is seen terminating ___ the stomach. Can be advanced approximately 3-4 cm. Dilated loops of small bowel likely represent post operative ___ 3:00 am SWAB HERNIA FLUID CULTURES Fluid should not be sent ___ swab transport media. Submit fluids ___ a capped syringe (no needle), red top tube, or sterile cup. **FINAL REPORT ___ GRAM STAIN (Final ___: 2+ ___ per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE ROD(S). 1+ (<1 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND SINGLY. FLUID CULTURE (Final ___: This culture contains mixed bacterial types (>=3) so an abbreviated workup is performed. Any growth of P.aeruginosa, S.aureus and beta hemolytic streptococci will be reported. IF THESE BACTERIA ARE NOT REPORTED BELOW, THEY ARE NOT PRESENT ___ this culture.. Work-up of organism(s) listed below discontinued (excepted screened organisms) due to the presence of mixed bacterial flora detected after further incubation. GRAM NEGATIVE ROD(S). SPARSE GROWTH. ESCHERICHIA COLI. SPARSE GROWTH. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ANAEROBIC CULTURE (Final ___: BACTEROIDES FRAGILIS GROUP. SPARSE GROWTH. BETA LACTAMASE POSITIVE. FUSOBACTERIUM NUCLEATUM. SPARSE GROWTH. BETA LACTAMASE NEGATIVE. Brief Hospital Course: ___ year old male admitted to the acute care service with abdominal pain. A cat scan done at an outside hospital showed an incarcerated hernia, small bowel obstruction with pneumo-peritoneium. He was started on zosyn and flagyl. Attempts at reducing the hernia were unsuccessful. The patient was transferred here for further management. He underwent abdominal assessment and his vital signs remained stable. On HD #2, he was taken to the operating room where he underwent an exploratory laparotomy, extensive lysis of adhesions, small bowel resection of 60 cm, primary anastomosis and repair of ventral hernia with bioprosthetic mesh. There were multiple adhesions throughout to the abdominal wall and to the bowel. The operative course was stable with a 250cc blood loss. Two JP drains were placed on either side of his abdomen at the close of the procedure. The patient was extubated after the procedure and monitored ___ the recovery room. Wound culture from the hernia repair fluid grew E.Coli and the patient was treated with a week course of ciprofloxacin. The post-operative course was notable for nausea and an isoalated episode of vomiting. A ___ tube was placed for decompression. It was removed and later replaced. Abdominal x-ray was notable for an ileus. The patient also had an episode of atrial fibrillation which was treated with metoprolol. His heart rate converted to normal sinus rhythm and there were no further episodes of rapid heart rate. The patient was placed on telemetry and closely monitored. The patient's surgical pain was controlled with intravenous analgesia. As his bowel function slowly recovered, the ___ tube and foley catheter were removed on POD #4. The patient was started on clear liquids and advanced to a regular diet. His intravenous analgesia was converted to oral agents. His right drain, which had limited output, was removed on POD # 6. The left JP continued to drain serosanguinous fluid and remained ___ place. During his post-operative recovery, the patient was noted to be jaundiced. Liver functions tests were notable for an elevation of the total bilirubin to 7.4. His liver enzymes were trended and slowly decreased. ___ search of an etiology, the patient underwent an ultrasound of the liver and gallbladder which showed numerous gallstones without ___ fluid or gallbladder wall edema. Hepatitis serology was drawn and it returned normal. On POD #9 his total bilirubin had decreased to 2.1, but his lipase and alkaline phosphatase remained mildly elevated. The patient was seen by physical therapy and recommendations were made to discharge to rehabilitation facility where he could further regain his strength and mobility. On POD 8, the patient was discharged ___ stable condition. Medications on Admission: HCTZ 25', omeprazole 20'', unisome for sleep Discharge Medications: 1. Docusate Sodium 100 mg PO BID 2. Heparin 5000 UNIT SC TID 3. Metoprolol Tartrate 12.5 mg PO TID 4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain 5. Pantoprazole 40 mg PO Q24H 6. Senna 1 TAB PO BID:PRN constipation Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: incarcerated hernia Secondary: elevated liver enzymes Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood ___ your urine, or experience a discharge. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change ___ your symptoms, or any new symptoms that concern you. Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Incision Care: *Please call your doctor or nurse practitioner if you have increased pain, swelling, redness, or drainage from the incision site. *Avoid swimming and baths until your follow-up appointment. *You may shower, and wash surgical incisions with a mild soap and warm water. Gently pat the area dry. *If you have staples, they will be removed at your follow-up appointment. *If you have steri-strips, they will fall off on their own. Please remove any remaining strips ___ days after surgery Followup Instructions: ___
10762495-DS-5
10,762,495
24,289,430
DS
5
2129-01-12 00:00:00
2129-01-12 16:36:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: Unresponsiveness Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ woman with history of malignant paraganglioma s/p debulking and palliative chemo/XRT followed at ___, who was transferred from ___ for further management of symptomatic orthostasis with markedly labile blood pressures in setting of known neuroendocrine tumor. The patient was recently hospitalized at ___ from ___ to ___ for further control of her extremely labile blood pressure with SBPs > 180s as well as symptomatic orthostatic hypotension. Given her known pheo, adjustment of antihypertensive regimen made alongside input for Endocrine team. She was continued on her home phenoxybenzamine 40/40/60, TID pronpanolol, and lisinopril for renal protection. Her home nifedipine was discontinued due to recurrent symptomatic hypotension. Additional interventions for her severe orthostasis included abdominal binder and 0.05mg Florinef. Patient was discharged to rehab. While at rehab earlier today, she developed acute onset of lightheadedness with the feeling that she was going to faint. She was subsequently taken to ___ where she had an ECG that demonstrated mild sinus tachycardia but was otherwise benign. At ___, the patient was again symptomatic with abrupt position change. She was given 1L IVF. Given her complicated oncologic history, the ___ did not feel comfortable admitting the patient for observation. Plan was to admit the patient to ___ where she receives all of her medical care, but the hospital was full. ___ also declined, thus she was transferred to ___. In the ED, initial VS were T97.8, BP 188/94, HR 101, RR16, 96% RA. ECG sinus rhythm without evidence of right heart strain. BMP demonstrated Cr 2.0 and Ca of 10.8 (no albumin) otherwise normal electrolytes, Hg 8.9, WBC 8.4, glucose 194. Patient received propranolol 20mg and lisinopril 5mg. Transfer VS were: HR 100, BP 180/87. On arrival to the floor, the patient reports feeling well as she is laying in bed. She denies any symptoms with orthostatic vitals obtained on arrival. Later that evening, she was observed by nursing experiencing an episode of expressive aphasia that lasted for one minute that resolved completely on repeat assessment. Of note, patient was last seen by oncologist, Dr. ___, on ___ to discuss the fact that recent CT scan from ___ that demonstrated progression of disease to her lungs and spine. Plan at that time was to start temozolomide, but this has not yet occurred, likely pending discharge from rehab. Past Medical History: Type 2 diabetes mellitus Diabetic peripheral neuropathy CKD (baseline Cr 1.9-2.1) Osteoporosis Cardiomyopathy Malignant paraganglioma Hyperlipidemia Hypertensive urgency Orthostatic hypotension Social History: ___ Family History: Father ? colon cancer; Mother alive, recent ___ diagnosis. No known family history of MEN or other endocrine tumors. Physical Exam: ADMISSION PHYSICAL EXAM: ====================== VS: T98.5 BP 182/100, HR 101, RR16 96% RA GENERAL: laying in bed in NAD HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no LAD, no JVD HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ DP pulses bilaterally NEURO: CNII-XII intact; ___ strength in all extremities. Sensation grossly intact. No ataxia. SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: ====================== VITALS: Temp: 98.6 PO BP: 131/76 R Sitting HR: 77 RR: 18 O2 sat: 95% O2 delivery: RA GENERAL: Older appearing woman in no acute distress. AAOx3. HEENT: NCAT. EOMI. MMM. CARDIAC: Rapid rate, regular rhythm. Normal S1/S2. No murmurs, rubs, or gallops. PULMONARY: Frequent expiratory wheezes over bilateral lung fields, improved. No increased work of breathing. ABDOMEN: Soft, non-tender, non-distended. EXTREMITIES: Warm, well perfused, non-edematous. SKIN: No significant rashes. Pertinent Results: ADMISSION LABS: ============== ___ 06:26PM BLOOD WBC-8.4 RBC-3.36* Hgb-8.9* Hct-29.1* MCV-87 MCH-26.5 MCHC-30.6* RDW-20.2* RDWSD-62.2* Plt ___ ___ 06:26PM BLOOD Neuts-63.6 Lymphs-18.1* Monos-10.6 Eos-3.3 Baso-0.5 NRBC-0.2* Im ___ AbsNeut-5.36 AbsLymp-1.53 AbsMono-0.89* AbsEos-0.28 AbsBaso-0.04 ___ 04:54AM BLOOD ___ PTT-29.7 ___ ___ 06:26PM BLOOD Glucose-194* UreaN-32* Creat-2.0* Na-140 K-4.4 Cl-96 HCO3-27 AnGap-17 ___ 04:54AM BLOOD ALT-16 AST-36 LD(LDH)-340* AlkPhos-163* TotBili-0.2 ___ 06:26PM BLOOD Calcium-10.8* Phos-4.6* Mg-1.6 ___ 04:54AM BLOOD calTIBC-178* Hapto-469* Ferritn-599* TRF-137* ___ 05:55AM BLOOD %HbA1c-8.4* eAG-194* ___ 05:55AM BLOOD Triglyc-176* HDL-43 CHOL/HD-3.1 LDLcalc-55 ___ 05:55AM BLOOD TSH-3.2 ___ 08:37AM BLOOD Type-ART pO2-106* pCO2-50* pH-7.41 calTCO2-33* Base XS-5 ___ 08:37AM BLOOD Lactate-1.6 DISCHARGE/PERTINENT LABS: ======================= ___ 07:45AM BLOOD WBC-7.6 RBC-3.00* Hgb-7.9* Hct-25.9* MCV-86 MCH-26.3 MCHC-30.5* RDW-20.1* RDWSD-63.0* Plt ___ ___ 07:45AM BLOOD Glucose-207* UreaN-22* Creat-2.1* Na-144 K-3.9 Cl-100 HCO3-26 AnGap-18 ___ 07:45AM BLOOD Calcium-10.2 Phos-3.8 Mg-1.7 ___ 04:54AM BLOOD calTIBC-178* Hapto-469* Ferritn-599* TRF-137* ___ 05:55AM BLOOD %HbA1c-8.4* eAG-194* ___ 05:55AM BLOOD Triglyc-176* HDL-43 CHOL/HD-3.1 LDLcalc-55 ___ 05:55AM BLOOD TSH-3.2 ___ 06:50AM BLOOD PTH-8___ 06:50AM BLOOD Cortsol-14.4 ___ 08:02AM BLOOD freeCa-1.31 IMAGING: ======== ___ CT HEAD W/O CONTRAST: 1. No acute hemorrhage. 2 .   N o   C T   evidence for an acute major vascular territorial infarction; MRI would be more sensitive if clinically warranted. 3 .   M u l t i p l e hypodensities in the subcortical and deep supratentorial white m a t t e r   a r e  nonspecific but likely sequela of chronic small vessel ischemic d i s e a s e   i n  this age group.  However, MRI would be more sensitive for small intracranial metastases, if clinically warranted. ___ MRI/MRA BRAIN W/O CONTRAST; MRA NECK W/O CONTRAST 1. No acute intracranial infarct mass effect or hydrocephalus. 2 .   N o   s i g nificant abnormalities on MRA of the head and neck with somewhat limited neck MRA without contrast. 3 .   L e f t s i d e d   neck mass is incompletely evaluated if clinically indicated neck CT or MRI can be obtained for further evaluation.  R E C O M M E N D A T I O N  Neck CT or MRI for further evaluationn of partially visualize neck mass. ___ CTA HEAD/NECK: 1. No acute intracranial abnormality. 2. No dissection, aneurysm or occlusion of the head neck. 3. No significant ICA stenosis by NASCET criteria. 4. Evidence of a 2.7 cm heterogeneously enhancing partially calcified mass resulting in erosion of the left C2 superior tick inner facet and possibly extending through the left C2-C3 and to a lesser extent C1-C2 neural foramen where causes mild encroachment on the spinal canal. Findings likely correlate with the patient's history of malignant paraganglioma. 5. The left cervical vertebral artery is at least partially encased by the mass. 6. A couple sclerotic lesions of the occipital calvarium measuring up to 1.0 cm are suspicious for metastatic deposits. 7. Multiple enlarged mediastinal lymph nodes measuring up to 1.5 cm in short axis possibly relates to the patient's history of a malignant paraganglioma. Addition, there are a few prominent left supraclavicular and posterior cervical space lymph nodes. 8. A 4 mm right upper lobe pulmonary nodule. Consider obtaining a complete CT chest for complete evaluation given patient's history of malignancy. 9. Right thyroid lobe 0.5 cm hypodense nodule for which no follow-up imaging is recommended. RECOMMENDATION(S): Thyroid nodule. No follow up recommended. Absent suspicious imaging features, unless there is additional clinical concern, ___ of Radiology guidelines do not recommend further evaluation for incidental thyroid nodules less than 1.0 cm in patients under age ___ or less than 1.5 cm in patients age ___ or ___. Suspicious findings include: Abnormal lymph nodes (those displaying enlargement, calcification, cystic components and/or increased enhancement) or invasion of local tissues by the thyroid nodule. ___, et al, "Managing Incidental Thyroid Nodules Detected on Imaging: White Paper of the ACR Incidental Findings Committee". J ___ ___ 12:143-150. ___ CXR PORTABLE AP: No acute intrathoracic process. MICROBIOLOGY: ============= NONE Brief Hospital Course: ___ woman with history of malignant paraganglioma s/p debulking and palliative chemo/XRT admitted for symptomatic orthostasis with markedly labile blood pressures, with hospital course complicated by episode of transient expressive aphasia ___ severe hypoglycemia. # LABILE BLOOD PRESSURE # SUPINE HYPERTENSION # ORTHOSTATIC HYPOTENSION Initially admitted for orhostatic episode at rehab facility. Overall no significant change from her prior ongoing symptoms. Continued on phenoxybenzamine/propranolol/lisinopril/fludrocortisone as part of complex regimen started by her primary oncologist for control of her hypertension that is secondary to her pheo and her orthostatic hypotension. The patient was euvolemic on exam so only received minimal fluid resuscitation, which did not make a difference in her orthostatics. AM cortisol was within normal limits. Thigh-high compression stockings and an abdominal binder were placed with some improvement in the patient's symptoms. After discussion with her primary oncologist, decision was made to keep her current regimen unchanged. We continued to provide teaching on positional changes and techniques to avoid loss of consciousness or falls. # ACUTE ENCEPHALOPATHY # TRANSIENT EXPRESSIVE APHASIA # SEVERE HYPOGLYCEMIA / TYPE 2 DIABETES Overnight ___ - ___ was found unresponsive with blood glucose <20. Resuscitated with D50 bolus / D10 water with modest improvement in mental status, however due to persistent somnolence was transferred to MICU for closer monitoring. Underwent repeat head imaging with CTA head/neck demonstrating no vascular territory infarct to account for symptoms. EEG without evidence of seizure activity. Mental status gradually improved overall consistent with severe hypoglycemia as etiology for her symptoms. Of note, the patient was previously on 45U of Lantus BID per her last ___ discharge summary and prior to discharge, was dropped to 18U daily given hypoglycemia. She was uptitrated back to 30U daily at rehab prior to readmission to the hospital. The etiology behind the declining insulin requirement was likely the severely decreased PO intake and malnutrition with 13kg weight loss in the last 5 months, likely with decreased insulin resistance. C-peptide was noted to be low. ___ was consulted and insulin continued to be downtitrated. Patient did not have any further episodes of unresponsiveness and blood glucose remained normal. At the time of discharge, was on 8U of Lantus QHS and was requiring 2U of Humalog TID per a standard sliding scale. # HYPERCALCEMIA Recent labs notable for elevated calcium to 12.8 (corrected for hypoalbuminemia) but with normal ionized calcium. On review of ___ records this appears to be relatively acute since her prior discharge. Unclear etiology, though suspicious for for malignancy-related hypercalcemia secondary to bony metastases. PTH was appropriately low. No EKG changes. Started on IV fluids with improvement in her serum calcium. Did not require further interventions, but needs further monitoring and may require bisphosphonate therapy if continues to worsen, given suspected etiology. # CONSTIPATION Patient presented with severe constipation without BM for up to 1 week prior to admission. Started on aggressive bowel regimen with 2 small BMs noted on ___ and ___. Abdominal XR still showing significantly large stool burden. # SEVERE MALNUTRITION Patient noted to have poor PO intake while in the hospital. Evaluated by nutrition and meets criteria for severe malnutrition. This is thought to be related to increasing nutrient needs due to her prolonged catabolic illness as well as poor PO intake for > 5 months due to poor appetite. The patient was lost 12.3 kg in the past few months with mild-moderate muscle/fat depletion noted. She was started on nutritional supplements (Glucerna 3x/day and Scandishake 2x/day), MVI with minerals, and thiamine. She was also started on Dronabinol on ___. # C1-C3 MASS # METASTATIC PHEOCHROMOCYTOMA PARAGANGLIOMA CTA neck with partially calcified mass eroding into C2 with extension from C1-C3. Overall most consistent with known paraganglioma. Unclear acuity. Continued management of Discussed with regular oncologist who agreed with transfer to ___ where normally receives care. # CHRONIC KIDNEY DISEASE Creatinine baseline approximately 1.8-2. Currently stable. TRANSITIONAL ISSUES: ================== [ ] Discuss blood pressure medication regimen with primary oncologist Dr. ___ [ ] Continue with aggressive bowel regimen given large stool burden and constipation [ ] F/U serum calcium [ ] Continue nutritional supplementation and monitor PO intake [ ] Monitor blood sugars and adjust insulin as needed [ ] Noted to have thyroid nodule on neck imaging # CODE STATUS: Full # CONTACT: ___ - ___ - ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Multivitamins 1 TAB PO DAILY 2. Glargine 30 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 3. Gabapentin 100 mg PO TID 4. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 5. Vitamin D ___ UNIT PO 1X/WEEK (FR) 6. Fludrocortisone Acetate 0.05 mg PO DAILY 7. Propranolol 20 mg PO TID 8. Senna 17.2 mg PO BID 9. Atorvastatin 80 mg PO QPM 10. Lisinopril 5 mg PO DAILY 11. Phenoxybenzamine HCl 40 mg PO BID 12. Lactulose 30 mL PO Q8H:PRN constipation 13. Phenoxybenzamine HCl 60 mg PO QHS 14. Melatin (melatonin) 3 mg oral qHS 15. TraZODone 25 mg PO QHS:PRN insomnia 16. Fleet Enema (Mineral Oil) ___AILY:PRN constipation 17. Ondansetron 8 mg PO Q8H:PRN nausea 18. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line Discharge Medications: 1. Bisacodyl 10 mg PO DAILY 2. Dronabinol 2.5 mg PO BID 3. Multivitamins W/minerals 1 TAB PO DAILY 4. Thiamine 100 mg PO DAILY Duration: 5 Days 5. Glargine 8 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 6. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 7. Atorvastatin 80 mg PO QPM 8. Fleet Enema (Mineral Oil) ___AILY:PRN constipation 9. Fludrocortisone Acetate 0.05 mg PO DAILY 10. Gabapentin 100 mg PO TID 11. Lactulose 30 mL PO Q8H:PRN constipation 12. Lisinopril 5 mg PO DAILY 13. Melatin (melatonin) 3 mg oral qHS 14. Ondansetron 8 mg PO Q8H:PRN nausea 15. Phenoxybenzamine HCl 40 mg PO BID 16. Phenoxybenzamine HCl 60 mg PO QHS 17. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 18. Propranolol 20 mg PO TID 19. Senna 17.2 mg PO BID 20. TraZODone 25 mg PO QHS:PRN insomnia 21. Vitamin D ___ UNIT PO 1X/WEEK (FR) Discharge Disposition: Extended Care Discharge Diagnosis: PRIMARY DIAGNOSES: - ORTHOSTATIC HYPOTENSION - HYPOGLYCEMIA - HYPERCALCEMIA - CONSTIPATION - SEVERE MALNUTRITION SECONDARY DIAGNOSES: - METASTATIC PARAGANGLIOMA - CHRONIC KIDNEY DISEASE Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at the ___ ___. You were admitted to the hospital because you were feeling lightheaded and almost passed out while you were at rehab. This was thought to be related to your underlying paraganglioma and your current medications to control your blood pressure. You were given a small amount of fluids, and we used a combination of thigh-high compression stockings and an abdominal binder to maintain your blood pressure from fluctuating too much while you had positional changes. While you were in the hospital, you had an episode of where you lost consciousness and you were noted to have a blood sugar of 20. You quickly recovered after we corrected your blood sugar. This was thought to be related to an insulin dose that was too high for you. We adjusted your home insulin dosing and lowered it further. You were also treated for constipation and were given supplements because you were not eating very well. After a discussion with your primary oncologist, Dr. ___ are transferring you to ___ for further management. Wishing you a speedy recovery, Your ___ Care Team Followup Instructions: ___
10762742-DS-17
10,762,742
22,694,250
DS
17
2164-08-04 00:00:00
2164-08-07 09:51:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fever, cough, SOB Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ ___ with past medical history of atrial fibrillation, HLD who presents with ___ days of productive cough, fever to 101 and body aches. He arrived to urgent care rigoring with oxygen saturation to 82% on room air improving with nasal cannula. He was given nebulizer treatment given diffuse wheezing. Chest x-ray revealing likely pneumonia. Patient ordered for ceftriaxone and azithromycin. Flu test was negative. Patient transferred to ___ emergency department for further care. He denies chest pain, extremity weakness or paresthesia, headache, neck pain. Past Medical History: HYPERLIPIDEMIA PALPITATIONS SLEEP APNEA ASTHMA COLONIC ADENOMA ATRIAL FIBRILLATION Social History: ___ Family History: Father - ATRIAL FIBRILLATION - PROSTATE CANCER Physical Exam: Admission Physical Exam ===================================== VITALS: ___ 2356 Temp: 98.5 PO BP: 115/71 R HR: 76 RR: 18 O2 sat: 91% O2 delivery: Ra General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Scattered rhonchi and end-expiratory wheezes. Abdomen: Normoaactive bowel sounds. Soft, non-tender, non-distended, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis. Trace peripheral edema ___ b/l ___. Skin: Skin type III. Warm, dry, no rashes or notable lesions. Neuro: CNII-XII intact. A&Ox3. No gross focal deficits. Discharge Physical Exam ===================================== Vitals: Temp 98.5 BP 117/69 HR 70 RR 16 O2sat 93 RA General: NAD Neck: No lymphadenopathy Lungs: Diffuse expiratory wheezing w/ rhonchi; no crackles; decreased air movement CV: RRR, no MRG GI: Soft, nondistended, no TTP diffusely Ext: No edema, erythema, TTP of ___: PERRL, EOMI Pertinent Results: ADMISSION LABS ================= ___ 05:20PM WBC-12.5* RBC-5.07 HGB-16.1 HCT-46.7 MCV-92 MCH-31.8 MCHC-34.5 RDW-12.5 RDWSD-42.0 ___ 05:20PM NEUTS-66.8 ___ MONOS-11.1 EOS-2.3 BASOS-0.2 IM ___ AbsNeut-8.31* AbsLymp-2.40 AbsMono-1.38* AbsEos-0.29 AbsBaso-0.03 ___ 05:20PM PLT COUNT-256 ___ 05:05PM OTHER BODY FLUID FLU A PCR-NEG FLU B PCR-NEG ___ 05:20PM GLUCOSE-141* UREA N-14 CREAT-1.0 SODIUM-144 POTASSIUM-3.9 CHLORIDE-98 TOTAL CO2-28 ANION GAP-18 DISCHARGE LABS ==================== ___ 07:05AM BLOOD WBC-8.7 RBC-4.20* Hgb-13.1* Hct-38.6* MCV-92 MCH-31.2 MCHC-33.9 RDW-12.6 RDWSD-41.7 Plt ___ ___ 07:05AM BLOOD Glucose-114* UreaN-17 Creat-0.8 Na-142 K-3.6 Cl-102 HCO3-25 AnGap-15 ___ 07:05AM BLOOD ALT-30 AST-19 LD(LDH)-234 AlkPhos-51 TotBili-0.4 MICROBIOLOGY ================= ___ 6:29 am URINE Source: ___. **FINAL REPORT ___ Legionella Urinary Antigen (Final ___: NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. ___ 12:53 am SPUTUM Source: Expectorated. **FINAL REPORT ___ GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. 2+ ___ per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND CLUSTERS. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE ROD(S). RESPIRATORY CULTURE (Final ___: MODERATE GROWTH Commensal Respiratory Flora. Test Result Reference Range/Units S. PNEUMONIAE ANTIGENS, Not Detected Not Detected URINE IMAGING ============== CXR IMPRESSION: Patchy right upper lobe consolidation compatible with pneumonia ___ the proper clinical setting. Follow-up after treatment is suggested to document resolution. Brief Hospital Course: Brief Hospital Course ========================================= ___ w/ hx of HLD, OSA, afib, and mediastinal lymphadenopathy presenting with 3 days of increasing cough, fevers, and SOB, discovered to have PNA on CXR, hypoxia and treated with CTX + Azithro. #Community Acquired Pneumonia: #Hypoxemic respiratory failure: Patient presented with several days of cough, fevers, malaise at home. Patient was diagnosed with CAP due to clinical signs and symptoms as well as a CXR demonstrating a RUL consolidation. At urgent care, he was noted to be hypoxic to 82% on room air, prompting referral to ___ and admission. Patient was started on IV CTX + Azithromycin which was then switched to PO Levaquin x5 days given the sputum Gram stain demonstrating GPCs and GNRs. Patient remained afebrile and his WBC decreased after initiation of antibiotics, and he was weaned to room air. Ambulatory O2 sat ___ the afternoon was 94% on room air. Patient discharged on oral levofloxacin 750mg PO Q24H to complete 5 day course (D1 = ___. #Headache: Patient noted a headache that had begun after admission. Given the dull, gradual onset, holosystolic nature of the headache without associated symptoms, headache is most likely related to his current infection as above. Improved with PRN acetaminophen and ibuprofen. #ETOH Use: Patient noted that he drank ___ drinks per day. No signs of ETOH withdrawal. Transitional Issues ========================================= [ ] Complete 5-day course of antibiotics for CAP treatment (D1 = ___ - D5 = ___. Discharged on levofloxacin 750mg PO Q24H. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Diazepam 10 mg PO QHS 2. Metoprolol Succinate XL 25 mg PO QPM 3. Docusate Sodium 100 mg PO BID 4. Simvastatin 40 mg PO QPM 5. Cetirizine 10 mg PO DAILY 6. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN SOB or wheezing 7. Benzonatate 200 mg PO TID:PRN cough Discharge Medications: 1. Levofloxacin 750 mg PO Q24H RX *levofloxacin 750 mg 1 tablet(s) by mouth once a day Disp #*4 Tablet Refills:*0 2. albuterol sulfate 90 mcg/actuation inhalation Q6H:PRN SOB or wheezing 3. Benzonatate 200 mg PO TID:PRN cough 4. Cetirizine 10 mg PO DAILY 5. Diazepam 10 mg PO QHS 6. Docusate Sodium 100 mg PO BID 7. Metoprolol Succinate XL 25 mg PO QPM 8. Simvastatin 40 mg PO QPM Discharge Disposition: Home Discharge Diagnosis: Community-acquired pneumonia Hypoxemic respiratory failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ====================== DISCHARGE INSTRUCTIONS ====================== Dear Mr. ___, It was a pleasure caring for you at ___ ___. WHY WAS I ___ THE HOSPITAL? - You were ___ the hospital for trouble breathing and your oxygen levels were low. Your chest x-ray showed a pneumonia (lung infection). WHAT HAPPENED TO ME ___ THE HOSPITAL? - We treated you with antibiotics and you felt better. - Your oxygen levels improved after IV antibiotics, and you were ready to go home. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Please take your first dose of your antibiotic, levofloxacin, tonight (___), and take until gone. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10762830-DS-20
10,762,830
23,483,846
DS
20
2113-10-20 00:00:00
2113-10-24 19:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Penicillins Attending: ___. Chief Complaint: Trauma: struck in face with pipe Major Surgical or Invasive Procedure: ___ intra oral ORIF mandible History of Present Illness: This patient is a ___ year old male who complains of ASSAULT. ___ was assaulted tonight with a lead pipe the left side of his face. + LOC. Was seen at ___ where he had a cat scan of the head and neck which were reportedly negative. He was found to have a comminuted mandibular fracture with dental injuries. Received 1 g of Ancef and morphine. Patient denies neck pain, back pain, chest pain, nausea, vomiting, shortness of breath or abdominal pain, extremity trauma. Takes Zoloft. Drinks alcohol, denies smoking or recreational drug use. He is allergic to penicillin. Labs at the outside hospital were unremarkable. Past Medical History: IVDA, Depression Social History: ___ Family History: Non-contributory. Physical Exam: PHYSICAL EXAMINATION upon admission: ___ Temp: 100.2 HR: 90 BP: 130/65 Resp: 16 O(2)Sat: 100 Normal HEENT: Pupils equal, round and reactive to light + deformity of the jaw Chest: Clear to auscultation Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Soft, Nontender, Nondistended Extr/Back: No cyanosis, clubbing or edema Skin: No rash, Warm and dry Neuro: Speech fluent Psych: Normal mood, Normal mentation ___: No petechiae Physical examination upon discharge: ___: vital signs: 97.8, bp=102/42, hr=73, 16, oxygen saturation 97% room air ___: resting, ice packs to face, face swollen CV: ns1, s2, -s3 -s4 LUNGS: clear ABDOMEN: soft, non-tender, hypoactive BS EXT: no pedal edema bil., + dp bil., mild tenderness right great toe, full flexion/extension NEURO: alert and oriented x 3, speech garbled related to jaw swelling Pertinent Results: ___ 12:31AM BLOOD WBC-17.7* RBC-4.91 Hgb-15.1 Hct-44.6 MCV-91 MCH-30.8 MCHC-33.9 RDW-12.9 Plt ___ ___ 12:31AM BLOOD Neuts-80.1* Lymphs-15.2* Monos-3.3 Eos-1.0 Baso-0.4 ___ 12:31AM BLOOD Plt ___ ___ 12:31AM BLOOD Glucose-100 UreaN-15 Creat-0.9 Na-148* K-3.9 Cl-107 HCO3-23 AnGap-22* ___ 12:31AM BLOOD ASA-NEG ___ Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG Panorex of mandible: ___: Fracture through the left mandibular body which appears to traverse the root of the bottom ___ left molar tooth. ___: panorex mandible: FINDINGS: In comparison with the study of ___, there is a fixation device about the fracture near the angle of the mandible on the left with_ no appreciable displacement. There are also metallic fixation devices about the medial aspect of the right mandible. Brief Hospital Course: The patient was admitted to the hospital after being struck in the face with a lead pipe. He reportedly sustained a loss of consciousness. Imaging studies of the head and neck were normal but the patient was reported to have a comminuted mandibular fracture with dental injuries. He was given a dose of ancef in the emergency room and was seen by OMFS. After examination by the ___ service, the patient was started on an intravenous course of clindamycin. The patient was taken to the operating room on HD #1 where he underwent an intraoral ORIF of bilateral mandible fracture. The operative course was stable with a 50 cc blood loss. The post-operative course was stable. The patient's was transitioned from intravenous analgesia to oral agents for management of his surgical pain. He was started on clears and advanced to full liquids. He was voiding without difficulty. Panorex imaging was obtained prior to discharge. Because of his loss of consciousness, the patient was evaulated by Occupational therapy to assess the need for outpatient cognitive therapy. No cognitive follow-up was indicated. The social worker provided social support and addressed the patient's concerns. The patient was discharged on POD #1 in stable condition. An appointment for follow-up was made with the ___ service. The patient was instructed to complete a 7 day course of clindamycin as per recommendations of the ___ service. Medications on Admission: zoloft 50 mg daily Discharge Medications: 1. Acetaminophen 650 mg PO Q8H 2. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID RX *chlorhexidine gluconate 0.12 % rinse mouth with 15cc twice a day Disp #*1 Bottle Refills:*0 3. Clindamycin 300 mg PO Q6H RX *clindamycin HCl 300 mg 1 capsule(s) by mouth every six (6) hours Disp #*26 Capsule Refills:*0 4. Docusate Sodium 100 mg PO BID 5. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN pain avoid driving while on this medication, may cause drowsiness RX *hydromorphone 2 mg ___ tablet(s) by mouth every 3 hours Disp #*40 Tablet Refills:*0 6. Senna 8.6 mg PO BID:PRN constipation 7. Sertraline 50 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: fractured mandible Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ___ were admitted to the hospital after ___ were hit in the face with a pipe. ___ sustained a loss of consciousness related to the injury. Imaging of your face showed a fractured jaw. ___ were taken to the operating room where ___ had your jaw repaired. Your vital signs have been stable and ___ are now preparing for discharge home with the following instructions: Postoperative instructions following jaw surgery Wound care: Do not disturb or probe the surgical area with any objects. The sutures placed in your mouth are usually the type that self dissolve. If ___ have any sutures on the skin of your face or neck, your surgeon will remove them on the day of your first follow up appointment. SMOKING is detrimental to healing and will cause complications. Bleeding: Intermittent bleeding or oozing overnight is normal. Placing fresh gauze over the area and biting on the gauze for ___ minutes at a time may control the bleeding. If ___ had nasal surgery, ___ may have occasional slow oozing from your nostril for the first ___ days. Bleeding should never be severe. If bleeding persists or is severe or uncontrollable, please call our office immediately. If it is after normal business hours, please come to the emergency room and request that the oral surgery resident on call be paged. ___: Normal healing after oral surgery should be as follows: the first ___ days after surgery, are generally the most uncomfortable and there is usually significant swelling. After the first week, ___ should be more comfortable. The remainder of your postoperative course should be gradual, steady improvement. If ___ do not see continued improvement, please call our office. Physical activity: It is recommended that ___ not perform any strenuous physical activity for a few weeks after surgery. Do not lift any heavy loads and avoid physical sports unless ___ obtain permission from your surgeon. Swelling & Ice applications: Swelling is often associated with surgery. Swelling can be minimized by using a cold pack, ice bag or a bag of frozen peas wrapped in a towel, with firm application to face and neck areas. This should be applied 20 minutes on and 20 minutes off during the first ___ days after surgery. If ___ have been given medicine to control the swelling, be sure to take it as directed. Hot applications: Starting on the ___ or ___ day after surgery, ___ may apply warm compresses to the skin over the areas of swelling (hot water bottle wrapped in a towel, etc), for 20 minutes on and 20 min off to help soothe tender areas and help to decrease swelling and stiffness. Please use caution when applying ice or heat to your face as certain areas may feel numb after surgery and extremes of temperature may cause serious damage. Tooth brushing: Begin your normal oral hygiene the day after surgery. Soreness and swelling may nor permit vigorous brushing, but please make every effort to clean your teeth with the bounds of comfort. Any toothpaste is acceptable. Please remember that your gums may be numb after surgery. To avoid injury to the gums during brushing, use a child size toothbrush and brush in front of a mirror staying only on teeth. Mouth rinses: Keeping your mouth clean after surgery is essential. Use 1 teaspoon of salt dissolved in an 8 ounce glass of warm water and gently rinse with portions of the solution, taking 5 min to use the entire glassful. Repeat as often as ___ like, but ___ should do this at least 4 times each day. If your surgeon has prescribed a specific rinse, use as directed. Showering: ___ may shower ___ days after surgery, but please ask your surgeon about this. If ___ have any incisions on the skin of your face or body, ___ should cover them with a water resistant dressing while showering. DO NOT SOAK SURGICAL SITES. This will avoid getting the area excessively wet. As ___ may physically feel weak after surgery, initially avoid extreme hot or cold showers, as these may cause some patients to pass out. Also it is a good idea to make sure someone is available to assist ___ in case if ___ may need help. Sleeping: Please keep your head elevated while sleeping. This will minimize swelling and discomfort and reduce pain while allowing ___ to breathe more easily. One or two pillows may be placed beneath your mattress at the head of the bed to prop the bed into a more vertical position. Pain: Most facial and jaw reconstructive surgery is accompanied by some degree of discomfort. ___ will usually have a prescription for pain medication. Some patients find that stronger pain medications cause nausea, but if ___ precede each pain pill with a small amount of food, chances of nausea will be reduced. The effects of pain medications vary widely among individuals. If ___ do not achieve adequate pain relief at first ___ may supplement each pain pill with an analgesic such as Tylenol or Motrin. If ___ find that ___ are taking large amounts of pain medications at frequent intervals, please call our office. Diet: Unless otherwise instructed, only a cool, clear liquid diet is allowed for the first 24 hours after surgery. After 48 hours, ___ can increase to a full liquid diet, but please check with your doctor before doing this. Avoid extreme hot and cold. It is important not to skip any meals. If ___ take nourishment regularly ___ will feel better, gain strength, have less discomfort and heal faster. Over the counter meal supplements are helpful to support nutritional needs in the first few days after surgery. A nutrition guidebook will be given to ___ before ___ are discharged from the hospital. Remember to rinse your mouth after any food intake, failure to do this may cause infections and gum disease and possible loss of teeth. Nausea/Vomiting: Nausea is not uncommon after surgery. Sometimes pain medications are the cause. Precede each pill with a small amount of soft food. Taking pain pills with a large glass of water can also reduce nausea. Try taking clear fluids and minimizing taking pain medications, but call us if ___ do not feel better. If your jaws are wired shut with elastics and ___ experience nausea/vomiting, try tilting your head and neck to one side. This will allow the vomitus to drain out of your mouth. If ___ feel that ___ cannot safely expel the vomitus in this manner, ___ can cut elastics/wires and open your mouth. Inform our office immediately if ___ elect to do this. If it is after normal business hours, please come to the emergency room at once, and have the oral surgery on call resident paged. ___ will be given prescriptions, some of which may include antibiotics, oral rinses, decongestants, nasal sprays and pain medications. Use them as directed. A daily multivitamin pill for ___ weeks after surgery is recommended but not essential. Followup Instructions: ___
10762853-DS-18
10,762,853
26,021,014
DS
18
2184-11-24 00:00:00
2184-12-10 00:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Possible syncope Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is ___ with history of dementia, HTN, cataracts who is presenting s/p possible syncopal event. Per the patient's son, the patient was eating dinner at 1:30 this morning when she slumped over to the right; the son repots that she was unresponsive for 5 minutes; however, he also states that he asked if she was alright during this time, and she said "no". The patient does not recall this event. Pt.'s son is not sure if she just fell asleep at the table; nothing like this has ever happened before prompting him to bring her to the ER. The patient's son reports that prior to this event she was in her usual state of good health. The son reports that after event, patient is currently back to her baseline now, AAOx1. She lives with her son and by report receives assistance with her ADLs. She can feed herself and often dress herself, but her son has helped her with these things as well. Her daughter will reportedly bathe her. On the floor, patient denies any palpitations, lightheadedness, chest pain, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, constipation, fevers/chills. Past Medical History: Hypertension Cataracts Osteoarthritis Fracture of surgical neck humerus (___), with non-operative management Dementia Social History: ___ Family History: Brother died of throat cancer. Physical Exam: ADMISSION: VS: ___ 94RA GENERAL: pleasantly demented, well appearing elderly woman, NAD, laying comfortably in bed HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART: RRR, no MRG, nl S1-S2 ABDOMEN: normal bowel sounds, soft, non-tender, non-distended, no rebound or guarding, no masses EXTREMITIES: no edema, 2+ pulses radial pulses NEURO: awake, A&Ox0-1 (she remembered her maiden name only),CNs II-XII grossly intact, able to do finger to nose though slowly, normal muscle strength throughout, able to ambulate with assistance DISCHARGE: VS: 98.5 ___ 94%RA GENERAL: well appearing elderly woman, NAD HEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART: RRR, no MRG, nl S1-S2 ABDOMEN: normal bowel sounds, soft, non-tender, non-distended, no rebound or guarding, no masses EXTREMITIES: no edema, 2+ pulses radial pulses NEURO: awake, A&Ox1, CNs II-XII grossly intact, able to do finger to nose though slowly, normal muscle strength throughout Pertinent Results: LABS: ___ 02:40AM BLOOD WBC-7.8# RBC-4.62 Hgb-14.7 Hct-45.7 MCV-99*# MCH-31.8 MCHC-32.2 RDW-12.4 Plt ___ ___ 06:55AM BLOOD WBC-10.4 RBC-4.29 Hgb-13.2 Hct-41.6 MCV-97 MCH-30.8 MCHC-31.8 RDW-12.4 Plt ___ ___ 08:00AM BLOOD WBC-6.1 RBC-4.08* Hgb-13.0 Hct-39.5 MCV-97 MCH-31.9 MCHC-32.9 RDW-12.6 Plt ___ ___ 02:40AM BLOOD Glucose-134* UreaN-16 Creat-1.0 Na-143 K-3.5 Cl-100 HCO3-32 AnGap-15 ___ 06:55AM BLOOD Glucose-115* UreaN-16 Creat-0.9 Na-144 K-3.8 Cl-101 HCO3-31 AnGap-16 ___ 08:00AM BLOOD Glucose-83 UreaN-17 Creat-0.9 Na-143 K-3.3 Cl-102 HCO3-34* AnGap-10 ___ 02:40AM BLOOD cTropnT-<0.01 ___ 06:55AM BLOOD Calcium-9.5 Phos-3.8 Mg-2.2 ___ 01:40AM URINE Color-Straw Appear-Hazy Sp ___ ___ 01:40AM URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-SM ___ 01:40AM URINE RBC-<1 WBC-1 Bacteri-NONE Yeast-NONE Epi-0 = = = = ================================================================ IMAGING/OTHER STUDIES: EKG ___ Sinus rhythm. Prolonged P-R interval. Possible old inferior myocardial infarction. Borderline left ventricular hypertrophy. Compared to the previous tracing of ___ ventricular ectopy is resolved. CXR ___ FINDINGS: PA and lateral views of the chest demonstrate cardiomegaly with some increased interstitial markings again noted. Costophrenic angles are clear. A tortuous aorta and scoliosis centered in the upper lumbar/lower thoracic spine is again present. No focal consolidations concerning for pneumonia. Brief Hospital Course: Ms. ___ is ___ with history of dementia, HTN who is was brought in by her son in the setting of possible syncope. While she did appear to have a brief episode of decreased consciousness, it does not appear classic for either a syncope or a seizure. The reported symptoms do resemble fatigue or decreased alertness, although they did not recurr during the admission, while the patient was continued on her home medication regimen. #Possible syncope: The patient slumped to the R while eating her dinner. Unclear precipitant and unclear if true syncope versus falling asleep, but differential includes cardiogenic versus neurocardiogenic. Orthostasis unlikely as the patient was not going from sitting to standing. She denied having any chest pain or shortness of breath (though unclear how reliable of a historian the patient is), and EKG without any evidence of ST-T changes that could be consistent with ischemia. There was report that the patient was unresponsive, but unclear if there was LOC or loss of pulse. Seizure unlikely as there was no reported post-ictal period. If indeed was true syncopal episode, most likely explanation would be bradyarrhythmia caused by high degree AV blook in setting of worsening 1st degree block (PR 206) and beta blockade. Upon admission, patient was back at her baseline, as per son. She was monitored overnight on telemetry without any evidence of significant bradycardia or high degree AV block. Most likely explanation is that patient fell asleep in setting of eating dinner at 1AM. We wondered if her multiple dementia/anti-parkinsonian medications could be contributing to generalized lethargy or possible hypotensive episodes, although she did not have similar episodes while admitted to our service. # Chronic Systolic CHF: Last ECHO in ___ with e/o dilated and globally hypokinetic LV, with mild pulmonary HTN, and MR. ___ home Lasix, ASA, lisinopril and metoprolol # Dementia: Unclear type, but possible that there is element of ___ disease, given her tremor. Continued home donepezil, Namenda, and Sinemet. = ================================================================ TRANSITIONAL ISSUES: Consider adjusting Dementia/Anti-Parkinsonian medications as they may be having significant sedative effects on patient, if the presenting symptoms recurr as an outpatient. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Multivitamins 1 TAB PO DAILY 2. Donepezil 10 mg PO HS 3. Memantine 10 mg PO BID 4. Docusate Sodium 100 mg PO BID 5. Aspirin 81 mg PO DAILY 6. Metoprolol Tartrate 25 mg PO BID 7. Lisinopril 10 mg PO DAILY 8. Furosemide 40 mg PO DAILY 9. Caltrate 600 + D *NF* (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit Oral BID 10. Carbidopa-Levodopa (___) 1 TAB PO TID Discharge Medications: 1. Caltrate 600 + D *NF* (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit Oral BID 2. Multivitamins 1 TAB PO DAILY 3. Metoprolol Tartrate 25 mg PO BID 4. Memantine 10 mg PO BID 5. Lisinopril 10 mg PO DAILY 6. Furosemide 40 mg PO DAILY 7. Donepezil 10 mg PO HS 8. Docusate Sodium 100 mg PO BID 9. Carbidopa-Levodopa (___) 1 TAB PO TID 10. Aspirin 81 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: presyncope possible sedation effect of medications Secondary: Dementia Chronic systolic congestive heart failure Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ were admitted to ___ for evaluation of an episode of unresponsiveness. Your lab work, chest x-ray, and urinalysis were all normal, with no evidence of infection. There was also no evidence of a stroke or seizure. There was no evidence of a heart attack or abnormal rhythm. This is all very reassuring. It is possible that some of your medications, including Sinemet, Namenda, and Aricept could be contributing to your sleepiness or affecting your blood pressure, so ___ should talk with your doctors about possibly ___ these medications. It was a pleasure taking part in your care and we wish ___ a speedy recovery! Followup Instructions: ___
10762853-DS-19
10,762,853
22,720,205
DS
19
2186-04-28 00:00:00
2186-04-28 20:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Right knee pain Right knee swelling Major Surgical or Invasive Procedure: Arthrocentesis of right knee (___) Video oropharyngeal swallow (___) History of Present Illness: Ms. ___ is a ___ with advanced dementia (AOx0), HTN, and cataracts who presented with right medial knee swelling and pain. The patient is mostly non-verbal at baseline and was unable to provide an account of his her history. Per her son, who cares for her and is her legal guardian, the patient had demonstrated increased difficulty ambulating during the week prior to admisison. Typically, the patient had been able to ambulate with the assistance of one nursing aid. However, beginning a week prior to admission, the patient required the assistance of multiple family members to ambulate. During this time the patient would say "ouch" when her right knee was manipulated. Her difficulty ambulating progressed to the point of requiring a wheelchair a few days prior to admission. Patient's son notes the patient has always had asymmetry between her knee (right larger than left), but the pain is new. Patient has been breathing more rapidly and shallowly over the past week. Patient's family denies patient having fever, cough, complaints of other pain, and emesis. Per patient's son and daughter: At baseline, the patient is mostly ___, speaking only single words when she is audible. Patient is urinary incontinent in the nighttime at baseline. Over the past week, the patient has been having increased daytime urinary incontinence. Over the past several months, the patient has demonstrated difficulty swallowing liquids, solids and medications. The patient's family notes they have been mixing the patient's medications in apple sauce instead of with the water they usually give her. As a consequence, they note the patient has been getting lees water than ususal. Patient has been noted to always be thirsty--drinking large beverages in seconds. Patient has a nurisng aid at home who helped care for her. Patient's son and daughter are patient's legal gaurdians. In the ED initial vitals were: 97.6 91 125/73 26 90%RA. Labs were significant for Na 157, K 3.1, Cl 114, Bicarb 37, BUN 47, Cr, 1.7. WBC 14.8 with 86%N. Patient had a joint aspiration performed that showed 10,167 WBC and ___ RBC's. Lactate 1.7. Patient was given Vancomycin 1g IV x1. Also, was given 40meq KCl in D5W 175cc/hr. On the floor, the patient says "hi." She says "no" when asked if she has pain. She does not follow commands. Interview is limited due to advanced dementia. Nurse notes patient has been incontinent. No complaints of shortness of breath, no cough. She hasn't been having diarrhea, vomiting. Past Medical History: Hypertension Cataracts Osteoarthritis Fracture of surgical neck humerus (___), with non-operative management Dementia Social History: ___ Family History: Brother died of throat cancer. Father died of lung cancer-was a smoker and worked in ___. Physical Exam: ======================================= PHYSICAL EXAM ON ADMISSION: ___ ======================================= VITALS: T: 98.0 140/63 89 24 95%1LNC, 90%RA GENERAL: NAD, nonverbal, tracks, does not follow commands HEENT: AT/NC anicteric sclera, dry MM NECK: no JVD CARDIAC: RRR, S1/S2, no murmurs LUNG: rapid shallow breaths, no accessroy muscle use, CTAB, no wheezes, rales, rhonchi, comfortable ABDOMEN: nondistended, +BS, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: R knee swollen, nontender, warm, no erythema, dressing in place ======================================= PHYSICAL EXAM AT DISCHARGE: ___ ======================================= Vitals: 98.7 | 98.2 | 140s-170s/60s-80s | 70s | 16 | 93% 2L General: NAD, lying comfortably, non-toxic appearing HEENT: AT/NC, PERRL, tracks, sclera anicteric, MMM, OP clear Neck: supple, JVP not elevated, no LAD Lungs: crackles at bilateral lung bases, no w/r/r, no appearance of resp distress, no accessory muscle use CV: RRR, normal S1/S2, no m/r/g Abdomen: soft, NT/ND, no rebounding or guarding, no organomegaly GU: no foley, in diaper Ext: R knee w/o swelling and erythema, no wincing when R knee is palpated, full passive motion of R knee w/o wincing, pt unable to cooperate for active motion testing, R foot WWP w/ palpable pulses, pneumoboots intact, dressing around R foot c/d/i Neuro: limited testing ___ advanced dementia, single words, tracks, smiles, resting tremor, spontaneously moves upper extremities, will move lower in response to painful stimulus, sensation unable to test Pertinent Results: =============================== LABS ON ADMISSION: ___ =============================== WBC-14.8*# RBC-4.19* Hgb-13.4 Hct-43.3 MCV-103* MCH-31.9 MCHC-30.9* RDW-13.2 Plt ___ BLOOD Neuts-86.2* Lymphs-6.7* Monos-6.4 Eos-0.7 Baso-0.1 BLOOD Plt ___ BLOOD Glucose-128* UreaN-47* Creat-1.7* Na-157* K-3.1* Cl-114* HCO3-37* AnGap-9 BLOOD Type-ART pO2-49* pCO2-54* pH-7.41 calTCO2-35* Base XS-7 BLOOD Calcium-8.3* Phos-2.9 Mg-2.5 BLOOD Lactate-1.7 =============================== PERTINENT LABS: =============================== ___ 07:33AM BLOOD WBC-10.0 RBC-3.41* Hgb-11.1* Hct-35.6* MCV-104* MCH-32.4* MCHC-31.1 RDW-13.1 Plt ___ ___ 07:07AM BLOOD WBC-7.8 RBC-3.46* Hgb-11.0* Hct-34.7* MCV-100* MCH-31.9 MCHC-31.8 RDW-13.0 Plt ___ ___ 08:10AM BLOOD WBC-8.0 RBC-3.50* Hgb-11.2* Hct-35.0* MCV-100* MCH-31.9 MCHC-31.9 RDW-13.7 Plt ___ ___ 08:32PM BLOOD Glucose-173* UreaN-35* Creat-1.2* Na-147* K-4.1 Cl-109* HCO3-33* AnGap-9 ___ 03:00PM BLOOD Glucose-138* UreaN-28* Creat-0.9 Na-144 K-4.1 Cl-109* HCO3-30 AnGap-9 ___ 05:00PM BLOOD Glucose-103* UreaN-16 Creat-0.8 Na-144 K-4.0 Cl-106 HCO3-34* AnGap-8 ___ 08:00AM BLOOD Glucose-101* UreaN-10 Creat-0.7 Na-145 K-3.9 Cl-106 HCO3-33* AnGap-10 =============================== LABS AT DISCHARGE: ___ =============================== BLOOD WBC-8.6 RBC-3.47* Hgb-11.1* Hct-35.4* MCV-102* MCH-31.9 MCHC-31.3 RDW-14.1 Plt ___ BLOOD Plt ___ BLOOD Glucose-84 UreaN-13 Creat-0.7 Na-140 K-4.9 Cl-103 HCO3-32 AnGap-10 ========== MICRO: ========== BLOOD CULTURE, ___: Negative BLOOD CULTURE, ___: - Culture (Final ___: Moraxella species. Beta lactamase negative. - Aerobic Bottle Gram Stain (Final ___: Gram negative rods. JOINT FLUID, ___: - Gram Stain (Final ___: PMN leukocytes. No microorganisms seen. - Fluid culture (Final ___: No growth. ========== IMAGING: ========== CXR, ___: Moderate cardiomegaly and pulmonary vascular congestion persist, but there is no pulmonary edema, pneumonia, or appreciable pleural effusion. Video Swallow, ___: Penetration with nectar and thin liquid. CXR, ___: The right lung base opacity is likely a pulmonary nodule, but may still represent overlapping structures. New platelike atelectasis at the left lung base. RIGHT LOWER EXT U/S, ___: No evidence of deep venous thrombosis in the right lower extremity veins. CXR, ___: The right lung base opacity is likely a pulmonary nodule, but may still represent overlapping structures. New platelike atelectasis at the left lung base. CXR, ___: 4 mm nodular opacity projecting over the right lung base, new since the prior study, for which shallow oblique radiographs or chest CT recommended for further evaluation. Vascular congestion. Streaky left basilar opacity may relate to atelectasis. If/when patient able, PA and lateral views may be helpful for further evaluation. XR R KNEE, ___: Osteoarthritic changes are seen including severe medial greater than lateral joint compartment narrowing and some marginal osteophytes. Tiny posterior patellar spurs are seen. There is a small to moderate suprapatellar joint effusion without fat fluid level seen. No acute fracture or dislocation is seen. XR PELVIS, ___: No evidence of acute fracture or dislocation is seen. There is relative osteopenia diffusely. The pubic symphysis and sacroiliac joints do not appear widened although the sacrum and sacroiliac joints are partially obscured by bowel gas. A large stool ball is noted in the rectum. There is lumbar scoliosis partially imaged and likely degenerative changes along the lower lumbar spine. Brief Hospital Course: Patient is a ___ woman with a history of advanced dementia (AOx0 baseline), HTN, cataracts who presented with right knee pain, warmth and swelling in the setting of a right knee effusion and SIRS, found to be hypernatremic and hypokalemic with ___, subsequently found to have Moraxella postive blood culture (likely of pulmonary etiology). ___ hospital course is listed by problem below: =============== ACTIVE ISSUES: =============== # Right Knee Effusion: Presented with right knee warmth, swelling, no erythema s/p resolution. Likely from an inflammtory process given aspirate WBC of 10k and underlying osteoarthritic changes seen on XR. Clinical picture was not consistent with septic arthritis since the patient was afebrile, with no pain on joint motion, aspirate WBC <50k with no prosthetic joint, negative aspirate cultures. In the setting of patient meeting ___ SIRS criteria with tachynpea, HR>90 and leukocytosis, along with elevated lactate, an infectious process could not be ruled out. Patient was initially treated with antibiotics as stated below. Less likely gout given no crystals in aspirated fluid. Tylenol and Tramadol were given as needed for pain control. # SIRS w/ Moraxella Bacteremia: Presented with tachynpea, HR>90 and leukocytosis--meeting ___ SIRS criteria. Blood cultures from ___ were positive for Moraxella species (beta lactamase negative) suggesting pulmonary etiology, especially in the setting of the productive cough she developed when initially taken off antibiotics. CXR did not show consolidated pneumonia, however other sources of infections were less likely given positive culture data for Morexlla (which commonly presents from the lungs), no urinary symptoms, joint w/o evidence of septic arthritis and benign abdomen. Patient was afebrile. Patient initially treated with 3d course Vancomycin 1g qdaily and Ceftriaxone 2gm qdaily (___). Subsequently, restarted on Ceftriaxone 1gm qdaily on ___ after culture data grew gram negative rods. Her Ceftriaxone was discontinued and she was transitioned to Levofloxacin 500 mg po qdaily on ___ after her cultures became positive for Moraxella. Scheduled to stop Levofloxacin on ___. # Functional Status (Ambulation/Cognition/Aspiration): Per family, patient demonstrated increased diffculty ambulating, poorer cognition, and increased trouble swallowing. Patient with strong social support from son and daughter who serve as the patient's legal ___. Patient receives home nursing aid x3 weekly. Recent decrease in functional status likely percipitated by subacute infection and underlying advanced dementia. Status post antibiotic therapy and correction of electrolye abnormalities, patient's cognition improved to better than baseline. Physical therapy recommended dispo to rehab. Per video swallow results, patient was recommended regular diet with thin liquids and crushed medications with puree by the speech and swallow team. # Right heel bulla: Solitary bulla on right heel likely from prolonged pressure in the setting of decreased right lower extremity movement prior to admission. The area was kept clean, kept dry and dressed appropriately during hospitalization. ================= RESOLVED ISSUES: ================= # Hypernatremia: Resolved. Patient hypernatremic to 158 on presentation likely from decreased free water intake and overdiuresis in the in the setting of poor mental status at baseline. Her Na downtrended from 158 to 143 over first 48 hours w/ D5W. Her Na remained stable and within normal limits subsequently. Her home Furosemide was held. # Acute Kidney Injury: Resolved. Presented with Cr up to 1.7 from baseline <1.0. Likely due to dehydration and overdiuresis in the setting of poor mental status at baseline. Cr downtrended to 0.7. Her home Furosemide was held. Her home Lisinopril was restarted upon her return of baseline Cr. ================ CHRONIC ISSUES: ================ # Dementia: Continued home Carbidopa/Levodopa, Donepezil, Memantine. # HTN: Continued home Metoprolol. Held home Furosemide. Restarted home Lisinopril after improvement resolution ___ and Furosemide at a reduced dose. # CV: Continued home Aspirin. ===================== TRANSITIONAL ISSUES: ===================== - Continue Levofloxacin 500mg for an additional 3 days (to finish ___ - New 4 mm pulmonary nodule was seen on CXR ___. Will require follow-up imaging. - Follow-up needed for patient's right heel blister. - Patient should only be fed only feed when awake, alert, attentive (regular solids, thin liquids, whole meds are safe per video swallow). - Patient would benefit from continued physical rehabilitation. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit Oral BID 2. Multivitamins 1 TAB PO DAILY 3. Metoprolol Tartrate 25 mg PO BID 4. Memantine 10 mg PO BID 5. Lisinopril 40 mg PO DAILY 6. Furosemide 40 mg PO DAILY 7. Donepezil 10 mg PO HS 8. Docusate Sodium 100 mg PO BID 9. Carbidopa-Levodopa (___) 1 TAB PO TID 10. Aspirin 81 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Carbidopa-Levodopa (___) 1 TAB PO TID 3. Docusate Sodium 100 mg PO BID 4. Donepezil 10 mg PO HS 5. Lisinopril 40 mg PO DAILY 6. Memantine 10 mg PO BID 7. Metoprolol Tartrate 25 mg PO BID 8. Multivitamins 1 TAB PO DAILY 9. Acetaminophen 650 mg PO Q6H 10. Levofloxacin 500 mg PO DAILY Duration: 3 Days To finish on ___. 11. TraMADOL (Ultram) 25 mg PO Q6H:PRN pain 12. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit Oral BID 13. Furosemide 20 mg PO EVERY OTHER DAY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: Osteoarthritis Acute blood stream infection Hyperatremia Acute kidney injury Pulmonary nodule SECONDARY DIAGNOSES: Dementia Hypertension Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear ___, ___ was a pleasure taking care of you during your hospitalization. You presented to the ___ for evaluation of right knee pain and difficulty walking. In the Emergency Department, samples of the fluid in your right knee were collected. You were started on antibiotics for concern of an underlying infection. Blood samples were also collected and showed that your sodium was high and your potassium was low. You were given IV fluids with potassium to correct your abnormal sodium and potassium abnormailites. You had a chest x-ray which did not show a pneumonia. However, incidentally, a lung nodule was seen which you should arrange follow-up for with your primary care provider. You were transferred to the medicine floor where you were seen by many doctors. ___ antibiotics were continued.. Significant improvement in your physical exam was observed. You were intermittently given IV fluids and your electrolyte abnormalities got better. While on the medicine floor, you were seen by wound care who took care of the ulcer on your right heel. Physical therapy and speech and swallow also saw you. It was felt by your family and physical therapy that you would benefit from rehab after leaving the hospital. Speech and swallow felt it was safe for you to continue eating your normal diet. Again, please follow up on the incidental lung nodule that was found. Please also remember to get drink an adequate amount of fluids to prevent your sodium from becoming high again. It was a pleasure taking part in your care and we wish you the best! Regards, Your ___ Medicine Team Followup Instructions: ___
10762853-DS-20
10,762,853
23,294,985
DS
20
2186-06-17 00:00:00
2186-06-17 22:06:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: altered mental status Major Surgical or Invasive Procedure: PICC line placement Lumbar Puncture (unsuccessful) History of Present Illness: Ms. ___ is a ___ year old female with advanced dementia, HTN, cataracts, recent hospitalization from ___ for right knee pain, lethargy and hypernatremia who is presenting from home with fatigue, fever, lethargy and tachypnea. She was discharged to rehab after her most recent hospitalization where she was ultimately treated for Moraxella bacteremia with Levofloxacin. She was at ___ Living for 2 weeks initially for rehab and then her stay was prolonged by an additional two weeks as the family was unsure whether they wanted to keep her there or bring her home. Her son notes that since last ___, she has become increasingly lethargic, sleeping more, not getting out of bed. ___ she did not get out of bed at all and did not take any of her medications, food or water. Her son decided that she wasn't getting adequate care and brought her home on ___ where he had ___ services set up (this is where she was initially living prior to her previous hospitalization). The ___ went in to see her yesterday (___) and noted her to be febrile and tachypneic and advised him to call ___. In the ED, initial vitals: T 102 P ___ BP 110/61 RR 30 O2 92% 3L NC. She was noted to be obtunded and not opening her eyes to stimuli. She was initially satting 92% on 3L NC and was tachypneic to the ___. She had a fever to 102 and blood cultures were drawn. She was then given Tylenol, Vancomycin and Zosyn. It was initially quite difficult to get a urine sample given baseline incontinence and multiple attempts at placing a Foley failed. Subsequently Urology was paged who was able to place a ___ coude with digital guidance in the setting of severe atrophic vaginitis. A urine sample was sent which was not concerning for infection. Because of her change in mental status and lack of focal infectious source, an LP was attempted by both ED resident and attending without success given her significant kyphosis. On transfer, vitals were: 98.8 90 114/48 28 100% RA. On arrival to the MICU, patient was obtunded with minimal response to pain. Review of systems: Unable to obtain Past Medical History: Hypertension Cataracts Osteoarthritis Fracture of surgical neck humerus (___), with non-operative management Dementia Social History: ___ Family History: Brother died of throat cancer. Father died of lung cancer-was a smoker and worked in ___. Physical Exam: >>EXAM ON ADMISSION: Vitals- T:98.9 BP:98/50 P:87 R:29 O2: 100% on shovel mask GENERAL: obtunded, no acute distress, tachypneic HEENT: Pupils pinpoint bilaterally, equal, sclera anicteric, mucus membranes very dry NECK: supple, JVP not elevated, no LAD LUNGS: coarse breath sounds on anterior exam but no wheezing or crackles CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 1+ pulses, no clubbing, cyanosis or edema SKIN: right heel ulcer, bandaged NEURO: unresponsive, unable to arouse, does not open eyes . >>EXAM ON DISCHARGE: Vitals: T 98.6, BP 150s/78-82, RR 20, O2 94 RA. General: Appears comfortable, no grimacing to pain. Warm to touch, no signs of distress. HEENT: Eyes edematous, sclera anicteric. Pupils reactive to light bilaterally, EOMI unable to examine. Neck: Supple, no cervical lymphad. Cardiac: Tachycardic. S1, S2. No extra sounds heard. Abd: Soft, does not grimace to pain. Non-distended. BS+ Extremities: 1+ bilaterally in hands and lower extremities. GYN: Foley in place. Neuro: GCS (3+1+4): 8 ; opens eyes to voice, no tracking. Non-purposeful movements. . Pertinent Results: LAB ON ADMISSION: ___ 03:00PM WBC-17.7*# RBC-4.54# HGB-14.3# HCT-48.0# MCV-106* MCH-31.6 MCHC-29.9* RDW-14.6 ___ 03:00PM NEUTS-87.0* LYMPHS-8.5* MONOS-4.2 EOS-0.2 BASOS-0.1 ___ 03:00PM PLT COUNT-115*# ___ 03:00PM ___ PTT-24.5* ___ ___ 03:00PM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 03:00PM ALBUMIN-3.6 ___ 03:00PM proBNP-1236* ___ 03:00PM cTropnT-0.09* ___ 03:00PM LIPASE-63* ___ 03:00PM ALT(SGPT)-36 AST(SGOT)-64* ALK PHOS-26* TOT BILI-0.5 ___ 03:00PM GLUCOSE-129* UREA N-90* CREAT-2.2*# SODIUM-170* POTASSIUM-5.7* CHLORIDE-128* TOTAL CO2-31 ANION GAP-17 ___ 03:50PM O2 SAT-87 ___ 03:50PM LACTATE-2.0 K+-4.4 ___ 03:50PM ___ PO2-59* PCO2-52* PH-7.41 TOTAL CO2-34* BASE XS-6 ___ 10:25PM URINE AMORPH-RARE ___ 10:25PM URINE RBC-1 WBC-0 BACTERIA-NONE YEAST-NONE EPI-1 ___ 10:25PM URINE BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-NEG ___ 10:25PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 10:45PM OSMOLAL-374* ___ 10:45PM cTropnT-0.07* ___ 10:45PM GLUCOSE-149* UREA N-89* CREAT-2.3* SODIUM-171* POTASSIUM-4.5 CHLORIDE-132* TOTAL CO2-33* ANION GAP-11 ___ 10:50PM LACTATE-1.5 PERTINENT LABS: ___ 10:45PM BLOOD Glucose-149* UreaN-89* Creat-2.3* Na-171* K-4.5 Cl-132* HCO3-33* AnGap-11 ___ 04:17AM BLOOD Glucose-137* UreaN-89* Creat-2.1* Na-170* K-4.5 Cl-132* HCO3-30 AnGap-13 ___ 06:30PM BLOOD Glucose-119* UreaN-80* Creat-1.7* Na-171* K-4.2 Cl-132* HCO3-30 AnGap-13 ___ 11:40PM BLOOD UreaN-84* Creat-1.8* Na-170* K-4.1 Cl-129* HCO3-30 AnGap-15 ___ 05:27AM BLOOD Glucose-394* UreaN-79* Creat-1.7* Na-165* K-3.7 Cl-129* HCO3-30 AnGap-10 ___ 11:32AM BLOOD Glucose-327* UreaN-67* Creat-1.5* Na-167* K-3.2* Cl-131* HCO3-31 AnGap-8 ___ 05:01PM BLOOD Glucose-174* UreaN-64* Creat-1.4* Na-168* K-3.5 Cl-133* HCO3-31 AnGap-8 DISCHARGE LABS: ___ 05:43AM BLOOD WBC-5.1 RBC-2.43* Hgb-7.7* Hct-24.3* MCV-100* MCH-31.5 MCHC-31.5 RDW-14.7 Plt ___ ___ 05:43AM BLOOD Glucose-94 UreaN-4* Creat-0.5 Na-144 K-3.9 Cl-108 HCO3-30 AnGap-10 MICROBIOLOGY: URINE CULTURE (Final ___: NO GROWTH. IMAGING: ___ CXR IMPRESSION: No evidence of acute disease. However, there is a new nodular focus in the right lower lung, likely a form of atelectasis; short-term follow-up radiographs are recommended to show resolution. ___ CT HEAD NONCONTRAST: IMPRESSION: Increase in prominence of ventricles with increased periventricular hypodensities from prior exam may represent normal pressure hydrocephalus and transependymal CSF migration. CXR ___ IMPRESSION: Left basal consolidation appears to be progressing and although might represent a combination of atelectasis with some degree of hiatal hernia still is very concerning for infectious process. Cardiomediastinal silhouette is unchanged. Right lung and left upper lungs are essentially clear LENIS ___ IMPRESSION: Left calf DVT in one of the two posterior tibial veins. Brief Hospital Course: Ms. ___ is a ___ with advanced dementia and recent hospitalization from ___ for right knee pain, lethargy, and hypernatremia who presented from home with fever, somnolence, and tachypnea and was found to have hypernatremia. Despite correction of laboratory abnormalities, she had very minimal neurologic recovery, and therefore palliative care and geriatric service were consulted to help address goals of care. . >> ACTIVE ISSUES: # Encephalopathy: Patient's baseline is at least AxOx1; however, presented obtunded, non-responsive and non-verbal, with worsening over several days prior to admission. Her altered mental status was likely ___ to hypernatremia (described below), and hypercarbia in the setting of obtundation with respiratory depression and possible healthcare associated pneumonia. Upon admission, non-contrast CT was negative for acute intracranial abnormality, but did demonstrate ventriculomegaly, raising concern for normal pressure hydrocephalus, which might have been contributory. Lumbar puncture was attempted unsuccessfully in the ED, with lesser clinical suspicion for meningoencephalitis. Mental status improved slightly with correction of hypernatremia and hypercarbia as below, however continued to be obtunded and only opened eye to voice spontaneously. Discussions with family regarding prognosis and neurologic recovery was discussed. During stay on hospital floor after being transferred from ICU, palliative care involved regarding neurologic recovery prognosis. Patient intermittently had minimal improvements, with intermittent episodes of tolerating PO thick liquids very slowly. However, daily discussions with palliative care, and geriatric service regarding grave prognosis in this case and unlikelihood of recovery. Family continued to want to wait to weigh options and wait for neurologic recovery. Although risks regarding aspirations were discussed, family would like to attempt feeding as much as possible, and therefore diet was liberalized. Patient was able to take soft PO intake, however very minimal with at times coughing. Patient continued to have no improvement in her neurologic status, opening eyes only to voice and tactile stimuli, with non-purposeful movements. After discussions with the family repeatedly for several days, focus of care regarding comfort and home based services with hospice were finalized. With this decision, patient's PICC line was discontinued and patient was transitioned home. . # Goals of care: As described above, goals of care were revisited frequently during hospital stay with family members. Patient was DNR/DNI, however after resolution of her hypernatremia and ___, neurologic recovery was poor. Palliative care was consulted regarding grave prognosis, and discussion revolved around goals of care and family did not want to transition to comfort measures and wanted to wait for more neurologic recovery. Patient was continued on IVF as below, and per goals of care discussions, PO feeding was attempted with aspiration precautions per family's interests. It was decided not to transfer to ICU if needed, however despite continuous conversations, family continued to have difficulty coping. Discussions with palliative care and the geriatrics service, with family helped delineate goals of care and focus on comfort at home with hospice. . # Hypernatremia: Sodium of 171 on presentation was felt to reflect poor access to free water in discussion with the nephrology service. Her free water deficit was corrected by approximately 8mEq per day with intravenous D5W, and upon transfer from the ICU her Sodium level was 150. While on the hospital floor, her sodium was kept in her baseline range of 145's with continuous intravenous hydration. Given a recurrence of her hypernatremia, it was discussed that it would highly likely for this hypernatremia to recur as she may have a diminished thirst drive and PO intake. Patient was placed on continuous D5w and electrolytes were checked. After discussions of goals of care, decided ultimately that continuous intravenous fluids did not align, and her PICC line was discontinued, and patient was transitioned home. . # Hypercarbic Respiratory Failure: She was hypercarbia to ___ on admission, likely due to obtundation with respiratory depression, obesity hypoventilation, severe kyphosis, and possible healthcare-associated pneumonia. In light of her DNR/DNI status, which was confirmed on admission, she was trialed on noninvasive ventilation, with eventual improvement in hypercarbia, and treated empirically with vancomycin, piperacillin/tazobactam, and levofloxacin, particularly in light of recent Moraxella bacteremia, though CXR never demonstrated a clear focal infiltrate. Broad-spectrum antibiotic regimen ultimately was narrowed to levofloxacin monotherapy, for a planned 7-day total course. She completed this, and was breathing well on room air without evidence of pulmonary infection. . # Sepsis: She meets SIRS criteria on admission on the basis of fever and leukocytosis, with possible pulmonary source of infection as above, prompting initiation of broad-spectrum antibiotics, with improvement in SIRS physiology. However, after receiving hydration and correction of her hypercarbia and hypernatremia, and patient remained normotensive and no increased tachycardia. Patient completed a 7 day complete course of Levofloxacin, and no other signs of infection. . # Acute kidney injury: Creatinine was 2.3 on admission, up from baseline of 0.7-0.8, felt to be prerenal in etiology in the setting of poor access to free water, with return to baseline following volume resuscitation and correction of free water deficit. Home lisinopril and furosemide were held in this setting. However, with continuous IVF her creatinine function improved significantly. . # Left lower extremity deep venous thrombosis: She was found to have left lower extremity deep venous thrombosis on admission, prompting initiation of systemic anticoagulation with heparin gtt. Patient was continued on heparing gtt, however after her kidney function had improved, she was transitioned to therapeutic dosing of Lovenox. Goals of care discussions regarding risks and benefits of anticoagulation in the acute setting were discussed, and ultimately decided that anticoagulation would be discontinued. . # Acute normocytic anemia: Hemoglobin down trended from 14 to 8 over the course of admission, likely in the setting of hydration, phlebotomy and oozing from multiple sites in the setting of systemic anticoagulation. . # Thrombocytopenia: Platelets were found to be ___ over the course of admission, down from 270s at baseline, likely reflecting marrow suppression in the setting of multiple physiologic insults and marrow suppression. Chronicity of decline was felt to be less consistent with HITT, and started to have resolution with increasing counts while on hospital floor. . # Troponinemia: Troponinemia peaked at 0.09 without associated acute ischemic EKG changes, likely reflecting demand in the setting of multiple physiologic insults, with contribution from poor renal clearance. . >> CHRONIC ISSUES # Right heel pressure ulcer: There was no evidence of superinfection throughout admission. Patient was continued on waffle boots and basic wound care with dressings on this ulcer during hospital stay. . # Dementia: Home dementia regimen was held in the setting of obtundation. . >> TRANSITIONAL ISSUES: # DNR/DNI, NO TRANSFER TO ICU ; ___, is Health Care Proxy. Patient has been transitioned to home hospice, with goals of care focused on comfort. HCP would like to have patient at home, and will attempt to feed PO slowly as tolerated. Throughout multiple family meetings held during hospitliazation, grave prognosis was discussed and patient's family ultimately decided on comfort measures as focus of care. Patient was also discharged with morphine 20 mg/ml, 30 cc for comfort measures. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Carbidopa-Levodopa (___) 1 TAB PO TID 3. Docusate Sodium 100 mg PO BID 4. Donepezil 10 mg PO HS 5. Lisinopril 40 mg PO DAILY 6. Memantine 10 mg PO BID 7. Metoprolol Tartrate 25 mg PO BID 8. Multivitamins 1 TAB PO DAILY 9. Acetaminophen 650 mg PO Q6H 10. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg(1,500mg) -400 unit Oral BID 11. Furosemide 20 mg PO EVERY OTHER DAY Discharge Medications: 1. Morphine Sulfate (Concentrated Oral Soln) ___ mg SL Q1H:PRN pain RX *morphine concentrate 100 mg/5 mL (20 mg/mL) ___ mg SL Q1 hour Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: 1. Severe Hypernatremia 2. Hypercarbic Respiratory Failure 3. Left lower extremity deep vein thrombosis SECONDARY DIAGNOSES: 1. Advanced Dementia Discharge Condition: Mental Status: Confused - always. Activity Status: Bedbound. Level of Consciousness: Lethargic and not arousable. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you during your hospital stay at ___. You were admitted here for concerns of a change in your mental status, and found to have a very high sodium level and difficulty breathing. You were admitted to the intensive care unit to lower this sodium in a controlled and safe environment, and it was lowered back to a normal level. You were then transferred to the medical floor, and we kept these IV fluids to make sure your salt level continued to stay at a normal level. While here, you were also found to have a blood clot in your left leg, and to prevent the clot from increasing in size or mobilizing to other areas of the body, you were placed on a blood thinner called Enoxaparin. Towards the end of your hospital stay, we had discussions with the palliative care team and your family, and we focused your health care towards comfort. We have discontinued your medications in an effort to focus on your comfort. Services regarding hospice at home have been set up. Take Care, Your ___ Team. Followup Instructions: ___
10762976-DS-5
10,762,976
24,206,390
DS
5
2170-05-11 00:00:00
2170-05-11 14:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: erythromycin / Heparin Agents / Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Hip fracture Major Surgical or Invasive Procedure: Left hip hemiarthroplasty Endotracheal Intubation and Mechanical Ventilation History of Present Illness: ___ with a history of mitral valve prolapse, atrial fibrillation s/p MAZE and mitral valvuloplasty in ___ at ___ that was complicated by a right MCA CVA, RLE DVT treated with coumadin presenting status post fall during transfer and fracture of his left hip. Patient underwent arthroplasty of the left hip on ___. After the operation, he developed a new oxygen requirement and was on 4L NC for the past 2 days until he was found to have a HR of 140s on tele on ___ at 1830 and an O2 sat of 71% on 4L NC. He was given 40mg IV lasix and 5mg IV lopressor, which was repeated when heart rates did not decrease with another 5mg IV lopressor. He diuresed 1 L of urine and his oxygen saturations increased to 100% on the non-rebreather. On arrival to the MICU, O2 sats are 100% on non-rebreather and patient has a new fever of 101.2. Patient denies chest pain, dyspnea, headache, or pleuritic pain. He is only AAO x name, and is unclear where he is or why he is here. His family is very involved in his care and were involved with this history taking. Past Medical History: - ___: AFib and went to ___ were mitral valvuloplasty/L atrial maze and L atrial appendage resection were done. After this surgery on post-po day 1 he suffered a long-standing post-op seizure tonic clonic and found on imaging a R+ MCA CVA. --- Pt reports that his Vimpat is being de-escalated and that he hasn't had a seizure since his initial seizure. - ___: pseudoaneurysm from R common femoral artery (discovered after going to the hospital bc swelling of L+ ankle) and DVT in R+ lower extremity. - Mitral valve prolapse - h/o DVT on Coumadin - Bilateral inguinal hernia repair - L+ knee arthroscopic surgery - h/o heparin-induced thrombocytopenia Social History: ___ Family History: non-contributory Physical Exam: Vitals: T: 101.2 BP:100/52 P:118 R:21 O2: 100% on non-rebreather General: Alert, oriented only to person, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, no LAD CV: tachycardic, regular rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation anteriorly, no wheezes, rales, ronchi, although upper airway sounds throughout. Abdomen: soft, non-tender, non-distended, bowel sounds present, no organomegaly GU: foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, teds and SCDs in place Neuro: CNII-XII intact, 4+/5 strength upper/lower extremities on right, 3+ on left, grossly normal sensation, 2+ reflexes bilaterally, gait deferred Discharge exam: Pertinent Results: ___ 07:05PM GLUCOSE-115* UREA N-12 CREAT-0.7 SODIUM-139 POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-25 ANION GAP-14 ___ 07:05PM CALCIUM-8.3* PHOSPHATE-3.9 MAGNESIUM-1.6 ___ 07:05PM WBC-21.8*# RBC-3.79* HGB-11.4* HCT-34.0* MCV-90 MCH-30.2 MCHC-33.6 RDW-12.7 ___ 07:05PM PLT COUNT-223 ___ 07:05PM ___ PTT-27.5 ___ ___ 12:48PM HCT-36.6* ___ 12:48PM HCT-36.6* ___ 11:50AM GLUCOSE-87 UREA N-12 CREAT-0.8 SODIUM-139 POTASSIUM-4.4 CHLORIDE-101 TOTAL CO2-29 ANION GAP-13 ___ 11:50AM estGFR-Using this ___ 11:50AM WBC-10.8# RBC-4.34*# HGB-13.0*# HCT-38.1*# MCV-88 MCH-29.9 MCHC-34.1 RDW-12.5 ___ 11:50AM NEUTS-82.4* LYMPHS-13.6* MONOS-3.0 EOS-0.9 BASOS-0.1 ___ 11:50AM PLT COUNT-247 ___ 11:50AM ___ PTT-30.0 ___ ___ 11:50AM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 11:50AM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.5 LEUK-NEG ___ Path Gross: The specimen is received fresh in a container labeled with the patient's name, ___, the medical record number, and additionally labeled "left femoral head". It consists of a normally shaped femoral head without a portion of femoral neck that measures 5.5 x 4.5 x 4.5 cm. The articular surface is unremarkable. Osteophytes are not present. The femoral neck margin is irregular. The specimen is cut along its length perpendicular to the articular cartilage. The cut surfaces reveal yellow-tan hemorrhagic cut surfaces. A fragment of femoral neck is also received in the container and measures 4.5 x 4.0 x 2.5 cm. It is cut perpendicular to the articular surface to reveal hemorrhagic bone marrow. Tissue is not present. Representative sections of the specimen are submitted for decalcification as follows: A= representative sections of femoral head, B = representative sections of femoral neck. ___ ECG: Sinus bradycardia. Intraventricular conduction defect. Left axis deviation, possibly due to left anterior fascicular block. Diffuse non-specific ST-T wave abnormalities. Compared to tracing #1 the heart rate is decreased but there are no other significant changes. TRACING #2 Intervals Axes Rate PR QRS QT/QTc P QRS T 56 0 ___ 0 -57 ___ Hip Xray: FINDINGS: Single frontal view of the pelvis and three views of the left hip were obtained. a complete fracture of the left femoral neck is present with mild varus angulation. No dislocation is identified. Vague lucencies of the left femoral shaft is suggestive of osteopenia. No radiopaque foreign bodies. IMPRESSION: 1. Left femoral neck fracture with mild varus angulation. 2. Left femoral shaft lucencies suggestive of osteopenia in the setting of decreased weght bearing from prior stroke. ___ CXR: FINDINGS: Single portable view of the chest compared to previous exam from ___. The lungs are clear of focal consolidation or effusion. Cardiomediastinal silhouette is within normal limits. Median sternotomy wires are again noted. The osseous and soft tissue structures otherwise unremarkable. IMPRESSION: No acute cardiopulmonary process. ___ Knee xray No prior studies for comparison. FINDINGS: Three views of the left knee demonstrate no evidence of acute fracture, dislocation, joint effusion, or soft tissue foreign body. ___ Cpine xrays CERVICAL SPINE, ___ No prior studies for comparison. On the lateral view, all seven cervical vertebral bodies are visualized, but the superior aspect of T1 is obscured and cannot be assessed. Prevertebral soft tissue structures are within normal limits. Bone mineral density is apparently slightly decreased throughout. Multilevel degenerative changes are present with small anterior osteophytes particularly at the C3 through C6 levels, as well as very minimal disc space narrowing. Reversal of the normal cervical lordosis is evident at C4-C5. Flexion and extension views demonstrate no evidence of instability. Incidental note is made of an oval-shaped calcification posterior to the spinous processes of C4 and C5, which may represent ossification or calcification of the posterior longitudinal ligament. IMPRESSION: 1. Multilevel degenerative changes in the cervical spine as described. No acute fracture or dislocation identified, but CT of the cervical spine is much more sensitive than conventional radiographs for detecting traumatic abnormalities and would be suggested if there is persistent clinical suspicion for a cervical spine injury. 2. Exam is limited by absence of an odontoid view and lack of visualization of C7-T1 disc space and top of T-1. AP CXR on ___ IMPRESSION: AP chest compared to ___: Lungs are appreciably smaller and there is greater but symmetric opacification in the lower lungs. Contributing to elevation of the diaphragm is a stomach severely distended with air and fluid. Since there is also increased upper lobe vascular congestion, and new small left pleural effusion, appearance could be explained by either bibasilar pneumonia or a combination of atelectasis and edema. Subsequent chest CT reported separately has findings of left lower lobe atelectasis, right lower lobe pneumonia and multifocal small regions of peribronchial opacification, probably bronchopneumonia. It shows vascular congestion but no pulmonary edema, and a stomach severely distended with air and fluid. CT Chest: FINDINGS: The thyroid gland, aorta and major branches, heart and pericardium are unremarkable with the exception of changes of mitral valve annuloplasty. No pericardial effusion is seen. The esophagus is patulous and fluid filled. There is no axillary, hilar, or mediastinal adenopathy. Gynecomastia is noted bilaterally. Though this study is not tailored for subdiaphragmatic evaluation, imaged upper abdomen reveals distended stomach. The trachea and central airways are patent to the segmental level. The pulmonary arterial tree is well opacified without filling defect to suggest pulmonary embolism, though evaluation of the subsegmental vessels is limited due to respiratory motion. Small bilateral pleural effusions are dependent and nonhemorrhagic. Right greater than left basal opacities with milder opacification of the dependent segment of the right upper lobe and right middle lobe are concerning for multifocal pneumonia which likely includes the anterior subpleural opacities. OSSEOUS STRUCTURES: There is no lytic or sclerotic bony lesion to suggest osseous malignancy. IMPRESSION: 1. No pulmonary embolism or acute aortic pathology. 2. Multifocla pneumonia with opacities in the lower lobes and left upper lobe. 3. Patulous esophagus, correlate with symptoms of dysphagia and outpatient esophagram can be obtained if indicated. Echo ___ The left atrium and right atrium are normal in cavity size. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). The estimated cardiac index is normal (>=2.5L/min/m2). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. The mitral valve leaflets are myxomatous. A mitral valve annuloplasty ring is present. The mitral annular ring appears well seated with normal gradient. Mild (1+) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Well seated mitral annuloplasty ring with normal gradient and mild mitral regurgitation. Pulmonary artery hypertension. Normal biventricular cavity sizes with preserved global and regional biventricular systolic function. AP CXR ___ FINDINGS: As compared to the previous radiograph, there is a substantial increase in extent and severity of the pre-existing multifocal pneumonia. These changes are evident at both lung bases. The lung apices are bilaterally spared from the pathologic process. Unchanged borderline size of the cardiac silhouette. Minimal fluid overload cannot be excluded. No larger pleural effusions. No pneumothorax. Mild over distention of the stomach, unchanged normal alignment of the sternal wires. ECG ___ Sinus tachycardia. Left anterior fascicular block. Non-specific ST-T wave abnormalities. Compared to the previous tracing of ___ the heart rate has increased, ST-T wave abnormalities have improved. TRACING #1 IntervalsAxes ___ ___ AP CXR ___ Last of 3 for the day There is again seen diffuse air space opacities bilaterally, more confluent in the right lung and have increased slightly since the prior study. Atelectasis at the left lung base is again seen. There are low lung volumes with poor inspiratory effort. There are no pneumothoraces. Median sternotomy wires are present. AP CXR ___ FINDINGS: A new left PICC terminates approximately 1 cm beyond the cavoatrial junction. Dense consolidation of the entire right lung as well as right-sided pleural effusion are unchanged. There is a persistent retrocardiac opacity as well as worsening consolidation of the left upper lobe when compared to the prior study from yesterday. There is improved aeration at the left costophrenic angle. There is no pneumothorax. Heart size is top normal and unchanged. Sternotomy cerclage wires are intact. IMPRESSION: 1. New left PICC should be withdrawn by 1.5 cm to ensure proper positioning in the lower SVC. 2. Multifocal pneumonia, slightly worse in the left upper lobe. BAL ___ Bronchioalveolar lavage: NEGATIVE FOR MALIGNANT CELLS. Numerous neutrophils, bronchial cells, and pulmonary macrophages. No viral cytopathic changes or fungi seen. AP CXR ___ CHEST, SINGLE AP PORTABLE VIEW The patient is status post sternotomy. An ET tube is present, tip in satisfactory position approximately 4.3 cm above the carina. A left-sided PICC line is present, tip over distal SVC. An NG tube is present, tip and side port beneath diaphragm, extending off film. There is diffuse alveolar opacity and air bronchograms throughout the right lung, with relative sparing of the right lung apex and minimal residual lucency at the right base. This has progressed compared with ___. Possibility of an associated effusion cannot be excluded. There is also prominent focal interstitial and alveolar opacity in the left upper zone, which appears more confluent than on the earlier film. There is increased retrocardiac density, with obscuration of the left hemidiaphragm, unchanged. The small left effusion is slightly more prominent on this exam. There is relative lucency at the left lung apex. However, I doubt this represents a pneumothorax. IMPRESSION: Interstitial and alveolar opacities in both lungs, progressed compared with ___ at 12:09 p.m. Differential diagnosis includes multifocal pneumonic infiltrates, ARDS and CHF. CHEST: Imaged portions of the thyroid gland appear within normal limits. There is a left upper extremity PICC line with its tip terminating in the SVC. The patient is status post endotracheal intubation with the tip of the ET tube lying approximately 4.9 cm above the carina. An NG tube is seen with its tip terminating in the stomach. There is no axillary, mediastinal, or hilar lymphadenopathy. The cardiac chambers appear grossly within normal limits. There are no filling defects within the central pulmonary arterial tree. The patient is status post median sternotomy and mitral valve replacement. There are large bilateral pleural effusions with adjacent compressive atelectasis, right greater than left. Patchy pulmonary opacities are noted in the remainder of the inflated upper lobes with hint of appearance of crazy pavement (series 2, image 13) in the left upper lobe and also within the right upper lobe (series 2, image 17) suggestive of pulmonary edema. There is no pneumothorax. Additional scattered regions of ground-glass opacification are also seen scattered within the lungs, for example, on series 2, image 35, suggestive of edema. FINDINGS IN THE ABDOMEN AND PELVIS: In the liver, there are two focal hypodensities seen centrally (series 2, image 56), which are less than a centimeter in size and are not well characterized on the current examination. There is no intra- or extra-hepatic biliary ductal dilatation. The portal vein is patent. The spleen is within normal limits in size. The adrenal glands, pancreas, and kidneys appear unremarkable. There is no mesenteric or retroperitoneal lymphadenopathy. There is minimal quantity of perihepatic fluid as well as a small quantity of fluid tracking into the right paracolic gutter. The gallbladder is distended and there is a small quantity of pericholecystic fluid (2, 82). Minimal periportal edema is seen in the liver. There is a small quantity of fluid in the dependent pelvis (2, 108). The urinary bladder demonstrates no obvious abnormalities. A Foley catheter is seen in place. No obvious abnormalities are seen in the colon. The stomach is slightly decompressed with NG tube in place, limiting evaluation. Small bowel appears within normal limits. There is subcutaneous soft tissue edema, most predominantly noted in the gluteal region as well as in the upper thighs. There are flame-shaped opacities involving the retroareolar regions suggestive of gynecomastia. Left hip replacement arthroplasty is seen. There are no suspicious osteolytic or osteoblastic lesions seen to suggest tumor. Surgical staples are seen in the left gluteal region. IMPRESSION: Large bilateral pleural effusions with adjacent compressive atelectasis. Crazy pavement changes in the lungs suggestive of mild pulmonary edema. Additional multifocal regions of atelectasis and consolidation, underlying pneumonia is not excluded. No intra-abdominal abscess. Distended gallbladder with small amount of pericholecystic fluid. Findings are nonspecific. If there is clinical concern for acute cholecystitis, this can be further evaluated with right upper quadrant sonogram. Minimal quantity of perihepatic and pelvic fluid, which could be related to third spacing. Additional diffuse regions of subcutaneous soft tissue edema in the pelvic girdle. CXR ___ INDICATION: Pneumonia, questionable ET tube placement. COMPARISON: ___. FINDINGS: As compared to the previous radiograph, the monitoring and support devices are constant. The tip of the endotracheal tube projects 4.9 cm above the carina. The parenchymal opacity at the left lung apex is minimally decreasing in extent. The extensive right-sided opacity is unchanged. Moderate cardiomegaly with borderline size of the cardiac silhouette and unchanged minimal blunting of the left costophrenic sinus, potentially reflecting a small pleural effusion. No evidence of pneumothorax. Brief Hospital Course: ___ y/o M with a history of mitral valve prolapse, atrial fibrillation s/p MAZE and mitral valvuloplasty in ___ that was complicated by a right MCA CVA and a RLE DVT presented status post fall and fracture of his left hip on ___. His hip was repaired with a L hemiarthroplasty on ___, and in the post-operative setting, he had persistent high oxygen requirements. He progressed to respiratory failure secondary to multifocal pneumonia and pulmonary edema, requiring re-intubation and transfer to the MICU. He was treated with a 10 day course of antibiotics and aggressive diuresis, as well as vasopressors until he improved. He was extubated and gradually weaned off oxygen. Once medically stable, ___ advised further inpatient physical therapy in ___ rehab. Active Problems: # Respiratory Failure: Multifocal PNA (aspiration?) and pulmonary edema. Following extubation from his orthopedic procedure, patient was maintained on 5L nasal canula on the floor. The evening of ___, he developed respiratory distress, not responsive to lasix. Patient was then transferred to the MICU, meeting SIRS criteria by RR, temperature, and heart rate. Pt was evaluated for a PE; CTA showed no evidence of PE, but did show a multifocal PNA. He was placed on broad-spectrum antibiotics (including vancomycin, and, at different points, cefepime, levofloxacin, and Meropenem). Blood, urine, and sputum cultures did not grow out any organism. The patient also developed hypotension and was volume-recusitated aggressively. His tachypnea increased, and he became hypoxic on BiPAP and required intubation on ___. Cultures from bronchoscopy following intubation were unremarkable, and visual inspection of the airways did not demonstate purulence. Further imaging with chest CT showed large bilateral pulmonary effusions, multifocal PNA, and pulmonary edema. He received a 10-day course of antibiotics for VAP coverage. As his pneumonia improved, concern lingered for pulmonary edema. He was started on Lasix drip for diuresis, and was extubated on ___. By ___, he was was able to oxygenate well on 2L by NC. By ___ he was stable on room air. . # Hip Fracture: His hip was repaired with a L hemiarthroplasty on ___. Orthopedic surgery followed the patient throughout his stay in the MICU. His surgical wound healed well, and staples were removed on ___, there was no concern for infection. Physical therapy began working with the patient when he was weaned off sedation prior to being extubated. They continued working with him during the remainder of his hospitalization and recommended ___ rehab after discharge. . # Pain Control: Patient had post-operative pain in his left thigh and hip. Before and during intubation and after extubation, the patient had pleuritic chest pain as well. At different points during his hospitalization, his pain was controlled with morphine, fentanyl, ibuprofen, IV Tylenol, and/or lidocaine patch. He will be discharged on tylenol and morphine prn. . # Fever/Thrombocytosis: Likely reactive to pneumonia versus drug reaction. The patient continued to spike fevers during his MICU stay. Initially the fever was c/w PNA and sepsis. However, even as his PNA resolved, he continued to spike fevers. He also developed a thrombocytosis to the 900s. The fever and thrombocytosis are thought to be due to systemic inflammation in the setting of resolving PNA. His platelets were down-trending by day of discharge. He has been afebrile for several days. . # Persistent sinus tachycardia in the MICU: This tachycardia was likely due to hypovolemia versus sepsis versus hypoxia. The patient's home metoprolol was held in the setting of hypotension. Troponins were sent and were negative. When the patient was extubated and his tachycardia resolved, he was restarted on metoprolol, and switched to metoprolol 75mg XL daily the day of discharge. However his dose was held on discharge due to his SBP in the ~90s. . # Hypotension: In the setting of SIRS and multifocal PNA. He required norepinephrine drip, but this was discontinued in the MICU when his BP improved with MAPs in the ___. He was normotensive on transfer to the floor and his Metoprolol was held with his SBP in the ~90s. . # Nausea/GERD: Likely mutifactorial, with components of GERD, clinical illness, and not taking POs for several days. Patient with history of GERD. Pt was initially on IV Protonix, then was switched to PO PPI. He was treated with Zofran, calcium carbonate, Aluminum-Magnesium Hydrox, and simethicone. On CTA of the chest, patulous esophagus was also seen (see transitional issues below), which may have also contributed to his difficulty taking POs. His symptoms had resolved by day of discharge. . # Rash: Over back, consistent with heat-induced follicullitis. First noted and resolved in the MICU. . # Altered mental status: On arrival to MICU, question hypoxia precipitating versus history of previous stroke. Per family, patient was initially off baseline, but improved with oxygen saturations, although patient still having episodes of confusion prior to intubation. He was treated with quetiapine, and his mental status improved while he weaned off sedation when he was intubated and then improved further after extubation. On transfer to the medical floor he was stable and remained oriented. . # Dropping HCT: HCT dropped from 28 on ___ to 22 on ___ without a source of bleeding. This may have been dilutional, but the patient was transfused with 1 unit PRBCs on ___. From that point, his HCT has been increasing. . Chronic Problems: # History of DVT: Pt has a hx of DVT and was treated previously with Coumadin. This was held during his hospitalization. Due to his history of being HIT antibody +, he was not treated with unfractionated heparin. He was treated with aspirin 81 mg PO/NG DAILY and Fondaparinux Sodium 2.5 mg SC DAILY. . # BPH: On Flomax at home. This was initially held, but was restarted on ___ The patient's Foley was removed on ___ and he maintained urine output on discontinuation of the Foley. . # History of stroke and seizures: The patient remained clinically stable on his home Lacosamide 50 mg PO/NG DAILY, Pravastatin 20 mg PO HS, and Aspirin 81 mg PO/NG DAILY. . # History of seasonal allergies: Inactive during this hospitalization. Home medications were initially held, but were restarted on discharge. . # History of depression: The patient remained clinically stable. His home Duloxetine 60 mg PO DAILY was held initially but restarted on ___ . . # Skin conditions: Pt on several home medications that were continued, including Hydrocortisone Cream 0.5% 1 Appl TP TID:PRN intching, Ketoconazole 2% 1 Appl TP DAILY, and Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID to scalp as needed. . Transitional issues: # The patient responds well to diuresis with IV furosemide 20mg if there are signs of fluid overload. # The patient's metoprolol 25mg tid was consolidated to metoprolol succinate 75 once a day, but his SBP has been in the high ___ towards the end of his hospital stay, so antihypertensives had been held. # Patulous esophagus seen on CTA Chest ___: outpatient esophagram can be obtained if indicated # The patient will need rehab for his left hip surgery. Medications on Admission: -Lacosamide (VIMPAT) 100 mg Oral Tablet ___ tab daily -Fluticasone 50 mcg/actuation Nasal Spray, Suspension Use 2 sprays in each nostril once daily -Tamsulosin (FLOMAX) 0.4 mg Oral Capsule, Ext Release 24 hr 1 tablet daily 30 minutes after breakfast -Nystatin (MYCOSTATIN) 100,000 unit/g Topical Powder use bid -Duloxetine (CYMBALTA) 60 mg Oral Capsule, Delayed Release(E.C.) 1 tab qd -Fluocinonide 0.05 % Topical Solution Apply twice daily as directed -Fexofenadine (ALLEGRA) 180 mg Oral Tablet Take 1 tablet daily as needed. Available over the counter. -Pravastatin (PRAVACHOL) 20 mg Oral Tablet 1 tablet in the evening -Metoprolol Tartrate 25 mg Oral Tablet 3 tablets daily total 75mg -Ketoconazole (NIZORAL) 2 % Topical Cream Apply twice daily -Ketoconazole (NIZORAL) 2 % Topical Shampoo Shampoo 5 minutes 2 to 5 times per week or as directed -Dantrolene (DANTRIUM) 25 mg Oral Capsule as directed -Triamcinolone Acetonide 0.1 % Topical Lotion apply bid to the scalp as needed -Lorazepam (ATIVAN) 0.5 mg Oral Tablet ___ tablet q 6hrs as need for anxiety -Acetaminophen (TYLENOL EXTRA STRENGTH) 500 mg Oral Tablet 2 tablets bid -Docusate Sodium (COLACE) 100 mg Oral Capsule once daily -SENNOSIDES (SENNA LAXATIVE ORAL) one tablet daily as needed for constipation -MULTIVITAMIN ORAL once a day -ASPIRIN 81 MG TAB Discharge Medications: 1. Acetaminophen 650 mg PO Q6H pain or fever patient may refuse 2. Albuterol Inhaler ___ PUFF IH Q6H:PRN SOB, wheezing 3. Aspirin 81 mg PO DAILY 4. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 5. Calcium Carbonate 500 mg PO BID calcium supplement please do not administer within 2 hours of Cipro doses 6. Docusate Sodium 100 mg PO BID 7. Duloxetine 60 mg PO DAILY 8. Fluticasone Propionate NASAL 2 SPRY NU DAILY 9. Fondaparinux Sodium 2.5 mg SC DAILY 10. Hydrocortisone Cream 0.5% 1 Appl TP TID:PRN intching 11. Ketoconazole 2% 1 Appl TP DAILY 12. Lacosamide 50 mg PO DAILY 13. Lidocaine 5% Patch 1 PTCH TD DAILY 14. Miconazole Powder 2% 1 Appl TP BID 15. Morphine Sulfate ___ 7.5 mg PO Q6H:PRN pain 16. Multivitamins 1 TAB PO DAILY 17. Omeprazole 40 mg PO DAILY 18. Ondansetron 4 mg IV Q6H:PRN nausea 19. Pravastatin 20 mg PO HS 20. Prochlorperazine 10 mg PO Q6H:PRN nausea Caution oversedation 21. Quetiapine Fumarate 25 mg PO TID:PRN agitation 22. Senna 1 TAB PO BID 23. Simethicone 40-80 mg PO QID:PRN abdominal discomfort 24. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN. 25. Tamsulosin 0.4 mg PO DAILY 26. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID to scalp as needed 27. Vitamin D 800 UNIT PO DAILY 28. Metoprolol Succinate XL 75 mg PO DAILY Hold if SBP<100, HR<60 Discharge Disposition: Extended Care Facility: ___ for Rehabilitation and Sub-Acute Care) Discharge Diagnosis: Primary: Left Hip Fracture, Respiratory Failure, Pneumonia, Pulmonary Edema Secondary: Depression, Congestive Heart Failure, Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. You were admitted because you had a broken hip which required surgery. Your recovery was complicated by pneumonia, pulmonary edema (fluid in your lungs), and respiratory failure, which required that we insert a breathing tube and provide mechanical ventilations in the medical ICU. We also treated you with oxygen, antibiotics for the pneumonia and diuretic medications, which remove fluid from your body. We also gave you medications to maintain your blood pressure. . You responded to treatment well, except for some confusion known at ICU delirium. Once you improved, we transferred you to the general medicine floor and monitored you for several more days until your oxygen was stopped completely. Please note the following changes in your medications: You should START Fondaparinux to prevent blood clots, as managed by your orthopedic surgeon. You should CHANGE Metoprolol to Metoprolol 75mg XL once a day for high blood pressure. You should START the skin ointments and powders for your rashes, as needed, for ___ weeks until they resolve. You may START acetaminophen and morphine for pain control, as needed. You may continue the rest of your medications as previously prescribed. Followup Instructions: ___
10762976-DS-8
10,762,976
29,275,009
DS
8
2172-08-17 00:00:00
2172-08-17 19:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: erythromycin / Heparin Agents / Sulfa (Sulfonamide Antibiotics) Attending: ___ Chief Complaint: Chest pain Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ with h/o history CVA (___) c/b subsequent DVT and seizure, mitral valve repair, HTN, and chronic anemia who presents with almost ~5 days of worsening right-sided chest pain/pressure. He was seen at ___ urgent care 2 days prior to admission where he was diagnosed with pnemonia/pleural effusion and prescibed 10 day course of levofloxacin. On day prior to admission he saw his neurologist who recommended changing antibiotics given that levofloxacin may lower seizure threshold. On night prior to admission his chest pain became very severe (___) while lying in bed, which prompted his presentation to the ED. He describes the pain as a pressure that feels like indigestion, most painful in center and right side of chest, with radiation to his right shoulder and down his right arm. He endorses pain with inspiration and worse with movement of the arm. Otherwise denies any palpitations, dyspean, shortness of breath, fever, chills, cough, leg swelling, hemoptysis. Patient reports some heart burn, indigestion, and constipation, last BM was four days ago. In the ED, initial vitals were: 97.2 86 146/84 18 99% RA. Labs were notable for a white count of 12.3K, Hgb 11.6 (c/w baseline), and normal electrolytes except for sodium of 131 (baseline low 130s). CTPA was negative for PE, showed small-moderate right pleural effusion with significant adjacent atelectasis, mild cardiomegaly, and not definitive lobar consolidation. EKG showed sinus rhythm, old LBBB, and no acute ST segment changes. Blood cultures were sent and patient was started on ceftriaxone and doxycycline and admitted to medicine. Vitals prior to transfer were: 98 146/79 18 99% RA. Past Medical History: - ___: AFib and went to ___ were mitral valvuloplasty/L atrial maze and L atrial appendage resection were done. After this surgery on post-po day 1 he suffered a long-standing post-op seizure tonic clonic and found on imaging a R+ MCA CVA. - Seizures - ___: pseudoaneurysm from R common femoral artery (discovered after going to the hospital bc swelling of L+ ankle) and DVT in R+ lower extremity. - Mitral valve prolapse - h/o DVT on Coumadin - Bilateral inguinal hernia repair - L+ knee arthroscopic surgery - h/o heparin-induced thrombocytopenia Social History: ___ Family History: No known fhx of cva Physical Exam: Admission physical: Discharge physical: Vitals- T 98.2 BP 136/75 HR 82 RR 18 SaO2 96%RA General- Alert, oriented, no acute distress HEENT- Sclerae anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- decreased breath sounds b/l (R>L), faint crackles in RLL, no focal rales or rhonchi CV- RRR, Nl S1, S2, No MRG Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, speech fluent Discharge physical: Vitals- T 98.2 BP 102/57 HR 76 RR 20 General- Alert, oriented, no acute distress HEENT- Sclerae anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- CTAB but faint breath sounds b/l, faint crackles in RLL, no focal rales or rhonchi Chest- No TTP over anterior chest wall CV- RRR, Nl S1, S2, No MRG Abdomen- soft, NT/ND bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, speech fluent, ___ strength in RUE otherwise not tested Pertinent Results: Admission labs: ___ 02:20AM BLOOD WBC-12.3*# RBC-3.97* Hgb-11.6* Hct-35.3* MCV-89 MCH-29.3 MCHC-32.9 RDW-13.0 Plt ___ ___ 02:20AM BLOOD Neuts-79.4* Lymphs-11.3* Monos-7.8 Eos-1.2 Baso-0.1 ___ 02:20AM BLOOD ___ PTT-30.4 ___ ___ 02:20AM BLOOD Plt ___ ___ 02:20AM BLOOD Glucose-109* UreaN-12 Creat-0.7 Na-131* K-4.3 Cl-94* HCO3-26 AnGap-15 ___ 02:20AM BLOOD ALT-13 AST-16 AlkPhos-78 TotBili-0.6 ___ 02:20AM BLOOD Lipase-20 ___ 07:35PM BLOOD cTropnT-<0.01 ___ 02:20AM BLOOD cTropnT-<0.01 ___ 07:35PM BLOOD CRP-183.6* Discharge labs: ___ 07:30AM BLOOD WBC-9.4 RBC-3.55* Hgb-10.6* Hct-31.0* MCV-87 MCH-29.8 MCHC-34.0 RDW-13.1 Plt ___ ___ 07:30AM BLOOD Neuts-68.5 ___ Monos-7.6 Eos-4.1* Baso-0.2 ___ 07:30AM BLOOD Plt ___ Pertinent labs: ___ 02:20AM BLOOD WBC-12.3* ___ 07:35PM BLOOD CRP-183.6* IMAGING: RUQ ___: Impression 1. Two stable hepatic hemangiomas. 2. No cholelithiasis. 3. Recurrent small bilateral pleural effusions, decreased in size compared to the prior CT of ___. CTPA ___: Impression 1. No evidence of pulmonary embolism. 2. Small-moderate right pleural effusion with significant adjacent atelectasis. No definitive lobar consolidation is identified. 3. 3 mm solid left perifissural nodule, stable since ___. 4. Moderate cardiomegaly. CXR ___: Lung volumes are low leading to crowding of the bronchovascular structures. Portions of the right hemidiaphragm and right heart border are obscured by a and adjacent airspace opacity. Streaky bibasilar atelectasis is present. The upper lung zones are clear. There is no pneumothorax or definite pleural effusion. The patient is status post median sternotomy. Mild cardiomegaly is noted, exaggerated by technique and poor inspiration. IMPRESSION: New airspace opacity overlying the right heart border is compatible with pneumonia in the appropriate clinical setting. Bibasilar atelectasis. Mild cardiomegaly. Brief Hospital Course: ___ with h/o history CVA (___) c/b subsequent DVT and seizure, mitral valve repair, HTN, and chronic anemia who presents with worsening right-sided pleuritic chest pain w/ radiation to the right shoulder and arm. # Chest pain: Pt presenting w/ pleuritic chest pain in setting of negative CTPA and normal vital signs. ___ be ___ diaphragmatic irritation due to pleural effusion/atelectasis resulting in referred right shoulder/arm pain. Pain w/ inspiration likely causing poor inspiratory effort and leading to further atelectasis of right lower lobe. Patient w/ some tenderness to palpation over anterior chest wall - questionable component of MSK strain to chest pain, improving with flexeril use. Patient reporting significant indigestion, acid reflux, and constipation - some improvement of pain w/ aggressive bowel regimen and GI cocktail. Radiographic findings with potential RLL pneumonia. Cardiac etiology unlikely given normal EKG and atypical presentation. Trops were negative x 3 LFTs and RUQ US were unremarkable. The pt was seen by IP who recommended follow up in ___ clinic with thoracentesis if effusion persistent. -Patient to continue antibiotics Augmentin 875mg BID (end date ___ -Patient to continue incentive spirometry and pulmonary conditioning w/ acapella/flutter valve at home -Patient to follow-up @ ___ at ___, will receive CXR prior to appt # Hyponatremia: Patient w/ baseline Na in 130s, presenting w/ Na 131. Stable during hospitalization. Inactive issues: # Anemia: stable # Hypertension: stable, continued home meds # S/p CVA with residual hemiparesis: received ___ eval who recommended home ___ services Transitional: ___ clinic for tapping of effusion. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Vitamin D 1000 UNIT PO QAM 2. Multivitamins 1 TAB PO QAM 3. Metoprolol Tartrate 37.5 mg PO BID 4. Pravastatin 20 mg PO HS 5. Duloxetine 60 mg PO BID 6. Tamsulosin 0.4 mg PO QAM 7. Dantrolene Sodium 50 mg PO BID 8. Omeprazole 40 mg PO BID 9. LACOSamide 200 mg PO QAM 10. LACOSamide 100-200 mg PO QPM 11. Loratadine 10 mg PO QAM 12. Aspirin 81 mg PO QAM 13. Senna 8.6 mg PO BID constipation 14. Ibuprofen 400 mg PO Q6H:PRN pain 15. Acetaminophen 1000 mg PO Q8H:PRN pain 16. Fluticasone Propionate NASAL 1 SPRY NU DAILY to each nostril 17. Lorazepam 0.25 mg PO Q6H:PRN anxiety 18. Calcium Carbonate 500 mg PO QID:PRN heart burn 19. Levofloxacin 500 mg PO Q24H 20. Olux (clobetasol) 0.05 % topical daily to scalp 21. Clindamycin 1% Solution 1 Appl TP BID:PRN to chest 22. Hydrocortisone Cream 2.5% 1 Appl TP BID:PRN to scalp, forehead, nose, sparingly to eyelids 23. Docusate Sodium 100 mg PO TID Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO QAM 3. Calcium Carbonate 500 mg PO QID:PRN heart burn 4. Clindamycin 1% Solution 1 Appl TP BID:PRN to chest 5. Dantrolene Sodium 50 mg PO BID 6. Docusate Sodium 100 mg PO TID 7. Duloxetine 60 mg PO BID 8. Fluticasone Propionate NASAL 1 SPRY NU DAILY to each nostril 9. Hydrocortisone Cream 2.5% 1 Appl TP BID:PRN to scalp, forehead, nose, sparingly to eyelids 10. Ibuprofen 400 mg PO Q6H:PRN pain 11. LACOSamide 200 mg PO QAM 12. LACOSamide 100-200 mg PO QPM 13. Loratadine 10 mg PO QAM 14. Lorazepam 0.25 mg PO Q6H:PRN anxiety 15. Metoprolol Tartrate 37.5 mg PO BID 16. Multivitamins 1 TAB PO QAM 17. Omeprazole 40 mg PO BID 18. Pravastatin 20 mg PO HS 19. Vitamin D 1000 UNIT PO QAM 20. Olux (clobetasol) 0.05 % topical daily to scalp 21. Tamsulosin 0.4 mg PO QAM 22. Senna 8.6 mg PO BID constipation 23. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Last day of antibiotic is ___. RX *amoxicillin-pot clavulanate 875 mg-125 mg one tablet(s) by mouth twice a day Disp #*17 Tablet Refills:*0 24. Bisacodyl ___AILY:PRN constipation RX *bisacodyl 10 mg one suppository(s) rectally daily Disp #*10 Suppository Refills:*0 25. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 17 gram one powder(s) by mouth daily Disp #*30 Packet Refills:*0 26. Maalox/Diphenhydramine/Lidocaine ___ mL PO TID:PRN epigastric pain You can take this as needed. RX *alum-mag hydroxide-simeth 200 mg-200 mg-20 mg/5 mL 15 ml by mouth three times a day Refills:*0 27. OxycoDONE (Immediate Release) 2.5 mg PO Q8H:PRN pain For limited time only. No alcohol or driving while on this medication. RX *oxycodone 5 mg 0.5 (One half) capsule(s) by mouth every 8 hours Disp #*15 Capsule Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Right lower-lobe pneumonia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane) *consistent w/ baseline Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. As you may know, you were admitted to the hospital for right-sided chest pain, worse with breathing, with radiation to your right shoulder and arm. When you arrived to the hospital, you received a CT scan of your lungs which did not show any evidence of blood clot to your lungs. Your EKG and labs were normal, which suggested this was not a heart attack. Your CT scan and chest x-ray did reveal a right lung pneumonia and a small collection of fluid in your right lung. It is likely that your pain with breathing is due to your pneumonia and this fluid collection. We consulted the pulmonary (lung) doctors who would ___ to see you in several weeks, please see the details below. Please call the number below and find out where and what time to report for your chest xray BEFORE the appointment. When you leave the hospital please continue taking your Augmentin antibiotics (two pills daily) until you finish the 10 day course on ___. Please continue strengthening your lungs and using the incentive spirometer and flutter/acapella valve at home. It is likely that your chest pain was also due to a combination of muscular strain as well as acid reflux. Please continue taking the muscle relaxant at home if needed as well as the acid suppressing medicines as needed. These should also help alleve your symptoms. Again, it was a pleasure taking care of you, we wish you all the best. Sincerely, Your ___ team Followup Instructions: ___
10762976-DS-9
10,762,976
28,335,304
DS
9
2173-05-24 00:00:00
2173-05-27 09:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: erythromycin / Heparin Agents / Sulfa (Sulfonamide Antibiotics) Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: Cardiac Catheterization without intervention History of Present Illness: ___ hx of mitral valve repair ___ c/b stroke, seizures, left hemiparesis, heparin induced thrombocytopenia, DVT on coumadin, HTN and hyperlipidemia who presents with 2 months of anginal symptoms, ruled out in ED, neg stress, admitted for catheterization. Pt describes 2 months of left sided chest tightness with exertion after 5 minutes. The pain always occurs with exertion, never at rest. He has also noted more general faitigue over this time. Over the last 2 days he noticed the pain starting to radiate down his left arm. Once it starts, it takes about ___ minutes of stopping and resting to relieve. Not positional, respiratory or reproducible with palpation. Pt notes is seperate and distinct from reflux. Was at the gym yesterday morning and noticed the same pain starting when he completed his work out. It lasted about 10 minutes. He took his daily baby aspirin and came to the ED. There troponins were negative x2 and EKG showed LBBB (chronic, w/ neg sgarbossa). Vital signs were stable. Concern for ACS remained high and patient underwent stress testing which was "Probably normal myocardial perfusion" but persantine portion induced symptoms in the presence of non-specific EKG changes. Accordingly, case was discussed w/ ___ attending who rec'd admission for cath. Of note, patient has remained chest pain free since ED. Past Medical History: - ___: AFib and went to ___ were mitral valvuloplasty/L atrial maze and L atrial appendage resection were done. After this surgery on post-po day 1 he suffered a long-standing post-op seizure tonic clonic and found on imaging a R+ MCA CVA. - Seizures - ___: pseudoaneurysm from R common femoral artery (discovered after going to the hospital bc swelling of L+ ankle) and DVT in R+ lower extremity. - Mitral valve prolapse - h/o DVT on Coumadin - Bilateral inguinal hernia repair - L+ knee arthroscopic surgery - h/o heparin-induced thrombocytopenia Social History: ___ Family History: No known fhx of cva Physical Exam: Admission Exam: VS: 97.6 84 130/87 16 100%RA GENERAL: Adult male in NAD. Oriented x3. Sitting comfortably in bed. NEURO: CNII-XII intact besides left shoulder shrug, strength ___ in upper extremities aside from ___ left deltoid, strength ___ in lower extremities aside from left ankle which was unable to plantar flex and minimally dorsiflex, sensation grossly intact to light touch HEENT: NCAT. PERRL, EOMI. Moist mucous membranes. NECK: Supple without JVD. CARDIAC: Regular with ___ systolic murmur LUNGS: Clear to ausculatation without wheezes or crackles, no accessory muscle use. ABDOMEN: Soft, NTND. BS+ EXTREMITIES: WWP, no edema, 2+ peripheral pulses Discharge Exam: Vitals: 98.4 75 125/75 18 97%RA General: Adult male in NAD, lying in bed comfortably HEENT: NCAT, MMM, no JVD Lungs: CTAB without increased WOB CV: RRR with ___ systolic murmur Abdomen: soft, NTND, BS+ Ext: WWP without edema Pertinent Results: Admission Labs =================== ___ 02:59PM BLOOD WBC-7.1 RBC-3.98* Hgb-11.8* Hct-35.3* MCV-89 MCH-29.6 MCHC-33.4 RDW-12.4 RDWSD-40.5 Plt ___ ___ 02:59PM BLOOD Neuts-64.0 ___ Monos-7.8 Eos-2.7 Baso-0.3 Im ___ AbsNeut-4.57 AbsLymp-1.77 AbsMono-0.56 AbsEos-0.19 AbsBaso-0.02 ___ 02:59PM BLOOD ___ PTT-30.9 ___ ___ 02:59PM BLOOD Glucose-84 UreaN-12 Creat-0.7 Na-133 K-4.2 Cl-97 HCO3-26 AnGap-14 ___ 02:59PM BLOOD cTropnT-<0.01 ___ 02:59PM BLOOD Calcium-9.0 Phos-3.5 Mg-2.1 Imaging ======================== CXR ___: Trace blunting of the bilateral posterior costophrenic angles suggests trace pleural effusions/pleural thickening. STRESS ___ INTERPRETATION: This ___ yo man with h/o PAF, MVR, HTN, and HLD was referred to the lab from the ED following negative serial cardiac enzymes for evaluation of chest discomfort. The patient was administered 0.142 mg/kg/min of Persantine over 4 minutes. There were no reports of chest, back, neck, or arm discomforts during the infusion. At 1 minute of recovery, the patient reported a ___ left-sided chest tightness. Post-MIBI, the Persantine was reversed with 125 mg Aminophylline IV and the chest discomfort resolved completely by 5 minutes of recovery. At peak infusion and early recovery, biphasic T waves were noted in leads V5-V6 before resolving back to baseline by 7 minutes of recovery. Rhythm was sinus with rare isolated VPBs and one APB. There was an appropriate heart rate and blood pressure response to the infusion. IMPRESSION: Persantine-induced symptoms in the presence of non-specific EKG changes. Nuclear report sent separately. SIGNED: ___ Cardiac Catheterization ___ LMCA normal, LAD 30% ostial stenosis, LCx normal, Ramus is a large vessel w/ 30% stenosis, RCA normal Discharge Labs ======================== ___ 08:00AM BLOOD WBC-8.2 RBC-4.40* Hgb-12.7* Hct-39.6* MCV-90 MCH-28.9 MCHC-32.1 RDW-12.6 RDWSD-41.3 Plt ___ ___ 08:00AM BLOOD Neuts-68.4 ___ Monos-7.6 Eos-2.9 Baso-0.2 Im ___ AbsNeut-5.60 AbsLymp-1.68 AbsMono-0.62 AbsEos-0.24 AbsBaso-0.02 ___ 08:00AM BLOOD ___ PTT-31.6 ___ ___ 08:00AM BLOOD Glucose-91 UreaN-13 Creat-0.8 Na-137 K-4.0 Cl-102 HCO3-29 AnGap-10 ___ 08:55PM BLOOD cTropnT-<0.01 ___ 08:00AM BLOOD Calcium-9.1 Phos-3.8 Mg-1.8 Brief Hospital Course: Summary ===================================== ___ PMH of mitral valve repair ___ (c/b stroke resulting in seizures, occurring to this day), left hemiparesis, heparin induced thrombocytopenia, DVT on coumadin, HTN and hyperlipidemia who presented to ED w/ 2 months of exertional chest pain. Underwent cardiac catheterization with non-occlusive disease and no intervention. Was chest pain free and discharged home in good condition. Chest pain ===================================== Presented to ED w/ 2 months of exertional chest pain, ruled out for ACS in ED, but stress test elicited symptoms and non-specific EKG changes so he was admitted to cardiology for catheterization. On ___ cardiac catheterization completed which revealed 30% pLAD, 30% ramus, 0% in the RCA which had previously been described as 30%. In light of arterial narrowing, his low dose statin was increased to 80mg of Atorvastatin. Fortunately, patient did not have any symptoms while hospitalized. He was discharged on an appropriate medication regimen with instructions to follow up with his primary care doctor regarding his shortness of breath and chest pain while exerting himself. Transitional Issues: ======================================== 1. Given exertional SOB, patient may benefit from outpatient PFTs and evaluation of asthma. 2. Patient should continue his current medications, and follow up with his primary care doctor regarding his chest pain with exertion. 3. Continue Atorvastatin 80mg given catheterization findings. 4. Due to catheterization with right wrist approach, patient was intstructed to avoid bearing to much pressure on this wrist for a few days. As this is his cane and transfer arm, he may need some additional assistance. # CODE: FULL confirmed # CONTACT: ___, wife: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Dantrolene Sodium 50 mg PO DAILY 3. Duloxetine 60 mg PO BID 4. Fluticasone Propionate NASAL 2 SPRY NU DAILY 5. Ibuprofen 400 mg PO Q6H:PRN pain 6. LACOSamide 200 mg PO QAM 7. Lorazepam 0.25 mg PO Q4H:PRN anxiety 8. Omeprazole 20 mg PO BID 9. Tamsulosin 0.4 mg PO QHS 10. Acetaminophen 1000 mg PO Q8H:PRN pain 11. Aspirin 81 mg PO DAILY 12. Calcium Carbonate 500 mg PO QID:PRN nausea 13. Vitamin D 1000 UNIT PO DAILY 14. Docusate Sodium 100 mg PO TID 15. Loratadine 10 mg PO DAILY 16. Multivitamins 1 TAB PO DAILY 17. Senna 8.6 mg PO BID:PRN constipation 18. Metoprolol Tartrate 37.5 mg PO BID 19. LACOSamide 200 mg PO EVERY OTHER NIGHT 20. LACOSamide 100 mg PO EVERY OTHER NIGHT Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Calcium Carbonate 500 mg PO QID:PRN nausea 4. Dantrolene Sodium 50 mg PO DAILY 5. Docusate Sodium 100 mg PO TID 6. Duloxetine 60 mg PO BID 7. LACOSamide 200 mg PO QAM 8. LACOSamide 200 mg PO EVERY OTHER NIGHT 9. LACOSamide 100 mg PO EVERY OTHER NIGHT 10. Lorazepam 0.25 mg PO Q4H:PRN anxiety 11. Metoprolol Tartrate 37.5 mg PO BID 12. Omeprazole 20 mg PO BID 13. Senna 8.6 mg PO BID:PRN constipation 14. Tamsulosin 0.4 mg PO QHS 15. Vitamin D 1000 UNIT PO DAILY 16. Fluticasone Propionate NASAL 2 SPRY NU DAILY 17. Ibuprofen 400 mg PO Q6H:PRN pain 18. Loratadine 10 mg PO DAILY 19. Multivitamins 1 TAB PO DAILY 20. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*1 Discharge Disposition: Home Discharge Diagnosis: Atypical Chest Pain Shortness of breath Discharge Condition: Discharge Condition: Stable Mental Status: AOx3 Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Mr. ___, It was a pleasure taking care of you while you were hospitalized at ___. As you know, you were admitted for chest pain, but fortunately, your EKG and lab studies showed that you were NOT suffering a heart attack. As you know, we performed a stress test which was slightly concerning so we proceeded with a catheterization of the heart which fortunately did not show any significant areas of narrowing or blockage. That said, it did show that you have some buildup in your arteries. While this is great news, it does not explain why you were newly short of breath while working with your personal trainer. Accordingly, you will need to follow up with your primary care doctor regarding these symptoms. We wish you the best! Your ___ team Followup Instructions: ___
10762986-DS-12
10,762,986
21,596,248
DS
12
2138-04-25 00:00:00
2138-04-25 21:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Seizures Major Surgical or Invasive Procedure: None History of Present Illness: ___ with HTN, HLD, h/o PE on warfarin, recent diagnosis of left temporoparietal mass with high grade glioma on biopsy, presenting today from rehab with seizures. She was recently on the Neurology service for workup of new brain mass and seizure management, discovered because she presented with seizures. She underwent brain biopsy on ___. She is on warfarin for PE, which was resumed after the biopsy and she was discharged to rehab. During that recent hospitalization she was started on AEDs by ___ for convulsive events - because of the location of her tumor, these were continued (Lacosamide and Keppra). She also had an EEG for several days negative for seizure, and had auditory hallucinations for which she started zyprexa. As above DCd from neurology service to rehab on ___. She presents today via ambulance from her rehabilitation facility after experiencing several seizures. She had another seizure en route to ___ in the ambulance. She is accompanied by her daughter who states that over the past 24-hour hours she has has been eating less and communicating less. Spoke with her daughter on the phone who states the seizures are that she is unresponsive and cant follow fingers and just stares. She comes out of it but when she came out of it a few minutes ago she was uncontrollably blinking. She has lost her ability to communicate in this past week and is not eating and drinking much. The seizures are lasting 45 seconds 1 minute max. in the last day including in ED pt has had 5 seizures per dtr. She is not able to interact in the past 36 hours even between seizures. When she left BI ___ she was able to communicate (was "frustrated in terms of word finding") but at this point per dtr you can't have a conversation with her at all. She has been reporting that her neck and head have been sore since before the biopsy and all along at rehab. She is continuing to say her neck and head hurt. Her voice has also become very weak per dtr. In the ED, initial VS were: 98.3 -> 101.6 111 138/68 16 95% RA. Labs were notable for: WBC 9.1 with 80% PMNs, CBC all up from prior. BUN 38, Cr 1.0. INR 4.8. UA neg. Imaging included: CT head neg. CXR neg. Consults called: Neurosurgery - recs: no surgical intervention Treatments received: lorazepam 1mg IV, APAP PR 650mg, 1L NS On arrival to the floor, initially she was answering questions without making much sense and only following some commands. However 20 minutes after arrival she suddently woke up completely, was fully oriented and conversant and able to give a complete review of systems and have coherent conversations which is much improved from what her daughter reported had been the status quo at this point. States that she is aware she was confused and seizing at rehab and states "but I am completely clear now". REVIEW OF SYSTEMS: Denies nausea/vomiting. Denies headache at this time. Has some right sided only neck pain but claims only mild and this has been going on since prior to last admission, not worse or new. States she has no nausea/vomiting. Denies dysuria denies hematuria/BRBPR, fever/chills, or rash. Endorses dehydration. All other 10 point ROS neg. Past Medical History: PAST ONCOLOGIC HISTORY: ___ Seizure ___ Brain biopsy by Dr. ___. Pathology is high grade glioma PAST MEDICAL HISTORY: 1. Left temporoparietal mass with path showing high grade glioma 2. Hypertension 3. Dyslipidemia 4. GERD 5. PE, on warfarin 6. Migraine headaches 7. Partial colectomy ___ 8. Hysterectomy Social History: ___ Family History: She has three daughters, one has MS, and she is taking care of her. Of her three siblings, one brother died of emphysema at ___ and the two sisters are healthy. Physical Exam: ADMISSION: VS: 98.7 122/78 86 18 98% RA GENERAL: NAD, when clear is fully oriented and conversant HEENT: NC/AT, EOMI, PERRL, MMM CARDIAC: RRR, normal S1 & S2, without murmurs, S3 or S4 LUNG: clear to auscultation, no wheezes or rhonchi ABD: +BS, soft, NT/ND, no rebound or guarding EXT: No lower extremity pitting edema PULSES: 2+DP pulses bilaterally NEURO: A&O x 3, lower extremities very weak but ___ strength, symmetric. Upper extr ___ strength, symmetric. PERRLA EOMI no asterixis or tremor SKIN: Warm and dry, without rashes DISCHARGE: VS: 98.1 125/59 59 16 96%RA Gen: sitting up in bed, comfortable-appearing Eyes - EOMI ENT - OP clear, MMM Heart - RRR no mrg Lungs - CTA bilaterally Abd - soft nontender, normoactive bowel sounds Ext - no edema Skin - no rashes Vasc - 2+ DP/radial pulses Neuro - moving all extremities Psych - appropriate Pertinent Results: ADMISSION ___ 03:00PM BLOOD WBC-9.1# RBC-3.99 Hgb-12.4 Hct-37.0 MCV-93 MCH-31.1 MCHC-33.5 RDW-14.6 RDWSD-49.4* Plt ___ ___ 03:00PM BLOOD ___ PTT-42.7* ___ ___ 03:00PM BLOOD Glucose-122* UreaN-38* Creat-1.0 Na-139 K-4.4 Cl-95* HCO3-28 AnGap-20 ___ 03:00PM BLOOD ALT-25 AST-48* CK(CPK)-33 AlkPhos-154* TotBili-0.3 DISCHARGE ___ 06:15AM BLOOD WBC-6.2 RBC-3.48* Hgb-10.6* Hct-32.7* MCV-94 MCH-30.5 MCHC-32.4 RDW-13.6 RDWSD-46.8* Plt ___ ___ 06:15AM BLOOD ___ PTT-40.2* ___ CXR ___ No acute cardiopulmonary abnormality. CT Head ___ 1. Left temporoparietal lobe ill-defined hyperdensity as well as smaller focal hyperdensity adjacent to the temporal horn of the left lateral ventricle are better characterized on MR dated ___. Findings are associated with minimal mass effect and effacement of adjacent sulci. 2. No evidence of acute hemorrhage or large territorial infarction. EEG - ___ This telemetry captured a single pushbutton activation, not showing evidence of seizures. Otherwise, the posterior background was normal in the bit disorganized. There was prominent though intermittent delta slowing in the left hemisphere, likely related to the report of a mass lesion. There were a few spikes in the same area, but there were no simple spike or sharp and slow-wave complexes, and there were no electrographic seizures. Brief Hospital Course: ___ year old female with past medical history of hypertension, prior pulmonary embolism on warfarin, recent diagnosis of L temporoparietal mass with high grade glioma on biopsy, admitted ___ with seizures, now s/p optimized regimen, planning for discharge home with hospice # High-Grade Glioma / Seizures / Acute metabolic encephalopathy - patient admitted with observed seizures; felt to likely be secondary to progression of her high grade glioma. She was seen by Dr. ___ Neuro-oncology, who recommended increasing lacosamide to 150 BID, starting dexamethasone and continuing keppra. Given high-grade features of glioma, life expectancy was felt to be ~2 months. Given her worsening symptoms, and poor prognosis, patient and daughter opted to pursue home with hospice. Prior to discharge MOLST form filled out, with opting to for "do not rehospitalize". Patient discharged home with hospice, with prescriptions for home medications including lacosamide 150 BID, Keppra 1500 BID, Dexamethasone 4mg PO daily. # HISTORY OF PE - Patient on chronic warfarin. As above, given that patient transitioned care to ___ focused, we discussed plan for anti-coagulation, at which time, patient and HCP opted for cessation of coumadin. #Goals of care: after thorough discussion with patient and her daughter, patient would like to go home with hospice and transition towards comfort focused care. Will keep medications such as anti-seizure meds, steroids as that may improve functioning, as well as ranitidine given patient report that she felt it helped to prevent discomfort from heartburn. As above, stopped coumadin. Patient discharged home with hospice. # Dysphagia - had previously been on dysphagia diet with pureed solids, thin liquids; given change in goals of care as above, can consider allowing patient to eat for comfort. Other medical issues managed this admission # ___ - Cr 1.0 on admission from baseline 0.5; resolved with fluids; given goals of care change above, no further monitoring prior to discharge # HTN - Discontinued torsemide as not within goals of care as above # Hyperlipidemia - Discontinued pravastatin as not within goals of care as above TRANSITIONAL ISSUES - Discharged home with hospice - Code status - DNR/DNI confirmed w/ HCP; MOLST form signed indicating "do not rehospitalize" - EMERGENCY CONTACT/HCP: daughter ___ ___ > 30 minutes spent on this discharge Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Pravastatin 40 mg PO QPM 2. Ranitidine 150 mg PO BID 3. Torsemide 20 mg PO DAILY 4. LACOSamide 100 mg PO BID 5. LeVETiracetam 1500 mg PO BID 6. Warfarin 5 mg PO EVERY OTHER DAY 7. Warfarin 6 mg PO EVERY OTHER DAY 8. OLANZapine 2.5 mg PO BID Discharge Medications: 1. Hospital Bed Dx: Malignant neoplasm of brain, unspecified C71.9 2. OLANZapine 2.5 mg PO BID RX *olanzapine 2.5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 3. Ranitidine 150 mg PO BID RX *ranitidine HCl 150 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 4. Dexamethasone 4 mg PO DAILY RX *dexamethasone 4 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 5. LACOSamide 150 mg PO BID RX *lacosamide [Vimpat] 150 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 6. LeVETiracetam 1500 mg PO BID RX *levetiracetam 750 mg 2 tablet(s) by mouth twice a day Disp #*120 Tablet Refills:*0 7. Acetaminophen 650 mg PO Q6H:PRN pain, fever RX *acetaminophen 325 mg ___ tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 8. Morphine Sulfate (Concentrated Oral Soln) 0.25-5 mg PO Q3H:PRN pain/SOB RX *morphine concentrate 20 mg/mL 0.25-5 mg by mouth q3h Disp #*30 Syringe Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: # High-Grade Glioma # Seizures # Acute metabolic encephalopathy # GERD # Dysphagia Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Ms. ___, It was a pleasure caring for you at ___. You were admitted to ___ with seizures. You were seen by neuro-oncologists who felt that the seizures were most likely from progression of your cancer. They recommended increasing anti-seizure medications--we increased your lacosamide to 150mg twice daily, you were started on dexamethasone once a day, and we kept your keppra dose the same. While here, we discussed your goals of care, and you decided that you wanted to focus on comfort and pursue hospice. You were set up with a hospice agency, and your medications were changed so that we would focus on your comfort. Followup Instructions: ___
10763063-DS-19
10,763,063
26,819,962
DS
19
2147-04-17 00:00:00
2147-04-17 08:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: Cipro / Macrobid Attending: ___. Chief Complaint: Right leg pain Major Surgical or Invasive Procedure: Right Femur Open Reduction Internal Fixation History of Present Illness: ___ on Coumadin for bilateral pulmonary embolism in ___, s/p right total hip arthroplasty ___ and right total knee arthroplasty ___ presents as a transfer from ___ with a right periprosthetic femur fracture sustained after a mechanical fall. The patient reports she was making dinner when she fell in her kitchen. She denies headstrike/loss of consciousness. She was unable to ambulate afterwards and presented to ___ where XRs were performed which showed a right periprosthetic femur fracture for which she was transferred and for which Orthopaedic Surgery was consulted. Past Medical History: Hypothyroid Bilateral PEs on Coumadin Hypertension Social History: ___ Family History: NC Physical Exam: Exam on admission: Right lower extremity: - Skin intact - Shortened and externally rotated - Soft, non-tender lower leg - Full, painless AROM/PROM of the ankle - ___ fire - SILT SPN/DPN/TN/saphenous/sural distributions - Palpable DP pulse - Foot warm and well-perfused Exam on discharge: Vital signs were stable. Patient was afebrile Patient was comfortable, no acute distress, alert and oriented. Right lower extremity: - Wound well approximated without erythema, mild ecchymosis, and minor serous drainage. - Skin intact - Soft, non-tender lower leg - Painless AROM/PROM of ankle. Minor stiffness for AROM/PROM of knee/hip - ___ fire - SILT SPN/DPN/TN/saphenous/sural - Palpable DP pulse - Foot warm and well-perfused Pertinent Results: ___ 05:30AM BLOOD WBC-4.2 RBC-2.86* Hgb-9.0* Hct-27.7* MCV-97 MCH-31.5 MCHC-32.5 RDW-15.5 RDWSD-55.3* Plt ___ Brief Hospital Course: The patient presented to the emergency department from an outside hospital and was evaluated by the orthopedic surgery team. The patient was found to have a right periprosthetic femur fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for right periprosthetic femur open reduction internal fixation, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient was given two units of blood due to intra-operative blood loss and low hematocrit. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is touch down weight bearing in the right lower extremity, and will be discharged on warfarin for DVT prophylaxis. The patient refused lovenox and therefore will not be bridged. She was counseled on the increased risk of DVT due to her history, acknowledged this, and continued to refuse bridging therapy. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: Prevacid 30 mg capsule,delayed release oral 1 capsule,delayed ___ Once Daily Lasix 20 mg tablet oral 1 tablet(s) , as needed Lotensin 20 mg tablet oral 1.5 tablet(s) Once Daily Synthroid ___ mcg tablet oral 1 tablet(s) 2x week ___ tab O Senokot 8.6 mg tablet oral 1 tablet(s) Once Daily Tylenol -- Unknown Strength 1 tablet(s) Coumadin 2 mg tablet oral 1 tablet(s) Once Daily2-5mg as directed calcium phosphate-vitamin D3 250 mg calcium-500 unit chewable tablet oral 1 tablet,chewable(s) Once Daily Bactrim -- Unknown Strength 1 tablet(s) Discharge Medications: 1. Lansoprazole Oral Disintegrating Tab 30 mg PO DAILY 2. Senna 8.6 mg PO DAILY 3. Acetaminophen 650 mg PO Q6H 4. Docusate Sodium 200 mg PO BID 5. Multivitamins 1 TAB PO DAILY 6. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN breakthrough pain RX *oxycodone 5 mg ___ tablet(s) by mouth q4 Disp #*150 Tablet Refills:*0 7. Polyethylene Glycol 17 g PO DAILY:PRN constipation 8. Vitamin D 400 UNIT PO DAILY 9. Furosemide 20 mg PO ONCE 10. Levothyroxine Sodium 100 mcg PO DAILY 11. Lotensin (benazepril) 30 mg ORAL DAILY 12. Warfarin ___ mg PO DAILY16 13. Bisacodyl ___ID:PRN Constipation Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Right periprosthetic femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery for your right leg fracture. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Touch down weight bearing of right lower extremity MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take warfarin for DVT prophylaxis. You refused a lovenox shots to help prevent clots as your INR levels are not therapeautic. As such it is extremely important to monitor your INR. WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns FOLLOW UP: Please follow up with your surgeon's team (Dr. ___, with ___, NP in the Orthopaedic Trauma Clinic 14 days post-operation for evaluation. Call ___ to schedule appointment upon discharge. Please follow up with your primary care doctor regarding this admission within ___ weeks and for and any new medications/refills and to monitor your INR Physical Therapy: Touch down weight bearing right lower extremity Treatments Frequency: -You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. Followup Instructions: ___
10763131-DS-16
10,763,131
28,463,082
DS
16
2166-01-29 00:00:00
2166-01-29 10:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: right femur fracture Major Surgical or Invasive Procedure: Open reduction, internal fixation, right femur fracture with application ___ plate and screws. History of Present Illness: ___ female presents with the above fracture s/p mechanical fall. She has a history of NIDDM with peripheral neuropathy, and this morning was walking to the bathroom when, due to decreased sensation in her feet, she tripped over them, falling to the floor, noting immediate R distal thigh/knee pain. She denies pain elsewhere. She denies weakness/dizziness/palpitations/ headache or other medical prodromal symptoms. She was placed in Hare traction by EMS. Past Medical History: OSTEOARTHRITIS MULTIFACTORIAL GAIT DISORDER HTN NIDDM Elevated cholesterol Fe deficiency Hypothyroidism GERD R TKR R THR Social History: ___ Family History: NC Physical Exam: GEN: NAD, AAOX4 RLE: in unlocked ___ brace. incisions lateral thigh c/d/I with staples to skin. minimal drainage, no edema or erythema. SILT s/s/spn/dpn/tn, Fires ___, 1+ distal pulses, toes wwp. Pertinent Results: ___ 10:40AM BLOOD WBC-8.6 RBC-2.88* Hgb-8.7* Hct-26.6* MCV-92 MCH-30.2 MCHC-32.7 RDW-14.6 RDWSD-49.3* Plt ___ ___ 05:45AM BLOOD WBC-9.9 RBC-2.97*# Hgb-8.8*# Hct-27.1* MCV-91 MCH-29.6 MCHC-32.5 RDW-15.4 RDWSD-51.1* Plt ___ ___ 06:15AM BLOOD WBC-8.5 RBC-2.33* Hgb-7.0* Hct-22.4* MCV-96 MCH-30.0 MCHC-31.3* RDW-13.7 RDWSD-47.8* Plt ___ ___ 10:29AM BLOOD Neuts-55.9 ___ Monos-8.5 Eos-2.2 Baso-1.0 Im ___ AbsNeut-3.87 AbsLymp-2.22 AbsMono-0.59 AbsEos-0.15 AbsBaso-0.07 ___ 10:40AM BLOOD Plt ___ ___ 05:45AM BLOOD Plt ___ ___ 06:15AM BLOOD Plt ___ ___ 01:35AM BLOOD Plt ___ ___ 01:35AM BLOOD Glucose-211* UreaN-19 Creat-0.6 Na-135 K-4.2 Cl-104 HCO3-23 AnGap-12 ___ 10:29AM BLOOD Glucose-206* UreaN-19 Creat-0.5 Na-137 K-4.7 Cl-102 HCO3-25 AnGap-15 ___ 01:35AM BLOOD Calcium-8.3* Phos-3.3 Mg-1.6 Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have right interprosthetic femur fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for ORIF of the right femur, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is touch down weight bearing in the right lower extremity, and will be discharged on lovenox for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: Medications - Prescription AMLODIPINE - amlodipine 5 mg tablet. 1 (One) tablet(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) ATORVASTATIN - atorvastatin 40 mg tablet. 1 (One) tablet(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) CEPHALEXIN - cephalexin 500 mg capsule. 4 capsule(s) by mouth ___ minutes prior to dental procedures as needed for ONCE CITALOPRAM [CELEXA] - Celexa 10 mg tablet. 1 tablet(s) by mouth daily DICLOFENAC SODIUM [VOLTAREN] - Voltaren 1 % topical gel. Apply a small amount of gel ___ times daily to bilateral hands TID/QID:PRN as needed for Pain GABAPENTIN - gabapentin 300 mg capsule. 1 (One) capsule(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) GLIMEPIRIDE - glimepiride 2 mg tablet. 1 (One) tablet(s) by mouth twice a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) LEVOTHYROXINE - levothyroxine 88 mcg tablet. 1 (One) tablet(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) LORAZEPAM [ATIVAN] - Ativan 0.5 mg tablet. tablet(s) by mouth as needed - (Prescribed by Other Provider: ___ METOPROLOL TARTRATE - metoprolol tartrate 50 mg tablet. 1 (One) tablet(s) by mouth once a day - (Prescribed by Other Provider) OMEPRAZOLE - omeprazole 20 mg capsule,delayed release. 1 (One) capsule,delayed ___ by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) SITAGLIPTIN-METFORMIN [JANUMET] - Janumet 50 mg-1,000 mg tablet. 1 (One) tablet(s) by mouth twice a day - (Prescribed by Other Provider) Medications - OTC ASPIRIN [ADULT LOW DOSE ASPIRIN] - Adult Low Dose Aspirin 81 mg tablet,delayed release. 1 (One) tablet,delayed release (___) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 2,000 unit capsule. 1 (One) capsule(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) FERROUS GLUCONATE - ferrous gluconate 325 mg (36 mg iron) tablet. 1 tablet(s) by mouth three times a day do not take with levothyroxine Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Aluminum-Magnesium Hydrox.-Simethicone ___ ml PO Q6H:PRN Dyspepsia 3. Amlodipine 5 mg PO DAILY 4. Atorvastatin 40 mg PO QPM 5. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 6. Citalopram 10 mg PO DAILY 7. Docusate Sodium 100 mg PO BID 8. Enoxaparin Sodium 40 mg SC QPM Duration: 28 Days Start: Today - ___, First Dose: Next Routine Administration Time 9. Ferrous GLUCONATE 324 mg PO TID 10. Gabapentin 300 mg PO DAILY 11. glimepiride 2 mg oral DAILY 12. Levothyroxine Sodium 88 mcg PO DAILY 13. Lorazepam 0.5 mg PO Q6H:PRN anxiety 14. MetFORMIN (Glucophage) 1000 mg PO BID 15. Metoprolol Tartrate 25 mg PO BID 16. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 4 hours Disp #*40 Tablet Refills:*0 17. Pantoprazole 40 mg PO Q24H 18. Senna 8.6 mg PO BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: right interprosthetic femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - touch down weight bearing in right lower extremity in unlocked ___ MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Lovenox 40mg daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns Physical Therapy: tdwb rle in unlocked ___ brace Treatments Frequency: please monitor wounds for s/s of infection; change dressings prn Followup Instructions: ___
10763516-DS-5
10,763,516
29,964,607
DS
5
2162-04-06 00:00:00
2162-04-08 09:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Arava / Macrobid / clindamycin / codeine / cephalexin Attending: ___. Chief Complaint: LLE critical limb ischemia Major Surgical or Invasive Procedure: Left lower extremity diagnostic angiogram History of Present Illness: Ms. ___ is a ___ female, former smoker, who was transferred to ___ for further evaluation of left lower extremity rest pain. She developed a new numbness sensation of the left foot on ___, which is about five days ago and this pain has persisted since onset. She underwent vascular noninvasive studies after admission to the hospital, which showed discrepant findings on the left lower extremity. Left lower extremity had a toe pressure of 28 and evidence of disease throughout the ___ segment. Given these findings, a left lower extremity angiogram was offered for the patient. Past Medical History: PMH: Rheumatoid arthritis Hypertension Hyperlipidemia Pre-diabetes PSH: Right total knee replacement Open appendectomy (remote) Social History: ___ Family History: Family History: Significant for CAD - 2 brothers died of MI Physical Exam: Vitals: 97.7 150-84 95 18 94%/RA General: NAD, AOx3 Chest: Normal work of breathing on room air Abd: Soft, nontender, nondistended Ext: Warm bilaterally Neuro: Moving all 4 extremities equally, sensation grossly intact Pulses: DP and ___ dopplerable bilaterally Pertinent Results: Labs----------- ___ 04:06AM BLOOD WBC-14.3* RBC-3.94 Hgb-11.6 Hct-37.2 MCV-94 MCH-29.4 MCHC-31.2* RDW-14.3 RDWSD-49.2* Plt ___ ___ 11:48AM BLOOD Neuts-57.2 ___ Monos-14.5* Eos-0.8* Baso-0.7 Im ___ AbsNeut-6.97* AbsLymp-3.18 AbsMono-1.77* AbsEos-0.10 AbsBaso-0.08 ___ 04:06AM BLOOD Plt ___ ___ 04:06AM BLOOD Glucose-167* UreaN-13 Creat-0.6 Na-141 K-4.4 Cl-105 HCO3-24 AnGap-12 ___ 04:06AM BLOOD Calcium-8.8 Phos-3.2 Mg-2.0 Diagnostic Angiogram ___-- ANGIOGRAM FINDINGS: 1. Diffusely diseased infrarenal abdominal aorta without evidence of flow-limiting stenoses. 2. Patent bilateral renal arteries with brisk nephrograms. 3. Patent bilateral common iliac, external and internal iliac arteries. 4. Heavily diseased left common femoral artery with a high-grade greater than 90% stenosis in the proximal common femoral. The left profunda femoris and its branches are patent. The left SFA is diffusely diseased throughout its course with multiple areas of high-grade stenoses in the mid SFA. 5. The above and below-knee popliteal arteries are patent. 6. Further distally, there is three-vessel runoff to the forefoot, the left anterior tibial and posterior tibial and peroneal arteries. The left peroneal artery feeds into posterior collaterals at the level of the ankle. Brief Hospital Course: ___ was admitted to ___ on ___ after she was evaluated for a cold and pulseless LLE in the ED and was found to have acute on chronic LLE ischemia. She was started on a heparin gtt with initial improvement in her LLE numbness and distal doppler signals over the next ___ hours. Noninvasive arterial studies done on ___ showed Left iliac, SFA, and distal tibial disease. Based on these findings she underwent LLE diagnostic angiogram on ___ which showed high grade stenosis in the left Common femoral artery and Left superficial femoral artery. For full details of the surgical procedure please see the dictated operative report. After a brief stay in PACU she was transferred to the vascular surgery floor where where she remained for the rest of her admission. He diet was advanced to a house diet which she tolerated well. She was able to void on her own QS and ambulate ad lib in her room. She was given PO APAP for any postoperative discomfort. Based on the results of her angiogram she will require a re-admission for an angiogram with intervention and this has been scheduled for ___. Of note, she was enrolled in the BEST-CLI study by the research team and has been randomized to endovascular intervention. Her heparin gtt was re-started after her angiogram. She was then transitioned to lovenox prior to discharge on ___. She will need to continue on lovenox 70mg SC BID until the day before her surgery when she should take the morning dose but hold the evening dose. She should also hold the morning dose on day of surgery. Patient is discharged home in an improved condition. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 20 mg PO QPM 3. amLODIPine 2.5 mg PO DAILY 4. Methylprednisolone 4 mg PO BID 5. leflunomide 20 mg oral DAILY 6. olmesartan 20 mg oral DAILY 7. Cyclobenzaprine 10 mg PO TID:PRN muscle spasms 8. Furosemide 20 mg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral DAILY 11. Ascorbic Acid ___ mg PO BID Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Enoxaparin Sodium 70 mg SC Q12H Start: Today - ___, First Dose: Next Routine Administration Time Continue this medication until you are re-admitted for your next procedure. RX *enoxaparin 80 mg/0.8 mL 70 mg SC twice a day Disp #*14 Syringe Refills:*0 3. Omeprazole 20 mg PO DAILY 4. Ascorbic Acid ___ mg PO DAILY 5. Atorvastatin 40 mg PO QPM 6. amLODIPine 2.5 mg PO DAILY 7. Aspirin 81 mg PO DAILY 8. Cyclobenzaprine 10 mg PO TID:PRN muscle spasms 9. Furosemide 20 mg PO DAILY 10. leflunomide 20 mg oral DAILY 11. Methylprednisolone 4 mg PO BID 12. Multivitamins 1 TAB PO DAILY 13. olmesartan 20 mg oral DAILY 14. Vitamin D3 (cholecalciferol (vitamin D3)) 2,000 unit oral DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Critical limb ischemia, peripheral vascular disease Secondary: Hypertension, rheumatoid arthritis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Ms. ___, It was a pleasure taking care of you at ___ ___. You were admitted to the hospital after a peripheral angiogram. To do the test, a small puncture was made in one of your arteries. The puncture site heals on its own: there are no stitches to remove. You tolerated the procedure well and are now ready to be discharged from the hospital. Please follow the recommendations below to ensure a speedy and uneventful recovery. Peripheral Angiography Puncture Site Care For one week: •Do not take a tub bath, go swimming or use a Jacuzzi or hot tub. •Use only mild soap and water to gently clean the area around the puncture site. •Gently pat the puncture site dry after showering. •Do not use powders, lotions, or ointments in the area of the puncture site. You may remove the bandage and shower the day after the procedure. You may leave the bandage off. You may have a small bruise around the puncture site. This is normal and will go away one-two weeks. Activity For the first 48 hours: •Do not drive for 48 hours after the procedure For the first week: •Do not lift, push , pull or carry anything heavier than 10 pounds •Do not do any exercises or activity that causes you to hold your breath or bear down with abdominal muscles. Take care not to put strain on your abdominal muscles when coughing, sneezing, or moving your bowels. After one week: •You may go back to all your regular activities, including sexual activity. We suggest you begin your exercise program at half of your usual routine for the first few days. You may then gradually work back to your full routine. Medications: Before you leave the hospital, you will be given a list of all the medicine you should take at home. If a medication that you normally take is not on the list or a medication that you do not take is on the list please discuss it with the team! For Problems or Questions: Call ___ in an emergency such as: •Sudden, brisk bleeding or swelling at the groin puncture site that does not stop after applying pressure for ___ minutes •Bleeding that is associated with nausea, weakness, or fainting. Call the vascular surgery office (___) right away if you have any of the following. (Please note that someone is available 24 hours a day, 7 days a week) •Swelling, bleeding, drainage, or discomfort at the puncture site that is new or increasing since discharge from the hospital •Any change in sensation or temperature in your legs •Fever of 101 or greater •Any questions or concerns about recovery from your angiogram Based on the findings from your angiogram you will require a repeat Left leg angiogram with intervention in the next several days. Your procedure is booked for ___. You will be contacted the night before this procedure by the endovascular team with your arrival time. Followup Instructions: ___
10763687-DS-17
10,763,687
28,190,914
DS
17
2205-06-02 00:00:00
2205-06-03 22:43:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Levofloxacin Attending: ___ Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: ___ y/o ___ male with h/o dCHF (EF 60% ___, Afib on warfarin, HTN, DM2 presenting with 1 day h/o SOB and several months of abdominal distention. History obtained with help of pt's son who is at the bedside. Pt has had progressive abdominal distention for several months as well as ___ swelling which was attributed to lymphedema per recent clinic notes. Pt awoke this morning with SOB, denies CP, palpitations. + stable ___ pillow orthopnea, denies fever/chills/night sweats, nausea/vomiting, diarrhea or constipation. Pt has been compliant with medications with the help of his daughter, no recent dietary indiscretion. In the ED, initial vitals were 98.2 65 100/76 18 97%. Labs significant for negative UA, lactate 3.0, normal Chem 7 with Cr 0.8. Tbili 1.7, lipase 15, proBNP 2738 (___), HCT 34.9, INR 2.3. CXR showed pulm edema and bilateral pleural effusions, R>L on initial report. Pt was given lasix 40mg IV x 1 at 1545, azithromycin and CTX. A foley was placed with 1300mL UOP in ED. Vitals on transfer 97.6 63 126/69 18 98% RA. On review of systems, s/he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools. S/he denies recent fevers, chills or rigors. S/he denies exertional buttock or calf pain. All of the other review of systems were negative. Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. Past Medical History: 1. Chronic Diastolic CHF 2. Atrial fibrillation on warfarin 3. Type 2 DM with poor compliance with medications. HgbA1C = 7.6% in ___ 4. Hyperlipidemia 5. Benign Hypertension. 6. Status post tib/fib fracture in ___, R leg. 7. Status post open cholecystectomy. 8. History of elevated PSA. 9. Questionable peripheral vascular disease Social History: ___ Family History: The patients parents died a long time ago. He does not report any family history of DM, cancer. He has two siblings who are alive and he doesn't know about their health. Physical Exam: ADMISSION PHYSICAL EXAM: VS:T 97.8, 126/72 75 18 97% RA WT 107kg General- Alert, wheezing HEENT- Sclera anicteric, MMM, oropharynx clear Neck- JVP to mandible @ 30 degrees Lungs- + wheezes, diminished at bases CV- irregularly irregular, distant S1 + S2, no murmurs, rubs, gallops Abdomen- soft, non-tender, distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly, 1+ pitting edema pannus GU- foley in place draining clear yellow urine Ext- cool, 1+ distal pulses, hyperpigmentation of both chins, L shin with overlying erythema no warmth or tenderness to palpation; 2+ pitting edema to knees and 1+ pitting lateral thighs bilaterally Neuro- motor function grossly normal DISCHARGE PHYSICAL EXAM: VS: 98.2 96/59 66 18 96%RA 24-hour I/O 1180/1130 Tele: Bradycardia to high ___ for several seconds, asx General: A&O, NAD. Son translating this morning. HEENT: Sclera anicteric, MMM, oropharynx clear Neck: Suppled, no LAD, JVP ~10 Lungs: Crackles bilaterally in lower lung fields CV: Distant heart sounds. Irregularly irregular, +S1/S2, no appreciable m/r/g Abdomen: Distended but soft, non-tender, bowel sounds present, no rebound/guarding. No fluid wave, but 1+ pitting edema around pannus GU: Foley in place draining clear yellow urine Ext: Cool, 1+ distal pulses, hyperpigmentation of both shins, L shin with overlying erythema, some warmth, tenderness improved; 1+ pitting edema to knees bilaterally Neuro: CN II-XII, motor, and sensation grossly normal. Pertinent Results: ADMISSION LABS: ___ 01:20PM BLOOD WBC-9.6 RBC-4.34* Hgb-11.4* Hct-34.9* MCV-81* MCH-26.3* MCHC-32.7 RDW-16.1* Plt ___ ___ 01:20PM BLOOD Neuts-81* Bands-0 Lymphs-12* Monos-5 Eos-2 Baso-0 ___ Myelos-0 ___ 01:20PM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-NORMAL Macrocy-2+ Microcy-1+ Polychr-NORMAL ___ 01:20PM BLOOD ___ PTT-38.8* ___ ___ 01:20PM BLOOD Glucose-177* UreaN-10 Creat-0.8 Na-133 K-4.6 Cl-96 HCO3-26 AnGap-16 ___ 01:20PM BLOOD ALT-17 AST-27 AlkPhos-124 TotBili-1.7* ___ 01:20PM BLOOD CK-MB-2 cTropnT-<0.01 proBNP-2738* ___ 01:20PM BLOOD Albumin-4.0 ___ 11:50PM BLOOD Calcium-9.7 Phos-3.4 Mg-2.0 ___ 01:34PM BLOOD Lactate-3.0* PERTINENT LABS: ___ 06:05AM BLOOD WBC-12.3* RBC-4.50* Hgb-11.6* Hct-36.1* MCV-80* MCH-25.8* MCHC-32.2 RDW-16.2* Plt ___ ___ 11:50PM BLOOD Glucose-128* UreaN-10 Creat-0.7 Na-134 K-4.7 Cl-92* HCO3-28 AnGap-19 ___ 06:05AM BLOOD Calcium-9.3 Phos-3.6 Mg-1.9 ___ 06:05AM BLOOD WBC-10.7 RBC-4.28* Hgb-11.2* Hct-34.4* MCV-80* MCH-26.2* MCHC-32.6 RDW-16.2* Plt ___ ___ 04:20PM BLOOD Glucose-190* UreaN-12 Creat-0.9 Na-133 K-4.0 Cl-92* HCO3-27 AnGap-18 ___ 04:20PM BLOOD Mg-2.2 ___ 06:05AM BLOOD WBC-9.9 RBC-4.41* Hgb-11.7* Hct-35.9* MCV-81* MCH-26.6* MCHC-32.7 RDW-16.4* Plt ___ ___ 06:05AM BLOOD Glucose-98 UreaN-12 Creat-1.0 Na-135 K-4.1 Cl-92* HCO3-31 AnGap-16 ___ 04:10PM BLOOD Mg-2.3 ___ 06:00AM BLOOD WBC-11.1* RBC-4.46* Hgb-11.6* Hct-35.5* MCV-80* MCH-26.0* MCHC-32.7 RDW-16.1* Plt ___ ___ 04:35PM BLOOD Glucose-151* UreaN-16 Creat-1.1 Na-133 K-3.5 Cl-88* HCO3-34* AnGap-15 ___ 04:35PM BLOOD Mg-2.3 ___ 06:00AM BLOOD WBC-10.0 RBC-4.60 Hgb-12.0* Hct-36.8* MCV-80* MCH-26.1* MCHC-32.6 RDW-16.0* Plt ___ ___ 06:00AM BLOOD WBC-10.0 RBC-4.60 Hgb-12.0* Hct-36.8* MCV-80* MCH-26.1* MCHC-32.6 RDW-16.0* Plt ___ ___ 04:40PM BLOOD Glucose-163* UreaN-18 Creat-0.9 Na-130* K-4.3 Cl-88* HCO3-33* AnGap-13 DISCHARGE LABS: ___ 04:50AM BLOOD WBC-9.5 RBC-4.61 Hgb-12.1* Hct-36.8* MCV-80* MCH-26.2* MCHC-32.8 RDW-15.9* Plt ___ ___ 12:30PM BLOOD Glucose-300* UreaN-18 Creat-1.0 Na-132* K-4.5 Cl-88* HCO3-35* AnGap-14 ___ 12:30PM BLOOD Mg-2.3 ANTICOAGULATION: ___ 06:05AM BLOOD ___ PTT-39.3* ___ ___ 06:05AM BLOOD ___ PTT-39.9* ___ ___ 06:05AM BLOOD ___ PTT-41.0* ___ ___ 06:00AM BLOOD ___ PTT-38.4* ___ ___ 06:00AM BLOOD ___ PTT-38.8* ___ ___ 06:00AM BLOOD ___ PTT-38.1* ___ ___ 06:05AM BLOOD ___ PTT-36.7* ___ ___ 06:00AM BLOOD ___ PTT-36.7* ___ ___ 04:50AM BLOOD ___ PTT-36.6* ___ REPORTS: ___ Cardiovascular ECHO Findings This study was compared to the prior study of ___. Intravenous administration of echo contrast was used due to poor native endocardial border definition. LEFT ATRIUM: Mild ___. No ___ (best excluded by TEE). RIGHT ATRIUM/INTERATRIAL SEPTUM: Moderately dilated RA. LEFT VENTRICLE: Mild symmetric LVH with normal cavity size and global systolic function (LVEF>55%). Suboptimal technical quality, a focal LV wall motion abnormality cannot be fully excluded. No resting LVOT gradient. RIGHT VENTRICLE: Mildly dilated RV cavity. Normal RV systolic function. [Intrinsic RV systolic function likely more depressed given the severity of TR]. AORTA: Normal aortic diameter at the sinus level. Focal calcifications in aortic root. Mildly dilated ascending aorta. AORTIC VALVE: Normal aortic valve leaflets (3). No AS. No AR. MITRAL VALVE: Normal mitral valve leaflets. No MVP. Mild to moderate (___) MR. ___ VALVE: Normal tricuspid valve leaflets. Moderate to severe [3+] TR. Moderate PA systolic hypertension. Given severity of TR, PASP may be underestimated due to elevated RA pressure. PULMONIC VALVE/PULMONARY ARTERY: Normal pulmonic valve leaflet. No PS. Physiologic PR. PERICARDIUM: No pericardial effusion. GENERAL COMMENTS: Suboptimal image quality - poor echo windows. Suboptimal image quality - patient unable to cooperate. The rhythm appears to be atrial fibrillation. Conclusions The left atrium is mildly dilated. No left atrial ___ seen (best excluded by transesophageal echocardiography). The right atrium is moderately dilated. There is mild symmetric left ventricular hypertrophy with normal cavity size and global systolic function (LVEF>55%). Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. The right ventricular cavity is mildly dilated with normal free wall contractility. [Intrinsic right ventricular systolic function is likely more depressed given the severity of tricuspid regurgitation.] The ascending aorta is mildly dilated. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild to moderate (___) mitral regurgitation is seen. Moderate to severe [3+] tricuspid regurgitation is seen. There is moderate pulmonary artery systolic hypertension. [In the setting of at least moderate to severe tricuspid regurgitation, the estimated pulmonary artery systolic pressure may be underestimated due to a very high right atrial pressure.] There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Right ventricular cavity dilation with preserved systolic function. Moderate to severe tricuspid regurgitation. Pulmonary artery hypertension. Mild symmetric left ventricular hypertrophy with preserved global systolic function. Mild-moderate mitral regurgitation. Dilated ascending aorta. Compared with the prior study (images reviewed) of ___, the severity of tricuspid regurgitation has increased. ___BD & PELVIS W/O CON FINDINGS: There is a moderate pleural effusion on the right and a trace effusion on the left with associated atelectasis. The visualized portions of the heart and pericardium are remarkable for coronary artery disease and mild cardiomegaly. Diffuse anasarca is also apparent. Evaluation of the liver is limited in the absence of intravenous contrast. However, there is obvious hypertrophy of the caudate lobe along with a mildly shrunken appearance suggestive of cirrhosis. The spleen is normal in size. There are no gastroesophageal varices. The gallbladder is absent. The pancreas is atrophic. There is no hydronephrosis or nephrolithiasis. The stomach and small bowel are unremarkable. Low volume ascites is noted. There is no evidence of obstruction. There is no free intraperitoneal air. CT PELVIS: The appendix is not definitely visualized. The colon, rectum, seminal vesicles, and prostate are normal. The urinary bladder is collapsed and contains a Foley catheter. There is no pelvic lymphadenopathy. OSSEOUS STRUCTURES: There is no lytic or blastic lesion worrisome for malignancy. Again seen are anterior wedge deformities of the lumbar spine and prominent anterior osteophytes. IMPRESSION: 1. No evidence of obstruction. 2. Low volume ascites, bilateral pleural effusions, anasarca, and hypertrophy of the left lobe of the liver are suggestive of hepatic congestion and chronic liver disease. No splenomegaly. ___ Imaging CHEST (PA & LAT) FINDINGS: PA and lateral views of the chest. There is a new large right pleural effusion with adjacent atelectasis. There is also new moderate left pleural effusion. There is increased opacity throughout both lungs, most consistent with pulmonary edema. The heart is not well evaluated due to the adjacent effusions. There are aortic knob calcifications. No pneumothorax. IMPRESSION: New large right and moderate left pleural effusions with pulmonary edema. ___ Cardiovascular ECG Atrial fibrillation with ventricular rate of 54 beats per minute. Inferior wall myocardial infarction of indeterminate age. Right bundle-branch block. Left axis deviation. Compared to the previous tracing of ___ atrial fibrillation persists but the ventricular rate has decreased markedly. Brief Hospital Course: Acute-on-chronic diastolic congestive heart failure: The patient has known diastolic congestive heart failure, and was admitted for shortness of breath in the setting of increased lower extremity swelling and abdominal girth. His most recent outpatient weight was 236.4 lbs on ___. On admission, the patient was significantly volume-overloaded with pulmonary edema, pleural effusions, ascites, pitting edema of bilateral extremities. He denied medication noncompliance and dietary indiscretion prior during this time. He also denied any chest pain, palpitations, and syncope. A transthoracic echocardiogram on ___ was notable for a small hypertrophic left ventricle and significant tricuspid regurgitation. He was treated by a furosemide bolus followed by a furosemide drip augmented with metolazone on several days for a diuresis goal of total body balance of -3 liters/day. The diuresis was complicated by asymptomatic hypotension with systolic blood pressures to ___ (see below), and hyponatremia (see below). At the time of admission, his weight was 107kg. At discharge, his weight was 92kg and he was without shortness of breath and lower extremity edema. Shortness of breath: The patient's shortness of breath was treated by azithromycin and ceftriaxone given a concern of infection. However, on admission to the Cardiology service, his shortness of breath with radiologic pulmonary edema and bilateral pleural effusions was attributed to fluid overload in the setting of acute-on-chronic congestive heart failure. The patient was afebrile and without productive cough. The patient's shortness of breath resolved with diuresis. Left lower extremity erythema: On admission, the patient was found to have hyperpigmentation of bilateral lower extremities consistent with chronic venous stasis dermatitis with overlying warmth and tenderness over her left lower extremity that was concerning for cellulitis. For this, he was treated with a 7 day course of Keflex ___. The erythema and tenderness of the patient's left lower extremity improved on Keflex and diuresis. Atrial fibrillation: The patient has a CHADS2 score of 3, and was anticoagulated on warfarin on admission. Throughout this admission, he was continued on his home dose of coumadin, with therapeutic INRs ___ during this admission. He was continued on his home metoprolol for rate control, which was held on a few occasions for low blood pressures during diuresis (see below). Hypertension: The patient was normotensive on admission, and home angiotension receptor blocker and beta blocker were continued. Over the course of diuresis, the patient was occasionally hypotensive to systolic blood pressures of ___ without any symptoms. His home losartan was discontinued in this setting. Abdominal distention/Ascites: The patient had abdominal distention on admission with an abdominal imaging that showed new, minimal ascites. This was thought likely due to portal hypertension in the setting of a congestive heart failure exacerbation. Throughout the hospitalization, the patient had a benign abdominal exam and his liver function tests remained within normal limits. Given the patients minimal ascites, paracentesis was deferred during this admission. TRANSITIONAL ISSUES: - The patient's angiotensin receptor blocker was held during this admission for low blood pressure in the setting of diuresis. Please reconsider starting ___ if blood pressure tolerates. - No pending results - ___ Abd CT showed "hypertrophy of the caudate lobe along with a mildly shrunken appearance suggestive of cirrhosis." - The patient remained full code throughout this hospitalization Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 20 mg PO DAILY 2. Docusate Sodium 100 mg PO BID:PRN constipation 3. Furosemide 40 mg PO DAILY 4. GlipiZIDE 10 mg PO BID 5. MetFORMIN (Glucophage) 1000 mg PO BID 6. Metoprolol Succinate XL 100 mg PO QAM 7. Metoprolol Succinate XL 50 mg PO QPM 8. Warfarin 2.5 mg PO DAILY16 9. Losartan Potassium 50 mg PO DAILY 10. Clotrimazole Cream 1 Appl TP BID Discharge Medications: 1. MetFORMIN (Glucophage) 1000 mg PO BID 2. GlipiZIDE 10 mg PO BID 3. Clotrimazole Cream 1 Appl TP BID 4. Warfarin 2.5 mg PO DAILY16 5. Docusate Sodium 100 mg PO BID:PRN constipation 6. Atorvastatin 20 mg PO DAILY 7. Metoprolol Succinate XL 50 mg PO QAM RX *metoprolol succinate 25 mg 2 tablet extended release 24 hr(s) by mouth Every morning Disp #*60 Tablet Refills:*5 8. Metoprolol Succinate XL 25 mg PO QPM RX *metoprolol succinate 25 mg 1 tablet extended release 24 hr(s) by mouth every night Disp #*30 Tablet Refills:*5 9. Torsemide 40 mg PO DAILY Start: ___, First Dose: Next Routine Administration Time RX *torsemide 20 mg 2 tablet(s) by mouth Once a day Disp #*60 Tablet Refills:*5 10. Outpatient Physical Therapy Rolling walker For gait training/transfer training For lifetime Diagnosis: Congestive Heart Failure Prognosis: Good Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnosis: acute diastolic congestive heart failure Secondary diagnoses: cellulitis, atrial fibrillation Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure to take care of you during your hospitalization. You were admitted to ___ for shortness of breath, leg and abdominal swelling. You were found to significant excess fluid in your lungs and your body because of "heart failure," decreased pumping of your heart. You were treated with intravenous medicines to help you get rid of this excess fluid. In total, you lost 35 lbs (16kg) of fluid. At the time of discharge, your weight was 200 lb (91kg). Weigh yourself every morning, call MD if weight goes up more than 3 lbs. You also had redness and left lower leg that was concerning for infection. You completed a 7 day course of antibiotics. Your medications and follow-up appointments are summarized below. Followup Instructions: ___
10763687-DS-19
10,763,687
28,711,626
DS
19
2207-07-16 00:00:00
2207-07-16 15:38:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Levofloxacin Attending: ___. Chief Complaint: Jaundice, anorexia Major Surgical or Invasive Procedure: ERCP History of Present Illness: Mr. ___ is a ___ year old man with dementia, a-fib (no longer on warfarin), HFpEF (LVEF >60%), IDDM2, history of cholecystectomy, CBD stricture (s/p stent ___ w/ "atypical" brushings), HLD and HTN who was brought in by his son for poor PO intake for 3 days and nausea. Per son, patient has been only taking minimal PO intake for several days, and has been vomiting very small amounts of food when he eats. He reports weight loss over the past few weeks, but is unable to quantify it. He has had dark urine and light colored loose stools over the past few days. He denies fevers, chills, abdominal pain, chest pain, shortness of breath. 10 point review of systems is otherwise negative. In the ED, VS were 98.3, 80, 102/59, 16, 95% on RA. He was found to have tbili 12.2, ALT/AST 128/74 and ALP 386. ERCP was notified of his admission, with plan for ERCP later in the day. He was given ceftriaxone/flagyl and admitted to medicine. Past Medical History: - CBD stricture s/p stent ___ (brushings w/ only "atypical" cells) - Heart failure w/ preserved EF - Atrial fibrillation currently off warfarin - NIDDM - Hyperlipidemia - Hypertension - Elevated PSA - Peripheral vascular disease/DVT - Cataracts - Memory Impairment - Sleep Apnea SURGICAL HISTORY - Status post tib/fib fracture in ___, R leg. - Status post open cholecystectomy Social History: ___ Family History: The patient's parents died a long time ago. He does not report any family history of DM, cancer. He has two siblings who are alive but he does not know about their health. Physical Exam: =============== DISCHARGE EXAM: =============== Vital signs: 98, 113/68, 54, 20, 98% on RA HEENT: AT/NC, EOMI, R cataract, scleral icterus improved, MMM, dentures, supple neck, no LAD Skin: Jaundice improving, warm and well perfused CV: Distant heart sounds, RRR, normal S1/S2, no audible m/r/g Lungs: Clear to auscultation bilaterally Abd: Non-tender, non-distended, no rebound/guarding on deep palpation, no asterixis Ext: 1+ edema bilateral lower extremities, 2+ distal pulses Neuro: Oriented only to self (baseline), no focal deficits Pertinent Results: ___ --------- BMP: 139 | 99 | 14 --------------< 60 3.8 | 28 | 1.0 Ca: 8.2 Mg: 2.1 P: 3.1 ALT: 47 AP: 363 Tbili: 3.2 Alb: 2.5 AST: 55 CBC: 21.4 > 9.7/30.3 < 695 ___: 19.2 PTT: 45.3 INR: 1.7 ___ --------- Lactate:1.7 ICTERIC SPECIMEN BMP: 130 93 28 AGap=17 ---|----|---< 194 3.3 23 1.3 CBC: 26.2 > 10.9/33.2 < 485 Ca: 8.7 Mg: 2.0 P: 3.1 ALT: 128 AP: 386 Tbili: 12.2 Alb: 2.9 AST: 74 LDH: Dbili: 9.7 TProt: ___: Lip: 6 ___: 20.6 PTT: 30.9 INR: 1.9 RUQ ultrasound: --------------- 1. Metal stent within the common bile duct which measures 11 mm, unchanged from prior. There is no intrahepatic biliary dilatation; however, there is no pneumobilia which raises the possibility of stent obstruction. 2. 2.5 cm hypoechoic ill-defined lesion within segment 8 of the liver which is incompletely characterized. 3. Cirrhotic liver morphology with sequela of portal hypertension including splenomegaly. 4. Large right pleural effusion. ERCP (___): --------------- Gastric deformity was noted with a tortuous lumen and J-shape. •Limited exam of the duodenum showed mucosal edema. •Evidence of a previous sphincterotomy was noted in the major papilla. •A metal stent placed in the biliary duct that migrated distally was found in the major papilla. It was entirely occluded by debris and pus. This was removed via snare. •Cannulation of the biliary duct was successful and superficial with a sphincterotome using a free-hand technique. •On cholangiogram, a single stricture that was 20 mm long was once again seen at the lower third of the common bile duct with post-obstructive dilation noted. •An RX Extractor Pro balloon was used to sweep the ducts. Multiple sweeps were performed which revealed copious debris and pus. •A ___ Wallflex Fully Covered Metal Stent (REF ___, LOT ___ 10cm by 60mm biliary stent was placed successfully with excellent biliary drainage noted endoscopically. Recommendations: •NPO overnight with aggressive IV hydration with LR at 200 cc/hr •If no abdominal pain in the morning, advance diet to clear liquids and then advance as tolerated •Continue with antibiotics for sepsis •Follow-up with Dr. ___ as previously scheduled. •Follow for response and complications. If any abdominal pain, fever, jaundice, gastrointestinal bleeding please call ERCP fellow on call ___ Brief Hospital Course: Mr. ___ is a ___ year old man with dementia, a-fib (no longer on warfarin), HFpEF (LVEF >60%), IDDM2, history of cholecystectomy, CBD stricture (s/p stent ___ w/ "atypical" brushings), HLD and HTN who was brought in by his son for poor PO intake for 3 days and nausea, found to have cholangitis due to migrated biliary stent. # Cholangitis / hyperbilirubinemia / migrated biliary stent / bacteremia: Patient found to have elevated bilirubin and LFTs. Underwent ERCP that showed metal stent placed in the biliary duct had migrated distally and was found in the major papilla. It was entirely occluded by debris and pus. It was removed and replaced with new metal stent. Course complicated by positive blood cultures growing citrobacter freundii and strep anginosus. He will complete a 14 day course of ceftriaxone 2g q24h. His LFTs improved steadily throughout the admission. # Leukocytosis: Patient had a persistent leukcytosis that was only partially improved at the time of discharge from 26 to 21. Symptoms were resolved, source control was achieved, and that he was on appropriate antibiotic therapy. He should have follow-up labs as an outpatient to ensure his leukocytosis continues to improve. # Acute renal failure: Creatinine initially 1.3 up from baseline of 1. Likely in the setting of decreased PO intake. Resolved with IVF and holding initial doses of diuretic. His home diuretic was resumed and he tolerated it well with stable renal function. # Heart failure with preserved ejection fraction: Appeared euvolemic on admission. - Torsemide 60mg qAM, 40mg qPM - Continued ASA 81 # IDDM2: Given decreased PO intake on admission, his home glargine dose was decreased and he was covered with sliding scale insulin. He can resume his home dose of insulin now that he has an improved appetite. If his appetite decreases as an outpatient, consider decreasing glargine dose. # OSA: - Continued CPAP. TRANSITIONAL ISSUES: [ ] Check CBC, BMP and LFTs at ___ appointment on ___ [ ] Continue ceftriaxone until ___ [ ] Consider outpatient palliative care involvement [ ] If leukocytosis does not resolve, please evaluate for other possible sources of infection if appropriate. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 50 mg PO QAM 2. Metoprolol Succinate XL 25 mg PO QPM 3. Multivitamins 1 TAB PO DAILY 4. Torsemide 60 mg PO QAM 5. Aspirin EC 81 mg PO DAILY 6. FoLIC Acid 1 mg PO DAILY 7. clotrimazole-betamethasone ___ % topical bid 8. Potassium Chloride 20 mEq PO DAILY 9. Torsemide 40 mg PO QPM 10. Atorvastatin 20 mg PO QPM 11. Glargine 32 Units Breakfast 12. Acetaminophen 325-650 mg PO Q6H:PRN pain/fever Discharge Medications: 1. CeftriaXONE 2 gm IV Q24H Duration: 14 Days RX *ceftriaxone in dextrose,iso-os 2 gram/50 mL 2 g IV Q24H Disp #*14 Intravenous Bag Refills:*0 2. Aspirin EC 81 mg PO DAILY 3. Glargine 32 Units Breakfast 4. Metoprolol Succinate XL 50 mg PO QAM 5. Metoprolol Succinate XL 25 mg PO QPM 6. Multivitamins 1 TAB PO DAILY 7. Torsemide 60 mg PO QAM 8. Acetaminophen 325-650 mg PO Q6H:PRN pain/fever 9. Atorvastatin 20 mg PO QPM 10. clotrimazole-betamethasone ___ % topical bid 11. FoLIC Acid 1 mg PO DAILY 12. Potassium Chloride 20 mEq PO DAILY 13. Torsemide 40 mg PO QPM Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Common bile duct stricture Migrated biliary stent Cholangitis Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you. You were admitted with nausea and elevated bilirubin levels. We found that the stent that had been placed last year in your bile duct had moved. This caused a blockage and led to an infection. A new stent was placed in your bile duct. The infection in your blood is being treated with IV antibiotics, which you will continue until ___. If you have any fevers, abdominal pain, or other concerning symptoms, please contact your doctor or return to the hospital. Please make sure to follow-up with your physician at your scheduled visit. You will need to have blood tests checked at that time. Thank you for choosing ___ for your care. ___, M.D. Followup Instructions: ___
10764017-DS-23
10,764,017
24,001,931
DS
23
2188-04-25 00:00:00
2188-04-25 20:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Fever, tachycardia ___ Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ year old young woman discharged on ___ from ___ after a prolonged hospital admission for anoxic brain injury secondary to EtOH withdrawal seizure with hospital course complicated by acute renal failure s/p temporary hemodialysis, hospital acquired pneumonia, urinary tract infection, tracheostomy and PEG tube placement, c.diff colitis, as well as cyclical fevers, tachycardia, tachypnea, and hypertension attributed to paroxysmal autonomic instability with dystonia, who now presents from her rehabilitation facility with fever and tachycardia, found to have a new left lower lobe pneumonia. At the outside facility, she was noted to be progressively hypoxic with a temperature of 106 (usual is not higher then 103 in setting of autonomic dysfunction), tachycardia to 180. CT abdomen (performed to assess for complications of C. diff) was concerning for a new left lower lobe infiltrate consistent with pneumonia. She was given IV fluids, ativan, and was externally cooled. She was also started on vancomycin, cefepime, and ciprofloxacin given her history of multi-drug resistant enterobacter in the lungs. Labs were notable for lactate 3.3 and WBC 30. Per report, HR improved from 180s to 140s and O2 sats were stable without ventilator. Of note, Ms. ___ was admitted to ___ from ___ with severe anoxic brain injury secondary to alcohol withdrawal seizure. As a result, patient has paroxysmal autonomic instability with dystonia, causing transient periods of fevers, tachycardia, hypertension, tachypnea, and diaphoresis. In the ED, patient was persistently tachycardic and required a labetolol drip. In the ED, initial vitals: 98.6 150 132/89 22 96% TM - Exam notable for: Rhonchi diffusely. No [appreciable] abdominal pain. Dry mucous membranes - Labs notable for: WBC 27.3, plts 460, Cl 114 - Imaging notable for: LLL PNA (OSH) - Pt given: IV LORazepam 1 mg PO/NG Baclofen 10 mg PO/NG Propranolol 80 mg PO CloNIDine .4 mg PO/NG Acetaminophen 1000 mg IV Labetalol 20 mg IV CefePIME 2 g IV Vancomycin 1000 mg PO/NG Baclofen 10 mg PO CloNIDine .4 mg PO Dantrolene Sodium 25 mg PO/NG Propranolol 80 mg IV Ciprofloxacin 400 mg PO/NG Acetaminophen 1000 mg IV LORazepam 1 mg IVF NS 1000 mL PO Dantrolene Sodium 25 mg PO/NG Baclofen 10 mg PO CloNIDine .4 mg IV CefePIME (2 g ordered) Started IV Ciprofloxacin Started in Other Location 400 PO/NG Vancomycin Oral Liquid Administered in Other Location - Vitals prior to transfer: 99.8 58 101/48 19 100% RA On the floor, patient appears comfortable. Laying in bed with trach mask. No increased WOB, not diaphoretic. Not responsive to voice. Father at bedside, states that current condition is worse than prior to discharge from ___. Past Medical History: Anxiety/Depression Social History: ___ Family History: No pertinent family history Physical Exam: ADMISSION PHYSICAL EXAM: ====================== VITALS: 98.8 114 / 66 61 19 100 40% TM General: Lying in bed, trach mask in place, breathing comfortably HEENT: Normocephalic, atraumatic. Trach in place with trach mask. CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation on the anterior surface, no wheezes, rales, rhonchi Abdomen: Soft, no appreciable tenderness to palpation, non-distended, bowel sounds present, no organomegaly, no rebound or guarding Ext: Several severe flexion contractures, worst R elbow, also significant contractures at bilateral wrists and L elbow. Less severe involvement of bilateral fingers. Plantar flexion contractures bilaterally. Skin: Warm, dry, no rashes or notable lesions. Neuro: Opens eyes to voice, does not track, does not blink to threat, does not respond to commands, no spontaneous movements of the upper or lower extremities DISCHARGE PHYSICAL EXAM: ====================== Vitals: T99.6 O BP 96 / 47 L Lying HR96 RR18 o2100 TM GENERAL: Young female lying in bed, mouth open. Unable to follow commands, does not interact. HEENT: NC/AT, eyes open, not tracking. CARDIAC: Regular rate and rhythm, S1S2, no murmurs, LUNGS: coarse transmitted upper airway sounds on anterior exam, not tachypneic while in room, secretions from trach ABDOMEN: Soft, +BS, no rebound or guarding. PEG c/d/I. EXTREMITIES: Warm, no edema, b/l upper extremities flexed and with increased tone, lower extremities contracted. Pulses intact. Pertinent Results: ADMISSION: ========== ___ 08:40PM BLOOD WBC-27.3*# RBC-3.78* Hgb-12.2 Hct-37.0 MCV-98 MCH-32.3* MCHC-33.0 RDW-12.7 RDWSD-45.1 Plt ___ ___ 08:40PM BLOOD Neuts-84.4* Lymphs-8.1* Monos-6.8 Eos-0.0* Baso-0.2 Im ___ AbsNeut-23.02*# AbsLymp-2.21 AbsMono-1.86* AbsEos-0.00* AbsBaso-0.05 ___ 08:40PM BLOOD Glucose-104* UreaN-21* Creat-0.6 Na-149* K-3.6 Cl-109* HCO3-23 AnGap-17 ___ 08:40PM BLOOD ALT-33 AST-30 AlkPhos-83 TotBili-0.4 ___ 04:35AM BLOOD Calcium-9.4 Phos-2.1* Mg-1.9 ___ 04:45AM BLOOD freeCa-1.25 ___ 08:40PM BLOOD Lactate-3.4* DISCHARGE: ========== ___ 04:32AM BLOOD WBC-10.8* RBC-3.70* Hgb-11.7 Hct-35.0 MCV-95 MCH-31.6 MCHC-33.4 RDW-11.9 RDWSD-40.7 Plt ___ ___ 04:32AM BLOOD Glucose-108* UreaN-32* Creat-0.4 Na-144 K-4.0 Cl-99 HCO3-30 AnGap-15 ___ 04:32AM BLOOD Calcium-12.6* Phos-3.5 Mg-2.3 IMAGING: ======== CXR ___: There is increased opacification at the left lower lung and obscuration at the retrocardiac border consistent with left lower lung pneumonia. Tracheostomy tube is midline trachea and in place. Cardiomediastinal silhouette is unchanged. There is no pneumothorax. CTA CHESTStudy Date of ___ 1. No pulmonary embolism. 2. Fluid/debris is noted within the segmental and subsegmental branches of the right lower lobe. CHEST (PORTABLE AP) Study Date of ___ Compared to chest radiographs ___ through ___. New areas of subsegmental atelectasis right lower lobe, could be due to aspiration, but there is no good evidence for pneumonia. Heart size normal. No pleural abnormality. Tracheostomy tube midline. MICROBIOLOGY: ============= ___ blood culture x1: negative ___ MRSA: negative ___ and ___ sputum cultures: contaminated ___ blood culture x2: negative ___ urine culture: negative ___ blood culture x2: negative ___ 10:00 pm URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH FECAL CONTAMINATION. UA ___ 10:00PM URINE Color-Yellow Appear-Hazy* Sp ___ ___ 10:00PM URINE Blood-NEG Nitrite-NEG Protein-30* Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-MOD* ___ 10:00PM URINE RBC-46* WBC-12* Bacteri-FEW* Yeast-NONE Epi-57 TransE-<1 ___ 10:00PM URINE CastHy-5* ___ blood culture x2: negative ___ blood culture x1: negative ___ 10:17 am URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: ENTEROBACTER AEROGENES. 10,000-100,000 CFU/mL. Piperacillin/Tazobactam test result performed by ___ ___. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROBACTER AEROGENES | CEFEPIME-------------- S CEFTAZIDIME----------- =>64 R CEFTRIAXONE----------- 16 R CIPROFLOXACIN--------- 1 I GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 128 R PIPERACILLIN/TAZO----- R TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S UA ___ 10:17AM URINE Color-Yellow Appear-Hazy* Sp ___ ___ 10:17AM URINE Blood-NEG Nitrite-POS* Protein-30* Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG* ___ 10:17AM URINE RBC-9* WBC-102* Bacteri-MANY* Yeast-FEW* Epi-1 TransE-<1 ___ 10:17AM URINE CastHy-15* CastCel-3* Brief Hospital Course: PLEASE NOTE THIS PATIENT JUST HAD AN EXTENSIVE HOSPITALIZATION ___ AND FOR CONVENIENCE THE PREVIOUS HOSPITAL COURSE IS COPIED BELOW. That discharge summary in its entirety will also be provided. CODE STATUS & CONTACT: ====================== FULL *If change in clinical status, both her Mother and Father should be called - Father/GUARDIAN/HCP: Mark ___ - Mother: ___ ___ TRANSITIONAL ISSUES: ==================== [ ] Please discontinue PO vancomycin after ___ [ ] Neurology followup appointment scheduled for ___ 02:30p with ___ at ___. [ ] She should have a CBC and Chem 10 performed within the first 3 days of transfer to establish baseline labs, ensure no ___ or asymptomatic elevation in WBC count. Respiratory Care: ----------------- -Tracheostomy care: See attached protocols. Trach is specifically a Portex Perfit #7 -Suctioning requirements: She has a strong cough but will require deep suctioning PRN (you will be able to hear wet cough that indicates need for suctioning. Typically ___ times per day. -Supplemental oxygen should be mixed with humidification continuously for patient comfort and to prevent excessive dryness of oropharynx -Supplemental oxygen stable at 35% via trach mask -Respiratory therapy noted her trach/pilot balloon to be stiff, but found that it was functioning well still. This was discussed with the respiratory therapy supervisor and IP, and it was felt appropriate to not exchange it. The only concern is that it may not form a tight seal if she needs ventilation, which she did not require at all during this hospitalization. Nursing Care: ------------- -Reposition Q2H. -Skin precautions, she has no significant current skin breakdown. She has an early pressure sore on her sacrum -She is completely incontinent. Please do not use briefs as this will cause skin breakdown. She will require voiding checks w/ cleaning frequently. -All meds are to be administered crushed through G-tube. NO PILLS or FEEDING BY MOUTH. -She requires regular mouth care ___ times a day and more frequently as necessary -Please use fan and maintain room at comfortably cool temperature, to help her regulate body temperature. Physical Therapy: ------------------ -The most important therapy is ROM exercises with arms and legs to prevent further contracture. -Please reposition & move OOB to chair 3x/day w/ overhead lift. -Please limit sitting time to 1 hour on air cushion as she is unable to reposition herself independently. -Apply multi-podus boots to both ___ with frequent skin checks to prevent foot drop Diet: ----- Continuous tubefeeding: Nepro; Full strength Tube Type: Percutaneous gastrostomy (PEG); Placement confirmed. Starting rate:40 ml/hr; Do not advance rate Goal rate:40 ml/hr Residual Check:Q4H Hold feeding for residual >= :200ml Flush w/ 30 mL water Per standard Free water amount: 180 mL; Free water frequency:Q6H Labs: ----- - She should have a CBC and Chem 10 performed within the first 3 days of transfer to establish baseline labs, ensure no ___ or asymptomatic elevation in WBC count. Medication Administration: ****All meds are to be administered crushed through G-tube. NO PILLS or FEEDING BY MOUTH.**** - Timing of medications is VERY IMPORTANT, because in the past she has had vital sign abnormalities when medication administration was delayed. VERY IMPORTANT CONTINGENCIES FOR THIS PATIENT: Ms. ___ suffered a very severe brain injury. Secondary to this she has extreme autonomic dysfunction consistent with a syndrome called paroxysmal autonomic instability with dystonia (PAID). She has transient periods of fevers, tachycardia, hypertension, tachypnea, diaphoresis, and general unwell appearance. It can be challenging to distinguish these episodes from infection. A few principles in the way we have managed fevers: # When she has a fever: - Start with techniques such as bedside fan, cold wash cloths, and administer standing Tylenol/Ibuprofen as prescribed. Please do not give an extra Tylenol outside of her scheduled doses as in the long term that could cause liver toxicity. If a cooling blanket is available, that may be a good option for her. - Assess for severity: She frequently has fevers up to 101, sometimes to 102, but rarely to 103. Fever 103 or higher tends to increase our suspicion for infection. - Assess for frequency: Intermittent fevers, daily or QOD, tend to not be of concern unless accompanied by other signs of infection. Consistent fevers greater than 2 days in duration tend to raise our suspicion for infection even in the absence of signs/symptoms. # In addition to fever, other signs that could increase concern for infection: - WBC >/= 18k, though this is not always consistent. - Other abnormal vital signs such as persistent tachycardia out of proportion to what we expect with her fever - Diarrhea, grimacing with abdominal palpation - Hypoxia # If concerned for infection, would obtain blood cultures, urine cultures and UA (which may require straight cath), CBC with differential, and CXR. OTHER: - If hypotensive, please note, sometimes due to diaphoresis the automated cuff is unable to read her blood pressure. In this case, please try a Doppler or Manual pressure on her arms. She has not had hypotension or lethargy during this admission, so these may be signs of infection in her. - If tachypnea with RR > 40, please suction her. You can give her 1 mg of Ativan in addition to her scheduled dose which will help her respiratory rates. - If hypertensive, consider treatment if systolic blood pressures > 180. If so, you can give ONE of her blood pressure medications early (this would be propranolol or clonidine). If she remains with blood pressures > 180, recommend short-term anti-hypertensive therapy with labetalol 200mg if her heart rate will tolerate. ============================= ___ HOSPITAL SUMMARY: ============================= Ms. ___ is a ___ with h/o ETOH use disorder & depression c/b one suicide attempt, who suffered possible cardiac arrest at home and was admitted to the MICU for post-arrest care. She suffered diffuse anoxic brain injury, respiratory failure, & anuric renal failure requiring dialysis. In the MICU, she was treated with targeted temperature management and empiric midazolam infusion for possible alcohol withdrawal seizures. She remained comatose and was found to have diffuse anoxic brain injury. Neurology was consulted for prognostication and stated that patient had a very limited chances of making meaningful recovery. Her MICU course was complicated by multiple infections including HSV-1 infection, sinusitis, and ventilator-associated pneumonia. Once stabilized, the patient had a tracheostomy and percutaneous endoscopic gastrostomy placed and was transferred to the General Medicine service for further stabilization. Her course was further complicated by persistent fevers, hypertension, tachycardia, & tachypnea. She underwent extensive work-up for these episodes which were ultimately thought to represent the post-anoxic brain injury syndrome known as paroxysmal autonomic instability w/ dystonia. Neurology was re-consulted for medical management of this autonomic instability and she was started on multiple neurologic medications which were titrated in order to achieve vital sign stability and patient comfort. These medications are clonidine, propranolol, bromocriptine, baclofen and dantrolene. She developed diarrhea which tested positive for C. difficile and she will continue treatment with vancomycin until ___. Once her vitals had stabilized and there was minimal concern for ongoing infection aside from C. difficile, it was felt that ___ care should continue at a skilled nursing facility. ACUTE ISSUES ADDRESSED: ======================= # Diffuse anoxic brain injury: # Acute respiratory failure: # Paroxysmal autonomic instability with dystonia: Initial presentation of being found down with described acute respiratory event, concern for possible cardiac arrest (although unclear if she had a pulse but did reportedly require brief CPR and no other medications) versus seizure (possibly from delirium tremens ISO acute ETOH w/d). Following arrest, patient underwent cooling w/ subsequent re-warming. Neurology was consulted for prognostication, & initial MRI Head ___ showed diffuse anoxic brain injury. Repeat MRI on ___ showed progressive worsening of anoxic brain injury. She notably did have some brainstem activity (breathing on own, brainstem reflexes present, nonpurposeful movements of extremities). For further Neurologic evaluation and prognostication, she underwent multiple EEGs which initially showed some activity to stimulation, but increasingly showed persistently diffuse slowing. Once initially stabilized, she underwent combined tracheostomy-PEG ___ & was transferred to the General Medicine Service for further stabilization. Throughout this time, the patient had intermittent periods of fevers (see below), tachypnea, tachycardia, diaphoresis, & HTN (see below). Neurology suggested that this could represent a central process ISO anoxic injury and could be a manifestation of the post-anoxic brain injury syndrome known as paroxysmal autonomic instability w/ dystonia (PAID). Neurology recommended medical management of this autonomic instability and she was started on multiple neurologic medications which were titrated in order to achieve vital sign stability and patient comfort. These medications are clonidine, propranolol, bromocriptine, baclofen and dantrolene (other medications trialed include amantadine [stopped b/c of worsening vital signs] & labetalol [changed to propranol for better BP control]). Per ___ ___ conversation with mother and father, they want to pursue all interventions with the hope that she will gain some responsiveness and be able to recognize them. Neurology stated that ultimate prognosis is guarded but cannot be fully known until 6 months - ___ years post injury. #Fevers: Initially patient febrile in the MICU with concerns for ongoing infection. She underwent treatment for various infections as detailed: -HSV-1: Oral cavity with ulcers and skin breakdown that were very severe, swab positive for HSV. Treated with acyclovir ___. -Sinusitis: Treated with clindamycin ___. -VAP: Initially for MSSA VAP with vancomycin & cefepime ___ – ___. BAL ___ showed Enterobacter aerogenes, treated w/ meropenem, then ciprofloxacin, (___). -UTI: Treated w/ nitrofurantoin ___. -UTI: Treated w/ ciprofloxacin ___. -C. difficile: Treated w/ vancomycin, to continue until ___. Ultimately, a thorough FUO work up was performed, including TTE w/o infection & CT C/A/P w/o source of infection. Following resolution of the above infections, patient has remained intermittently febrile w/ unstable vital signs and our conclusion along with Neurology is that this is a manifestation of PAID as above. # Hypertension: Hypertensive with SBPs >180 on admission. Initially required nitroglycerin drip and transitioned to a labetalol drip while in the ICU. Her blood pressure labiality is due to autonomic instability in the setting of anoxic brain injury. She was ultimately stabilized on a regimen of clonidine, amlodipine, & propranolol. # Severe C. difficile colitis: Patient had diffuse diarrhea ___, C. difficile toxin positing ___, started on PO vancomycin 125mg Q6H ___ - ___ (7 days after completion of latest course of antibiotic therapy for pneumonia). # Anuric renal failure: Initially patient presented with a large metabolic acidosis and evidence of renal failure thought likely ATN ___ inciting event. She underwent CVVH and HD per Nephrology throughout ICU stay. Renal function improved w/ last HD session on ___ and creatinine recovered and was normal on discharge. # Hypercalcemia: Non-ionized calcium intermittently > 11.0, PTH 27, VD 17. Ultimately concluded that this was due to contractures and immobility. Ionized calcium normal. Discussed case w/ ___ who recommended no intervention (specifically, no bisphosphonate therapy) w/ intermittent monitoring of ionized calcium. # Normocytic Anemia: Monitored, did not require transfusion. Normal on discharge. CURRENT HOSPITALIZATION SUMMARY ___: ============================================= Patient re-presented to OSH soon after discharge to rehab (per the above summary) with fever of 106, tachycardia to 180s, and LLL infiltrate on CT, was admitted to the medicine floor on IV antibiotics. # HAP: Rehab staff noted patient to have temperature of 106, tachycardia to 180. A CT abdomen (performed to assess for complications of C. diff) was concerning for a new left lower lobe infiltrate consistent with pneumonia. She was transferred to ___ for further care and started on IV vancomycin, cefepime & ciprofloxacin given a history of resistant Enterobacter in sputum. WBC was 27 on admission. The patient was admitted to the floor and maintained on IV antibiotics. ID was consulted for antibiotic recommendations and advice for any other work-up. IV vancomycin was d/c'd ___ given negative MRSA swab, ciprofloxacin was d/c'd ___ per ID recommendations. She was maintained on cefepime until ___ for a 7-day course of antibiotics for HAP. ID recommended no further work-up. # PAID/autonomic dysfunction Given frequent fevers, standing tylenol dosing was increased initially to 1g Q6H given breakthrough fevers, ultimately discharged with 800 mg Q6H to ensure a safe long-term dosage. Ibuprofen was added for further control of fevers and uptitrated to 600 mg Q6H, briefly discontinued due to ___, and restarted at 400 mg Q8H. She was started on ranitidine for GI protection due to plan for long-term NSAID use. She had a few episodes of bradycardia to <40 for which propranolol was held for a brief period, after which she became tachycardic and it was restarted with good effect. Dosing was not adjusted. CTA chest was obtained due to tachycardia, was negative for PE. She will have neurology followup as an outpatient. # Severe C. difficile: Completed a course of PO vancomycin treatment for severe c diff. ___, with last day ___ (7 days post PNA treatment). She received C diff PPX while undergoing treatment for UTI, to finish 7 days post-UTI treatment (last day ___. # UTI She was noted to have more frequent fevers than typical, with new leukocytosis to 18. Infectious workup was sent and revealing for UA consistent with infection. Initially treated with bactrim and nitrodantin based on previous culture data, narrowed to Bactrim based on urine culture growing ENTEROBACTER AEROGENES. She completed an 8 day course (___). # ___: Baseline Cr 0.2-0.6. Increased to 1.2 overnight ___. Thought prerenal i/s/o insensible losses from fevers and inadequate free water with tube feeds. ___ resolved with 1L IVF and increasing free water flushes. Had also recently received contrast for CTA to r/o PE. Ibuprofen was held, restarted upon resolution of ___. # Nutrition Per nutrition recommendation, she was transitioned from ___ to ___ tube feeds. She was titrated to goal. Please see above for current diet regimen. # Goals of Care # Disposition Family meeting was conducted with family, primary medical team and neurology this admission. Neurology had been consulted for re-prognostication and felt it was highly unlikely she would ever function independently, but felt that it would take 6 months to ___ years before definitive prognostication could occur. Family continues to hope for recovery and she is full code. With this goal in mind, an extensive search was conducted by case management to find the most suitable place for the patient given her complicated needs. LTAC level of care was thought the safest transition out of the hospital setting, with possibility to transition to SNF when possible. Of note, her father is her guardian/HCP. #Code: Full confirmed #HCP: Mark ___ Relationship: father Phone number: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO HS 2. CloNIDine 0.4 mg PO TID 3. Nystatin Oral Suspension 5 mL PO QID:PRN thrush 4. Polyethylene Glycol 17 g PO DAILY:PRN constipation 5. Senna 17.2 mg PO BID:PRN constipation 6. Thiamine 100 mg PO DAILY 7. FoLIC Acid 1 mg PO DAILY 8. Acetaminophen 1000 mg PO Q8H 9. Baclofen 10 mg PO TID 10. Bromocriptine Mesylate 5 mg PO BID 11. Dantrolene Sodium 25 mg PO QID 12. Heparin 5000 UNIT SC BID 13. Propranolol 80 mg PO Q6H 14. LORazepam 1 mg PO BID tachypnea 15. Vancomycin Oral Liquid ___ mg PO Q6H Discharge Medications: 1. Fish Oil (Omega 3) ___ mg PO BID 2. Ibuprofen 400 mg PO Q8H 3. Ranitidine 75 mg PO BID 4. Acetaminophen 800 mg PO Q8H 5. amLODIPine 10 mg PO HS 6. Baclofen 10 mg PO TID 7. Bromocriptine Mesylate 5 mg PO BID 8. CloNIDine 0.4 mg PO TID 9. Dantrolene Sodium 25 mg PO QID 10. FoLIC Acid 1 mg PO DAILY 11. Heparin 5000 UNIT SC BID 12. LORazepam 1 mg PO BID tachypnea 13. Polyethylene Glycol 17 g PO DAILY:PRN constipation 14. Propranolol 80 mg PO Q6H 15. Senna 17.2 mg PO BID:PRN constipation 16. Thiamine 100 mg PO DAILY 17. Vancomycin Oral Liquid ___ mg PO Q6H Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis: ================== fever Healthcare associated pneumonia Sepsis leukocytosis urinary tract infection Secondary Diagnosis: ==================== anoxic brain injury paroxysmal autonomic instability with dystonia tachypnea severe C. difficile normocytic anemia thrombocytosis Acute kidney Injury Hyponatremia Hypercalcemia Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Lethargic but arousable. Activity Status: Bedbound. Discharge Instructions: Dear Mr. ___ Mrs. ___, ___ you for choosing the ___ for your daughter's care. ___ was admitted with a fever and pneumonia. While she was in the hospital, we gave her IV antibiotics to treat her pneumonia and continued all of her other medications. Over the course of admission, she also developed a urinary tract infection. We gave her separate antibiotics to treat her urinary tract infection. Once ___ leaves the hospital, she will transition to an LTAC. At this facility she will continue to work with therapists and doctors who ___ continue to evaluate her and try to help her. We communicated with an accepting physician and the nursing director and told them about ___ care. We conveyed our perspectives on aspects of her care that are of particular concern, including fevers and managing her tracheostomy. She will be connected to outpatient neurology for after discharge. We wish your family the best. It was a pleasure caring for ___ and we will miss her. Your ___ Care Team Followup Instructions: ___
10764127-DS-14
10,764,127
26,051,300
DS
14
2131-01-18 00:00:00
2131-01-18 13:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Found down Major Surgical or Invasive Procedure: ___ RIGHT HUMERAL FRACTURE STATUS-POST OPEN REDUCTION AND INTERNAL FIXATION ___ LEFT SHOULDER FRACTURE STATUS-POST CLOSED REDUCTION History of Present Illness: ___ PMHx metastatic lung adenocarcinoma (diagnosed 7 months prior, thought to be second primary lung cancer) found down and unresponsive in his home. Last known contact was 16 hours prior. The patient lives alone and one of his brother entered the apartment by force when he went to check on the patient. The brother found the patient moaning and unresponsive with dried, ___, khaki-colored secretions. Initially transported by EMS to ___ whereupon he was sent to ___ out of concern for multiple orthopedic trauma given right humerus fracture and left shoulder fracture. The patient remained minimally responsive and has no recollection of the events preceding his loss of consciousness until he was post-op at ___. Upon arrival to ___, he was found to have HR in the 130s. EKG showing sinus tachycardia with TWI in lateral leads unchanged from previous EKG. Labs significant for wbc of 17, hct 27, platelets 172, Na 149, K 4.2, Cr 1.5, glucose 114. Imaging significant for CXR showing possible pneumonia, CT head and C-spine normal, and XR showing acute fracture of right humeral head. Upon arrival to ___ ED initial vs were: 98.0 128 127/79 20 100% Non-Rebreather. The patient was noted to be moaning and not responsive to commands. He was intubated given poor mental status. Labs were notable for a leukocytosis of 14.9 with 86% PMNS, Cr of 1.4 from an unknown baseline, CK of 3000, HCT of 26, lactate of 1.9, negative urine and serum tox screens. Head CT was negative. CT torso showed bilateral shoulder fractures, and opacities at the lower aspect of the left lung. Patient given ceftriaxone, vanc, levoquin. Review of systems: (Obtained later from the patient and his family). Denies alcohol, tobacco, or drug use. Past Medical History: Lung adenocarcinoma likely metastatic to the R adrenal (diagnosed ___, undergoing cisplatin and primetrexed (alimta) chemotherapy. Social History: ___ Family History: Mother- Lung cancer, alive. Father-Lung cancer, expired. Physical Exam: ON ADMISSION: ----------------- Vitals: 99.4 167/106, 112, 92% on FiO2 40%. General: intubated and sedated HEENT: Sclera anicteric, PEARL, OGT in place Neck: supple, JVP not elevated, Lungs: course breaths appreciated from anterior lung fields, R>L CV: sinus tachy, no MMG Abdomen: soft, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: foley in place Ext: warm, 1+ pulses, no edema Access: R port-a-cath: no edema, erythema or discharge from site Neuro: sedated, withdrawals all extremities from painful stimuli DISCHARGE PHYSICAL EXAM: Vitals- 98.5 176/61 81 16 95/RA I/O:1100+/2700 General- awake, alert, NAD HEENT- OMM, no lesions Neck- supple, JVP not elevated, no LAD Lungs- CTAB. No w/r/r. CV- Regular rate, regular rhythm, no m/r/g appreciated Abdomen- soft, nontender, BS+, no r/g/r GU- no foley Ext- WWP, RUE ACE bandage placed, LUE with immobilizer, both upper extremities neurovascularly intact Neuro- CNs2-12 intact, motor function grossly normal Pertinent Results: LABS ON ADMISSION: ___ 08:00PM BLOOD WBC-14.9* RBC-2.38* Hgb-8.6* Hct-26.3* MCV-110* MCH-35.9* MCHC-32.5 RDW-16.5* Plt ___ ___ 08:00PM BLOOD Neuts-85.7* Lymphs-8.4* Monos-5.1 Eos-0.6 Baso-0.2 ___ 08:00PM BLOOD ___ PTT-26.1 ___ ___ 08:00PM BLOOD Glucose-93 UreaN-32* Creat-1.4* Na-134 K-4.6 Cl-103 HCO3-22 AnGap-14 ___ 08:00PM BLOOD ALT-32 AST-71* CK(CPK)-3141* AlkPhos-57 TotBili-0.5 ___ 08:00PM BLOOD Lipase-9 ___ 08:00PM BLOOD Albumin-3.8 ___ 08:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 08:01PM BLOOD Lactate-1.9 ___ 08:39PM BLOOD Type-ART Rates-16/ Tidal V-550 PEEP-5 FiO2-100 pO2-497* pCO2-36 pH-7.42 calTCO2-24 Base XS-0 AADO2-183 REQ O2-40 Intubat-INTUBATED PERTINENT LABS: ___ 03:33AM BLOOD Calcium-8.3* Phos-3.8 Mg-1.4* ___ 03:33AM BLOOD Triglyc-140 ___ 03:33AM BLOOD CK-MB-18* MB Indx-0.3 ___ 06:45AM BLOOD CK-MB-3 cTropnT-<0.01 ___ 03:20PM BLOOD CK-MB-3 cTropnT-<0.01 ___ 06:45AM BLOOD calTIBC-161* Ferritn-980* TRF-124* ___ 08:00PM URINE Color-Yellow Appear-Hazy Sp ___ ___ 08:00PM URINE Blood-MOD Nitrite-NEG Protein-30 Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-TR URINE: ___ 08:00PM URINE RBC-9* WBC-10* Bacteri-FEW Yeast-NONE Epi-6 TransE-<1 ___ 08:00PM URINE bnzodzp-NEG barbitr-NEG opiates-NEG cocaine-NEG amphetm-NEG mthdone-NEG CSF: ___ 12:39AM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-1* Polys-0 ___ ___ 12:39AM CEREBROSPINAL FLUID (CSF) TotProt-27 Glucose-68 ___ 12:39AM CEREBROSPINAL FLUID (CSF) HERPES SIMPLEX VIRUS PCR-PND MICRO: BLOOD CX- URINE CX-NEG CSF GRAM STAIN/CX-NEG SPUTUM GRAM STAIN/CX-NEG IMAGING: EEG ___: FINDINGS: CONTINUOUS EEG: The background consisted of frontocentrally predominant ___ Hz activity superimposed on admixed irregular diffuse ___ Hz delta/theta activity. Significant low voltage frontally predominant beta activity is present. There are no epileptiform discharges or seizures. SPIKE DETECTION PROGRAMS: There were no automated spike detections. There were no epileptiform discharges. SEIZURE DETECTION PROGRAMS: There were no automated seizure detections. There were no electrographic seizures. QUANTITATIVE EEG: Trend analysis was performed with Persyst Magic Marker software. Panels included automated seizure detection, rhythmic run detection and display, color spectral density array, absolute and relative asymmetry indices, asymmetry spectrogram, amplitude integrated EEG, burst suppression ratio, envelope trend, and alpha delta ratios. Segments showing abnormal trends were reviewed and showed no focal asymmetries and no periods of increased rhythmicity. PUSHBUTTON ACTIVATIONS: There were no pushbutton activations. SLEEP: No structured sleep architecture was present. CARDIAC MONITOR: Showed a regular rhythm with a rate of approximately 110 bpm. IMPRESSION: This was an abnormal routine EEG study because of generalized background theta/delta slowing without focal features consistent with a moderate-severe encephalopathy of non-specific etiology. Significant admixed frontally predominant beta activity may be medication side effect. There were no epileptiform discharges or seizures. CXR ___: FINDINGS: Semi-upright portable AP view of the chest was provided. ETT tip resides approximately 4.6 cm above the carina. The NG tube courses into the left upper abdomen. The Port-A-Cath is unchanged with tip in the region of the mid SVC. There is volume loss in the left lung with evidence of prior left upper lobectomy with clips in the left mid to upper lung noted. Scarring in the right upper lung is present. There is no definite evidence for pneumonia or CHF. No large effusion or pneumothorax is seen. Cardiomediastinal silhouette is stable. Bony deformities in the left upper rib cage are unchanged, reflective of prior surgery. IMPRESSION: Appropriately positioned ET and NG tubes. Post-surgical changes in the left upper lung. CT TORSO ___: FINDINGS: CT chest: The visualized thyroid is unremarkable. There is no supraclavicular lymph node enlargement. The airways are patent to the subsegmental level. The patient is status post left lower lobectomy. Surgical clips are noted in the left apex and left hilum. Severe paraseptal emphysema is noted. A fluid collection at the left apex measuring 3.4 x 2.5 cm may represent a postoperative seroma or pleural ___. However, given there is no prior imaging available is of unclear chronicity. Opacification in the lower aspect of the left lung with air bronchograms could represent atelectasis, although infection, aspiration or malignancy versus post treatment changes are also possibe. If prior exist for comparison this would be helpful in determining the stability of this lesion. There is no mediastinal, hilar or axillary lymph node enlargement by CT size criteria. There is a small pericardial effusion. No pleural effusion or pneumothorax is present. An ET tube ends 5 cm above the carina. An enteric tube is seen with the tip and side hole in thestomach. CT abdomen: The liver enhances homogeneously without focal lesions or intrahepatic biliary dilatation. The gallbladder is unremarkable and the portal vein is patent. The pancreas, spleen and left adrenal gland are unremarkable. There is a 13 mm nodule in the right adrenal gland. There is a 15 mm cyst in the lower pole of the right kidney. The kidneys otherwise present symmetric nephrograms and excretion of contrast with no pelvicaliceal dilation or perinephric abnormalities. The stomach, duodenum and small bowel are unremarkable. The colon is within normal limits. The appendix is not visualized but there is no evidence of appendicitis. The intraabdominal vasculature is unremarkable. There is no mesenteric or retroperitoneal lymph node enlargement by CT size criteria. No ascites, free air or abdominal wall hernia is noted. CT pelvis: Streak artifact from the right hip prosthesis limits evaluation of the pelvis. The urinary bladder is decompressed with a Foley. There is no pelvic free fluid. There is no inguinal or pelvic wall lymphadenopathy. Osseous structures: No lytic or sclerotic lesions suspicious for malignancy is present. There is a fracture dislocation of the right shoulder and a fracture of the left humeral head and left glenoid. IMPRESSION: 1. Postoperative changes in the left lung with an 3.5 cm fluid collection at the lung apex which may represent a postoperative seroma or pleural fluid. If prior exams for comparison document stability this would be helpful. 2. Opacities at the lower aspect of the left lung could represent atelectasis; although, infection, aspiration or malignancy versus or treatment change are also possible. If priors exist for comparison it could be helpful to document stability. 3. 13 mm nodule in the right adrenal gland concerning for malignancy given patient's history. 4. Fractures of the bilateral shoulders are partially visualized. SHOULDER XR ___: FINDINGS: Right shoulder 3 views. There is a subcapital fracture of the humeral head with the humeral head displaced laterally and rotated approximately 180 degrees so that the articular surface is oriented inferiorly and laterally. A right chest wall Port-A-Cath is noted. The visualized right lung is clear. IMPRESSION: Severely displaced and angulated humeral head fracture FINDINGS: Left shoulder 3 views. There is a the posterior bony Bankart fracture (better appreciated on the CT) as well as a reverse ___ deformity. Osseous fragment is noted inferior to the glenoid. There is no evidence of dislocation at this time however the mechanism of injury was likely posterior dislocation. The visualized left upper lung demonstrates numerous surgical clips. An ET tube and NG tube are partially visualized. IMPRESSION: Posterior bony Bankart's fracture and reverse ___ deformity consistent with a previous posterior dislocation although no evidence of current dislocation. WRIST XR ___: THREE VIEWS, LEFT WRIST: There is mild ulnar positive variance. The carpal rows are aligned. There is no fracture or dislocation. IMPRESSION: No fracture or dislocation. MR HEAD ___: FINDINGS: There is no evidence of hemorrhage or infarction. Ventricles and extra axial spaces are within normal limits for age. The major intracranial vessels exhibit the expected signal void related to vascular flow. No abnormal enhancement is appreciated. The paranasal sinuses demonstrate scattered areas of mucosal thickening most prominent within the right maxillary and scattered ethmoid air cells. The mastoid air cells demonstrate scattered areas of fluid signal and inflammatory change. The sella turcica, craniocervical junction, and orbits are unremarkable. IMPRESSION: Mild paranasal sinus mucosal thickening and mastoid air cell fluid. Otherwise normal study. Brief Hospital Course: ___ PMHx metastatic lung cancer (diagnosed 7 months prior) found down and unresponsive in his home, likely due to seizure, found to have rhabdomyolysis; new onset, difficult to control hypertension; R humeral head fracture s/p ORIF; and L shoulder posterior dislocation s/p closed reduction. --------------- ACTIVE ISSUES BY PROBLEM: #ACUTE ENCEPHALOPATHY: Resolved. Unclear etiology, but most consistent with seizure evidenced by his post-ictal state and likely LEFT posterior shoulder dislocation. Alternate etiologies include 1) ingestions (synergy from alcohol, opiods, cannabinoids), which is less likely given collateral information from patient's family who is closely involved in his care, negative alcohol screen at ___, and absence of withdrawal symptoms; 2) cardiogenic etiologies, which is less likely in the absence of arrhythmia on EKG or telemetry. Tox screen negative, no obvious electrolyte or other metabolic abnormalities at ___. No obvious masses on head CT or MRI. LP performed in ED and CSF bland. EEG performed at ___ showed abnormal routine EEG study because of generalized background theta/delta slowing without focal features consistent with a moderate-severe encephalopathy of non-specific etiology. Significant admixed frontally predominant beta activity may be medication side effect. There were no epileptiform discharges or seizures. - will follow up with Neurology in 1 month (appt is not yet made on discharge, patient will be called with date and time) # RIGHT HUMERAL FRACTURE S/P ORIF ___: Subcapital fracture of the humeral head with the humeral head displaced laterally and rotated approximately 180 degrees so that the articular surface was oriented inferiorly and laterally. - Followup with ___ Trauma for staple removal and post-op on ___ - pain control with tylenol and oxycodone - non-weightbearing # LEFT HUMERAL FRACTURE : STABLE. Posterior bony Bankart's fracture and reverse ___ deformity consistent with a previous posterior dislocation - Continue immobilization in a sling and nonweightbearing. - Outpatient followup with Dr. ___ ___ for operative intervention. - pain control with tylenol and oxycodone # HYPERTENSION: Stable. Remains difficult to control. High pre-test probability for pheochromocytoma evidenced by hypertensive episodes which remain difficult to control, paroxysms of anxiety, paroxysms of sweat, and right adrenal mass. Alternate diagnoses include 1) primary hypertension, which is less likely given the acuity of onset in the setting of no past medical history of hypertension. - Continue labetolol, clonidine with further titration as needed - Urine metanephrines and catecholamines, Plasma metanephrine pending (will follow up) # ___: Baseline Cr 1.3-1.4. Unclear etiology, most likely delayed manifestation of nonoliguric ATN in the setting of rhabdomyolysis. Alternate etiologies include 1) pre-renal azotemia, which is less likely in the setting of excellent ongoing positive urine output and overall volume overload. - Renal dosage, CrCl # CHEST PAIN: Stable. Multifactorial. Alternate etiologies include 1) pulmonary parenchymal irritation in the setting of pneumonia and lung cancer; 2) musculoskeletal pain, evidenced by the trauma associated with his fall and acute encephalopathic episode; 3) paroxysms of anxiety; 4) pulmonary embolus, which is less likely given absence absence of hypoxemia; 5) ACS, which is less likely given normal ECG and multiple, negative troponin rule-outs while an inpatient. - Treat with home oxycodone schedule. - Outpatient transitional issue: stress echo. #ASPIRATION PNEUMONIA: chest CT findings of LLL opacities and cough productive of green sputum, consistent with aspiration pneumonia. - Received 1 day of vancomycin and cefepime (___) - Continue levofloxacin (___), clindamycin (___) for coverage of anaerobes for 8 days through ___. #ACUTE ON CHRONIC ANEMIA S/P 1U pRBC INTRAOPERATIVE TRANSFUSION on ___: STABLE. Baseline Hgb 9.3 on ___. Acute blood loss anemia attributable to bilateral humeral fractures. Evidenced by significant ecchymoses. Superimposed on anemia of chronic disease ___ lung adenocarcinoma evidenced by iron studies consistent with the same. # RHABDOMYOLYSIS: RESOLVED. Due to extended period of unconsciousness during his period of acute encephalopathy. CK peaked at ___, ran Lactated Ringer's aggressively to reduce the risk of rhabdomyolysis induced ATN. Cr 1.6 on discharge (baseline appears to be 1.3-1.5) - Follow Cr with repeat chem panel on ___ # CONSTIPATION: Patient has not passed stool in 7 days. Currently receiving senna, decussate, PO polyethylene glycol, and PR biscodyl. --------- CHRONIC ISSUES: #LUNG ADENOCARCINOMA, LIKELY METASTATIC TO THE RIGHT ADRENAL GLAND: Followed by Dr. ___ (___) at ___ ___. Received cycle 5 of palliative cisplatin and primetrexed (alimta) with good tolerance of regimen and significant improvement when last staged after cycle 3. Scheduled for cycle 6 but this is currently on hold given his current illness. - Continue to wean dexamethasone to 3 mg x3 days, 2mg x 3 days, 1mg x 3 days then stop - will follow up with Dr ___ as an outpatient after he is discharged from rehab -------- TRANSITIONAL ISSUES: # POSSIBLE SEIZURE: will need to follow up with neurology, appt is pending at discharge and the patient will be contacted. # BILATERAL HUMERAL FRACTURES: - Right s/p ORIF, needs to follow up with Dr. ___ on ___. - Left has not been fixated, will follow up with Dr. ___ ___. - He will need to be non-weight bearing in both arms # CONSTIPATION: Patient has not stooled in 7 days despite bowel regimen. Escalate bowel regimen as needed. # HYPERTENSION: will need to continue to monitor and uptirate medications as needed. SERUM METANEPHRINE AND URINE METANPEHRINE / CATECHOLAMINE RESULTS pending on discharge, will be followed up by inpatient attending. # CHEST PAIN: intermittent chest pain while hypertensive, should consider stress testing as an outpatient # RIGHT ADRENAL MASS: Most likely metastatic disease from lung primary; however, differential includes pheochromocytoma. # LUNG ADENOCARCINOMA: Followup with Dr. ___ (aware of the patient's hospitalization) after completing rehab stay. Chemo will be on hold until he gets out of rehab. Dexamethasone is being tapered, as this may have contributed to his hypertension -- 3 mg x3 days, 2mg x 3 days, 1mg x 3 days then stop # RHABDOMYOLYSIS: please check chem 7 on ___ to ensure Cr remains in baseline range 1.3-1.5 # FULL CODE Medications on Admission: The Preadmission Medication list is accurate and complete. 1. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN PAIN 2. FoLIC Acid 1 mg PO DAILY 3. Ibuprofen 600 mg PO Q8H:PRN pain 4. Lactulose 15 mL PO DAILY:PRN constipation 5. Dexamethasone 4 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: ACUTE KIDNEY INJURY HYPERTENSION ASPIRATION PNEUMONIA ACUTE ENCEPHALOPATHY ACUTE ON CHRONIC ANEMIA RIGHT HUMERAL FRACTURE STATUS-POST OPEN REDUCTION AND INTERNAL FIXATION LEFT SHOULDER FRACTURE STATUS-POST CLOSED REDUCTION RHABDOMYOLYSIS LUNG ADENOCARCINOMA RIGHT ADRENAL MASS Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a privilege caring for you at ___. You were admitted because you lost consciousness for several hours and were found unresponsive by your brother. It is difficult to know with certainty the cause of your loss of consciousness, but we believe you sustained a seizure. You underwent an MRI scan of you brain which did not show masses inside. You underwent an electrical study of your brain which did not show specific locations where seizures would start. You were noted to have new high blood pressure and you were started on new medications to control these pressures. You will have followup with your PCP to ensure we continue to learn why this is the case as there are still some test we sent which will not return for several more days. You were noted to have a broken right arm. It was fixed by surgeons. You will followup in 2 weeks to ensure it is still healing. You were noted to have a broken left shoulder. It was put in a splint, You will followup in 10 days with a different surgeon who specializes in fixing broken shoulders like these. You were noted to have some injury to your kidneys, and you continued to received fluids to prevent this from worsening. Followup Instructions: ___
10764329-DS-11
10,764,329
26,616,803
DS
11
2143-06-02 00:00:00
2143-06-02 13:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: headache, pituitary lesion Major Surgical or Invasive Procedure: Endoscopic endonasal approach to suprasellar pituitary lesion; resection of pituitary lesion History of Present Illness: ___ year old male with intermittent headaches for 4 days. He presented to ___ ED on ___, and reportedly had a negative NCHCT. He represented on ___ with continued headaches, and underwent an MRI that was also reported to be negative. On the morning of ___, he saw his PCP due to continued concern, who ordered a second MRI that reportedly showed a pituitary mass at the optic chiasm with reported bleeding/apoplexy. Therefore he was referred to ___ for further evaluation. Past Medical History: diabetes hypertension hyperlipidemia CLL diagnosed ___ Social History: ___ Family History: NC Physical Exam: EXAM ON DISCHARGE: GEN: well appearing, NAD NEURO: A/Ox3, strength ___ throughout, SILT HEENT: CNII-XII grossly intact, no epistaxis, visual fields full b/l, no nystagmus, MMM, oropharynx without blood clot, no nasal packing CARDS: RRR, S1 and S2 heard throughout PULM: CTAB b/l ABD: soft, NTND Pertinent Results: CT HEAD: ___ IMPRESSION: 1. Expected post-procedure changes status post resection of known pituitary adenoma with expected fluid and small amount of local hemorrhage. 2. No evidence of intracranial hemorrhage or infarctions. MRI w/ & w/o CONTRAST (___): IMPRESSION: 1. Expected trans-sphenoidal partial resection of a pituitary mass with fat packing is identified. 2. There is residual 1.7cm lobulated enhancing tissue along the posterior superior aspect of the sella, which may represent any combination of residual lesion versus postoperative changes. The infundibulum is deviated to the left, unchanged from prior exam. The optic chiasm is unremarkable. Long-term followup is recommended. 3. There is no evidence of intra-axial mass, acute hemorrhage or infarct. Brief Hospital Course: Patient presented to ___ after referral from her PCP when he was found to have a pituitary lesion that had concern for apoplexy. He had no neurologic findings on exam and was admitted to the floor for further workup. He remained stable overnight into ___ and was awaiting results of endocrine labs and setting up of visual field testing with neuro-Ophth. He continued to remain stable in hospital and after receiving visual field testing was scheduled for the OR on ___ for resection of his pituitary mass. On ___, he was brought to the OR and underwent an endoscopic endonasal approach to resection of his suprasellar pituitary lesion. He tolerated the procedure well, was extubated in the OR and sent to the PACU in good condition. Initial frozen pathology was consistent with pituitary adenoma. Immediately post-op, he did well - his blood pressure was well controlled, no focal neurological deficits and his urine output was <250cc/hr. Visual fields post-operatively were full bilaterally and epistaxis was controlled with his nasal packing. Follow up non-contrast head CT imaging did not show any gross residual tumor and no signs of gross hemorrhage. On ___, he continued to do well in the PACU awaiting transfer to the step-down unit. His UOP increased briefly to >250cc/hr for 2 hours. Serum Na and spec ___ were sent which came back WNL. His UOP subsequently decreased to 100cc/hr and he was tolerating a regular diet and IV KVO. . His pain continued to be well controlled and no signs of continuing epistaxis. Nasal packing remained in place. On ___, he underwent a follow MRI w/ & w/o contrast which demonstrated a small focus of enhanging tissue possibly representing residual disease. No hemorrhage or other acute processes. He was otherwise neurologically stable. On ___, the patient remained neurologically stable. His urine output remained stable and his foley was removed. His labs were stable. His nasal packing was removed and there was no drainage noted from nares. He ambulated in the hallways without difficulty. On ___, the patient remained neurological and hemodynamically stable. He expressed readiness to be discharge home and he was discharged home in stable conditions. All his discharge instructions and follow up were given prior to discharge. Medications on Admission: metformin, pravastatin, amlodipine, lisinopril Discharge Medications: 1. MetFORMIN (Glucophage) 500 mg PO BID 2. Pravastatin 20 mg PO QPM 3. Lisinopril 10 mg PO DAILY 4. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN Pain Please do not drive or operate mechanical machinery while taking narcotics. RX *oxycodone 5 mg 1 tablet(s) by mouth Q4 hrs Disp #*60 Tablet Refills:*0 5. Docusate Sodium 100 mg PO BID 6. Amlodipine 5 mg PO DAILY 7. Acetaminophen 325-650 mg PO Q6H:PRN Mild Pain/Fever Please do not exceed more than 4 grams in 24hrs. Discharge Disposition: Home Discharge Diagnosis: Pituitary lesion Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ¨Take your pain medicine as prescribed. ¨Exercise should be limited to walking; no lifting, straining, or excessive bending. ¨Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication. ¨Unless directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, and Ibuprofen etc. ¨Clearance to drive and return to work will be addressed at your post-operative office visit. ¨Continue Sinus Precautions for an additional two weeks. This means, no use of straws, forceful blowing of your nose, or use of your incentive spirometer. ¨If you have been discharged on Prednisone, take it daily as prescribed. ¨If you are required to take Prednisone, an oral steroid, make sure you are taking a medication to protect your stomach (Prilosec, Protonix, or Pepcid), as this medication can cause stomach irritation. Prednisone should also be taken with a glass of milk or with a meal. CALL YOUR DOCTOR IMMEDIATELY IF YOU EXPERIENCE ANY OF THE FOLLOWING ¨New onset of tremors or seizures. ¨Any confusion or change in mental status. ¨Any numbness, tingling, weakness in your extremities. ¨Pain or headache that is continually increasing, or not relieved by pain medication. ¨Any signs of infection at the wound site: redness, swelling, tenderness, or drainage. ¨It is normal for feel nasal fullness for a few days after surgery, but if you begin to experience drainage or salty taste at the back of your throat, that resembles a “dripping” sensation, or persistent, clear fluid that drains from your nose that was not present when you were sent home, please call. ¨Fever greater than or equal to 101° F. ¨If you notice your urine output to be increasing, and/or excessive, and you are unable to quench your thirst, please call your endocrinologist. Followup Instructions: ___
10764758-DS-8
10,764,758
28,056,123
DS
8
2133-02-06 00:00:00
2133-02-06 14:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: polytrauma Major Surgical or Invasive Procedure: Left Olecranon Fracture ORIF ___ History of Present Illness: ___ ___ s/p fall from 15ft off ladder with multiple orthopedic injuries. Past Medical History: Per medical record: none Social History: ___ Family History: NC Physical Exam: Per Medical Record: PHYSICAL EXAMINATION: In general, the patient is an awake alert ___ Vitals: AVSS Right upper extremity: Skin intact Right shoulder deformity Full, painless AROM/PROM of shoulder, elbow, wrist, and digits +EPL/FPL/DIO (index) fire +SILT axillary/radial/median/ulnar nerve distributions +Radial pulse Left upper extremity: Proximal forearm deep laceration w/ olecrenon seen +EPL/FPL/DIO (index) fire +SILT axillary/radial/median/ulnar nerve distributions +Radial pulse Right lower extremity: Skin intact Soft, non-tender thigh and leg Full, painless AROM/PROM of hip, knee, and ankle ___ fire +SILT SPN/DPN/TN/saphenous/sural distributions ___ pulses, foot warm and well-perfused Left lower extremity: Skin intact Soft, non-tender thigh and leg Full, painless AROM/PROM of hip, knee, and ankle ___ fire +SILT SPN/DPN/TN/saphenous/sural distributions ___ pulses, foot warm and well-perfused Pertinent Results: ___ 06:21PM LACTATE-3.5* ___ 06:00PM GLUCOSE-306* UREA N-27* CREAT-1.3* SODIUM-138 POTASSIUM-3.9 CHLORIDE-102 TOTAL CO2-22 ANION GAP-18 ___ 06:00PM ALT(SGPT)-41* AST(SGOT)-45* ALK PHOS-70 TOT BILI-0.4 ___ 06:00PM CALCIUM-8.8 PHOSPHATE-4.8* MAGNESIUM-1.9 ___ 06:00PM WBC-22.2* RBC-4.25* HGB-13.4* HCT-39.7* MCV-93 MCH-31.5 MCHC-33.7 RDW-12.6 ___ 06:00PM NEUTS-87.8* LYMPHS-6.0* MONOS-5.7 EOS-0.3 BASOS-0.2 ___ 06:00PM PLT COUNT-258 ___ 06:00PM ___ PTT-24.8* ___ ___ 02:39PM COMMENTS-GREEN TOP ___ 02:39PM GLUCOSE-245* LACTATE-6.5* NA+-139 K+-3.8 CL--100 TCO2-21 ___ 02:30PM UREA N-26* CREAT-1.4* ___ 02:30PM estGFR-Using this ___ 02:30PM WBC-17.4* RBC-4.79 HGB-14.6 HCT-44.9 MCV-94 MCH-30.5 MCHC-32.5 RDW-12.1 ___ 02:30PM PLT COUNT-283 ___ 02:30PM ___ PTT-24.6* ___ Brief Hospital Course: The patient was taken to the operating room on ___ for L olecranon fracture ORIF, which the patient tolerated well (for full details please see the separately dictated operative report). The patient was taken from the OR to the PACU in stable condition and after recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given perioperative antibiotics and anticoagulation per routine. The patients home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to <<>> was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient was afebrile with stable vital signs that were within normal limits, pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is NWB in the operative extremity, and will be discharged on Lovenox for DVT prophylaxis. The patient will follow up in two weeks per routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course, and all questions were answered prior to discharge. Medications on Admission: None Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: L olecranon fx, L rib fx ___, L-sided pelvic fractures (L inferior/superior pubic rami, L anterior column, L sacral ala), R shoulder anterior dislocation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take lovenox 40mg daily for 2 weeks WOUND CARE: - No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet ACTIVITY AND WEIGHT BEARING: - WBAT bilateral lower extremities - NWB bilateral upper extremities Followup Instructions: ___
10764840-DS-17
10,764,840
29,666,044
DS
17
2122-01-05 00:00:00
2122-01-07 20:05:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Bactrim / Sulfa (Sulfonamide Antibiotics) / Cefazolin / Vancomycin / Celexa / Cipro Cystitis Attending: ___ Chief Complaint: Confusion; incontinence Major Surgical or Invasive Procedure: None History of Present Illness: Mrs. ___ is an ___ with history of ___ disease c/b dystonia, likely lung CA metastatic to bones who presents with ___ days of confusion. History gathered from chart as patient not able to provide history and daughter not presents. Per documentation from patient's nursing home, patient was noted to be confused on saunday. UA was sent which was negative however she was started on Macrobid for empiric treatment of UTI. Urine culture returned negative; since patient continued to be altered; she was sent to ED. Per documentation, patient is usually alert and oriented x3, so her current mentation is not at baseline. Patient is wheelchair bound however recently she has been having difficulty with taking her pills which is different from her baseline. She has also been more sleepy than usual. Currently patient is awake and alert and able to snwer simple question. She denies any fevers, chills, night sweats, cough, chest pain, abdominal pain, nausea, vomiting, diarrhea, dysuria, numbness, focal weakness or headaches. Per documentation patient was recently placed on hospice care at the nursing home. Past Medical History: - Lung nodules on CT chest in ___ patient did not want further ___ CT scan: ___: Lesions on spine consistent with bone metastasis; likely lung cancer - ___ Disease followed by Dr. ___ at ___ - Dystonia secondary to ___ disease - Polymyalgia Rheumatica and Temporal arteritis: managed by Dr. ___ and PCP - ___ - HTN - S/p minor stroke ___ no obvious deficits - S/p cataract surgery- R eye - History of hyponatremia on salt tabs Social History: ___ Family History: Mother died at ___ from cardiac disease. Father had DM and cardiac disease. Physical Exam: Admission Physical Exam: Vitals: 98.4 133/43 93%RA General: Alert, oriented to self only HEENT: Sclera anicteric, MMM, EOMI, PERRL Neck: Supple CV: Regular rate and rhythm, normal S1 + S2, no murmurs Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, ___ Ext: Warm, well perfused Neuro: ___ intact, ___ strenght upper/lower extremities, grossly normal sensation to light touch Discharge Physical Exam: Vitals: Tc/Tm BP 92/34, HR71, O297RA General: lethargic, responds to half of questions before falling back asleep. Oriented to name and location ("in the hospital") HEENT: Neck dystonic. Fluid collection lateral to right eye, nontender. Neck: supple, JVP not elevated, no LAD Lungs: clear to auscultation bilaterally, no wheezes, rales, ronchi CV: regular rate and rhythm, normal S1 + S2, holosystolic murmur best appreciated at the apex. Abdomen: mild distention, nontender GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Skin tear over left lower extremity ___, nonfluctuant with no evidence of purulent drainage. Pertinent Results: Lab Results =============================================================== ___ 05:06PM BLOOD ___ ___ Plt ___ ___ 05:06PM BLOOD ___ ___ ___ 05:06PM BLOOD ___ ___ ___ 06:24AM BLOOD ___ LD(LDH)-272* ___ ___ ___ 06:24AM BLOOD ___ ___ 06:24AM BLOOD ___ ___ 06:24AM BLOOD ___ ___ 04:53AM BLOOD ___ ___ Plt ___ ___ 05:23AM BLOOD Ret ___ ___ 05:05AM BLOOD ___ ___ ___ 05:05AM BLOOD ___ ___ 05:23AM BLOOD ___ Blood cultures drawn ___ and ___ Pending at the time of discharge Urine cultures drawn ___ Preliminary growth ___ rods>100,000, enterococcus>100,000 Imaginag Results = = = = = = = ================================================================ - CHEST (PORTABLE AP) Study Date of ___: IMPRESSION: Previously detected right lower lobe pulmonary nodule not clearly seen. No signs of superimposed pneumonia or edema. - CT HEAD W/O CONTRAST Study Date of ___: IMPRESSION: No acute intracranial process. - CHEST (PORTABLE AP) Study Date of ___: IMPRESSION: As compared to ___ chest radiograph, the lungs remain hyperinflated without evidence of focal consolidation to suggest the presence of pneumonia. Brief Hospital Course: Primary Reason for Hospitalization = = = = = = = = = = = = = = ================================================================ ___ with ___ dementia c/b dystonia, hypothyroidism, T2DM, and likely metastatic lung cancer here with altered mental status. Hospital course complicated by hypotension likely in the setting of straining due to constipation; however, infectious workup revealed UA with bacteria and WBC concerning for UTI, so was treated with zosyn. Active Issues = = = = = = = = = = = = = = = = = ================================================================ #Anemia, normocytic: The patient had a hct drop from 31-->26.3 between ___ and ___. Stool was guaiac positive, suggesting a likely GI source of bleeding. Hemolysis labs were negative. Given the patient's move to hospice and desires for no invasive intervention, no further workup was undertaken for her GI bleeding. She did not require a blood transfusion, and her hematocrit improved to 29 on ___. #Delirium: The patient had waxing and waning mental status throughout admission, though level of alertness improved somewhat with holding lorazepam. The patient was found to have a TSH of 32, and she was maintained on her home dose of levothyroxine. She had some constipation that resolved with manual disimpaction. She developed a urinary tract infection that may have been contributing to her symptoms and was treated with five days of zosyn; she will not be discharged on any antibiotics. Workup for other infections including pneumonia was negative. Blood and urine cultures were pending at discharge. She did not require any PRN medications for agitation. # Hypotension: She had some episodes of hypotension to the ___ systolic. These episodes improved with IV fluid repletion. Possible sources of her hypotension include straining due to constipation and infection due to urinary tract infection. She was treated with disimpaction and zosyn as above. Hypotensive episodes resolved with these interventions. Her home metoprolol was held. ___ Disease with severe neck dystonia: the patient was maintained on her home sinement ___ 2 tablets at 7am, 1.5 tablets at 11am, 2 tablets at 4pm, and 1 tablet at 9pm #Depression: the patient was maintained on her home fluoxetine and mirtazapine #Hyponatremia, chronic: the patient was maintained on her home salt tablets, and her sodium maintained in a normal range throughout admission. On discharge, as goals of care are focused on comfort, salt tablets were discontinued. #Hypothyroidism: As above, the patient's TSH was 32 on admission, and her family thought that perhaps she had not been taking her levothyroxine as directed at home. She was maintained on her home dose of levothyroxine. #DM2: Blood sugars were ___ throughout admission. Patient's home actos was held, and she did not require insulin. #Glaucoma: the patient was maintained on her home eyedrops throughout admission. #Wound care: Pt has a traumatic skin tear on her left calf secondary to hitting her leg on her wheelchair during a transfer prior to admission. She had no documentation of recent tetanus vaccine so received the vaccine in the hospital. The wound remained clean and not infected throughout admission. Transitional Issues = = = = = = = = = = = = = ================================================================ -Please ___ TSH in ___ weeks to ensure that it declines appropriately with levothyroxine. -Patient had episodes of hypotension during hospitalization, likely secondary to straining from constipation thus preadmission metoprolol was held; may consider restarting if patient is hypertensive after discharge -Patient had hypokalemia during hospitalization, likely nutritional, and received PO potassium supplementation. Please recheck potassium in 2 days after discharge and replete as necessary - the following preadmission medications were discontinued: ASA, omeprazole, lorazepam, salt tabs. - was discharged on oxycodone 2.5mg q4hrs PRN; please titrate pain medication as needed. - completed a ___ course of Zosyn for UTI. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lumigan (bimatoprost) 0.01 % ophthalmic one drop to both eyes at bedtime 2. Fluoxetine 50 mg PO DAILY 3. ___ 1.5 TAB PO QAM ___ Disease 4. ___ 2 TAB PO BID 5. Pioglitazone 15 mg PO DAILY 6. Metoprolol Succinate XL 50 mg PO DAILY 7. Aspirin 81 mg PO DAILY 8. Vitamin D 1000 UNIT PO DAILY 9. Senna 8.6 mg PO BID:PRN contipation 10. Omeprazole 20 mg PO DAILY 11. Levothyroxine Sodium 25 mcg PO DAILY 12. Lorazepam 1 mg PO BID 13. Mirtazapine 30 mg PO QHS 14. sodium chloride 1 gram oral BID 15. Ibuprofen 600 mg PO Q8H 16. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain 17. ___ 1 TAB PO QHS 18. Istalol (timolol maleate) 0.5 % ophthalmic BID Glaucoma 19. Artificial Tears Preserv. Free ___ DROP BOTH EYES BID 20. Ferrous Sulfate 325 mg PO DAILY Discharge Medications: 1. Artificial Tears Preserv. Free ___ DROP BOTH EYES BID 2. ___ 1.5 TAB PO QAM ___ Disease 3. ___ 2 TAB PO BID 4. ___ 1 TAB PO QHS 5. Fluoxetine 50 mg PO DAILY 6. Levothyroxine Sodium 25 mcg PO DAILY 7. Senna 17.2 mg PO HS 8. Acetaminophen 1000 mg PO TID 9. Istalol (timolol maleate) 0.5 % ophthalmic BID Glaucoma 10. Lumigan (bimatoprost) 0.01 % ophthalmic one drop to both eyes at bedtime 11. Mirtazapine 30 mg PO QHS 12. Bisacodyl ___AILY:PRN Constipation 13. Docusate Sodium 100 mg PO BID 14. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain RX *oxycodone 5 mg 0.5 (One half) tablet(s) by mouth q4hrs Disp #*10 Tablet Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Altered mental status/ metabolic encephalopathy Hypothyroidism Urinary Tract Infection Constipation with fecal impaction ___ Disease SECONDARY: probable lung ca with bone metastasis Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, It was a pleasure to care for you while you were a patient at ___. As you know, you were admitted for confusion. To better understand the causes of your confusion, we did a thorough investigation of the medications you were taking prior to admission and did some blood tests looking for infections and hormone changes that could contribute to your confusion. We found that you had recently been taking more lorazepam that you had been previously taking, which may have contributed to your confusion. Additionally, our lab tests indicated that your thyroid hormone levels were low. To treat this, we held your lorazepam and gave you levothyroxine. During your hospitalization, you became constipated and developed a urinary tract infection. This was treated with an antibiotic. You will not need to continue this antibiotic after discharge. You will not need to take more antibiotics after discharge. Again, we really enjoyed caring for you while you were a patient at ___. Please do not hesitate to contact our team with any questions. We wish you all the best. Your care team at ___ Followup Instructions: ___
10765204-DS-11
10,765,204
26,964,163
DS
11
2186-09-26 00:00:00
2186-09-27 22:08:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Codeine / Ceftin / Ampicillin / Erythromycin Base Attending: ___. Chief Complaint: Bloody stool Major Surgical or Invasive Procedure: None. History of Present Illness: this is a ___ year old female ___'s witness with a history of HTN, Grave's, DCIS s/p radiation in remission, GERD, and HLD who presents with GI bleeding. She reports one episode of BRBPR coating her stool 3 days ago. This is the first time this has happened to her knowledge. She was unable to quantify the amount of blood, but thinks it was less than a cup. She denies any history of dark stool. Denies a history of hemorrhoids. She denies any recent fevers or recent diarrhea. She also complains of blood "spotting" after urination on toilet paper over this same period. Yesterday, she had the onset of bilateral lower abdominal pain beginning at 0130 AM. It was sharp, non-radiating, and accompanied by sweats and bloody diarrhea x 3. She denies any lightheadedness, fevers, or chest pain. She had a colonscopy in ___ which was normal. Her last menstrual period was ___ years ago. She was hemodymically stable in the ED, received antibiotics, had a CT as detailed below, 1L NS and was transferred to the medicine floor for evaluation. Past Medical History: 1. Hypertension. 2. History of Graves' disease. 3. History of DCIS, diagnosed in ___, in remission 4. Pulmonary nodules on chest CT, final follow-up ___ stable. 5. Mildly dilated aortic root on echocardiogram. Stable follow-up ___. 6. GERD. 7. Hyperlipidemia. 8. osteopenia Social History: ___ Family History: mother passed away 4 months ago from complications of pneumonia and pericardial effusion at age ___. Siblings and father-hypertension and hyperlipidemia Physical Exam: ADMISSION PHYSICAL EXAMINATION: VITALS: 98.1, 128/.84, 65, 18, 96% RA GENERAL: pleasant female, NAD HEENT: PERRL, EOMI LUNGS: CTAB HEART: RRR, normal S1 S2, no MRG ABDOMEN: Soft, TTP over LLQ, NABS, no organomegaly EXTREMITIES: No c/c/e NEUROLOGIC: A+OX3 DISCHARGE PHYSICAL EXAMINATION: VITALS - T 97.7 HR 72 RR 18 BP 110/72 SaO2 100 on RA GENERAL - Well-appearing middle-aged woman ambulating around the wards and is in NAD. HEENT - MMM, sclera nonicteric, PEERL. Conjunctiva pale CARDIOVASCULAR - III/VI pansystolic murmur heard best over left sternal border. Regular rate & rhythm. No rubs or gallops. PULMONARY - CTAB. Moving air well. No accessory muscle use. ABDOMINAL - BS normoactive. Mild tenderness to palpation of midepigastrium. NEUROLOGICAL - A&Ox3. Moving all four limbs. Follows commands. RECTAL - Full rectal tone. Small nonulcerated external hemorrhoid seen at 6 o'clock. Normal-appearing rectal mucosa and surrounding skin. Pertinent Results: ___ 04:20PM BLOOD WBC-9.1# RBC-4.24 Hgb-12.8 Hct-37.8 MCV-89 MCH-30.2 MCHC-33.8 RDW-12.9 Plt ___ ___ 06:45AM BLOOD WBC-8.5 RBC-4.06* Hgb-12.2 Hct-37.1 MCV-91 MCH-30.1 MCHC-33.0 RDW-13.2 Plt ___ ___ 08:10AM BLOOD WBC-6.4 RBC-4.17* Hgb-12.6 Hct-37.9 MCV-91 MCH-30.1 MCHC-33.1 RDW-13.0 Plt ___ ___ 08:10AM BLOOD Glucose-133* UreaN-6 Creat-0.8 Na-144 K-3.8 Cl-108 HCO3-25 AnGap-15 ___ 8:48 am STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). FECAL CULTURE (Pending): CAMPYLOBACTER CULTURE (Pending): FECAL CULTURE - R/O E.COLI 0157:H7 (Pending): VIRAL CULTURE (Pending): CT ABDOMEN AND PELVIS WITH CONTRAST (___) ================================================ INDICATION: ___ female with left lower quadrant pain and bloody stools. Evaluate for diverticulitis. COMPARISON: CT of the abdomen and pelvis from ___. TECHNIQUE: Volumetric MDCT images from the lung bases to the pubic symphysis were acquired following the uneventful administration of 130 cc of IV Omnipaque. No oral contrast material was administered. Coronal and sagittal reformats were performed. FINDINGS: The partially imaged lung bases show an unchanged 4-mm ground glass nodule in the lingula. The partially imaged heart is unremarkable as well. CT OF THE ABDOMEN WITH IV CONTRAST: The liver, spleen, both adrenals, pancreas, and gallbladder are unremarkable. Scattered hypodensities in both kidneys are sub-cm in size and too small to accurately characterize. Both kidneys otherwise are unremarkable. No abdominal, retroperitoneal or mesenteric lymphadenopathy by CT size criteria is present. No abdominal free fluid or free air is present. Abdominal aorta is normal in caliber. Abdominal loops of small bowel and stomach are normal. CT OF THE PELVIS WITH IV CONTRAST: The small bowel loops show fatty replacement within the wall of the terminal ileum. Also noted is fatty replacement in the descending colon. No surrounding fat stranding is noted about the terminal ileum. There is mild wall thickening with surrounding stranding of the descending colon and sigmoid colon. Additionally, intramural fat deposition is seen within the descending colon. No bowel obstruction is present. The rectum is unremarkable. No pelvic or inguinal lymphadenopathy or pelvic free fluid is present. The uterus, both adnexa, and bladder are unremarkable. OSSEOUS STRUCTURES: The visible osseous structures show no suspicious lytic or blastic lesions or fractures. IMPRESSION: Mild sigmoid and descending colitis which may be due to inflammatory or infectious etiologies. Fatty deposition within the wall of the terminal ileum and descending colon suggests underlying chronic inflammatory bowel disease. COLONOSCOPY (___): Normal colonoscopy to cecum and terminal ileum. EGD (___) - Medium hiatal hernia (biopsy) - Schatzki's ring - Erythema and patchy erythema in the antrum and stomach body (biopsy) - Erythema, friability and edema in the distal bulb/proximal second part of the duodenum (biopsy) (biopsy) - Otherwise normal EGD to second part of the duodenum PATHOLOGY: GI BIOPSIES (___) A) Gastroesophageal junction: 1. Squamous epithelium with a rare intraepithelial eosinophil. 2. Cardiofundic-type mucosa with mild chronic, inactive inflammation. 3. No intestinal metaplasia seen. B) Antrum: 1. Chronic, focally active gastritis. 2. ___ stain is negative for H. pylori, with a satisfactory control. C) Duodenal bulb: Preservation of villous architecture with focally-increased intraepithelial lymphocytes. See note. Note: The findings are mild and non-specific , but can be seen with certain infections (e.g. H. pylori), as a result of a drug effect or other immune mediated etiologies such as Celiac disease. Clinical correlation is suggested. Brief Hospital Course: PRIMARY REASON FOR HOSPITALIZATION ================================== #) GI BLEED: Has been afebrile, hemodynamically stable, without leukocytosis, not anemic, and without hematocrit drop during this admission. Had one further guaiac positive formed stool here. No frank blood. Colitis seen on CT scan is likely source of bleed, however no diverticula noted. Previous EGD in ___ showed focally active gastritis, so this could be the source as well. Etiology inflammatory vs. infectious. Stool cultures sent, final results pending. Has been hemodynamically stable and with hct at baseline. Given hemodynamic stability, OK to follow-up on this as an outpatient. - Discharged on ciprofloxacion 400mg BID + metronidazole 500mg TID. Continue for 6 more days. - Initiated PPI, omeprazole 20mg QD TRANSITIONAL ISSUES =================== - Final stool cultures/studies are still pending upon discharge. Please follow-up on these. - Consider repeat colonoscopy/EGD given signs of chronic inflammatory colitis given fat deposition seen on CT and history of focally active gastritis from EGD in ___. Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from Patient. 1. Amlodipine 5 mg PO DAILY 2. Atenolol 50 mg PO DAILY 3. Hydrochlorothiazide 25 mg PO DAILY 4. Simvastatin 20 mg PO DAILY 5. Claritin *NF* 10 mg Oral daily 6. Calcium Carbonate 500 mg PO Frequency is Unknown Discharge Medications: 1. Simvastatin 20 mg PO DAILY 2. Amlodipine 5 mg PO DAILY 3. Atenolol 50 mg PO DAILY 4. Calcium Carbonate 500 mg PO HS:PRN vitamin 5. Claritin *NF* 10 mg Oral daily 6. Hydrochlorothiazide 25 mg PO DAILY 7. Ciprofloxacin HCl 500 mg PO Q12H Duration: 6 Days RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp #*12 Tablet Refills:*0 8. MetRONIDAZOLE (FLagyl) 500 mg PO Q8H Duration: 6 Days RX *metronidazole 500 mg 1 tablet(s) by mouth three times a day Disp #*18 Tablet Refills:*0 9. Omeprazole 40 mg PO DAILY RX *omeprazole 40 mg 1 capsule(s) by mouth once a day Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Gastroinestinal bleed Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___ ___. You were admitted for the evaluation of a gastrointestinal bleed. We treated you with IV fluids, antibiotics, and you improved. Your blood levels were normal and stable throughout your admission, so we were not concerned for a life-threatening GI bleed. We recommend you call your GI doctor, ___ ___, to arrange for a follow up appointment. Please make the following changes to your medications: - START: Ciprofloxacin and metronidazole, which are antibiotics to treat a possible infection that may have led to your GI bleeding. It is important to not drink alcohol when taking this medication. - START: Omeprazole 20 mg by mouth daily to help decrease any inflammation in your GI tract, specifically your stomach. Followup Instructions: ___
10765488-DS-12
10,765,488
25,734,954
DS
12
2198-05-28 00:00:00
2198-06-02 15:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Chest pain Major Surgical or Invasive Procedure: CT-guided core biopsy History of Present Illness: Mr. ___ is an ___ with a h/o severe AS ___ 0.8cm2 w/plan for SAVR vs. TAVR), HTN, CAD s/p PCI to LAD ___ who presented to the hospital on ___ with progressively worsening substernal chest pain radiating to the back and both shoulders as well as unilateral leg swelling. Post-PCI placement in ___, he was able to ambulate one-mile pain free. However, one month prior to admission, he took a walk along the ___ and suddenly developed an acute episode of dull chest discomfort without radiation. Since that time, his exercise and functional capacity has declined significantly. He endorsed generalized fatigue and difficulty even with ADLs and difficulty walking across the room and also described recent epigastric pain, a "squeezy pain" that lasted all day prior to admission. He denied n/v/f/c and shortness of breath. He endorsed fatigue, weakness, and presyncopal symptoms of dizziness with exertion without LOC. Denied PND, orthopnea, ankle edema. He has had progressive anemia since ___, on dual antiplatelet. Never had a colonoscopy, denied any blood in stool. Notes significant constipation. In the ED, initial vitals were: T 97.8, HR 60, BP 109/42, RR 17, O2 100% RA. Left blood pressure 108/66 right arm 112/50. Labs were notable for: anemia with initial hemoglobin of 8.7, down to 7.8 on recheck 7 hours later (compared to baseline ~ 12). Initial troponin negative. Cr 2.2 (baseline ~ 1.6-1.8). U/A showed > 182 WBCs. Blood cultures x2 pending. Patient was given: 1 x cipro 500 for UTI, ASA 325 CXR showed a new 3.7 cm elliptical opacity in the mid left upper lung, concerning for an extra pulmonary process located in either the pleura or chest wall. There was also progression of loss of height of a mid thoracic compression fracture. EKG with NSR @ 61 bpm, prolonged PR interval consistent with ___ degree AV block, LAD, TWI in leads III, aVR, and V1. UA concerning for UTI. Vitals prior to transfer: 98.4 66 106/52 12 98% RA. On review of systems, he denied any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, myalgias, joint pains, cough, hemoptysis, black stools or red stools. He denies recent fevers, chills or rigors. All of the other review of systems were negative. Past Medical History: - Aortic stenosis - HTN - HLD - Hypothyroidism - BPH - B12 deficiency - History of ___ and ___ Social History: ___ Family History: Family History: Significant for cancer and heart disease. Physical Exam: PHYSICAL EXAM ON ADMISSION: VS: 97.5 BP 122/54 HR 65 RR 18 O2Sat 98% RA GENERAL: Well-appearing male in NAD. Oriented x3. Hard of hearing even with hearing aid in place. Mood, affect appropriate. Speaking full sentences. HEENT: NCAT. PERRL, EOMI. Scar on bridge of nose s/p BCC. No xanthelasma. NECK: Supple, JVP flat. CARDIAC: RRR, normal S1, diminished S2, ___ SEM with diffuse radiation to bilateral carotids. No thrills, lifts, No S3 or S4. PMI located in ___ intercostal space, midclavicular. LUNGS: Respirations unlabored, no accessory muscle use, CTAB, no crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. No abdominal bruits. EXTREMITIES: WWP, No c/c/e. PULSES: 2+ DP, ___ NEURO: A&Ox3. CNs grossly intact DISCHARGE PHYSICAL EXAM: Vitals: T: 98.2, BP: 126/70, HR: 62, RR: 18, OS=97% Gen: Well appearing, alert in NAD, talkative and kind HEENT: No conjunctival pallor. No icterus. MMM. OP clear. LYMPH: No cervical or supraclavicular LAD CV: Regular rate, normal S1, S2 with III/VI holosystolic murmur, best heard @ R ___ intercostal space with radiation to b/l carotids. LUNGS: No accessory muscle use. Clear to auscultation b/l. No wheezes, rales, or rhonchi. ABD: soft, non tender to palpation. SKIN: No rashes/lesions, petechiae/purpura ecchymoses. Pertinent Results: LABS ON ADMISSION ___ 10:00AM BLOOD WBC-6.4 RBC-3.05* Hgb-8.7* Hct-26.9* MCV-88 MCH-28.5 MCHC-32.3 RDW-16.3* RDWSD-52.2* Plt ___ ___ 10:00AM BLOOD Neuts-80.0* Lymphs-8.6* Monos-9.8 Eos-0.8* Baso-0.3 Im ___ AbsNeut-5.12 AbsLymp-0.55* AbsMono-0.63 AbsEos-0.05 AbsBaso-0.02 ___ 10:00AM BLOOD ___ PTT-32.0 ___ ___ 05:04PM BLOOD Ret Aut-1.7 Abs Ret-0.05 ___ 10:00AM BLOOD Glucose-112* UreaN-49* Creat-2.2* Na-138 K-4.8 Cl-101 HCO3-25 AnGap-17 ___ 10:00AM BLOOD cTropnT-<0.01 ___ 05:04PM BLOOD cTropnT-<0.01 ___ 09:58PM BLOOD cTropnT-<0.01 ___ 10:00AM BLOOD Iron-36* ___ 10:00AM BLOOD calTIBC-299 Ferritn-106 TRF-230 LABS ON DISCHARGE: ___ 12:00AM BLOOD WBC-8.0 RBC-3.14* Hgb-9.2* Hct-28.2* MCV-90 MCH-29.3 MCHC-32.6 RDW-17.1* RDWSD-54.2* Plt ___ ___ 12:00AM BLOOD Neuts-83.2* Lymphs-5.5* Monos-9.0 Eos-1.1 Baso-0.1 Im ___ AbsNeut-6.63* AbsLymp-0.44* AbsMono-0.72 AbsEos-0.09 AbsBaso-0.01 ___ 12:00AM BLOOD Glucose-131* UreaN-42* Creat-1.7* Na-138 K-4.2 Cl-102 HCO3-28 AnGap-12 ___ 12:00AM BLOOD ALT-27 AST-19 LD(LDH)-336* AlkPhos-64 TotBili-0.3 ___ 04:15PM BLOOD Calcium-10.5* Phos-2.9 UricAcd-3.9 CXR (___): 1. Interval development of a 3.7 cm elliptical opacity in the mid left upper lung. The incomplete sharp borders suggest an extra pulmonary process located in either the pleura or chest wall. CT is recommended for further evaluation to exclude a malignant lesion. 2. Interval progression of loss of height of a mid thoracic compression fracture. ___ ___: No evidence of deep venous thrombosis in the left lower extremity veins. CT Chest ___: IMPRESSION: 1. Multiple pulmonary nodules, pleural based and extrapleural lesions and retroperitoneal masses/lymphadenopathy consistent with malignancy such as lymphoma or metastatic disease of unknown primary. One extrapleural posterior mediastinal lesion likely involves adjacent T 6 and 7 vertebral bodies. 2. Retroperitoneal mass, which is probably a conglomerate of para-aortic lymph nodes, displaces IVC anteriorly and encases the right renal vascular pedicle and abdominal aorta. Posterior mediastinal mass/ lymphadenopathy encases distal thoracic aorta. 3. Right hydronephrosis is partially imaged. 5. Splenomegaly. ___ CT-guided biopsy ___: - Touch prep of core biopsy - LN workup FINDINGS: Noncontrast CT performed for preprocedure evaluation demonstrates a 3.1 x 1.6 cm left anterior pleural-based mass. This nodule was targeted for biopsy. Additional smaller pleural-based nodules are identified as well as pulmonary parenchyma nodules, the largest at the right lung base measuring 3 x 3.1 cm. Trace bilateral pleural effusions with adjacent atelectasis are noted. The heart is enlarged. There are dense coronary artery vascular calcifications. There is soft tissue density around the thoracic and visualized abdominal aorta, compatible with metastatic disease. CT ABD/PELVIS ___: 1. 6.6 x 6.2 x 7.4 cm (AP x TRV x CC) soft tissue mass mass effaces the lower pole of the right kidney, and obstructs an upper pole calyx (2:37, 601b:36). 2. Large nodal conglomerate mass in the retroperitoneum displaces the IVC and encases the abdominal aorta, as described on the recently obtained CT of the chest from earlier today, as is extensive upper abdominal lymphadenopathy. 3. Diffuse bladder wall thickening with an enlarged and nodular prostate gland. 4. Enlarged spleen with hypodense 2 cm mass, as described on abdominal ultrasound from earlier today. 5. Bilateral pars defects at the L5 level contribute to grade 1 anterolisthesis of L5 on S1. CT CHEST ___: 1. Multiple pulmonary nodules, pleural based and extrapleural lesions and retroperitoneal masses/lymphadenopathy consistent with malignancy such as lymphoma or metastatic disease of unknown primary. One extrapleural posterior mediastinal lesion likely involves adjacent T 6 and 7 vertebral bodies. 2. Retroperitoneal mass, which is probably a conglomerate of para-aortic lymph nodes, displaces IVC anteriorly and encases the right renal vascular pedicle and abdominal aorta. Posterior mediastinal mass/ lymphadenopathy encases distal thoracic aorta. 3. Right hydronephrosis is partially imaged. 5. Splenomegaly. RENAL ULTRASOUND IMPRESSION ___: 1. There is a 7.4 cm mass in the mid right kidney, concerning for malignancy. There is right upper pole calyceal dilation consistent with obstruction by tumor. 2. Limited evaluation of spleen shows 2 cm and 0.7cm masses also concerning for metastasis. There is evidence of additional metastatic disease in the abdomen including retroperitoneal masses and a possible deep pelvic mass. The findings could represent diffuse lymphoma or other diffuse metastatic disease. CARDIAC ECHO, ___ The left atrium and right atrium are normal in cavity size. No atrial septal defect is seen by 2D or color Doppler. There is moderate symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>65%). The estimated cardiac index is normal (>=2.5L/min/m2). Right ventricular chamber size and free wall motion are normal. The aortic root, ascending aorta and arch are mildly dilated. The aortic valve leaflets are severely thickened/deformed. There is very severe aortic valve stenosis (Vmax ___ or mean gradient >=60mmHg; valve area <1.0cm2). Mild [1+] aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is mild pulmonary artery systolic hypertension. There is a very small pericardial effusion. IMPRESSION: Very severe aortic valve stenosis. Moderate symmetric left ventricular hypertrophy with preserved regional and global biventricular systolic function. Mildly dilated thoracic aorta. Mild aortic regurgitation. Mild pulmonary artery systolic hypertension. Compared with the prior study (images reviewed) of ___, the aortic valve gradient has further progressed and the estimated PA systolic pressure is now lower. CLINICAL IMPLICATIONS: The patient has severe aortic valve stenosis. Based on ___ ACC/AHA Valvular Heart Disease Guidelines, if a surgical or TAVI candidate, a mechanical intervention is recommended. CHEST PORT LINE PLACEMENT ___ There is a new right-sided PICC line with the distal lead tip in the right atrium. This could be pulled back 3-4 cm for more optimal placement. Heart size is within normal limits. There is again noted multiple masses within the left upper lobe which are pleural based on the recent CT scan. There are no pneumothoraces. There is atelectasis versus developing infiltrate at the right base. MR HEAD W/O CONTRAST 1. Study is moderately degraded by motion. 2. 9 x 18 x 14 mm right frontal extra-axial suppressed and 9 x 6 x 9 mm left middle cranial fossa masses as described. Differential considerations include meningioma and dural metastatic lesion. Recommend clinical correlation and attention on followup imaging. If clinically indicated, CT of the head may be obtained for evaluation for osseous involvement. RECOMMENDATION(S): 1. 9 x 18 x 14 mm right frontal extra-axial suppressed and 9 x 6 x 9 mm left middle cranial fossa masses as described. Differential considerations include meningioma and dural metastatic lesion. Recommend clinical correlation and attention on followup imaging. If clinically indicated, CT of the head may be obtained for evaluation for osseous involvement. Brief Hospital Course: Mr. ___ is an ___ w/severe aortic stenosis ___ 0.8), HTN, CAD s/p DES to LAD ___ who p/w substernal CP found on admission to have metastatic disease ___ DLBCL, final pathology from a L subpleural nodule core bx pending. # DLBCL: Patient presented with newly discovered mass in LUL on CXR, which revealed a 3.7 cm elliptical opacity in the mid left upper lung. CT chest on ___ revealed multiple pulmonary nodules with many pleural and extrapleural lesions and retroperitoneal masses/LAD c/w lymphoma vs metastatic disease. Also notes one posterior mediastinal lesion likely involving T6 and 7 vertebral bodies. Abdominal CT also on ___ revealed splenomegaly, a 8.1x7.9 cm retroperitoneal mass encasing the abdominal aorta, and a posterior mediastinal mass/ lymphadenopathy encasing distal thoracic aorta. The CT also revealed a 7.2x 6.4 mass in the R kidney and 2.0cm splenic lesion. Patient underwent CT guided pleural biopsy of a lung nodule, pathology consistent with Diffuse Large B cell lymphoma. Given patient's co-morbidities, mini-CHOP was chosen as treatment. Brain MRI on ___ revealed extra-axial lesions concerning for most likely meningioma.Patient started on Prednisone on ___, day 1 of chemotherapy was ___. The patient received three days of mini chop and five days of prednisone. # Hypercalcemia: Corrected calcium on admission 13.7. Likely secondary to lytic bone metastasis vs paraneoplastic. PTH 9 appropriately low. Patient symptomatic with constipation. Received 60 iv pamidronate ___ and 1L NS @ 150cc/r w/ 20 iv lasix given severe AS. PTHrP was within normal limits. Hypercalcemia closely monitored on ___ service and improved with prednisone and chemotherapy treatment. # AoCKD Stage III: Creatinine 2.4 on admission, up baseline of 1.5. Likely multifactorial from renal mass causing R hydronephrosis, hypercalcemia, potential pre-renal. Urine lytes from ___ w/ FeNa 1.3%, FeUrea 41.7% inconsistent with pre-renal etiology. Urology consulted, did not think patient a candidate for ureteral ___. Creatinine improved with Prednisone therapy, and was 1.7 on discharge. # Hyperuricemia: Uric acid ~11 on admission. Patient presented with hyperuricemia in the setting ___ on CKD, but may have been exacerbated by urate nephropathy or tumor lysis syndrome, though electrolytes did not meet ___ criteria (Uric acid>8 (his:11s), K>6 (his:5.0), Phos>4.5(his:3.3), Ca<7 (his:12s). Treated with allopurinol ___ QD with excellent effect. Uric acid was 4.2 upon admission and we increased the allopurinol to 200 daily upon discharge. # R Hydronephrosis: Worsening renal function likely related to hydronephrosis found on CT in the setting of metastasis and CKD stage III. ___ also have a cardiorenal component. Cr 2.4 (baseline 1.5, uptrending since ___. Renal ultrasound revealed right upper pole calyceal dilation consistent with obstruction by tumor. Urology consulted, weighed in on his R hydronephrosis ___ obstruction with uptrending Cr, but because patient was making adequate urine, with significant ureter obstruction, determined patient not a candidate for ___. Percutaneous approach contraindicated in the setting of dual antiplatelet agents for his ___. # Anemia: s/p transfusion ___ with 1U PRBCs well tolerated. Patient reported profound generalized fatigue and progressive anemia since ___ while on dual antiplatelet agents. H/H 7.8/23.5 (down from 8.7/26.9) on admission. Likely ___ malignancy with a component of CKD (Cr 2.2). Could also be related to ___ syndrome, given combination of severe AS and anemia. No BRBPR, hematochezia, or melena. Guaic negative in ED, though guaic positive on the floor. Iron studies: Fe 36 (low), ferritin 106, TRF, B12 wnl 645. H/H was stable at 9.2 upon discharge. Still anemic likely secondary to chemotherapy effect. # Severe Aortic Stenosis ___ 0.8cm2): Last saw Dr. ___ ___ with plan to discuss options with family. Patient intermediate risk for SAVR, but given his metastatic disease, his evaluation for this procedure was placed on hold. Disqualified for SURTAVI Trial. Likely considering balloon valvuloplasty for palliation if chest pain worsens. Patient presented with progressively worsening substernal chest pain radiating to the back and shoulder with minimal exertion and increasing frequency. His worsening AS was likely a contributor to his chest pain, though he had no episodes of CP while inhouse. Workup negative for a cardiac etiology, with negative CEx2 and EKG without significant changes from ___. In the setting of significant pulmonary and per-aortic metastasis, likely chest pain related to his significant tumor burden. ___ recommended holding off while patient undergoes treatment for metastatic disease. ___ consider balloon valvuloplasty if patient's conditions worsens during treatment for his lymphoma. # Hypothyroidism: TSH 42 ___. T3, FREE 1.2 (low). T4, FREE 1.2 (wnl). Repeat TSH 27. Continued on home dose of Levothyroxine. Labs should be repeated as an outpatient given the patient's acute illness in the hospital making TFTs more diffciult to interpret. # CAD s/p DES to LAD: PCI placed ___, and patient tolerated well with significant improvement in functional and exercise capacity. Patient continued on clopidogrel, atorvastatin, amlodipine, metoprolol and ASA. Plavix was stopped prior to initiation of treatment with mini-CHOP, and aspirin was stopped before the patient was discharged. Pt had no CP during admission. # UTI: Patient afebrile and asymptomatic on presentation, but UA showed pyruia, positive nitrite, and few bacteria. Received cipro x 1 in ED. Completed course of Ceftriaxone (D1: ___ - ___. UCx w/ pansensitive E coli. # Left lower extremity edema: LENIs negative. Patient presented with acute onset, no calf tenderness, asymmetric swelling compared to right side. Given progressively limited functional capacity over the past month, h/o malignancy, concern for DVT. Patient given SQH for ppx while inpatient. TRANSITIONAL ISUSES: - Patient had urinary retention during admission when tamsulosin was held; please confirm patient is urinating well at outpatient appointments and obtain PVR if concern for continued retention - He was started on colace and senna given constipation. Should be titrated as needed - Plavix and Aspirin stopped given expected platelet drop - He was started on acyclovir, allopurinol and bactrim ss for ppx. Outpatient providers should adjust as necessary. - Patient will follow up in clinic for Neulasta on ___ - Please follow Cr (discharge Cr 1.7) - MRI brain imaging showed a 9 x 18 x 14 mm right frontal extra-axial suppressed and 9 x 6 x 9 mm left middle cranial fossa masses as described felt most likely meningioma versus dural metastatic disease per report - final tissue from core biopsy and immunphenotyping pending - Full code Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Clopidogrel 75 mg PO DAILY 4. Levothyroxine Sodium 112 mcg PO DAILY 5. Lorazepam 0.5 mg PO QHS:PRN Anxiety, insomnia 6. Metoprolol Succinate XL 100 mg PO DAILY 7. Ascorbic Acid ___ mg PO DAILY 8. Aspirin 81 mg PO DAILY Discharge Medications: 1. Acyclovir 400 mg PO Q12H RX *acyclovir 400 mg 1 tablet(s) by mouth q 12 Disp #*30 Tablet Refills:*0 2. Sulfameth/Trimethoprim SS 1 TAB PO DAILY RX *sulfamethoxazole-trimethoprim 400 mg-80 mg 0.5 (One half) tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Loratadine 10 mg PO DAILY Duration: 2 Days Please take this medication on ___ and ___ (___). RX *loratadine 10 mg 1 tablet(s) by mouth one pill on ___. one pill on ___. Disp #*2 Tablet Refills:*0 4. Amlodipine 5 mg PO DAILY 5. Ascorbic Acid ___ mg PO DAILY 6. Levothyroxine Sodium 112 mcg PO DAILY 7. Lorazepam 0.5 mg PO QHS:PRN Anxiety, insomnia 8. Metoprolol Succinate XL 100 mg PO DAILY 9. Tamsulosin 0.4 mg PO QHS 10. Allopurinol ___ mg PO DAILY RX *allopurinol ___ mg 2 tablet(s) by mouth daily Disp #*60 Tablet Refills:*0 11. Atorvastatin 80 mg PO QPM 12. Senna 17.2 mg PO QHS Please hold if you develop loose stools. RX *sennosides [senna] 8.6 mg 2 capsules by mouth 1 time in the evening Disp #*28 Capsule Refills:*0 13. Docusate Sodium 100 mg PO BID Hold for loose stools. RX *docusate sodium 100 mg 1 capsule(s) by mouth two times per day Disp #*28 Capsule Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis Diffuse Large B Cell Lymphoma Secondary Diagnoses Severe aortic stenosis Acute on Chronic Kidney Disease Coronary Artery Disease Hypercalcemia Hyperuricemia Hypothyroidism Discharge Condition: Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure to participate in your care at ___. You were admitted on ___ with chest pain and leg swelling. During your work-up, we discovered abnormalities in your lung and abdomen. Because of this, we took a biopsy of one of the masses in your lungs, and the pathology is consistent with Diffuse Large B Cell Lymphoma. Your chemotherapy regimen was started with five days of prednisone followed by three days of chemotherapy before discharge. Some of your medications have changed. Please make sure you follow the new medication list. You will need to return to clinic tomorrow for an injection of a medication to help your bone marrow. Please take the medication called loratadine on ___ morning before coming to clinic and then again on ___ morning. Again, it was a pleasure participating in your care. Sincerely, Your ___ care team Followup Instructions: ___
10765488-DS-13
10,765,488
25,807,675
DS
13
2198-07-25 00:00:00
2198-07-26 14:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: This is a ___ yo M with PMH of DLBCL on R-CHOP, CAD s/p stent, severe aortic stenosis, who presented with increasing dyspnea on exertion. Patient's symptoms has been going on for 2 weeks, but appeared to be progressing. He stated dyspnea walking from car to home, and sometimes even from bed to bathroom. Symptom started 2 weeks ago. He sleeps in recliner and does not typically lie flat. He denies chest pain, diaphoresis, nausea, vomiting. He did not notice weight gain. While in the ___ clinic, pt was noted to have worsening anemia, and was given 1 u pRBC. He also received 20 mg iv lasix. Lab was notable for neutropenia (___ 112), BNP 19826, normal cardiac markers. CXR in the clinic showed b/l effusions with possible R sided hilar infiltrate. He was referred to the ED, given the lack of immediate bed openning. Initial VS in the ED were: 97.7 82 119/70 18 99% RA. Patient was also given vancomycin and cefepime, as well as repeat 20 mg lasix. Past Medical History: - Aortic stenosis - CAD s/p DES to LAD (___) - HTN - HLD - Hypothyroidism - BPH - B12 deficiency - History of ___ and ___ Social History: ___ Family History: Brother with lymphoma. another brother with pacemaker placement and sudden death. Daughter with breast cancer. Physical Exam: ============================= ADMISSION PHYSICAL EXAM: ============================= VS: 97.4 88 127/70 18 98% on RA GENERAL: NAD HEENT: NC/AT, EOMI, PERRL, MMM CARDIAC: RRR, ___ systolic ejection murmur, ___ heart @ LSB, very faint S2, radiation to carotids LUNG: Clear to auscultation, no wheezes or rhonchi ABD: +BS, soft, NT/ND, no rebound or guarding EXT: 2+ pitting edema to thigh PULSES: 2+DP pulses bilaterally NEURO: CN II-XII intact SKIN: Warm and dry, without rashes ============================= DISCHARGE PHYSICAL EXAM: ============================= Vitals: 98.1 F, HR ___, BP 90-140/60-80, RR 18, 96% RA General: NAD, hard of hearing, pleasant HEENT: NCAT, MMM, JVP 5-6 cm at clavicle Lungs: CTAB CV: loud mechanical-sounding holosystolic murmur, normal rate Abdomen: + BS, NT ND Ext: warm, well perfused, no edema Pertinent Results: ===================== ADMISSION LABS: ===================== ___ WBC-0.6*# RBC-2.35* Hgb-7.5* Hct-22.6* MCV-96 MCH-31.9 MCHC-33.2 RDW-19.1* RDWSD-67.7* Plt Ct-84*# ___ Neuts-23* Bands-5 ___ Monos-13 Eos-11* Baso-3* ___ Myelos-1* AbsNeut-0.17* AbsLymp-0.26* AbsMono-0.08* AbsEos-0.07 AbsBaso-0.02 ___ Glucose-151* UreaN-28* Creat-1.1 Na-140 K-4.0 Cl-110* HCO3-21* AnGap-13 ___ ALT-13 AST-12 LD(LDH)-205 CK(CPK)-55 AlkPhos-63 TotBili-0.6 ___ TotProt-5.8* Albumin-4.0 Globuln-1.8* Calcium-8.7 Phos-2.5* Mg-1.9 ======================== PERTINENT RESULTS: ======================== ___ cTropnT-0.01 ___ ___ cTropnT-0.02* ___ CK-MB-4 cTropnT-0.02* ___ Lactate-1.3 ___ 05:28AM BLOOD WBC-1.0* RBC-2.79* Hgb-8.8* Hct-25.9* MCV-93 MCH-31.5 MCHC-34.0 RDW-18.8* RDWSD-63.8* Plt ___ ___ 06:15AM BLOOD WBC-2.4*# RBC-2.69* Hgb-8.5* Hct-24.7* MCV-92 MCH-31.6 MCHC-34.4 RDW-18.6* RDWSD-62.0* Plt Ct-95* ___ 05:47AM BLOOD WBC-4.2# RBC-2.52* Hgb-8.1* Hct-23.3* MCV-93 MCH-32.1* MCHC-34.8 RDW-18.3* RDWSD-60.6* Plt Ct-97* ___ 05:20AM BLOOD WBC-6.8# RBC-2.52* Hgb-8.0* Hct-23.5* MCV-93 MCH-31.7 MCHC-34.0 RDW-18.7* RDWSD-62.2* Plt Ct-99* ___ 12:04AM BLOOD WBC-10.6*# RBC-2.64* Hgb-8.3* Hct-24.8* MCV-94 MCH-31.4 MCHC-33.5 RDW-19.3* RDWSD-64.3* Plt ___ ___ 05:10AM BLOOD WBC-12.7* RBC-2.71* Hgb-8.4* Hct-25.7* MCV-95 MCH-31.0 MCHC-32.7 RDW-19.7* RDWSD-65.7* Plt ___ ___ 05:20AM BLOOD WBC-11.4* RBC-2.64* Hgb-8.1* Hct-25.2* MCV-96 MCH-30.7 MCHC-32.1 RDW-19.8* RDWSD-67.1* Plt ___ ___ 05:19AM BLOOD WBC-10.4* RBC-2.47* Hgb-7.7* Hct-23.7* MCV-96 MCH-31.2 MCHC-32.5 RDW-19.9* RDWSD-68.0* Plt ___ ___ 05:47AM BLOOD Neuts-78* Bands-2 Lymphs-11* Monos-7 Eos-1 Baso-0 ___ Myelos-1* AbsNeut-3.36 AbsLymp-0.46* AbsMono-0.29 AbsEos-0.04 AbsBaso-0.00* ___ 05:20AM BLOOD Neuts-83* Bands-0 Lymphs-12* Monos-2* Eos-1 Baso-1 ___ Myelos-1* AbsNeut-5.64 AbsLymp-0.82* AbsMono-0.14* AbsEos-0.07 AbsBaso-0.07 ___ 06:00PM BLOOD cTropnT-0.02* ___ 05:28AM BLOOD CK-MB-4 cTropnT-0.02* ___ 05:20AM BLOOD CK-MB-4 cTropnT-0.03* ___ 12:04AM BLOOD CK-MB-4 cTropnT-0.02* === CXR (___): Mild interstitial pulmonary edema and bilateral pleural effusions increased since ___, representing volume overload. Opacity in the right infrahilar region may represent vascular congestion, however superimposed pneumonia cannot be ruled out. === CXR (___): A right chest port is again seen in stable position with distal tip projecting over the right atrium. Again seen are low lung volumes by suboptimal inspiratory effort. There is unchanged mild enlargement of the cardiac silhouette. Diffuse, centrally predominant interstitial prominence is compatible with pulmonary vascular congestion and likely mild pulmonary edema. A small to moderate right pleural effusion is again noted. A trace left pleural effusion is difficult to exclude. Retrocardiac opacification is unchanged, likely reflective of relaxation atelectasis. There is no pneumothorax. === CT ___: Interval development of relatively extensive bilateral pleural effusions, right more than left and subsequent areas of lobar collapse. The known posterior mediastinal mass is unchanged in size. Unchanged up to 6 mm large lung nodules. Evidence of mucous plugging at the level of the left lower lobe. === CT Abdomen/Pelvis (___): Interval decrease in disease burden, including decrease in size of a known right renal lesion and retroperitoneal and mesenteric lymphadenopathy, reflecting therapeutic response. No new focus of disease or new lymphadenopathy. Splenomegaly. Diverticulosis. Please see the chest CT dictation regarding intrathoracic findings. === ___ (___): The left atrial volume index is severely increased. Color-flow imaging of the interatrial septum raises the suspicion of an atrial septal defect, but this could not be confirmed on the basis of this study. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. There is moderate global left ventricular hypokinesis (LVEF = 35 %). The right ventricular free wall is hypertrophied. Right ventricular chamber size is normal. with normal free wall contractility. The aortic arch is mildly dilated. There are focal calcifications in the aortic arch. The aortic valve leaflets are severely thickened/deformed. There is severe aortic valve stenosis (valve area = 0.6cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Moderate (2+) mitral regurgitation is seen. Moderate [2+] tricuspid regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. Compared with the prior study (images reviewed) of ___, the left ventricular ejection fraction is markedly reduced. === CXR (___): Small right pleural effusion is smaller. Small left pleural effusion is the same or larger and mild interstitial pulmonary edema is the same. Heart size top-normal. Right hilar enlargement appears vascular and probably reflects biventricular cardiac decompensation. There is no good evidence of adenopathy in the mediastinum. Right supraclavicular central venous infusion port ends in the upper right atrium, as before. ===================== DISCHARGE LABS: ===================== ___ 06:17AM BLOOD WBC-10.9* RBC-2.97* Hgb-9.3* Hct-28.5* MCV-96 MCH-31.3 MCHC-32.6 RDW-20.1* RDWSD-69.8* Plt ___ ___ 12:04AM BLOOD Neuts-81* Bands-4 Lymphs-5* Monos-2* Eos-4 Baso-2* ___ Myelos-2* AbsNeut-9.01* AbsLymp-0.53* AbsMono-0.21 AbsEos-0.42 AbsBaso-0.21* ___ 12:04AM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-2+ Macrocy-1+ Microcy-NORMAL Polychr-1+ Ovalocy-1+ Schisto-OCCASIONAL Tear Dr-1+ Acantho-1+ ___ 06:17AM BLOOD Plt ___ ___ 06:17AM BLOOD Glucose-109* UreaN-17 Creat-1.2 Na-138 K-4.1 Cl-100 HCO3-28 AnGap-14 ___ 06:17AM BLOOD Calcium-9.2 Phos-3.6 Mg-2.0 Brief Hospital Course: Mr. ___ is an ___ man with DLBCL on cycle 3 of R-CHOP, CAD s/p DES, and severe aortic stenosis who presented to the Bone Marrow Transplantation service with increasing dyspnea on exertion. BNP was elevated to ___ from 3247 in ___ and the patient was hypervolemic on exam. Imaging showed bileratal, right greater than left, pleural effusions. He was transferred to ___ (cardiology service) For further management of diuresis. =================== ACTIVE ISSUES: =================== # Acute on Chronic Systolic Heart Failure: The patient presented from ___ clinic with two weeks of progressively worsening dyspnea on exertion. In clinic, the patient was noted to have worsening anemia, and was transfused 1 unit pRBCs followed by Lasix 20 mg IV. CXR in the clinic showed bilateral effusions with possible right-sided hilar infiltrate. The patient was started on empiric therapy with Vancomycin (___) and cefepime (___). On admission, BNP was elevated to ___ from 3247 in ___ and the patient was hypervolemic on exam. Imaging showed bileratal, right greater than left, pleural effusions. Cardiology was consulted, and the patient was gently diuresed with Lasix 20 mg IV daily initially, and then Lasix 10 mg PO daily, with symptomatic improvement. ___ showed LVEF of 35% from 65% on ___ on ___, with possible apical wall motion abnormality. EKG was without ST or T wave changes; troponins were 0.02 with flat MB. His amlodipine was discontinued. He was continued on metoprolol 150 mg daily. Worsening systolic dysfunction was attributed to possible anthracycline toxicity vs. stent restenosis. He was then transferred to ___ for further management. Weight on day of transfer: 136.2 lbs. He was diuresed with 20 mg IV lasix on his first day, and transitioned to 20 mg Lasix BID with good output. == # Aortic stenosis: Patient has severe AS ___ 0.6cm2 on ___ ___ with initial plan for SAVR vs. TAVR. However patient was admitted to the hospital on ___ for chest pain and shortness of breath and subsequently found to have a new lung mass and diagnosed with DLBCL. At that time, cardiac surgery recommended holding off intervention while patient undergoes treatment for metastatic disease. He is not considered a candidate for balloon valvuloplasty at the moment because he is responding to diuresis, and given that he is doing well on diuretics already, the risks of bleeding in a patient on Plavix and ASA would be high. == # DLBCL: Diagnosed in ___. C3D13 R-CHOP. Continued allopurinol, acyclovir prophylaxis. CT on ___ showed interval decrease in disease burden. The pt will f/u with his oncologist to discuss new chemo regimen given that he is thought to have chemo-induced cardiotoxicity. == # CAD s/p DES to LAD: Cardiac catheterization done in ___ noted 2VD with mLAD 85% and OM4 50% stenosis. Coronary intervention to LAD was performed with DESx1 on ___. Continued aspirin and plavix. Continued atorvastatin 80 mg qd. Continued metoprolol 150 mg qd. =================== CHRONIC ISSUES: =================== # Hypothyroidism: Continued levothyroxine 112 mcg qd. ========================= TRANSITIONAL ISSUES: ========================= - onc follow up: Patient will follow up with Dr. ___ on ___. He is not a candiate for balloon valvuloplasty at the moment because he responds to diuresis, and because valvuloplasty would carry a high risk of bleeding and 2-3% chance of periprocedure stroke. Should he become volume overloaded during chemotherapy and not responding diuretics, we can consider valvuloplasty at that time. He should continue to take his Plavix and aspirin. He needs to discuss a new chemotherapy regimen with Dr. ___ his acute doxorubicin cardiomyopathy. Given EF < 40% we recommend against further doxorubicin. - diuresis: he will get a 20 mg lasix BID prescription to take at home. - recommend repeat ___ in ___ weeks - pacemaker: given his new low EF of 35%, the pt may need EP followup to discuss ICD placement (he does have a RBBB). This can be discussed after repeat ___. === CODE: Full (confirmed) EMERGENCY CONTACT HCP: ___ (daughter) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Atorvastatin 80 mg PO QPM 3. Clopidogrel 75 mg PO DAILY 4. Levothyroxine Sodium 112 mcg PO DAILY 5. Lorazepam 0.5 mg PO QHS:PRN insomnia 6. Metoprolol Succinate XL 150 mg PO DAILY 7. Ascorbic Acid ___ mg PO DAILY 8. Aspirin 81 mg PO DAILY 9. Acyclovir 400 mg PO Q12H 10. Tamsulosin 0.4 mg PO QHS 11. Allopurinol ___ mg PO DAILY 12. Docusate Sodium 100 mg PO BID 13. Senna 8.6 mg PO BID Discharge Medications: 1. Acyclovir 400 mg PO Q12H 2. Allopurinol ___ mg PO DAILY 3. Ascorbic Acid ___ mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 80 mg PO QPM 6. Clopidogrel 75 mg PO DAILY 7. Docusate Sodium 100 mg PO BID 8. Levothyroxine Sodium 112 mcg PO DAILY 9. Lorazepam 0.5 mg PO QHS:PRN insomnia 10. Senna 8.6 mg PO BID 11. Tamsulosin 0.4 mg PO QHS 12. Furosemide 20 mg PO BID RX *furosemide 20 mg 1 tablet(s) by mouth twice daily Disp #*60 Tablet Refills:*0 13. Lisinopril 5 mg PO DAILY RX *lisinopril 5 mg 1 tablet(s) by mouth once daily Disp #*30 Tablet Refills:*0 14. Metoprolol Succinate XL 150 mg PO DAILY 15. Amlodipine 5 mg PO DAILY 16. Outpatient Lab Work Check CBC, Chem 10 on ___ Please fax results to Dr. ___: ___ Phone: ___ Fax: ___ Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses: - Acute Systolic Heart Failure - Aortic Stenosis Secondary Diagnoses: - Diffuse Large B-Cell Lymphoma - Pancytopenia - Hypothyroidism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to us because you were having shortness of breath. We found that your heart was not beating as strongly as it was before, and that you had fluid on your lungs. We gave you a water pill to help you get rid of the extra fluid. You will need to follow up with Dr. ___ to discuss what your new chemotherapy regimen should be. You will also follow up with Dr. ___ of our heart failure specialists, in clinic (we will call to make an appointment for you, but if you don't hear back by next ___, please call the number listed below). It was a pleasure taking care of you and we wish you the ___! Sincerely, Your ___ Team Followup Instructions: ___
10765596-DS-4
10,765,596
24,666,496
DS
4
2122-03-08 00:00:00
2122-03-09 23:11:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: None History of Present Illness: ___ with history of gestational hypertension who presents with shortness of breath, found to have hypertensive emergency. Patient developed acute onset dyspnea around 7PM yesterday and presented to the ED. Notes headache, but denies vision changes. Moved from ___ 2 months ago. Takes no medications at home. No drug use or supplements. Has not checked blood pressure in years, but had gestational HTN while pregnant with her son ___ years ago. In the emergency department, vitals notable for heart rate of 128 and BP 239/158, satting 99% on 2 L NC on arrival. Her labs are notable for WBC 14.4, Hb 10.0, BMP notable for creatinine 1.3. Normal LFTs. proBNP 7623. Troponin undetectable x1. D-dimer 1352. VBG pH 7.40 PCO2 35. EKG showing sinus tachycardia at 131 bpm. Chest x-ray showing pulmonary vascular congestion, moderate pulmonary edema, small left pleural effusion, no focal consolidations. CTA chest negative for PE, notable for cardiomegaly with moderate pulmonary edema and right greater than left nonhemorrhagic pleural effusions. Enlarged pulmonary artery. She was placed on a nitroglycerin drip, currently at 5 mcg/kg/min. Also received 1 g Tylenol, 20 mg IV Lasix, Ativan 0.5 mg. Blood pressures improved on nitro drip, currently 160/106, heart rate 105, 98% RA. On the floor, patient on nitro drip at 5 mcg/kg/min. She reports her symptoms have improved. She says she has had these symptoms on and for for the past month, came for evaluation as symptoms have progressed. She was unable to lie flat while she was at home for the past month, and this is the first time she is able to lie down. In fact she has been sleeping sitting up for the past month. Denies peripheral edema. No palpitations. When she was pregnant ___ years ago she did have preeclampsia, says she spent a lot of time in the hospital. She denies any heart problems during the time of and after that pregnancy. She reports that she does have significant family history of heart disease. Mother died of MI in ___, ___ year old cousin with ?genetic heart condition now s/p transplant doing well (not sure what condition). She reports recent onset of bilateral leg pain in her calves and hamstrings. She also notes headache since being on nitro gtt. REVIEW OF SYSTEMS: Cardiac review of systems is notable for absence of chest pain, ankle edema, palpitations, syncope, or presyncope. Past Medical History: 1. CARDIAC RISK FACTORS Hx gestational hypertension 2. CARDIAC HISTORY - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY Social History: ___ Family History: As above - mother died of MI in ___. Grand mother MI in ___. Great grandmother died of MI as well unsure what age. ___ yo cousin w/ apparent genetic heart failure condition now doing well s/p heart transplant. Physical Exam: ADMISSION EXAM: ================ GENERAL: Well-developed, well-nourished. NAD. Mood, affect appropriate HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with JVP of 6 cm CARDIAC: Rapid regular rhythm, normal S1, S2. Difficult to ascertain in the setting of tachycardia but possible systolic murmur. Thrill present over PMI at ___ intercostal space, midclavicular. S3 less noticeable than before. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi ABDOMEN: Soft, NTND. No HSM or tenderness EXTREMITIES: Mild lower extremity edema, minimal SKIN: No stasis dermatitis, ulcers, scars, or xanthomas PULSES: Distal pulses palpable and symmetric DISCHARGE EXAM: =============== VITALS: 24 HR Data (last updated ___ @ 1117) Temp: 97.6 (Tm 99.9), BP: 108/76 (99-119/63-83), HR: 71 (69-86), RR: 18 (___), O2 sat: 99% (99-100), O2 delivery: Ra GENERAL: Well-developed, well-nourished. NAD. Mood, affect appropriate HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no pallor or cyanosis of the oral mucosa. NECK: JVP 8 cm CARDIAC: Rapid regular rhythm, normal S1, S2. ___ harsh holosystolic murmur heard throughout but best at the LLSB. Hyperdynamic precordium. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi ABDOMEN: Soft, NTND. No HSM or tenderness EXTREMITIES: No lower extremity edema SKIN: No stasis dermatitis, ulcers, scars, or xanthomas PULSES: Distal pulses palpable and symmetric Pertinent Results: ADMISSION LABS =============== ___ 09:00PM BLOOD WBC-14.4* RBC-4.75 Hgb-10.0* Hct-34.2 MCV-72* MCH-21.1* MCHC-29.2* RDW-16.7* RDWSD-42.5 Plt ___ ___ 09:00PM BLOOD Neuts-76.8* Lymphs-16.8* Monos-3.8* Eos-1.6 Baso-0.6 Im ___ AbsNeut-11.04* AbsLymp-2.42 AbsMono-0.55 AbsEos-0.23 AbsBaso-0.09* ___:07PM BLOOD D-Dimer-1352* ___ 04:20PM BLOOD Ret Aut-1.6 Abs Ret-0.07 ___ 09:00PM BLOOD Glucose-95 UreaN-20 Creat-1.3* Na-135 K-3.7 Cl-100 HCO3-20* AnGap-15 ___ 09:00PM BLOOD Albumin-4.2 Calcium-9.3 Phos-3.8 Mg-1.9 ___ 09:00PM BLOOD ALT-17 AST-22 AlkPhos-69 TotBili-0.5 ___ 09:00PM BLOOD proBNP-7623* ___ 09:00PM BLOOD cTropnT-<0.01 ___ 10:25PM URINE Color-Straw Appear-Hazy* Sp ___ ___ 10:25PM URINE Blood-NEG Nitrite-NEG Protein-30* Glucose-NEG Ketone-TR* Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-LG* ___ 10:25PM URINE RBC-1 WBC-20* Bacteri-NONE Yeast-NONE Epi-13 TransE-<1 ___ 11:24PM URINE Hours-RANDOM Na-<20 K-16 ___ 11:24PM URINE Osmolal-194 ___ 10:25PM URINE UCG-NEGATIVE ___ 11:24PM URINE bnzodzp-NEG barbitr-NEG opiates-NEG cocaine-NEG amphetm-NEG oxycodn-NEG mthdone-NEG PERTINENT LABS ============== ___ 06:40AM BLOOD Hypochr-1+* Anisocy-1+* Poiklo-2+* Microcy-1+* Echino-1+* Ellipto-2+* RBC Mor-SLIDE REVI ___ 04:20PM BLOOD Calcium-9.2 Phos-4.4 Mg-1.8 Iron-21* ___ 08:20AM BLOOD %HbA1c-5.2 eAG-103 ___ 08:20AM BLOOD Triglyc-88 HDL-58 CHOL/HD-3.0 LDLcalc-100 ___ 04:20PM BLOOD TSH-1.5 ___ 08:20AM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG ___ 08:20AM BLOOD PEP-NO SPECIFI IgG-1521 IgA-285 IgM-120 IFE-NO MONOCLO ___ 06:30AM BLOOD FreeKap-32.7* FreeLam-31.5* Fr K/L-1.0 ___ 06:27AM BLOOD HIV Ab-NEG ___ 08:20AM BLOOD HCV Ab-NEG PERTINENT IMAGING ================== CTA Chest ___: IMPRESSION: 1. No evidence of pulmonary embolism or aortic abnormality 2. Cardiomegaly with moderate pulmonary edema and bilateral, right greater than left, nonhemorrhagic pleural effusions 3. The main pulmonary artery is enlarged, suggestive of pulmonary artery hypertension ___ Duplex Renal Ultrasound Normal renal ultrasound. No evidence of renal artery stenosis. ___ TTE Report LVEF 30%. severe concentric left ventricular hypertrophy with moderate-to-severe left ventricular systolic dysfunction with regional variation (inferior and posterior walls worst) ___ Bilateral Doppler US for DVT No evidence of deep venous thrombosis in the right or left lower extremity veins. No focal fluid collection. ___ Cardiac MRI Moderate left ventricular hypertrophy with severely increased mass index. Severely dilated left ventricle and severe global systolic dysfunction with preservation of function of the apical segments (see schematic). No late gadolinium enhancement c/w absence of focal fibrosis/scar. Normal right ventricular cavity size with mild global systolic dysfunction. Mild aortic and mitral regurgitation. Given the presence of significant left ventricular hypertrophy and absence of gadolinium enhancement, the CMR findings are most suggestive of a hypertensive cardiomyopathy. DISCHARGE LABS =============== ___ 06:40AM BLOOD Glucose-91 UreaN-27* Creat-1.3* Na-138 K-4.4 Cl-100 HCO3-22 AnGap-16 ___ 06:40AM BLOOD Calcium-9.5 Phos-4.7* Mg-2.2 ___ 06:40AM BLOOD proBNP-130 Brief Hospital Course: TRANSITIONAL ISSUES: ==================== [ ] Hepatitis non-immune. Encourage vaccination as outpatient [ ] Consider genetic counseling as outpatient given young age and presentation with HF and HTN [ ] Plans to return to ___ in ___, please consider this with relevant testing [ ] Repeat Metanepherine urine testing pending, if positive or for questions contact endocrine fellow ___, she saw patient inpatient from endocrine [] Patient provided with financial services information to assist her in affording appointments. Please keep her lack of insurance in mind when prescribing new medications, setting up appointments etc SUMMARY STATEMENT: ==================== ___ from ___ 2 months prior to admission presented with dyspnea, found to have heart failure exacerbation and hypertensive emergency. She initially required a nitro drip and IV diuresis improving prior to discharge. Her heart failure etiology was thought to be ___ hypertension. Extensive secondary hypertension evaluation showed elevated metanephrines in her urine for which endocrine was consulted and recommended repeat testing. # CORONARIES: unknown # PUMP: 30% # RHYTHM: sinus tach ACTIVE ISSUES: ============== # Acute Heart Failure with reduced EF New diagnosis. Extensively laboratory eval as below w/o findings. MRI w/o infiltrative disease. She did have elevated urine metanephrines in the setting of her hypertensive episode. Notably a pheochromocytoma can cause a cardiomyopathy. Endocrine was consulted as below. She was iron deficient and received IV iron and goal directed heart failure management with lisinopril, spironolactone, and carvedilol. Work up: HIV neg, ferritin 21 wnl, TSH 1.5 wnl, Hep B neg/unvaccin, HCV b neg, urine tox negative, SPEP/UPEP, free kappa/lambda light chains (elevated, normal ratio) Considered lyme (no conduction abnormality noted but prolonged QT). # Hypertensive emergency # Elevated urine metanephrines Given severe elevation in this patient with history of gestational hypertension secondary HTN work up initiated. Sent renin/aldosterone ratio, 24 hour urine fractionated metanephrines & catechols, serum metanephrines. Urine metanephrines were positive, but this was during hospitalization when she was hypertensive which can raise the levels in any patient. We repeated testing inpatient prior to discharge. If it remains elevated she will likely require abdominal imaging. A renal artery ultrasound w/ doppler was negative. Pt was weaned off nitro gtt and uptitrated GDMT per above. She also was started on amlodipine, which was later d/c'd in favor of ACE inhibitor and carvedilol for goal directed medical therapy. # Microcytic anemia, iron deficiency No evidence of bleeding. Unclear cause given pt history. Possibly menorrhagia, as it is the most common cause and patient recounts myomectomies. Sent iron studies, retic count, hemolysis labs, and started IV iron given iron deficiency seen on labs. # Prolonged QT Pt found to have prolonged QT so we avoided QT prolonging agents # Leg pain Patient reporting bilateral leg pain. No edema, no skin changes; low concern for DVT but given reoccurred got doppler US of LEs that was negative. Pain may be a side effect of diuretic, and has resolved. # ___ Likely cardiorenal given improvement following diuresis. Diuresed per above. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever RX *acetaminophen 500 mg 2 tablet(s) by mouth every 8 hours as needed for pain Disp #*180 Tablet Refills:*3 2. CARVedilol 6.25 mg PO BID RX *carvedilol 6.25 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*3 3. Furosemide 60 mg PO DAILY RX *furosemide 20 mg 3 tablet(s) by mouth once a day Disp #*90 Tablet Refills:*3 4. Lisinopril 40 mg PO DAILY RX *lisinopril 40 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*3 5. Spironolactone 25 mg PO DAILY RX *spironolactone 25 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*3 Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSES: Acute heart failure exacerbation with reduced ejection fraction Hypertension SECONDARY DIAGNOSIS: Anemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, It was a pleasure taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? - You were admitted to the hospital because you were short of breath. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? - In the hospital you were found to have new heart failure. We did many blood and imaging tests and think your heart failure is because of high blood pressure. - We did a work up to find out why your blood pressure is so high. Some of the tests indicate you may be producing too much adrenaline. This can also happen when your blood pressure is high so we repeated the test before you were discharged. WHAT SHOULD I DO WHEN I GO HOME? - Please take all of your medications exactly as prescribed and attend all of your follow-up appointments listed below. We are providing you with information from financial services to help you since you do not have insurance. - If your weight goes up or down by more than 3 lbs (discharge weight 93.8 kg or 207 lbs), please call the cardiology office for instructions (___) We wish you the best! Your ___ Care Team Followup Instructions: ___
10765746-DS-10
10,765,746
28,051,876
DS
10
2156-01-09 00:00:00
2156-01-09 16:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: Codeine Attending: ___ Chief Complaint: left sided weakness Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ left-handed man with a history of alcoholism, CAD, NIDDM, peripheral neuropathy, and hyperlipidemia who presents with left-sided weakness started at 4 ___ on ___. He was at home yesterday afternoon sitting at a table. He says he put his ___ down to take a nap, and awoke ~15 minutes later and discovered he had difficulty using his left arm. He tried to get up and discovered his left leg was weak and he could not walk. He minimized his symptoms to his wife over the subsequent hours, and refused to go to the hospital. His adult son came home ~9PM, and during the subsequent hours as they had to carry him around, to the bathroom, etc, they eventually convinced him he needed to go to the hospital. They arrived in the ED at ~2:20AM on ___, about 10 hours after last known well. He was far out of the window for tPA. CTA was done which showed no vessel cutoffs, particularly in any areas which would be amenable to endovascular intervention this many hours post-ictus. He was recently admitted in the ED (observation) from ___ for vomiting, diarrhea, and hyperglycemia related to poor medication compliance and heavy alcohol use. He had previously been taken off of insulin due to concerns for hypoglycemia given his drinking. According to his son, he drinks "all the time", ___ to an entire bottle of liquor at a time. He takes his metformin inconsistently. His compliance with his other medications is questionable. His son says it is difficult to believe anything he says. His son does say that he has been drinking less alcohol following the ED admission earlier this month, though he did drink heavily last ___. His son notes that he has not been eating much in the last month, and has lost weight in the last year. He does not weigh himself, but his son says he looks much thinner than he did ___ year ago. Past Medical History: - DM2: last HbA1C 8.3, on Metformin 500mg BID which he takes faithfully - Dyslipidemia - Hypertension - Past tobacco abuse - Alcohol abuse Social History: ___ Family History: Multiple family members with DM Father died of snake bite Mother and eldest brother died of complications of diabetes 5 children all health No known family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM: General: NAD HEENT: NCAT, no oropharyngeal lesions, neck supple ___: RRR, no M/R/G Pulmonary: CTAB, no crackles or wheezes Abdomen: Soft, NT, ND, +BS, no guarding Extremities: Warm, no edema. Neurologic Examination: - Mental status: Awake, alert, oriented x 3. Able to relate history without difficulty. Speech is fluent with full sentences, intact repetition, and intact verbal comprehension. Naming intact to items on stroke card. No paraphasias. No dysarthria on "pa-ma-ta-ka-ga". Normal prosody. No apraxia. No evidence of hemineglect. No left-right confusion. Able to follow both midline and appendicular commands. - Cranial Nerves: PERRL 3->2 brisk. VF full to confrontation. EOMI, no nystagmus. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to speech. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No drift. No tremor or asterixis. [___] L 4 5 5 4 4 4- 2+ 4 4- 4 5 5 R 5 5 5 5 5 5 5 5 5 5 5 5 - Reflexes: Brisk [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 0 R 2+ 2+ 2+ 2+ 0 Plantar response mute on left, extensor on right. - Sensory: No deficits to light touch, proprioception, or cold sensation. No extinction to DSS. - Coordination: On left, mild dysmetria on FNF and slowed repetitive finger tapping, however both appear in proportion to weakness. - Gait: Not able. DISCHARGE PHYSICAL EXAM: General: Awake, cooperative, lying in bed NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: Lungs CTA bilaterally without R/R/W Cardiac: RRR, nl. S1S2, no M/R/G noted Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or organomegaly noted. Extremities: No ___ edema. Skin: no rashes or lesions noted. Neurologic Examination: - Mental status: Awake, alert, oriented to person, place, and date. Able to relate history without difficulty. Speech is fluent with full sentences, intact repetition, and intact verbal comprehension. Naming intact to items on stroke card. No paraphasic errors. Normal prosody. No apraxia. No evidence of hemineglect. No left-right confusion. Able to follow both midline and appendicular commands. - Cranial Nerves: PERRL 2->1 brisk. VF full to confrontation. EOMI, no nystagmus. V1-V3 without deficits to light touch bilaterally. No facial movement asymmetry. Hearing intact to speech. Palate elevation symmetric. SCM/Trapezius strength ___ bilaterally. Tongue midline. - Motor: Normal bulk and tone. No tremor or asterixis. [___] L 4+ 5 5- 4+ 4 4 4- 5 4 4+ 5 5 R 5 5 5 5 5 5 5 5 5 5 5 5 - Reflexes: [Bic] [Tri] [___] [Quad] [Gastroc] L 2+ 2+ 2+ 2+ 0 R 2+ 2+ 2+ 2+ 0 Plantar response mute on left, extensor on right. - Sensory: No deficits to light touch, proprioception, or cold sensation. No extinction to DSS. - Coordination: On left, + dysmetria on FNF and slowed finger tapping - Gait: Not able. Pertinent Results: ___ 06:25AM BLOOD WBC-5.2 RBC-4.33* Hgb-14.4 Hct-38.7* MCV-89 MCH-33.3* MCHC-37.2* RDW-13.2 RDWSD-43.2 Plt ___ ___ 02:37AM BLOOD WBC-6.6 RBC-4.32* Hgb-14.6 Hct-39.4* MCV-91 MCH-33.8* MCHC-37.1* RDW-13.3 RDWSD-45.1 Plt ___ ___ 06:25AM BLOOD ___ PTT-30.4 ___ ___ 02:37AM BLOOD ___ PTT-26.9 ___ ___ 06:25AM BLOOD Glucose-118* UreaN-18 Creat-1.5* Na-134 K-4.1 Cl-97 HCO3-23 AnGap-18 ___ 02:37AM BLOOD Glucose-287* UreaN-25* Creat-2.3*# Na-131* K-6.3* Cl-95* HCO3-20* AnGap-22* ___ 04:17AM BLOOD ALT-17 AST-14 AlkPhos-80 Amylase-80 TotBili-0.3 ___ 04:17AM BLOOD Lipase-105* GGT-44 ___ 06:25AM BLOOD Calcium-9.6 Phos-3.7 Mg-2.1 ___ 02:37AM BLOOD Calcium-9.6 Phos-3.2 Mg-2.2 ___ 04:17AM BLOOD Albumin-4.0 Cholest-138 ___ 05:44AM BLOOD %HbA1c-8.4* eAG-194* ___ 04:17AM BLOOD Triglyc-198* HDL-36 CHOL/HD-3.8 LDLcalc-62 ___ 04:17AM BLOOD TSH-1.2 ___ 02:37AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG - ___ CTA ___ & Neck 1. Acute infarcts in the right pons and medulla seen on subsequent MRI are not well visualized on this CT. No hemorrhage. Extensive bilateral white matter changes suggestive of chronic small vessel ischemic disease. 2. High-grade focal narrowing at the origin of the basilar artery. Otherwise, unremarkable ___ CTA aside from scattered atherosclerotic disease. 3. Mixed soft and calcified plaque at the carotid bifurcations does not result in significant luminal narrowing of the internal carotid arteries by NASCET criteria. 4. Mild multifocal atherosclerotic plaque along the course of the vertebral arteries without appreciable luminal narrowing. 5. Filling defect in a subsegmental left upper lobe pulmonary artery is suspicious for pulmonary embolism. Dedicated CTA chest is recommended for confirmation. 6. Diffuse esophageal wall thickening likely representing nonspecific esophagitis. 7. 3 mm right upper lobe pulmonary nodule. ___ Chest 1. Re-demonstration of left upper lobe subsegmental pulmonary embolus. No other pulmonary emboli visualized. No signs of right heart strain. 2. Mild, left greater than right bilateral lower lobe atelectasis. 3. Moderate coronary calcific atherosclerosis. 4. Cholelithiasis. ___ ___ w/o 1. Focus of late acute infarction involving the right anterior pons and right upper medulla. 2. Extensive white matter changes, suggestive of chronic small vessel ischemic disease and chronic lacunar infarcts in the left cerebellum, left thalamus, and bilateral basal ganglia. 3. No hemorrhage. Brief Hospital Course: Pt presented to ___ with new onset of left hand and leg weakness although was seen to be outside of tPA window and not a thrombectomy candidate. He was admitted to the Neurology Stroke Service and was monitored on telemetry. On imaging, he was seen to have basilar artery narrowing on CTA as well as acute infarct in right anterior pons and upper medulla on MRI, suggestive of large vessel disease producing infarct in small vessel territory. He was also noted to have a subsegmental pulmonary embolism on CTA Chest and per discussion with Medicine was started on Eliquis as anticoagulation therapy for 3 months. He was continued on his home statin and underwent Echocardiogram. While admitted, his diabetes regimen was adjusted per ___ Diabetes Team although pt did not want to start insulin and wished to remain on home PO diabetes medications. He was evaluated by ___ and deemed candidate for acute rehab. AHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic Attack 1. Dysphagia screening before any PO intake? (X) Yes, confirmed done - () Not confirmed – () No 2. DVT Prophylaxis administered? (X) Yes - () No 3. Antithrombotic therapy administered by end of hospital day 2? (X) Yes - () No 4. LDL documented? (X) Yes (LDL = 62 ) - () No 5. Intensive statin therapy administered? (simvastatin 80mg, simvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, rosuvastatin 20mg or 40mg, for LDL > 100) (X) Yes - () No [if LDL if LDL >70, reason not given: [ ] Statin medication allergy [ ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist [ ] LDL-c less than 70 mg/dL] 6. Smoking cessation counseling given? () Yes - (X) No [reason (X) non-smoker - () unable to participate] 7. Stroke education (personal modifiable risk factors, how to activate EMS for stroke, stroke warning signs and symptoms, prescribed medications, need for followup) given (verbally or written)? (X) Yes - () No 8. Assessment for rehabilitation or rehab services considered? (X) Yes - () No 9. Discharged on statin therapy? (X) Yes - () No [if LDL >70, reason not given: [ ] Statin medication allergy [ ] Other reasons documented by physician/advanced practice nurse/physician ___ (physician/APN/PA) or pharmacist [ ] LDL-c less than 70 mg/dL 10. Discharged on antithrombotic therapy? (X) Yes [Type: () Antiplatelet - (X) Anticoagulation] - () No 11. Discharged on oral anticoagulation for patients with atrial fibrillation/flutter? () Yes - () No - (X) N/A Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Gabapentin 200 mg PO DAILY 3. GlipiZIDE 10 mg PO BID 4. Hydrochlorothiazide 25 mg PO DAILY 5. Lisinopril 40 mg PO DAILY 6. Metoprolol Succinate XL 100 mg PO DAILY 7. Rosuvastatin Calcium 40 mg PO QPM 8. amLODIPine 10 mg PO DAILY 9. MetFORMIN XR (Glucophage XR) ___ mg PO DAILY Discharge Medications: 1. Apixaban 10 mg PO BID Take twice daily for 7 days followed by 5mg twice daily for 3 months RX *apixaban [Eliquis] 5 mg 2 tablet(s) by mouth Twice daily Disp #*60 Tablet Refills:*2 2. amLODIPine 10 mg PO DAILY 3. Gabapentin 200 mg PO DAILY 4. GlipiZIDE 10 mg PO BID 5. Hydrochlorothiazide 25 mg PO DAILY 6. Lisinopril 40 mg PO DAILY 7. MetFORMIN XR (Glucophage XR) ___ mg PO DAILY 8. Metoprolol Succinate XL 100 mg PO DAILY 9. Rosuvastatin Calcium 40 mg PO QPM 10. HELD- Aspirin 81 mg PO DAILY This medication was held. Do not restart Aspirin until completion of three month therapy of Eliquis and PCP agrees Discharge ___: Extended Care Facility: ___ Discharge Diagnosis: Acute ischemic stroke in R anterior pons and upper medulla Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid ___ or cane). Discharge Instructions: Dear ___, You were hospitalized due to symptoms of left sided weakness resulting from an ACUTE ISCHEMIC STROKE, a condition where a blood vessel providing oxygen and nutrients to the brain is blocked by a clot. The brain is the part of your body that controls and directs all the other parts of your body, so damage to the brain from being deprived of its blood supply can result in a variety of symptoms. Stroke can have many different causes, so we assessed you for medical conditions that might raise your risk of having stroke. In order to prevent future strokes, we plan to modify those risk factors. Your risk factors are: High blood pressure High cholesterol Coronary artery disease Diabetes Mellitus We are changing your medications as follows: Please continue taking Eliquis 10mg twice daily for 7 days. Then, take 5mg twice daily for 3 months to treat blood clot in lungs. After completion of this therapy, start taking Aspirin 81mg daily. Please take your other medications as prescribed. Please followup with your primary care physician and obtain referral to see a neurologist. Please call Nephrology at ___ ___ to schedule appointment per your PCP's recommendations. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to you - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team Followup Instructions: ___
10765746-DS-11
10,765,746
26,589,808
DS
11
2156-01-15 00:00:00
2156-01-16 07:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Codeine Attending: ___. Chief Complaint: Extremity stiffness / weakness Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ gentleman witha PMHx of recent right pontine and medullar infarcts (admitted___, residual left ___ weakness in UMN pattern and LUE dysmetria), HTN, HL, DM, tobacco use, and active alcohol use disorder who presented with acute worsening of his weakness at 1pmthe day PTA and left sided stiffness that started at 12:30pm on day of admission and has been improving since then. The patient was recently discharged to ___ from the neurology stroke service on ___. He had residual left-sided weakness on discharge, but felt that his weakness had been improving since presentation on ___ (although not full strength). He notes that he first experienced worsening of his new baseline yesterday (___) at 1:00pm. However, per his son who was at the bedside, this first took place on ___ at 1:00pm. At that time, the patient was sitting up in a wheelchair and watching television when he developed left arm and leg stiffness and was unable to move those limbs. He also had paresthesias in his left fingertips. He denied any numbness, headache, dysarthria, aphasia, or facial droop. His symptoms resolved after a few hours and then he returned to his recent baseline. The following day (___), at 1:00pm, he had the same symptoms as above. He was again sitting in a wheelchair watching television. These symptoms persisted until 9:00pm, at which time they spontaneously resolved. On the morning of presentation (___), he was able to participate with ___ at 10:00am and do exercises with his left side and ambulate. However, at 12:30pm (note: patient initially said it startedtoday at 5:25pm but later changed the timeframe), again while sitting in a wheelchair watching television, he experienced the same symptoms as above. On EMS arrival, his stiffness began to improve but he still had trouble lifting his left arm and leg up. Notably, the patient has a longstanding history of active alcohol use disorder. However, he denies any alcohol intake in rehab. At baseline, he has been drinking 0.5-1 bottles of alcohol(usually whisky) daily for the last ___ years. Also, of note, the patient notes that his voice becomes hoarse in the afternoons; this has been going on for 6 months. In the emergency room he was seen by neurology who initially recommended inpatient MRI and to resume home apixaban, hold home antihypertensives and perform strict glycemic control. He was given 2L NS in the ED. On arrival to the floor, patient stated that he felt he was moving better and confirmed story as above. On ROS, the pt denies headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, vertigo, tinnitus, and hearing difficulty. Denies difficulties producing or comprehending speech. No bowel or bladder incontinence or retention. +Recent weight loss over last year Denies recent fever or chills. No night sweats. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea,vomiting, diarrhea, constipation, or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: - pontine and medullar infarcts (admitted ___ - DM2 - Dyslipidemia - Hypertension - Past tobacco abuse - Alcohol abuse Social History: ___ Family History: Multiple family members with DM Father died of snake bite Mother and eldest brother died of complications of diabetes 5 children all health No known family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM ======================= Vital Signs: 97.5 164/91 76 18 98%RA General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL. Neck: Supple. JVP not elevated. no LAD CV: Regular rate and rhythm. Normal S1+S2, no murmurs, rubs, gallops. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNIII-XII intact with the exception of mildly decreased L face sensation, ___ LUE and LLE strength ___ shoulder and elbow flexion/extension, ___ ankle dorsiflexion, ___ ankle plantarflexion, ___ hip flexion) DISCHARGE PHYSICAL EXAM ======================= Vital Signs: T 97.5 BP 146/74 HR 74 RR 18 O2Sat 97% RA General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL. Neck: Supple. JVP not elevated. no LAD CV: Regular rate and rhythm. Normal S1+S2, no murmurs, rubs, gallops. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNIII-XII intact with the exception of mildly decreased L face sensation, ___ LUE and LLE strength ___ shoulder and elbow flexion/extension, ___ ankle dorsiflexion, ___ ankle plantarflexion, ___ hip flexion) Pertinent Results: ADMISSION LABS ============== ___ 06:50PM BLOOD WBC-6.2 RBC-4.45* Hgb-14.9 Hct-39.8* MCV-89 MCH-33.5* MCHC-37.4* RDW-13.4 RDWSD-43.8 Plt ___ ___ 06:50PM BLOOD Neuts-61.0 ___ Monos-12.0 Eos-1.9 Baso-1.0 Im ___ AbsNeut-3.76 AbsLymp-1.47 AbsMono-0.74 AbsEos-0.12 AbsBaso-0.06 ___ 06:50PM BLOOD ___ PTT-31.4 ___ ___ 06:50PM BLOOD Glucose-202* UreaN-25* Creat-1.9* Na-132* K-4.7 Cl-94* HCO3-21* AnGap-22* ___ 06:50PM BLOOD CK(CPK)-100 ___ 06:50PM BLOOD CK-MB-4 ___ 06:50PM BLOOD cTropnT-<0.01 ___ 08:05AM BLOOD CK-MB-4 cTropnT-<0.01 ___ 06:50PM BLOOD Calcium-10.2 Phos-4.0 Mg-2.1 ___ 07:14PM BLOOD Glucose-194* Lactate-4.0* Na-132* K-4.5 Cl-98 calHCO3-20* PERTINENT LABS ============== ___ 10:35PM BLOOD Lactate-2.1* ___ 08:40AM BLOOD Lactate-2.0 PERTINENT STUDIES/IMAGING/MICRO =============================== ___ 10:40 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. ___ 6:50 pm BLOOD CULTURE STROKE. Blood Culture, Routine (Pending): CT HEAD ___: FINDINGS: There is no evidence of no evidence of vascular territorial acute infarction, hemorrhage, edema, or mass. Prominent ventricles and sulci is suggestive of cerebellar atrophy. Periventricular and subcortical confluent white matter hypodensities is likely secondary to chronic small vessel ischemic disease. Chronic bilateral thalamic lacunar infarcts are again noted. Old left cerebellar infarcts are also noted. There is preservation of gray-white matter differentiation. The basal cisterns remain patent. No osseous abnormalities seen. A mucous retention cyst is seen in the left maxillary sinus. The remainder of the paranasal sinuses, mastoid air cells, and middle ear cavities are essentially clear. The orbits are unremarkable. IMPRESSION: No evidence for acute intracranial process. Extensive white matter hypodensities which are likely sequela of chronic small vessel disease. If persistent clinical concern for an acute infarct, MRI may prove to be of use. CXR ___: FINDINGS: The lungs are clear without lobar consolidation, pleural effusion, pneumothorax, or pulmonary edema. Left streaky retrocardiac airspace opacity is noted, similar to prior and likely representing atelectasis. The cardiomediastinal contours are unchanged. IMPRESSION: Left lower lobe atelectasis. Otherwise, no evidence for acute cardiopulmonary process. DISCHARGE LABS ============== ___ 07:50AM BLOOD WBC-4.7 RBC-4.45* Hgb-14.5 Hct-39.6* MCV-89 MCH-32.6* MCHC-36.6 RDW-13.2 RDWSD-43.4 Plt ___ ___ 07:50AM BLOOD Glucose-173* UreaN-24* Creat-1.6* Na-136 K-4.3 Cl-98 HCO3-23 AnGap-19 ___:50AM BLOOD Calcium-10.0 Phos-4.8* Mg-2.2 Brief Hospital Course: Mr. ___ is a ___ gentleman with h/o CAD, NIDDM, peripheral neuropathy, hld, EtOH abuse discharge on ___ from neurology with basilar artery narrowing and R anterior pons/upper medulla stroke along with incidental subsegmental PE started on apixaban who presented with concern for repeat stroke symptoms likely due to recrudescence in the setting of toxic-metabolic insult with acute kidney injury and lactic acidosis related to metformin, vs muscle spasm in setting of recent stroke. Antihypertensives were initially held due to concern for stroke but neurology recommended restarting. He was also complaining of intermittent stiffness thought due to muscle spasm per neurology. His stroke symptoms improved back towards his recent post-discharge baseline after fluid resuscitation and discontinuation of metformin. Neurology saw the patient and thought there was no concern for new or repeat stroke so repeat MRI was not performed. As he improved back towards his recent baseline and remained clinically stable he was cleared for discharge back to rehab. ACTIVE ISSUES: # Stroke symptoms: Thought to be likely recrudescence in setting of toxic/metabolic insult with ___ and metformin-related lactic acidosis. No evidence of infection or acute intracranial process was found. Neurology felt there was not significant concern for new or repeat stroke so repeat MRI was not performed. He was continued on his home rosuvastatin. His home antihypertensives were restarted with the exception of lisinopril which was held given ___. He was continued on his home apixaban and restarted on aspirin 81mg daily. # Extremity stiffness: Likely due to post-stroke muscle spasm per neurology. Patient did not find it bothersome enough to start medication. Neurology's recs as below: -If significant symptoms can start baclofen 5mg PO TID and uptitrate as needed # Acute kidney injury, improving: Cr down to 1.5 on ___ after fluid administration though baseline is likely 1.2. Likely at new baseline after repeat insults. Discontinued metformin given Cr and lactic acidosis. Held lisinopril. Will need ongoing monitoring as an outpt. # Lactic acidosis, resolved: Lactate 4.0 on admission down to 2.1 with hydration. Thought due to metformin administration with ___. Resolved after fluid resuscitation and discontinuing metformin. # Subsegmental PE: Incidentally found on previous admission as part of diverticulitis workup. He is getting a therapeutic course of apixaban. Continue home apixaban (in the midst of 10mg BID x7 days through ___ change to 5mg PO BID on ___ plan for 3 months anticoagulation) # Hyperlipidemia: -continued home rosuvastatin 40mg # Diabetes mellitus: -Humalog SS AC and HS while in house -held home glipizide in-house, restarted on discharge -discontinued metformin given Cr -Appointment set up for ___ follow up on discharge # Coronary artery disease -3VD, recommended medical therapy on cardiac cath ___ -restarted home aspirin at 81mg daily -continued metoprolol at home dose # Hypertension -restarted home antihypertensives (amlodipine, HCTZ) after briefly being held, but continued to hold lisinopril given ___ -If persistently hypertensive, would recheck Cr and if stable (1.5), or improved, would consider restarting lisinopril # Alcohol use disorder -last drink ___ -multivitamin TRANSITIONAL ISSUES =================== [ ] HELD lisinopril in setting of recent ___. Cr 1.6 on discharge (baseline 1.5-1.6). Please repeat chem 7 in ___ days to ensure stability and restart lisinopril at that time. [ ] Continue home apixaban (changed to 5mg PO BID on ___ plan for 3 months anticoagulation to end ___ [ ] Restarted on reduced dose aspirin 81mg daily. [ ] If persistent muscle spasm symptoms can consider starting baclofen 5mg PO QHS and uptitrate to TID as needed. [ ] Patient scheduled with Neurology for stroke, please ensure attendance at this appointment [ ] Patient continuing to refuse insulin, discharged on PO glipizide, please continue to address diabetes education, potential need to start insulin # CODE: full (confirmed) # CONTACT: ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Apixaban 10 mg PO BID 2. GlipiZIDE 5 mg PO BID 3. Gabapentin 200 mg PO DAILY 4. Rosuvastatin Calcium 40 mg PO QPM 5. Metoprolol Succinate XL 100 mg PO DAILY 6. amLODIPine 10 mg PO DAILY 7. Hydrochlorothiazide 25 mg PO DAILY 8. Lisinopril 40 mg PO DAILY 9. MetFORMIN XR (Glucophage XR) 1000 mg PO BID Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Apixaban 5 mg PO BID last dose of ___ 3. amLODIPine 10 mg PO DAILY 4. Gabapentin 200 mg PO DAILY 5. GlipiZIDE 5 mg PO BID 6. Hydrochlorothiazide 25 mg PO DAILY 7. Metoprolol Succinate XL 100 mg PO DAILY 8. Rosuvastatin Calcium 40 mg PO QPM 9. HELD- Lisinopril 40 mg PO DAILY This medication was held. Do not restart Lisinopril until discussing with your doctor. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS ================= Recrudescent stroke Muscle spasm Acute kidney injury SECONDARY DIAGNOSIS =================== Hypertension Coronary artery disease Alcohol use disorder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, You were brought to the hospital because you were having stiffness in your arm and leg. You were seen by neurology who thought that these symptoms were due to muscle spasms and not a new or repeat stroke. You also had some kidney damage which made it unsafe for you to be on your metformin, so this medication was stopped. You were feeling closer to how you felt when you last left the hospital so you were able to be discharged back to rehab to help you regain your strength after your stroke. It is important that you follow up with your doctors and continue to take your medications as directed. It was pleasure taking care of you, Your ___ Care Team Followup Instructions: ___
10765746-DS-12
10,765,746
21,456,554
DS
12
2156-11-01 00:00:00
2156-11-02 08:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Codeine Attending: ___. Chief Complaint: referral from outpatient nephrologist for worsening creatinine Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old man with ___ CAD, DM2 c/b peripheral neuropathy and nephropathy, CVA who was referred by outpatient nephrologist for worsening creatinine. Outpatient At___ nephrologist Dr. ___ him to come to the ED for admission and expedited work-up with nephrology referral. Dr. ___ a creatinine 1.6 in ___, ~2.0 in ___ and then 2.5 in ___. A TTE had been ordered given low BP, rising Cr and worsening edema. Dr. ___ stated he would reach out to inpatient renal team. Otherwise amlodipine was recently reduced to 2.5mg, he continues on torsemide 5mg daily. He noted mild swelling in both ankles, no orthopnea and variable weight but no notable recent gain. In the ED, initial vitals: T: 98.5 HR: 65 BP: 134/72 RR:16 SO2: 97% RA - Exam notable for: none documented - Labs notable for: creat 2.2 - Imaging notable for: none ordered - Patient was given: 1L NS - Consults: none - Vitals prior to transfer: T: 97.5 HR: 70 BP: 134/58 RR: 16 SO2: 99% RA Notably patient is on aspirin 325 mg given history of stroke, typically this would be held for seven days prior to renal biopsy. I discussed this with the ED team, who requested admission based on outpatient request rather then renal ultrasound with nephrology consult and discharge. On arrival to the floor, patient confirms he is asymptomatic. Denies recent medication changes, no change in urination, no frothy/bubbly urine, no new back pain, no n/v/itching, no chest pain. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative less otherwise noted in the HPI. Past Medical History: - pontine and medullar infarcts (admitted ___ - DM2 - Dyslipidemia - Hypertension - Past tobacco abuse - Alcohol use disorder Social History: ___ Family History: Multiple family members with DM Father died of snake bite Mother and eldest brother died of complications of diabetes 5 children all health No known family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM: VS: ___ 0234 Temp: 98.0 PO BP: 140/74 HR: 73 RR: 18 O2 sat: 97% O2 delivery: Ra GENERAL: Pleasant, lying in bed comfortably HEENT: mucosa moist, no JVD CARDIAC: Regular rate and rhythm, no murmurs, rubs, or gallops LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi ABD: Normal bowel sounds, soft, nontender, nondistended, no hepatomegaly, no splenomegaly EXT: Warm, well perfused, 2+ edema to shins PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses NEURO: Alert, oriented, CN II-XII intact other than delayed activation of left facial, motor LUE and LLE 4+/5 vs ___ on right SKIN: No significant rashes DISCHARGE PHYSICAL EXAM: VITALS: 97.7PO132 / 76 R SittingHR 71 RR18POx 97%Ra GENERAL: standing up arranging his breakfast, friendly, NAD HEENT: mucosa moist, no JVD CARDIAC: Regular rate and rhythm, no murmurs, rubs, or gallops LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi ABD: Normal bowel sounds, soft, nontender, nondistended EXT: Warm, well perfused, 1+ pitting edema to shins NEURO: Alert, oriented, moving all extremities with purpose Pertinent Results: ADMISSION LABS =============== ___ 10:41PM BLOOD WBC-7.4 RBC-4.97 Hgb-14.9 Hct-41.0 MCV-83 MCH-30.0 MCHC-36.3 RDW-13.9 RDWSD-41.3 Plt ___ ___ 10:41PM BLOOD Neuts-58.8 ___ Monos-12.3 Eos-2.2 Baso-1.5* Im ___ AbsNeut-4.33 AbsLymp-1.85 AbsMono-0.91* AbsEos-0.16 AbsBaso-0.11* ___ 10:41PM BLOOD Glucose-325* UreaN-19 Creat-2.2* Na-137 K-4.2 Cl-96 HCO3-24 AnGap-17 ___ 10:41PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Tricycl-NEG URINE ======= ___ 10:26PM URINE Color-Yellow Appear-Hazy* Sp ___ ___ 10:26PM URINE Blood-MOD* Nitrite-NEG Protein-100* Glucose-1000* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 10:26PM URINE RBC-4* WBC-2 Bacteri-FEW* Yeast-RARE* Epi-0 TransE-<1 ___ 10:26PM URINE CastGr-9* CastHy-8* CastWBC-1* ___ 08:30AM URINE Color-Straw Appear-Clear Sp ___ ___ 08:30AM URINE Blood-SM* Nitrite-NEG Protein-30* Glucose-300* Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG ___ 08:30AM URINE RBC-<1 WBC-2 Bacteri-NONE Yeast-NONE Epi-<1 ___ 08:30AM URINE Hours-RANDOM Creat-76 Na-130 Cl-106 TotProt-60 Prot/Cr-0.8* PERTINENT INTERVAL AND DISCHARGE LABS =================================== ___ 05:43AM BLOOD WBC-7.3 RBC-4.48* Hgb-13.4* Hct-36.9* MCV-82 MCH-29.9 MCHC-36.3 RDW-13.9 RDWSD-41.1 Plt ___ ___ 05:17AM BLOOD Glucose-92 UreaN-20 Creat-2.2* Na-141 K-3.3* Cl-99 HCO3-28 AnGap-14 ___ 05:17AM BLOOD Calcium-9.8 Phos-4.1 Mg-2.6 ___ 05:43AM BLOOD Albumin-3.8 ___ 05:43AM BLOOD HBsAg-NEG HBsAb-POS HBcAb-POS* ___ 05:43AM BLOOD HCV Ab-NEG IMAGING AND STUDIES =================== ___ RENAL US No hydronephrosis. 2.8 cm right renal cyst. ___ CXR In comparison with the study of ___, there are slightly lower lung volumes. There is increased prominence of the cardiac silhouette with indistinctness of pulmonary vessels, consistent with the clinical diagnosis of elevated pulmonary venous pressure. No evidence of acute focal pneumonia or pleural effusion. ___ ECHO (TTE) The left atrial volume index is normal. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. There is severe symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>65%). The estimated cardiac index is normal (>=2.5L/min/m2). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve appears structurally normal with trivial mitral regurgitation. The estimated pulmonary artery systolic pressure is normal. There is a trivial/physiologic pericardial effusion. IMPRESSION: Marked symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function. No valvular pathology or pathologic flow identified. Increased PCWP. In the absence of a prominent history fo hypertension, an infiltrative process (e.g., early amyloid) or primary HCM should be considered. Compared with the prior study (images reviewed) of ___, the findings are similar. Brief Hospital Course: ___ year old man with PMH CAD, DM2 c/b peripheral neuropathy and nephropathy, CVA who was referred by outpatient nephrologist for worsening creatinine. ACTIVE ISSUES: # Acute on chronic kidney disease Patient has had ongoing worsening creatinine over the past several months, most recently found to be 2.5. On admission, Cr found to be 2.2 with no other electrolyte abnormalities. He was given 1L of NS, and Cr remained stable at 2.2. Renal was consulted. A renal ultrasound was done, showing normal kidneys and no evidence of hydronephrosis. A chest x-ray should no evidence of pulmonary edema. Hepatitis serologies were significant for evidence of a previous Hep B infection. Otherwise, remained stable. TTE showed LV hypertrophy, unchanged from prior ECHO in ___. Given no plan for renal biopsy, was able to be discharged home. A UPEP, which was drawn as an outpatient, is pending and will require follow-up. Plan for patient to follow-up with renal outpatient. # Diabetes mellitus type 2 Uncontrolled most recent A1c of 9.4 ___. Patient was continued on basal standing 36U, Humalog 6U with meals and HS. Held home sitagliptin while inpatient. # Hyperlipidemia: Continued home rosuvastatin 40mg # Hypertension: Continued home amlodipine. Held home HCTZ, lisinopril given concern for ___ and normotension. # Coronary artery disease: h/o 3VD on cardiac cath ___. Continued on aspirin 325 (on full dose given stroke), metoprolol, and statin. # h/o CVA: On full dose aspirin and statin. # Alcohol use disorder: Reportedly no use 8 days prior to admission. No evidence of withdrawal while in house. ============================================ TRANSITIONAL ISSUES ============================================ [] Recommend Cr be checked later this week to trend [] Given ECHO showed LV hypertrophy, further w/u for infiltration process should be considered if patient does not have history of poorly controlled hypertension. [] Home HCTZ and Lisinopril were held given concern for worsening Cr - could consider restarting if remains stable on recheck [] Torsemide was increased to 10mg daily per renal recommendations [] Would continue to work with patient on strategies for weight loss, exercise, and diabetes management [] Hep serologies are significant for evidence of past infection. ___ require followup and treatment prior to any future chemotherapy or immunosuppressive regimen # Contact: ___ ___ # Code: Full (confirmed) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 2.5 mg PO DAILY 2. Hydrochlorothiazide 25 mg PO DAILY 3. Metoprolol Succinate XL 100 mg PO DAILY 4. Rosuvastatin Calcium 40 mg PO QPM 5. Aspirin 325 mg PO DAILY 6. Lisinopril 40 mg PO DAILY 7. Gabapentin 200 mg PO DAILY 8. Glargine 35 Units Bedtime 9. Torsemide 5 mg PO DAILY 10. Tamsulosin 0.4 mg PO QHS 11. SITagliptin 50 mg oral DAILY 12. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Torsemide 10 mg PO DAILY RX *torsemide 10 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 2. Glargine 35 Units Bedtime 3. amLODIPine 2.5 mg PO DAILY 4. Aspirin 325 mg PO DAILY 5. Gabapentin 200 mg PO DAILY 6. Metoprolol Succinate XL 100 mg PO DAILY 7. Rosuvastatin Calcium 40 mg PO QPM 8. SITagliptin 50 mg oral DAILY 9. Tamsulosin 0.4 mg PO QHS 10. Vitamin D 1000 UNIT PO DAILY 11. HELD- Hydrochlorothiazide 25 mg PO DAILY This medication was held. Do not restart Hydrochlorothiazide until your doctor tells you it is safe to do so. 12. HELD- Lisinopril 40 mg PO DAILY This medication was held. Do not restart Lisinopril until your doctor tells you it is safe to do so. Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: - acute on chronic renal failure Secondary Diagnoses: - diabetes type 2 - hypertension - prior stroke - coronary artery disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, It was a pleasure to be a part of your care team at ___ ___. You were admitted to the hospital because your kidneys are not working very well. You were seen by the kidney doctors. We also did an ultrasound of your kidneys, which looked fine. We did an ultrasound of your heart, which showed that the muscles in your heart are enlarged, and will need to be looked at further. Your primary care doctor will be able to arrange this for you. You were then able to be discharged home. We think it will be important that you continue to work with your doctor to see if you need to make any changes to your diet or exercise routine. Again, it was very nice to meet you, and we wish you the best. Sincerely, Your ___ Care Team Followup Instructions: ___
10765748-DS-14
10,765,748
20,758,998
DS
14
2172-02-09 00:00:00
2172-02-09 13:21:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Worsening Back Pain Major Surgical or Invasive Procedure: ___: T11 laminectomy with T9-L2 fusion ___: T11 Corpectomy with placement of cage and right T9 screw revision History of Present Illness: ___ with known oligometastatic HCC lesion to T11 re-presents to the ___ ED on ___ with worsening back pain and bilateral lower extremity weakness. He is known to Dr. ___ Oncology for this lesion, in which surgical excision was recommended for pain control. At time of presentation, he is scheduled for T11 corpectomy on ___ with Dr. ___. The patient reports that over the previous two days leading up to admission he declined from being able to use a walker to requiring assistance from two people for ambulation. He denies bladder or bowel incontinence. Past Medical History: HCV cirrhosis s/p harvoni with SVR c/b HE, HCC, ascities and 3 cords of grade I varices on nadolol. DMII Depression Anxiety Social History: ___ Family History: Father: ___ (Lung CA) Mother: ___ (Lung CA) Brother: ___ (Sudden cardiac death in ___ Sister: Living, multiple medical issues. Physical Exam: ON ADMISSION: ************* PHYSICAL EXAM: Temp: 97.2 °F, Pulse: 52, RR: 16, BP: 146/79, O2 sat: 99 RA Gen: WD/WN, comfortable, NAD. HEENT: Pupils: 3-2mm bilaterally Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Motor: TrapDeltoidBicepTricepGrip IPQuadHamATEHLGast NO Clonus NO ___ [x]Sensation intact to light touch Skin: Erythema noted bilaterally across lower thoracic and lumbar spine from prolonged hot pack usage. ======================================================== ON DISCHARGE: ************ General: ___ Temp: 99.0 PO BP: 89/54 HR: 69 RR: 16 O2 sat: 96% O2 RA Exam: Opens Eyes: [x]Spontaneous [ ]To voice [ ]To noxious Orientation: [x]Person [x]Place [x]Time Follows Commands: [ ]Simple [x]Complex [ ]None Speech Fluent: [x]Yes [ ]No Comprehension Intact: [x]Yes [ ]No Motor: Trapezius Deltoid Biceps Triceps Grip Right5 5 5 5 5 Left5 5 5 5 5 IP Quad Hams AT ___ ___ Right4+ 5 5 5 4+ 5 Left 4 5 4- 5 4+ 5 [x]Sensation intact to light touch Surgical Incision: [x]Clean, dry, intact Staining noted on pillow; no active or expressible drainage. [x]Staples Drain Site: [x]Clean, dry, intact [x]Sutures Pertinent Results: Please see OMR for pertinent imaging and lab results Brief Hospital Course: #T11 metastatic lesion ___ is a ___ year old male with history of HCC and known T11 lesion. Patient was schedule for surgery on ___ ___, but presented to ED on ___ with worsening back pain and lower extremity pain. Patient was admitted to the neurosurgery service for pain control and to preop for already scheduled surgical intervention. A CT spine was obtained to evaluate for any acute interval changes in spine since last MRI on ___. CT showed stable T11 lesion. Upon return to his room after CT RN noted worsening weakness and the patient was also noted to have new ___ decreased sensation. He went to the OR for urgent decompression at T11 with T9-L2 fusion. He was then brought to the operating room for the previously scheduled T11 corpectomy with placement of cage. At that time the R T9 pedicle screw was also revised slightly. For further details about the surgical procedures, please see the separately dictated operative reports. On ___, a T-spine CT scan was ordered to assess the cage, which showed good placement. Surgical drain was removed on ___ without complications. At the time of discharge, he has made significant progress with return of his strength. In collaboration with ___, it was decided that he would be best ___ for a short rehabilitation stay where he would continue to improve his strength and conditioning. At request of patient's oncologist, Dr. ___ patient had a CT torso which showed increased ascites, see below. AFP was 446.9. There was however, no evidence of distant disease. Therefore, it was decided that the patient would not need chemotherapy until after he recovered from his surgery. His oncology team will be in contact with him to set up outpatient follow-up. #Ascites CT torso ___ revealed increased ascites. Patient denied any abdominal pain. Hepatology was consulted and ___ guided drainage was recommended. Cell count was not suggestive of infection. Cultures had not finalized at the time of discharge. 4.7L was removed and patient was given 37.5 g IV albumin x1. #Aphasia On the evening of ___, the patient had new onset expressive aphasia and a code stroke was called. CT/CTA was negative for stroke. HemeOnc and Hepatology were consulted and felt aphasia was likely hepatic encephalopathy, see below. #Hepatic encephalopathy Consults were placed to HemeOnc and Hepatology, both of which believed the new onset expressive aphasia and change in mental status were due to hepatic encephalopathy. The patient had not had a BM or been given his prescribed Lactulose since admission. His Lactulose was resumed on overnight on ___, and was changed to on ___ and titrated back to ___ BMs per day. No expressive aphasia was noted during the patient's neurological exam the morning of ___. Per Hepatology, lactulose was changed to titrate to ___ BMs per day. Per hemeonc, patient was restarted on Romiplostim, which he received evert ___. #Anemia The patient's H+H was low and remained stably low postoperatively. Stool guaiac was sent and was positive on ___. Medicine was consulted given concern for a GI bleed and deferred to Hepatology. Hepatology was consulted and recommended sending labs, continuing the PPI, and follow-up in the Liver Clinic. Hepatology recommended outpatient follow up with endoscopy. Medicine recommended starting on ferric gluconate IV x4 days followed by daily ferrous gluconate after 4 days or at time of discharge. At the time of discharge, his hematocrit had been stable for several days. #Elevated BUN The patient's BUN became elevated postoperatively. Medicine was consulted and deferred to Hepatology given that it could be related to a GI bleed. Hepatology noted that it is possible that this elevation is related to a small GI bleed, but thought that it was more likely related to dehydration. BUN started to down trend on ___. #Hypocalcemia The patient's calcium was low and was repleted as needed. Per Medicine, the patient's albumin is low, so his corrected calcium is actually appropriate. #Suicidal Ideation The patient expressed suicidal ideation, and Psychiatry was consulted. The patient was briefly put under a ___ with suicide precautions and a 1:1 sitter. Psychiatry later re-evaluated the patient and cleared him for discharge. Social work continued to follow the patient. #T2DM Patient has T2DM managed on Insulin at home. He was ordered for his home insulin regimen on admission. When patient was made NPO for surgery, his Insulin was adjusted according to protocol and sugars were monitored closely. #Disposition ___ and OT evaluated the patient and recommended rehab. Medications on Admission: * Lantus 100 unit/mL subcutaneous solution 16 units once daily am * Xifaxan 550 mg tablet 1 tablet(s) by mouth po bid * furosemide 20 mg tablet 1 tablet(s) by mouth daily * hydromorphone 2 mg tablet ___ tablet(s) by mouth every four (4) hours as needed * magnesium 200 mg tablet 2 (Two) tablet(s) by mouth once daily * nadolol 20 mg tablet 1 tablet(s) by mouth once daily in addition to the 40mg tablet to take a total dose of 60 mg daily * nadolol 40 mg tablet 1 tablet(s) by mouth daily at night total dose 60 mg daily * pantoprazole 20 mg tablet,delayed release 2 tablet(s) by mouth once daily * spironolactone 50 mg tablet 1 (One) tablet(s) by mouth every other day as needed * ursodiol 500 mg tablet 1 tablet(s) by mouth twice a day * insulin lispro (U-100) 100 unit/mL subcutaneous pen subcutaneous 1 insulin pen(s) sliding scale * OxyContin 60 mg tablet,crush resistant,extended release oral 1 tablet,oral only,ext.rel.12 hr(s) Three times daily Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild No more than 4000mg of acetaminophen (Tylenol) total daily. 2. Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line 3. Docusate Sodium 100 mg PO BID 4. Ferric Gluconate 250 mg IV DAILY Duration: 4 Doses Please stop after 4 doses total which will occur ___ 5. Ferrous GLUCONATE 324 mg PO DAILY Initiate after final dose of ferric gluconate 6. Glargine 16 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 7. Lidocaine 5% Patch 2 PTCH TD QAM 8. Senna 8.6 mg PO BID:PRN Constipation - First Line Reason for PRN duplicate override: Alternating agents for similar severity 9. Furosemide 20 mg PO DAILY 10. Gabapentin 300 mg PO TID 11. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN Pain - Moderate 12. Lactulose ___ mL PO BID 13. LORazepam 0.5 mg PO BID:PRN Anxiety 14. Magnesium Oxide 400 mg PO DAILY 15. Nadolol 40 mg PO QPM 16. Nadolol 20 mg PO QAM 17. OxyCODONE SR (OxyconTIN) 60 mg PO Q8H 18. Pantoprazole 40 mg PO Q24H 19. Rifaximin 550 mg PO/NG BID 20. Romiplostim 67 mcg SC 1X/WEEK (TH) 21. Spironolactone 50 mg PO EVERY OTHER DAY 22. Ursodiol 500 mg PO BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: T11 metastatic Lesion Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Discharge Instructions Spinal Fusion Surgery •Your dressing may come off on the second day after surgery. •Your incision is closed with staples. You also have sutures at the site where your surgical drain was. You will need suture and staple removal. •Do not apply any lotions or creams to the site. •Please keep your incision dry until removal of your sutures/staples. •Please avoid swimming for two weeks after suture/staple removal. •Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity •We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. •You make take leisurely walks and slowly increase your activity at your own pace. ___ try to do too much all at once. •No driving while taking any narcotic or sedating medication. •No contact sports until cleared by your neurosurgeon. •Do NOT smoke. Smoking can affect your healing and fusion. Medications •Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. •Do not take any anti-inflammatory medications such as Motrin, Advil, Aspirin, and Ibuprofen etc… until cleared by your neurosurgeon. •You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. •It is important to increase fluid intake while taking pain medications. We also recommend a stool softener like Colace. Pain medications can cause constipation. When to Call Your Doctor at ___ for: •Severe pain, swelling, redness or drainage from the incision site. •Fever greater than 101.5 degrees Fahrenheit •New weakness or changes in sensation in your arms or legs. Followup Instructions: ___
10765748-DS-15
10,765,748
29,224,743
DS
15
2172-09-13 00:00:00
2172-09-16 17:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Altered mental status Major Surgical or Invasive Procedure: NONE History of Present Illness: Mr. ___ is a ___ with history of HCV cirrhosis c/b metastatic HCC to T11 (s/p RFA ___, TACE ___, SBRT ___, cryoptherapy ___, vertebroplasty ___, T11 laminectomy and coprectomy with cage ___, RT ___, 4 cycles of nivolumab, and most recently C1 levatinib ___ who presents with acute encephalopathy. Per history obtained in the ED, the patient is typically coherent at baseline. About three weeks ago, he stopped taking his rifaximin due to high copays. He continued taking his lactulose BID and had been stooling ___ with this regimen. On ___, the patient's family noticed that he was becoming increasing somnolent/confused. He endorsed a new cough productive of yellow sputum, though his family notes this is chronic for him due to his active tobacco use. He also reports decreased appetite and intermittent nausea/vomiting over the past week since starting levatinib. In the ED, initial vitals were: T 98.2 BP 160/80 HR 50 RR 18 O2 98% RA Exam was notable for: - Neuro: A&Ox2.5 (knows it is ___ but thinks it is ___. Can recite ___ forward but not backward. +Asterixis Labs were notable for: - WBC 5.8, Hgb 14.6 - INR 1.5 - BUN 21, Cr 1.0 - ALT 23, AST 57, AP 124, Tbili 2.9, Alb 3.5 - Lactate 2.6 - Serum acetaminophen level 6 Studies were notable for: - ___ CXR 1. No radiographic evidence of pneumonia. 2. 1.8 cm round opacity left lung base was seen previously, worrisome for metastasis. The patient was given: - Lactulose 30mL x3, Rifaximin 550mg, Ursodiol 500mg - Amlodipine 10mg Consults: - Hepatology: Admit to ET, re-start lactulose/rifaxamin, consider CT head if new neuro deficits, pan culture On arrival to the floor, patient is unable to provide much additional history but feels that he has been somewhat more confused at home. He believes he has been taking his lactulose. He denies fevers, chills, abdominal pain, nausea, vomiting, cough, shortness of breath, or dysuria. REVIEW OF SYSTEMS: ================== Per HPI, otherwise, 10-point review of systems was within normal limits. Past Medical History: - HCV cirrhosis s/p harvoni with SVR c/b HE, HCC, ascities and 3 cords of grade I varices on nadolol - DMII - HTN - Depression - Anxiety ONCOLOGIC HISTORY: ================== - ___: surveillance MRI showed a 1.2 x 0.9 cm segment VI OPTN ___ lesion. - ___: Repeat imaging showed that lesion, and more anteriorly, a second area of arterial enhancement measuring 1.2 x 1.6 cm. Both meeting criteria for HCC. - ___: RFA to segment VI lesion - ___: TACEx2 to segment VI lesions - ___: MRI without new liver lesions, but incidentally found 2 x 1.5 cm focus of arterial enhancement in the right lateral aspect of the T11 vertebral body concerning for metastasis. - ___: Bone Bx showed metastatic HCC - ___: SBRT (2700 cGy in 3 fx) - ___: AFP rising to 80 from ___ - ___: MRI showed 2.6 x 1.7 x 1.8 cm right T11 lesion that was stable, however there was a new 1.3 x 0.7 cm posterior nodule consistent with disease progression - ___: cryotherapy of the new area of disease recurrence. Bx showed metastatic HCC - ___: vertebroplasty, completing therapy - ___: MR showed progression of disease at T11 - ___: started romiplostim - ___: CT Torso without other evidence of disease, growth of T11 lesion - ___: T11 laminectomy with T9-L2 fusion - ___: T11 Corpectomy with placement of cage and right T9 screw revision - ___: RT at ___ 3500 cGy in 10 fx to T10-12 - ___: C1 nivolumab - ___: C2 nivolumab - ___: C3 nivolumab - ___: C4 nivolumab (delayed a week). Concern for progression in the spine, discuss lenvatinib - ___: Start lenvatinib Social History: ___ Family History: Father: ___ (Lung CA) Mother: ___ (Lung CA) Brother: ___ (Sudden cardiac death in ___ Sister: Living, multiple medical issues. Physical Exam: ADMISSION EXAM ============== VITALS: Temp: 97.8 PO BP: 181/85 R Lying HR: 48 RR: 18 O2 sat: 98% O2 delivery: Ra GENERAL: Well-appearing, laying in bed comfortably, in NAD HEENT: NC/AT, EOMI, PERRL, anicteric sclera, MMM NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing, cyanosis, or edema. SKIN: Warm. Cap refill <2s. No rashes. NEUROLOGIC: Alert, oriented to person/place, slow speech, CN II-XII intact, ___ strength in bilateral upper/lower extremities with normal sesnsation, subtle asterixis DISCHARGE EXAM ============== VITALS: ___ 0736 Temp: 97.9 PO BP: 160/86 L Lying HR: 59 RR: 17 O2 sat: 97% O2 delivery: Ra FSBG: 143 ___ Total Intake: 360ml PO Amt: 360ml ___ Total Output: 0ml Urine Amt: 0ml GENERAL: Thin and chronically ill appearing, laying in bed comfortably, in NAD. HEENT: NC/AT, EOMI, R pupil is slightly smaller than L (4mm vs. 5mm), dermatochalasis on R, MMM. NECK: No cervical lymphadenopathy. No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. ABDOMEN: Normal bowels sounds, non distended, non-tender to deep palpation in all four quadrants. No organomegaly. EXTREMITIES: No clubbing, cyanosis, or edema. SKIN: Warm. Cap refill <2s. No rashes. NEUROLOGIC: Alert, oriented to person/place, slow speech, CN exam notable for anisocoria as above, ___ strength in bilateral upper/lower extremities with normal sensation, no dysmetria, subtle asterixis. Pertinent Results: ADMISSION LABS ============== ___ 07:40PM BLOOD WBC-5.8 RBC-4.71 Hgb-14.6 Hct-43.7 MCV-93 MCH-31.0 MCHC-33.4 RDW-16.2* RDWSD-52.1* Plt Ct-43* ___ 07:40PM BLOOD Neuts-60.0 Lymphs-17.8* Monos-10.3 Eos-10.9* Baso-0.7 Im ___ AbsNeut-3.48 AbsLymp-1.03* AbsMono-0.60 AbsEos-0.63* AbsBaso-0.04 ___ 07:40PM BLOOD ___ PTT-23.1* ___ ___ 06:32PM BLOOD Glucose-163* UreaN-21* Creat-1.0 Na-136 K-5.1 Cl-100 HCO3-25 AnGap-11 ___ 06:32PM BLOOD ALT-23 AST-57* AlkPhos-124 TotBili-2.9* ___ 06:32PM BLOOD Albumin-3.5 Calcium-8.8 Phos-3.5 Mg-2.4 ___ 07:40PM BLOOD Calcium-8.5 Phos-3.6 Mg-2.4 ___ 06:32PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-6* Tricycl-NEG DISCHARGE LABS ============== ___ 04:51AM BLOOD WBC-5.1 RBC-4.05* Hgb-12.4* Hct-36.7* MCV-91 MCH-30.6 MCHC-33.8 RDW-17.0* RDWSD-53.6* Plt Ct-35* ___ 04:51AM BLOOD Neuts-67.7 Lymphs-16.5* Monos-8.1 Eos-6.9 Baso-0.4 Im ___ AbsNeut-3.45 AbsLymp-0.84* AbsMono-0.41 AbsEos-0.35 AbsBaso-0.02 ___ 04:51AM BLOOD Plt Ct-35* ___ 04:51AM BLOOD ___ PTT-30.9 ___ ___ 04:51AM BLOOD Glucose-151* UreaN-29* Creat-1.3* Na-139 K-4.6 Cl-104 HCO3-23 AnGap-12 ___ 04:51AM BLOOD ALT-15 AST-28 LD(LDH)-264* AlkPhos-108 TotBili-2.1* ___ 04:51AM BLOOD Calcium-8.0* Phos-3.2 Mg-2.1 NOTABLE LABS ============ ___ 06:02AM BLOOD Anisocy-1+* Polychr-1+* Spheroc-1+* Acantho-1+* RBC Mor-SLIDE REVI ___ 06:02AM BLOOD ___ 06:02AM BLOOD Ret Aut-3.5* Abs Ret-0.15* ___ 04:51AM BLOOD Hapto-<10* ___ 06:02AM BLOOD calTIBC-263 Hapto-<10* Ferritn-149 TRF-202 ___ 07:48PM BLOOD Lactate-2.6* STUDIES/IMAGING =============== CXR ___ IMPRESSION: 1. No radiographic evidence of pneumonia. 2. 1.8 cm round opacity left lung base was seen previously, worrisome for metastasis. RUQUS ___ IMPRESSION: 1. Patent hepatic vasculature. 2. Cirrhotic morphology of the liver with sequela of portal hypertension including small volume ascites and marked splenomegaly. The previously seen ablation cavity in the right hepatic lobe is not well seen on the current study. 3. The gallbladder contains sludge without wall thickening or edema. CTA H/N ___ IMPRESSION: 1. No acute intracranial findings. 2. Mild-to-moderate narrowing bilateral cavernous, supraclinoid ICA. 3. No significant ICA or vertebral artery narrowing in the neck. 4. Two separate 2 mm right upper lobe solid pulmonary nodules. No imaging follow-up is indicated. 5. Severe biapical paraseptal and moderate centrilobular emphysema. 6. Severe cervical spine degenerative changes.. 7. Nasal septAl perforation. RECOMMENDATION(S): For incidentally detected nodules smaller than 6mm in the setting of an incomplete chest CT, no CT follow-up is recommended. Brief Hospital Course: Patient is a ___ with history of HCV cirrhosis c/b metastatic HCC to T11 (s/p RFA ___, TACE ___, SBRT ___, cryotherapy ___, vertebroplasty ___, T11 laminectomy and corpectomy with cage ___, RT ___, 4 cycles of nivolumab, and most recently C1 levatinib ___ who presented with acute encephalopathy, now with significant hypertension likely a side effect of lenvatinib, course also complicated by possible new metastatic brain lesion and laboratory signs of hemolysis. Patient was quite hypertensive upon arrival, SBPs 180-200s, responsive to initiation of hydralazine. HRs remained 40-50s on nadolol. Severe HTN was likely ___ lenvatinib, which was held. Given initial concern for HE, lactulose frequency was increased and patient was noted to have some improvement in mental status though continued to have mild asterixis (AOx3 and able to do the days of the week forwards/backwards on discharge). Patient's wife was able to confirm that patient will be able to get rifaximin as an outpatient. Infectious/bleeding work-ups were NEGATIVE, patient did not submit a urine sample prior to discharge. Sedating meds were held other than lorazepam. Given concern for anisocoria and R ptosis on admission, patient underwent CTA H/N, which did not show any acute bleeding (final read still pending). Neurology was consulted and confirmed that patient has physiologic anisocoria (L>R) and dermatochalasis. Of note, neurology was concerned for frontal lesion, patient was ordered for MRI brain to assess for metastatic disease. This was not performed prior to discharge as patient and his wife wanted to be at home as quickly as possible. Labs were otherwise notable for normocytic anemia and acute on chronic thrombocytopenia with signs of hemolysis. No schistocytes on RBC morphology. Fibrinogen 159. Coombs NEGATIVE. Possibly related to hypertension. Hb relatively stable at time of discharge. Iso increased BM ___ lactulose, patient was noted to have acute kidney injury, Cr 1.3 ___. He was given 37.5g 5% albumin. Patient will have close outpatient follow-up with his oncologist ___. TRANSITIONAL ISSUES =================== - Lenvatinib was held - Patient was initiated on hydralazine, continue to monitor blood pressures - Outpatient rifaximin prescription was confirmed, patient will be able to take without issue - Repeat BMP to ensure resolution ___ - Repeat CBC to ensure stability of Hb/plts - Continue to work-up for hemolysis - Order MRI brain to assess for metastatic disease - f/u UA/UCx - Furosemide was held given ___, restart as needed - Restart oxycontin/dilaudid/gabapentin as needed, patient did not have any pain issues this admission - Patient should have referral to palliative care - Patient confirmed DNR/DNI - Patient should be assessed for home services including ___ This patient was prescribed, or continued on, an opioid pain medication at the time of discharge (please see the attached medication list for details). As part of our safe opioid prescribing process, all patients are provided with an opioid risks and treatment resource education sheet and encouraged to discuss this therapy with their outpatient providers to determine if opioid pain medication is still indicated. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY 2. Ursodiol 500 mg PO BID 3. Spironolactone 50 mg PO EVERY OTHER DAY 4. Pantoprazole 40 mg PO Q24H 5. OxyCODONE SR (OxyCONTIN) 80 mg PO Q12H 6. LORazepam 0.5 mg PO Q8H:PRN anxiety, insomnia 7. HYDROmorphone (Dilaudid) 8 mg PO Q4H:PRN Pain - Moderate 8. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 9. Nadolol 60 mg PO DAILY 10. Gabapentin 300 mg PO BID 11. Furosemide ___ mg PO DAILY 12. Glargine 16 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 13. Lactulose ___ mL PO BID 14. Rifaximin 550 mg PO/NG BID Discharge Medications: 1. HydrALAZINE 25 mg PO Q8H RX *hydralazine 25 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 2. amLODIPine 10 mg PO DAILY 3. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 4. Glargine 16 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 5. Lactulose ___ mL PO BID 6. LORazepam 0.5 mg PO Q8H:PRN anxiety, insomnia 7. Nadolol 60 mg PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. Rifaximin 550 mg PO BID 10. Spironolactone 50 mg PO EVERY OTHER DAY 11. Ursodiol 500 mg PO BID 12. HELD- Furosemide ___ mg PO DAILY This medication was held. Do not restart Furosemide until you are told to do so by your doctor. 13. HELD- Gabapentin 300 mg PO BID This medication was held. Do not restart Gabapentin until you are told to do so by your doctor. 14. HELD- HYDROmorphone (Dilaudid) 8 mg PO Q4H:PRN Pain - Moderate This medication was held. Do not restart HYDROmorphone (Dilaudid) until you are told to do so by your doctor. 15. HELD- OxyCODONE SR (OxyCONTIN) 80 mg PO Q12H This medication was held. Do not restart OxyCODONE SR (OxyCONTIN) until you are told to do so by your doctor. Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses ================= Acute encephalopathy Hypertension Secondary Diagnoses =================== Cirrhosis with hepatocellular carcinoma Hemolytic anemia Acute kidney injury Thrombocytopenia Normocytic anemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You were confused at home. WHAT HAPPENED TO ME IN THE HOSPITAL? - You were given more lactulose and your mental status improved. - The neurologists evaluated you and did not feel that you were having a stroke. - You had a CT scan of your head, which did not reveal any bleeding. - Some of your sedating medications were stopped so as not to make you more confused. - Your cancer medication (lenvatinib) was stopped because your blood pressure was quite elevated. You were started on a new medication to help treat your high blood pressure. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Please take your medications and go to your follow up appointments as described in this discharge summary. - If you experience any of the danger signs listed below, please call your primary care doctor or go to the emergency department immediately. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10765786-DS-16
10,765,786
24,983,535
DS
16
2113-07-19 00:00:00
2113-07-20 17:07:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: ETT-MIBI (Exercise Stress Test) History of Present Illness: HISTORY OF PRESENTING ILLNESS: Mr ___ is a ___ y/o M with PMH significant for CAD (s/p DES to ___ LAD in ___, HTN, HLD, who presents for chest pain. Of note, this is a patient of Dr ___. In ___ he suffered an NSTEMI with angiography showing total occlusion of the proximal LAD which was stented successfully with a 3.0 x 12 mm Promus drug-eluting stent. Otherwise there was 50% disease in the circumflex, ramus and less in the right coronary. Echocardiography initially showed anteroapical akinesis with an ejection fraction of 31%. A subsequent echocardiogram on ___ showed persistence of anteroseptal and lateral hypokinesis and apical akinesis but with ejection fraction increased to 55%. He has had occaisonal chest pain since this time, and underwent cardiac cath in ___ which showed patent stent and otherwise stable disease. Patient notes that for the last few months he has had occasional on and off chest pain. The pain is described as in his upper chest especially on the left side. It is a dull aching pressure. It is not clearly induced by activity and does not clearly go away with rest. Episodes last for hours. Is better over the last 2 weeks, however and within last 24 hours it started he once again and this time radiated into his back. Given his ongoing symptoms, he presented to the emergency room. An EKG did not reveal any evidence of acute ischemia. Troponins x2 were negative. Patient was then discussed with the cardiology fellow, and is ultimately admitted for stress test. Past Medical History: - HTN - HLD - CAD s/p PCI (DES to LAD on ___ - HCV s/p interferon Social History: ___ Family History: - Father with pacemaker and colon CA - Mother with breast CA - No family history of early MI, cardiomyopathies, or sudden cardiac death. Physical Exam: GEN: Well appearing, NAD HEENT: Conjunctiva clear, PERRL, MMM NECK: No JVD. LUNGS: CTAB HEART: RRR, nl S1, S2. No m/r/g. ABD: NT/ND, normal bowel sounds. EXTREMITIES: No edema. WWP. SKIN: No rashes. NEURO: AOx3. Pertinent Results: Admission Labs ============== ___ 07:45AM BLOOD WBC-7.4 RBC-4.87 Hgb-14.5 Hct-43.8 MCV-90 MCH-29.8 MCHC-33.1 RDW-12.9 RDWSD-41.9 Plt ___ ___ 07:45AM BLOOD Neuts-68.5 Lymphs-18.7* Monos-10.4 Eos-1.6 Baso-0.4 Im ___ AbsNeut-5.09 AbsLymp-1.39 AbsMono-0.77 AbsEos-0.12 AbsBaso-0.03 ___ 07:45AM BLOOD Plt ___ ___ 07:45AM BLOOD Glucose-103* UreaN-17 Creat-1.0 Na-140 K-5.0 Cl-104 HCO3-25 AnGap-11 ___ 07:45AM BLOOD cTropnT-<0.01 Discharge Labs ============== ___ 06:47AM BLOOD WBC-6.2 RBC-5.03 Hgb-15.0 Hct-46.3 MCV-92 MCH-29.8 MCHC-32.4 RDW-13.1 RDWSD-43.7 Plt ___ ___ 06:47AM BLOOD Plt ___ ___ 06:47AM BLOOD ___ PTT-37.6* ___ ___ 06:47AM BLOOD Glucose-106* UreaN-18 Creat-0.9 Na-140 K-4.1 Cl-101 HCO3-27 AnGap-12 ___ 06:47AM BLOOD Calcium-9.6 Phos-3.5 Mg-2.0 Exercise Stress Test INTERPRETATION: This ___ year old man with h/o CAD s/p MI and LAD stent in ___ was referred to the lab for evaluation of chest discomfort. He exercised for 10 minutes and 30 seconds on modified ___ protocol and stopped for fatigue. The peak estimated MET capacity is 8.7, which represents an average exercise tolerance for his age. No chest, arm, neck or back discomfort reported. No significant ST segment changes noticed. Rhythm was sinus with frequent isolated APBs and rare atrial couplets in early recovery. Appropriate HR and BP response to exercise and recovery. IMPRESSION : No anginal symptoms or ischemic EKG changes to the achieved workload. Nuclear report sent separately. Brief Hospital Course: Patient Summary =============== Mr ___ is a ___ y/o M with PMH significant for CAD (s/p DES to ___ LAD in ___, HTN, HLD, who presented for chest pain and underwent an ETT-MIBI which showed: EF 46%, no symptoms or ECG changes, large fixed perfusion defect in mid/apical segment in LAD territory (consistent with old infarct in ___. Hypokinesis of anterior wall, akinesis of apex. Acute Issues ============ # CAD (s/p DES in ___ to ___ LAD) Pt presented with several months of atypical chest pain that acutely worsened on ___ evening. The pain is not reproduced with activity or relieved with rest. His EKG does not show any evidence of active ischemia and his troponins were negative x2. However, given his significant coronary artery disease history, he was admitted to undergo cardiac stress testing. His home aspirin and atorvastatin were continued. He had an exercise stress test which showed no new changes from prior. Chronic Issues ============== #Hypertension Home lisinopril and carvedilol were continued. #Hyperlipidemia Home atorvastatin was continued. Transitional Issues =================== none Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 5 mg PO DAILY 2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 3. CARVedilol 3.125 mg PO BID 4. Atorvastatin 80 mg PO QPM 5. Multivitamins 1 TAB PO DAILY 6. Nitroglycerin SL 0.3 mg SL PRN chest pain 7. Aspirin 81 mg PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. CARVedilol 3.125 mg PO BID 5. Lisinopril 5 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. Nitroglycerin SL 0.3 mg SL PRN chest pain Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis ================= Unstable Angina Coronary Artery Disease Secondary Diagnosis =================== Hypertension Hyperlipidemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital because you had intermittent chest pain. Please see below for more information on your hospitalization. It was a pleasure participating in your care! What happened while you were in the hospital? - You had a stress test which was to assess how your heart functioned under stress. It showed EF 46%, no symptoms or ECG changes, large fixed perfusion defect in mid/apical segment in LAD territory (consistent with old infarct in ___. Hypokinesis of anterior wall, akinesis of apex. There was no need for any intervention, so you were discharged home. All of your home medications were continued in the hospital. What should you do after leaving the hospital? - Please take your medications as listed below and follow up at the listed appointments. We wish you the best! - Your ___ Healthcare Team Followup Instructions: ___
10765994-DS-16
10,765,994
22,815,090
DS
16
2114-05-15 00:00:00
2114-05-17 23:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: seizure Major Surgical or Invasive Procedure: Lumbar puncture ___ History of Present Illness: Mr. ___ is a ___ manwith a history of extensive stage small cell lung cancer, statuspost four cycles of cisplatin and etoposide (completed ___ concomitant palliative radiation to the chest (completed ___ who has since developed brain metastases, status postwhole brain radiation and a CyberKnife radiation on ___. Herestarted chemotherapy with cisplatin and irinotecan and is now s/p 6 cycles with a response seen on CT scan. He was recently seen in ___ clinic follow-up and at that time, started on levofloxacin for possible pneumonia. He presented to the ED on ___ with persistent cough and bronchitis symptoms; abx were switched to doxycycline as he couldn't afford the levofloxacin. This morning, while at home watching the news, he experienced his first seizure. He was found by his wife to be in the chair, gasping for air, shaking, and eyes rolling back. This lasted for approximately ___ minutes and resolved when EMS arrived. He was confused after but returned to his baseline mental status by the time he came to the ED. In the ED, VSS; CT head demonstrated a new hyperdense area near the left parietal mets (?blood) with increased edema. He was loaded with 1 gm keppra and admitted to medicine for further management. Currently, he denies any c/o or complaints except for being tired. No headache, lightheadedness, dizziness, shortness of breath, CP, abd pain, n/v, urinary or bowel symptoms. 12-pt ROS otherwise negative in detail except for as noted above. Past Medical History: PAST ONCOLOGIC HISTORY: - Presented in ___ with left upper quadrant pain, which had been present for six months. Abdominal CT showed lower lung mass. Chest CT on ___ revealed a left lower lobe lung mass and mediastinal lymphadenopathy. - ___: bronchoscopy with lymph node biopsy was done. Lymph nodes 4L, 4R, and 7 were sampled, all with small cell carcinoma. - ___: PET scan showed left lower lobe FDG avid mass as well as an area of avidity in the left upper lobe and right middle lobe. He also had lymphadenopathy in the mediastinum and bilateral hila. - ___: MRI of the head showed no metastatic disease in the brain. - ___: cycle one of cisplatin and etoposide. - ___: cycle two Cisplatin/Etoposide - ___: cycle three Cisplatin/Etoposide - ___: cycle four Cisplatin/Etoposide - ___: chest radiation 3500 cGy in 14 fractions - ___: whole brain radiation due to metastatic disease in the left parietal lobe. - ___: MRI Head with L parietal lobe mass 1.7 cm in size with surrounding edema. CT Chest with increasing mediastinal lymphadenopathy. - ___: CK to L parietal lesion - ___: bone marrow biopsy done for thrombocytopenia showed hypocellular marrow with dysplasia; no carcinoma seen. - ___: Cycle 1 Cisplatin 30 mg/m2 + Irinotecan 65 mg/m2 given on days 1 and 8 of a 21 day cycle. - ___: Cycle 2 Cisplatin/Irinotecan days 1 and 8 - ___: Cycle 3 Cisplatin/Irinotecan days 1 and 8 - ___: Cycle 4 Cisplatin 22 mg/m2 (dose reduced due to pancytopenia) and Irinotecan 50 mg/m2 (dose reduced due to pancytopenia) - ___: Cycle 5 Cisplatin 22mg/m2, Irinotecan 50 mg/m2 on day 1; day 8 dose was held due to pancytopenia - ___: CT chest without evidence of progression. - ___: Cycle 6 Cisplatin 15 mg/m2, Irinotecan 40 mg/m2 on days 1 and 8. Other medical history: 1. C-spine fracture in ___, currently maintained on methadone. 2. Coronary artery disease status post MI in ___ with stent placed at ___. 3. Past history of alcoholism and drug abuse, sober now for ___ years. Social History: ___ Family History: Father with history of non-Hodgkin's lymphoma Physical Exam: VS: T 98, BP 120/70, HR 85, RR 16, SaO2 95/RA General: Comfortable-appearing male in NAD, AO x 3 HEENT: NC/AT, PERRL, EOMI. MM sl dry, OP clear Neck: supple, no LAD Chest: CTA-B, no w/r/r CV: RRR s1 s2 normal, no m/g/r Abd: soft, NT/ND, NABS Ext: no c/c/e/, wwp Neuro: AO x3, CN II-XII intact, MS ___ except in RUE which was ___ with flexion and abduction (chronic); sensation grossly intact to light touch Skin: warm, dry Pertinent Results: ___ 06:10AM PLT COUNT-104* ___ 06:10AM NEUTS-74.1* LYMPHS-15.6* MONOS-8.4 EOS-1.6 BASOS-0.3 ___ 06:10AM WBC-4.8 RBC-2.91* HGB-9.7* HCT-27.8* MCV-96 MCH-33.3* MCHC-34.8 RDW-18.3* ___ 07:24AM ___ PTT-36.1 ___ ___ 01:10PM PLT COUNT-109* ___ 01:10PM WBC-5.0 RBC-2.47* HGB-8.2* HCT-23.0* MCV-93 MCH-33.4* MCHC-35.9* RDW-17.7* ___ 01:10PM OSMOLAL-271* ___ 01:10PM GLUCOSE-97 UREA N-12 CREAT-1.2 SODIUM-134 POTASSIUM-3.8 CHLORIDE-101 TOTAL CO2-26 ANION GAP-11 . ___ head CT: IMPRESSION: 1. Hyperdense material surrounding the known left parietal lobe metastasis is concerning for blood. 2. New hyperdensities in the white matter of the left parietal lobe and right occipital lobe may represent edema radiation changes. These findings were discussed with Dr. ___ at 6:50 a.m. on ___ by telephone. ATTENDING NOTE: The hyperdensity surrounding calcified lesion likely blood product or mass. There is increased surrounding edema. No acute hematoma.There are hypodensities in both occipital lobes. The right occipital hypodensity appears slightly more pronounced and the left occipital hypodensity is new since previous CT. . ___ MRI spine: IMPRESSION: 1. Three foci of high STIR signal with mild enhancement involving T2, T4 and T6, while the end plate abnormalities may represent degenerative changes, metastatic disease cannot be excluded. Followup examination or a whole-body bone scan could be helpful for further evaluation. 2. Small loculated left pleural effusion. Correlate with CT torso of ___ for additional details. 3. Diffuse fatty infiltration throughout the cervical, thoracic, and lumbar vertebral bodies, probably related to prior therapy. . ___ MRI head: 1. Interval significant increase in size and surrounding edema of the previously seen metastatic left superior parietal lesion as well as new lesions seen involving the right occipital, right temporal, right cerebellum and left inferior parietal lobe when compared to the prior examination of ___. 2. No acute infarct. Brief Hospital Course: ___ y/o male with small cell CA with mets to the brain, p/w new-onset seizure. His course is summarized by problem below: . Seizure - Head CT with ?new blood around known mets. MRI of the head demonstrated new mets as well as increased edema around the left parietal metastasis. He was started on keppra 1 gm bid and decadron per neurology; no further seizures occured during his hospitalization. Due to the new brain mets, an LP was performed on ___ to evaluate for CSF extension of the mets - prelim cytology was negative; however this was PENDING upon discharge and will be followed up by his neuro-oncologist, Dr. ___, as an outpatient. The patient will be seeing Dr. ___ on ___, ___, to discuss further treatment options for the new brain mets. . Small cell lung CA, metastatic - CT torso done in-house demonstrated slight increase in the burden of disease and an MRI of the spine demonstrated several foci of possible mets (could not be ruled out definitively). A bone scan can be considered and this was discussed with the patient and his primary oncologist, who will follow-up with the patient on ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Baclofen 10 mg PO TID 2. Citalopram 20 mg PO DAILY 3. Methadone 25 mg PO TID 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Omeprazole 20 mg PO DAILY 6. Simvastatin 40 mg PO DAILY 7. Terazosin 5 mg PO HS Discharge Medications: 1. Baclofen 10 mg PO TID 2. Citalopram 20 mg PO DAILY 3. Methadone 25 mg PO TID 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Omeprazole 20 mg PO DAILY 6. Simvastatin 40 mg PO DAILY 7. Polyethylene Glycol 17 g PO EVERY OTHER DAY constipation 8. Terazosin 5 mg PO HS 9. Dexamethasone 4 mg PO DAILY RX *dexamethasone 4 mg One tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 10. LeVETiracetam 1000 mg PO BID RX *levetiracetam 1,000 mg One tablet(s) by mouth twice daily Disp #*60 Tablet Refills:*2 Discharge Disposition: Home Discharge Diagnosis: Seizure Small cell lung CA with metastatic disease, brain mets Chronic cervical pain HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted after having a new-onset seizure. This was felt to be secondary to increased swelling around one of the lesions. You were started on an anti-seizure medication and a steroid, both which you will need to continue taking unless told otherwise. As you know, the MRI of your head demonstrated increased lesions. You underwent a lumbar puncture, results of which are still PENDING. You also underwent an MRI of the spine, which did not show obvious lesions but could not rule out metastatic spread definitively. It is recommended you undergo a body scan, which can be discussed with your ___. Please follow-up with Dr. ___ on ___ and Dr. ___ on ___. No other changes were made to your medications. Followup Instructions: ___
10766131-DS-11
10,766,131
22,925,978
DS
11
2137-07-01 00:00:00
2137-07-01 21:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: weakness, hypotension, ___ Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ y/o ___ woman presenting with concern for weakness. Patient is a poor historian presenting from adult day care with hypotension and weakness. Patient was at her daycare where she was complaining of generalized weakness and was found to have systolic pressures in the ___. She also noted rectal pain and nausea with no bowel movements in several days. With interpreter at bedside in the ED, patient denied abdominal pain, vomiting, urinary symptoms, fevers, chills, BRBPR, melena, chest pain, cough, or shortness of breath. There was also a question of chest heaviness per the patient. Upon presentation in the ED, VS: Labs significant for WBC 3.9 (baseline), Plt 106 (previously 170-200's), Cr 1.8 (baseline ___ with BUN 23, INR 1.6, trop <0.01, and a negative UA. Blood and urine cx were drawn. On rectal exam, patient had no stool in the vault and was heme negative. Abdomen was benign but patient did complain of abdominal pain and a CT abd/pelvis was ordered, which showed a celiac artery calcification but no acute processes. She was given 1L fluid before and after imaging due to ___. CXR no acute processes, EKG with more pronounced lateral TWI and mild inferior STD's. VS on transfer: 97.4 70 106/66 14 100% RA. Of note, the patient's Coumadin is monitored through ___. On the floor, an interpreter was paged but the patient was only able to give vague answers to questions. She said that her low back hurt and her R leg felt "heavy" but said these problems have been going on "for a long time". She denied chest pain or difficulty breathing. She also initially denied abdominal pain, but then said her abdomen felt "not quite right". Past Medical History: Hypertension Hyperlipidemia PAF on coumadin hypothyroidism, post-radioactive iodine ablation for hyperthyroidism in ___. Deep venous thrombophelbitis Peripheral Vascular Disease. Social History: ___ Family History: Mother and father died of MI. Physical Exam: PHYSICAL EXAM ON ADMISSION: Vitals - T98.4 137/70 98 18 100 ra. GENERAL: Patient lying in bed, occasionally grimacing with movement. HEENT: AT/NC NECK: nontender CARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs LUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, soft, +BS, patient grimacing when abdomen palpated around the umbilicus. EXTREMITIES: no cyanosis, clubbing or edema. Some tenderness to palpation of the bilateral legs. PULSES: 2+ DP pulses bilaterally NEURO: Difficult to assess mental status even with interpreter present. Patient answered some questions but appeared confused when asked to follow commands. Fine touch sensation intact in the groin region and patient able to lift both legs off the bed with effort. Unable to comprehend other strength-testing exercises for the legs. Grip strength equal bilaterally. SKIN: warm and well perfused, some scars on legs. PHYSICAL EXAM ON DISCHARGE: T 98.8 106-148/83-83, HR 70, 100%RA , wt ___ 58.9kg Gen: AOx3, comfortable, Lungs: CTAB Abd: Soft nt/nd Ext: Trace edema bilat. Pertinent Results: LABS ON ADMISSION: ----------------- ___ 11:45PM cTropnT-<0.01 ___ 08:30PM ___ PTT-31.1 ___ ___ 08:10PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 08:10PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 04:45PM GLUCOSE-123* UREA N-23* CREAT-1.8* SODIUM-138 POTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-21* ANION GAP-16 ___ 04:45PM cTropnT-<0.01 ___ 04:45PM CALCIUM-9.5 PHOSPHATE-3.8 MAGNESIUM-2.2 ___ 04:45PM WBC-3.9* RBC-4.06* HGB-12.9 HCT-39.9 MCV-98 MCH-31.7 MCHC-32.3 RDW-13.3 ___ 04:45PM NEUTS-56.7 ___ MONOS-5.6 EOS-2.7 BASOS-0.7 ___ 04:45PM PLT COUNT-106* RELEVANT LABS: -------------- ___ 05:13AM BLOOD Neuts-46.8* Lymphs-44.0* Monos-6.2 Eos-2.6 Baso-0.3 ___ 04:23AM BLOOD ___ PTT-28.7 ___ ___ 05:13AM BLOOD ALT-19 AST-24 CK(CPK)-129 AlkPhos-51 TotBili-0.5 ___ 05:13AM BLOOD TSH-35* ___ 03:56AM BLOOD Lactate-1.1 LABS ON DISCHARGE: ------------------ MICROBIOLOGY: --------------- __________________________________________________________ ___ 8:30 pm BLOOD CULTURE Blood Culture, Routine (Pending): __________________________________________________________ ___ 8:10 pm URINE STRAIGHT CATHETER PLAIN RED. **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. __________________________________________________________ ___ 4:45 pm BLOOD CULTURE Blood Culture, Routine (Pending): IMAGING: ----------- ___ CT abd/pelvis IMPRESSION: 1. No small bowel obstruction. 2. Dense calcification at the origin of narrowed but patent celiac axis ___ CXR FINDINGS: Left chest wall dual lead pacing device is again noted. The lungs are clear without consolidation, effusion, or vascular congestion. Cardiac silhouette is enlarged, unchanged. No acute osseous abnormalities. IMPRESSION: Cardiomegaly without acute cardiopulmonary process. ___ EKG ECG-> a paced, lateral TWI (new, more pronouced than previous), mild inferior STDs Discharge Labs: ___ 07:40AM BLOOD WBC-3.7* RBC-3.99* Hgb-12.9 Hct-38.5 MCV-96 MCH-32.3* MCHC-33.5 RDW-13.5 Plt ___ ___ 07:40AM BLOOD ___ PTT-32.7 ___ ___ 07:40AM BLOOD Glucose-107* UreaN-19 Creat-1.0 Na-141 K-4.3 Cl-107 HCO___-25 AnGap-13 Brief Hospital Course: Ms. ___ is a ___ y/o ___ woman presenting with concern for weakness and hypotension. She also had other vague complaints including back pain, abdominal pain, questionable chest heaviness, found to have ___ and hypothyroidism. ___ was prerenal in etiology due to dehydration; Cr on discharge 1.1. Pt's TSH on admission was 35 and she is on levothyroxine 125mcg on discharge (was on 100mcg at home but unclear whether she was compliant). She was hypotensive on admission most likely due to hypovolemia in the setting of dehydration and it resolved on discharge and home anti-hypertensives and diuretics were resumed. ACTIVE MEDICAL ISSUES: #Hypotension: likely in the setting of poor fluid intake as responded to volume in the ED. She also has a history of labile blood pressures and is alternatively hyper and hypotensive. ACE-in was restarted on ___ after ___ resolved. ___: patient w/ Cr increase from baseline Cr ___ to 1.8 on admission. Resolved with fluids. Likely pre-renal in setting of poor PO intake at home. #Weakness/lethargy: Likely secondary to hypothyroidism as TSH found to be 35. Family states she has been taking her synthroid although does not appear to have been filled recently at pharmacy. Her levothyroxine dose was increased from 100 mcg to 125 mcg. Other possibly etiologies which were ruled out include infection (UA neg, blood cx NGTD). ___ consulted and recommended rehab #Abdominal pain: Difficult to assess the extent of the patient's pain, as she grimaces upon exam but does not endorse significant pain upon questioning. CT abdomen showed a calcification at the level of the celiac axis, raising concern that poor perfusion may be contributing to her pain. Lactate wnl which is reassuring against mesenteric ischemia. Otherwise, no acute findings on CT. Likely secondary constipation in setting of hypothyroidism. Per family, it is usual for her to go ___ weeks w/o BM. Her BM regimen was increased #Back and leg pain: per patient, chronic in nature. No red flags on physical exam. Rectal wnl on admission. Gait intact (walks with walker at baseline). Pain was controlled with tylenol (standing) and prn oxycodone as needed #Chest heaviness: the patient reportedly had chest heaviness in the ED but denied chest discomfort on the floor. Two trops negx3. EKG with lateral TWI (new, more pronouced than previous), mild inferior STDs. Her symptoms later resolved, although she had a mild episode night of ___, EKG without changes, self resolved. #Thrombocytopenia: below patient's baseline on admission, unclear etiology. Resolved #A-fib on coumadin: INR subtherapeutic on admission. Coumadin dosing increased per pharmacy recommendations. #CHF: Pt on 10 mg lasix started by her cardiologist for volume overload. Last ECHO in ___ with preserved EF. Pt appeared more euvolemic on exam and was dry on admission, therefore lasix was held #HLD: Pt continued atorvastatin TRANSITIONAL ISSUES: =================== [] monitor INR daily as pt on coumadin for AF [] check TSH six weeks after discharge which would be around ___ and adjust levothyroxine dose as necessary [] monitor volume status and restart lasix dose as appropriate Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Furosemide 10 mg PO DAILY 3. Hydrocortisone (Rectal) 2.5% Cream 1 Appl PR TID:PRN irritation 4. Lactulose 15 mL PO BID:PRN constipation 5. Levothyroxine Sodium 100 mcg PO DAILY 6. Lisinopril 30 mg PO DAILY 7. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID:PRN skin irritation 8. Warfarin 6 mg PO 2X/WEEK (___) 9. Warfarin 4 mg PO 5X/WEEK (___) 10. Docusate Sodium 100 mg PO BID 11. Acetaminophen 1000 mg PO BID:PRN pain 12. Bisacodyl 5 mg PO DAILY:PRN constipation 13. Omeprazole 20 mg PO DAILY 14. Senna 8.6 mg PO DAILY Discharge Medications: 1. Acetaminophen 1000 mg PO BID:PRN pain 2. Atorvastatin 40 mg PO QPM 3. Bisacodyl 5 mg PO DAILY:PRN constipation 4. Docusate Sodium 100 mg PO BID 5. Hydrocortisone (Rectal) 2.5% Cream 1 Appl PR TID:PRN irritation 6. Levothyroxine Sodium 125 mcg PO DAILY 7. Lisinopril 30 mg PO DAILY 8. Omeprazole 20 mg PO DAILY 9. Senna 8.6 mg PO DAILY 10. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID:PRN skin irritation 11. Warfarin 6 mg PO DAILY16 12. Warfarin 4 mg PO 5X/WEEK (___) Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: ACUTE DIAGNOSES: 1. hypothyroidism 2. ___ 3. hypotension CHRONIC DIAGNOSES: 1. atrial fibrillation 2. CHF Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you here at ___. You presented to us with weakness and you were found to be dehydrated, resulting in low blood pressures and kidney dysfunction. We believe your weakness is most likely due to low thyroid hormone levels, and you are being treated for it. You are now being discharged to rehab in order to regain your strength. Please take all your medications as instructed. Please attend all your follow up appointments. Best, Your ___ team Followup Instructions: ___
10766131-DS-14
10,766,131
23,740,277
DS
14
2139-02-16 00:00:00
2139-02-17 22:17:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Fall Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ old ___ woman who presented to ___ ED as a trauma for a fall from standing at 1pm on ___. She is on home Xarelto, which was held on admission. She states she felt dizzy before falling. She did not have any chest pain or palpitations at the time. On imaging, she was found to have a small subarachnoid hemorrhage, a small subdural hematoma, and L zygomaticomaxillary complex fractures. Neurosurgery has cleared her for outpatient followup and plastic surgery has also decided on non-operative management of the facial fractures and follow up outpatient. She has been persistently hypertensive while on home medications. A syncopal workup has been initiated, with ECHO within normal limits. UA and urine culture has been ordered. T-spine tenderness to palpation was observed on tertiary trauma survey and a CT T-spine has been ordered Past Medical History: Hypertension Hyperlipidemia PAF on rivoraxaban hypothyroidism, post-radioactive iodine ablation for hyperthyroidism in ___. Deep venous thrombophelbitis Peripheral Vascular Disease Social History: ___ Family History: Mother and father died of MI. Physical Exam: ADMISSION EXAM ================= Vital signs: 98, 69, 158/72, 15, O2sat100% Gen: WD/WN, comfortable, NAD. HEENT: Pupils: ___ EOMI Lungs: CTA bilaterally. Cardiac: RRR. S1/S2. Abd: Soft, NT, BS+ Extrem: Warm and well-perfused. Back: denies TTP, no step offs; left gluteal decubitus ulcer, clean, with wick/dressing intact Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person and place only, baseline per family. Language: ___ Creole speaking only. CN ___ intact Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift DISCHARGE EXAM ================= Vitals: 98.3, 155/83, 69, 16; 100% RA GENERAL - Awake, alert, oriented to person, place (not to year, at baseline) HEENT - PERRLA, EOMI with the exception of upward gaze (baseline), minimal ___ swelling and residual ecchymosis HEART - RRR, nl S1-S2, no MRG LUNGS - CTAB ABDOMEN - Soft/NT/ND, +bowel sounds EXTREMITIES - WWP, 2+ peripheral pulses, no edema NEURO - CNII-XII intact. Lifts upper and lower extremities to gravity. Sensation intact. Pertinent Results: ADMISSION LABS ===================== ___ 08:20PM BLOOD WBC-11.5*# RBC-4.45 Hgb-13.8 Hct-41.4 MCV-93 MCH-31.0 MCHC-33.3 RDW-12.2 RDWSD-41.8 Plt ___ ___ 08:20PM BLOOD Neuts-88.3* Lymphs-7.9* Monos-3.3* Eos-0.0* Baso-0.1 Im ___ AbsNeut-10.17*# AbsLymp-0.91* AbsMono-0.38 AbsEos-0.00* AbsBaso-0.01 ___ 08:20PM BLOOD ___ PTT-28.5 ___ ___ 07:15PM BLOOD Glucose-143* UreaN-13 Creat-0.7 Na-136 K-3.7 Cl-100 HCO3-22 AnGap-18 ___ 07:15PM BLOOD ALT-13 AST-21 AlkPhos-66 TotBili-0.7 ___ 07:15PM BLOOD cTropnT-<0.01 ___ 01:45AM BLOOD cTropnT-<0.01 ___ 04:56PM BLOOD cTropnT-<0.01 ___ 07:15PM BLOOD Albumin-3.8 ___ 01:45AM BLOOD Calcium-9.7 Phos-3.2 Mg-1.8 DISCHARGE LABS ===================== ___ 07:52AM BLOOD WBC-6.0 RBC-4.08 Hgb-12.7 Hct-39.6 MCV-97 MCH-31.1 MCHC-32.1 RDW-13.5 RDWSD-47.8* Plt ___ ___ 07:52AM BLOOD ___ PTT-25.6 ___ ___ 07:52AM BLOOD Glucose-105* UreaN-19 Creat-0.7 Na-139 K-5.4* Cl-103 HCO3-25 AnGap-16 ___ 07:52AM BLOOD Calcium-10.0 Phos-3.8 Mg-2.0 ___ 12:35AM BLOOD TSH-23* ___ 01:01AM BLOOD ___ pO2-209* pCO2-41 pH-7.43 calTCO2-28 Base XS-3 Comment-GREEN TOP IMAGING ====================== CXR ___ NO No discrete fracture identified. CT HEAD W/O CONTRAST ___ 1. Small volume acute subarachnoid hemorrhage in the left sylvian fissure and tiny acute subdural hematoma along the left inferior temporal lobe. No mass effect. 2. Left facial fractures, described in further detail on dedicated facial bone CT exam. CT MAXILLOFACIAL ___ Left zygomaticomaxillary complex fracture pattern: Complex fracture involving the left maxillary sinus along the medial, post oral lateral and anterior walls. The posterior fracture extends to the level of the base of the left pterygoid plate. The anterior fractures extend to the left orbital floor with mild associated extraconal hematoma along the left orbital floor. No signs of muscle entrapment. The left globe appears intact. Left maxillary hemo sinus is noted. There is a subtle fracture involving the left lateral orbital wall with small amount of adjacent extraconal hematoma. Also noted is an acute fracture of the left zygomatic arch which appears segmental and mildly depressed. Nasal bones appear intact. The mandible appears intact. The patient is edentulous. Partial opacification of the right inferior mastoid air cells. CT C-SPINE ___ No fracture or malalignment. XRAY LEFT KNEE ___ AP, lateral, obliques views of the left knee provided. There is no acute fracture or dislocation. No signs of joint effusion. There is no significant degenerative disease. Diffuse osteopenia noted. Vascular calcification is seen. ECHO ___ IMPRESSION: Suboptimal image quality. Normal biventricular regional/global systolic function. No atrial septal defect is seen by 2D or color Doppler. Normal left ventricular wall thickness, cavity size, and regional/global systolic function (biplane LVEF = 73 %). Doppler parameters are indeterminate for left ventricular diastolic function. Right ventricular chamber size and free wall motion are normal. The number of aortic valve leaflets cannot be determined. There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. REPEAT CT HEAD ___ 1. Interval increased conspicuity of subarachnoid hemorrhage layering along the anterior left temporal lobe and posterior aspect of the sylvian fissure. Extension of subarachnoid hemorrhage along the left parietal lobe is not seen on prior examination. 2. There is a subtle 2 mm thick subdural hematoma along the posterior aspect of the left temporal lobe. 3. No definite parenchymal contusion is identified. Additional findings as described above. CT T-SPINE ___ 1. No evidence of fracture or subluxation. 2. Diffuse demineralization. 3. Enlargement of the main pulmonary artery suggests pulmonary arterial hypertension. 4. Bilateral renal cysts. 5. A 4 mm perifissural nodule in the right middle lobe. The ___ pulmonary nodule recommendations are intended as guidelines for follow-up and management of newly incidentally detected pulmonary nodules smaller than 8 mm, in patients ___ years of age or older. Low risk patients have minimal or absent history of smoking or other known risk factors for primary lung neoplasm. High risk patients have a history of smoking or other known risk factors for primary lung neoplasm. CT HEAD W/O CONTRAST ___ 1. Possible 3-mm left frontal lobe contusion now with new hemorrhage. 2. Enlargement of the left convexity subdural fluid collection since the prior examination. 3. Evolving intraparenchymal hematoma at the depth of the left sylvian fissure. 4. Multiple comminuted left fractures and hemorrhage in left maxillary sinus. CXR ___ In comparison with the study of ___, there is little change and no evidence of acute cardiopulmonary disease. Continued enlargement of the cardiac silhouette with dual channel pacer and leads extending to the right atrium and apex of the right ventricle. No vascular congestion or pleural effusion or acute focal pneumonia. ___ ___ No evidence of deep venous thrombosis in the right or left lower extremity veins. Head CT (___): IMPRESSION: 1. Expected evolution of multi compartmental intracranial hemorrhage, as described above. 2. No new foci of intracranial hemorrhage. 3. No acute large vascular territorial infarction. CXR (___): IMPRESSION: No radiographic evidence of acute cardiopulmonary disease. Enlarged cardiac silhouette, unchanged. Brief Hospital Course: BRIEF HOSPITAL COURSE ============================= Ms. ___ is an ___ year old ___ female with a history Afib on rivoraxaban and sinus node dysfunction s/p PPM found to have subdural hemorrhage, subarachnoid hemorrhage, intraparenchymal hemorrhage, and left facial fracture s/p fall. She was initially managed in the trauma ICU, where she had a stable neurologic exam without focal deficits. Her blood pressure was frequently elevated above goal SBP < 160 per neurosurgery, requiring PRNs. She was transferred to the medicine floor, where her home lisinopril was uptitrated from 10mg lisinopril to 40mg lisinopril. She was also started on amlodipine 5 mg at night. At the time of discharge, she was not requiring PRN medications to maintain SBP < 160. Her neuro exam was without focal deficits. DETAILED HOSPITAL COURSE ============================= #SDH, SAH, IPH: Likely secondary to fall with headstrike given multiple bleeds and facial fracture, though primary hemorrhagic CVA as inciting event for fall cannot be definitively ruled out. Per neurosurgery, goal systolic BP < 160. She was initially managed in the trauma ICU, where she had a stable neurologic exam without focal deficits. Her blood pressure was frequently elevated above goal SBP < 160, requiring PRNs. She was transferred to the medicine floor, where her home lisinopril was uptitrated from 10 mg lisinopril to 40 mg lisinopril. She was also started on amlodipine 5 mg at night. During one episode of hypertension with SBP > 160, she developed a new left facial droop. STAT head CT showed new 3mm bleed in left frontal lobe and interval increase in SDH. Per neurosurgery, she did not need change in treatment plan or surgical intervention. Her facial droop resolved the next day. At discharge, she had no focal neuro deficits on exam and her blood pressures were SBP < 160 without PRNs. She received Keppra 500mg BID seizure prophylaxis for 7 days during admission. Rivoraxaban was restarted on ___ (10 days after her fall). She will follow up with Dr. ___ in 8 weeks with a repeat head CT. #Fall: Given that patient reported she was amnestic of the event, it was difficult to assess the cause of the fall however most likely etiology is mechanical fall i/s/o peripheral neuropathy and deconditioning v. orthostatic syncope i/s/o hypovolemia. Infection was less likely given UA and CXR were unremarkable. UCx was c/w contamination. Her chronic pressure ulcer had no surrounding erythema or purulent exudate. Cardiac event is less likely given TTE showed normal valves and biventricular regional/global systolic function, PPM interrogation showed no malfunction, troponins x3 were negative. CT head showed no e/o structural brain abnormalities. Her hemorrhages are more likely secondary to headstrike given her facial fracture than CVA inciting fall, though this cannot be definitively ruled out. #Pressure ulcer, chronic and present on admission: Patient has pressure ulcer on left buttock, which has been cared for by ___ at home. Per wound nurse, it tracks 3cm upward from the base of the wound. There was no surrounding erythema or purulent exudate concerning for infection. It was dressed per wound care recommendations. #Facial fractures: Found to have L zygomaticomaxillary complex fx. Per plastics, there was no indication for surgery, so she was kept on sinus precautions. She will follow-up with plastics as outpatient. Chronic issues: ================= #Paroxysmal AFib: Initially held rivoraxaban in the setting of intracranial hemorrhages. This was restarted on ___. #Sinus node dysfunction s/p PPM: -PPM interrogation showed functioning device #Hypertension, uncontrolled -Blood pressure medications as above -Goal SBP < 160 per NSGY Resolved issues: ================= #New left sided facial droop: Resolved. Was observed on ___ in the setting of systolic blood pressures of 190s in the early AM, with improvement after hydralazine. CT showed new 3mm left frontal lobe hemorrhage and small increase in prior SDH. Facial droop resolved the next day and exam remained stable through remainder of admission. ___ have been secondary to facial swelling i/s/o her facial fractures. #Dyspnea: Resolved. Patient endorsed new dyspnea during admission. LENIs were negative and CXR showed no e/o PNA, edema, atelectasis or other abnormalities to explain her dyspnea. Was likely secondary to deconditioning and minimal activity during admission. Dyspnea resolved the next day without intervention. #Yeast infection: Patient was noted to have vaginal swelling and discharge, concerning for a vaginal yeast infection. Treated with 150mg fluconazole x1 #FEN: Per speech and swallow, she was initially kept NPO given concern for aspiration risk on their exam. Her diet was advanced per their recommendations, and she was tolerating puree solids and nectar thick liquids safely. Transitional issues: -Her lisinopril was increased to 40 mg qAM and we added amlodipine 5 mg qPM to control her elevated blood pressures. Goal SBP<160. Amlodipine can be uptitrated if necessary. -She needs follow-up neurosurgery appointment with Dr. ___ in 6 weeks with a repeat head CT prior to that appointment. -She needs to follow-up with plastic surgery for her facial fracture in 1 week. -An incidental 4 mm lung nodule was found on her PE-CT. Per ___ pulmonary nodule recommendations, she does not need follow-up for this since nodule size <= 4 mm and she is a never-smoker, making her low risk. -She should not drink through a straw or blow her nose until she sees the plastic surgeons in clinic, per sinus precautions. -Patient is being discharged home with services and 24h care. She is a ___ person assist and should not be moved without the help of two people. She needs a ___ lift for transfers. -Patient noted to be orthostatic during her stay, likely secondary to severe deconditioning. She should continue to work with ___. -Patient had elevated TSH to 23, which is difficult to interpret in the setting of known hypothyroidism and current illness. Please re-check in 6 weeks to assess whether she may need titration of her levothyroxine. -CODE: Full (confirmed with interpreter at bedside) -COMMUNICATION: ___ (niece - ___ speaking) - ___, ___ (health care proxy and daughter - not ___ speaking)- ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Levothyroxine Sodium 125 mcg PO DAILY 3. Lisinopril 10 mg PO DAILY 4. Rivaroxaban 15 mg PO DAILY 5. Docusate Sodium 100 mg PO BID 6. Vitamin D 400 UNIT PO DAILY Discharge Medications: 1. amLODIPine 5 mg PO HS RX *amlodipine 5 mg 1 tablet(s) by mouth at bedtime Disp #*30 Tablet Refills:*0 2. Lisinopril 40 mg PO DAILY RX *lisinopril 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Atorvastatin 40 mg PO QPM 4. Docusate Sodium 100 mg PO BID 5. Levothyroxine Sodium 125 mcg PO DAILY 6. Rivaroxaban 15 mg PO DAILY 7. Vitamin D 400 UNIT PO DAILY 8.DME Hoyer lift and sling Length of need: 99 ICD-10: Z74.01 ___ bed Length of need: 99 ICD-10: Z74.01 10.DME Alternating pressure pad for hospital bed Length of need: 99 ICD-10: Z74.01 11.DME Roho Cushion Length of need: 99 ICD-10: Z74.01 12.DME Standard Wheelchair Length of need: 99 ICD-10: Z74.01 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Subdural hematoma, Subarachnoid hemorrhage, Left zygomaticomaxillary complex fracture Secondary: Uncontrolled benign essential hypertension, Pressure ulcer present on admission, Hypothyroidism, Paroxysmal Atrial fibrillation, Sinus Node Dysfunction s/p PPM Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, You were admitted to ___ after falling at home and injuring your head. The bleeding in your head was evaluated by neurosurgery, and they said you did not need surgery. You will get a repeat CAT scan of your head to see how the bleeding is healing, and the neurosurgeons will see you again in 6 weeks. The plastic surgeons will see you in 1 week for your broken facial bones. During your hospital stay, we monitored your blood pressures to make sure they did not get too high. We are sending you home on new blood pressure medicines which you should take every day. This is VERY important to make sure you brain bleeds do not get worse. You are recovering well and are now ready for discharge. Please follow the instructions below to continue your recovery: New medicines: 1. We increased your lisinopril to 40 mg. Please take it every morning. 2. Take amlodipine 5 mg every night before you sleep. Please get plenty of rest, continue to walk several times per day with assistance, and drink adequate amounts of fluids. Please attend all of your follow-up appointments (listed below). It was a pleasure to participate in your care. Sincerely, Your ___ team Followup Instructions: ___
10766131-DS-16
10,766,131
25,184,449
DS
16
2139-12-01 00:00:00
2139-12-01 19:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: elevated Cr Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo ___ woman with history of HFpEF, AF on rivaroxaban, s/p PPM, prior traumatic SAH/SDH, nonverbal at baseline presenting w/ lethargy, and pink/orange urine found to have acute renal failure. Family notes that she has been increasingly lethargic and had recently moved from rehab back home with the family. Her urine has become a pink/orange color over the past 24 hours. No fever/chills. No change in PEG intake. +cough which is chronic. OR debridement of sacral and scapula ulcers on ___ PEG placed ___ and PICC in place for IV antibiotics (end date ___. Of note, she was recently admitted to ___ from ___ to ___ w/ infected pressure ulcers on her sacrum and right scapula from which cultures grew multiple organisms including staph epi, proteus m., bacteroides, pseudomonas. She was switched to vanc/flagyl/cefepime for a 4 week course (d1 = ___ - ___, to be followed by ID OPAT. She also had an NSTEMI w/ Tn peak 0.13 and EKG unchanged, likely representing a type II demand ischemia (in setting of significant sacral infection) or small branch vessel disease. Further testing was deferred (stress, cath) as she is a poor candidate for antiplatelet therapy given her recent SDH/SAH and overall is chronically ill. PEG placement was undertaken on ___ malnutrition. A Foley catheter was placed because of the location of the decubiti and incontinence. Notably, on ___ OPAT labs were Vanco: 18.4 BUN: 45 Creat: 0.7 WBC: 11.1 Neuts%: 69.3 Eos: 2.7. On ___ vanco level was 22.7 so on ___, dose was reduced to 750mg IVQ24 hours. On ___ one of the ID fellows received a phone call from outside facility regarding her vanco trough being 35; the level was drawn at 9.30 am and vanco was given at 10. They asked her nurse to discontinue IV vancomycin and check BUN, Cr; vanco random will be checked again on ___ around ___ am. In the ED, initial vitals were: 97.1 146/89 78 18 100%RA - Exam notable for: Abd: benign Rectal: solid dark brown stool, heme + Foley with pink urine Large sacral stage 4 decub, right shoulder stage 4 decub - Labs notable for: UA with >182 RBC, 92WBC, few bacteria, few yeast, no epis, 300 protein, normal specific gravity 13.5>7.5/___.8<279 with 85%N ___ -----------<140 4.5/___/3.2 phos 6.5 troponin 0.7 @2150, CK 40 MB 5 INR 1.8 lactate 1.8 - Imaging was notable for: CXR (portable): Right PICC seen at the level of the upper SVC. Tip obscured by transvenous pacing wires which end in the right atrium and right ventricle. Mild cardiomegaly is unchanged. No pneumothorax. There is increasing left basilar airspace opacity with obscuration of the left costophrenic angle. - Patient was given: ceftriaxone 1g and started on NS at 150cc/hr - Vitals prior to transfer: 113/79 74 17 94%RA Past Medical History: Hypertension Hyperlipidemia PAF on rivoraxaban hypothyroidism, post-radioactive iodine ablation for hyperthyroidism in ___. Deep venous thrombophelbitis Peripheral Vascular Disease Social History: ___ Family History: per OMR, mother and father died of MI. Physical Exam: Admission PHYSICAL EXAM: Vital Signs: 97.4 153 / 80 70 97RA General: Laying in bed, eyes closed, NAD HEENT: Sclerae anicteric, MMM Neck: Supple. JVP not elevated. no LAD CV: Regular rate and rhythm. Normal S1+S2, no murmurs, rubs, gallops. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present GU: + foley Skin: Large 5X5 wound, few mm deep, pink/red in sacral region, non purulent, but very open with some granulation tissue, small ~3X2 wound near R shoulder, also non-purulent but very open pink/red w/ some granulation tissue, R sided PICC Ext: Warm, well perfused, 2+ pulses, 2+ pitting edema to RLE, 1+ to LLE, 2+ pitting edema to R hand, none on L hand Neuro: non-verbal on exam, does not open eyes, does not follow commands, per reports, pt is somewhat more responsive when family asks questions DISCHARGE EXAM: VITALS: No vitals. RR ___ GENERAL: Opens eyes, does not follow commands CV: RRR Pertinent Results: Day of Admission Labs: ====================== ___ 09:51PM BLOOD WBC-13.5*# RBC-2.39* Hgb-7.5* Hct-23.8* MCV-100*# MCH-31.4 MCHC-31.5* RDW-20.0* RDWSD-71.1* Plt ___ ___ 07:00AM BLOOD WBC-11.1* RBC-2.33* Hgb-7.2* Hct-23.6* MCV-101* MCH-30.9 MCHC-30.5* RDW-19.9* RDWSD-73.1* Plt ___ ___ 09:51PM BLOOD Neuts-84.6* Lymphs-6.4* Monos-7.0 Eos-1.1 Baso-0.2 Im ___ AbsNeut-11.41* AbsLymp-0.86* AbsMono-0.95* AbsEos-0.15 AbsBaso-0.03 ___ 09:51PM BLOOD ___ PTT-28.2 ___ ___ 07:00AM BLOOD ___ PTT-74.8* ___ ___ 09:51PM BLOOD Glucose-140* UreaN-143* Creat-3.2*# Na-139 K-4.5 Cl-101 HCO3-16* AnGap-27* ___ 07:00AM BLOOD Glucose-104* UreaN-142* Creat-3.3* Na-139 K-4.3 Cl-103 HCO3-15* AnGap-25* ___ 11:37AM BLOOD Glucose-108* UreaN-137* Creat-3.3* Na-142 K-4.2 Cl-104 HCO3-15* AnGap-27* ___ 07:00AM BLOOD ALT-15 AST-29 LD(LDH)-441* CK(CPK)-36 AlkPhos-70 TotBili-0.2 ___ 09:51PM BLOOD CK-MB-5 cTropnT-0.70* ___ 07:00AM BLOOD CK-MB-5 cTropnT-0.48* ___ 11:37AM BLOOD CK-MB-5 cTropnT-0.52* ___ 09:51PM BLOOD Albumin-2.7* Calcium-8.5 Phos-6.5* Mg-3.3* ___ 11:37AM BLOOD Calcium-8.3* Phos-6.8* Mg-3.2* ___ 09:51PM BLOOD Vanco-31.2* ___ 01:15AM BLOOD Lactate-1.6 ___ 01:13PM BLOOD Lactate-2.2* Other significant labs: ___ 09:51PM BLOOD CK-MB-5 cTropnT-0.70* ___ 07:00AM BLOOD CK-MB-5 cTropnT-0.48* ___ 11:37AM BLOOD CK-MB-5 cTropnT-0.52* ___ 09:51PM BLOOD Vanco-31.2* ___ 02:05AM BLOOD Vanco-25.3* ___ 02:40AM BLOOD Vanco-24.6* ___ 05:42PM URINE Color-Yellow Appear-Clear Sp ___ ___ 05:42PM URINE Blood-MOD Nitrite-NEG Protein-100 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD ___ 05:42PM URINE RBC-10* WBC-55* Bacteri-FEW Yeast-NONE Epi-0 TransE-1 ___ 12:05AM URINE Hours-RANDOM UreaN-464 Creat-25 Na-<20 ___ 12:05AM URINE Osmolal-358 Micro: ___ CULTURE-FINALINPATIENT ___ Urinary Antigen -FINALINPATIENT ___ STAIN-FINAL; RESPIRATORY CULTURE-FINALINPATIENT ___ Urinary Antigen -FINALINPATIENT ___ CULTUREBlood Culture, Routine-PENDINGEMERGENCY WARD ___ CULTUREBlood Culture, Routine-PENDINGEMERGENCY WARD ___ CULTURE-FINAL {YEAST}EMERGENCY WARD Discharge Labs: - No labs performed Imaging: CXR ___ IMPRESSION: Compared to chest radiographs since ___ most recently ___. Previous left lower lobe consolidation has substantially cleared. Small left pleural effusion is unchanged for at least a month. Moderate cardiomegaly is chronic. Right lung clear. No pneumothorax. Right PIC line ends in the right brachiocephalic vein just above the origin of the SVC, no less than 7 cm from the estimated location of the superior cavoatrial junction. Indwelling atrial ventricular pacer leads are continuous from the left pectoral generator. CT Head ___ FINDINGS: There is no evidence of intracranial hemorrhage, edema, or mass. The ventricles and sulci are prominent consistent with involutional changes. Periventricular white matter hypodensities stable in appearance, nonspecific, in a pattern suggestive of chronic small vessel ischemic changes. Hypodensity in the left corona radiata consistent with chronic infarct appears unchanged. No new hypodensities are identified. No acute osseous abnormalities seen. The paranasal sinuses, left mastoid air cells, and middle ear cavities are clear. Partial opacification of the right mastoid air cells are nonspecific and possibly due to prolonged supine positioning, and unchanged in appearance from prior examination. The orbits are unremarkable. IMPRESSION: No acute intracranial process. Renal U/S ___ FINDINGS: The right kidney measures 11.0 cm. The left kidney measures 10.9 cm. There is no hydronephrosis. There is a 3.1 cm simple cyst in the right kidney. Normal corticomedullary differentiation is seen in the right kidney. Views of the left kidney are limited. Foley seen within a decompressed bladder. IMPRESSION: Limited views of the left kidney, but no hydronephrosis bilaterally. Brief Hospital Course: ___ yo ___ woman with history of HFpEF, AF on rivaroxaban, s/p PPM, prior traumatic SAH/SDH, and recent admission for infected sacral and R scapular decubitus ulcers s/p 4 week course of vanc/cef/flagyl for polymicrobial infection, who was admitted on ___ for acute renal failure and found to be in septic shock and in afib with RVR. Patient was transitioned to ___-based care after extensive discussion with patient's family and health care proxy given her significant comorbidities and poor prognosis. Tube feeds were stopped given goals of care discussion and patient was started on oral care regimen. Patient's symptoms were controlled with dilaudid liquid administered through PEG tube, Ativan for anxiety (which she did not require), and glycopyrlate for secretions. Her symptoms were well controlled and she stabilized for transition to home-based care. She will be followed by a palliative ___ after discharge with follow up with palliative care doctor/hospice per family wishes. Hospice saw patient in the hospital, but patient's family declined hospice in favor of ___. #Goals of care: Patient with multiple serious comorbidities including end stage dementia, multiple severe skin ulcers, acute renal failure, and serious infection. After extensive discussion with family regarding the patient's poor quality of life over the last month and potential for pain with further interventions, her family felt it appropriate to focus care on comfort. Her tube feeds were stopped and her symptoms were controlled with dilaudid, lorazepam, zofran, and glycopyrollate. Per family wishes, she will be discharge with palliative ___ instead of hospice. Family was concerned regarding nutrition status of patient, but reiterated that tube feeds were not helping patient given multi-organ failure and poor prognosis even with treatment and were not well tolerated. #Septic Shock ___ pneumonia #UTI: CXR at admission showed LLL infiltrate. Patient with multiple chronic decubitus ulcers, but these were not thought to represent the souce of infection per infectious disease. She had been previously treated with 4 week course of vanc/cefepime/flagyl which ended ___. She was started on meropenem at admission which was discontinued after ___ discussion on ___. #Acute Renal Failure: Presented with Cr increased to 3.3 from baseline of 0.5. Likely in the setting of hypovolemia from infection with possibly contribution from supratherapeutic vancomycin levels. Stopped trending based on GOC. #Anemia: Worsening anemia without clear course of bleed. Likely bone marrow suppression in setting of critical illness and nutritional deficiency. Stopped monitoring. #Acute toxic-metabolic encephalopathy on chronic vascular dementia Baseline bedbound, A+Ox ___. Persistently somnolent and not following commands. Intermittently opens eyes, but no further interaction. CT head negative for acute bleed. This remained throughout course and likely in setting of infection, kidney failure, and metabolic derangements. #NSTEMI (type 2): Trop peak at 0.7, with flat CK-MB. Likely demand in setting of renal failure and hypovolemia in setting of Afib with RVR. #Afib with RVR. RVR occurred in setting of sepsis/hypovolemia. Converted back to sinus rhythm after volume resuscitation and broadening antibiotics. Likely precipitated by hypovolemia and underlying infection. #HFpEF: LVEF >55% in ___. Moderate edema may be from low albumin vs. HF. Did not diurese after GOC dission. #Sacral decubitus ulcer #R upper back pressure ulcer No signs of new acute infection and has completed 4 week broad abx course for polymicrobial infection. #Severe malnutrition PEG tube placed last admission on ___ secondary malnutrition and inability to take PO. Patient continued with low albumin despite initiation. After extensive discussion with family regarding poor prognosis, multi-organ failure, and inability to tolerate feeds, decided to stop tube feeds and focus on comfort based care. She continued to receive medications through G-tube. #HTN: Held lisinopril. #Constipation: Held lactulose BID, docusate, and bisacodyl PRN. Will give bicacodyl PR for use after discharge if pain. #Hypothyroidism: Held home levothyroxine after CMO. Transitional Issues =================== [] Transitioned to comfort-based care during this hospitalization. Will be discharged with palliative ___ per patient's family preferences instead of hospice. [] Palliative ___ will refer patient to palliative care MD depending on how she does after discharge with reconsideration of hospice referral. [] Filled out MOLST forming prior to discharge indicating no further hospitalizations and CMO [] Started morphine PO to be given through PEG tube for discomfort and respiratory distress [] Started lorazepam PRN for anxiety. Patient did not require this medication during hospitalization [] Started scopolamine patch to be given for excess secretions q72 hours [] Tube feeds will not be continued after discussion with patient's family. She will only use PEG tube for medications to control symptoms and improve comfort. [] All other medications were discontinued that did not directly improve comfort. # CMO # CONTACT: Proxy name: ___ Relationship: son Phone: ___ Comments: alternate ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H 2. Atorvastatin 40 mg PO QPM 3. Docusate Sodium 100 mg PO BID 4. Lactulose 30 mL PO BID 5. Levothyroxine Sodium 137 mcg PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Polyethylene Glycol 17 g PO DAILY:PRN constipation 8. Rivaroxaban 15 mg PO DAILY 9. Senna 8.6 mg PO BID 10. Aquaphor Ointment 1 Appl TP TID:PRN wound care 11. Ascorbic Acid ___ mg PO DAILY 12. CefePIME 2 g IV Q8H 13. MetroNIDAZOLE 500 mg PO Q8H 14. Multivitamins W/minerals 1 TAB PO DAILY 15. Vitamin A ___ UNIT PO DAILY 16. Zinc Sulfate 220 mg PO DAILY 17. Bisacodyl 5 mg PO DAILY:PRN constipation 18. Vitamin D 800 UNIT PO DAILY 19. TraMADol 25 mg PO Q6H:PRN pain 20. amLODIPine 5 mg PO DAILY 21. Lisinopril 40 mg PO DAILY 22. Ipratropium-Albuterol Neb 1 NEB NEB Q6H 23. Aspirin 81 mg PO DAILY 24. Metoprolol Tartrate 6.25 mg PO BID Discharge Medications: 1. Bisacodyl 10 mg PR QHS:PRN constipation RX *bisacodyl [Bisac-Evac] 10 mg 1 suppository(s) rectally once a day Disp #*12 Suppository Refills:*0 2. LORazepam 0.25 mg PO Q4H:PRN anxiety RX *lorazepam [Ativan] 0.5 mg 0.5 (One half) tablet(s) by mouth every four (4) hours Disp #*10 Tablet Refills:*0 3. Morphine Sulfate (Concentrated Oral Solution) 20 mg/mL ___ mg PO Q2H:PRN Pain - Moderate RX *morphine concentrate 20 mg/mL ___ mg by mouth every 2 hours as needed Disp #*50 Syringe Refills:*0 4. Scopolamine Patch 1 PTCH TD ONCE Duration: 72 Hours Apply behind ear RX *scopolamine base [Transderm-Scop] 1.5 mg (delivers 1 mg over 3 days) Apply behind ear Q72H Disp #*10 Patch Refills:*0 5. Acetaminophen 1000 mg PO Q8H 6. Aquaphor Ointment 1 Appl TP TID:PRN wound care 7. Ipratropium-Albuterol Neb 1 NEB NEB Q6H Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis ================== Septic shock secondary to pneumonia Acute renal failure Severe malnutrition Secondary Diagnosis =================== Atrial fibrillation with rapid ventricular response Sacral decubitus ulcer Hypertension Constipation Hypothyroidism Discharge Condition: Activity Status: Bedbound. Level of Consciousness: Lethargic and not arousable. Mental Status: Confused - always. Discharge Instructions: Dear Ms. ___, You were admitted to ___ because you had severely infected skin wounds on your back, kidney failure, and a very fast heart rate. You were treated with antibiotics, but your condition continued to worsen. After an extensive conversation with your family, we switched you to comfort-based care. We started medications to control your symptoms. You were seen by our hospice team for control of your symptoms, but you family declined hospice care at this time. You will be followed by a palliative care visiting nurse after discharge. Your family was provided with instructions on administering pain and anxiety medications through your PEG tube. Your family should ask the visiting nurse if they have any questions regarding use of the PEG tube or inadequate control of your symptoms. It was a privilege taking care of you and we wish you the best. Sincerely, Your ___ Team. Followup Instructions: ___
10766212-DS-9
10,766,212
25,818,661
DS
9
2111-12-07 00:00:00
2111-12-07 14:20:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Penicillins Attending: ___. Chief Complaint: Bilateral infected heel ulcers with necrotizing infection of right lower leg Major Surgical or Invasive Procedure: ___ Right Below the Knee Amputation Site Closure ___ Right Guillotine Below the Knee Amputation ___ Right foot and lower extremity debridement History of Present Illness: ___ year old male who presents to the ED with foot ulcerations. Patient's friends had called EMS after the patient stated his feet were bleeding and he smelled a foul odor from his feet. Past Medical History: Denies Social History: ___ Family History: Non-contributory Physical Exam: Admission Physical Exam: General: NAD, AOx3 Lower extremity focused exam: ___ pulses non palpable on the right, faintly palpable on the left. Superficial ulcerations noted sub first and fifth metatarsal heads on the left without surrounding erythema, purulent drainage, or local signs of infection. Large necrotic ulceration noted to the lateral aspect of the right foot and right heel with bone exposed. Purulence and malodor noted. Ulceration tracks proximally and dorsally along the foot with purulence expressed. fifth digit on the right is necrotic. Light touch sensation absent bilaterally. Physical Exam: Alert and oriented x 3. Cooperative. VS:BP 146/84 HR 100 RR 18 Resp: Lungs clear Abd: Soft, non tender Left: Femoral palp, DP palp ,___ palp Dry eschar left heel . Right : Surgical stump incision, clean dry and intact. Soft, no hematoma or ecchymosis. Slightly edematous. Dry DSD and ACE wrapped. Pertinent Results: Imaging: Right foot radiograph Findings highly worrisome for acute osteomyelitis in the right foot involving in plantar calcaneus and the lateral base of the fifth metatarsal, with extensive subcutaneous gas seen tracking along the dorsal and lateral foot, from the level of the ankle to at least the middle phalanx, as well as plantar to the calcaneus ___ 06:50AM BLOOD WBC-12.6* RBC-3.07* Hgb-8.1* Hct-26.3* MCV-86 MCH-26.4 MCHC-30.8* RDW-18.2* RDWSD-56.5* Plt ___ ___ 06:50AM BLOOD Glucose-184* UreaN-21* Creat-0.7 Na-139 K-4.6 Cl-102 HCO3-23 AnGap-19 ___ 06:50AM BLOOD Calcium-7.9* Phos-3.5 Mg-2.1 ___ 06:54PM BLOOD %HbA1c-11.6* eAG-286* ___ 03:10PM BLOOD calTIBC-159* Ferritn-1854* TRF-122* Brief Hospital Course: The patient presented to the emergency department and was evaluated by the podiatric surgery team. The patient was found to have b/l infected ulcerations with gas in the soft tissue and was admitted to the podiatric surgery service. The patient was taken to the operating room urgently on ___ for ___ Debridement, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications. ___ was consulted to help evaluate the pts comorbid conditions. ___ was consulted due the pts uncontrolled DM and subsequently titrated his insulin regimen during his stay. Psych was consulted to evaluate any underlying and unresolved mental health issues. Social work and OT were also consulted to evaluate the patent. The patient was then transferred to the vascular surgery service and he was taken back to the operating room on ___ for a right guillotine below-the-knee amputation. The procedure was tolerated well and he had good hemostasis achieved at this BKA wound, which was left open. He had hemodynamic improvement after this procedure. He was continued on broad-spectrum antibiotics (vanc/clinda/zosyn). The clindamycin had been started due to concern for necrotizing infection and it was thereafter discontinued 48-hours ___. He returned to the ___ on ___ for closure of the guillotine amputation. This was well tolerated. He worked with ___ who recommended rehab to restore functioning to baseline. Mr. ___ had not received medical care for many years. Multiple medical issues have been identified and treated. His sister ___ is his health care proxy. Ongoing Issues -Psychotic-spectrum symptoms Psych was consulted to determine capacity given his degree of agitation, paranoia and inattention to personal care on admission. They found he had capacity to consent for surgery. Haldol was started. On follow up postop, this psychotic-spectrum symptoms improved but were still consistent with schizotypal personality disorder. THey felt it was reasonable to continue low dose Haldol 2.5 mg qhs. Persistent tachycardia was thoroughly worked up and was untimely felt to be related to the Haldol. -Diabetes A1c on admission 11.6. ___ diabetes team was consulted who initiated lantus and sliding scale humalog with excellent glucose control. Will need teaching/insulin titration. -Dispo Per report, he lives at his home in unsanitary/unsafe conditions. Our social worker has been involved who contacted the his elder services caseworker ___: ___ regarding pt admission and safety concerns. Caseworker reports pt consented to speak with her since admission, but that pt had declined both visits and conversation prior to admission. SW provided information regarding the extent of pt's home disarray (per communication with pt's sister) and general information regarding ___ medical status and plan for d/c to acute rehab and subsequent SNF (per case management note). In the event that he does return to his home. A local PCP has been arranged his ongoing medical needs if he dose return home. -Gangrene of right lower extremity A closure BKA was evidentially done on ___. We suggest continuing for 2 weeks prophylactic oral antibiotics. It is imperative that the area is protected with DSD and ACE to allow healing. Gabapentin and Tylenol have been sufficient to control pain. He does have tissue loss on his contralateral leg that podiatry will follow closely as there is not evidence of vascular compromise. Medications on Admission: noneThe Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. Acetaminophen 650 mg PO Q6H 2. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 14 Days 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 20 mg PO QPM 5. Docusate Sodium 100 mg PO BID 6. Gabapentin 100 mg PO TID 7. Haloperidol 2.5 mg PO QHS 8. Glargine 35 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 9. OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain 10. Senna 8.6 mg PO BID:PRN constipation 11. TraMADol 50 mg PO Q4H:PRN Pain - Moderate Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Gangrene Right Lower extremity Diabetes Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Mr. ___, It was a pleasure taking care of you at ___ ___. During your hospitalization, you had surgery to remove unhealthy tissue on your lower extremity. You tolerated the procedure well and are now ready to be discharged from the hospital. Please follow the recommendations below to ensure a speedy and uneventful recovery. LOWER EXTREMITY AMPUTATION DISCHARGE INSTRUCTIONS ACTIVITY •You should keep your amputation site elevated and straight whenever possible. This will prevent swelling of the stump and maintain flexibility in your joint. •It is very important that you put no weight or pressure on your stump with activity or at rest to allow the wound to heal properly. •You may use the opposite foot for transfers and pivots, if applicable. It will take time to learn to use a walker and learn to transfer into and out of a wheelchair. MEDICATION •Before you leave the hospital, you will be given a list of all the medicine you should take at home. If a medication that you normally take is not on the list or a medication that you do not take is on the list please discuss it with the team! •You will likely be prescribed narcotic pain medication on discharge which can be very constipating. If you take narcotics, please also take a stool softener such as Colace. If constipation becomes a problem, your pharmacist can suggest an additional over the counter laxative. •You should take Tylenol ___ every 6 hours, as needed for pain. If this is not enough, take your prescription narcotic pain medication. You should require less pain medication each day. Do not take more than a daily total of 3000mg of Tylenol. Tylenol is used as an ingredient in some other over-the-counter and prescription medications. Be aware of how much Tylenol you are taking in a day. BATHING/SHOWERING: •You may shower when you feel strong enough but no tub baths or pools until you have permission from your surgeon and the incision is fully healed. •After your shower, gently dry the incision well. Do not rub the area. WOUND CARE: •Please keep the wound clean and dry. It is very important that there is no pressure on the stump. If there is no drainage, you may leave the incision open to air. •Your staples/sutures will remain in for at least 4 weeks. At your followup appointment, we will see if the incision has healed enough to remove the staples. •Before you can be fitted for prosthesis (a man-made limb to replace the limb that was removed) your incision needs to be fully healed. CALL THE OFFICE FOR: ___ •Opening, bleeding or drainage or odor from your stump incision •Redness, swelling or warmth in your stump. •Fever greater than 101 degrees, chills, or worsening incisional/stump pain NO OTHER PROVIDER, EXCEPT YOUR VASCULAR SURGEON, SHOULD DETERMINE IF YOUR STAPLES ARE READY TO BE REMOVED FROM YOUR STUMP! IF THERE ARE ANY QUESTIONS, THE PROVIDER SHOULD CALL THE VASCULAR SURGERY OFFICE AT ___ TO DISCUSS. THE STAPLES WILL BE REMOVED IN THE OFFICE AT YOUR FOLLOWUP APPOINTMENT WHEN IT IS DETERMINED BY THE VASCULAR SURGEON THAT THE WOUND HAS SUFFICIENTLY HEALED. Followup Instructions: ___
10766244-DS-11
10,766,244
25,892,239
DS
11
2174-01-25 00:00:00
2174-01-27 17:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Syncope Major Surgical or Invasive Procedure: None. History of Present Illness: Mrs. ___ is a ___ year old woman with a history of asthma, otherwise mostly healthy, who presents after syncopal episode while at work. Patient works as a ___ at ___. She was loading books onto a cart during which time she started to feel weaker than usual. A few minutes later she sat down in her chair at her desk. She does not recall the next few minutes. She was told she complained of feeling lightheaded and unwell and then collapsed from her chair to the ground. She awoke a few seconds later on the ground. She is unable to recall specific symptoms before the episode, but denies being aware of any chest pain, shortness of breath or palpitations in the immediate moments surrounding it. She had significant left ankle pain after the fall and she believes that her ankle twisted under her as she fell. She reports palpitations while in church the day prior to admission. She says she was standing in church when she felt her heart beating very quickly along with pleuritic pain. She says she palpated her chest and found that it was tender at the site of pain so she attributed this to lifting heavy books earlier in the day. This pain resolved within a few minutes as did the palpitations. ROS: Comprehensive 10-point ROS is otherwise negative. ED course: - VS: 98.0, 60, 125/94, 18, 100% on RA - Labs: TnT <0.01, TSH 2.2, otherwise unremarkable - EKG: NSR, RBBB, compared to prior from ___ the QRS is longer - Meds: None - Imaging: CXR - no acute process, ANKLE - L fibula fracture Past Medical History: - ADHD - Osteopenia - Asthma - Dry eyes Social History: ___ Family History: Mother: ___ yo, HTN Father: died at ___ yo from SBO, had CAD, CKD, prostate cancer Physical Exam: ADMISSION PHYSICAL EXAM: VS: T 97.9, BP 121/58, P 63, RR 18, O2 99% on RA Gen: Well appearing, in no apparent distress HEENT: NCAT, oropharynx clear Lymph: no cervical lymphadenopathy CV: No JVD present, regular rate and rhythm, no murmurs appreciated Resp: CTA bilaterally in anterior and posterior lung fields, no increased work of breathing GI: soft, non-tender, non-distended. No hepatosplenomegaly appreciated. GU: No suprapubic tenderness Extremities: L ankle swollen, medial aspect very tender to palpation, range of motion limited by pain Neuro: no focal neurologic deficits appreciated. Moves all 4 extremities purposefully and without incident, no facial droop. Psych: Euthymic, speech non-tangential, appropriate DISCHARGE PHYSICAL EXAM: Vital Signs: 98.0 118/62 67 16 GEN: Alert, NAD HEENT: NC/AT CV: RRR, no m/r/g PULM: CTA B GI: soft, BS present EXT: L leg in walker boot NEURO: Alert, Oriented, face symmetric PSYCH: calm, appropriate Pertinent Results: Admission Labs: ___ 12:06PM BLOOD WBC-8.2 RBC-4.20 Hgb-13.8 Hct-41.1 MCV-98 MCH-32.9* MCHC-33.6 RDW-12.9 RDWSD-46.8* Plt ___ ___ 12:06PM BLOOD Neuts-85.5* Lymphs-8.4* Monos-5.0 Eos-0.2* Baso-0.4 Im ___ AbsNeut-7.04* AbsLymp-0.69* AbsMono-0.41 AbsEos-0.02* AbsBaso-0.03 ___ 12:06PM BLOOD Glucose-99 UreaN-19 Creat-0.8 Na-138 K-5.0 Cl-101 HCO3-21* AnGap-21* ___ 09:48PM BLOOD D-Dimer-1849* ___ 12:06PM BLOOD TSH-2.2 ___ 12:06PM BLOOD cTropnT-<0.01 ___ 05:47PM BLOOD cTropnT-<0.01 ___ 09:48PM BLOOD CK-MB-2 cTropnT-<0.01 Discharge Labs: ___ 09:40AM BLOOD WBC-5.8 RBC-4.34 Hgb-13.7 Hct-41.9 MCV-97 MCH-31.6 MCHC-32.7 RDW-13.1 RDWSD-46.8* Plt ___ ___ 09:40AM BLOOD Glucose-86 UreaN-13 Creat-0.7 Na-140 K-4.2 Cl-103 HCO3-29 AnGap-12 ___ 09:40AM BLOOD Calcium-9.8 Phos-3.7 Mg-2.0 ECG - Sinus bradycardia. Right axis deviation. Right bundle-branch block. Possible right ventricular hypertrophy. No previous tracing available for comparison. ECG - Sinus rhythm. Borderline right axis deviation. Right bundle-branch block. Possible left ventricular hypertrophy. Compared to the previous tracing of the same date, there is no significant change. L Ankle Films - IMPRESSION: Oblique fracture involving the lateral malleolus likely representing a Weber B injury without mortise disruption or significant displacement. CXR - IMPRESSION: COPD. No acute cardiopulmonary process. L Tib/Fib Films - FINDINGS: There is an obliquely orientated Weber B type fracture of the left distal fibula extending to the level of the tibiofibular syndesmosis. Minimal fracture fragment distraction. No significant change in position with gravity stress view. No new bony injury. IMPRESSION: Weber B type fibular fracture. TTE - The left atrium and right atrium are normal in cavity size. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). Right ventricular chamber size and free wall motion are normal. The aortic arch is mildly dilated. The number of aortic valve leaflets cannot be determined. There is no aortic valve stenosis. Trace aortic regurgitation is seen. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Normal global and regional biventricular systolic function. Mild mitral regurgitation. CTA Chest - IMPRESSION: 1. No evidence of pulmonary embolism or aortic abnormality. 2. Limited evaluation of the left subclavian vein due to artifact. Extensive collateral vessels in the left upper chest is suspicious for occlusion or severe stenosis of the left subclavian vein. This can be further evaluated on ultrasound. 3. Mild interlobular septal thickening in the left base may represent early volume overload. LUE US - IMPRESSION: No evidence of deep vein thrombosis in the left upper extremity. The visualized left subclavian vein demonstrates normal color flow throughout. Brief Hospital Course: ___ y/o F with no significant PMHx, who was admitted following syncopal episode c/b L ankle frx. # Syncope: She endorses several episodes of palpitations over the past few weeks; however, she does not recall the events surrounding this syncopal so is unsure whether she had experienced palpitations this time. No events on tele here. CTA (performed ___ elevated D-dimer) was negative for PE. Of note, she did have significant orthostatic symptoms while working with ___, which improved after 1LNS. While this does argue to orthostasis as a possible etiology for her presentation, her syncopal episode as well as prior episodes of lightheadedness/palpitations occurred while she was sitting, making this less likely. Given normal TTE and no events on tele here, pt is medically stable for discharge home. Encouraged pt to adequately hydrate. Would consider ambulatory heart monitor to further evaluate for any arrhythmias, given reports of palpitations over the past few weeks. # Left Distal Fibular Fracture: Likely ___ fall. Ortho evaluated. Recommended walker boot with f/u in 1 week. D/c'ed with walker and home ___. # Subclavian Stenosis: Suggested by CTA but not seen on ultrasound. # Asthma: Restarted home albuterol and Flovent. TRANSITIONAL ISSUES: - continue outpatient ambulatory cardiac monitoring, given reports of palpitations (no events on tele here) - ortho f/u in 1 week Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Restasis 2 gtts Other BID 2. Vitamin D ___ UNIT PO DAILY 3. Fluticasone Propionate 110mcg 2 PUFF IH BID 4. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob/wheeze 5. Docusate Sodium 150 mg PO QHS 6. Multivitamins 1 TAB PO DAILY 7. Primrose Oil (eve prim-linoleic-gamolenic ac) 1,000 mg oral DAILY 8. Glucos Chond Cplx Advanced (glucosam-chond-hrb 149-hyal ac) 750 mg-100 mg- 125 mg-1.65 mg oral DAILY 9. flaxseed oil 1,000 mg oral DAILY Discharge Medications: 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob/wheeze 2. Docusate Sodium 150 mg PO QHS 3. Fluticasone Propionate 110mcg 2 PUFF IH BID 4. Multivitamins 1 TAB PO DAILY 5. flaxseed oil 1,000 mg oral DAILY 6. Glucos Chond Cplx Advanced (glucosam-chond-hrb 149-hyal ac) 750 mg-100 mg- 125 mg-1.65 mg oral DAILY 7. Primrose Oil (eve prim-linoleic-gamolenic ac) 1,000 mg oral DAILY 8. Restasis 2 gtts Other BID 9. Vitamin D ___ UNIT PO DAILY 10. Medical Equipment Rolling Walker Dx: Left Fibular Fracture Prognosis: Good Length of Need: 13 months Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Syncope L Fibular Fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: You presented to the hospital after an episode of passing out. You were placed on a heart monitor and had no concerning arrhythmias. You had an ultrasound of your heart which was unremarkable. You had a CAT scan of your chest which did not show any blood clot. You worked with physical therapy and were noted to be mildly dehydrated. This improved with IV fluids. It is important that you continue to hydrate well after you go home. You were also found to have a fracture in your left ankle. You were fitted with a boot for this. You are being discharged home with a walker and home physical therapy. Followup Instructions: ___
10766251-DS-8
10,766,251
21,570,032
DS
8
2170-09-19 00:00:00
2170-09-19 18:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Zithromax / Keflex Attending: ___. Chief Complaint: BRBPR Major Surgical or Invasive Procedure: Colonoscopy History of Present Illness: Ms. ___ is a ___ with internal hemorrhoids and prior episodes of diverticulitis. She now presents with abdominal pain and blood in stool with colitis in descending colon on CT. She has had previously colitis three times in the same region. Her colonoscopy appeared grossly normal, but no biopsies were taken. She has had lower abdominal pain and BRBPR since evening of ___. She had formed bowel movements but noted that there was blood covering the stool. Later that evening she had 3x diarrhea with blood and mucus. Her bowel movements are not painful. She has not recently had fevers or chills. She had similar symptoms before when she had diverticulitis. In the ED, initial vitals were notable for normotension, no fever. Exam notable for: Rectal: heme + brown stool mixed with bright red blood Labs notable for: WBC 12.7, no anemia CRP 2.0 Normal lactate Imaging notable for descending colitis as below. In the ED, she was treated with IV cipro/flagyl. Gastroenterology was consulted and recommended admission to medicine with GI following for further workup. She also received IV morphine and 1L LR. She had nausea after the morphine (no vomiting). Vitals prior to transfer: 98.7 80 112/64 18 96% RA Upon arrival to the floor, the patient reports her abdominal pain has resolved. She had diarrhea 3x last night but no bowel movements today (just a little blood and mucus). She feels nauseous but has not had vomiting. No unintentional weight loss. She has emphysema and had a cold in ___, s/p steroid taper (this is completed). Past Medical History: Problems (Last Verified - None on file): BREAST AUGMENTATION HYPERLIPIDEMIA HYPERTENSION LEFT BUNDLE BRANCH BLOCK OSTEOPENIA RHINOPLASTY TONSILLECTOMY TUBAL LIGATION CHRONIC OBSTRUCTIVE PULMONARY DISEASE CORONARY ARTERY DISEASE coronary calcifications, negative ETT, aggressive risk factor modification EMPHYSEMA PSORIASIS ASTHMA Surgical History (Last Verified - None on file): BREAST AUGMENTATION RHINOPLASTY TONSILLECTOMY TUBAL LIGATION Social History: ___ Family History: Family History (Last Verified - None on file): Relative Status Age Problem Onset Comments Other CORONARY ARTERY father DISEASE COLON CANCER mother Mother ___ ___ RECTAL CANCER Father ___ MYOCARDIAL INFARCTION HYPERTENSION Physical Exam: Admission exam: VITALS: 98.0 120 / 67 85 18 96 RA General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Warm, dry, no rashes or notable lesions. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally. Discharge exam: Vital signs: 24 HR Data (last updated ___ @ 806) Temp: 97.9 (Tm 97.9), BP: 134/76 (111-134/63-76), HR: 107 (104-107), RR: 18, O2 sat: 92% (87-94), O2 delivery: RA (0.5L-1L) GENERAL: Alert and in no apparent distress, coughing EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. MMMs CV: regular, borderline tachy RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored. trace basilar crackles GI: Abdomen soft, non-distended, non-tender to palpation. BS+ SKIN: No rashes or ulcerations noted EXTR: wwp minimal edema NEURO: Alert, interactive, face symmetric, gaze conjugate with EOMI, speech fluent, motor function grossly intact/symmetric PSYCH: pleasant, appropriate affect Pertinent Results: Pertinent data: WBC 12.7 -> 9.6 -> 7.3 -> ___ hgb 14.5 ----> ___ Plt 170s->140s->170s CKMB 2, trop <0.01 x2 proBNP 1639 CRP 2.0 Stool cultures, c diff, urine culture, negative O&P pnd CXR ___ Pulmonary interstitial edema and small bilateral pleural effusions. EKG ___ incomplete LBBB similar to prior except with nonspecific lateral ST-T changes Colonoscopy ___ -high residue material throughout -abnormal segment of mucosa with erythema, loss of vascularity, friability, and contact bleeding in the descending colon from 30 to 40 cm. Proximal and distal areas appeared normal -internal hemorrhoids GI path PATHOLOGIC DIAGNOSIS: 1. Ascending/transverse colon, biopsy: Colonic mucosa within normal limits. 2. Descending colon, biopsy: Colonic mucosa with ischemic pattern of injury. See note. 3 .Sigmoid colon, biopsy: Colonic mucosa within normal limits. 4. Rectum, biopsy: Colonic mucosa within normal limits. Note: Differential diagnoses of this pattern of injury includes vascular causes of ischemia, certain infections (e.g. C. difficile, enterohemorrhagic E. coli), or drug effect. Clinical correlation is recommended. Brief Hospital Course: ___ is a ___ year old woman with HTN, CAD, COPD, asthma, and prior episodes of descending colitis who presented with abdominal pain and bloody diarrhea, and was found to have recurrent descending colitis on CT. Course complicated by dyspnea and hypoxia. # Descending colitis - suspect ischemic etiology Patient with recurrent descending colitis, underwent colonoscopy on ___ that confirmed ~10 cm area of inflammation in proximal descending colon. Based on endoscopic appearance and biopsy results colonic ischemia seems most likely, which also fits with recurrences in same distribution. She received 5 days of cipro/flagyl. Her pain and bloody diarrhea improved within ___ hours. She had loose stools the day of discharge but no pain or blood, so this was felt to be less likely recurrence of her ischemia. Cause of ischemia unclear. however in reviewing outpatient notes there has been suspicion for white coat HTN. Her BPs were low normal through most of the early admission, so her lisinopril was held. She should monitor BPs closely as an outpatient and discuss with outpatient providers whether or not to resume treatment. #Suspected acute diastolic heart failure / hypoxia No known history of heart failure and had normal echo 3 weeks ago in ___. However she desatted overnight on ___ and had wet appearing CXR and elevated BNP, and she felt improved after 20 mg IV Lasix. Suspect that she has some underlying diastolic dysfunction that led to some overload in setting of IV fluids. Subsequently her sats were 90-95% on room air while at rest. She briefly desatted to 87-88% with ambulation on the day of discharge but quickly recovered. She was offered further inpatient care to consider another trial of diuresis (although she appeared euvolemic and her desat was likely multifactorial including asthma and viral infection), but she preferred discharge home. It was recommended she have vitals checked in the next ___ days and ___ very closely with PCP and cardiology. Inpatient echo felt to be unnecessary since her troponin was negative, EKG overall unchanged from prior, and therefore new cardiac event felt to be highly unlikely. She was not discharged with IV diuretics given her loose stools and concern for precipitating further colonic ischemia if over-diuresed. # Suspected URI # Asthma Patient with recent respiratory infection prior to admission. Endorsed fluctuating headache and post-nasal drip, which she feels may be sinusitis related. Also lower respiratory symptoms of cough and dyspnea, which may be in part viral infection triggering asthma, in addition to a component of volume overload. Sats as per above. She did endorse some improvement in symptoms with nebulizer and with codeine-guaifenesin cough syrup. She was discharged on her home inhalers and with codeine-guaifenesin cough syrup. Prednisone was considered but given uncertain etiology this was deferred for now. #Tachycardia HRs ___ early in admission, but up to ___ later in admission, and slightly higher with ambulation. This occurred after her nebulizer frequency was increased, so this was a likely cause, in conjunction with her respiratory process(es). # CV: Continued ASA # HTN: Holding lisinopril as per above # HLD: Continue rosuvastatin ***DISCHARGE PLAN*** Patient continued to have respiratory symptoms (mainly cough), borderline sats, and mild tachycardia prior discharge, as well as some loose stools. However she also strongly preferred to return home, as she was sleeping poorly in the hospital and generally felt she would be more comfortable at home. I explained that I thought this plan was acceptable conditional upon her having very close ___, including vitals check in the next ___ days, and returning to care with any worsening symptoms or failure to improve. She expressed an understanding and preferred discharge home. She was not sufficiently unwell to warrant an AMA discharge. =================================== =================================== TRANSITIONAL ___ - given concern for volume overload during admission, suspect she may have some diastolic dysfunction. could consider repeat TTE. otherwise would monitor for any evidence of volume overload moving forward - should respiratory symptoms fail to improve could consider prednisone burst for possible asthma flare +/- trial of diuresis for ?volume overload - given suspicion for colonic ischemia, her lisinopril was stopped. she plans to monitor BPs closely at home and discuss with cardiology and PCP providers in ___ =================================== =================================== >30 minutes in patient care and coordination of care Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 10 mg PO DAILY 2. Benzonatate 100 mg PO TID:PRN Cough 3. Rosuvastatin Calcium 20 mg PO QPM 4. Aspirin 81 mg PO DAILY 5. Ustekinumab Dose is Unknown IV ONCE 6. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 7. albuterol sulfate 90 mcg/actuation inhalation QID:PRN wheeze Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever 2. Guaifenesin-CODEINE Phosphate 10 mL PO QID RX *codeine-guaifenesin 10 mg-100 mg/5 mL 10 ml by mouth up to three times daily as needed Refills:*0 3. Ustekinumab 260 mg IV ONCE Duration: 1 Dose 4. albuterol sulfate 90 mcg/actuation inhalation QID:PRN wheeze 5. Aspirin 81 mg PO DAILY 6. Benzonatate 100 mg PO TID:PRN Cough 7. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 8. Rosuvastatin Calcium 20 mg PO QPM 9. HELD- Lisinopril 10 mg PO DAILY This medication was held. Do not restart Lisinopril until instructed by your doctor Discharge Disposition: Home Discharge Diagnosis: Ischemic colitis Hypoxia Suspected congestive heart failure Suspected upper respiratory infection Asthma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital because of bloody diarrhea and abdominal pain. We suspect that this was due to "ischemic colitis", also called "colonic ischemia", which often results from not having enough blood flow to the bowel for a period of time. This can occur if you are dehydrated or if your blood pressure is too low. For now we recommend stopping your lisinopril and closely monitoring your blood pressures at home. You will need to address this with your primary care doctor and cardiologist. You also had other symptoms, including cough, shortness of breath, and nasal congestion during your admission. These seemed to be in part related to a viral illness, but we were also concerned that you had a brief period of "congestive heart failure", which led to some fluid in your lungs. Your symptoms improved somewhat after a diuretic ("water pill") called Lasix, which helped remove fluid. We also suspect that your asthma played a role in these symptoms. Your oxygen levels were at times on the borderline of the point where we would recommend additional oxygen therapy. It will be very important to seek medical care if you have any worsening symptoms and to be seen in the upcoming days to have your oxygen, blood pressure, and heart rate checked. For now it is not clear that you need more Lasix for fluid removal or steroids for your asthma, but should your symptoms worsen or fail to improve you should discuss with your doctor. Followup Instructions: ___
10766534-DS-12
10,766,534
21,547,865
DS
12
2188-04-10 00:00:00
2188-04-10 20:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Left hemiparesis & hemiataxia Major Surgical or Invasive Procedure: None History of Present Illness: ___ is a ___ old man with a history of hyperlipidemia who presents with left-sided sensory and movement abnormalities which have largely resolved. He was in his normal state of health this evening at church when he had the sudden onset of a funny feeling in his left face, feeling swollen as if he had been bitten by a bug. Two minutes later, the sensation abruptly spread to include entire the left side of his body. He walked home and when he arrived home about fifteen minutes after onset, he had started to feel dizzy (a sensation of spinning) and like his tongue felt thick. He called out to his wife who saw him and noticed that his left face was drooping. He tried to sit down to rest but his symptoms did not improve. His wife took him to the hospital. There, he had difficulty walking because of weakness vs dyscoordination in the left leg. At this point his symptoms had persisted for about an hour. They gradually began to resolved to the point that he was able to walk unassisted to the bathroom. His facial droop resolved and his weakness improved. By the time he had been transferred over to ___ his only residual complaint was a "thick tongue." Prior to the onset of these symptoms he had had a mild headache all day which was not associated with photophobia, phonophobia, nausea or visual aura. He does not have a history of headache or migraine. He did not have any infectious symptoms prior to these events. Nothing like these symptoms has ever happened before. On neuro ROS, the pt denies loss of vision, blurred vision, diplopia, dysphagia, lightheadedness, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. Denies focal weakness, numbness, parasthesiae. No bowel or bladder incontinence or retention. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: Hyperlipidemia (per his wife) Social History: ___ Family History: - Father passed away from an MI in her ___. Physical Exam: **Unchanged from admission to discharge . T 97.6; HR 76; BP 134/81 RR 18; SpO2 95% General: Well-nourished, jolly man, lying in bed laughing in no apparent distress. HEENT: NC/AT, moist mucus membranes. Neck: Supple, no carotid bruits appreciated. Pulmonary: Normal work of breathing. Vesicular breath sounds bilaterally, no wheezes or crackles appreciated. Cardiac: S1/S2 appreciated, RRR, no M/R/G. Abdomen: Obese, soft, nontender, nondistended. Bowel sounds present. Extremities: No lower extremity edema Skin: No rashes or lesions noted. Neurologic: - Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. Attentive, able to name ___ backward without difficulty. Pt. was able to register 3 objects and recall ___ at 5 minutes. The pt. had good knowledge of current events. There was no evidence of apraxia or neglect. Calculations were intact. -Cranial Nerves: I: Olfaction not tested. II: PERRL 4 to 3mm, both directly and consentually; brisk bilaterally. VFF to confrontation with finger counting. Funduscopic exam revealed no papilledema, exudates, or hemorrhages. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch in all distributions, and ___ strength noted bilateral in masseter VII: Slight left facial droop and slightly delayed activation. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Upper motor neuron pattern weakness in the 4+ range on the left side. Normal bulk, tone throughout. Pronation but no drift on the left. No adventitious movements, such as tremor, noted. No asterixis noted. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 - Plantar response was flexor bilaterally. - Pectoralis Jerk was absent, and Crossed Adductors are absent. -Sensory: No deficits to light touch, pin, direction sense, cold sensation throughout. No extinction to DSS. -Coordination: Left-sided dysmetria in upper and lower extremities. Intention tremor on L FNF, ataxia on HKS. Overshoot on L finger following, impaired cadence on finger and toe tapping on L. Normal on right. -Gait: Good initiation. Wide-based, cautious. Cannot walk in tandem. Romberg absent. Pertinent Results: ========== LABS ========== ___ 01:16AM BLOOD WBC-6.7 RBC-6.10 Hgb-12.7* Hct-39.8* MCV-65* MCH-20.8* MCHC-31.9* RDW-18.6* RDWSD-38.7 Plt ___ ___ 01:16AM BLOOD Neuts-47.4 ___ Monos-11.3 Eos-1.8 Baso-0.4 Im ___ AbsNeut-3.17 AbsLymp-2.62 AbsMono-0.76 AbsEos-0.12 AbsBaso-0.03 ___ 01:16AM BLOOD Plt ___ ___ 01:16AM BLOOD ___ PTT-31.4 ___ ___ 01:16AM BLOOD Glucose-129* UreaN-13 Creat-0.9 Na-138 K-4.1 Cl-103 HCO3-25 AnGap-14 ___ 06:25AM BLOOD cTropnT-<0.01 ___ 01:16AM BLOOD Calcium-9.3 Phos-3.0 Mg-1.9 ___ 06:25AM BLOOD Triglyc-145 HDL-34 CHOL/HD-5.8 LDLcalc-134* ___ 06:25AM BLOOD TSH-1.6 ___ 06:25AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 06:25AM BLOOD %HbA1c-PND . ============== IMAGING ============== - MRI brain There is a small region of slow diffusion with corresponding T2/FLAIR signal hyperintensity in the right thalamus. Findings are compatible with late acute/early subacute infarction. There is no evidence of hemorrhage, edema, masses, mass effect, or extra-axial collection. The ventricles and sulci are normal in caliber and configuration. Major vascular flow voids are preserved. The orbits are unremarkable. The paranasal sinuses and mastoid air cells are clear. IMPRESSION: Late acute/early subacute right thalamic infarction. . - Head CT: There is no evidence of hemorrhage, edema, masses, mass effect, or infarction. - Head CTA: There are no intracranial vascular abnormalities. There is no evidence of aneurysm, stenosis or occlusion. - Neck CTA: The carotid and vertebral arteries and their major branches are patent with no evidence of stenoses. . - CXR: Cardiomediastinal contours are normal. Lungs and pleural surfaces are clear. Right hemidiaphragm is mildly elevated. Brief Hospital Course: Mr. ___ was admitted to the hospital for left hemibody sensory changes and on examination was found to have a left ataxic hemiparesis - together implying a likely right thalamocapsular infarct which is what was found on MRI. CTA head/neck did not show any acute abnormality. He was hyperlipidemic (a diagnosis which he likely carried per his wife but refused to believe). As such, we started ASA 81mg daily and atorvastatin 40mg daily. He did do well with ___ in hospital and was cleared for home. We have referred him for ___, OT, and speech therapy (for a slight dysarthria). . Remaining work-up includes - TTE (to be ordered by PCP ___ - A1c (pending at time of discharge) . Transitional issues include: - Follow-up with Dr. ___ (we will have our assistant contact the patient with a date and time of an appointment approximately 3 months from now) - Re-testing lipids at time of follow up to determine whether statin dose needs to be adjusted further Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*3 2. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*3 3. Outpatient Physical Therapy 434.1 Ischemic Stroke Left hemibody weakness and ataxia Please evaluate and treat 4. Outpatient Occupational Therapy 434.1 Ischemic Stroke Left hemibody weakness and ataxia Please evaluate and treat 5. Outpatient Speech/Swallowing Therapy 434.1 Ischemic Stroke Slurred speech Please evaluate and treat Discharge Disposition: Home Discharge Diagnosis: - small vessel stroke, right capsule Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ because of left sided clumsiness, weakness, and sensory complaints caused by a small stroke in the right side of your brain. We started you on aspirin 81mg daily and atorvastatin 40mg daily to reduce your risk of another stroke. Your blood pressures were generally within the normal range but we would like you to follow up with your primary care doctor to have your blood pressures checked in the future. There is a blood test pending (hemoglobin A1c) to be followed up by your primary care doctor. We would also like you to have an outpatient echocardiogram (ultrasound of your heart) to make sure that the same problems that affected your brain (causing stroke) are not affecting your heart. You will be contacted with a time and date for a follow-up appointment with Dr. ___ in stroke neurology in ___ months. Followup Instructions: ___
10766542-DS-9
10,766,542
21,202,882
DS
9
2161-10-07 00:00:00
2161-10-07 16:10:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Poison ___ / Poison Oak Extract / Poison Sumac Extract Attending: ___. Chief Complaint: difficulty breathing, left leg pain and swelling Major Surgical or Invasive Procedure: None this hospitalization History of Present Illness: This is a ___ old Female with PMH significant for anxiety disorder, history of recurrent urinary tract infections (on chronic ___ antibiotics) and ___ nighttime asthma who presents with left lower extremity pain and swelling with exertional shortness of breath. ___ notes that she took a flight back from ___ that was ___ in late ___. Two weeks ago she noted gradual onset of left calf pain that is worsened with ambulation. She denied any swelling or redness until today in which she noted mild swelling. She also reports that in the last ___ days she had the acute onset of shortness of breath with exertion, improved with resting. The patient reports that exercising during her cycling class or unloading groceries from her car in the last few days has made her dyspnea worse. She has no cardiac or pulmonary disease history. She has no fevers or chills. She denies cough or URI symptoms. She has no personal history of clotting disorder or malignancy. She denies hemoptysis. She has no history of immobilization, recent surgery or venous thromboembolic disease. She has been taking NSAIDs and applying warm compresses to manage the pain in her leg. She does note feeling more fatigued lately and having less overall energy in the last few weeks. She had dinner with a friend last evening who is a physician and she recommended she see her primary care physician - who ultimately recommended she proceed to the ER. ED course: - initial VS 99.4 62 129/77 16 100% RA - Labs unremarkable, normal WBC, hemoglobin and creatinine, INR 1.0 - LLE US notable for DVT in popliteal - EKG obtained - U/A reassuring - received rivaroxaban 15 mg PO x 1 REVIEW OF SYSTEMS: See HPI for pertinent details. Denies fevers or chills; (+) nightsweats. No headaches or visual changes. No chest pain, but (+) difficulty breathing. No notable upper respiratory symptoms or cough. Denies nausea and emesis or abdominal pain. No loose stools or diarrhea, constipation or other changes in bowel habits. No dysuria or hematuria. No new rashes, lesions or ulcers. (+) left lower extremity swelling, but no athralgias or joint complaints. No pertinent weight loss or gain, change in dietary habits. Past Medical History: - anxiety disorder - history of recurrent urinary tract infections (on chronic ___ antibiotics) - ___ nighttime asthma Social History: ___ Family History: The patient denies a history of premature cardiac disease such as MI, arrhythmia or sudden cardiac death. MGF with CAD and PGF with DM2. MGM with colon cancer in her ___, mother with lung cancer (from smoking) in her ___. Father had a DVT in the setting of arterial stenting (___). Physical Exam: ADMISSION EXAM: ================ Vitals: 98.4 101/60 68 16 97% RA General: patient appears in NAD. Appears stated age. ___ appearing. HEENT: normocephalic, atraumatic. PERRL. EOMI. Nares clear. Oropharynx with no notable lesions. Good dentition. Neck supple. No lymphadenopathy. ___: regular rate and rhythm. No murmurs. S1 and S2. JVP not elevated while upright. Respiratory: demonstrates unlabored breathing. Clear to auscultation bilaterally without adventitious sounds such as wheezing, rhonchi or rales. Abdomen: soft, ___ with normoactive bowel sounds. Extremities: warm, ___ distally; 2+ distal pulses bilaterally with no cyanosis, clubbing; left calf medially with some trace swelling and overlying erythema that is mild; ___ equivocal. Derm: skin appears intact with no significant rashes or lesions Neuro: alert and oriented to self, place and time. Normal bulk and tone. Motor and sensory function are grossly normal. DTRs 2+ throughout. Gait deferred. DISCHARGE EXAM: ================ Vitals: 98.8 97.8 100/60 56 16 97% RA General: patient appears in NAD. Appears stated age. ___ appearing. HEENT: normocephalic, atraumatic. PERRL. EOMI. Nares clear. Oropharynx with no notable lesions. Good dentition. Neck supple. No lymphadenopathy. ___: regular rate and rhythm. No murmurs. S1 and S2. JVP not elevated while upright. Respiratory: demonstrates unlabored breathing. Clear to auscultation bilaterally without adventitious sounds such as wheezing, rhonchi or rales. Abdomen: soft, ___ with normoactive bowel sounds. Extremities: warm, ___ distally; 2+ distal pulses bilaterally with no cyanosis, clubbing; left calf medially with some trace swelling and overlying erythema that is mild, now improved; ___ equivocal. Derm: skin appears intact with no significant rashes or lesions; lipoma noted on back Neuro: alert and oriented to self, place and time. Normal bulk and tone. Motor and sensory function are grossly normal. DTRs 2+ throughout. Gait deferred. Pertinent Results: ADMISSION LABS: ================ ___ 10:30PM BLOOD ___ ___ Plt ___ ___ 10:30PM BLOOD ___ ___ ___ 10:30PM BLOOD ___ ___ ___ 10:30PM BLOOD ___ ___ DISCHARGE LABS: ================ ___ 07:40AM BLOOD ___ ___ Plt ___ ___ 07:40AM BLOOD ___ ___ ___ 07:40AM BLOOD ___ ___ ___ 07:40AM BLOOD ___ MICROBIOLOGY: ============== ___ Urine culture - no growth EKG: ===== ECG (___): Sinus bradycardia @ 56 bpm. Normal axis, PR interval shortened. Poor ___ progression across the precordium. Peaked ___ in leads ___. No ischemic concerns. IMAGING STUDIES: ================= ___ CTA CHEST W&W/O C&RECON - Bilateral segmental and subsegmental pulmonary emboli, as described above. There is no evidence of right heart strain or pulmonary infarction. Incompletely imaged right hepatic lobe lesions are almost certainly hemangiomas. Correlation with prior imaging is recommended. If prior imaging is not available, an ultrasound of the liver is recommended. Incidentally noted persistent left superior vena cava, a normal variant. ___ UNILAT LOWER EXT VEINS - Deep venous thrombosis in the left lower extremity involving the popliteal vein and calf veins. No deep venous thrombosis in the right lower extremity. Brief Hospital Course: ___ with PMH significant for anxiety disorder, history of recurrent urinary tract infections (on chronic ___ antibiotics) and ___ nighttime asthma who presents with left lower extremity pain and swelling with exertional shortness of breath found to have likely provoked left lower extremity DVT and evidence of bilateral pulmonary embolism. # Pulmonary embolism- Her EKG with poor ___ progression and exertional dyspnea made pulmonary embolism a serious concern. CTA indeed demonstrated bilateral pulmonary emboli. No evidence of right heart strain. She was initially given LMWH with 60 mg SC Q12 hours and then per patient preference, we agreed to dose her with rivaroxaban 15 mg PO BID for ___ and transition to 20 mg PO daily for the remainder of ___. BNP flat and troponin negative which is prognostically favorable. Discharge ambulatory oxygen saturations were normal. # Deep venous thrombosis - Recent travel history with period of immobilization noted, suggesting provoked event. No prior VTE disease history. Family history mildly concerning given father's DVT history. She was initially given LMWH with 60 mg SC Q12 hours and the after a discussion with the anticoagulation pharmacist and the patient, we agreed to dose her with rivaroxaban 15 mg PO BID for ___ and transition to 20 mg PO daily for the remainder of ___. # Liver hemangiomas - Incidental finding on CT chest imaging. No symptoms. Will obtain outpatient RUQ US to confirm finding. Study ordered and patient given contact number for radiology. # Anxiety disorder - Stable. Continued SSRI treatment. # History of recurrent UTIs - No current symptoms. U/A negative in ED. # ___ nighttime asthma - Stable symptoms. Continued rescue albuterol inhaler. TRANSITIONAL ISSUES: - would consider outpatient evaluation for thrombophilic disorder, has ___ at ___ clinic scheduled - obtain outpatient RUQ US to confirm finding of liver hemangiomas on CT chest imaging. Study ordered and patient given contact number for radiology. Dr. ___ attending) will ___ results. - discharged with rivaroxaban 15 mg PO BID for ___ and transition to 20 mg PO daily for the remainder of ___ called her PCP's office and discussed this plan. She received the prescription for the first ___ here and will need to have her PCP prescribe the 20 mg PO daily dosing. Her PCP/PA agreed to ___ this issue (phone conversation noted in OMR). PCP ___ scheduled. - encouraged her to wear knee high ___ stockings going forward Medications on Admission: The Preadmission Medication list is accurate and complete. 1. sertraline 100 mg oral DAILY 2. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath 3. Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY:PRN ___ Discharge Medications: 1. Albuterol Inhaler ___ PUFF IH Q6H:PRN shortness of breath 2. sertraline 100 mg oral DAILY 3. Nitrofurantoin Monohyd (MacroBID) 100 mg PO DAILY:PRN ___ 4. Rivaroxaban 15 mg PO/NG BID 15 mg PO BID dose for ___ and change to 20 mg PO daily thereafter for at least ___. RX *rivaroxaban [Xarelto] 15 mg 1 tablet(s) by mouth twice daily Disp #*42 Tablet Refills:*0 5. Equipment ___ embolism stockings (knee high). ___: 415.1 Discharge Disposition: Home Discharge Diagnosis: - Bilateral pulmonary embolism - Left lower extremity deep venous thrombosis - Exertional hypoxemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mrs. ___, ___ were admitted to the Internal Medicine service at ___ ___ on ___ 7 regarding management of your left lower extremity deep venous thrombosis (DVT) and pulmonary embolism. Your oxygen saturations improved once your started anticoagulation. ___ received injectable enoxaparin and on discharge were transitioned to oral rivaroxaban. This medication needs to be continued at 15 mg by mouth twice daily for ___, and then 20 mg by mouth daily thereafter. Take the medication with food. ___ should talk with your primary care doctor about testing for inherited clotting disorders and testing for these conditions. Please wear ___ compression stockings going forward to prevent further clotting. ___ should also have a right upper quadrant ultrasound to evaluate the small lesions in your liver that were noted on your chest imaging. These are likely benign hemangiomas or vascular lesions. The number to schedule the imaging study is listed below. Please call your doctor or go to the emergency department if: * ___ experience new chest pain, pressure, squeezing or tightness. * ___ develop new or worsening cough, shortness of breath, or wheezing. * ___ are vomiting and cannot keep down fluids, or your medications. * If ___ are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include: dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. * ___ see blood or dark/black material when ___ vomit, or have a bowel movement. * ___ experience burning when ___ urinate, have blood in your urine, or experience an unusual discharge. * Your pain is not improving within 12 hours or is not under control within 24 hours. * Your pain worsens or changes location. * ___ have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. * ___ develop any other concerning symptoms. Followup Instructions: ___
10766641-DS-8
10,766,641
26,953,099
DS
8
2119-09-07 00:00:00
2119-09-08 09:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: S/P assault Injuries: bilateral orbital floor fractures L zygomaticomaxillary complex fx Communited b/l nasal bone fx Major Surgical or Invasive Procedure: None History of Present Illness: This patient is a ___ year old male who complains of ASSAULTED. Patient was found alert and oriented times one at a ___, after being assaulted about the face with a full Snapple bottle. Unknown loss of consciousness. The patient denies fall or any truncal assault. He is only complaining of facial pain. He does admit to significant amount of alcohol. Past Medical History: Denies Social History: ___ Family History: Non contributory Physical Exam: PHYSICAL EXAMINATION (___) Constitutional: Constitutional: Alert and oriented x1, significantly agitated, boarded and collared Head/Eyes: Significant facial swelling with multiple abrasions and lacerations. No clear proptosis. Right pupil ___, left pupil nonvisualized due to surrounding swelling, active bleeding from left nares multiple dental problems of unclear acuity, midface grossly stable ENT/Neck: C-collar intact Chest/Resp: NO chest wall tenderness or crepitus, bilateral breath sounds Cardiovascular: Regular rate and rhythm GI/Abdominal: Soft, nontender, nondistended GU/Flank: No Costovertebral angle tenderness Musculoskeletal: No deformity Skin: No abrasions, lacerations, ecchymosis Neuro: GCS 15, spontaneously moves all extremities to command. Psych: Normal mood Pertinent Results: ___ 05:40AM BLOOD WBC-11.6* RBC-4.40* Hgb-12.8* Hct-36.7* MCV-84 MCH-29.1 MCHC-34.8 RDW-13.2 Plt ___ ___ 01:20PM BLOOD WBC-16.2* RBC-4.44* Hgb-13.0* Hct-37.1* MCV-84 MCH-29.2 MCHC-35.0 RDW-13.3 Plt ___ ___ 03:40AM BLOOD WBC-11.2* RBC-5.36 Hgb-15.7 Hct-44.3 MCV-83 MCH-29.2 MCHC-35.3* RDW-13.2 Plt ___ ___ 03:40AM BLOOD Glucose-120* UreaN-21* Creat-1.1 Na-143 K-3.7 Cl-103 HCO3-22 AnGap-22* ___ 03:40AM BLOOD ASA-NEG ___ Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG CT C-SPINE W/O CONTRAST (___) 1. Slightly motion limited study. No cervical spine fracture seen. No subluxation. 2. Dextroconvex curvature at C4-5, chronicity unknown. If acute ligamentous injury is suspected, then MRI would be more sensitive for further evaluation. CT SINUS/MANDIBLE/MAXILLOFACIA (___) Multiple complex facial bone fractures. Bilateral ___ Fort fractures, combined type. Left zygomaticomaxillary complex fracture. Left orbital floor and inferior orbital rim fracture with herniation of orbital fat and possible left inferior rectus muscle entrapment. Minimally displaced left lateral and medial orbital wall fractures. Communited bilateral nasal bone and nasal septum fractures, with probable comminution of left medial canthus ligament attachment. Brief Hospital Course: The patient is a ___ y/o male who presented to the ED after an assault. He was admitted to the Acute Care Surgery Service after sustaining facial fractures. A CT Scan of his sinus/maxillary revealed " Multiple complex facial bone fractures. Bilateral ___ Fort fractures, combined type. Left zygomaticomaxillary complex fracture. Left orbital floor and inferior orbital rim fracture with herniation of orbital fat and possible left inferior rectus muscle entrapment. Minimally displaced left lateral and medial orbital wall fractures. Communited bilateral nasal bone and nasal septum fractures, with probable comminution of left medial canthus ligament attachment". Due to the nature of his injuries, plastic surgery was consulted and they recommended outpatient surgery. The patient was also seen by occupational therapy during the admission, and they recommended outpatient cognitive neurology secondary to poor recall. Social work assessed the patient's support system and he seems to have a good relationship with his grandparents and states he has many friends for support. Lastly, Ophthalmology was consulted and did not have any have need for intervention as the patient's vision was intact. The patient's pain was well controlled with PO oxycodone. He was given instructions to followup at his scheduled appointment in the Plastics Clinic and to keep sinus precautions upon discharge. Medications on Admission: Denies Discharge Medications: 1. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain Discharge Disposition: Home Discharge Diagnosis: S/P assault Injuries: Bilateral orbital floor fractures Left zygomaticomaxillary complex fracture Communited bilateral nasal bone fractures Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital after you were assaulted; in which you sustained several facial fractures. During your hospitalization, you were seen by plastic surgery and the recommended operating on an outpatient basis. You will be discharged with pain medications and the necessary outpatient followup appointments. SINUS PRECAUTIONS Because of the close relationship between the upper back teeth and the sinus, a communication between the sinus and the mouth sometimes results from surgery. This condition has occurred in your case, which often heals slowly and with difficulty. Certain precautions will assist healing and we ask that you faithfully follow these instructions: 1. Take the prescribed medications as directed. 2. Do not forcefully spit for several days. 3. Do not smoke for several days. 4. Do not use straws for several days. 5. Do not forcefully blow your nose for at least 2 weeks, even though your sinus may feel “stuffy” or there may be some nasal drainage. 6. Try not to sneeze; it will cause undesired sinus pressure. If you must sneeze, keep your mouth open. 7. Eat only soft foods for several days, always trying to chew on the opposite side of your mouth. 8. Do not rinse vigorously for several days. GENTLE salt water swishes may be used. Slight bleeding from the nose is not uncommon for several days after the surgery. Please keep our office advised of any changes in your condition, especially if drainage or pain increases. It is important that you keep all future appointments until this condition has resolved. Followup Instructions: ___
10766795-DS-13
10,766,795
26,139,956
DS
13
2154-01-03 00:00:00
2154-01-03 18:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Percocet / Penicillins / amoxicillin Attending: ___. Chief Complaint: Hematuria Major Surgical or Invasive Procedure: None History of Present Illness: ___ hx of schizophrenia not currently on medications, carcinoma of the thyroid s/p removal and subsequent hypothyroidism, inconsistently adherent to replacement regimen, with recent admission for hypothyroidism presenting for hematuria and generalized weakness, found to have pericardial effusion, ___, uncontrolled hypothyroidism, and pyuria/hematuria. Of note, was recently admitted (___) for hypothyroidism, r scalp cellulitis, SOB (found to have moderate pericardial effusion and AI), RLE wound, BV, and ___. Regarding hypothyroidism, she had thyroid carcinoma removed at ___ and was on chronic T4 replacement therapy, although had been intermittently non-adherent to therapy. Her sx on last admission included constipation, hypothermia, and myalgias. She was treated with IV levothyroxine and discharged on 200mcg PO and her TFTs improved. Given SOB, she had TTE that found mild-moderate circumferential pericardial effusion without tamponade physiology, and mild-moderate AI. She was planned to get repeat TTE in ___ weeks. - In the ED, initial vitals were: 98.3 72 112/63 18 100% RA - Exam was notable for: cv-muffled pulm-coarse RLQ tenderness R>L lower back tenderness - Labs were notable for: CBC: wml, BMP K3.4, BUN 16, Cr 1.9 TSH 165 Lactate 2.2 - Studies were notable for: 1. Moderate low-density pericardial effusion. 2. Normal unenhanced appearance of the bilateral kidneys without hydroureteronephrosis. No evidence of obstructing stone or lesion. Normal appendix. No bowel obstruction. No visualized acute abdominal pathology U/A: >182 WBCs, 103 RBCs - The patient was given: IVF, APAP, cipro On arrival to the floor, patient was somnolent, only awaking to loud voice and tactile stimulation. She was only able to say that she had abdominal pain for the past two days without diarrhea and diffuse myalgias. She also has urinary frequency without dysuria, change in color, or odor. She denies CP, SOB, fevers, or chills. She has NOT been taking any of her medications as prescribed. Past Medical History: Carcinoma of the thyroid s/p removal Hypothyroidism Pericardial effusion Cocaine use Bacterial vaginosis CKD Scalp cellulitis Schizophrenia Social History: ___ Family History: No FH of hypothyroidism Physical Exam: Admission Physical Exam: ======================== GENERAL: Somnolent, but when awake oriented x3. Awakes to loud voice and tactile stimulation. HEENT: Pupils constricted, but equal and reactive to light. NECK: JVP not appreciated above clavicle at 30 degrees. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. Soft pericardial rub. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. ABDOMEN: Abdomen diffusely tender with guarding, no rebound. EXTREMITIES: Warm with trace edema bilaterally. NEUROLOGIC: Somnolent, but A&Ox3 when awake. Moving all extremities, but unable to assess due to patient's ability to cooperate. Discharge Physical Exam: ======================== General: Well-appearing female in no acute distress HEENT: Extra ocular movements intact. Sclera anicteric CV: RRR Pulm: CTAB Abd: Soft, non-distended, non-tender in all quadrants Back: Tender to touch throughout lower back Ext: Painful to touch in pretibial area Pertinent Results: Admission Labs: ___ 04:52PM BLOOD WBC-8.6 RBC-4.01 Hgb-12.3 Hct-38.6 MCV-96 MCH-30.7 MCHC-31.9* RDW-16.0* RDWSD-56.7* Plt ___ ___ 04:52PM BLOOD Glucose-88 UreaN-16 Creat-1.9* Na-143 K-3.4* Cl-104 HCO3-27 AnGap-12 ___ 02:35AM BLOOD T4-<0.4* calcTBG-1.23 TUptake-0.81 Free T4-<0.1* ___ 07:53AM BLOOD T4-0.8* calcTBG-1.22 TUptake-0.82 T4Index-0.7* Free T4-<0.1* ___ 08:45PM BLOOD TSH-165* Discharge Labs: ___ 10:14AM BLOOD WBC-5.4 RBC-3.74* Hgb-11.5 Hct-35.9 MCV-96 MCH-30.7 MCHC-32.0 RDW-16.6* RDWSD-58.5* Plt ___ ___ 07:37AM BLOOD TSH-181* ___ 07:37AM BLOOD T4-3.4* T3-32* Free T4-0.5* Relevant Imaging: TTE: There is mild symmetric left ventricular hypertrophy with a normal cavity size. Overall left ventricular systolic function is hyperdynamic. The visually estimated left ventricular ejection fraction is 75%. There is abnormal interventricular septal motion. The aortic valve leaflets (3) appear structurally normal. There is no aortic valve stenosis. There is mild [1+] aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is trivial mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is moderate [2+] tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is a small to moderate circumferential pericardial effusion. There are no 2D or Doppler echocardiographic evidence of tamponade. Compared with the prior TTE (images reviewed) of ___, the findings are similar. CT Abdomen/Pelvis: IMPRESSION: 1. Moderate low-density pericardial effusion. 2. Normal unenhanced appearance of the bilateral kidneys without hydroureteronephrosis. No evidence of obstructing stone or lesion. Normal appendix. No bowel obstruction. No visualized acute abdominal pathology. Relevant Micro: __________________________________________________________ ___ 10:37 am URINE Source: ___. **FINAL REPORT ___ REFLEX URINE CULTURE (Final ___: NO GROWTH. __________________________________________________________ ___ 10:40 pm BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. __________________________________________________________ Time Taken Not Noted Log-In Date/Time: ___ 10:56 pm BLOOD CULTURE Blood Culture, Routine (Pending): No growth to date. __________________________________________________________ ___ 5:26 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 CFU/mL OF TWO COLONIAL MORPHOLOGIES. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ =>16 R MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ 4 S TRIMETHOPRIM/SULFA---- =>16 R Brief Hospital Course: ___ hx of schizophrenia not currently on medications, carcinoma of the thyroid s/p removal and subsequent hypothyroidism, inconsistently adherent to replacement regimen, with recent admission for hypothyroidism presenting for severe hypothyroidism and E.coli UTI. Unfortunately, once patient began to feel better, she no longer wished to remain in the hospital while her further follow-up was arranged. A follow-up appointment could not be scheduled prior to her leaving. ACUTE/ACTIVE ISSUES: ==================== # Hypothyroidism: Patient with known severe symptomatic post-surgical hypothyroidism, and recent admission for hypothyroidism from which patient left AMA. On admission, she reported that she had not been taking levothyroxine. She did not have bradycardia, hypothermia, hypotension, hyponatremia, or hypoglycemia, although she was somewhat somnolent and diffusely TTP. Labs notable for TSH 165, T4 <0.4, FT4 <0.1. CPK elevated to 1179 on admission and down trended to 786 on discharge. Endocrine consulted. Given 200 mcg IV levothyroxine x3 days. Transitioned to oral 1200 mcg PO levothyroxine on ___, which is the new weekly dose. Patient may benefit from in-clinic weekly levothyroxine dosing at discharge. Unfortunately, patient left prior to a formal plan being established. [] Patient is being discharged with a plan for 1200mcg of PO levothyroxine once weekly. [] Patient can be seen at the ___ for help with medication compliance. Unfortunately, a follow-up appointment could not be scheduled prior to patient leaving the hospital. [] She should have repeat Thyroid studies (TSH, T4, T3) in ___ weeks to continue to monitor her response to therapy. [] Patient has information for endocrine Fellow clinic ___ ___ floor on ___ -- she can come by any ___ in the ___ and walk-in if she needs refills or help administering her weekly Synthroid dose # Hematuria/pyuria: Patient presented with increased urinary frequency without dysuria or odor. Urine micro with >182 WBCs and 103 RBCs. Received cipro in ED ___. CT without evidence of stones. Endocrine concerned patient may not mount normal inflammatory response to infection in setting of hypothyroidism. Transitioned to IV CTX ___ due to concern for pyelo with CVA tenderness, although patient diffusely tender. UCx with E.coli sensitive to Cipro and CTX. Symptoms improved on CTX and repeat UCx negative. Transitioned to PO cefpodoxime on discharge given interaction of Cipro and LT4. [] She was discharged with 7 days of Cefpodoxime 200mg BID, with plan to complete a 10 day course of antibiotics. # Pericardial effusion: Patient had known small to moderate circumferential pericardial effusion without e/o clinical or echo tamponade on last admission. Etiology felt likely due to hypothyroidism, although it was felt that she could benefit from pericardiocentesis as an outpatient to rule out malignancy if it fails to resolve. Pulsus <6 on exam so low likelihood of tamponade physiology. TTE with stable findings this admission. Repeat chest pain on ___ with negative cardiac workup (EKG, Trop, CK-MB and pulsus <6). [] Patient will benefit from a repeat TTE in ___ weeks to further monitor her pericardial effusion. # AoCKD: Baseline Cr appears to be ___, presenting at 1.9 but improved to 1.5 with fluids. CT without e/o hydro, pyelo, or obstructing stone. On discharge, back to baseline Cr of 1.4. [] CPK elevated throughout admission. It was still 786 at discharge. Would recommend repeat labs in ___ weeks to monitor for resolution. # Abdominal pain: Patient presented with diffuse abdominal pain and TTP. CT unrevealing. Lactate mildly elevated to 2.2 although resolved to WNL. Lipase WNL. Patient complaining of pain throughout body likely due to hypothyroid state. Appeared stable at discharge. # Somnolence: Patient presented with somnolence, likey iso severe hypothyroidism as similar to prior presentation. MS improved by discharge. # Alcohol use disorder: Patient reported that she drinks 1 pint daily of liquor. She was maintained on diazepam CIWA, but did not score high enough to require benzos. She declined social work. # Back pain: Patient presented c/o lower back pain, non radiating, felt possible ___ diffuse pain resulting from hypothyroidism. No bony lesions or fracture on CT. Treated with APAP CHRONIC/STABLE ISSUES: ====================== # Schizophrenia: Home risperidone was held in setting of somnolence. # Cocaine use disorder: Reported continued active cocaine use, most recently on ___. No signs of withdrawal. TRANSITIONAL ISSUES =================== [] Patient is being discharged with a plan for 1200mcg of PO levothyroxine once weekly. [] Patient can be seen at the ___ for help with medication compliance. Unfortunately, a follow-up appointment could not be scheduled prior to patient leaving the hospital. [] She should have repeat Thyroid studies (TSH, T4, T3) in ___ weeks to continue to monitor her response to therapy. [] Patient has information for endocrine Fellow clinic ___ ___ floor on ___ -- she can come by any ___ in the ___ and walk-in if she needs refills or help administering her weekly Synthroid dose [] She was discharged with 7 days of Cefpodoxime 200mg BID, with plan to complete a 10 day course of antibiotics. [] Patient will benefit from a repeat TTE in ___ weeks to further monitor her pericardial effusion. [] CPK elevated throughout admission. It was still 786 at discharge. Would recommend repeat labs in ___ weeks to monitor for resolution. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Methocarbamol 1000 mg PO TID:PRN back pain 2. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 3. Levothyroxine Sodium 200 mcg PO DAILY 4. RisperiDONE 1 mg PO BID Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Cefpodoxime Proxetil 200 mg PO Q12H RX *cefpodoxime 200 mg 1 tablet(s) by mouth twice a day Disp #*14 Tablet Refills:*0 3. FoLIC Acid 1 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Thiamine 100 mg PO DAILY 6. Levothyroxine Sodium 1200 mcg PO 1X/WEEK (___) RX *levothyroxine 300 mcg 4 tablet(s) by mouth once a week Disp #*16 Tablet Refills:*0 7. Methocarbamol 1000 mg PO TID:PRN back pain 8. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 9. RisperiDONE 1 mg PO BID Discharge Disposition: Home Discharge Diagnosis: Hypothyroidism Urinary Tract Infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ====================== DISCHARGE INSTRUCTIONS ====================== Dear Ms. ___, It was a pleasure caring for you at ___ ___. WHY WAS I IN THE HOSPITAL? - You were admitted because you had a urinary tract infection and very low thyroid hormone levels. WHAT HAPPENED TO ME IN THE HOSPITAL? - We treated your urinary tract infection with antibiotics and gave you thyroid replacement hormone. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. It is especially important to finish your course of antibiotics (until ___ and take your levothyroxine 1200 mcg per week (please take this on ___ and weekly thereafter). We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
10767156-DS-3
10,767,156
21,154,323
DS
3
2176-06-02 00:00:00
2176-06-03 10:43:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ACE Inhibitors / ___ Receptor Antagonist Attending: ___. Chief Complaint: nausea Major Surgical or Invasive Procedure: none History of Present Illness: ___ with presumed nonischemic cardiomyopathy (EF45% in ___, PVD s/p fem-post tib BPG with perioperative NSTEMI, R BKA, DMII, HTN, CKD, and HLD who presents with chronic nausea. His nausea has been going on for >6 months. It primarily occurs when taking his medications on an empty stomach. It is not dependent on movement or exertion. He denies heartburn or sour taste. Eating food typically improves symptoms. He adamantly denies CP, SOB, or DOE. He has baseline orthopnea that is unchanged over several months. There is no radiation with these symptoms. He does occasionally get diaphoretic. He denies palpitations. Denies emesis, melena, or hematochezia. He does endorse significant constipation, particularly when taking iron. He notes occasional cough with clear phlegm in the mornings. He denies syncope and presyncope. Endorses headache with nitrates. His admits to non adherence to most of his medications, altering timing for his nausea. In particular, he does not like his torsemide, causing him social inconvenience with frequent urination. ED COURSE In the ED intial vitals were: 98.8 84 181/94 18 99% RA EKG: Labs/studies notable for: Lactate 1.3, TropT 0.14, K 5.8, Cr 3.6, MB 3, ___ ___, Hgb 10.3 Patient was given: Gabapentin 400 mg, Labetalol 1000 mg, Isosorbide Dinitrate 60 mg ___ On the floor, patient is pleasant and denies symptoms of CP, SOB, or palpitations. He denies any nausea. REVIEW OF SYSTEMS: On review of systems, denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, hemoptysis, black stools or red stools. Denies recent fevers, chills or rigors. Denies exertional buttock or calf pain. All of the other review of systems were negative. Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, ankle edema, palpitations, syncope or presyncope. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes, +PVD 2. CARDIAC HISTORY: - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY: PVD s/p fem-post tib BPG, BKA, and left peroneal artery stenting Perioperative NSTEMI Cardiomyopathy with systolic dysfunction (EF 45% ___ HTN HLD CKD stage IV Anemia ___ CKD DMII complicated by peripheral neuropathy Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Significant family history of diabetes and PVD Physical Exam: ADMISSION PHYSICAL EXAMINATION: VS: 97.8 174/88 95 20 100%RA GENERAL: WDWN man in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with flat neck veins CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: 1+ pedal edema. No femoral bruits. R BKA SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: trace distal left DP pulse DISCHARGE PHYSICAL EXAMINATION: VS: 98.1 150/66 76 19 100%RA, BPs better controlled in 120s with regular medication administration GENERAL: WDWN man in NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: Supple with flat neck veins CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: 1+ pedal edema. No femoral bruits. R BKA SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: trace distal left DP pulse Pertinent Results: LABS ==== ___ 10:30AM BLOOD WBC-4.7 RBC-4.47* Hgb-10.3* Hct-36.0* MCV-81* MCH-23.0* MCHC-28.6* RDW-18.3* RDWSD-52.6* Plt ___ ___ 06:05AM BLOOD WBC-5.0 RBC-4.11* Hgb-9.6* Hct-32.9* MCV-80* MCH-23.4* MCHC-29.2* RDW-17.9* RDWSD-50.9* Plt ___ ___ 10:30AM BLOOD Neuts-63.8 Lymphs-17.7* Monos-17.3* Eos-0.6* Baso-0.2 Im ___ AbsNeut-2.98 AbsLymp-0.83* AbsMono-0.81* AbsEos-0.03* AbsBaso-0.01 ___ 10:30AM BLOOD ___ PTT-31.6 ___ ___ 10:30AM BLOOD Glucose-92 UreaN-56* Creat-3.6* Na-143 K-5.8* Cl-113* HCO3-18* AnGap-18 ___ 04:50PM BLOOD Glucose-116* UreaN-57* Creat-3.6* Na-139 K-5.3* Cl-111* HCO3-19* AnGap-14 ___ 06:05AM BLOOD Glucose-86 UreaN-56* Creat-3.9* Na-142 K-5.6* Cl-112* HCO3-18* AnGap-18 ___ 06:05AM BLOOD ALT-9 AST-13 CK(CPK)-66 AlkPhos-66 TotBili-0.3 ___ 10:30AM BLOOD CK-MB-3 ___ ___ 10:30AM BLOOD cTropnT-0.14* ___ 04:50PM BLOOD CK-MB-4 cTropnT-0.13* ___ 06:05AM BLOOD CK-MB-4 cTropnT-0.12* ___ 06:05AM BLOOD Albumin-3.4* Calcium-8.6 Phos-4.3 Mg-1.9 ___ 10:45AM BLOOD Lactate-1.3 CXR ___ The lungs are relatively hyperinflated but clear without consolidation, effusion, or edema. Moderate cardiac enlargement is noted compatible with patient's history. No acute osseous abnormalities. EKG: NSR@90 bpm, LVH, TWI in I, II, III, AVL, V4-V6. J point elevation in V1, V2 Brief Hospital Course: ___ with cardiomyopathy (___% in ___, extensive PVD s/p fem-post tib BPG with perioperative NSTEMI, R BKA, DMII, HTN, CKD, and HLD who presents with chronic nausea and elevated troponin. #Nausea: Chronic (>6months), episodic nausea relates directly to taking medications on an empty stomach. There is no nausea on exertion or at rest. He has had no emesis nor other GI complaints outside of constipation. No hematochezia, melena or diarrhea. His nausea is not associated with chest pain, dyspnea, or palpitations. His nausea often causes medication nonadherence. #Cardiomyopathy with systolic dysfunction: Most recent EF in ___ was 45% Despite ___ in the 36,000 range, no clinical signs of heart failure. No elevated JVD, no crackles, no lower extremity edema. ___ likely elevated in setting of HTN and significant CKD. Continued on Torsemide 30 mg daily. Discharge weight 88.5kg. #Troponinemia/ ?ACS: Patient with several cardiac risk factors (PVD, HTN, HLD, DMII) presented with troponin to 0.14 and vague story of chest pain. He continues to be unclear of his symptoms but did note an episode of pressure 1 month ago, nothing more recent. There were no associated symptoms. Troponinemia remained flat between 0.12-0.14 and flat MB. Troponins likely related to HTN and CKD as opposed to ACS. EKG changes likely related to LVH and hypertension. Presenting EKG NSR@90 bpm, LVH, TWI in I, II, III, AVL, V4-V6. J point elevation in V1,V2. Continued on ASA81, Plavix 75, Rosuvastatin 20. #HTN: Continued home meds: labetalol 1200mg tid, 10mg amlodipine, torsemide 30 mg, isosorbide dinitrate 60 mg tid #PVD: continued ASA, Plavix, rosuvastatin #Hyperkalemia: Appears chronic without EKG changes. Discharge K was 5.6 #CKD Stage IV: Discharge Creatinine 3.9 #DMII: controlled on diet, most recent A1C ___ 6.3% #Anemia ___ CKD: To resume home iron. Patient missed iron infusion as outpatient #GERD: Continued omeprazole TRANSITIONAL ISSUES ==================== - Medication Adherence/Nausea: Continue to encourage small meals/crackers/applesauce to help take meds. - Cardiomyopathy: Patient should get TTE as an outpatient to continue asses systolic dysfunction - History of chest pain: Outpatient nuclear stress testing may provide more information regarding his chest pain as well as any defect in myocardial perfusion - Hyperkalemia: Please check electrolytes at next appointment - Anemia: Patient missed iron infusion as outpatient; will need to be rescheduled - Discharge Creatinine 3.9 - Discharge weight 88.5kg. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Labetalol 1200 mg PO TID 2. Amlodipine 10 mg PO DAILY 3. Clopidogrel 75 mg PO DAILY 4. Gabapentin 400 mg PO TID 5. Isosorbide Dinitrate 60 mg PO TID 6. Torsemide 30 mg PO DAILY 7. Rosuvastatin Calcium 20 mg PO QPM 8. Aspirin 81 mg PO DAILY 9. Omeprazole 20 mg PO DAILY 10. Sodium Bicarbonate 650 mg PO BID 11. Ferrous Sulfate 325 mg PO DAILY Discharge Medications: 1. Amlodipine 10 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Clopidogrel 75 mg PO DAILY 4. Gabapentin 400 mg PO TID 5. Isosorbide Dinitrate 60 mg PO TID 6. Labetalol 1200 mg PO TID 7. Omeprazole 20 mg PO DAILY 8. Rosuvastatin Calcium 20 mg PO QPM 9. Torsemide 30 mg PO DAILY 10. Sodium Bicarbonate 650 mg PO BID 11. Docusate Sodium 100 mg PO BID 12. Ferrous Sulfate 325 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: Nausea Cardiomyopathy Hypertension CKD Discharge Condition: Activity Status: Out of Bed with assistance to chair or wheelchair. Level of Consciousness: Alert and interactive. Mental Status: Clear and coherent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital because of nausea and concern for a heart condition. There was no evidence for a heart attack or heart failure. What was done? ============== -Heart attack was ruled out based on EKGs and bloodwork -Your medications were restarted. What to do next ================ -Take all medications as directed. This is the best thing to control many of your symptoms and protect your kidneys. -Follow up with your PCP. Please talk with him about ways to make sure you take your medicines. Please tell him what medicines you are or are not taking. -You should talk with your doctor about getting an outpatient stress test to further test heart function. Wishing you the best of health moving forward, Your ___ team Followup Instructions: ___
10767156-DS-4
10,767,156
23,833,234
DS
4
2176-08-28 00:00:00
2176-08-28 17:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ACE Inhibitors / ___ Receptor Antagonist Attending: ___ Chief Complaint: hyperkalemia Major Surgical or Invasive Procedure: None this hospitalization History of Present Illness: Mr. ___ is a ___ y/o M followed at ___ w/CKD Stage IV/V w/chronic hyperkalemia, extensive peripheral vascular disease s/p ___ tibia bypass graft w/perioperative NSTEMI, right below the knee amputation, type II diabetes mellitus, hypertension, hyperlipidemia, presenting to ___ for hyperkalemia to 6.4. Patient has felt well recently and went to see his PCP ___ ___ at ___. He had routine labs drawn given chronic hyperkalemia and was found to have a K of 6.4 and referred in. Per HMED attending who discussed with ___ nephrologist NP at ___, patient has been poorly compliant with diet and also in ___ for dialysis planning. He has had persistent hyperkalemia for months, and is able to urinate, presumably his ESRD is from ___ and HTN. His home situation is difficult since he cares for his sick wife, and his daughter provides a majority of his medical assistance at home but does not have the patient adhere to a renal diet. Despite multiple nutrition visits, the patient continues to have difficulties with his potassium and is felt to be refractory to medical therapy at this time, and likely in need of dialysis. He was referred in to ___, where his initial vitals were: 98.4 81 156/68 18 100% RA Labs were significant for: ___ 02:07 K:4.9 ___ 21:58 142 109 64 =============<113 6.4 22 3.9 Ca: 8.4 Mg: 2.2 P: 3.9 7.8 < 11.6/40.4> 130 N:68.9 L:19.1 M:8.6 E:2.6 Bas:0.4 ___: 0.4 Absneut: 5.40 ___ Abslymp: 1.49 Absmono: 0.67 Abseos: 0.20 Absbaso: 0.03 In comparison to ___ labs (outpatient): ___: K of 6.4 ___: K of 5.7, Cr 4.11 ___: K of 5.5, Cr 4.84 ___: K of 5.6, Cr 5.78 ___: K of 5.7, Cr 3.97 OTHER ___ labs: ___ - 212 on ___ Vitamin D of 52 on ___ BNP of 183 Imaging showed: EKG: NSR @ 66 bpm, PR 175, QTc 444, stable from prior w/o significant peaking of T waves. In the ED, she received: ___ 23:38 IV Insulin Regular 10 units ___ 23:38 IV Dextrose 50% 25 gm ___ 23:49 IV Furosemide 20 mg ___ 00:01 PO/NG Sodium Polystyrene Sulfonate 30 gm ___ 08:41 PO/NG Aspirin 81 mg ___ 08:41 PO/NG Clopidogrel 75 mg ___ 08:41 PO/NG amLODIPine 10 mg ___ 08:41 PO/NG Isosorbide Dinitrate 60 mg ___ 08:53 PO/NG Gabapentin 400 mg Vitals prior to transfer: 97.6 70 142/50 16 100% RA Currently, patient feels well w/o complaints. ROS: No fevers, chills, night sweats, or weight changes. No changes in vision or hearing, no changes in balance. No cough, no shortness of breath, no dyspnea on exertion. No chest pain or palpitations. No nausea or vomiting. No diarrhea but no bowel movements since ___. No dysuria or hematuria. No hematochezia, no melena. No numbness or weakness, no focal deficits. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes, +PVD 2. CARDIAC HISTORY: - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY: PVD s/p ___ tib BPG, BKA, and left peroneal artery stenting Perioperative NSTEMI Cardiomyopathy with systolic dysfunction (EF 45% ___ HTN HLD CKD stage IV Anemia ___ CKD ___ complicated by peripheral neuropathy Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise ___. Significant family history of diabetes and PVD Mother - ___, died from kidney disease Brothers/Sisters- one sister ___ Physical Exam: ADMISSION EXAM: --------------- VS: 97.9 ___ RA GEN: Alert, sitting up in bed, no acute distress HEENT: Moist MM, anicteric sclerae, no conjunctival pallor NECK: Supple w/mild JVD elevation PULM: Mild bibasilar crackles. COR: RRR (+)S1/S2 no m/r/g ABD: Soft, ___ EXTREM: LLE w/evidence of prior left extremity bypass graft and 2+ pitting edema to the shin, right below the knee amputation. NEURO: CN ___ grossly intact, motor function grossly normal DISCHARGE EXAM: --------------- VS: 98.1 | 81 (___) | 148/67 (___) | 18 | 100%RA GEN: Alert, sitting up in bed, no acute distress HEENT: Moist MM, anicteric sclerae, no conjunctival pallor NECK: Supple PULM: Mild bibasilar crackles. COR: RRR (+)S1/S2 no m/r/g ABD: Soft, ___ EXTREM: LLE w/evidence of prior left extremity bypass graft and 2+ pitting edema to the shin, right below the knee amputation. NEURO: CN ___ grossly intact, motor function grossly normal Pertinent Results: ADMISSION LABS: --------------- ___ 09:58PM BLOOD ___ ___ Plt ___ ___ 09:58PM BLOOD ___ ___ Im ___ ___ ___ 09:58PM BLOOD ___ ___ ___ 09:58PM BLOOD ___ ___ 09:58PM BLOOD ___ ___ 09:58PM BLOOD ___ ___ 07:45AM BLOOD ___ INTERVAL LABS: -------------- ___ 02:07AM BLOOD ___ ___ 01:41PM BLOOD ___ ___ 09:40PM BLOOD ___ ___ 07:45AM BLOOD ___ ___ 08:12AM BLOOD ___ ___ Plt ___ ___ 08:12AM BLOOD ___ ___ Im ___ ___ ___ 08:12AM BLOOD ___ ___ ___ 08:12AM BLOOD ___ ___ ___ 08:12AM BLOOD ___ MICROBIOLOGY: -------------------- ___ ___ PPD PLACEMENT on ___ - left forearm - 0mm induration, 0mm erythema IMAGING/STUDIES: -------------------- ___: Vein Mapping (upper extremities): Patent brachial and radial arteries without significant calcification. With the exception of the right upper arm cephalic vein the remaining veins are patent. Please refer to technologist worksheet for vein diameters. Discharge Labs: ---------------- ___ 02:40AM BLOOD ___ ___ Plt ___ ___ 02:40AM BLOOD Plt ___ ___ 02:40AM BLOOD ___ ___ ___ 02:40AM BLOOD ___ Brief Hospital Course: Mr. ___ is a ___ y/o M followed at ___ w/CKD Stage IV/V w/chronic hyperkalemia, extensive peripheral vascular disease s/p ___ tibia bypass graft w/perioperative NSTEMI, right below the knee amputation, type II diabetes mellitus, hypertension, hyperlipidemia, presenting to ___ for hyperkalemia to 6.4, currently stable undergoing ___ workup and ongoing monitoring of potassium levels w/stabilization. Discharge potassium of K =5. #Acute on Chronic Hyperkalemia: Likely in context of CKD, poor dietary adherence to renal diet. No evidence of hemolysis, rhabdomyolysis or other causes of hyperkalemia. Managed ___ with the following regimen: - Received 2 doses of IV Lasix and uptitrated home torsemide to 40mg PO daily. - BID Miralax, docusate, senna to ensure ___ daily stooling; also received kayexalate x2 and initiated on weekly kayexalate - Dialysis planning as below - Strict renal diet w/1g potassium - Nutritional consultation provided as an inpatient w/information sheets #CKD Stage IV/V: Patient w/progressive CKD, likely multifactorial including from hypertension and diabetes. Poorly compliant with diet, and per outpatient nephrology NP will need planning for HD. Patient was interested in PD but may be a poor candidate given to difficult home situation. Vitamin D 46, PTH 269, Calcium 8.8. Continued on Sodium Bicarbonate 1300 mg PO/NG BID and Calcium Carbonate 1000 mg PO/NG TID W/MEALS. - PPD was read on ___ and is 0mm induration/0mm erythema #Hypertension: Initially poorly controlled, but now stable on home medications: amLODIPine 10 mg PO/NG DAILY Carvedilol 25 mg PO/NG BID #Diabetes Mellitus Type II w/neuropathy: Diet controlled. Stable, patient not on home insulin due to history of hypoglycemia. Started ISS here in house, A1c 5.4%. Transitioned from gabapentin 400 mg TID, to renal dosing 200 mg TID. #Microcytic Anemia: Stable, chronic. Patient had iron studies in the past as recently as ___ ___ with serum iron of 30 (low), TIBC 196 (low), transferrin (140) low. Although consistent with anemia of chronic disease, the patient does not appear to have had screening colonoscopy. Would advise outpatient screening colonscopy. #sCHF (EF of 45% in ___, acute on chronic) + CAD: Patient w/evidence of volume overload, no recent TTE. -940cc during stay. Initially on IV diuresis and then transition to PO increased dose of torsemide on ___ and again on ___. 2g sodium diet and 2L fluid restriction. #PAD: stable. s/p R ___ BPG with perioperative MI (___) and R BKA (osteomyelitis R foot, ___ and PCI ___ to L tibial artery. Maintained on home aspirin, clopidogrel, rosuvastatin, isosorbide dinitrate. #GERD: Stable. Omeprazole 20 mg PO DAILY. #Constipation: stable. Maintained on docusate sodium, polyethylene glycol, senna #Hyperlipidemia Stable. Continue crestor. #BPH: Stable. Continue Doxazosin 2 mg PO/NG HS TRANSITIONAL ISSUES: -------------------- - ___ with PCP - ___ with transplant nephrology for dialysis planning (Dr. ___ - ___ with nephrology - Obtain labs ___ to recheck potassium and creatinine - Weekly kayexelate 30g on ___ - Repeat TTE as outpatient for ___ - Outpatient colonoscopy for microcytic anemia - PPD NEGATIVE on ___ - 0mm induration, 0mm erythema (documented in OMR) - See medication changes below - Patient should be set up with low potassium "meals on wheels" delivery due to his disability (below the knee amputation) - Physical therapy as tolerated - Low potassium teaching and ongoing outpatient nutrition FULL CODE CONTACT: Wife ___ Daughter ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Torsemide 10 mg PO QAM 2. Doxazosin 2 mg PO HS 3. Calcium Carbonate 1000 mg PO TID W/MEALS 4. Rosuvastatin Calcium 20 mg PO QPM 5. Carvedilol 25 mg PO BID 6. Sodium Bicarbonate 1300 mg PO BID 7. Gabapentin 400 mg PO TID 8. Aspirin 81 mg PO DAILY 9. amLODIPine 10 mg PO DAILY 10. Epoetin ___ ___ units SC Q10DAYS anemia 11. Clopidogrel 75 mg PO DAILY 12. Isosorbide Dinitrate 60 mg PO TID 13. Omeprazole 20 mg PO DAILY 14. Slow Release Iron (ferrous sulfate;<br>ferrous sulfate, dried) 47.5 mg iron oral Q24H 15. Docusate Sodium 100 mg PO DAILY 16. Vitamin D ___ UNIT PO DAILY 17. LORazepam ___ mg PO DAILY:PRN anxiety Discharge Medications: 1. Polyethylene Glycol 17 g PO BID hold for loose stools RX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by mouth twice a day Disp #*60 Packet Refills:*0 2. Senna 8.6 mg PO BID:PRN constipation hold for loose stools RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 3. Sodium Polystyrene Sulfonate 30 gm PO 1X/WEEK (SA) hyperkalemia RX *sodium polystyrene sulfonate [Kayexalate] 30g powder(s) by mouth ___ Disp #*1814.4 Gram Gram Refills:*0 4. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 5. Gabapentin 200 mg PO TID RX *gabapentin 100 mg 2 capsule(s) by mouth three times a day Disp #*180 Capsule Refills:*0 6. Torsemide 60 mg PO DAILY RX *torsemide 20 mg 3 tablet(s) by mouth qdaily Disp #*90 Tablet Refills:*0 7. amLODIPine 10 mg PO DAILY 8. Aspirin 81 mg PO DAILY 9. Calcium Carbonate 1000 mg PO TID W/MEALS 10. Carvedilol 25 mg PO BID 11. Clopidogrel 75 mg PO DAILY 12. Doxazosin 2 mg PO HS 13. Epoetin ___ ___ units SC Q10DAYS anemia 14. Isosorbide Dinitrate 60 mg PO TID 15. Omeprazole 20 mg PO DAILY 16. Rosuvastatin Calcium 20 mg PO QPM 17. Slow Release Iron (ferrous sulfate;<br>ferrous sulfate, dried) 47.5 mg iron oral Q24H 18. Sodium Bicarbonate 1300 mg PO BID 19. Vitamin D ___ UNIT PO DAILY 20.Outpatient Lab Work ICD10: E87.5 Hyperkalemia Please obtain CHEM10 on ___ Please fax results to: ___., ___ Address:___, ___, ___ ___ Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: Acute on Chronic Hyperkalemia CKD Stage IV/V Hypertension SECONDARY DIAGNOSIS: Type 2 DM Microcytic Anemia ___ (EF of 45% in ___, acute on chronic) PAD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. You were sent in by your primary doctor because had a blood potassium level of 6.4. While you were here, we used a combination of medications called Lasix and Kayexalate to help you eliminate potassium from your body. The transplant surgeons also took a look at the blood vessels in your arms to begin planning for dialysis in the future. Things to remember: - low salt diet (2g per day) - low potassium diet (1g per day) - limit fluid intake to 64oz per day - weigh yourself daily and let your primary doctor know if your weight goes up more than 3 lbs - please have your blood drawn on ___ for additional tests and ___ as scheduled with your primary doctor. Thank you for letting us participate in your care. -Your ___ team Followup Instructions: ___
10767284-DS-12
10,767,284
28,161,130
DS
12
2196-06-04 00:00:00
2196-06-05 14:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: ___: Flexible and rigid bronchoscopy with aspiration of secretions and 12 x 20 mm covered metal stent placement in BI; EBUS TBNA of #4R and ___: chest port placement History of Present Illness: ___ w/ PMH of asthma vs bronchiectasis on proAir (never been intubated) and HTN presenting with ___ weeks of cough with yellow sputum that transitioned to dry cough, nonradiating chest pressure, and dyspnea five days ago. She continued to use her ProAir without improvement and was referred to the ED by her PCP earlier today for PNA r/o. She notes that she had a similar episode one year ago and was diagnosed with PNA. She denies fevers, chills, leg swelling, weight gain, abdominal pain, n/v, diarrhea or dysuria. Of note, pt presented to the ED with very similar sxs and was treated for CAP in ___ as an outpt. In ___, there was an incidental finding of pulmonary nodules on a CT abd/pel for nephrolithiasis; these nodules have not been worked up further. In the ED: VS: 98.2, HR 99 153/65 20 92% RA Labs: 11.4 12.5 253 38.9 138 99 13 118 AGap=20 3.7 23 0.8 ___: 11.9 PTT: 28.3 INR: ___ FluAPCR: Negative FluBPCR: Negative Lactate:2.4 CXR: New right hilar and paramediastinal mass worrisome for underlying adenopathy or primary mass as well as suspected subcarinal adenopathy. Chest CT is suggested. CT chest: Large 8.3 cm right hilar/mediastinal mass likely in part conglomerate adenopathy and possible primary underlying mass. Innumerable bilateral pulmonary nodules concerning for metastases. EKG: NSR 85 NI NA no STE/D/TWI Exam notable for: comfortable, c/o difficulty breathing LLL crackles abd soft/nt/nd BLE no edema On the floor, she feel smuch better, but still SOB and wheezy. She endorses a cough for the last few weeks and sputum production, which had increased, but is now dry. No home O2. No CP. No f/c. Has been using her albuterol inhaler only once a day because she didn't know how often she could use it. Says that all her friends have had a similar illness w/ cough and SOB. No abd pain/n/v/d. No PND. Review of systems: (+) Per HPI Past Medical History: ASTHMATIC BRONCHITIS CUTANEOUS T CELL LYMPHOMA PEPTIC ULCER DISEASE POST CONCUSSION SYNDROME PULMONARY NODULE STREP THROAT URINARY TRACT INFECTION EPISTAXIS Social History: ___ Family History: sister and brother both had lung cancer, she is ___ of 11 children, and all 6 of her sisters have died Physical Exam: ADMISSION PHYSICAL EXAM ================ VITALS: 97.5 195/ 98 96 20 97 2L GENERAL: Alert, oriented, no acute distress HEENT: NCAT, sclerae anicteric, MMM, oropharynx clear, EOMI, neck supple, JVP right above clavicle when sitting ~60' CARDIOVASCULAR: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops LUNGS: Diffuse wheezing over upper lung fields, crackles at bases ABDOMEN: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley EXTREMITIES: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, ankles are large with soft tissue growth (she says are known lipomas on lateral aspects of ankles bilaterally) NEURO: Face grossly symmetric. Moving all limbs with purpose against gravity. Pupils equal and reactive, no dysarthria. DISCHARGE PHYSICAL EXAM: ======================= Vitals: T 97.8 BP 161/81 HR 92 RR 20 O2 97% on 2L NC GENERAL: Alert, oriented Caucasian female, awake and smiling. Slightly less energetic than previous days, speech less loquacious. Mildly tremulous throughout, in no acute distress. HEENT: Sclerae anicteric, mucous membranes tacky. Mild erythema of the soft palate and posterior oropharynx, stable. No oral ulcers. CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops LUNGS: Expiratory wheezing and rhonchi throughout, with decreased breath sounds at bases bilaterally. Improved compared to yesterday's exam. ABDOMEN: NABS. Abdomen is soft, minimally tender in the RLQ (where Pt states she gets her heparin shots), non-distended, with no rebound or guarding. EXTREMITIES: WWP, 2+ pulses, feet with minimal nonpitting edema. NEURO: Moves all four extremities spontaneously. Pertinent Results: ADMISSION LABS: ___ 10:29AM ___ PTT-28.3 ___ ___ 10:29AM cTropnT-<0.01 ___ 10:29AM estGFR-Using this ___ 10:29AM GLUCOSE-118* UREA N-13 CREAT-0.8 SODIUM-138 POTASSIUM-3.7 CHLORIDE-99 TOTAL CO2-23 ANION GAP-20 ___ 10:52AM LACTATE-2.4* ___ 11:40AM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 12:06PM PLT COUNT-253 ___ 12:06PM NEUTS-69.4 ___ MONOS-6.3 EOS-1.1 BASOS-0.5 IM ___ AbsNeut-7.87* AbsLymp-2.48 AbsMono-0.72 AbsEos-0.13 AbsBaso-0.06 ___ 12:06PM WBC-11.4* RBC-4.27 HGB-12.5 HCT-38.9 MCV-91 MCH-29.3 MCHC-32.1 RDW-13.4 RDWSD-44.6 SODIUM TREND: ___ 10:29AM BLOOD Glucose-118* UreaN-13 Creat-0.8 Na-138 K-3.7 Cl-99 HCO3-23 AnGap-20 ___ 06:15AM BLOOD Glucose-119* UreaN-11 Creat-0.8 Na-137 K-3.8 Cl-99 HCO3-25 AnGap-17 ___ 04:25AM BLOOD Glucose-112* UreaN-15 Creat-1.2* Na-134 K-3.6 Cl-94* HCO3-25 AnGap-19 ___ 03:12PM BLOOD UreaN-15 Creat-1.1 Na-130* K-3.3 Cl-93* HCO3-23 AnGap-17 ___ 04:33AM BLOOD Glucose-107* UreaN-12 Creat-0.9 Na-128* K-3.3 Cl-88* HCO3-26 AnGap-17 PERTINENT IMAGING: -___ (___): IMPRESSION: 1. There is no evidence of acute intracranial process or hemorrhage -CT A/P (___): IMPRESSION: 1. No definite evidence of metastasis in the abdomen or pelvis. New 8 mm nodule in the right posterior perirenal fat is nonspecific, may represent metastasis. Recommend attention on follow-up. 2. Small rounded hypodensity in the left lobe of the liver was previously diagnosed as a benign hemangioma in ___ and is similar. 3. Hyperdense fluid adjacent to the anterior wall of the third portion of the duodenal. This could reflect a duodenal and periduodenal hematoma. Consider uncinate process pancreatitis with a hemorrhagic component. Please correlate with pancreatic enzymes. A duodenal perforation cannot be excluded. There is no adjacent air. 4. Persistent nonspecific stranding in the right hemipelvis similar to the study of ___. Findings may be reactive. Consider sequela of thrombophlebitis. Recommend attention on follow-up. 5. Numerous small pulmonary nodules better assessed on recent dedicated CT of the chest. 6. Nonobstructing stone in the right kidney. 7. Diverticulosis without evidence of diverticulitis. 8. Unchanged hyperdense gallbladder sludge without evidence of cholecystitis. MRI HEAD (___): 1. No evidence of mass or abnormal enhancement. 2. Diffuse parenchymal volume loss with chronic small vessel microangiopathy. 3. Unchanged 3 mm tonsillar ectopia similar to prior study from ___. ___ Lymph node, biopsy: - Metastatic small cell carcinoma ___ INTERPRETATION: No immunophenotypic evidence of a non-Hodgkin lymphoma is seen in this specimen. However, an expanded population of CD56(+), CD45(-), CD38(-), CD3(-) and CD20(-) cells is seen, comprising 11% of total analyzed events. Corresponding biopsy shows involvement by a neuroendocrine carcinoma (see separate pathology report ___-___). Thus, the population of CD56(+) cells is favored to represent carcinoma cells, detected by flow cytometry. Correlation with clinical, radiologic, and morphologic (see ___-___) findings is recommended. Flow cytometry immunophenotyping may not detect all abnormal populations due to topography, sampling or artifacts of sample preparation. Brief Hospital Course: ___ year-old woman w/h/o asthma vs chronic bronchitis, ___ pack-year smoking history (quit ___ years ago), and stable pulmonary nodules, who presents with ___ weeks of cough productive of yellow sputum that developed to worsening dyspnea, dry cough, sinus congestion, and non-radiating chest pressure 5 days prior to admission. #Extensive small cell lung cancer: CXR revealed right hilar enlargement and additional opacities in the subcarinal and right paramediastinal/suprahilar regions. Follow-up CT Chest demonstrated right paratracheal adenopathy measuring 8.3x5.1 cm encasing the right mainstem bronchus, bronchus intermedius, and right pulmonary artery, with mass effect on the RUL pulmonary artery and possible involvement of the right lateral wall of the esophagus. In addition, many pulmonary nodules scattered throughout both lungs were identified, with the largest measuring 9 mm. Given high suspicion for malignancy, patient subsequently underwent flexible and rigid bronchoscopy with aspiration of secretions and placement of covered metal stent placement in bronchus intermedius. Also underwent EBUS TBNA of LN. She was found to have extensive small cell lung CA with mets to LN #4R and #7. Staging MRI brain and CT torso revealed potential ___ fat metastasis but no other clear evidence of metastases, including no evidence of mets to brain. She underwent evaluation by rad-onc and was determined not to be a candidate for XRT to brain or to the primary lung mass at least immediately but may undergo XRT after cycles of chemotherapy. Patient initiated on C1 carboplatin/etoposide (Carboplatin chosen over cisplatin due to severe h/o Meniere's disease), C1D1 was ___. She tolerated chemo well and received Neulasta on ___. Notably on day 2, uric acid 5.8 from 5.0 (LDH 181) and so renally dosed allopurinol added due to concern for TLS. #SIADH: Patient noted to have hyponatremia to 127; felt to be ___ SIADH in setting of lung disease. Patient was placed on fluid restriction and placed on high protein diet with ensure TID. Na+ improved and was tolerating po without fluid restriction by discharge. ___: Baseline Cr 0.9, increased to 1.2 but improved to baseline prior to discharge. Felt to be prerenal in setting of poor po intake. # Men___'s: Patient has a history of vertigo and nausea, which has previously been treated with meclizine and Ativan. She takes meclizine at home, and reports frequent hospitalizations for treatment when her nausea is more severe. No acute intracranial process on CT head, MRI without obvious metastases. She reports improvement with Ativan and Zofran. CHRONIC ISSUES: #Hypertension: Continued home losartan, diltiazem, and HCTZ #Depression: continued home fluoxetine 40mg daily #Peptic ulcer disease: pt was started on omeprazole reportedly for chronic cough concerning for laryngeal reflux but also beneficial for PUD. Continued home omeprazole #Hypothyroidism: ___ wnl; continued home levothyroxine 125 mcg daily #Hx of cutaneous T-cell lymphoma: Followed by Dr. ___ ___ ___. Treated with PUVA ___ years prior without evidence of recurrence and without complications. TRANSITIONAL ISSUES -Patient will initiate care with ___ oncology after initially establishing care with ___. She has appointment for this ___ - Patient will require follow up with interventional pulmonary clinic on ___ ___hest on that date; will see Dr. ___. - Radiation-onc was consulted for ?candidacy for whole lung irradiation given lung nodules seen. It was felt that this should be re-evaluated after ___ cycles of chemo. - Patient received Neulasta on the day of discharge ___, 24h after completing chemotherapy - Patient had chest port placed on ___ - Please ensure medication compliance, as some concern for Ativan overuse although no issues per ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Losartan Potassium 100 mg PO DAILY 2. Meclizine 25 mg PO DAILY 3. LORazepam 0.5 mg PO DAILY:PRN anxiety 4. Diltiazem Extended-Release 120 mg PO DAILY 5. Fluticasone Propionate NASAL 1 SPRY NU DAILY 6. Fluticasone Propionate 110mcg 2 PUFF IH DAILY 7. Naproxen 250 mg PO BID:PRN Pain - Mild 8. Omeprazole 40 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. FLUoxetine 40 mg PO DAILY 11. Hydrochlorothiazide 25 mg PO DAILY 12. Levothyroxine Sodium 125 mcg PO DAILY 13. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H:PRN Discharge Medications: 1. Allopurinol ___ mg PO DAILY RX *allopurinol ___ mg 0.5 (One half) tablet(s) by mouth daily Disp #*7 Tablet Refills:*1 2. Ondansetron 8 mg PO Q8H:PRN nausea RX *ondansetron 8 mg 1 tablet(s) by mouth q8h PRN Disp #*21 Tablet Refills:*0 3. Pegfilgrastim Onpro (On Body Injector) 6 mg SC ONCE Duration: 1 Dose RX *pegfilgrastim [Neulasta] 6 mg/0.6 mL deliverable (0.64 mL) 1 injector SQ once Refills:*0 4. Aspirin 81 mg PO DAILY 5. Diltiazem Extended-Release 120 mg PO DAILY 6. FLUoxetine 40 mg PO DAILY 7. Fluticasone Propionate 110mcg 2 PUFF IH DAILY 8. Fluticasone Propionate NASAL 1 SPRY NU DAILY 9. Hydrochlorothiazide 25 mg PO DAILY 10. Levothyroxine Sodium 125 mcg PO DAILY 11. LORazepam 0.5 mg PO DAILY:PRN anxiety 12. Losartan Potassium 100 mg PO DAILY 13. Meclizine 25 mg PO DAILY 14. Omeprazole 40 mg PO DAILY 15. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H:PRN Discharge Disposition: Home Discharge Diagnosis: Primary: Extensive small cell lung cancer Secondary: Syndrome of inappropriate antidiuretic hormone, resolved. Meniere's disease Acute renal failure, resolved. Hypertension Hypothyroidism Depression Peptic ulcer disease Discharge Condition: Level of Consciousness: Alert and interactive. Mental Status: Clear and coherent. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were seen at ___ due to cough and shortness of breath. You were found to have lung cancer, specifically extensive small cell lung cancer. You were transferred from the medical service to the oncology service. You were started on a chemotherapy regimen for the cancer and will follow up with your oncologist next week (see below for appointments). Please take all medications as prescribed and please follow up with the appointments we have arranged. It was a pleasure taking care of you at ___. Sincerely, Your ___ care team Followup Instructions: ___
10767527-DS-6
10,767,527
29,369,637
DS
6
2205-12-07 00:00:00
2205-12-07 22:21:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: shortness of breath Major Surgical or Invasive Procedure: none History of Present Illness: ___ PMH asthma, obesity, OSA on CPAP, ADD, who presents with DOE and chest pain. Patient reports he was in his USOH until about ___ weeks ago, when he noticed increasing DOE when exercising (usually biking). He also noted some pain in his L leg starting slightly after he noticed the increased DOE, starting in the L popliteal fossa and over the course of days to weeks spreading into the calf and up into the posterior thigh, also worse with exertion. DOE got gradually worse, and over the past few days he had it at rest as well. He had some associated chest pain with exertion generally described as band-like and burning across the chest. Had some discomfort to deep inspiration. Had some nausea/vomiting from pain today prior to admission. He has had a slight non-productive cough which tends to be seasonal, and denies fevers/chills. He denies any recent travel or immobilization; any change in medications; any known peripheral vascular disease or claudication symptoms. He has had some weight loss over the past month or two, but this has been concurrent with exercising more after the winter. He denies diarrhea, constipation, black/bloody stools or any abnormalities in his stools, abdominal pain, dysuria/hematuria, and has otherwise been in his USOH. In the ED, initial vitals were: 97.0 153/87 103 19 100/RA - Exam notable for: rrr, s1/s2, no mgr. ctabl no wheezes, trace non pitting edema bilaterally - Labs notable for: Trp <0.01 D - dimer ___ Chem 7 WNL BNP 163 CBC WNL - Imaging was notable for: - CTA chest: 1. Bilateral pulmonary emboli involving right main, right segmental, and left segmental pulmonary arteries. 2. Mild enlargement of the main pulmonary artery and equivocal flattening of the interventricular septum could suggest right heart strain. Echocardiogram could be obtained for further evaluation. 3. Peripheral wedge-shaped opacity in the right lower lobe could represent atelectasis or infarct. - EKG: NSR, no ischemic changes, no RV strain - PE/MASCOT was consulted: EKG reviewed, no signs of RV strain or ischemia. Troponin negative. Evidence of RV strain on CT, however remains hemodynamically stable. Given stability with minimal oxygen requirement and lack of symptoms at rest, no indication for higher level of care or advanced therapy such as catheter directed TPA. -OK for floor, either medicine or ___ -no indication for EKOS or TPA - Patient was given: ASA 325 (risk of ACS), started on heparin GTT Vitals prior to transfer: Upon arrival to the floor, patient reports generally feeling well, with improved dyspnea with oxygen and no pain. REVIEW OF SYSTEMS: (+) Per HPI (-) 10 point ROS reviewed and negative unless stated above in HPI Past Medical History: Sleep apnea ADD obesity Mild Persistent Asthma - has mildly obstructed PFTs, seen in past by pulm but not on medications vasovagal syncope SURGICAL: rotator cuff surgery Social History: ___ Family History: Uncle with PE in his ___ father age ___ hypoglycemia mother age ___ h/o uterine cancer No other significant family history of cancer, hematologic disorders Physical Exam: ADMISSION PHYSICAL EXAM: ======================== Vital Signs: 98.3 144/81 86 18 92/3L General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL. Neck: Supple. JVP not elevated. no LAD CV: Regular rate and rhythm. Normal S1+S2, no murmurs, rubs, gallops. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, adipose but non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: LLE tender to palpation, calf slightly larger than R, positive ___ sign; otherwise warm, well perfused, 2+ pulses, no clubbing, cyanosis Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation. DISCHARGE PHYSICAL EXAM: ======================== Vitals: 98.0 PO 126 / 85 L Sitting 92 18 95 Ra Gen: Well appearing obese man, able to finish sentences without pausing for breath Neck: No LAD, JVP not elevated, supple Card: RRR, No MRG Pulm: Clear to auscultation, no w/r/r Ab: Non-tender, non-distended, liver edge 1 cm beneath costal margin, normoactive bowel sounds Extr: Tightened left calf, trace non-pitting edema, LLE slightly larger than RLE, bilateral DP pulses appreciated Neuro: AOx3, Grossly normal motor Pertinent Results: ADMISSION LABS: =============== ___ 08:54PM cTropnT-<0.01 ___ 02:40PM GLUCOSE-116* UREA N-15 CREAT-0.9 SODIUM-141 POTASSIUM-3.8 CHLORIDE-106 TOTAL CO2-21* ANION GAP-18 ___ 02:40PM estGFR-Using this ___ 02:40PM cTropnT-<0.01 ___ 02:40PM proBNP-163* ___ 02:40PM ___ ___ 02:40PM WBC-9.0# RBC-4.44* HGB-14.0 HCT-41.6 MCV-94 MCH-31.5 MCHC-33.7 RDW-12.2 RDWSD-41.7 ___ 02:40PM NEUTS-59.8 ___ MONOS-11.2 EOS-3.5 BASOS-0.4 IM ___ AbsNeut-5.35# AbsLymp-2.23 AbsMono-1.00* AbsEos-0.31 AbsBaso-0.04 ___ 02:40PM PLT COUNT-191 DISCHARGE LABS: =============== ___ 06:35AM BLOOD WBC-8.1 RBC-4.56* Hgb-14.5 Hct-43.1 MCV-95 MCH-31.8 MCHC-33.6 RDW-12.0 RDWSD-41.9 Plt ___ ___ 06:35AM BLOOD Glucose-95 UreaN-11 Creat-1.0 Na-142 K-4.8 Cl-106 HCO3-21* AnGap-20 IMAGING: ======== + CTA chest: 1. Bilateral pulmonary emboli involving right main, right segmental, and left segmental pulmonary arteries. 2. Mild enlargement of the main pulmonary artery and equivocal flattening of the interventricular septum could suggest right heart strain. Echocardiogram could be obtained for further evaluation. 3. Peripheral wedge-shaped opacity in the right lower lobe could represent atelectasis or infarct. + EKG: NSR, normal axis and intervals, no ischemic changes, no RV strain + TTE ___: The left atrium is mildly dilated. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF = 70%). Tissue Doppler imaging suggests an increased left ventricular filling pressure (PCWP>18mmHg). Right ventricular chamber size and free wall motion are normal. The aortic root is mildly dilated at the sinus level. The ascending aorta is mildly dilated. The aortic arch is mildly dilated. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve appears structurally normal with trivial mitral regurgitation. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. Brief Hospital Course: ___ year old man w/ PMH obesity, mild asthma, OSA on CPAP who presented with dyspnea on exertion and found to have hemodynamically stable unprovoked PE. #Unprovoked PE: He presented with dyspnea on exertion, chest tightness and left leg pain and found to have bilateral pulmonary emboli involving right main, right segmental, and left segmental pulmonary arteries. He was hemodynamically stable, but did have an O2 requirement of ___ on hospital day 1. No clear inciting factor (no known malignancy, hypercoag, immobilization, travel), no evidence of right heart strain (trp wnl, BNP normal, EKG w/ no right heart strain, and TTE w/o right heart strain). No signs/ symptoms of malignancy (no weight loss, night sweats, LAD, cough, change in bowel patterns, hematuria). Given uncle (although in his ___ w/ prior PE and patient's age ___ yo), hereditary coagulopathy could be possible (although, typically use guideline of patient ___ yo OR first degree relative ___ yo w/ PE/DVT). Patient initially managed on heparin but then was transitioned to apixiban 15 mg BID for 21 days with plan to switch to 20 mg daily at day 22. Length of need for first unprovoked PE will be determined by PCP. #OSA: History of OSA, CPAP at home. CPAP used inpatient. #ADD: Continue home regimen, Adderall 40 mg PO daily. TRANSITIONAL ISSUES: ==================== #NEW MEDICATIONS: Xarelto (15 mg BID for 21 days and then 20 mg daily- length to be determined) [] xarelto due to start 20 mg daily on ___ [] Please pursue malignancy work-up as outpatient (however, no signs/sx of malignancy at this time) - would consider colonoscopy [] Please consider hypercoag w/u as outpatient (although pt not ___ year old and relative with DVT was an uncle in his ___ [] Please discuss length of need for xarelto in the setting of first unprovoked PE - recommend minimum of 9 months [] FYI- seen on CTA was peripheral wedge-shaped opacity in the right lower lobe could represent atelectasis or infarct. # CODE: full # CONTACT: Proxy name: ___, Relationship: wife Phone: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Amphetamine-Dextroamphetamine XR 40 mg PO DAILY Discharge Medications: 1. Rivaroxaban 15 mg PO BID RX *rivaroxaban [Xarelto] 15 mg (42)- 20 mg (9) 1 tablets(s) by mouth twice a day Disp #*1 Dose Pack Refills:*0 2. Amphetamine-Dextroamphetamine XR 40 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: Pulmonary Embolism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, It was a pleasure caring for you at ___! You were in the hospital because you had shortness of breath and were found to have a blood clot in your lungs. This is also known as a "pulmonary embolism". You were started on a blood thinner, called "rivaroxaban" also known as "Xarelto", to prevent future blood clots. You should take this medication with food. A side effect of this medicine is bleeding. Please do not taking any "NSAIDS" such as ibuprofen, naproxen or aspirin while on this medicine, as the combination can lead to serious bleeding. Please follow up with your doctor to determine how long you have to take "Xarelto" and to try to determine why you had a blood clot. Your appointment is listed in this paperwork. We wish you the best! - Your ___ Team Followup Instructions: ___
10767569-DS-5
10,767,569
24,222,102
DS
5
2168-10-19 00:00:00
2168-10-20 16:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Sulfa (Sulfonamide Antibiotics) / Gantrisin Attending: ___. Chief Complaint: Altered mental status, acute kidney injury, hyperkalemia Major Surgical or Invasive Procedure: None. History of Present Illness: The patient is a ___ year old female with chronic kidney disease (baseline 1.3-1.6), insulin-dependent diabetes, diastolic heart failure (EF >55%), and dementia who was sent in from her nursing home after she was noted to have altered mental status with acute on chronic renal failure (creatinine 3.2, potassium of 5.7). Per the nurse taking care of her the day PTA, she was having more difficulty eating than usual although she was still drinking fluids, and she was developed a new cough with nasal congestion. At baseline the patient is oriented x1-2, is nonambulatory for the last ___ months, and is incontinent, although she is able to express herself verbally. She has not had fevers, abdominal pain, N/V, dysuria, or hematuria. Of note, her dose of Lasix was recently increased to 40 mg daily (___). She was started on lisinopril 25 mg daily on ___ but this was discontinued on ___. Outside labs show potassium 5.7, Cr 3.4, BUN 153, albumin 2.5, WBC 13.7, HCT 30.0. . In the ED, initial vitals were: 97.8 65 111/41 16 100% 2L. On exam, patient was awake, oriented x1, slow to respond, appeared dry. Labs were remarkable for WBC count of 12.2, HCT of 31.8 (baseline high twenties), creatinine of 3.5, sodium of 131, potassium of 5.8, phosphorus of 4.9. UA with urine lytes was obtained. EKG showed sinus w/ peaked T wave. CXR showed atelectasis with no acute process. Foley catheter placed. Patient was given calcium gluconate 2gram iv, x1 amp D50, and regular insulin 8 units iv at 1525 for potassium 5.8 (dysphagia so not given kayexcelate) for hyperkalemia). Given 500cc normal saline. Vitals on Transfer: Temp - 97.6 oral, HR - 70, RR - 16, BP - 135/39, O2 Sat 100% 2lnc. On the floor the patient was stable but having some difficulty swallowing water. Past Medical History: DM (HbA1C 8.3% ___ Congestive Heart Failure, TTE in ___: EF >55%, mild-to-mod aortic regurgitation, mild-to-mod mitral regurgitation Paranoid schizophrenia Urinary incontinence Chronic cystitis Dementia HTN Osteoporosis Chronic renal failure, baseline Cr 1.5 (stage III) Anemia, has refused colonoscopy in the past. Hypercholesterolemia Multiple GI bleeds managed conservatively, last in ___ requiring 3u pRBCs ORIF left hip fracture ___ complicated by blood loss (Hct 25.9 1u pRBC, 1u FFP) Social History: ___ Family History: Per OMR, Unknown. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: T: 98.0 BP: 118/62 P: 67 R: 20 O2: 99% 2L General: Elderly woman, no acute distress, A&Ox1 HEENT: Sclerae anicteric, proptosis worse on left than right. Oropharynx very dry with small amount of white material on tongue; no exudate or erythema. Neck: supple, JVP not elevated, no LAD, no thyromegaly Lungs: Inspiratory crackles at left base, otherwise clear to auscultation bilaterally. Poor inspiratory effort. No wheezes, or rhonchi. CV: Regular rate and rhythm, normal S1 + S2. ___ holosystolic murmur. No rubs or gallops. Abdomen: Soft, non-distended. Large ventral hernia present, tender to palpation, not reducible. Bowel sounds present, no rebound tenderness or guarding, no organomegaly. Ext: Warm, well perfused, 2+ DP pulses. Trace edema in ___ to thighs bilaterally. No clubbing, cyanosis. GU: Foley in place, filled with purulent fluid and frank blood. DISCHARGE PHYSICAL EXAM: Vitals: T: 97.6, Tm: 98.6 BP: 134/52 (127-148/50-62) P: 92 (80-100) R: 18 O2: 98% RA General: Elderly woman, no acute distress, A&Ox1-2 HEENT: Oropharynx very dry with small amount of dried blood on tongue and hard palate. Lungs: Bibasilar crackles, but otherwise clear to auscultation bilaterally. Poor inspiratory effort. No wheezes, or rhonchi. CV: Regular rate and rhythm, normal S1 + S2. ___ holosystolic murmur. No rubs or gallops. Abdomen: Soft, non-distended. Large ventral hernia present, tender to palpation, not reducible. Bowel sounds present, no rebound tenderness or guarding, no organomegaly. Ext: Warm, well perfused, 2+ DP pulses. Trace edema in BLE. L arm with increased swelling. Pertinent Results: ADMISSION LABS: ___ 03:00PM BLOOD WBC-12.2*# RBC-3.79* Hgb-9.9* Hct-31.8* MCV-84 MCH-26.2* MCHC-31.2 RDW-14.6 Plt ___ ___ 03:00PM BLOOD Neuts-84* Bands-1 Lymphs-10* Monos-5 Eos-0 Baso-0 ___ Myelos-0 ___ 03:00PM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-OCCASIONAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL Ovalocy-OCCASIONAL ___ 03:00PM BLOOD ___ PTT-26.1 ___ ___ 03:00PM BLOOD Glucose-321* UreaN-136* Creat-3.5*# Na-131* K-5.8* Cl-103 HCO3-16* AnGap-18 ___ 03:00PM BLOOD Calcium-8.4 Phos-4.9*# Mg-2.3 ___ 05:57PM BLOOD Lactate-1.8 DISCHARGE LABS: ___ 07:30AM BLOOD WBC-9.7 RBC-3.72* Hgb-9.5* Hct-31.9* MCV-86 MCH-25.5* MCHC-29.7* RDW-15.2 Plt ___ ___ 07:30AM BLOOD Neuts-85.1* Lymphs-12.4* Monos-2.3 Eos-0.2 Baso-0.1 ___ 07:30AM BLOOD Glucose-205* UreaN-52* Creat-1.5* Na-143 K-4.5 Cl-113* HCO3-23 AnGap-12 ___ 07:30AM BLOOD Calcium-8.7 Phos-2.1* Mg-1.9 MICROBIOLOGY: URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- 8 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S ___ Blood Culture, Routine (Pending): ___ Blood Culture, Routine (Pending): IMAGING ___ ECG: Sinus rhythm. Prominent voltage in leads I and aVL for left ventricular hypertrophy. Low precordial lead voltage. Compared to the previous tracing of ___ no diagnostic interim change. ___ CHEST (PA & LAT): Frontal and lateral views of the chest demonstrate low lung volumes accentuating cardiomediastinal silhouette which is likely within normal limits. Minimal tortuosity is present along the thoracic aorta, with arch calcifications. There is mild peribronchial cuffing and interstitial opacities which could represent atypical infection in the appropriate clinical setting. There is no confluent consolidation, pneumothorax, or pleural effusion. Small amount of dependent atelectasis is present in the left base. Diffuse osteopenia is present, allowing for which no compression fracture is evident. ___ RENAL U.S.: The left kidney measures 10 cm. The right kidney measures 9 cm. There is no hydronephrosis, stone, or mass on the right. The left kidney demonstrates new moderate hydronephrosis. The ureter is not well seen; however, within the bladder, there is a 4.6 x 3.1 x 2.3 cm mildly echogenic nonvascular mass, potentially the cause of obstruction. This could represent a hematoma or conglomerate debris, versus mass. A urinary catheter is in place. Also noted is a lateral interpolar left renal cyst measuring 2.6 x 2.4 cm. Brief Hospital Course: ___ yo F w/ DM II (on insulin), CKD III (baseline Cr 1.5), ___, who presents from her nursing home with AMS ___ UTI, ___, and hyperkalemia. # AMS secondary to infection - Most likely secondary to UTI. With treatment of UTI with antibiotic, mental status has improved. Hyponatremia upon admission was thought to be possibly contributory but this corrected and pt still not at baseline. She was treated for her UTI per below. . # UTI - Pt w/ urinary tract infection due to E.Coli only resistant to Ciprofloxacin and Ampicillin. Initially treated with IV Ciprofloxacin prior to sensitivites returning, but then was switched to Meropenem on ___. Antibiotics should continue for a total of 14 days to treat for a complicated UTI given frank pus that was draining from her foley, new moderate left hydronephrosis and the 4.6cm mass in the bladder that was concerning for debris. A heparin-dependent mid-line was placed in pts left brachial artery for administration of antibiotics. Her last dose of antibiotics will be ___. . # Acute on chronic kidney disease - Baseline Cr 1.5, but elevated to 3.5 upon admission. FeUrea 19.65% indicating pre-renal in etiology. Physical exam corroborates this finding as she appeared clinically very dry. In addition, it was noted that her lasix had recently increased from 40mg daily to 20mg daily on ___, which may have contributed to her volume depletion. This was held during the hospitalization given her volume depletion and she was discharged on 20mg lasix daily as it was believed that 40mg daily may be too much for her. Pt's creatinine improved to baseline with volume repletion. Atenolol was held during her hospitalization given her ___, but re-started upon discharge. Renal ultrasound showed new moderate left hydronephrosis with a 4.6 x 3.1 cm soft tissue mass within the posterior aspect of the bladder, potentially obstructing. However, given right kidney was unaffected (no hydronephrosis), it would be unlikely for it to be affecting the creatinine. . # Hyperkalemia - Pt's K was 5.8 upon admission w/ peaked T waves on EKG, and she was given calcium gluconate, insulin w/ dextrose given, with repeat K 5.1 in the ED. Etiology likely secondary to acute kidney injury. She was initiated on lisinopril 2.5mg daily on ___ but this was discontinued on ___. Potassium improved as kidney function improved. . # Hematuria - Likely due to cysititis, though could be due to traumatic foley insertion as well. Unclear if 4.6cm mass in bladder seen on renal ultrasound contributing. Foley intermittently obstructed by clots, but cleared with irrigation. Urine was clear and yellow by hospital day 3. Was seen by Urology in-house, who didn't feel that urgent cystoscopy was indicated and recommended follow-up as an outpatient in 3 months for cystoscopy. . # Hyponatremia/Hypernatremia - Pt's Na 131 upon admission, which is below pt's baseline. Unclear in etiology but since pt appeared clinically dry, it is likely that pt was secreting ADH, and her Na is lower in concentration because of increased water absorption. Urine osmolality was consistent with this. Pt's sodium improved with volume repletion. However, she developed hypernatremia, likely secondary to normal saline administration (in the attempt to volume resuscitate). She was then started on free water, as her free water defecit was calculated around 3L. Her sodium improved to 143 with free water repletion upon discharge. . # Soft-Tissue Bladder Mass - Renal ultrasound on ___ showed left kidney with new moderate hydronephrosis and a 4.6 x 3.1 x 2.3 cm mildly echogenic nonvascular mass in the bladder. Urology was consulted and felt that it was most likely inflammatory debris admixed with blood clot within the bladder. Per Urology's consult note, she had a negative cystoscopy as recently as 3 months ago and a negative urine cytology as well. They recommended follow-up with Dr. ___ in the ___ clinic in 3 months with cystoscopy. . # Non-anion gap acidosis - Unclear in etiology though could have been caused by administration of IVF. Her acidosis was likely exacerbating (or causing) pts hyperkalemia. Pt was given D5W w/ 3 amps bicarb to help correct the acidosis (while repleting volume), and her acidosis slowly resolved. . # Chronic diastolic heart failure - Pt on lasix 40mg daily at home, which was recently increased from 20mg daily. She did not receive her dose on the day of admission and her lasix was held throughout the admission. She did have trace BLE edema and bibasilar crackles, but appeared volume down. It is likely that 40mg lasix daily is too large of a dose for this patient, and so she will be discharged on 20mg lasix daily. Upon clinical re-assessment, this may be re-titrated up as indicated. . # DM II - Pt's blood sugars ran high during the admission (even before administration of D5W). However, when she was given D5W for free water repletion, her blood sugars ran in the 200-300s and so her lantus was increased to 22 units BID and her SSI titrated up slightly. However, she was discharged on her home lantus of 20mg BID and her home regular insulin sliding scale as the D5W administration was likely contributing to her high blood sugars while she was in the hospital. TRANSITIONAL ISSUES # Please continue Ertapenem once daily until ___ # Recommend f/u pending blood cultures # Discharged pt on lasix 20mg daily (decreased from 40mg daily) though this medication was held during admission given that she was volume down. Can consider up-titrating as deemed necessary for fluid overload. # Would consider uptitration of lantus and/or SSI if blood sugars continue to run high # Pt was evaluated by Speech and Swallow in-house, who recommended Honey-thick liquids, pureed solids, meds crushed in applesauce, strict 1:1 supervision with all PO intake, NO STRAW with liquids, TID oral care, and encouraged continued swallow follow up to assess diet tolerance and consider further diet advancement. Medications on Admission: ALENDRONATE - 70mg tablet: 1 tab PO weekly every ___ ATENOLOL - 25 mg Tablet - 1 Tablet(s) by mouth once a day ATORVASTATIN [LIPITOR] - 20 mg Tablet - 1 Tab by mouth once a day CALCITRIOL - 0.25 mcg Capsule - 1 Capsule(s) by mouth every ___ and ___ FUROSEMIDE - 40 mg Tablet - one Tablet(s) by mouth daily INSULIN GLARGINE [LANTUS] - (Prescribed by Other Provider) - 100 unit/mL Solution - 20 U sq twice daily (at 6:30am and 4:30pm) LACTULOSE - 10 gram/15 mL Solution - 15 ml by mouth once a day prn constipation OLANZAPINE - 5 mg Tablet - 1 Tablet(s) by mouth at bedtime INSULIN REGULAR HUMAN [HUMULIN R] - SSI LANTUS 100 units/ml - Inject 20 units subq twice daily at 6:30am and 4:30pm Medications - OTC ACETAMINOPHEN - 325 mg Tablet - 2 Tablet(s) by mouth q4h prn pain CALCIUM CARBONATE - 500mg Tablet - 1 Tablet PO daily VITAMIN D3 - 400 IU Tablet - 2 Tablets PO daily DOCUSATE SODIUM - 100 mg Capsule - 1 Capsule(s) by mouth twice a day MULTIVITAMIN - (Prescribed by Other Provider) - Tablet - 1 Tablet(s) by mouth once a day SENNOSIDES [SENNA] - 8.6 mg Tablet - 2 Tablet(s) by mouth twice daily DULCOLAX 10MG SUPP - 1 SUPP daily prn constipation if senna ineffective FLEET ENEMA - 1 enema per rectum daiy prn constipation if dulcolax suppository ineffective ?Oxycodone 2.5mg PO q6h prn pain Discharge Medications: 1. alendronate 70 mg Tablet Sig: One (1) Tablet PO once a week: Every ___. 2. atenolol 25 mg Tablet Sig: One (1) Tablet PO once a day. 3. Lipitor 20 mg Tablet Sig: One (1) Tablet PO once a day. 4. calcitriol 0.25 mcg Capsule Sig: One (1) Capsule PO three times weekly, on ___. 5. furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day. 6. Lantus 100 unit/mL Solution Sig: Twenty (20) units Subcutaneous twice a day. 7. lactulose 10 gram/15 mL Solution Sig: Fifteen (15) mL PO once a day as needed for constipation. 8. olanzapine 5 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO QHS (once a day (at bedtime)). 9. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO every four (4) hours as needed for pain. 10. calcium carbonate 500 mg calcium (1,250 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO once a day. 11. Vitamin D3 400 unit Tablet, Chewable Sig: Two (2) Tablet, Chewable PO once a day. 12. docusate sodium 50 mg/5 mL Liquid Sig: One (1) Tablet PO BID (2 times a day). 13. senna 8.6 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 14. Dulcolax 10 mg Suppository Sig: One (1) Suppository Rectal once a day as needed for constipation: If senna ineffective. 15. Fleet Enema ___ gram/118 mL Enema Sig: One (1) Enema Rectal once a day as needed for constipation: If dulcolax suppository ineffective. 16. Regular Insulin Sliding Scale BS ___ = 0 units sub-q BS 201-250 = 2 units sub-q BS 251-300 = 4 units sub-q BS 301-350 = 6 units sub-q BS 351-400 = 8 units sub-q BS > 400 = CALL MD 17. ertapenem 1 gram Recon Soln Sig: One (1) gram Intravenous once a day for 11 days. Last dose on ___. 18. Heparin Flush (10 units/ml) 2 mL IV PRN line flush Mid-line, heparin dependent: Flush with 10 mL Normal Saline followed by Heparin as above, daily and PRN per lumen. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis Urinary Tract Infection Secondary Diagnosis Acute Kidney Injury Hyperkalemia Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you during your hospital stay at ___. You were admitted because your labs showed worsening of your kidney function and high potassium levels. You were also found to have a urinary tract infection. Your kidney dysfunction was likely caused by dehydration and obstruction. An ultrasound of your kidney was performed which showed a small mass in the bladder that was obstructing urine flow from the left kidney, which could represent debris in the bladder and may clear. You should call the Urology office at ___ to schedule a follow-up cystoscopy with Dr. ___ in 3 months. Your high potassium levels were likely caused by your kidney dysfunction. You were treated with medications to help your body get rid of the potassium, and your levels were normal upon discharge. Your urinary tract infection was treated with antibiotics, which should continue for another 11 days, until ___. Please note the following changes to your medications. Please START taking: # Ertapenem once daily Please CHANGE: # Lasix - take 20mg daily instead of 40mg daily Please continue taking your other medications as prescribed. Followup Instructions: ___
10768040-DS-12
10,768,040
22,531,257
DS
12
2143-06-14 00:00:00
2143-06-16 16:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Codeine Attending: ___. Chief Complaint: Altered mental status Major Surgical or Invasive Procedure: None History of Present Illness: ___ man with a history of T1DM, ESRD on PD, GERD and hiatal hernia, and chronic back pain s/p recent fusion who presents with confusion presumed secondary to an aspiration event. He has had several recent pneumonias attributed to aspirations. Two nights prior to this admission, he had a "coughing fit" precipitated by severe reflux. The next day, he felt weak, tired, and slightly confused (eg. unable to list days of week backwards). When this persisted, his wife brought him to the hospital. In the ED, initial VS were T 98.2, HR 75, BP 129/46, RR 12 SpO2 100% on RA. Labs showed leukocytosis of 14.1, HCT of 36.5, Creatinine of 2.5, glucose of 202. LFTs showed AP of 186 otherwise WNL. UA showed few bacteria and trace protein. Peritoneal fluid was obtained and was negative for BP. Lactate was 1.6. CT head was negative except for atropy and mild small vessel ischemic disease. Portable CXR showed residual scattered right opacities thought to be associated with chronic aspiration. Hiatal hernia was also present. Received Zosyn and Vancomycin prior to admission. VS prior to transfer were T 98.6, HR 75, BP 129/46, RR 12 satting 100%. Review of Systems: Patient denies any fevers, chills, headaches, shortenss of breath, chest pain. No new rashes. No back pain at his sugical site or new tenderness. No new swelling in his lower extremities. No abdominal pain or tenderness. Past Medical History: -T1DM c/b retinopathy, neuropathy, nephropathy -ESRD on PD: 7mo on dialysis ___ T1DM, cycler, 4 exchanges per day, 1800mL x 1.5hrs per dwell -GERD: Has had for about ___ years. Hiatal hernia diagnosed on last admission. -L2-3 lumbar stenosis, buldging disc s/p lumbar fusion ___ -Gout: Last episode ___ -HTN -HLD -Hyperparathyroidism -S/p appendectomy Social History: ___ Family History: Mother: ___ at ___ with liver failure Father: Alive and healthy at ___ Physical Exam: Admission: Vitals: Afebrile HR 70 BP 120/50 RR 14 satting 100% General: NAD. Slow, one word answers. HEENT: Aniceteric sclera. Pinpoint pupils. No oral lesions or ulcers Braces present on bottom row of teeth. Neck: No thyroidmegaly. No elevated JVP. Heart: ___ pansystolic murmur. No rubs or gallops. Lungs: Bilateral crackles at the bases otherwise CTABL throughout. Abdomen: Soft, nontender abdomen. R side were recent lumbar surgery is appears well healed and slightly erythematous. Peritoneal dialysis site on left is CDI with tubing in place and capped. Back: Surgical site revelas bilateral erythematous marking consistent with surgery. No purulence or calor. No tenderness to palpation in the area. Mild edema at the site of surgery. Extremities: 2+ Pitting edema to the lower shin bilaterally. Neurological: AOx3. Slow to respond. Terse, 1 word to short sentence answers. Pinpoint pupils but reactive. Can do days of week backwards. Rest of CN exam is normal. Moving in bed without assitance. Walks with cane (not assessed as requires TLSO for ambulation) Discharge: Vitals: T 98 BP 123/54 HR 65 RR 16 SpO2 100%RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, pinpoint pupils, MMM Neck: Supple, no LAD Lungs: Mild crackles at bases, otherwise clear bilaterally CV: Regular rate, irregular rhythm. Normal S1/S2. No murmurs/rubs/gallops appreciated. Abdomen: Soft, non-tender, non-distended, bowel sounds present. Peritoneal dialysis site on left is clean and nonerythematous. GU: Deferred Ext: Warm, well perfused, 1+ pulses, no clubbing, cyanosis or edema. Neuro: Alert and fully oriented. Speech fluent. Pertinent Results: Pertinent Labs ___ 04:36PM BLOOD WBC-14.1*# RBC-3.84*# Hgb-11.4*# Hct-36.5*# MCV-95 MCH-29.6 MCHC-31.2 RDW-17.3* Plt ___ ___ 07:05AM BLOOD WBC-9.1 RBC-3.32* Hgb-9.9* Hct-31.2* MCV-94 MCH-29.7 MCHC-31.6 RDW-17.2* Plt ___ ___ 07:00AM BLOOD WBC-8.6 RBC-3.39* Hgb-10.1* Hct-32.2* MCV-95 MCH-29.6 MCHC-31.2 RDW-17.1* Plt ___ ___ 04:36PM BLOOD Glucose-202* UreaN-56* Creat-2.5* Na-134 K-4.3 Cl-94* HCO3-28 AnGap-16 ___ 07:00AM BLOOD Glucose-191* UreaN-57* Creat-2.6* Na-136 K-4.3 Cl-96 HCO3-28 AnGap-16 ___ 04:36PM BLOOD ALT-25 AST-34 AlkPhos-186* TotBili-0.2 ___ 04:36PM BLOOD Albumin-3.4* Calcium-9.8 Phos-2.9 Mg-2.2 ___ 07:00AM BLOOD Albumin-2.8* Calcium-8.3* Phos-4.0 Mg-1.9 Imaging ___ CT HEAD W/O CONTRAST: No evidence of hemorrhage or infarction. Atrophy. Mild small vessel ischemic disease. ___ CHEST (PORTABLE AP): FINAL READ PENDING Prelim read: Cardiomediastinal silhouette and hilar contours are unremarkable. Scattered bilateral residual densities are suggestive of chronic aspiration. There is no pleural effusion or pneumothorax. A hiatal hernia is observed in the midline. The osseous structures are grossly unremarkable. Brief Hospital Course: PRINCIPLE REASON FOR ADMISSION ___ man with DMI, ESRD on PD dialysis, hiatal hernia with severe GERD and recurrent aspiration who presented with confusion and leukocytosis. ACTIVE PROBLEMS # Leukocytosis Possibly reactive following aspiration event. Empiric antibiotics (vanc/zosyn) were started initially, but there were no localizing symptoms for infection, leukocytosis quickly resolved, and initial culture results were not suggestive of infection, so the antibiotics were discontinued. # Confusion Although the patient reported having felt confused prior to presentation (eg. unable to list days of the week backwards), he was near his baseline upon initial evaluation, and denied further confusion following this. The confusion is thought to have been caused by transient hypoxia from aspiration. # Aspiration Patient with extensive history of aspiration. CT on prior admission showed a dilated esophagus which may represent a mechanical obstruction secondary to hiatal hernia. While admitted, the head of his bed was kept elevated, he had a puree/thickened liquid diet, and he had no further aspiration events. Patient will be seen as an outpatient by Dr. ___ ___ assessment of surgical options to prevent future episodes. CHRONIC ISSUES # Recent discectomy/fusion: Patient without pain and doing well with rehab following back surgery. # ESRD: Received peritoneal dialysis while admitted. # HLD: Continued Simvastatin 20mg daily. # DM Type 1: Patient with diabetes complicated by retinopathy, neuropathy, and nephropathy. Continued on SSI plus standing NPH. # GERD: Continued home Omeprazole. TRANSITIONAL ISSUES: -___ with surgery regarding surgical options of hiatal hernia to prevent aspiration Medications on Admission: 1. Allopurinol ___ mg PO twice daily 2. Gentamicin 0.1% Cream 1 Appl TP DAILY Apply to cream for exit site of peritoneal dialysis 3. Furosemide 40 mg PO twice daily hold for SBP<100mmhg 4. Omeprazole 20 mg PO BID 5. Metoclopramide 10 mg PO QIDACHS 6. Simvastatin 20 mg PO DAILY 7. Epoetin Alfa 8000 8000 SC 3XWEEK 3x a week 8. Nephrocaps 1 CAP PO DAILY 9. Amoxicillin ___ mg PO PRIOR TO DENTAL WORK 10. TraZODone 25 mg PO HS:PRN insomnia 11. BuPROPion 300 mg PO DAILY 12. Lorazepam 0.5-1 mg PO HS:PRN insomnia 13. Senna 2 TAB PO BID:PRN constipation 14. Docusate Sodium 100 mg PO BID 15. Aspirin 81 mg PO 4X A WEEK 16. NovoLIN N *NF* (NPH insulin human recomb) 100 unit/mL Subcutaneous qhs ___ U QhS 17. Lantus *NF* (insulin glargine) 12 U Subcutaneous qam qam 18. Pro-Stat RC *NF* (nut.tx.imp.renal fxn,lac-free) unknown Oral qday ?19. Losartan 25mg daily [NOTE: some question about whether this had been d/c'd by an outpatient provider, but could not find any documentation.] Discharge Medications: 1. Allopurinol ___ mg PO DAILY 2. Aspirin 81 mg PO 4X A WEEK 3. BuPROPion 300 mg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Epoetin Alfa 8000 8000 SC 3XWEEK 6. Furosemide 40 mg PO BID 7. Gentamicin 0.1% Cream 1 Appl TP DAILY 8. Lidocaine 5% Patch 1 PTCH TD DAILY 9. Losartan Potassium 25 mg PO DAILY 10. Metoclopramide 10 mg PO QIDACHS 11. Nephrocaps 1 CAP PO DAILY 12. Omeprazole 20 mg PO BID 13. Senna 2 TAB PO BID:PRN constipation 14. Simvastatin 20 mg PO DAILY 15. TraZODone 25 mg PO HS:PRN insomnia 16. Amoxicillin ___ mg PO PRIOR TO DENTAL WORK 17. Lantus *NF* (insulin glargine) 12 U SUBCUTANEOUS QAM 18. Lorazepam 0.5-1 mg PO HS:PRN insomnia 19. NovoLIN N *NF* (NPH insulin human recomb) 100 unit/mL SUBCUTANEOUS QHS 20. Pro-Stat RC *NF* (nut.tx.imp.renal fxn,lac-free) 0 1 ORAL QDAY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: 1. Aspiration pneumonitis 2. Confusion/inattention Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were admitted to the hospital at ___ from ___ to ___ with mild confusion, likely due to aspiration. You were started on antibiotics, but these were stopped because there were no signs of pneumonia. You recovered quickly. You are scheduled to follow up with Dr. ___ on ___ to discuss treatment options to prevent future aspiration events. However, you may be able to reschedule this appointment sooner. It was a pleasure caring for you during your admission. Followup Instructions: ___
10768342-DS-16
10,768,342
20,041,764
DS
16
2132-03-25 00:00:00
2132-03-27 05:45:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Caladryl / Caladryl Clear / Tucks / Flagyl / Latex / Potassium Chloride / polyester / cilantro / Statins-Hmg-Coa Reductase Inhibitors Attending: ___. Chief Complaint: Small bowel obstruction Large parastomal herniation Major Surgical or Invasive Procedure: None during this admission History of Present Illness: ___ with complicated surgical/medical history most notable for rectal cancer s/p LAR, neoadjuvant and adjuvant therapy, subsequent laparoscopy, end colostomy and VHR with mesh c/b large parastomal hernia most recently seen by Dr. ___ ongoing management of colitis in neo rectum now presenting with 1 day of abdominal pain and nausea. She reports normal ostomy function until the day prior to consultation and then no ostomy output for the past day. She developed distension and nausea but no vomiting and ultimately presented for evaluation to the emergency department. An NGT was placed which resulted in 1.5L of feculent output. Past Medical History: End colostomy ___ Colon adenocarcinoma s/p resection (___), ileostomy, and takedown (___). s/p chemo and XRT s/p ventral hernia repair w/ mesh (___) Osteoarthritis Dyslipidemia Hypothyroid Social History: ___ Family History: Aunt died of colon ca Physical Exam: Exam at presentation: 98.1 94 154/71 16 95% RA AOx3, NGT in place, not in distress RRR S1S2 Normal unlabored respirations Abd is obese, incisions well healed. Prominent LLQ parastomal hernia, soft. Stoma is pink, productive of small amount of liquid stool. No gas in bag. Ext WWP Exam at discharge: VS: AVSS GEN: AOx3, NAD ABD: large parastomal hernia, mildly distended, NT, no rebound tenderness or guarding, stoma pink Pertinent Results: ___ 06:25AM BLOOD WBC-4.2 RBC-3.47* Hgb-10.5* Hct-32.3* MCV-93 MCH-30.4 MCHC-32.7 RDW-13.5 Plt ___ ___ 06:51AM BLOOD WBC-6.7# RBC-3.95* Hgb-11.9* Hct-36.2 MCV-92 MCH-30.0 MCHC-32.8 RDW-13.7 Plt ___ ___ 03:00AM BLOOD Neuts-89.7* Lymphs-5.6* Monos-4.0 Eos-0.6 Baso-0.1 ___ 06:25AM BLOOD Glucose-96 UreaN-10 Creat-0.5 Na-135 K-3.4 Cl-101 HCO3-24 AnGap-13 ___ 06:51AM BLOOD Glucose-136* UreaN-21* Creat-0.6 Na-133 K-4.2 Cl-100 HCO3-25 AnGap-12 ___ 10:20PM BLOOD ALT-11 AST-18 AlkPhos-96 TotBili-0.4 Brief Hospital Course: Mrs. ___ presented to the ED at ___ on ___ for symptoms of a small bowel obstruction. She was non-operatively managed with placement of an NGT tube. After a brief and uneventful stay in the ED, the patient was transferred to the floor for further management. Neuro: Her pain was well controlled during this admission. CV: Her CV status was stable throughout her hospitalization. Pulm: She was breathing comfortably at room air during this admission. She did not have any respiratory distress, and her O2 saturation was stable and at goal. GI: Mrs. ___ was noted to have a large parastomal hernia, visible on exam and CT scan. She was having abdominal pain, nausea, and vomiting at the time of admission. Her UGI symptoms were managed with NPO/IVF and placement of a nasogatric tube. She tolerated that well, and the NGT helped decompress her bowel. On ___ she was noted to be passing a small amount os liquid stool and a small amount of gas from the stoma. In the afternoon this increased, and the following day she passed multiple bowel movements from the Colostomy. the NGT was removed. She began a clear liquid diet and was monitored closely. She was followed throughout her admission by the wound ostomy nurses. On ___ she reported feeling nauseated after prune juice, she felt as though she could continue to attempt clear liquid and tried watermellon. She was monitored closely for responce to PO challange. A KUB was obtained which showed persistent partial SBO. On ___, her upper GI symptoms improved. She tolerated a regular diet on day of discharge. ID: There was no issue from an ID standpoint during this admission. Heme: There was no issue from a Heme standpoint during this admission. On ___, the patient was discharged to home. At discharge, she was tolerating a regular diet, passing flatus, stooling, voiding, and ambulating independently. She will follow-up in the clinic in ___ weeks. This information was communicated to the patient directly prior to discharge. Post-Surgical Complications During Inpatient Admission: [ ] Post-Operative Ileus resolving w/o NGT [X] Ileus requiring management with NGT [ ] UTI [ ] Wound Infection [ ] Anastomotic Leak [ ] Staple Line Bleed [ ] Congestive Heart failure [ ] ARF [ ] Acute Urinary retention, failure to void after Foley D/C'd [ ] Acute Urinary Retention requiring discharge with Foley Catheter [ ] DVT [ ] Pneumonia [ ] Abscess [ ] None Social Issues Causing a Delay in Discharge: [ ] Delay in organization of ___ services [ ] Difficulty finding appropriate ___ hospital disposition. [ ] Lack of insurance coverage for ___ services [ ] Lack of insurance coverage for prescribed medications. [ ] Family not agreeable to discharge plan. [ ] Patient knowledge deficit related to ileostomy delaying discharge. [x] No social factors contributing in delay of discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 20 mg PO DAILY 2. Pantoprazole 20 mg PO Q24H 3. Levothyroxine Sodium 150 mcg PO DAILY 4. Cyanocobalamin 500 mcg PO DAILY 5. Aspirin 81 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Cyanocobalamin 500 mcg PO DAILY 3. Levothyroxine Sodium 150 mcg PO DAILY 4. Lisinopril 20 mg PO DAILY 5. Pantoprazole 20 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: Large parastomal hernia Small bowel obstruction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Small Bowel Obstruction (Conservatively Treated) You were admitted to the hospital for a small bowel obstruction. You were given bowel rest and intravenous fluids and a nasogastric tube was placed in your stomach to decompress your bowels. Your obstruction has subsequently resolved after conservative management. You have tolerated a regular diet, are passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. After anesthesia it is not uncommon for patient’s to have some decrease in bowel function but you should not have prolonged constipation. Some loose stool and passing of small amounts of dark, old appearing blood are expected. However, if you notice that you are passing bright red blood with bowel movements or having loose stool without improvement please call the office or go to the emergency room if the symptoms are severe. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms do not improve call the office. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Followup Instructions: ___
10768342-DS-18
10,768,342
28,213,986
DS
18
2132-11-27 00:00:00
2132-11-27 17:55:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Caladryl / Caladryl Clear / Tucks / Flagyl / Latex / Potassium Chloride / polyester / cilantro / Statins-Hmg-Coa Reductase Inhibitors / Benadryl / Pentasa Attending: ___. Chief Complaint: Abdominal Pain, Nausea/Vomiting Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ woman with history of rectal cancer diagnosed ___ s/p chemo/radiation followed by a LAR and diverting ileostomy with loop ileostomy reversal in ___ complicated by ventral hernia requiring repair with mesh in ___ who presents with abdominal pain and nausea/vomiting. She reports a 2 day history of decreased ostomy output. She reports that the last time she had gas in her bag was this morning and has had approximately 1 teaspoon of stool over the past two days. She also reports having increasing abdominal pain over the past 2 days, as well as abdominal distension, nausea, and emesis (x6 with little output). An NG tube was placed in the emergency department with 400cc of light brown output initially. She reports having some chills, but no fevers. She denies any changes in her hernia over the past two days. She does report some weakness preventing her from standing currently. In the ED, initial vitals: 97.4 88 158/80 18 95% RA. Labs were notable for WBC 10.6 (85% PMNs, 12% lymphs), H/H 14.3/43.0, Plt 475, Na 129, Cl 89, HCO3 20, Cr 1.0 (baseline 0.6-0.7), lactate 4.1 -> 4.4, LFTs wnl, UA bland. Imaging was significant for CT with high-grade small bowel obstruction likely secondary to the patient's large left-sided peristomal hernia. Per ED resident bedside ultrasound, patient appeared volume down based on compressible IVC and lung exam did not show significant fluid. Surgery was consulted and recommended admission to medicine given she does not want surgical intervention (unless to save her life), NPO/IVF, NG tube, and foley for urine output monitoring. Surgery also attempted a bedside manual reduction of the hernia. She received a total of 4L NS. She had a total of 3L out by NGT. Patient was given Vancomycin 1g IV, Dilauid 0.5mg IV, Zosyn 4.5mg IV, Ativan 0.5mg IV, Zofran 4mg IV. Vitals prior to transfer were: 98.9 115 100/69 16 96% 3L NC. As noted in the colorectal surgery note: She has a history of rectal cancer, treated treated with neoadjuvant chemo and radiation in ___, followed by a LAR and diverting ileostomy with subsequent ileostomy takedown. She then had a large ventral hernia s/p repair and a rectovaginal fistula requiring an end-colostomy (___), with neorectum and part of her left colon left in-situ at the time of her colostomy. She has had diversion colitis intermittently since then, typically managed with enemas. She has also had a history of obstruction secondary to a large parastomal hernia. These obstructions have been treated conservatively in the past and has frequently been able to self reduce her hernia at home. The patient has been followed by colorectal surgery, and has been involved in multiple discussions regarding possible surgical intervention to address her diversion colitis and parastomal hernia. As noted in the prior note, the definitive treatment would be to resect the remaining colon and neorectum, along with reconstruction of her abdominal wall and re-siting of her colostomy. It has previously been thought that given her age and medical comorbidities that this would be a very high risk surgery in this particular patient. Given this, surgical intervention was not recommended. The patient has also previously stated that she does not want to have any surgical intervention unless she needs surgery to save her life. Her most recent colonoscopy was on ___, which demonstrated friability, erythema, and ulcers concerning for colitis. She has been treated with hydrocortisone enemas, mesalamine enemas, and cortifoam through her stoma. She has recently been treated with po prednisone. She is currently on an 8 week prednisone taper. GI has been following, and are concerned for possible inflammatory bowel disease. She also has a history of bleeding from her stoma and intermittent rectal bleeding, but has not had any bleeding recently. On arrival to the FICU, pt c/o abdominal pain and back pain. Past Medical History: End colostomy ___ Colon adenocarcinoma s/p resection (___), ileostomy, and takedown (___). s/p chemo and XRT s/p ventral hernia repair w/ mesh (___) Osteoarthritis Dyslipidemia Hypothyroid Breast cancer Rectovaginal fistula factor V Leiden carrier GERD HTN Social History: ___ Family History: Father with CAD and stroke. Sister with brain cancer. Aunt with colorectal cancer. Physical Exam: ADMISSION: Vitals: 95.1 100/58 115 33 97% 3L. Pulsus 6mm Hg. GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, MM dry NECK: supple, difficult to appreciate JVP d/t body habitus LUNGS: crackles right base, decreased breath sounds at bilateral bases CV: Tachycardic, difficult to appreciate murmur ABD: soft, tender to palpation with rebound, nonreducible ventral hernia in left lower quadrant EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or significant edema SKIN: no apparent rashes NEURO: moving all extremities, AAOx3 DISCHARGE: T 98.1 P 81 BP 143/66 RR 18 Sat 97%RA GEN: NAD, AAOx3, Pleasant CV: RRR PULM: CTAB ABD: soft, nontender, nondistended, minimal discomfort to palp, no rebound/guarding, NABS EXT: no edema Pertinent Results: ADMISSION: ___ 12:00AM BLOOD WBC-10.6# RBC-5.13# Hgb-14.3# Hct-43.0# MCV-84 MCH-28.0 MCHC-33.3 RDW-13.4 Plt ___ ___ 12:00AM BLOOD Neuts-85* Bands-1 Lymphs-12* Monos-2 Eos-0 Baso-0 ___ Myelos-0 ___ 12:00AM BLOOD Hypochr-NORMAL Anisocy-NORMAL Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL ___ 12:00AM BLOOD Plt Smr-HIGH Plt ___ ___ 12:15PM BLOOD ___ PTT-27.9 ___ ___ 12:00AM BLOOD Glucose-185* UreaN-19 Creat-1.0 Na-129* K-3.7 Cl-89* HCO3-20* AnGap-24* ___ 12:00AM BLOOD ALT-13 AST-15 AlkPhos-76 TotBili-0.4 ___ 12:00AM BLOOD Lipase-22 ___ 12:00AM BLOOD Albumin-4.3 ___ 12:15PM BLOOD Calcium-7.8* Phos-5.9*# Mg-1.7 ___ 06:12AM BLOOD Type-ART pO2-70* pCO2-35 pH-7.38 calTCO2-22 Base XS--3 ___ 12:12AM BLOOD Lactate-4.1* ___ 06:12AM BLOOD O2 Sat-92 ___ 06:12AM BLOOD freeCa-1.01* IMAGING: KUB ___ Impression: Multiple air-fluid levels and dilated loops of small bowel, compatible with early small bowel obstruction given that air is still noted within the rectum. CT Abdomen/Pelvis w/ Contrast ___ 1. High-grade small bowel obstruction, likely secondary to the patient's large left-sided peristomal hernia. Trace free intra-abdominal fluid without evidence of pneumoperitoneum. 2. Postoperative appearance status post lower anterior resection for rectal cancer, with end colostomy. Note that the location of the residual left colon and ___ pouch within the left peristomal hernia is unchanged. 3. Cholelithiasis without evidence of acute cholecystitis. Brief Hospital Course: ___ w/history of rectal cancer s/p LAR and now with end colostomy c/b ventral hernia, with SBO likely related to hernia, complicated by hypotension, rule out septic shock, with acute kidney injury, hyponatremia. She had spontaneous return of bowel function and diet was advanced as tolerated. # SBO: high-grade small bowel obstruction and stomach protruduing through her parastomal hernia. Patient is not interested in surgical intervention unless life threatening. Proceeded with conservative management of SBO including NPO/IVF, NG tube decompression, foley output monitoring. Her lactate improved. She was started on ampicillin-sulbactam for empriric antibiotic coverage on admision and stopped on ___. She started having stool via her ostomy output on ___. After ensuring stabilization, she was transferred to the surgery service where we continued NPO/IVF/NGT. She began to have some return of bowel function reduced NGT output, a clamp trial demonstrate minimal residual and the NGT was removed on ___. Her diet was slowly advanced as tolerated starting on HD#3 and was tolerating regular diet by HD#5. Abdominal exam was essentially normal at this point. # Hypotension: Pt presented initially with significant hypotension requiring vasoactive support. This was likely a result of her volume losses and inability to replace these, with improvement in BP after volume resuscitation with 4L. Other considerations included potential septic shock from bowel source (though no e/o perforation at this time), obstructive shock from pericardial effusion noted on CT chest (but pulsus not elevated), adrenal insufficiency given pt has been on steroids for her colitis--however the patient responded well to fluids. She also required norepinephrine for BP support, but was weaned early in her hospital course. Her lactate improved with continued monitoring. She was started on stress dose steroids with hydrocortisone 100mg q8h x24hr which should be gradually weaned. Her blood pressure was stable after transfer to the surgical service. # Acute kidney injury: Likely related to reduced renal perfusion from hypovolemia given reduced intake, continuing volume losses, hemoconcentration resulting in ATN. Improved with fluid recussitation. # Hypothyroidism: Home levothyroxine # GERD: Continued pantoprazole daily. # HTN: held home lisinopril in setting of hypotension. At time of discharge, she was afebrile, hemodynamically intact, tolerating regular diet. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 500 mg PO QAM, QPM 2. Acetaminophen 500 mg PO QNOON 3. Aspirin 81 mg PO MON, WEDS, FRI 4. Celecoxib 200 mg oral daily 5. Cyanocobalamin 500 mcg PO DAILY 6. Ferrous Sulfate 325 mg PO DAILY 7. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN pain 8. Levothyroxine Sodium 150 mcg PO ___, MO, ___, WE, TH, FR 9. Levothyroxine Sodium 75 mcg PO QSAT 10. Lisinopril 20 mg PO DAILY 11. Multivitamins 1 TAB PO DAILY 12. Pantoprazole 40 mg PO Q24H 13. Calcium Carbonate 500 mg PO DAILY 14. PredniSONE 30 mg PO DAILY Tapered dose - DOWN 15. Vitamin D 400 UNIT PO DAILY 16. Ascorbic Acid ___ mg PO DAILY 17. Budesonide Nasal Inhaler 2 sprays Other daily 18. red yeast rice extract (bulk) 600 mg miscellaneous BID 19. Glucosamine Sulf-Chondroitin (glucosamine ___ 2KCl-chondroit) 500-400 mg oral daily Discharge Medications: 1. Ascorbic Acid ___ mg PO DAILY 2. Aspirin 81 mg PO MON, WEDS, FRI 3. Calcium Carbonate 500 mg PO DAILY 4. Cyanocobalamin 500 mcg PO DAILY 5. Levothyroxine Sodium 150 mcg PO ___, MO, ___, WE, TH, FR 6. Levothyroxine Sodium 75 mcg PO QSAT 7. Lisinopril 20 mg PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. PredniSONE 30 mg PO DAILY Tapered dose - DOWN 10. Vitamin D 400 UNIT PO DAILY 11. Acetaminophen 500 mg PO QAM, QPM 12. Acetaminophen 500 mg PO QNOON 13. Budesonide Nasal Inhaler 2 sprays Other daily 14. Celecoxib 200 mg ORAL DAILY 15. Ferrous Sulfate 325 mg PO DAILY 16. Glucosamine Sulf-Chondroitin (glucosamine ___ 2KCl-chondroit) 500-400 mg oral daily 17. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN pain 18. Multivitamins 1 TAB PO DAILY 19. red yeast rice extract (bulk) 600 mg miscellaneous BID Discharge Disposition: Home Discharge Diagnosis: Small bowel obstruction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: You were admitted to the hospital for a small bowel obstruction. You were given bowel rest and intravenous fluids and a nasogastric tube was placed in your stomach to decompress your bowels. Your obstruction has subsequently resolved after conservative management. You have tolerated a regular diet, are passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. Please monitor your bowel function closely. You may or may not have had a bowel movement prior to your discharge which is acceptable, however it is important that you have a bowel movement in the next ___ days. After anesthesia it is not uncommon for patient’s to have some decrease in bowel function but you should not have prolonged constipation. Some loose stool and passing of small amounts of dark, old appearing blood are expected. However, if you notice that you are passing bright red blood with bowel movements or having loose stool without improvement please call the office or go to the emergency room if the symptoms are severe. If you are taking narcotic pain medications there is a risk that you will have some constipation. Please take an over the counter stool softener such as Colace, and if the symptoms do not improve call the office. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Followup Instructions: ___
10768342-DS-22
10,768,342
29,624,496
DS
22
2135-01-25 00:00:00
2135-01-26 03:06:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Caladryl / Caladryl Clear / Tucks / Flagyl / Latex / Potassium Chloride / polyester / cilantro / Statins-Hmg-Coa Reductase Inhibitors / Benadryl / Pentasa / prednisone Attending: ___ ___ Complaint: Nausea/Vomiting/Abdominal Pain Major Surgical or Invasive Procedure: none History of Present Illness: Per colorectal surgery consult note in the emergency department: Mrs. ___ is a ___ with h/o rectal CA s/p neoadj chemo/XRT, LAR/ileostomy, takedown, c/b incisional hernia s/p repair w/ mesh, rectovaginal fistula s/p LOA/end-colostomy c/b parastomal hernia & ECF, multiple prior SBOs who p/w nausea, vomiting and decreased ostomy output. Briefly, patient has had numerous SBOs in the past ___ complicated surgical hx for which she typically manages symptoms of N/V, abdominal pain and low output and home until they eventually self-resolve. She reports persistent N/V, abdominal pain and essentially no ostomy over the past 36 hours c/w prior SBO episodes. She presents to the ED given persistence of symptoms. She reports a diagnosis of UTI by her PCP two days ago for which she was started on Macrobid that she has not been taking recently as she has been unable to tolerate PO. She otherwise denies fevers/chills, CP/SOB, overlying skin changes to known parastomal hernia. While in the ED, the patient received PO and IV contrast for CT A/P and was noted to have active extravasation of contrast from her R antecubital PIV causing some edema and discomfort - she was evaluated by Hand Surgery who ruled out compartment syndrome and recommended RUE elevation and ice to R AC PRN. Past Medical History: DVT/PE ___ on coumadin End colostomy ___ Colon adenocarcinoma s/p resection (___), ileostomy, and takedown (___). s/p chemo and XRT Osteoarthritis Dyslipidemia Hypothyroid Breast cancer Rectovaginal fistula factor V Leiden carrier GERD HTN PSH: Rectal cancer s/p resection and choanal anastomosis with ileostomy ___ ___ Ileostomy closure ___ ___ Laparoscopic ventral hernia repair with insertion of mesh. ___ ___ Rectovaginal fistula s/p laparoscopy with lysis of adhesions end colostomy ___ ___ Left wire localized lumpectomy and sentinel lymph node biopsy ___ ___ Rectal pain s/p anal dilatation, transanal excision of polyp (___) GI History: She has a history of colitis (Diversion vs IBD). She has had bleeding from the excluded rectum and a lot of secretions. She was placed on Rowasa enemas in the past. She underwent an examination of the excluded colon and the stoma on ___. The excluded colon showed erythema, friability and exudate in the rectum to the end of the colon at 60 cm. Through the stoma, there was normal mucosa from 25 cm to the end of the colon in the cecum, which was at 45 cm and in the terminal ileum. At 25 cm distally, there were aphthous ulcerations. From 5 cm distally, there was diffuse erythema, congestion and friability consistent with colitis. There were two inflammatory polyps seen with a question of a fistula adjacent to one. The biopsies showed in the excluded colon chronic active colitis. Through the stoma at 5 cm, there was chronic active colitis and at 25 cm chronic inactive colitis with normal at the cecum. These findings raised the question of IBD. She was seen in the office in ___ and the thought was that she had IBD. She was started on pentasa which caused diarrhea. She was admitted in ___ with bleeding. CT scan showed thickened residual right colon leading up to and into the colostomy consistent with colitis. She was treated with IV steroids and then transitioned to oral prednisone. She was admitted in ___ with an SBO which was treated conservatively. She as dischaged on 30 mg of prednisone and she tapered off by ___. Social History: ___ Family History: Father with CAD and stroke. Sister with brain cancer. Aunt with colorectal cancer. Physical Exam: General: tolerating a regular diet, pain controlled, ambulating VSS Neuro: A&OX3 Cardio/Pulm: no chest pain or shortness of breath Abd: obese, well healed prior surgical incisions, soft, non distended Ext: WWP Pertinent Results: ___ 06:44AM BLOOD WBC-4.4 RBC-3.63* Hgb-10.9* Hct-33.7* MCV-93 MCH-30.0 MCHC-32.3 RDW-13.7 RDWSD-46.7* Plt ___ ___ 08:30AM BLOOD WBC-8.1 RBC-4.34 Hgb-13.1 Hct-40.5 MCV-93 MCH-30.2 MCHC-32.3 RDW-14.1 RDWSD-47.8* Plt ___ ___ 02:28PM BLOOD WBC-16.2*# RBC-4.52 Hgb-13.7 Hct-41.3 MCV-91 MCH-30.3 MCHC-33.2 RDW-14.3 RDWSD-47.8* Plt ___ ___ 02:28PM BLOOD Neuts-87.8* Lymphs-6.0* Monos-5.8 Eos-0.0* Baso-0.1 Im ___ AbsNeut-14.22*# AbsLymp-0.98* AbsMono-0.94* AbsEos-0.00* AbsBaso-0.02 ___ 06:44AM BLOOD ___ PTT-36.6* ___ ___ 08:30AM BLOOD ___ PTT-39.0* ___ ___ 06:44AM BLOOD Glucose-102* UreaN-24* Creat-0.5 Na-132* K-3.5 Cl-97 HCO3-26 AnGap-13 ___ 08:30AM BLOOD Glucose-139* UreaN-32* Creat-0.7 Na-133 K-4.5 Cl-96 HCO3-26 AnGap-16 ___ 02:28PM BLOOD Glucose-177* UreaN-33* Creat-1.0 Na-129* K-9.0* Cl-89* HCO3-22 AnGap-27* ___ 06:44AM BLOOD Calcium-8.0* Phos-2.6* Mg-2.1 ___ 08:30AM BLOOD Calcium-8.9 Phos-4.5 Mg-2.3 ___ 09:19PM BLOOD Lactate-1.6 ___ 03:49PM BLOOD Lactate-3.5* K-4.7 ___ 02:36PM BLOOD Lactate-3.7* Brief Hospital Course: Mrs. ___ was admitted to the inpatient colorectal surgery service with a small bowel obstruction. A peripheral IV was placed in the patient's right antecubital area which infiltrated while CT contrast dye was administered in radiology. This was evaluated by hand surgery in the emergency department and the patients arm was elevated and monitored closely throughout the admission. A nasogastric tube was placed for decompression. She was hydrated appropriately. On the afternoon of hospital day one she reported passing flatus. On the morning of hospital day two the nasogastric tube was removed and she was advanced to a clear liquid diet. She tolerated the clear liquids well, but started having increased abdominal cramping and on hospital day three was taken back down to sips and IV fluids. The abdominal pain resolved, and on hospital day four a regular diet was resumed. Upon discharge, Mrs. ___ was ambulating independently, her pain was well controlled, her stoma had adequate output, and she was voiding appropriately. Medications on Admission: macrobid (recently started as outpatient for UTI), coumadin (10mg 5days/week, 12.5mg 2days/week), levothyroxine 150', lisinopril 20', pantoprazole 20', hydromorphone 2 q4h PRN pain, celecoxib 200', ASA 81', acetaminophen, tums, budesonide nasal spray QHS, Vitamin D3, Vitamin B12, Colace, MVI, iron supplement, glucosamine chondroitin, red yeast rice Discharge Medications: 1. CeleBREX (celecoxib) 200 mg oral DAILY 2. Ciprofloxacin HCl 500 mg PO Q12H infection RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth twice a day Disp #*7 Tablet Refills:*0 3. Levothyroxine Sodium 150 mcg PO DAILY 4. Lisinopril 20 mg PO DAILY 5. Pantoprazole 20 mg PO Q24H 6. Warfarin 10 mg PO DAILY16 Discharge Disposition: Home Discharge Diagnosis: Small Bowel Obstruction IV infiltrate of contrast media into right AC Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital for a small bowel obstruction. You were given bowel rest and intravenous fluids and a nasogastric tube was placed in your stomach to decompress your bowels. Your obstruction has subsequently resolved after conservative management. You have tolerated a regular diet, are passing gas and your pain is controlled with pain medications by mouth. You may return home to finish your recovery. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Thank you for allowing us to participate in your care! Our hope is that you will have a quick return to your life and usual activities. Good luck! Followup Instructions: ___
10768342-DS-23
10,768,342
27,743,384
DS
23
2135-05-19 00:00:00
2135-05-21 21:28:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Caladryl / Caladryl Clear / Tucks / Flagyl / Latex / Potassium Chloride / polyester / cilantro / Statins-Hmg-Coa Reductase Inhibitors / Benadryl / Pentasa / prednisone / ciprofloxacin Attending: ___ ___ Complaint: abdominal pain, nausea, vomiting Major Surgical or Invasive Procedure: none History of Present Illness: HPI: ___ w/ complicated abdominal surgical history including LAR for rectal cancer, lap incisional hernia repair, and LOA w/ end colostomy for colovaginal fistula now w/ large parastomal hernia and recurrent SBOs presenting with an SBO. The patient reports that she has ___ obstructions per year, some of which she treats at home with bowel rest alone. She was last admitted for an SBO in ___ and was managed conservatively. She reports that yesterday she began to develop abdominal distention and decreased ostomy output around lunchtime. Throughout the day and overnight, her distention became increasingly worse and she began to have nausea and multiple episodes of vomiting. She also reports becoming extremely weak and being unable to ambulate and reports intermittent chills without subjective fever. Past Medical History: DVT/PE ___ on coumadin End colostomy ___ Colon adenocarcinoma s/p resection (___), ileostomy, and takedown (___). s/p chemo and XRT Osteoarthritis Dyslipidemia Hypothyroid Breast cancer Rectovaginal fistula factor V Leiden carrier GERD HTN PSH: Rectal cancer s/p resection and choanal anastomosis with ileostomy ___ ___ Ileostomy closure ___ ___ Laparoscopic ventral hernia repair with insertion of mesh. ___ ___ Rectovaginal fistula s/p laparoscopy with lysis of adhesions end colostomy ___ ___ Left wire localized lumpectomy and sentinel lymph node biopsy ___ ___ Rectal pain s/p anal dilatation, transanal excision of polyp (___) GI History: She has a history of colitis (Diversion vs IBD). She has had bleeding from the excluded rectum and a lot of secretions. She was placed on Rowasa enemas in the past. She underwent an examination of the excluded colon and the stoma on ___. The excluded colon showed erythema, friability and exudate in the rectum to the end of the colon at 60 cm. Through the stoma, there was normal mucosa from 25 cm to the end of the colon in the cecum, which was at 45 cm and in the terminal ileum. At 25 cm distally, there were aphthous ulcerations. From 5 cm distally, there was diffuse erythema, congestion and friability consistent with colitis. There were two inflammatory polyps seen with a question of a fistula adjacent to one. The biopsies showed in the excluded colon chronic active colitis. Through the stoma at 5 cm, there was chronic active colitis and at 25 cm chronic inactive colitis with normal at the cecum. These findings raised the question of IBD. She was seen in the office in ___ and the thought was that she had IBD. She was started on pentasa which caused diarrhea. She was admitted in ___ with bleeding. CT scan showed thickened residual right colon leading up to and into the colostomy consistent with colitis. She was treated with IV steroids and then transitioned to oral prednisone. She was admitted in ___ with an SBO which was treated conservatively. She as dischaged on 30 mg of prednisone and she tapered off by ___. Social History: ___ Family History: Father with CAD and stroke. Sister with brain cancer. Aunt with colorectal cancer. Physical Exam: Exam at discharge: VS: WNL General: NAD HEENT: NC/AT, EOMI, no scleral icterus, dry mucous membranes Resp: breathing comfortably without distress CV: regular rate and regular rhythm Abd: soft, large parastomal hernia, lower abd mild tender to palpation, no rebound or guarding, ostomy putting bag full with stool, pink mucosa Ext: well-perfused Pertinent Results: ___ 06:00AM BLOOD WBC-8.1 RBC-3.77* Hgb-11.3 Hct-34.9 MCV-93 MCH-30.0 MCHC-32.4 RDW-13.8 RDWSD-47.1* Plt ___ ___ 07:00PM BLOOD WBC-8.3 RBC-3.98 Hgb-12.1 Hct-36.7 MCV-92 MCH-30.4 MCHC-33.0 RDW-13.9 RDWSD-46.9* Plt ___ ___ 10:13AM BLOOD WBC-12.7* RBC-4.56 Hgb-13.9 Hct-42.2 MCV-93 MCH-30.5 MCHC-32.9 RDW-13.9 RDWSD-47.5* Plt ___ ___ 03:50AM BLOOD WBC-22.7*# RBC-5.31*# Hgb-16.1*# Hct-49.1*# MCV-93 MCH-30.3 MCHC-32.8 RDW-13.6 RDWSD-46.5* Plt ___ ___ 05:12AM BLOOD ___ PTT-39.0* ___ ___ 03:50AM BLOOD Plt ___ ___ 06:00AM BLOOD Glucose-158* UreaN-53* Creat-1.0 Na-145 K-4.2 Cl-101 HCO3-27 AnGap-17 ___ 07:00PM BLOOD Glucose-237* UreaN-49* Creat-1.3* Na-141 K-5.6* Cl-99 HCO3-27 AnGap-15 ___ 10:13AM BLOOD Glucose-168* UreaN-38* Creat-1.8* Na-141 K-4.9 Cl-94* HCO3-23 AnGap-24* ___ 03:50AM BLOOD Glucose-298* UreaN-30* Creat-1.9*# Na-134* K-4.6 Cl-83* HCO3-20* AnGap-31* ___ 10:13AM BLOOD ALT-11 AST-19 AlkPhos-80 TotBili-0.3 ___ 07:00PM BLOOD Calcium-7.8* Phos-5.2* Mg-2.1 ___ 10:13AM BLOOD Albumin-4.3 Calcium-9.1 Phos-6.0* Mg-2.2 ___ 03:50AM BLOOD Calcium-11.1* Phos-6.7* Mg-2.5 ___ 06:23AM BLOOD Lactate-2.8* ___ 10:21AM BLOOD Lactate-5.2* ___ 06:45AM BLOOD Lactate-4.4* ___ 04:11AM BLOOD Lactate-8.3* CT ABD & PELVIS W/O CONTRAST Study Date of ___ 6:22 AM IMPRESSION: 1. Small-bowel obstruction with a transition point at the proximal jejunum as the bowel exits the inferior edge of the parastomal hernia. Small bowel distal to the parastomal hernia remains dilated with gradual tapering to the terminal ileum likely due to superimposed ileus. No evidence of ischemia. No free air. 2. Stable left perinephric fluid. 3. Cholelithiasis without cholecystitis. Brief Hospital Course: ___ was admitted to the inpatient colorectal surgery service ___ from the emergency with a small bowel obstruction. The Nasogastric tube was putting out increased amounts of thick brown/bilious liquid. Her electrolytes were off however this improved with hydration. ___ stable, ready for dc, tol PO ___ INR 2.5, CLD, foley out, post void, tol clears, good ostomy OP ___ INR 5.2--> 2 u FFp--> INR 3.0 ___ min NGT Op, ostomy OP dark stool, OOB, encourage amb, maroon op rectum ___ pm C10 hemolyzed, difficult IV access. Nausea-zofran ___ pain, soft abd, full ostomy bag ___ trend labs, fluids Neuro: Pain was well controlled on tylenol CV: Vital signs were routinely monitored during the patient's length of stay. Pulm: The patient was encouraged to ambulate, sit and get out of bed as tolerated. GI: The patient was initially kept NPO with an NGT in place. After 3 days her ostomy opened up and her NGT stopped putting out thick feculent material. The patient was later advanced to and tolerated a regular diet at time of discharge. GU: Patient had a foley catheter that was removed at time of discharge. Urine output was monitored as indicated. At time of discharge, the patient was voiding without difficulty. ID: The patient's vital signs were monitored for signs of infection and fever. Heme: The patient had vital signs, including heart rate and blood pressure, monitored throughout the hospital stay. Her INR was elevated to 5.2 on hospital day 3 despite her warfarin being held. At the time of dischage her INR had returned to therapeutic levels and she was instructed to restart her warfarin on day of discharge with close follow-up with her ___ clinic. On hospital day 5, the patient was discharged to home. At discharge,she was tolerating a regular diet, passing flatus, stooling out of her ostomy, voiding, and ambulating independently, She will follow-up in the clinic as need be and will follow up with her PCP and her ___ clinic this week. This information was communicated to the patient directly prior to discharge. Include in Brief Hospital Course for Every Patient and check of boxes that apply: Complications During Inpatient Admission: [ ] Post-Operative Ileus resolving w/o NGT [ ] Post-Operative Ileus requiring management with NGT [ ] UTI [ ] Wound Infection [ ] Anastomotic Leak [ ] Staple Line Bleed [ ] Congestive Heart failure [ ] ARF [ ] Acute Urinary retention, failure to void after Foley D/C'd [ ] Acute Urinary Retention requiring discharge with Foley Catheter [ ] DVT [ ] Pneumonia [ ] Abscess [x] None Social Issues Causing a Delay in Discharge: [ ] Delay in organization of ___ services [ ] Difficulty finding appropriate rehab hospital disposition. [ ] Lack of insurance coverage for ___ services [ ] Lack of insurance coverage for prescribed medications. [ ] Family not agreeable to discharge plan. [ ] Patient knowledge deficit related to ileostomy delaying dispo [x] No social factors contributing in delay of discharge. Medications on Admission: CELECOXIB [CELEBREX] - Celebrex ___ mg capsule. 1 Capsule(s) by mouth once a day - (Prescribed by Other Provider) HYDROMORPHONE - hydromorphone 2 mg tablet. 1 Tablet(s) by mouth every four (4) hours as needed for pain LEVOTHYROXINE [SYNTHROID] - Synthroid ___ mcg tablet. 1 tablet(s) by mouth 150mcg 6xwk; 75mcg 1day/wk No generics - (Prescribed by Other Provider) LISINOPRIL - lisinopril 20 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) PANTOPRAZOLE - pantoprazole 20 mg tablet,delayed release. 1 tablet(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) WARFARIN [COUMADIN] - Coumadin 5 mg tablet. ___ tablet(s) by mouth once a day or as directed. Currently 10mg 5 days/wk and 12.5mg 2days/wk, awaiting preop instructions from MD - (Prescribed by Other Provider) Medications - OTC ACETAMINOPHEN [TYLENOL] - Tylenol ___ mg tablet. ___ tablet(s) by mouth three times a day Taking 5/day - (OTC) ASPIRIN - aspirin 81 mg tablet,delayed release. 1 tablet(s) by mouth ___ - (Prescribed by Other Provider) BUDESONIDE [RHINOCORT ALLERGY] - Rhinocort Allergy 32 mcg/actuation nasal spray. 2 sprays in each nostril at bedtime usually - (OTC) CALCIUM CARBONATE [TUMS] - Tums 200 mg calcium (500 mg) chewable tablet. 1 tablet(s) by mouth once a day as needed - (OTC) CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 1,000 unit tablet. tablet(s) by mouth once a day - (OTC) CYANOCOBALAMIN (VITAMIN B-12) - cyanocobalamin (vit B-12) 500 mcg tablet. 1 Tablet(s) by mouth once a day - (Prescribed by Other Provider) DOCUSATE SODIUM - docusate sodium 100 mg capsule. 1 capsule(s) by mouth once a day - (OTC) GLUCOSAMINE SUL-CHONDROITN-MSM - Dosage uncertain - (OTC) IRON,CARBONYL-VITAMIN C - Dosage uncertain - (Prescribed by Other Provider) MULTIVITAMIN - multivitamin tablet. 1 Tablet(s) by mouth once a day - (Prescribed by Other Provider) RED YEAST RICE - red yeast rice 600 mg capsule. 1 capsule(s) by mouth twice a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) Discharge Medications: 1. Warfarin 7.5-10 mg PO DAILY16 DVT prevention please take as directed by Outside Provider 2. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN Pain - Moderate 3. Levothyroxine Sodium 150 mcg IV DAILY 4. Lisinopril 20 mg PO DAILY 5. Pantoprazole 20 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: small bowel obstruction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ were admitted to the hospital for a small bowel obstruction. ___ were given bowel rest and intravenous fluids and a nasogastric tube was placed in your stomach to decompress your bowels. Your obstruction has subsequently resolved after conservative management. ___ have tolerated a regular diet, are passing gas and your pain is controlled with pain medications by mouth. ___ may return home to finish your recovery. If ___ have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Thank ___ for allowing us to participate in your care! Our hope is that ___ will have a quick return to your life and usual activities. Have a very happy birthday! Followup Instructions: ___
10768342-DS-24
10,768,342
21,650,232
DS
24
2136-01-24 00:00:00
2136-01-25 11:51:00
Name: ___. Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Caladryl / Caladryl Clear / Tucks / Flagyl / Latex / Potassium Chloride / polyester / cilantro / Statins-Hmg-Coa Reductase Inhibitors / Benadryl / Pentasa / prednisone / ciprofloxacin Attending: ___ ___ Complaint: Recurrent small bowel obstruction Major Surgical or Invasive Procedure: None this admission History of Present Illness: ___ w/ rectal ca s/p LAR, lap VHR with mesh, and LOA with end colostomy for colovaginal fistula c/b parastomal hernia presents with recurrent SBO. Past Medical History: DVT/PE ___ on coumadin End colostomy ___ Colon adenocarcinoma s/p resection (___), ileostomy, and takedown (___). s/p chemo and XRT Osteoarthritis Dyslipidemia Hypothyroid Breast cancer Rectovaginal fistula factor V Leiden carrier GERD HTN PSH: Rectal cancer s/p resection and choanal anastomosis with ileostomy ___ ___ Ileostomy closure ___ ___ Laparoscopic ventral hernia repair with insertion of mesh. ___ ___ Rectovaginal fistula s/p laparoscopy with lysis of adhesions end colostomy ___ ___ Left wire localized lumpectomy and sentinel lymph node biopsy ___ ___ Rectal pain s/p anal dilatation, transanal excision of polyp (___) GI History: She has a history of colitis (Diversion vs IBD). She has had bleeding from the excluded rectum and a lot of secretions. She was placed on Rowasa enemas in the past. She underwent an examination of the excluded colon and the stoma on ___. The excluded colon showed erythema, friability and exudate in the rectum to the end of the colon at 60 cm. Through the stoma, there was normal mucosa from 25 cm to the end of the colon in the cecum, which was at 45 cm and in the terminal ileum. At 25 cm distally, there were aphthous ulcerations. From 5 cm distally, there was diffuse erythema, congestion and friability consistent with colitis. There were two inflammatory polyps seen with a question of a fistula adjacent to one. The biopsies showed in the excluded colon chronic active colitis. Through the stoma at 5 cm, there was chronic active colitis and at 25 cm chronic inactive colitis with normal at the cecum. These findings raised the question of IBD. She was seen in the office in ___ and the thought was that she had IBD. She was started on pentasa which caused diarrhea. She was admitted in ___ with bleeding. CT scan showed thickened residual right colon leading up to and into the colostomy consistent with colitis. She was treated with IV steroids and then transitioned to oral prednisone. She was admitted in ___ with an SBO which was treated conservatively. She as dischaged on 30 mg of prednisone and she tapered off by ___. Social History: ___ Family History: Father with CAD and stroke. Sister with brain cancer. Aunt with colorectal cancer. Physical Exam: GEN: WD, WN in NAD HEENT: NCAT, EOMI, anicteric CV: RRR, No JVD PULM: normal excursion, no respiratory distress ABD: soft, mild ttp low abdomen, ND, Colostomy LLQ, parastomal hernia, ileostomy scar RLQ well healed. EXT: WWP, no CCE, 2+ B/L radial NEURO: A&Ox3, no focal neurologic deficits PSYCH: normal judgment/insight, normal memory, normal mood/affect WOUND: [ ] ___ ___________ [ ] ostomy ___________ [ ] surgical drain ___________ [ ] prevena ___________ Pertinent Results: ___ 08:50AM BLOOD WBC-6.7 RBC-3.74* Hgb-10.7* Hct-33.4* MCV-89 MCH-28.6 MCHC-32.0 RDW-12.9 RDWSD-42.0 Plt ___ ___ 01:00PM BLOOD ___ ___ 08:50AM BLOOD Plt ___ ___ 08:50AM BLOOD Glucose-150* UreaN-51* Creat-1.2*# Na-133* K-4.1 Cl-99 HCO3-21* AnGap-13 ___ 08:50AM BLOOD Calcium-8.0* Phos-3.0 Mg-1.8 Brief Hospital Course: Ms. ___ presented to ___ holding at ___ on ___ with a small bowel obstruction. Neuro: Pain was well controlled on Tylenol. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Pulm: The patient remained stable from a pulmonary standpoint; oxygen saturation was routinely monitored. Had good pulmonary toileting, as early ambulation and incentive spirometry were encouraged throughout hospitalization. GI: The patient was initially kept NPO. The patient was later advanced to and tolerated a regular diet at time of discharge. Patient's intake and output were closely monitored. GU: The patient had a Foley catheter that was removed at time of discharge. Urine output was monitored as indicated. At time of discharge, the patient was voiding without difficulty. ID: The patient was closely monitored for signs and symptoms of infection and fever. Heme: The patient had blood levels checked daily during their hospital course to monitor for signs of bleeding. The patient received subcutaneous heparin and ___ dyne boots were used during this stay, she was encouraged to get up and ambulate as early as possible. The patient is being discharged on a prophylactic dose of Lovenox. On ___, the patient was discharged to home. At discharge, she was tolerating a regular diet, passing flatus, stooling, voiding, and ambulating independently. She will follow-up in the clinic in ___ weeks. This information was communicated to the patient directly prior to discharge. Include in Brief Hospital Course for Every Patient and check of boxes that apply: Post-Surgical Complications During Inpatient Admission: [ ] Post-Operative Ileus resolving w/o NGT [ ] Post-Operative Ileus requiring management with NGT [ ] UTI [ ] Wound Infection [ ] Anastomotic Leak [ ] Staple Line Bleed [ ] Congestive Heart failure [ ] ARF [ ] Acute Urinary retention, failure to void after Foley D/C'd [ ] Acute Urinary Retention requiring discharge with Foley Catheter [ ] DVT [ ] Pneumonia [ ] Abscess [x] None Social Issues Causing a Delay in Discharge: [ ] Delay in organization of ___ services [ ] Difficulty finding appropriate rehab hospital disposition. [ ] Lack of insurance coverage for ___ services [ ] Lack of insurance coverage for prescribed medications. [ ] Family not agreeable to discharge plan. [ ] Patient knowledge deficit related to ileostomy delaying dispo [x] No social factors contributing in delay of discharge. Medications on Admission: CELECOXIB [CELEBREX] - Celebrex ___ mg capsule. 1 capsule(s) by mouth at bedtime - (Prescribed by Other Provider) CELECOXIB [CELEBREX] - Celebrex ___ mg capsule. 1 Capsule(s) by mouth once a day - (Prescribed by Other Provider) HYDROMORPHONE - hydromorphone 2 mg tablet. 1 Tablet(s) by mouth every four (4) hours as needed for pain LEVOTHYROXINE [SYNTHROID] - Synthroid ___ mcg tablet. 1 tablet(s) by mouth once a day No generics - (Prescribed by Other Provider) LISINOPRIL - lisinopril 20 mg tablet. 1 tablet(s) by mouth daily - (Prescribed by Other Provider) PANTOPRAZOLE - pantoprazole 20 mg tablet,delayed release. 1 tablet(s) by mouth once a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) WARFARIN [COUMADIN] - Coumadin 5 mg tablet. ___ tablet(s) by mouth once a day or as directed. Currently 10mg 1 day/wk and 7.5.5mg 6 days/wk, awaiting preop instructions from MD - (Prescribed by Other Provider) Medications - OTC ACETAMINOPHEN [TYLENOL EXTRA STRENGTH] - Tylenol Extra Strength 500 mg tablet. ___ tablet(s) by mouth three times a day Taking 5/day - (OTC) ASPIRIN - aspirin 81 mg tablet,delayed release. 1 tablet(s) by mouth ___ - (Prescribed by Other Provider) BUDESONIDE [RHINOCORT ALLERGY] - Rhinocort Allergy 32 mcg/actuation nasal spray. 2 sprays in each nostril at bedtime usually - (OTC) CALCIUM CARBONATE [TUMS] - Tums 200 mg calcium (500 mg) chewable tablet. 1 tablet(s) by mouth once a day as needed - (OTC) CHOLECALCIFEROL (VITAMIN D3) - cholecalciferol (vitamin D3) 1,000 unit tablet. tablet(s) by mouth once a day - (OTC) CYANOCOBALAMIN (VITAMIN B-12) - cyanocobalamin (vit B-12) 500 mcg tablet. 1 Tablet(s) by mouth once a day - (Prescribed by Other Provider) DOCUSATE SODIUM - docusate sodium 100 mg capsule. 1 capsule(s) by mouth once a day - (OTC) GLUCOSAMINE SUL-CHONDROITN-MSM - Dosage uncertain - (OTC) IRON,CARBONYL-VITAMIN C - Dosage uncertain - (Prescribed by Other Provider) MULTIVITAMIN - multivitamin tablet. 1 Tablet(s) by mouth once a day - (Prescribed by Other Provider) PROBIOTICS - probiotics . three times a week - (OTC) RED YEAST RICE - red yeast rice 600 mg capsule. 1 capsule(s) by mouth twice a day - (Prescribed by Other Provider; Dose adjustment - no new Rx) Discharge Medications: 1. Acetaminophen 650 mg PO TID Pain 2. Celecoxib 100 mg oral QHS 3. Aspirin 81 mg PO DAILY 4. Calcium Carbonate 500 mg PO DAILY:PRN on this at home 5. Cyanocobalamin 500 mcg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Levothyroxine Sodium 150 mcg PO DAILY 8. Lisinopril 20 mg PO DAILY 9. Pantoprazole 20 mg PO Q24H 10. Vitamin D 1000 UNIT PO DAILY 11. Warfarin 7.5 mg PO DAILY Duration: 1 Dose 10 mg on ___ and 7.5 mg every day for rest of week. Discharge Disposition: Home Discharge Diagnosis: SBO Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital for a small bowel obstruction. You were given bowel rest and intravenous fluids. Your obstruction has subsequently resolved after conservative management. You are tolerating a regular diet, passing gas and your pain is controlled with pain medications by mouth. If you have any of the following symptoms please call the office for advice or go to the emergency room if severe: increasing abdominal distension, increasing abdominal pain, nausea, vomiting, inability to tolerate food or liquids, prolonged loose stool, or extended constipation. Our hope is that you will have a quick return to your life and usual activities. Thank you for allowing us to participate in your care! Followup Instructions: ___
10768526-DS-19
10,768,526
21,362,639
DS
19
2177-07-03 00:00:00
2177-07-03 17:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Left leg swelling Major Surgical or Invasive Procedure: none History of Present Illness: ___ w/ PMH of moderately severe RA (on etanercept), OA, HTN, peripheral neuropathy and other issues presented to the ED with a recently diagnosed extensive LLE DVT. The patient had a fall about 3 weeks ago and noted progressively increasing LLE swelling since then. He has had mild discomfort but no pain. The swelling persisted, so he his PCP in the office, and an ultrasound was obtained which showed an extensive LLE clot burden. PCP called the patient and advised him to go to the ED for vascular surgery evaluation given extensive clot burden. He denies weight loss, decreased appetite, night sweats, CP/SOB, DOE, or decreased activity tolerance. He has no FHx of bleeding or clotting disorders, and no recent periods of immobility or orthopedic surgery. His last colonoscopy was ___ years ago (3 polyps removed), he is ___ year overdo for his repeat colonoscopy. No changes in bowel habits, blood in stool, or melena. In the ED, initial VS were 99.5 71 123/85 18 100% RA. Labs were unremarkable with the exception of 14.9% monocytes on diff, and a grossly hemolyzed K 5.6 (3.7 on recheck). Venous dopplers showed extensive LLE clot burden: "Acute thrombus (partially occlusive) left common femoral and superficial femoral veins with Complete occlusion of left popliteal and tibial veins" (per verbal report, prelim read not available). Vascular surgery was consulted and recommended no surgical intervention. The patient was started on a heparin gtt, received acetaminophen, and was admitted. Vitals prior to transfer were: 98.6 61 151/86 18 100% RA. Upon arrival to the floor, patient felt well and had no complaints. REVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, pharyngitis, rhinorrhea, nasal congestion, cough, fevers, chills, sweats, weight loss, dyspnea, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, hematochezia, dysuria, rash, paresthesias, and weakness. Past Medical History: -Rheumatoid arthritis on Etanercept -Osteoarthritis -HTN -Peripheral neuropathy -Insomnia -Seasonal allergies -Lumbago Social History: ___ Family History: No FHx of bleeding or clotting disorders, no FHx of malignancy Physical Exam: ADMISSION PHYSICAL EXAM VITALS: 104.2 kg 97.8 139/88 69 18 99% RA GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP flat. CARDIAC: RRR, normal S1/S2, no murmurs PULMONARY: Clear to auscultation bilaterally, without wheezes or crackles. ABDOMEN: Slightly distended, normal bowel sounds, soft, non-tender. EXTREMITIES: Warm, well-perfused, 1+ pitting edema of LLE to knee. SKIN: Without rash. NEUROLOGIC: A&Ox3, grossly normal DISCHARGE PHYSICAL EXAM UNCHANGED Pertinent Results: ADMISSION LABS -------------- ___ 07:30PM BLOOD WBC-4.8 RBC-4.56* Hgb-14.0 Hct-41.3 MCV-91 MCH-30.7 MCHC-33.9 RDW-13.0 RDWSD-43.1 Plt ___ ___ 07:30PM BLOOD Neuts-52.7 ___ Monos-14.9* Eos-2.5 Baso-0.6 Im ___ AbsNeut-2.51 AbsLymp-1.39 AbsMono-0.71 AbsEos-0.12 AbsBaso-0.03 ___ 07:30PM BLOOD ___ PTT-27.6 ___ ___ 07:30PM BLOOD Glucose-91 UreaN-15 Creat-1.0 Na-136 K-5.6* Cl-100 HCO3-25 AnGap-17 ___ 05:49AM BLOOD Calcium-9.6 Phos-3.8 Mg-2.0 ___ 11:29PM BLOOD K-3.7 DISCHARGE LABS -------------- ___ 05:49AM BLOOD WBC-4.8 RBC-4.47* Hgb-13.6* Hct-40.9 MCV-92 MCH-30.4 MCHC-33.3 RDW-13.2 RDWSD-43.6 Plt ___ ___ 05:49AM BLOOD Neuts-31.4* ___ Monos-16.4* Eos-5.7 Baso-1.1* Im ___ AbsNeut-1.50* AbsLymp-2.15 AbsMono-0.78 AbsEos-0.27 AbsBaso-0.05 ___ 09:11AM BLOOD PTT-129.7* ___ 05:49AM BLOOD Glucose-82 UreaN-13 Creat-0.9 Na-141 K-4.0 Cl-103 HCO3-27 AnGap-15 IMAGING ------- BILATERAL LOWER EXTREMITY ULTRASOUND ___: REPORT NOT FINALIZED -NONOCCLUSIVE THROMBUS OF THE LEFT COMMON FEMORAL VEIN, FEMORAL VEIN -OCCLUSIVE THROMBUS OF THE LEFT POPLITEAL VEIN, POSTERIOR TIBIAL VEINS Brief Hospital Course: ___ w/ PMH of moderately severe RA (on etanercept), OA, HTN, peripheral neuropathy and other issues presented to the ED with a recently diagnosed extensive LLE DVT. #LEFT DVT: Appears unprovoked, though patient does have underlying inflammatory disorder (RA). There are no specific features of the history to suggest underlying malignancy. The patient was initially on a heparin drip and was transitioned to apixaban. He was counseled about bleeding risks and indications for return to medical attention. He will follow up ___ in vascular surgery clinic with Dr. ___. He will wear ACE bandages and elevate his leg at home. Total treatment duration is as yet undetermined, but at least 3 months are planned #Rheumatoid arthritis: He is followed by Dr. ___ and is on etanercept. #OA: Not currently an active issue. Continued home Tramadol #Hypertension: Continued home lisinopril 20 mg PO QD and HCTZ 50 mg PO QD TRANSITIONAL ISSUES: []follow up in clinic with Dr. ___ repeat ultrasound Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Enbrel (etanercept) 50 mg/mL (0.98 mL) subcutaneous 1X/WEEK 2. Albuterol Inhaler ___ PUFF IH Q6H:PRN sob 3. Fluticasone Propionate NASAL 2 SPRY NU BID 4. Hydrochlorothiazide 50 mg PO DAILY 5. Lisinopril 20 mg PO DAILY 6. Lidocaine Jelly 2% 1 Appl TP ASDIR 7. LORazepam ___ mg PO QHS:PRN insomnia 8. TraMADol 50 mg PO BID:PRN pain 9. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Apixaban 10 mg PO BID Duration: 7 Days RX *apixaban [Eliquis] 5 mg 2 tablet(s) by mouth twice daily Disp #*27 Tablet Refills:*0 2. Apixaban 5 mg PO BID Duration: 6 Months RX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth twice daily Disp #*90 Tablet Refills:*1 3. Albuterol Inhaler ___ PUFF IH Q6H:PRN sob 4. Fluticasone Propionate NASAL 2 SPRY NU BID 5. Hydrochlorothiazide 50 mg PO DAILY 6. Lisinopril 20 mg PO DAILY 7. LORazepam ___ mg PO QHS:PRN insomnia 8. Enbrel (etanercept) 50 mg/mL (0.98 mL) subcutaneous 1X/WEEK 9. Lidocaine Jelly 2% 1 Appl TP ASDIR 10. TraMADol 50 mg PO BID:PRN pain 11. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: #Deep vein thrombosis of the left leg #Rheumatoid arthritis #Hypertension #Peripheral neuropathy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, you were admitted because of a blood clot in your left leg. This may be due to your rheumatoid arthritis because inflammation is a risk factor for blood clots. Alternatively, it may be due to your recent injury to your leg. We will have you follow up in clinic with Dr. ___ Vascular ___ in 1 month. You should elevate your leg when you can and use an ACE bandage to compress the leg from the ankle to the thigh. The new medication for your blood clot is called "apixaban". -Take 2 pills twice daily for 7 days, then take 1 pill twice daily afterward (you will need ___ months of treatment) This medication raises the risk of bleeding. If you note bloody or black stools, please call your doctor or go to the ER immediately. Followup Instructions: ___
10768638-DS-21
10,768,638
28,665,403
DS
21
2158-01-10 00:00:00
2158-01-10 18:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Doxycycline / Latex / pineapple Attending: ___. Chief Complaint: asthma exacerbation, acute Major Surgical or Invasive Procedure: none History of Present Illness: ___ h/o asthma who experienced 2 weeks of worsened cough, dyspnea on exertion, nocturnal dyspnea that peaked at a severe level impairing her breathing even while sitting still yesterday. This worsened shortness of breath occurred in the context of lack of advair refill, tobacco smoke and cat allergens from her neighbors and spending time packing in her basement. She could barely breathe at home and her husband noted that she appeared pale so she presented to the ___ ED. She experienced some tightness across her chest and a dry cough. She did not have myalgias, fever or chills. In the ED she was tachycardic and her room air sat was 93%. She says she could barely speak and needed to text her history to the treating providers. She received IV solumedrol, magnesium, bronchodilators and a dose of prednisone 60mg. She denies pain currently. 13pt ROS is only notable for night sweats but is otherwise negative Past Medical History: Mild persistent asthma Migraine Allergic rhinitis Depression Low back pain Social History: ___ Family History: asthma in several relatives Physical ___: ADMISSION 98.2 102/62 HR 102 in bed, when she walked back from toilet her pulse was 122, room air sat 92%, then 96% on 2L aox3 not confused able to speak full sentences but reporting ___ dyspnea when sitting in bed and reporting history facial features and oropharynx symmetric lips dry regular tachycardic s1 and s2, soft early systolic murmur in RUSB c/w flow no s3 or s4 heard diffuse exp wheeze also with insp wheeze when she takes deep breath, no focal crackles soft abdomen, no palpable hepatomegaly no peripheral edema steady gait, all extremity movements are coordinated calm, fluent speech no visible rash to face or extremities no bruising DISCHARGE VS: 98.3 127/78 98 16 95%RA Gen: sitting up in bed, comfortable Eyes - EOMI ENT - OP clear, MMM Heart - RRR no mrg Lungs - mild expiratory wheezing bilaterally, moderate air movement; no crackles or ronchi Abd - soft nontender, normoactive bowel sounds Ext - no edema Skin - no rashes Vasc - 2+ DP/radial pulses Neuro - AOx3, moving all extremities Psych - appropriate Pertinent Results: CTA Chest - ___ - Significantly limited study secondary to patient motion/ coughing during the exam. No evidence of large central pulmonary embolism or aortic abnormality. No secondary signs of pulmonary embolism such as right heart strain or ___ hump. No lung parenchymal abnormality identified. CXR - ___ - Cardiomediastinal silhouette is within normal limits. There are no focal consolidations, pleural effusion, or pulmonary edema. There are no pneumothoraces. ADMISSION ___ 11:35PM BLOOD WBC-14.1*# RBC-5.02 Hgb-15.1 Hct-43.6 MCV-87 MCH-30.1 MCHC-34.6 RDW-13.0 RDWSD-40.5 Plt ___ ___ 11:35PM BLOOD Glucose-100 UreaN-10 Creat-0.8 Na-140 K-3.6 Cl-102 HCO3-25 AnGap-17 DISCHARGE ___ 05:15AM BLOOD WBC-14.8* RBC-4.35 Hgb-12.9 Hct-38.8 MCV-89 MCH-29.7 MCHC-33.2 RDW-13.1 RDWSD-42.7 Plt ___ ___ 05:15AM BLOOD Glucose-95 UreaN-18 Creat-0.7 Na-141 K-3.8 Cl-104 HCO3-25 AnGap-16 Brief Hospital Course: This is a ___ year old female with past medical history of mild persistent asthma with known triggers, admitted ___ with acute asthma exacerbation, on steroids, with slow response, now satting well on room air, ambulating comfortably with improved peak flow (to 300) requiring 6 day inpatient stay, now ready for discharge home to complete an additional 4 days of steroid pulse (total 10 days). # Mild Persistent Asthma with Acute Exacerbation / Seasonal allergies - admitted with tachypnea, cough and significant wheezing; patient reported recent exposure to environmental triggers including second hand smoke, cat hair, as well as unintentional interruption in her advair use; given failure to initially improve with steroids and trigger for tachypnea, she underwent at ___ that was a poor quality study but did not show signs of central pulmonary embolism or infiltrates; she was continued on PO prednisone, azithromycin, standing nebs with slow improvement; continued home advair, cetirizine; patient was discharged with prescription for 4 additional days of prednisone (total 10 day course), as well as limited course of benzonatate (reported symptomatic improvement with this). # GERD - continued home PPI Transitional issues - Discharged home - Patient declined influenza vaccine despite extensive counseling Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Epinephrine 1:1000 0.5 mg SC ONCE MR1 2. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 3. Omeprazole 20 mg PO DAILY 4. Cetirizine 10 mg PO DAILY 5. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN sob 6. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheeze Discharge Medications: 1. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN sob 3. Cetirizine 10 mg PO DAILY 4. Omeprazole 20 mg PO DAILY 5. PredniSONE 60 mg PO DAILY RX *prednisone 20 mg 3 tablet(s) by mouth once a day Disp #*12 Tablet Refills:*0 6. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheeze 7. Epinephrine 1:1000 0.5 mg SC ONCE MR1 8. Benzonatate 100 mg PO BID please do not operate heavy machinery while taking RX *benzonatate 100 mg 1 capsule(s) by mouth twice a day Disp #*8 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: # Mild Persistent Asthma with Acute Exacerbation # Seasonal Allergies Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___: It was a pleasure caring for you at ___. You were admitted for an asthma exacerbation. You were treated with antibiotics and steroids with slow improvement. You are now ready for discharge home. We recommend avoiding triggers for your asthma (cigarette smoke, cats, dust). We also recommend that you obtain a flu shot to help prevent future infection. Followup Instructions: ___
10769030-DS-6
10,769,030
21,539,481
DS
6
2168-08-14 00:00:00
2168-08-14 18:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal Pain Major Surgical or Invasive Procedure: None History of Present Illness: HPI: Ms. ___ is a ___ year old female with history of HTN, adult acne who presented to the ED with RUQ pain. THe patient about 2 months ago and earlier this month had been feeling intermittent sensations of epigastric burning, nonradiating, thought to be from what she thought was heartburn. She was taking ranitidine for this. She felt it was heartburn especially because her parents unfortunately passed away that time as well and was experiencing a lot of stress. She saw her PCP, ___ discovered abnormal LFTs and RUQ US was done on ___ that showed cholelithiasis. However, yesterday evening she ate a quiche at about 6PM, then at 8PM she noticed new acute onset of RUQ pain, different in characteristic from the previously thought heartburn sensation. She took Pepcid which did not help. She had associated nausea, but no vomiting. No fever, cough, SOB, diarrhea. Her last bowel movement was normal yesterday. At time of this interview she does not have any pain at rest, but does feel some She does not have a history of any prior abdominal or major surgery including C sections. ED: Found to have lipase ___ and Tbili 1.6, Dbili 1.1, AST 547, AST 518, ALP 165. Abdominal US was done showing cholelithiasis without findings of acute cholecystitis. Given zosyn, spironolactone, ranitidine, 1L NS Past Medical History: - Adult Acne - HTN - Cholelithiasis Social History: ___ Family History: Sister Living ___ HYPERTENSION BASAL CELL CARCINOMA Mother deceased ___ HYPERTENSION GLAUCOMA ANOMALOUS PULMONARY VENOUS RETURN WITH SHUNTING VASCULAR DEMENTIA SUBAORTIC WEBBING AORTIC VALVULAR DISEASE Father ___ ___ CORONARY ARTERY DISEASE PROSTATE CANCER NORMAL PRESSURE HYDROCEPHALUS Brother Living ___ HYPERTENSION Brother Living ___ ANAL CANCER Physical Exam: VITALS: Afebrile and vital signs stable GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. CV: Heart regular, no murmur RESP: Lungs clear to auscultation with good air movement bilaterally GI: Abdomen soft, non-distended, non-tender to palpation except in RUQ with deep palpation there is focal discomfort. BS present GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities PSYCH: pleasant, appropriate affect NEUROLOGIC: MENTATION: alert and cooperative. Oriented to person and place and time. Pertinent Results: AST: 518 --> 1037 ALT: 547 --> 474 Alk Phos: 165 --> 212 Lipase on admission: ___ WBC: 10.5 --> 4.1 Hgb: 14.1 --> 13.6 Brief Hospital Course: #Suspected passed CBD stone/choledocholithiasis #Cholelithiasis #Gallstone pancreatitis -Elevated lipase suggests inflammation of pancreas likely related to a potentially passed gallstone. No ongoing pain now or evidence of SIRS at time of admission or discharge. Elevated LFTs most likely from passed stone and without symptoms at this time will not keep patient here. Discussed that patient should follow with primary care provider to get her LFTs rechecked this week to ensure downtrend. If uptrending she should return to the hospital at htat time. Patient did received 1 dose of Zosyn in ED, this was held after admission. ___ surgery was consulted while patient inpatient for possible cholecystectomy, but was not able to get a booking on the day of discharge. Patient feels well at this time so will d/c home with close followup from me (___) and Dr. ___ ___ timing of surgery in near future. At time of discharge patient was told she should return if she has return of symptoms/fevers/chills etc... Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Spironolactone 200 mg PO DAILY 2. Prempro (conj estrog-medroxyprogest ace) 0.3-1.5 mg oral DAILY 3. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315-250 mg-unit oral DAILY 4. minoxidil 2 % topical DAILY 5. Ranitidine 75 mg PO BID Discharge Medications: 1. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315-250 mg-unit oral DAILY 2. minoxidil 2 % topical DAILY 3. Prempro (conj estrog-medroxyprogest ace) 0.3-1.5 mg oral DAILY 4. Ranitidine 75 mg PO BID 5. Spironolactone 200 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Gallstone pancreatitis and cholecystitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to ___ with gallstone pancreatitis and also gall stone cholecystitis. Your labs were with very elevated lipase and LFTs. Due to your not having many symptoms and imaging without evidence of a blockage at this time, it was discussed that removal of your gall bladder is the best course of action at this time. Followup Instructions: ___
10769032-DS-10
10,769,032
22,531,963
DS
10
2171-10-05 00:00:00
2171-10-08 18:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Facial fractures Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old male with no known past medical history presents to ___ ED after sustaining a blow to the right jaw during rugby plan one week ago (last ___. Patient denies loss of consciousness, head strike, or down time. Patient had some swelling of jaw which resolved but pain has continued. He has some right lower lip paresthesia but is otherwise sensate and neuro-intact. He constituted a liquid and semi-soft diet initially with improvement of pain but was convinced to come to ___ ED by college friend tonight. Patient has non displaced R mandibular body fx and L mandibular angle fx seen on CT sinus/max/mandible and was seen by OMFS with operative plan. Request for ACS consult for ___ admission. Patient denies other symptoms. No head aches or evidence of head injury, no nose bleeds, ear bleeds, or oral bleeds, no injury to tongue. Patient denies fevers, chills, night sweats. No chest pain, shortness of breath, trouble breathing or managing secretions. No change in bowel habits. No dysuria or hematuria. No abdominal pain. No ___ swelling or MSK pain. Patient is otherwise healthy. Past Medical History: Childhood cardiac murmur w/o treatment or further f/u Social History: ___ Family History: NC Physical Exam: VS: 97.2 63 140/67 20 100% RA Gen: AAOx3, affable, white young male, NAD Neuro: PERRLA, EOMI, CN2-12 intact HEENT: no maxillary ttp, head atraumatic, no hematympanium, right mandibular ttp, minimal malocclusion right jaw, no evidence of oral trauma or other external injury CV: RRR no MRG, split S2 Pulm: CTAB No adventitious breath sounds Abd: Soft nttp no guarding or rebound Ext: distal pulses, UE and ___ ___ strength, no evidence of injury Chest: no sternal or chest wall ttp no evidence of injury Brief Hospital Course: The patient presented to the emergency department and was evaluated by the Acute Care Surgery Team. The patient was found to have R mandibular body fx and L mandibular angle fx and was admitted to the Acute Care Surgery Team for operative treatment by ___. On HD1 it was determined by ___ that the patient should follow-up outpatient on ___ 8:30am, ___ ___ outpatient operative intervention. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient will follow up with ___ 8:30am, ___ ___. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: None Discharge Medications: 1. Chlorhexidine Gluconate 0.12% Oral Rinse 15 mL ORAL BID RX *chlorhexidine gluconate [Peridex] 0.12 % Oral Rinse 15mL twice a day Refills:*0 2. Acetaminophen 650 mg PO Q6H:PRN pain 3. Cephalexin 500 mg PO QID RX *cephalexin 500 mg 1 capsule(s) by mouth four times a day Disp #*8 Capsule Refills:*0 4. OxycoDONE Liquid 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg/5 mL 5 ml by mouth q4hrs Refills:*0 Discharge Disposition: Home Discharge Diagnosis: R mandibular body fx and L mandibular angle fx Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___: You were admitted to the hospital for your mandibular fractures. You will follow up on ___ 8:30am, ___ ___ at: ___ First Floor, ___ Until then please continue a: -Full Liquid diet -Keflex ___ qid -Peridex BID 15ml swish and spit Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid lifting weights greater than ___ lbs until you follow-up with your surgeon. Avoid driving or operating heavy machinery while taking pain medications. Followup Instructions: ___
10769115-DS-15
10,769,115
28,192,020
DS
15
2157-05-07 00:00:00
2157-05-07 16:16:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Lipitor Attending: ___ Chief Complaint: chest pain Major Surgical or Invasive Procedure: ___ Cardiac cath History of Present Illness: ___ with history of nonischemic cardiomyopathy, myocardial bridge across mid LAD, DM, HLD, presenting with chest pain. Woke up at ___ this AM with severe ___ substernal pressure associated with nausea and numbness in his right arm. Lasted about a half hour and then subsided. Since then has had some residual ___ pain in the area. Took a full dose aspirin at home. Says he has never had this type of pain before. No change with position or activity. Has been feeling lightheaded for the last week. Denies any recent changes in meds, diets, or lifestyle. Last Cath was in ___ showing myocardial bridge with 50% compression of LAD during systole. No other CAD evident. Last Echo in ___ showed EF 45%, LV systolic dysfunction unchanged from prior. In the ED, initial vitals were: 96.8 58 161/94 18 100% RA - Labs were significant for trop <0.01, ProBNP 135 - The patient was given Nitro SL x 2 for chest pain while in the ED Upon arrival to the floor, he states he only has a faint feeling of pain, and that the nitro helped his pain. Past Medical History: IDIOPATHIC DILATED CARDIOMYOPATHY ___ DIABETES TYPE II HYPERCHOLESTEROLEMIA CHRONIC RIGHT LOW BACK PAIN BETA THALASSEMIA TRAIT HYPERTENSION Social History: ___ Family History: Extensive CAD in father, died age ___, siblings (also premature in father and cousins) Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 53 125/53 18 100% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: bradycardic, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation DISCHARGE PHYSICAL EXAM: Vitals: 98.1 ___ 42-65 ___ 98-100% General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: Supple, JVP not elevated, no LAD CV: bradycardic, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation Pertinent Results: ADMISSION LABS: ___ 03:00AM BLOOD WBC-8.8 RBC-5.97 Hgb-13.0* Hct-42.0 MCV-70* MCH-21.8* MCHC-31.0* RDW-18.6* RDWSD-42.5 Plt ___ ___ 03:00AM BLOOD Neuts-43.4 ___ Monos-12.0 Eos-3.9 Baso-0.9 Im ___ AbsNeut-3.80 AbsLymp-3.43 AbsMono-1.05* AbsEos-0.34 AbsBaso-0.08 ___ 03:00AM BLOOD Glucose-130* UreaN-29* Creat-1.3* Na-139 K-4.3 Cl-101 HCO3-27 AnGap-15 ___ 03:00AM BLOOD Calcium-9.7 Phos-3.9 Mg-2.1 PERTINENT LABS: ___ 03:00AM BLOOD cTropnT-<0.01 ___ 10:15AM BLOOD cTropnT-<0.01 DISCHARGE LABS: ___ 06:44AM BLOOD Glucose-125* UreaN-21* Creat-0.8 Na-138 K-4.6 Cl-103 HCO3-25 AnGap-15 STUDIES: ECG: Sinus bradycardia with LBBB. CXR: No acute cardiopulmonary process. Stable mild cardiomegaly. CARDIAC CATH ___: Anatomy: Dominance: RIght LMCA: Long with mild luminal irregularities LAD: Minimal luminal irregularities. Diffuse segment of the mid LAD was intramyocardial with systolic compression/milking; there is slow flow into distal LAD. The LAD also supplied a branching diagonal. LCx: The AV groove CX gave off 2 very high large OM branches (functioning like a ramus intermedius). The true AV groove CX had mild plaquing and supplied 3 small short OM branches, a modest sized OM6, and 2 long LPLs (both with mild plaquing). Flow in the CX system was slow and pulsatile, consistent with microvascular dysfunction. RCA: Somewhat vertical take-off with a mild near-ostial angulated plaque. The mid RCA had mild plaquing, with slow, somewhat pulsatile flow consistent with microvascular dysfunction. The RPDA and RPL1 were long vessels; RPL2 was shorter, and RPL3 was even shorter still. Impressions: 1. No angiographically-apparent flow-limiting CAD, although scattered atherosclerosis and diffuse slow flow consistent with microvascular dysfcuntion were readily evident. 2. Intramyocardial bridging of the mid LAD with dynamic systolic compression. 3. Moderate LV diastolic heart failure (most likely acute on chronic) in the setting of mild LV systolic dysfunction. Brief Hospital Course: ___ with history of nonischemic cardiomyopathy, myocardial bridge across mid LAD, DM, HLD, presenting with chest pain. #Chest pain: Patient with h/o myocardial bridge and long history of chest pain. IN house this was responsive to nitroglycerin sublingual. He underwent cardiac cath which showed no significant CAD. He was started on imdur given possible cardiac etiology via spasm vs myocardial bridge. ___: On admission Cr 1.3 from baseline around 0.8. Cardiac cath showed elevated LVEDP and he received IV lasix. Lisinopril held and not restarted given that he was normotensive on imdur as above. Cr returned to normal. #Nonischemic Cardiomyopathy: Lisinopril held for ___ and not restarted prior to discharge. Carvedilol and ASA continued. #HLD: Simvastatin continued. #DM2: Metformin held, continued on sliding scale insulin in house. #Anemia: Chronic, from Thalassemia trait. H/H at baseline. # CODE STATUS: Full # CONTACT: ___ Relationship: wife Phone number: ___ # TRANSITIONAL ISSUES: -Patient started on imdur 30 mg daily given CP responsive to nitro -Carvedilol decreased from 12.5 mg bid to 6.25 mg bid; consider adjusting as tolerated given patient's bradycardia to ___ and symptoms of dizziness -Lisinopril held for ___ and not restarted as BPs adequate after starting imdur; consider restarting if needed Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 30 mg PO DAILY 2. Carvedilol 12.5 mg PO BID 3. MetFORMIN XR (Glucophage XR) 1000 mg PO DAILY 4. Simvastatin 40 mg PO QPM 5. Aspirin 81 mg PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Simvastatin 40 mg PO QPM 3. Carvedilol 6.25 mg PO BID RX *carvedilol 6.25 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 4. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. MetFORMIN XR (Glucophage XR) 1000 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary Chest pain Secondary Acute kidney injury Nonischemic cardiomyopathy Hyperlipidemia Type 2 diabetes Anemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital because you had chest pain. In the hospital this improved with nitroglycerin. You had blood tests that did not show any damage to your heart, and your EKG was normal. You had a cardiac cath procedure which showed that one of your coronary arteries dips into the heart muscle, as was previously known, but no coronary artery disease. Although it is not clear what caused your chest pain, it is possible that it was caused by a spasm of a blood vessel. We are starting a medication called imdur (isosorbide mononitrate) that can help with this. We have also stopped your lisinopril; please follow up with Dr. ___ when to restart this. The dizziness that you had is likely unrelated to your chest pain. You did have a very slow heart rate, 40-50 beats per minute, that may explain your dizziness. We decreased your carvedilol which should allow your heart rate to be higher. Please follow up with your outpatient cardiologist. It was a pleasure taking care of you during your stay in the hospital. Very best wishes, Your ___ Team Followup Instructions: ___
10769137-DS-19
10,769,137
22,740,463
DS
19
2169-07-17 00:00:00
2169-07-22 14:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Headache Major Surgical or Invasive Procedure: None History of Present Illness: ___ is a ___ year-old female who presents with headache and SAH. 6 weeks prior, she gave birth to her second child. She has been taking care of her ___ year old and 6 week old, so was feeling very tired. She decided to take 40 mg of Adderall, which she is not prescribed but occasionally takes 30- 60 mg). After which, around 7 pm, her heart started racing and she began to have a headache. She describes her headache as "finger slammed in door" " throbbing" "wanted to break head open like an egg" lots of pressure". The location is bifrontal to vertex to neck. She tried ibuprofen 600 mg x1 without relief and Xanax 0.25 mgx 1 for her anxiety. Pain was so terrible, she couldn't open eyes, so she went to the ED. Her headache resolved ~11 pm, when was given morphine and other medications. At ___, a ___ was done and revealed a SAH at parietal vertex, so she was transferred for neurosurgical eval. Since transfer, she has had intermittent headache, resolved with pain medication. Her head mostly feels sore now, and is worse with sitting up, but not when walking; no nausea/ photophobia/phonophobia. She does not usually have headache. Past Medical History: s/p C-Section Social History: ___ Family History: Grandfather lung cancer, Uncle leukemia, Grandmother aortic aneurysm rupture. HTN Physical Exam: ADMISSION EXAM: General: Awake, cooperative, NAD. HEENT: NC/AT, no scleral icterus, MMM, no lesions noted in oropharynx Neck: Supple, no carotid bruits. Pulmonary: CTABL. No R/R/W Cardiac: RRR, nl. S1S2, no M/R/G Abdomen: soft, NT/ND, +BS, no masses or organomegaly noted. Extremities: No C/C/E bilaterally Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, able to name ___ backward without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. Pt was able to register 3 objects and recall ___ at 5 minutes. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 3 to 2mm and brisk. EOMI without nystagmus. Normal saccades. VFF to confrontation. Unable to fully visualize fundus b/l. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 Plantar response was flexor bilaterally. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Able to walk in tandem without difficulty. Romberg absent. DISCHARGE EXAM: Exam remains non focal without weakness, numbness. Afebrile. No meningismus. trigger point in the left greater occipital nerve exit point. Pertinent Results: ___ 03:15AM WBC-9.4 RBC-4.49 HGB-12.9 HCT-38.9 MCV-87 MCH-28.7 MCHC-33.2 RDW-12.6 RDWSD-39.4 ___ 03:15AM PLT COUNT-299 ___ 03:15AM NEUTS-80.1* LYMPHS-15.1* MONOS-4.1* EOS-0.0* BASOS-0.4 IM ___ AbsNeut-7.51* AbsLymp-1.42 AbsMono-0.38 AbsEos-0.00* AbsBaso-0.04 ___ 03:15AM ___ PTT-33.8 ___ ___ 03:15AM GLUCOSE-108* UREA N-15 CREAT-0.9 SODIUM-139 POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-22 ANION GAP-17 ___ 03:15AM ALT(SGPT)-85* AST(SGOT)-51* ALK PHOS-139* TOT BILI-0.2 ___ 03:15AM ASA-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG CTA Head/Neck (___): 1. Small amount of right frontal vertex subarachnoid hemorrhage at the vertex with slight increased vascularity, which is likely reactive in nature. Trace associated gyral hypodensity. 2. Short-segment right vertebral dissection within the transverse foramen of C1, with a patent distal right vertebral artery. 3. No evidence of aneurysm or AV malformation. 4. There is a 3 mm right upper lobe pulmonary nodule. If the patient has no known risk factors, no further follow-up is advised by ___ criteria. Otherwise, ___hest followup is recommended. MRI Head (___): 1. Re-demonstrated is right frontal convexity subarachnoid hemorrhage with some redistribution into the cerebral aqueduct and fourth ventricle. 2. No acute intracranial infarct is seen. CTA Head/Neck (___): 1. Stable small right frontal vertex subarachnoid hemorrhage. 2. Short segment right vertebral artery dissection in the transverse foramen of C1 with patent distal right vertebral artery. 3. Probable short segment dissection involving the left vertebral artery just proximal to the origin of left posterior inferior cerebellar artery with patent distal artery. 4. No aneurysm or AV malformation. 5. 3 mm right upper lobe pulmonary nodule for which no further follow-up is advised by the ___ criteria in case of no known risk factors. If the patient has known risk factors then ___ year follow-up with chest CT is recommended. Brief Hospital Course: Mrs. ___ was admitted to the ___ Stroke service on ___ after presenting at an OSH ED for severe headache and noted to have a subarachnoid hemorrhage. She was transferred to ___ for further management. Repeat CTA Head/Neck demonstrated a small amount of right frontal vertex subarachnoid hemorrhage at the vertex with slight increased vascularity, which is likely reactive in nature. There was trace associated gyral hypodensity. She was also noted to have a short-segment right vertebral dissection within the transverse foramen of C1, with a patent distal right vertebral artery. There was no evidence of aneurysm or AV malformation. Neurosurgery was consulted and did not recommend surgical intervention. Basic labs upon admission including CBC, Chem, Coags, and Utox were unremarkable. She was admitted to the stroke service for observation and treatment of headache. Patient was started on Verapamil 40 mg TID which was subsequently increased to 80 mg TID the following day due to ongoing headache. Mrs. ___ used Fioricet and Oxycodone q6h PRN for pain. Her pain was well controlled on this regimen. MRI was performed to reevaluate her SAH and assess for any intracranial pathology associated with her R vertebral dissections. MRI re-demonstrated right frontal convexity subarachnoid hemorrhage with some redistribution into the cerebral aqueduct and fourth ventricle, unchanged from previous CTA. Prior to discharge one more image was taken due to ongoing complaints of L sided neck pain. Initial wet read of the image showed stable findings as compared to previous images. Patient's neck pain showed improvement with heat, therefore, this was felt to be likely musculoskeletal in origin. She was felt to be stable for discharge home with Fioricet as needed for HA and Valium as needed for neck pain. TRANSITIONAL ISSUES: -CTA Head/Neck was also notable for a 3 mm right upper lobe pulmonary nodule. It was advised that if the patient has no known risk factors, no further follow-up is advised by ___ criteria. Otherwise, ___hest followup is recommended. Addenedum: At the time this discharge summary was written (___), final read of CTA Head/Neck from ___ was reviewed and final read notes: Stable small right frontal vertex subarachnoid hemorrhage. Short segment right vertebral artery dissection in the transverse foramen of C1 with patent distal right vertebral artery and probable short segment dissection involving the left vertebral artery just proximal to the origin of left posterior inferior cerebellar artery with patent distal artery. There was not notable aneurysm or AV malformation. This new finding was reviewed by myself and the attending physician who were in agreement with the read. Patient is to be contacted by attending to determine further evaluation and potential initiation of ASA. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Prenatal Vitamins 1 TAB PO DAILY Discharge Medications: 1. Acetaminophen-Caff-Butalbital ___ TAB PO Q6H:PRN headache RX *butalbital-acetaminophen-caff 50 mg-325 mg-40 mg ___ capsule(s) by mouth every 6 hours Disp #*30 Capsule Refills:*1 2. Prenatal Vitamins 1 TAB PO DAILY 3. Verapamil SR 240 mg PO Q24H RX *verapamil 240 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 4. Diazepam 5 mg PO Q8H:PRN neck spasm/pain RX *diazepam 5 mg 1 tablet(s) by mouth every eight (8) hours Disp #*10 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Subarachnoid Hemorrhage Reversible Cerebral Vasoconstrictive Syndrome Right/Left Vertebral Dissection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ were admitted to the ___ Neurology service for symptoms of severe headache due to subarachnoid hemorrhage, related to reversible cerebral vasoconstriction syndrome (___). ___ were also noted to have an incidental right vertebral dissection noted on your CT scan, but we do not feel this was related to your presenting symptoms. ___ were started the following medications: 1. Verapamil - to prevent your headaches 2. Fioricet - to treat the current headache ___ can take Valium 5mg at home if your neck pain continues. Followup Instructions: ___
10769306-DS-17
10,769,306
20,349,567
DS
17
2182-10-11 00:00:00
2182-10-14 10:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Weakness Major Surgical or Invasive Procedure: lumbar puncture History of Present Illness: Patient is a ___ year-old right-handed woman with no significant past medical history presenting for evaluation of weakness and numbness. Symptoms started a week ago with numbness, tingling and hyperesthesia over the dorsal aspect of her left forearm. This was accompanied by numbness and tingling in her ___ and ___ finger on the left. A couple days later, she developed numbness over the entirety of her RLE. She also noticed around that time that her left leg seemed to be 'jerky' at night. She has had this before but never to the extent or as persistently as she does currently. The movement would be preceded by a sense of needing to move her leg, and she would feel better after moving her leg. Then, a couple of days ago, she noticed that her left hand felt weak. She noticed herself dropping things. She also had onset of weakness in her left leg around the same time and noticed that her left leg seemed to be dragging. Around the same time, the abnormal sensation in her left ___ and ___ fingers transitioned to a burning sensation. She saw her PCP 3 days ago and had labs done then, including negative HIV, normal B12 and folate, NR syphilis, A1c 5.1. Chlamydia and gonorrhea pending. Lyme ab + (2.12, ref range < 1.0) with Western blot pending. She saw a neurologist at ___ today who was concerned for a central process based on hyperreflexia and an upgoing toe on the left. She was referred to the BI ED for further evaluation and management. She has otherwise been well with no headache, no dizziness, no visual changes, no difficulty speaking or swallowing, no difficulty urinating or stooling although she has not had a bowel movement in a couple of days and would normally stool every day, no fever, no URI symptoms, no nausea, no vomiting, no diarrhea, no rash, no joint aches. She did have sharp pains over her lower ribs on the right a couple nights ago that resolved by morning, otherwise no back or other pain. She has not had similar symptoms in the past. Review of Systems: Negative except as per HPI. Past Medical History: Depression Anxiety Social History: ___ Family History: Dad with Type ___ DM. Maternal aunt with ___. Mom with restless legs. Physical Exam: Examination: Head and face: Normal head shape, no dysmorphic features. Eyes: No conjunctival injection, pupils equal, round and reactive to light. Ears, nose, mouth and throat: Nasal mucosa not inflamed. Lips, teeth and gums without lesions. Palate intact, posterior pharynx without exudate. Neck: Appeared normal, no meningismus. Respiratory: Breathing comfortably. Cardiovascular: Normal rate. Gastrointestinal: Non-distended. Musculoskeletal: Back and spine showed no abnormalities, FROM. Skin: No noted rash or induration. Neurological exam: Mental Status: alert and active. Orientation: oriented to person, place and date. Language: Speech assessment revealed fluent, articulate speech without paraphasic errors. Follows commands. She had a normal fund of knowledge. Attention: Listened carefully to my questions and answered without requiring repetition or clarification. Cranial nerves: Pupils equal, round and reactive. Visual fields intact to confrontation. Extra-ocular movements intact with conjugate gaze and good tracking of objects. Facial sensation and strength normal and symmetric. Palate raised symmetrically in the midline. Sternocleidomastoid and trapezius strong bilaterally. Tongue protruded in the midline with no evidence of atrophy or fasciculation. Motor: Normal bulk and tone. No pronation or drift. No adventitious movements. D T B WE WF FE FF IP Q H TA G L ___ ___ 4* 5- 5- 4+ 5- 5- R ___ ___ ___ ___ * Most prominent in ___ and ___ digits. Deep tendon reflexes: 2+ but brisker on the left than on the right, especially at patella. Sustained clonus at left ankle, none at rigth. Left toe up, right toe down. Sensory: Intact to light touch, joint position, and vibration. Decreased temperature over anterior aspect of right lower extremity. Decreased pin over anterior surface of right lower extremity and dorsal and plantar surface of right foot. Coordination: Finger-nose-finger and heel-to-shin movements normal. No truncal ataxia. Gait: Mild left leg circumduction. Normal based and able to perform toe, heel and tandem gait but movements were not as robust on left as compared to right. Pertinent Results: ___ 06:20AM BLOOD WBC-11.3* RBC-4.25 Hgb-12.9 Hct-35.4* MCV-83 MCH-30.3 MCHC-36.4* RDW-13.5 Plt ___ ___ 09:52AM BLOOD Neuts-82.5* Lymphs-13.8* Monos-3.3 Eos-0.3 Baso-0.1 ___ 06:20AM BLOOD ___ PTT-28.6 ___ ___ 06:20AM BLOOD Glucose-100 UreaN-16 Creat-0.6 Na-143 K-4.7 Cl-106 HCO3-30 AnGap-12 ___ 11:05AM BLOOD ALT-18 AST-24 AlkPhos-62 TotBili-0.4 ___ 06:20AM BLOOD Calcium-9.1 Phos-3.8 Mg-2.4 ___ 01:00PM BLOOD Homocys-PND ___ 01:20PM BLOOD TSH-2.1 ___ 01:00PM BLOOD 25VitD-17* ___ 01:20PM BLOOD ANCA-NEGATIVE B ___ 01:20PM BLOOD ___ dsDNA-NEGATIVE ___ 01:20PM BLOOD RheuFac-5 CRP-1.3 ___ 01:20PM BLOOD C3-112 C4-21 ___ 11:05AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG Brief Hospital Course: Otherwise healthy ___ F presents w subacute bilateral sensory alteration and left sided weakness. MRI shows enhancing incomplete transverse myelitis at C6. Visual evoked potentials negative. MRI brain shows "nonspecific subtle FLAIR hyperintensity in the right periventricular white matter" - unclear significance. Treated with IV methylprednisone 1000mg x5 days. Exam on discharge stable. Also found to have slightly enlarged paratrachial LN on CT torso. Taken for bx with interventional pulm. Bx results pending. LP done. CSF results negative (including bands), though ACE and NMO Abs remain pending at time of d/c. Vitamin D deficiency - started on vitamin D 50,000 qWeek x8 weeks, followed by daily dose. HR to 30's while sleeping- EKG with sinus rhythm, QTc 411. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. LaMOTrigine 100 mg PO DAILY 2. Escitalopram Oxalate 20 mg PO DAILY Discharge Medications: 1. Escitalopram Oxalate 20 mg PO DAILY 2. LaMOTrigine 100 mg PO DAILY 3. Vitamin D 50,000 UNIT PO 1X/WEEK (FR) Duration: 8 Weeks RX *ergocalciferol (vitamin D2) 50,000 unit 1 capsule(s) by mouth ___ Disp #*7 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary: transverse myelitis, vitamin D deficiency Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted for symptoms of left sided weakness and bilateral sensory disturbances. We believe that your symptoms are the result of an inflammatory lesion in your spinal cord - called transverse myelitis. We are treating this inflammation with high dose IV steroids and expect you to have complete or near-complete recovery over the next several weeks. You will need to have an echocardiogram as an outpatient due to an unclear finding during an ultrasound of your lymph nodes. Please coordinate with your PCP. It was a pleasure taking care of you. ___ Neurology Dear Ms. ___, You were admitted for symptoms of left sided weakness and bilateral sensory disturbances. We believe that your symptoms are the result of an inflammatory lesion in your spinal cord - called transverse myelitis. We are treating this inflammation with high dose IV steroids and expect you to have complete or near-complete recovery over the next several weeks. You will need to have an echocardiogram as an outpatient due to an unclear finding during an ultrasound of your lymph nodes. Please coordinate with your PCP. It was a pleasure taking care of you. ___ Neurology Followup Instructions: ___
10769306-DS-18
10,769,306
27,076,206
DS
18
2182-11-07 00:00:00
2182-11-11 09:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Spinal Lesion on MRI Major Surgical or Invasive Procedure: Lumbar Puncture History of Present Illness: Ms. ___ is a ___ year old right-handed woman followed by ___ for her recently found enlarging, enhancing left sided C5-C7 cord lesion. Per her history, her symptoms began on ___, when she noticed acute onset numbness/paresthsias on the dorsal medial side of the left forearm. She noted that the dorsal forearm was very sensitive to touch at that point, but denied weakness. She presented to urgent care, where she was diagnosed with L ulnar neuropathy; however, the next day, she then noticed that her entire right leg had numbness and paresthesias. On ___, she noted that her left leg would feel restless at nighttime, such that she would have to move it to make it feel better. On ___, she started noticing that the dorsal surface of her L ___ and ___ fingers were becoming particularly painful and the L hand feels weak. She started dropping things, like her cup and her comb. She also noted that her left leg started dragging, although no falls occured. The patient confirmed to Dr. ___ myself that she has had no prior episodes of diplopia, optic neuritis, dysphagia, dysarthria, other episodes of previous neurologic symptoms. Denies bowel/bladder issues. No recent viral infections, immunizations, URIs, rashes. Dr. ___ the patient on ___, and given concern for a L cervical hemicord lesion advised her to present to the ___ ED. She was admitted to ___ from ___. MRI brain C/T spine (images reviewed) demonstrated a T2 hyperintense, enhancing lesion within the left-sided aspect of the spinal cord at C5-6 to C6-7, most likely due to demyelinating disease, and a nonspecific subtle FLAIR hyperintensity in the right periventricular white matter. LP performed demonstrated WBC 1, TP 20, glu 64, LDH 15, OCB neg (1 band). ACE 58 (nl) NMO neg. ___, ESR 2. VEPs were negative. She was diagnosed with vitamin D deficiency, and started on vitamin D 50,000 qWeek x8 weeks, followed by daily dose. IV methylprednisone 1000mg x5 days helped improve her symptoms; paratrachial lymph node incidentally seen on imaging underwent biopsy was negative for malignant cells. Other labs of note from ___: HIV neg, Lyme Western blot neg, B12 303, folate 18.5, RPR NR Follow-up on ___ revealed significant improvement; however, her numbness had spread up the arm and into the right hand, which subsequently stabilized. Per Dr. ___, "She did complain of some feelings of restlessness in her right leg, so her iron studies were checked and I did prescribe some PRN pramipexole. Overall, except for a feeling in her R leg "like I'm sitting on a vibrating cell phone", she reports stability of her weakness and sensory changes since her visit on ___. However, because of the possibility of neoplasm, and because her exam had progressed since I first saw her on ___, we obtained repeat MRI C-spine on ___, which demonstrated an interval increase in the intramedullary lesion in C5-C7, now crossing the midline involving a majority of the cord with sparing of the far right lateral aspect of the cord, with an increase in enhancement, and cord expansion. On neuro ROS, the pt denies headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, vertigo, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. No bowel or bladder incontinence or retention. Denies difficulty with gait. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: - Depression - Anxiety - Iron deficiency anemia - Asymptomatic bradycardia (hr in ___ noted on last admission - Paratrachial lymph node incidentally seen on imaging underwent biopsy was negative for malignant cells Social History: ___ Family History: - Mother with ___ - Father with DM2 - ___ and PGF - melanoma - Grandmother with PD - Aunt with ___ Physical Exam: # Admission Exam # T=99.1F, HR=73, BP=126/70, RR=18, SaO2=98% RA General: Awake, cooperative, NAD. HEENT: NC/AT Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: CTABL Cardiac: RRR, no murmurs Abdomen: soft, nontender, nondistended Extremities: no edema, pulses palpated Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. Attentive, with good knowledge of current events. There was no evidence of apraxia or neglect. -Cranial Nerves: I: Olfaction not tested. II: PERRL 4 to 2mm, both directly and consentually; brisk bilaterally. VFF to confrontation. III, IV, VI: EOMI with extinguishing end gaze nystagmus (few beats bilaterally). Normal saccades. V: Facial sensation intact to light touch, pinprick in all distributions, and ___ strength noted bilateral in masseter VII: No facial droop, facial musculature symmetric and ___ strength in upper and lower distributions, bilaterally VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline, and is equal ___ strength bilaterally as evidenced by tongue-in-cheek testing. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L ___ 5 5* ___ ___ 5 5 5 R ___ ___ ___ 5 5 5 5 5 * weakness noted in flexor carpi ulnaris ___ compared to flexor carpi radialis -DTRs: Bi Tri ___ Pat Ach L 3 3 3 3 2 R 2 2 2 2 1 - Plantar response was flexor on right, extensor majestically on left. - Pectoralis Jerk and Crossed Adductors were present on the left. -Sensory: Deficits pinprick noted in patchy distribution along the , cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Romberg absent. # Discharge Exam # - Unchanged Pertinent Results: ___ 05:35PM BLOOD WBC-7.8 RBC-4.43 Hgb-13.7 Hct-36.2 MCV-82 MCH-30.8 MCHC-37.7* RDW-13.7 Plt ___ ___ 06:15AM BLOOD WBC-6.1 RBC-4.48 Hgb-13.2 Hct-36.9 MCV-82 MCH-29.5 MCHC-35.9* RDW-13.7 Plt ___ ___ 06:36AM BLOOD WBC-6.0 RBC-4.59 Hgb-13.5 Hct-38.1 MCV-83 MCH-29.5 MCHC-35.5* RDW-13.7 Plt ___ ___ 06:55AM BLOOD WBC-8.3 RBC-4.69 Hgb-13.9 Hct-38.9 MCV-83 MCH-29.6 MCHC-35.7* RDW-13.5 Plt ___ ___ 05:35PM BLOOD Neuts-54.7 ___ Monos-6.1 Eos-1.9 Baso-0.3 ___ 05:35PM BLOOD ___ PTT-33.2 ___ ___ 05:35PM BLOOD Plt ___ ___ 06:15AM BLOOD ___ PTT-33.1 ___ ___ 06:15AM BLOOD Plt ___ ___ 06:36AM BLOOD ___ PTT-31.8 ___ ___ 06:36AM BLOOD Plt ___ ___ 06:55AM BLOOD ___ PTT-34.5 ___ ___ 05:35PM BLOOD Glucose-95 UreaN-17 Creat-0.7 Na-138 K-3.9 Cl-103 HCO3-30 AnGap-9 ___ 06:15AM BLOOD Glucose-86 UreaN-14 Creat-0.7 Na-139 K-4.4 Cl-104 HCO3-26 AnGap-13 ___ 06:36AM BLOOD Glucose-94 UreaN-11 Creat-0.7 Na-140 K-4.3 Cl-104 HCO3-26 AnGap-14 ___ 06:55AM BLOOD Glucose-95 UreaN-10 Creat-0.6 Na-138 K-3.8 Cl-103 HCO3-24 AnGap-15 ___ 06:15AM BLOOD ALT-17 AST-17 LD(LDH)-234 AlkPhos-58 TotBili-0.3 ___ 05:35PM BLOOD Calcium-9.5 Phos-3.9 Mg-2.0 ___ 06:15AM BLOOD Albumin-4.3 Calcium-9.1 Phos-3.9 Mg-2.0 Iron-50 ___ 06:15AM BLOOD calTIBC-173* Ferritn-47 TRF-133* ___ 06:36AM BLOOD ANCA-NEGATIVE B ___ 06:36AM BLOOD CRP-1.3 ___ 06:15AM BLOOD b2micro-1.8 ___ 06:36AM BLOOD b2micro-1.7 ___ 06:36AM BLOOD ANGIOTENSIN 1 - CONVERTING ___ ___ 06:36AM BLOOD RO & ___ ___ 06:36AM BLOOD SM ANTIBODY-Test ___ 06:36AM BLOOD CARDIOLIPIN ANTIBODIES (IGG, IGM)-Test ___ 06:36AM BLOOD SED RATE-Test ___ 08:19PM URINE Color-Straw Appear-Clear Sp ___ ___ 08:19PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 08:19PM URINE UCG-NEGATIVE ___ 07:45PM URINE VoidSpe-PND ___ 07:45PM URINE VoidSpe-PND ___ 07:45PM URINE VoidSpe-PND ___ 02:00PM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-2950* Polys-46 ___ ___ 02:00PM CEREBROSPINAL FLUID (CSF) WBC-2 ___ Polys-49 ___ ___ 02:00PM CEREBROSPINAL FLUID (CSF) TotProt-57* Glucose-66 ___ 02:00PM CEREBROSPINAL FLUID (CSF) BETA 2 MICROGLOBULIN-Test ___ 02:00PM CEREBROSPINAL FLUID (CSF) ANGIOTENSIN 1 CONVERTING ENZYME-Test ___ 02:00PM CEREBROSPINAL FLUID (CSF) CSF HOLD-PND ___ 02:00PM CEREBROSPINAL FLUID (CSF) NEUROMYELITIS OPTICA (NMO)/AQUAPORIN-4-IGG CELL-BINDING ASSAY, CSF-Test Name ___ ___: ___ CT Abd/Pelvis w/ contrast ___: IMPRESSION: 1. Normal CT of the abdomen/pelvis. No evidence of malignancy or acute process. MRI L Spin w/ and w/o contrast ___: IMPRESSION: 1. Mildly decreased T1 marrow signal throughout the lumbar spine which could be seen in the setting of anemia. A marrow infiltrative process could also result in this appearance. Clinical correlation is recommended. 2. No high-grade spinal canal stenosis or neural foraminal narrowing. 3. No abnormal enhancing lesions on post-contrast images. 4. Mild epidural lipomatosis in the lower lumbar region. Brief Hospital Course: ___ RHW h/o depression and recent admission for left C5-C6 left intramedullary lesion s/p IV Steroids presents with increasing lesion size on repeat MRI. Concerning for possible intramedulary neoplasm vs demyelinating diease. # Spinal Cord lEsion - She was admitted to the neurology service. Prior outside imaging was uploaded and reviewed. While lesion did appeared enlarged compared to prior, formal comparison was felt to be difficult due to differences in technique. She underwent a repeat serum evaluation for causes of myelopathy including ___, ANCA, DSDNA, b2 microglobulin, CRP and ESR. These were unrevealing. She underwent ___ guided LP following failure of bedside LP with repeat CSF evaluation including, but not limited to NMO, Sarcoid, CSF flow and cytology. These studies were pending at the time of discharge Neuro-oncology was made aware of the case, though not fomrally consulted and endorsed concern for a possible cord malignancy. Given recent CT chest evaluating for sarcoid and prior LN biopsy, further chest CT imaging was deferred. CT abdomen and pelvis w/o contrast was done to evaluate for malignancy, without concerning findings. Further L-spine MRI imaging was done to assess for evidence of malignancy or possible drop mets, but was notable only for mild signal change within the L-spine itself- on discussion with the radiology staff, this was felt to likely represent a normal finding for age, though anemia or infiltrative process could not be excluded. She was started on prednisone 60mg Daily, Bactrim SS for PCP prophylaxis, PPI and Calcium+D. Prednisone treating any possible underlying demyelinating process. After discussion with her outpatient neurologist, Dr. ___ will manage her prednsione and guide further evaluation. Ms. ___ was felt to be safe for discharge. =========== - Transitional Issues: - Outpatient MRI in approximately 4 weeks - CSF and Serum studies to be followed by outpatient neurologist. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Pramipexole 0.125 mg PO QHS Resless Leg symptoms 2. LaMOTrigine 200 mg PO QHS Depression 3. Escitalopram Oxalate 20 mg PO DAILY 4. Tretinoin 0.05% Cream 1 Appl TP QHS 5. Ferrous Sulfate 325 mg PO DAILY 6. Vitamin D 50,000 UNIT PO 1X/WEEK (FR) 7. Mirena (levonorgestrel) 20 mcg/24 hr ___ years) injection As directed by your prescribing physician. Discharge Medications: 1. Escitalopram Oxalate 20 mg PO DAILY 2. Ferrous Sulfate 325 mg PO TID 3. LaMOTrigine 200 mg PO QHS Depression 4. Pramipexole 0.125 mg PO QHS Resless Leg symptoms 5. Vitamin D 50,000 UNIT PO 1X/WEEK (FR) 6. Mirena (levonorgestrel) 20 mcg/24 hr ___ years) injection As directed by your prescribing physician. 7. Tretinoin 0.05% Cream 1 Appl TP QHS 8. Outpatient Occupational Therapy ICD9: 336.9, M62.81 Focus on Hand strengthening, dexterity Provider: ___, MD ___ 9. Sulfameth/Trimethoprim SS 1 TAB PO DAILY RX *sulfamethoxazole-trimethoprim [Bactrim] 400 mg-80 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*2 10. PredniSONE 60 mg PO Q24H RX *prednisone 20 mg 3 tablet(s) by mouth Daily Disp #*90 Tablet Refills:*1 11. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth Daily Disp #*30 Tablet Refills:*1 12. TraZODone 25 mg PO QHS:PRN insomnia RX *trazodone 50 mg ___ tablet(s) by mouth QHS PRN Disp #*30 Tablet Refills:*1 Discharge Disposition: Home Discharge Diagnosis: C5-C6 Spinal Enhancing Lesion Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were hospitalized at ___ due to concern that your previously known C5-C6 Spinal lesion might be growing. While in the hospital you underwent an evaluation looking for causes of spinal cord lesions- including malignancy (cancer) and demyelinating lesions. At the time of your discharge, the cause of your spinal cord lesion is not entirely clear. You were started on Prednisone daily to treat an possible demyelinationg. It is critical that you take this medication and follow with your Neurologist to help determine the cause of your symptoms. While you are on prednisone, you should take the medication bactrim daily. This is to prevent infections while you are on steroids. We also started you on pantoprazole to protect your stomach while you are on steroids. You should continue taking your vitamin D vitamin as well. If you have trouble sleeping, you can fill the prescription that we provided for trazadone at night. It was a pleasure taking care of you, Your ___ Care Team Followup Instructions: ___
10769428-DS-3
10,769,428
21,434,381
DS
3
2171-08-12 00:00:00
2171-08-12 12:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Left periprosthetic fracture Major Surgical or Invasive Procedure: none History of Present Illness: ORTHOPAEDIC SURGERY CONSULT NAME: ___ MRN: ___ DATE: ___ Home Phone: ___ CC: Left hip pain HPI: ___ year old male w/ L Total Hip Replacement s/p fall from a short ladder when he suddenly tripped and fell landing on his Left side. He had immediate pain and inability to bear weight. He was taken by ambulance to ___ where imaging reportedly revealed a left periprosthetic femur fracture. He was transported to ___ for further management. ROS: No chest pain, shortness of breath, headache, vision change, abdominal pain, no weakness outside of H&P PMH: Atrial fibrillation s/p porcine valve placement Hypertension BPH Unknown Rheumatologic Condition PSH: Left Total Hip Replacement ___ years ago at ___ in ___ by Dr. ___ Total ___ Replacements Right Total Shoulder Replacement MED: Coumadin 2 mg qd for INR goal ___ Terazosin Hydrochloride Metoprolol Tartrate Finasteride Prednisone ALL: ___ Sulfa SH: Activity Level: Community ambulator Mobility Devices: none Occupation: ___ Tobacco: none EtOH: none PE: T-98.7 HR-62 BP-125/64 RR-18 SaO2-96% RA A&O x 3 Calm and comfortable BUE skin clean and intact No tenderness, deformity, erythema, edema, induration or ecchymosis Arms and forearms are soft No pain with passive motion Radial/Median/Ulnar/Axillary ___ EPL FPL EIP EDC FDP FDI fire 2+ radial pulses Fires biceps/triceps/deltoid LLE skin clean and intact Tenderness about the left hip. No noticeable deformity, erythema, edema, induration or ecchymosis. Thighs and legs are soft Pain with passive motion of the hip Saph Sural DPN SPN MPN LPN ___ FHL ___ TA PP Fire 1+ ___ and DP pulses IMAGING: AP Pelvis: Left Periprosthetic Hip Fracture. Left Hip (3 views): *** Intertrochanteric femur fracture. Left ___ Replacement in good alignment. No fx. LABS: CBC: 8>35.6<150 BMP: ___ INR: 1.0 UA: neg IMPRESSION & RECOMMENDATIONS: ___ year old man w/ Left hip periprosthetic fracture s/p mechanical fall. This will require operative fixation. Admit to Orthopaedic Surgery NWB LLE Hold Coumadin Lovenox for DVT prophylaxis Contact ___ Department of Medical Records to elucidate the design of the Left Hip Prosthesis NPO w/ IVF for OR in am ___________________________ ___ MD ___ Combined Orthopaedic ___ Past Medical History: Atrial fibrillation s/p porcine valve placement Hypertension BPH Unknown Rheumatologic Condition PSH: Left Total Hip Replacement ___ years ago at ___ in ___ by Dr. ___ Total ___ Replacements Right Total Shoulder Replacement Social History: ___ Family History: N/C Physical Exam: PE: T-98.7 HR-62 BP-125/64 RR-18 SaO2-96% RA A&O x 3 Calm and comfortable BUE skin clean and intact No tenderness, deformity, erythema, edema, induration or ecchymosis Arms and forearms are soft No pain with passive motion Radial/Median/Ulnar/Axillary ___ EPL FPL EIP EDC FDP FDI fire 2+ radial pulses Fires biceps/triceps/deltoid LLE skin clean and intact Tenderness about the left hip. No noticeable deformity, erythema, edema, induration or ecchymosis. Thighs and legs are soft Pain with passive motion of the hip ___ Sural DPN SPN MPN LPN ___ FHL ___ TA PP Fire 1+ ___ and DP pulses Pertinent Results: ___ 06:15PM BLOOD WBC-6.3 RBC-3.38* Hgb-12.3* Hct-33.9* MCV-101* MCH-36.5* MCHC-36.3* RDW-12.5 Plt ___ ___ 07:30AM BLOOD ___ PTT-29.7 ___ ___ 07:30AM BLOOD Glucose-139* UreaN-17 Creat-0.9 Na-140 K-4.0 Cl-104 HCO3-28 AnGap-12 Brief Hospital Course: Mr. ___ was admitted to the Orthopedic service on ___ for left periprosthetic femur fracture. He was evaluated and treated closed without operative intervention. He had adequate pain management and worked with physical therapy while in the hospital. He is weight bearing status is LLE TDWB. Overnight on HD2, he was noted to have emesis x2 which resolved the next day with increased zofran and a bowel movement, with no further emesis. KUB unremarkable, abd soft, pt tolerating PO well. The remainder of his hospital course was uneventful. Mr. ___ is being discharged to rehab in stable condition. Repeat films as inpatient showed no change in fracture, patient explains he will obtain follow up images as outpatient and send to ___ clinic. Medications on Admission: HOME MEDICATIONS (As per PCP): --Proscar 5mg QD --Terazosin 1mg QHS --Pantoprazole 40mg QD --Metoprolol 50mg BID --Simvastatin 20mg QD --Dronedarone 400mg BID --Citalopram 20mg QD --Prednisone 2.5mg QD --Coumadin ___ QD Discharge Medications: ** Patient should have QTC monitored for combination Dronedarone and Celexa. 1. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours). 2. alum-mag hydroxide-simeth 200-200-20 mg/5 mL Suspension Sig: ___ MLs PO Q6H (every 6 hours) as needed for Dyspepsia. 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 4. bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for Constipation. 5. magnesium hydroxide 400 mg/5 mL Suspension Sig: Thirty (30) ML PO BID (2 times a day) as needed for Constipation. 6. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 7. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID (3 times a day). 8. cholecalciferol (vitamin D3) 400 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. finasteride 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 10. terazosin 1 mg Capsule Sig: One (1) Capsule PO HS (at bedtime). 11. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 12. dronedarone 400 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 13. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO QHS (once a day (at bedtime)). 14. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 15. prednisone 2.5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 16. warfarin 2 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): Target INR ___. Adjust dose daily according to INR. 17. enoxaparin 80 mg/0.8 mL Syringe Sig: One (1) syringe Subcutaneous BID (2 times a day): Discontinue when INR is > 2. 18. oxycodone 5 mg Tablet Sig: ___ Tablets PO Q3H (every 3 hours) as needed for Pain. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left periprosthetic femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Activity: - Continue to be touch down weight bearing on your left leg - Obtain follow up Xrays of your left leg and send/fax to the orthopaedic office with follow up as needed based on xrays. Other Instructions - Resume your regular diet. - Avoid nicotine products to optimize healing. - Resume your home medications. Take all medications as instructed. - Continue taking the Lovenox to prevent blood clots. - You have also been given Additional Medications to control your pain. Please allow 72 hours for refill of narcotic prescriptions, so plan ahead. You can either have them mailed to your home or pick them up at the clinic located on ___. We are not allowed to call in narcotic (oxycontin, oxycodone, percocet) prescriptions to the pharmacy. In addition, we are only allowed to write for pain medications for 90 days from the date of surgery. - Narcotic pain medication may cause drowsiness. Do not drink alcohol while taking narcotic medications. Do not operate any motor vehicle or machinery while taking narcotic pain medications. Taking more than recommended may cause serious breathing problems. - If you have questions, concerns or experience any of the below danger signs then please call your doctor at ___ or go to your local emergency room. Physical Therapy: Activity: Activity as tolerated Left lower extremity: Touchdown weight bearing Encourage turn, cough and deep breathe q2h when awake Treatments Frequency: Follow INR, Coumadin dose, Lovenox therapeutic bridge until INR>2.0 Follow intrinsic factor and heme labs with outpatient PCP. Follow QTc with PCP, patient on Celexa and citalopram with possible side effects. Obtain follow up Xrays in 2weeks left femur and send/fax to ___ office of Dr. ___ review and follow up planning. Followup Instructions: ___
10770039-DS-18
10,770,039
26,588,427
DS
18
2166-12-05 00:00:00
2166-12-09 14:17:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain and distension Major Surgical or Invasive Procedure: Liver Biopsy (___)- results consistent with Alcoholic Fatty Liver Disease History of Present Illness: Ms ___ is a ___ with no substantial PMHx who presents with abdominal pain, nausea, anorexia and jaundice. She reports that her issues with her abdomen and her liver are longstanding, starting with an admission approximately ___ year prior to admission at ___. She reports at that time she was admitted and noted to have both EBV and influenza. She reports that her hospitalization was complicated by jaundice, hepatitis and very low blood cell counts. She was discharged from the hospital, and followed by her PCP for her cytopenias and transaminitis. She reports that over the past 6 weeks she has had issues with abdominal distention and anorexia. She notes that her belly feels pregnant, though she has been having regular menstrual cycles. She denies recent fevers. She notes drinking wine socially, with maximum 8 drinks per week. She notes she has been using both acetaminophen and ibuprofen regularly since last year when she was discharged after her ___ admission. She reports taking up to 4g of APAP in one day, more usually taking 2g (as two divided doses). She denies using other OTC cold remedies which may also contain Tylenol. She denies IDU, recent new sexual partners. She denies sick contacts. Her last travel outside of the ___ area was to ___, ___ in ___. Past Medical History: EBV infection c/b cytopenias and transaminitis Social History: ___ Family History: Grandmother with ovarian cancer Sister with breast cancer No family history of cirrhosis or autoimmune conditions Physical Exam: On Admission: VITALS - 98.7| 119/80 | 102 | 16 | 99% on RA GENERAL - subtly jaundiced, lying in bed, pleasant and conversational HEENT - scleral icterus more pronounced on the medial and lateral canthi; palatal jaundice. Mucus membrane moist. PERRL. No nystagmus. CARDIAC - tachycardic, regular rate and rhythm, normal S1 and S2 LUNGS - clear to auscultation, normal work of breathing ABDOMEN - notably distended and abdominal veins visible. Soft, normal percussion, tender to percussion. Mildly tender to percussion, particularly at the lower R quadrant. Hepatomegaly on percussion. Normal bowel sounds. BACK: no ecchymosis EXTREMITIES - warm and well perfused. No edema appreciated. SKIN - excoriations all over abdomen, chest, and back. NEUROLOGIC - no asterixis. Alert and oriented to place, date, and name. On Discharge: VITALS - 98.7| 119/80 | 102 | 16 | 99% on RA GENERAL - Lying in bed, pleasant and conversational HEENT - scleral icterus more pronounced on the medial and lateral canthi; palatal jaundice. Mucus membrane moist. PERRL. No nystagmus. CARDIAC - tachycardic, regular rate and rhythm, normal S1 and S2 LUNGS - clear to auscultation, normal work of breathing ABDOMEN - notably distended and abdominal veins visible. Soft, normal percussion, tender to percussion. Mildly tender to percussion, particularly at the lower R quadrant. Hepatomegaly on percussion. Normal bowel sounds. BACK: no ecchymosis EXTREMITIES - warm and well perfused. No edema appreciated. SKIN - excoriations all over abdomen, chest, and back. NEUROLOGIC - no asterixis. Alert and oriented to place, date, and name. Pertinent Results: On Admission: ___ 08:20PM BLOOD WBC-8.3 RBC-2.92* Hgb-10.4* Hct-30.1* MCV-103* MCH-35.6* MCHC-34.6 RDW-14.7 RDWSD-56.2* Plt ___ ___ 08:20PM BLOOD Neuts-70.3 Lymphs-15.4* Monos-12.0 Eos-1.0 Baso-0.7 Im ___ AbsNeut-5.81 AbsLymp-1.27 AbsMono-0.99* AbsEos-0.08 AbsBaso-0.06 ___ 08:20PM BLOOD ___ PTT-29.2 ___ ___ 08:20PM BLOOD Glucose-100 UreaN-8 Creat-0.6 Na-129* K-3.5 Cl-95* HCO3-23 AnGap-15 ___ 08:20PM BLOOD ALT-43* AST-173* AlkPhos-154* TotBili-7.3* ___ 08:20PM BLOOD Albumin-2.7* ___ 04:40AM BLOOD TotProt-6.2* Calcium-7.8* Phos-1.4* Mg-1.4* Iron-117 Cholest-148 ___ 04:40AM BLOOD calTIBC-122* Ferritn-609* TRF-94* ___ 04:40AM BLOOD Triglyc-160* HDL-LESS THAN LDLmeas-100 ___ 04:40AM BLOOD IgG-1593 IgA-483* IgM-476* ___ 08:20PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG On Discharge: ___ 04:45AM BLOOD WBC-8.1 RBC-2.56* Hgb-9.3* Hct-27.3* MCV-107* MCH-36.3* MCHC-34.1 RDW-15.8* RDWSD-62.0* Plt ___ ___ 04:45AM BLOOD ___ PTT-40.7* ___ ___ 04:45AM BLOOD Glucose-71 UreaN-7 Creat-0.6 Na-137 K-4.3 Cl-102 HCO3-20* AnGap-19 ___ 04:45AM BLOOD ALT-31 AST-143* AlkPhos-110* TotBili-6.3* ___ 04:45AM BLOOD Calcium-8.4 Phos-3.0 Mg-1.8 Imaging: ___ RUQ US w/Doppler: IMPRESSION: Cirrhotic morphology of the liver with sequela of portal hypertension including variable flow in the portal veins, patent paraumbilical vein, splenomegaly, and ascites. ___: Diagnostic/Therapeutic Paracentesis: IMPRESSION: Technically successful ultrasound guided diagnostic and therapeutic paracentesis. 1.7 L fluid removed Microbiology: ___ Blood Culture: no growth ___: Peritoneal Fluid Culture: -Gram stain: POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. -Fluid Culture: no growth -Anaerobic culture: no growth ___: Urine Culture: no growth Pathology: ___ Ascites Cytology: Peritoneal fluid: NEGATIVE FOR MALIGNANT CELLS. ___ Liver Biopsy: PATHOLOGIC DIAGNOSIS: Liver, needle core biopsy: 1. Established cirrhosis (reticulin and trichrome stains evaluated). 2. Moderate predominantly macrovesicular steatosis with frequent ballooning degeneration and frequent intracytoplasmic hyaline. 3. Moderate portal/septal and lobular mixed inflammation comprised of lymphocytes, neutrophils, eosinophils and rare plasma cells with few scattered apoptotic hepatocytes. 4. Patchy lobular neutrophilic aggregates seen. 5. Iron stain shows mild focal iron deposition in hepatocytes. Note: Overall, the histologic features are compatible with steatohepatitis due to toxic metabolic injury and cirrhosis. Definite features of autoimmune hepatitis or primary biliary disorders are not seen in this biopsy sample. Clinical correlation is required. Dr. ___. ___ reviewed and concurs, and discussed the case with Dr. ___ on ___ at 2 pm. Brief Hospital Course: Ms ___ is a ___ with no substantial PMHx who presents with abdominal pain, nausea, decreased appetite, pruritus, and abdominal distension found to have evidence of new onset cirrhosis of unknown etiology. ACTIVE ISSUES: # Cirrhosis c/b ascites and varices: Patient presents with acute on chronic history of hepatic dysfunction of unclear etiology. Abnormal liver studies first presented in ___ with steatosis, with repeated cycles of symptomatic elevation and resolution. Imaging confirm liver cirrhosis and abdominal varices on ___ and she was immediately sent to ___ for evaluation. Her MELDNa was 21 and ___ discriminant function = 54 on admission. Paracentesis confirms portal hypertension and no SBP. Serological testing suggestive of autoimmune process. Pt's alcoholic liver disease to NAFLD index [ANI] score based off of MCV, AST/ALT, BMI, and gender, which translates to a 99.9% probability of alcoholic liver disease. Liver biopsy showed NO sign of autoimmune process and was more consistent with alcoholic fatty liver disease. Patient was started on spironolactone, furosemide, ursodiol, cholestyramine, multivitamin with minerals, folic acid, pyridoxine, and zinc. Nutritional recommendations include <=2g of sodium daily, high protein, high calorie diet, and nutritional supplement shakes TID. EGD, immunosuppression, and HFE testing as an outpatient (follow up with Dr. ___ in ___ #Hypophosphatemia: On admission, patient had phosphate level of 1.4. She did not endorse any symptoms of hypophosphatemia. In retrospect, her hypophosphatemia may have been due to alcohol use, however phosphate levels dipped again as an inpatient. She was repleted her final phosphate level was 3.0 at discharge. #Tachycardia: HR consistently in the 100s-110s since admission. This may be due to pain or could be an early sign of hypovolemia. However, she has good urine output and mucus membranes are moist. EKG consistent with supraventricular tachycardia. # Constipation: Patient had 2 episode of constipation during admission. ___ have been exacerbated by oxycodone use. Responded well to senna, bisacodyl, miralax, and lactulose (lactulose was given for constipation and not encephalopathy). #Urinary Retention: Towards the end of her stay, patient developed urinary hesitancy and retention (post void residual volume of 400cc). Patient did not have a fever, leukocytosis or dysuria. Urine analysis showed hazy urine with trace leukocytes, many bacteria, no nitrites. Urine culture results are still pending. Since patient is asymptomatic, determined to be asymptomatic bacteriuria. No antibiotics was initiated. Key New Medications: -Cholestyramine 4mg PO BID -Furosemide 20mg PO QD -Lactulose 15mg PO QD PRN constipation -Oxycodone ___ PO Q4H PRN pain -Pyridoxine 50mg PO QD -Ramelteon 8mg PO QHS PRN insomnia -Spironolactone 50mg PO QD -Ursodiol 300mg TID Transitional Issues -f/u with hepatology on ___ (Dr. ___ -Plan for outpatient EGD with hepatology -Consider further workup as an outpatient for autoimmune hepatitis -Counsel alcohol abstinence -Do not give patient more than 2g acetaminophen each day -2L fluid restriction Medications on Admission: none Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 2. Bisacodyl 10 mg PO DAILY:PRN constipation RX *bisacodyl 5 mg 2 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. Cholestyramine 4 gm PO BID RX *cholestyramine (with sugar) 4 gram 4 grams by mouth twice daily Refills:*0 4. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Furosemide 20 mg PO DAILY ascites RX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 6. Hydrocortisone Cream 0.5% 1 Appl TP TID:PRN itching RX *hydrocortisone 0.5 % Apply to affected area three times daily Refills:*0 7. HydrOXYzine 50 mg PO Q6H:PRN PRURITUS RX *hydroxyzine HCl 50 mg 1 tab by mouth every 6 hours Disp #*30 Tablet Refills:*0 8. Lactulose 15 mL PO DAILY:PRN constipation RX *lactulose 10 gram/15 mL (15 mL) 15 mL by mouth daily Refills:*0 9. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 10. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate RX *oxycodone 10 mg ___ tablet(s) by mouth every 4 hours Disp #*60 Tablet Refills:*0 11. Polyethylene Glycol 17 g PO DAILY:PRN constipation RX *polyethylene glycol 3350 17 gram/dose 17 grams by mouth daily Refills:*0 12. Pyridoxine 50 mg PO DAILY RX *pyridoxine (vitamin B6) 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 13. Ramelteon 8 mg PO QHS:PRN insomnia RX *ramelteon [Rozerem] 8 mg 1 tablet(s) by mouth at bed Disp #*30 Tablet Refills:*0 14. Sarna Lotion 1 Appl TP QID:PRN itching 15. Senna 17.2 mg PO BID RX *sennosides [senna] 8.6 mg 2 tabs by mouth twice daily Disp #*120 Tablet Refills:*0 16. Simethicone 40-80 mg PO QID GAS, BLOATING RX *simethicone 80 mg 80 mg PO every 6 hours Disp #*30 Tablet Refills:*0 17. Spironolactone 50 mg PO DAILY RX *spironolactone 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 18. Ursodiol 300 mg PO TID RX *ursodiol 300 mg 1 capsule(s) by mouth three times daily Disp #*90 Capsule Refills:*0 19. Zinc Sulfate 220 mg PO DAILY RX *zinc sulfate 220 mg (50 mg zinc) 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis Alcoholic Fatty Liver Disease Secondary Diagnosis none Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: --Why was I admitted? You were admitted to the hospital because you had signs and symptoms of a severe liver disease, cause unknown. --What was done ? We tested you for many things that can cause severe liver disease. We also took a tiny piece of your liver for further testing. The final diagnosis was "Alcoholic Fatty Liver Disease" --What should I do going forward? Please take the medicines that we started during this admission. Please follow up with your primary care doctor, follow up with your liver doctor(Dr. ___. Your liver doctor has more tests and treatments planned for you. Please drink no more than 2 liters of fluid each day. It was a pleasure taking care of! Best of luck. -Your ___ Care Team Followup Instructions: ___
10770039-DS-19
10,770,039
26,878,910
DS
19
2167-01-03 00:00:00
2167-01-06 17:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: abdominal pain, nausea, vomiting and malaise Major Surgical or Invasive Procedure: ___ Paracentesis (diagnostic and therapeutic, ultrasound guided) ___ ___ tube placement (fluoroscopically guided) History of Present Illness: Ms ___ is a ___ year old woman with a history of alcoholic hepatitis and alcoholic cirrhosis complicated by portal HTN, ascites diagnosed during recent hospitalizion in ___ presenting with worsening abdominal pain, nausea, vomiting, malaise, myalgias. Symptoms started on ___ with fatigue, muscle aches,abdominal discomfort, distension and decreased appetite. She states that she really hasn't felt better since her last hospital admission Two nights ago she noted increased frequency in urination every 30 mins, with no burning, or incontinence. She has had lower back discomfort. No fevers or chills. She has been also having dizziness, nausea and vomiting. She vomited 3 times on ___. She had gone to her PCPs office and had UA that showed increased WBC. Not given antibiotics. She called the covering doctor for her other symptoms and was given Zofran and meclizine. Her last paracentesis was this pass ___ at ___ ___ and she had 2.9L removed. She feels like she is still getting worse. No sick contacts. No recent travel. No flu shot this year. Patient denies fevers, chills, cough, rhinorrhea, chest pain, shortness of breath. Patient was admitted from ___ to ___ for alcoholic hepatitis, jaundice, ascites requiring large volume para. Patient had a DF of 42 but steroids were not started given risk of infection. As an outpatient she has had an upper endoscopy that showed evidence of portal hypertension with three small to medium sized varicies. In the ED, initial vitals were: 99.0 106 122/81 20 100% RA - Exam notable for: jaundice, LUQ ttp, diffuse tenderness on the abdomen, no peripheral edema, clear lungs. - Labs notable for: 10.0 7.5 >---< 153 29.7 N:80.0 L:10.5 M:7.6 E:1.1 Bas:0.4 Nrbc: 0.4 136 101 16 -------------- 103 3.7 20 0.9 ALT: 45 AP: 117 Tbili: 5.6 Alb: 2.7 AST: 143 Lip: 142 ___: 19.0 INR: 1.7 Lactate:2.0 Serum tox negative UA Hazy, 4 Urobilinin, small amount of bili, Lg Leuks, Trace protein, 10 ketones, 25 WBC, few bacteria, Epi 6, 1 hyaline casts and 6 cast WBC - Imaging was notable for: RUQUS 1. Cirrhotic liver, with sequelae of portal hypertension including splenomegaly and ascites. 2. Thickening of the gallbladder wall likely secondary to third spacing from known liver disease. - Patient was given: ___ 15:08 PO Ibuprofen 400 mg ___ 15:08 PO OxyCODONE (Immediate Release) 5 mg ___ 17:31 PO/NG Spironolactone 100 mg ___ 17:31 PO/NG Furosemide 40 mg ___ 17:31 PO/NG HydrOXYzine 50 mg ___ 17:31 PO/NG Mirtazapine 30 mg ___ 17:31 PO Ursodiol 300 mg Attempted to do diagnostic para however no pocket available for safe tap. Patient decided to admit to ET service for further evaluation. On arrival to the floor the patient reports symptoms as listed above. She still feels ill. Not currently having urinary frequency but she does report lower back pain. No fevers or chills. Past Medical History: EBV infection c/b cytopenias and transaminitis Alcoholic Fatty Liver Disease complicated the jaundice, ascities nad portal hypertension -- three small to medium sized varicies Alcoholic Hepatitis Social History: ___ Family History: Maternal Grandmother with ovarian cancer Aunt with breast cancer Father with colon cancer No family history of cirrhosis or autoimmune conditions Grandfather with DM Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VITAL SIGNS: 98.4 126 / 73 88 18 97 Ra GENERAL: well appearing woman, non-toxic laying in bed HEENT: PERRL, no nystagmus, mild scleral icterus, OP clear without lesions, jaundice under frenulum NECK: supple, no LAD CARDIAC: tachycardic, regular, ___ systolic murmur at LSB LUNGS: CTAB without wheezing ABDOMEN: mildly distended, soft, ttp in RUQ, no rebound or guarding. Hepatomegaly noted. EXTREMITIES: warm well perfused no edema SKIN: warm no rashes BACK: Left sided CVA tenderness DISCHARGE PHYSICAL EXAM: ======================== VITAL SIGNS: 98.0 PO 109 / 64 L Sitting 76 18 ___ Ra GENERAL: young woman eating breakfast in NAD HEENT: mild scleral icterus. MMM. tonsillar erythema improved. No LAD. CARDIAC: RRR, ___ systolic murmur LUNGS: non-labored, CTAB ABDOMEN: soft, mild ttp at RUQ, no rebound or guarding, +BS. EXTREMITIES: warm, well perfused, no edema NEURO: normal mental status Pertinent Results: ___ 12:07PM BLOOD WBC-7.5 RBC-2.94* Hgb-10.0* Hct-29.7* MCV-101* MCH-34.0* MCHC-33.7 RDW-13.2 RDWSD-49.1* Plt ___ ___ 05:16AM BLOOD WBC-6.3 RBC-2.59* Hgb-9.1* Hct-26.3* MCV-102* MCH-35.1* MCHC-34.6 RDW-13.4 RDWSD-49.7* Plt ___ ___ 05:08AM BLOOD WBC-5.7 RBC-2.49* Hgb-8.6* Hct-25.4* MCV-102* MCH-34.5* MCHC-33.9 RDW-13.3 RDWSD-49.9* Plt ___ ___ 05:12AM BLOOD WBC-6.1 RBC-2.56* Hgb-8.8* Hct-26.4* MCV-103* MCH-34.4* MCHC-33.3 RDW-13.2 RDWSD-49.1* Plt ___ ___ 05:46AM BLOOD WBC-6.3 RBC-2.62* Hgb-9.1* Hct-27.0* MCV-103* MCH-34.7* MCHC-33.7 RDW-13.4 RDWSD-50.5* Plt ___ ___ 12:12PM BLOOD ___ ___ 05:16AM BLOOD ___ PTT-37.2* ___ ___ 05:08AM BLOOD ___ PTT-37.6* ___ ___ 05:12AM BLOOD ___ PTT-39.0* ___ ___ 05:46AM BLOOD ___ PTT-36.7* ___ ___ 12:07PM BLOOD Glucose-103* UreaN-16 Creat-0.9 Na-136 K-3.7 Cl-101 HCO3-20* AnGap-19 ___ 05:16AM BLOOD Glucose-101* UreaN-15 Creat-1.1 Na-140 K-3.7 Cl-104 HCO3-25 AnGap-15 ___ 05:08AM BLOOD Glucose-78 UreaN-12 Creat-0.9 Na-142 K-3.8 Cl-106 HCO3-25 AnGap-15 ___ 05:12AM BLOOD Glucose-96 UreaN-13 Creat-0.8 Na-139 K-4.3 Cl-106 HCO3-27 AnGap-10 ___ 05:46AM BLOOD Glucose-103* UreaN-18 Creat-0.8 Na-142 K-4.3 Cl-107 HCO3-25 AnGap-14 ___ 12:07PM BLOOD ALT-45* AST-143* AlkPhos-117* TotBili-5.6* ___ 05:16AM BLOOD ALT-35 AST-102* AlkPhos-96 TotBili-4.6* ___ 05:08AM BLOOD ALT-30 AST-87* AlkPhos-85 TotBili-4.0* ___ 05:12AM BLOOD ALT-33 AST-90* AlkPhos-91 TotBili-3.5* ___ 05:46AM BLOOD ALT-32 AST-88* LD(LDH)-172 AlkPhos-96 TotBili-3.1* ___ 12:07PM BLOOD Lipase-142* ___ 12:07PM BLOOD Albumin-2.7* ___ 05:30AM BLOOD Albumin-3.0* Calcium-8.7 Phos-3.1 Mg-1.8 ___ 05:46AM BLOOD Albumin-2.9* Calcium-9.1 Phos-3.7 Mg-2.1 ___ 12:07PM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG IMAGING & STUDIES ========================= ___ RUQ US 1. Cirrhotic liver, with sequelae of portal hypertension including splenomegaly and ascites. 2. Collapsed gallbladder containing sludge. Thickening of the gallbladder wall likely secondary to third spacing from known liver disease. KUB ___: FINDINGS: No findings of small bowel obstruct. Mild-to-moderate stool load. There is no free intraperitoneal air.Enteric tube appears to terminate in the stomach. IUD projects over the mid pelvis. Patient is status post Essure tubal ligation. Faint density projecting over the right upper quadrant may represent layering gallstones. IMPRESSION: Nonobstructive bowel gas pattern. Mild-to-moderate stool load. Brief Hospital Course: ___ with recently diagnosed EtOH hepatitis and cirrhosis who presented with ongoing abdominal pain and nausea. No evidence for infection, obstruction, or alternate etiology. # Acute Alcoholic Hepatitis in Alcoholic Cirrhosis Leading to abdominal pain and nausea. Pt denied any recent ETOH ingestion. Baseline Childs C, MELD 20. While the patient's Discriminant Function was quite elevated (35-42), steroids were held due to initial concern for infection as well as gradual spontaneous improvement in her symptoms and labs. An enteric feeding tube was fluoroscopically placed to correct the patient's severe malnutrition and aid healing. Also had a therapeutic para of 1.5L with resuming of her home diuretic therapy. Still with mild abdominal pain with patient previously given limited amounts of oxycodone that was recommended tapering as leading to significant constipation that improved with aggressive bowel regiment. Also given cholestyramine and ursodiol for pruritus. She was discharged with adequate symptom control and close follow-up with primary care, hepatology, and alcohol abstention services. # Pharyngitis Likely viral. Centor ___, no fevers or exam findings to suggest bacterial pharyngitis/sinusitis or lower respiratory infection. Given anti-histamines for symptom control. # Malnutrition Likely due to cirrhosis with high nutritional needs in setting of alc hep as above. Nutrition consulted with post-pyloric feeding tube placed. Continued on TFs with ___ at home. #Sterile pyuria Urine culture negative, no fevers or leukocytosis, so discontinued short course of CTX (___) given. ___ Suspect pre-renal given N/V and improvement with albumin. No e/o HRS. TRANSITIONAL ISSUES: ================== - Discharge weight: 55.9 kg (124 lb) - Discharge labs: DF 40, MELD 17, Hgb 9.1, INR 1.8, Cr 0.8, Tbili 3.1, ALT/AST ___ - Important medications: -- Continued furosemide 20/ spironolactone 50 -- Substituted polyethylene glycol for lactulose to improve abdominal discomfort/distention -- Added cholestyramine and continued ursodiol for pruritus - Please continue to counsel patient on alcohol abstention and encourage her to join AA or a similar program. - Could consider SBP prophylaxis since meets some criteria: ascites total protein < 1.5, ___ Score > 9, bilirubin > 3.0. # CODE: Full (confirmed) # CONTACT: Father ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 2. Bisacodyl 10 mg PO DAILY:PRN constipation 3. Cholestyramine 4 gm PO BID 4. FoLIC Acid 1 mg PO DAILY 5. Furosemide 20 mg PO DAILY ascites 6. Hydrocortisone Cream 0.5% 1 Appl TP TID:PRN itching 7. HydrOXYzine 50 mg PO Q6H:PRN PRURITUS 8. Lactulose 15 mL PO DAILY:PRN constipation 9. Multivitamins W/minerals 1 TAB PO DAILY 10. Polyethylene Glycol 17 g PO DAILY:PRN constipation 11. Pyridoxine 50 mg PO DAILY 12. Sarna Lotion 1 Appl TP QID:PRN itching 13. Senna 17.2 mg PO BID 14. Simethicone 40-80 mg PO QID GAS, BLOATING 15. Spironolactone 50 mg PO DAILY 16. Ursodiol 300 mg PO TID 17. Zinc Sulfate 220 mg PO DAILY 18. Mirtazapine 7.5 mg PO QHS:PRN insomnia Discharge Medications: 1. Chloraseptic Throat Spray 1 SPRY PO Q4H:PRN sore throat RX *phenol [Chloraseptic Throat Spray] 1.4 % as directed as directed Disp #*1 Bottle Refills:*0 2. Docusate Sodium 200 mg PO BID RX *docusate sodium 100 mg ___ tablet(s) by mouth daily as needed Disp #*60 Tablet Refills:*0 3. Fexofenadine 60 mg PO BID RX *fexofenadine 60 mg 1 tablet(s) by mouth twice a day as needed Disp #*30 Tablet Refills:*0 4. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Propranolol 20 mg PO BID RX *propranolol 20 mg 1 tablet(s) by mouth twice daily Disp #*60 Tablet Refills:*0 6. Thiamine 100 mg PO DAILY RX *thiamine HCl (vitamin B1) 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 7. Acetaminophen 500 mg PO Q8H:PRN Pain - Mild RX *acetaminophen 500 mg 1 tablet(s) by mouth every 8 hours as needed Disp #*90 Tablet Refills:*0 8. OxyCODONE (Immediate Release) 5 mg PO BID:PRN Pain - Moderate Duration: 7 Days Reason for PRN duplicate override: Alternating agents for similar severity RX *oxycodone 5 mg 1 tablet(s) by mouth twice daily as needed Disp #*14 Tablet Refills:*0 9. Polyethylene Glycol 17 g PO BID:PRN constipation RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 17 grams powder(s) by mouth twice daily as needed Refills:*0 10. Bisacodyl 10 mg PO DAILY:PRN constipation RX *bisacodyl 5 mg 1 tablet(s) by mouth daily as needed Disp #*30 Tablet Refills:*0 11. Cholestyramine 4 gm PO BID 12. FoLIC Acid 1 mg PO DAILY 13. Furosemide 20 mg PO DAILY ascites 14. Hydrocortisone Cream 0.5% 1 Appl TP TID:PRN itching 15. HydrOXYzine 50 mg PO Q6H:PRN PRURITUS 16. Mirtazapine 7.5 mg PO QHS:PRN insomnia 17. Pyridoxine 50 mg PO DAILY 18. Sarna Lotion 1 Appl TP QID:PRN itching 19. Senna 17.2 mg PO BID 20. Simethicone 40-80 mg PO QID GAS, BLOATING 21. Spironolactone 50 mg PO DAILY 22. Ursodiol 300 mg PO TID 23.Tube Feeds IsoSource 1.5 at 50 ml/hr over 24 hours. ___ cycle as tolerated. Dispense 1 month supply with 2 refills. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES ============================== alcoholic hepatitis decompensated alcoholic cirrhosis with ascites SECONDARY DIAGNOSES ================================ severe protein calorie malnutrition acute renal failure anemia, thrombocytopenia, and coagulopathy secondary to cirrhosis sterile pyuria viral pharyngitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___. Why you were admitted: - Nausea and stomach pain What happened while you were here: - We determined that the cause of your symptoms is most likely a condition called alcoholic hepatitis, meaning inflammation and swelling of the liver from drinking alcohol. - We determined you were very malnourished and placed a feeding tube to help your liver and body heal. - We drained fluid from your stomach to make sure you did not have an infection and to relieve the pressure. - We gave you medications to control your pain, remove excess fluid, and protect your stomach from bleeding. Instructions for when you leave the hospital: - Please enroll in a program to help you stay sober. This is the most important thing you can do to protect yourself from this dangerous condition, which can be life-threatening. - Continue to take all of your medications as prescribed. It is important to take your bowel medications to not become constipated. - Follow up with your primary care and liver doctors. ___ see below for a complete list of follow-up appointments. - Do not hesitate to call your doctor or return to the hospital if you have severe pain, vomiting, fever, chills, confusion, bloody or black stool, or any other symptoms that concern you. We wish you all the best. Sincerely, Your ___ Care Team Followup Instructions: ___
10770039-DS-22
10,770,039
29,572,052
DS
22
2169-01-21 00:00:00
2169-01-22 11:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Hypotension, GI Bleed Major Surgical or Invasive Procedure: Intubation ___ ___ ___ TIPS ___ LP ___ History of Present Illness: ___ w/ PMH of EtOH use disorder c/b cirrhosis, portal HTN ascites, varices, h/o EtOH hepatitis, presents with hematemesis. Patient originally lives in ___, and was in ___ and was visiting father who is hospitalized at ___ when she started to feel nauseous. Pt reports 3 episodes of bright red blood vomiting that began about 6pm with last episode of large volume (>500cc). She says she ran out of her propranolol 1 week ago. No history of GI bleed. Described diffuse abdominal pain. Has been taking ibuprofen 600mg daily x1 week for some back pain. Denies any fevers chills, chest pain, dyspnea, melena, hematochezia, worsening abd distention, constipation, diarrhea, swelling in legs, confusion. She has been compliant with her medications besides her propranolol. EMS was called and said she was pale/diaphoretic. Was given fluid bolus. Initial SBP in the ___. Endorses feeling lightheaded. Her last endoscopy on ___, showed a small varices that were without red marking. Was taking 10mg propranolol BID In the ED, Initial Vitals: 97.8 120 86/52 16 98% RA Exam: LUQ tenderness, epigastric guaiac neg brown stool Labs: 7.6 ___ 40 -------------<143 5.4 20 1.3 ___: 15.8 PTT: 24.8 INR: 1.5 Consults: Hepatology -admit to MICU -transfuse to goal 7 -serial CBC -albumin 25% for volume support -octreotide -ppi -ceftriaxone -blood cultures -NPO -plan for EGD In the ED, patient had another episode of hematemesis (~500cc of dark red blood emesis, not coffee ground). Patient given 3u PRBC, 3L IVF, IV pantoprazole 40mg, Octreotide gtt, CTX, ondansetron 4mg IV, lorazepam 1mg IV VS Prior to Transfer: 129 78/47 22 96% RA ROS: Positives as per HPI; otherwise negative. Past Medical History: alcoholic hepatitis with cirrhosis (biopsy proven) complicated the jaundice, ascities and portal hypertension -- three small to medium sized varicies EBV infection c/b cytopenias and transaminitis Social History: ___ Family History: -Maternal Grandmother with ovarian cancer -Aunt with breast cancer -Father with colon cancer -Cousin with breast cancer diagnosed at ___ (negative for BRCA, patient and sister tested negative for BRCA) -No family history of cirrhosis or autoimmune conditions -Grandfather with DM Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS: 98.6 ___ 100% RA GEN: laying in bed in NAD HEENT: PERRL. Nonicteric sclera. Dry MM NECK: Right EJ IV in place CV: tachycardic. RRR. No mrg RESP: Unlabored breathing, speaking in full sentences. CTA b/l GI: +BS. Soft, nondistended, diffusely tender. No rebound, guarding EXT: Warm well perfused. No ___ edema NEURO: AOx3. Moving all extremities. No focal deficits PSYCH: euthymic DISCHARGE PHYSICAL EXAM: ======================== 24 HR Data (last updated ___ @ 1127) Temp: 98.4 (Tm 99.0), BP: 104/64 (98-106/60-68), HR: 81 (81-100), RR: 17 (___), O2 sat: 96% (95-99), O2 delivery: Ra, Wt: 142.3 lb/64.55 kg GENERAL: Alert, interactive, no apparent distress. HEENT: NC/AT, PERRL, EOMI, No scleral icterus, MMM, OP Clear NECK: No JVD. CARDIAC: RRR, no R/M/G. LUNGS: CTAB, no R/R/W. ABDOMEN: S/NT/ND. EXTREMITIES: WWP, no edema. SKIN: No rash. NEUROLOGIC: Alert, oriented to person, place, time. Str ___ in BUE and BLE grossly. No asterixis. Pertinent Results: ADMISSION LABS: =============== ___ 10:11PM BLOOD WBC-7.8 RBC-3.04* Hgb-7.6* Hct-26.0* MCV-86 MCH-25.0* MCHC-29.2* RDW-21.4* RDWSD-65.5* Plt ___ ___ 10:11PM BLOOD Neuts-64.7 ___ Monos-11.3 Eos-1.0 Baso-0.4 Im ___ AbsNeut-5.06 AbsLymp-1.73 AbsMono-0.88* AbsEos-0.08 AbsBaso-0.03 ___ 10:11PM BLOOD ___ PTT-24.8* ___ ___ 05:50AM BLOOD ___ ___ 10:11PM BLOOD ALT-23 AST-45* AlkPhos-59 TotBili-0.8 ___ 10:11PM BLOOD Lipase-60 ___ 10:11PM BLOOD Albumin-3.3* Calcium-9.8 Phos-3.4 Mg-1.9 ___ 05:50AM BLOOD Hapto-<10* ___ 10:01PM BLOOD calTIBC-213* Ferritn-188* TRF-164* ___ 10:11PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Tricycl-NEG ___ 10:22PM BLOOD Lactate-5.5* Creat-1.3* ___ 10:22PM BLOOD Hgb-8.2* calcHCT-25 RELEVANT LABS: ============== ___ 07:00PM CEREBROSPINAL FLUID (CSF) TNC-6* RBC-8* Polys-2 ___ Macroph-6 ___ 07:00PM CEREBROSPINAL FLUID (CSF) TotProt-25 Glucose-65 LD(LDH)-24 ___ 07:00PM CEREBROSPINAL FLUID (CSF) HERPES SIMPLEX VIRUS PCR-Test Name negative RELEVANT IMAGING: ================= ___ TIPS 1. Pre-TIPS right atrial pressure of 14 mmHg and portal pressure measurement of 28 mmHg resulting in portosystemic gradient of 14 mmHg. 2. Portal venogram demonstrating a portosystemic shunt supplied predominantly by a short gastric vein as well as extensive esophageal varices from the coronary vein. Additionally, there was contrast extravasation prior to TIPS placement likely from an extracapsular portal puncture site. 3. Post TIPS placement portal venogram demonstrated resolution of the active contrast extravasation. 4. Post TIPS venogram demonstrated persistent flow in the portosystemic shunt. 5. Post-TIPS right atrial pressure of 9 mmHg and portal pressure of 15 mmHg resulting in portosystemic gradient of 6 mmHg. 6. Splenic venogram demonstrating brisk active contrast extravasation into the stomach with deflation of the ___ tube. 7. Successful embolization and sclerosis of the portosystemic shunt with embolization on the both the systemic and portal sides. 8. Successful embolization of the coronary vein. 9. Post TIPS and left gastric embolization and portosystemic shunt embolization right atrial pressure of 18 mmHg and portal pressure of 28 mmHg for a portosystemic gradient of 10 mmHg. Successful transjugular intrahepatic portosystemic shunt placement, coronary vein embolization a and portosystemic shunt embolization/sclerosis. ___ EGD Paraphrased from OMR Esophagus 1 grade II varices, ___ tear, Stomach Pooled fresh blood, gastric varix near fundus CTA Head/Neck ___ 1. No acute fracture, infarction, hemorrhage or edema. 2. Normal CTA head and neck. 3. Diffuse interlobular septal thickening in the setting of small bilateral pleural effusions may suggest pulmonary edema. 4. Enlarged main pulmonary artery suggests pulmonary artery hypertension. EEG ___ This telemetry captured no pushbutton activations. It showed a slow background with bursts of generalized slowing, together indicating a widespread encephalopathy, similar to that on the previous day's recording. Some of the bursts of generalized slowing included blunted sharp waves, but there were no overtly epileptiform features or electrographic seizures in the recording. EEG ___ IMPRESSION: This telemetry captured no pushbutton activations. It showed a slow and disorganized background throughout, with frequent bursts of generalized slowing, all indicative of a continuing encephalopathy, as on earlier recordings. Over the course of the recording, however, background frequencies increased and the bursts of slowing decreased, suggesting some improvement in the encephalopathy. There were no areas of prominent focal slowing, but encephalopathies may obscure focal findings. There were no definitely epileptiform features in the recording, and no electrographic seizures. EEG ___: PENDING EEG ___: PENDING ___ MR ___ WITH/WITHOUT CONTRAST 1. Mild degenerative changes cervical spine. 2. Mild paraspinal edema, likely reactive, see above. ___ MR HEAD W & W/O CONTRAST 1. No acute findings, no mass. 2. Findings consistent with chronic liver disease. No acute changes. 3. Mild cerebral, moderate cerebellar atrophy.. ___ RIGHT UPPER QUADRANT ULTRASOUND WITH DOPPLER 1. Patent TIPS, but with low velocity(<100 cm/sec) internal flow which is without prior study for comparison. Additionally, no color flow seen within the right anterior portal vein which is nonspecific but could be related to technique or slow flow. Suggest short interval follow up. 2. Cirrhosis with mild splenomegaly. No ascites. Suspected liver lesions previously described on the MR of ___ are not seen on the current study. 3. Gallbladder stones and sludge with mild wall thickening. While the gallbladder is not distended, acute cholecystitis is not excluded. HIDA scan should be considered. 4. Small bilateral pleural effusions. MICROBIOLOGY: ============= All cultures throughout admission negative including blood, urine, sputum, CSF DISCHARGE LABS: =============== ___ 07:08AM BLOOD WBC-6.0 RBC-3.42* Hgb-10.1* Hct-31.6* MCV-92 MCH-29.5 MCHC-32.0 RDW-18.6* RDWSD-60.6* Plt ___ ___ 07:08AM BLOOD ___ PTT-29.5 ___ ___ 07:08AM BLOOD Glucose-73 UreaN-15 Creat-0.9 Na-137 K-4.9 Cl-104 HCO3-19* AnGap-14 ___ 07:08AM BLOOD ALT-25 AST-37 LD(LDH)-421* AlkPhos-69 TotBili-1.6* ___ 07:08AM BLOOD Albumin-3.5 Calcium-8.8 Phos-3.4 Mg-2.2 Brief Hospital Course: TRANSITIONAL ISSUES: ==================== -Follow Up Appointments: Hepatology, ___ -Follow Up Labs: CBC within ___ weeks of discharge to make sure H/H not downtrending -Discharge Hgb 10.1 -New Medications: Multivitamins w/ minerals, Pantoprazole 40mg BID, Rifaximin 550mg BID -Held Medications: Folic Acid, Furosemide, Hydroxyzine, Mirtazipine, Spironolactone, Vitamin B []Slow flow visualized on post-TIPS ultrasound, will need repeat study as outpatient []Will continue propranolol until outpatient follow up given slow flow seen on TIPS Ultrasound MICU COURSE (___) =========================== ___ w/ PMH of EtOH use disorder c/b cirrhosis, portal HTN ascites, varices, h/o EtOH hepatitis, presented with hematemesis c/f for brisk variceal bleed. She was intubated out of concern for airway protection iso massive hematemesis. An urgent EGD was performed which showed significant extravasation, ___ tears, and significant gastric varices, but no intervenable lesion. Given her transfusion requirement, ___ was placed. Despite her impressive blood loss, she never required pressors. ___ subsequently took the patient for TIPS w/ coiling and embolization. Her transfusion requirement stabilized and she remained HDS. Following TIPS, sedation was weaned, however patient remained obtunded. EEG was c/f epileptiform activity and AEDs were initiated w/ the guidance of neurology. Her encephalopathy persisted, attributed to acute HE iso portosystemic shunting and significant blood digestion. LP was performed to r/o infection which was negative. EtOH withdrawal was also considered, but patient's family did not believe she had been drinking. With initiation of aggressive lactulose/rifaximin and AED medications, patient's mental status improved and she was extubated. She remained HDS, without need of a transfusion for >48hrs s/p TIPS and was called out to the floor ___. In terms of reason for her presentation, EtOH abuse was discussed, but patient adamantly denies any EtOH use in ___Y PROBLEM (___) =================================== #Gastric variceal bleed s/p embolization s/p TIPS See above for the MICU course. Since arrival to the floor, the patient did not have any further episodes of hematemesis or other evidence of GI bleed. H/H was stable. #Encephalopathy Upon transfer to floor initial, the patient was still fairly encephlopathic, with slow speech and poor attention. She clinically improved significantly in the first 24h. EEG also showed improvement. Keppra was initially downtitrated then stopped before discharge per discussion with Neurology, as it was felt that any seizure activity was provoked in the setting of the acute illness and potential withdrawal, with continued improvement in mental status. Continued on lactulose and rifaximin. #Fever Had previously been febrile in the MICU, thought to be secondary to a ventilator-associated pneumonia, and had been on cefepime before arrival to the floor without a fever for >48h. Then again spiked to 101.8F. Infectious studies including blood, urine, CXR were negative. Ultrasound without evidence of ascites, though could not rule out cholecystitis. However, patient without abdominal pain and clinically appeared well, hence did not feel presentation to be c/w acute cholecystitis. Etiology remained unclear but patient was clinically improving and completed a course of antibiotics for HAP on ___ with cefepime as below. #Ventilator-associated pneumonia Febrile ___ morning while in MICU. CXR with possible PNA. Treated initially with vanc/cefepime. Vanc stopped once MRSA swab came back negative. Finished 7 days of cefepime. #EtOH Cirrhosis Known alcoholic cirrhosis (biopsy proven) c/b portal hypertension with splenomegaly and ascites, now s/p TIPS. Ultrasound on ___ did not show ascites. Started on lactulose and rifaximin for encephalopathy. Her diuretics were held post-TIPS procedure and patient appeared to be maintaining euvolemia. Urosdiol/hydroxyzine initially held while in MICU, then restarted. Patient noted to have slow flow on TIPS US and will need to continue beta-blocker therapy until repeat study. #CODE STATUS: Full Code #EMERGENCY CONTACT: Next of Kin: ___ (Sister) Phone: ___ ___ on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Spironolactone 100 mg PO DAILY 2. Mirtazapine 30 mg PO QHS 3. HydrOXYzine 50 mg PO Q6H 4. Furosemide 40 mg PO DAILY 5. FoLIC Acid 1 mg PO DAILY 6. Propranolol 10 mg PO BID 7. Ursodiol 300 mg PO TID 8. Lactulose 15 mL PO DAILY:PRN constipation 9. Ondansetron ODT 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 10. Vitamin B Complex 1 CAP PO DAILY Discharge Medications: 1. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals [Vitamins and Minerals] 1 tab-cap by mouth once a day Disp #*30 Tablet Refills:*0 2. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 3. rifAXIMin 550 mg PO BID 4. Lactulose 30 mL PO TID:PRN Titrate to ___ BMs 5. Ondansetron ODT 4 mg PO Q8H:PRN Nausea/Vomiting - First Line 6. Propranolol 10 mg PO BID 7. Ursodiol 300 mg PO TID 8. HELD- Mirtazapine 30 mg PO QHS This medication was held. Do not restart Mirtazapine until you are told to do so by your physician ___: Home Discharge Diagnosis: PRIMARY DIAGNOSES #Hematemesis #Hepatic Encephalopathy #Epileptiform discharges #Ventilator Associated Pneumonia #EtOH Cirrhosis SECONDARY DIAGNOSIS: ==================== #Acute Blood Loss Anemia #Thrombocytopenia #Coagulopathy #Hypernatremia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was our pleasure taking care of you at the ___ ___! WHAT BROUGHT YOU TO THE HOSPITAL? - You were vomiting blood. This was concerning for bleeding from your esophagus or stomach. This happened because of your cirrhosis. WHAT HAPPENED IN THE HOSPITAL? - You were initially admitted to the intensive care unit because you were having a significant amount of bleeding. - You needed to be intubated to protect you from having blood go into your lungs. - The Gastroenterologists performed multiple endoscopies of your esophagus and stomach but did not find a clear source of bleeding. - You continued to bleed from your GI tract, due to your cirrhosis, which causes a condition called portal hypertension. To stop the bleeding, the Interventional Radiologists performed a procedure called a transjugular intrahepatic portosystemic shunt (TIPS). This ultimately stopped the bleeding. - You were found to be very confused. This was likely because of your cirrhosis, as well as possible seizures. You received lactulose and rifaximin for the cirrhosis, and temporarily required anti-seizure medications as well. This helped you become less confused. - Once you had improved enough, you were transitioned to the regular medicine floor, where you continued to improve. WHAT SHOULD YOU DO ONCE YOU LEAVE THE HOSPITAL? - Please take your medications as prescribed and attend your doctor's appointments. - Please take your lactulose and rifaximin. Aim for ___ bowel movements a day. If you are having fewer than ___ stools a day, increase the frequency of lactulose. If you are having more than ___ stools a day, decrease the frequency of lactulose. - Please abstain from drinking alcohol. We wish you all the best! Your ___ Care Team Followup Instructions: ___
10770392-DS-7
10,770,392
23,519,093
DS
7
2133-05-05 00:00:00
2133-05-06 21:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ pmhx CAD STEMI ___ s/p DES to ___ @ ___, gout, HFrEF (45 -> 50% on TTE), Grave's s/p RAI on levothyroxine presenting with chest pain. Patient reports feeling well since his DES. He was recently treated for lyme and finished his course of doxycycline a couple weeks ago. He has had some increasing joint pains and gout activity for which he was prescribed allopurinol. He has not taken his colchicine since ___ (was prescribed previously for a gout flare). On day of presentation 1500 after a meeting at work he developed central substernal chest pain at rest. Non-radiating. No associated symptoms. Felt similar to prior STEMI. Non-pleuritic. However, it improves with sitting up, worsens when laying flat. He takes Brilinta and aspirin in the morning. Has never missed a dose. He received 4 baby aspirin by EMS prior to arrival. The pain has persisted throughout the day. No abdominal pain, leg pain, fever, chills, cough. - In the ED, initial vitals were: 98.9, 77, 115/79, 16, 99% RA - Exam was notable for: No marked abnormalities on exam - Labs were notable for: Neg trop x2 No leukocytosis - Studies were notable for: Clean CXR - The patient was given: Nitro SL and morphine without any significant change in symptoms On arrival to the floor, he gives the above history. He also endorses longstanding issues with severe GERD. Past Medical History: CAD c/b STEMI ___ s/p ___ HFrEF EF 45% recovered to 50% Gout Grave's s/p RAI on levothyroxine Social History: ___ Family History: Strong fmhx CAD; father Physical ___: ADMISSION PHYSICAL EXAM: ======================== VITALS: ___ 0039 Temp: 98.1 PO BP: 132/81 R Sitting HR: 67 RR: 18 O2 sat: 98% O2 delivery: Ra deceased lung ca age ___ GEN: well appearing, comfortable, NAD HEENT: MMM CV: RRR nl s1/s2 no mrg PULM: CTA b/l GI: S/ND/NT EXT: WWP, non-edematous DISCHARGE PHYSICAL EXAM: ======================== 24 HR Data (last updated ___ @ 923) Temp: 98.0 (Tm 98.1), BP: 119/72 (117-132/69-81), HR: 68 (67-73), RR: 17 (___), O2 sat: 97% (97-98), O2 delivery: RA, Wt: 165.12 lb/74.9 kg Fluid Balance (last updated ___ @ 919) Last 8 hours Total cumulative -330ml IN: Total 120ml, PO Amt 120ml OUT: Total 450ml, Urine Amt 450ml Last 24 hours Total cumulative -210ml IN: Total 240ml, PO Amt 240ml OUT: Total 450ml, Urine Amt 450ml GENERAL: Lying in bed. Speaking to me in no acute distress. HEENT: NCAT NECK: No JVD. CARDIAC: S1/S2, regular, no obvious murmurs. LUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or rales. No increased work of breathing. EXTREMITIES: No lower extremity edema. His extremities are warm. SKIN: Warm. Dry. Pertinent Results: ADMISSION LABS ============== ___ 07:10PM BLOOD WBC-9.9 RBC-4.61 Hgb-13.8 Hct-42.4 MCV-92 MCH-29.9 MCHC-32.5 RDW-13.9 RDWSD-47.1* Plt ___ ___ 07:10PM BLOOD Glucose-81 UreaN-22* Creat-1.2 Na-141 K-4.2 Cl-101 HCO3-28 AnGap-12 ___ 03:35PM BLOOD ALT-66* AST-48* DISCHARGE LABS ============== ___ 06:49AM BLOOD WBC-8.7 RBC-4.50* Hgb-13.7 Hct-41.6 MCV-92 MCH-30.4 MCHC-32.9 RDW-13.8 RDWSD-46.9* Plt ___ ___ 06:49AM BLOOD Glucose-88 UreaN-20 Creat-1.1 Na-140 K-4.2 Cl-101 HCO3-24 AnGap-15 ___ 06:49AM BLOOD ALT-71* AST-54* LD(LDH)-212 AlkPhos-75 TotBili-0.9 CARDIAC MARKERS =============== ___ 06:49AM BLOOD CK-MB-1 cTropnT-<0.01 ___ 11:44PM BLOOD cTropnT-<0.01 ___ 07:10PM BLOOD cTropnT-<0.01 Brief Hospital Course: ================= SUMMARY STATEMENT ================= ___ pmhx CAD STEMI ___ s/p DES to ___ @ ___, gout, HFrEF (45 -> 50% on TTE), Grave's s/p RAI on levothyroxine presenting with chest pain. The pain was thought to be atypical for angina and a TTE only showed a mild wall motion abnormality consistent with his prior infarction. His pain had resolved by discharge. ==================== ACUTE/ACTIVE ISSUES: ==================== # Chest pain CAD/ACS vs pericarditis (esp with recurrent gout and recent lyme infxn though admittedly treated) vs musculoskeletal vs. GI pain. PR interval only mildly prolonged from baseline, otherwise EKG not markedly changed. Voltage reasonable. Trops were negative x3. Acute phase markers not highly elevated. No effusion on TTE. Overall evaluation not concerning for pericarditis, and it is likely that is pain is musculoskeletal in nature. - Trial of maalox - ___, tricagrelor # CAD, STEMI s/p ___ ___ We increased his atorvastatin from 40mg to 80mg as an outpatient. Due to the transaminases we switched the atorvastatin 80mg to ___ 20mg QD. - Home ___ - Home ticagrelor - ___ 20mg QD # HFrEF EF recovered to 50% - Home lisinopril - Home metop # Transaminitis Previously thought to be related to statin so dose reduced to 40mg. Notably not a significant improvement on lower dose of statin. RUQUS negative for hepatic steatosis although the study was limited. - hepatitis b serologies show non-immune, non-exposed status - Switched atorvastatin 80mg to ___ 20mg QD # Gout - Uric acid - 8.8 - Home allopurinol - Initiate colchicine recently prescribed by PCP (but not yet initiated by patient at home). # Graves s/p RAI - TSH 0.08 -> Asx at this time, will f/u as outpt - home levothyroxine =================== TRANSITIONAL ISSUES =================== [ ] Consider repeat TSH as an outpatient as his TSH was found to be 0.08. He did not endorse symptoms of hyperthyroidism. [ ] We switched his atorvastatin 40mg to ___ 20mg QD given the elevation in LFTs; please trend his LFTs on this new medication as he has a mild transaminitis. [ ] We started him on colchicine [prescribed as an outpatient] as he was recently started on allopurinol. Please follow up regarding sxs related to his gout after tx. [ ] Found to be non-immune to Hep B, consider vaccination if indicated. [ ] Please consider a stress echo as an outpatient Discharge Weight: 165.12 Discharge Creatinine: 1.1 Discharge Diuretic: None - New Meds: Started colchicine 0.6mg [prescribed as outpt] Started ___ 20mg QD - Stopped/Held Meds: Stopped atorvastatin 80mg QD - Changed Meds: None - Post-Discharge Follow-up Labs Needed: Please trend LFTs - Incidental Findings: Elevated LFTs - Code Status: Full - Contact Information: Wife ___ (Home) Discharge time 25 min Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 5 mg PO DAILY 2. PredniSONE 60 mg PO ONCE:PRN gout flare 3. Allopurinol ___ mg PO DAILY 4. Metoprolol Succinate XL 12.5 mg PO DAILY 5. Atorvastatin 40 mg PO QPM 6. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN CP 7. diclofenac sodium 1 % topical TID:PRN arthritis pain 8. TiCAGRELOR 90 mg PO BID 9. Aspirin 81 mg PO DAILY 10. Levothyroxine Sodium 137 mcg PO DAILY 11. Colchicine 0.6 mg PO DAILY Discharge Medications: 1. ___ Calcium 20 mg PO QPM RX ___ 20 mg 1 (One) tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 2. Allopurinol ___ mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Colchicine 0.6 mg PO DAILY 5. diclofenac sodium 1 % topical TID:PRN arthritis pain 6. Levothyroxine Sodium 137 mcg PO DAILY 7. Lisinopril 5 mg PO DAILY 8. Metoprolol Succinate XL 12.5 mg PO DAILY 9. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN CP 10. PredniSONE 60 mg PO ONCE:PRN gout flare 11. TiCAGRELOR 90 mg PO BID Discharge Disposition: Home Discharge Diagnosis: Noncardiac Chest Pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you while you were admitted to ___ ___. WHY WERE YOU ADMITTED TO THE HOSPITAL? You were admitted to the hospital so we can rule out a primary cardiac problem for your chest pain. WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL? While you were in the hospital we ran many tests including an EKG showing you heart was in a normal rhythm, a blood test that demonstrated there was no damage to your heart, and an echocardiogram that was not significant for structural abnormalities. Your liver enzymes were also elevated and it may be related to your statin use, so we changed your lipid medication from atorvastatin 80mg to ___ 20mg once a day. Finally, we started you on colchicine that was prescribed as an outpatient for your gout. WHAT SHOULD YOU DO WHEN YOU GO HOME? -Carefully review the attached medication list as we may have made changes to your medications. Sincerely, ___, MD, PhD Followup Instructions: ___
10770705-DS-7
10,770,705
22,587,359
DS
7
2129-05-27 00:00:00
2129-05-29 21:47:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: prednisone Attending: ___ Chief Complaint: DEHYDRATION AND WEAKNESS Major Surgical or Invasive Procedure: none History of Present Illness: ___ hx HTN, CAD, arthritis and inflammatory colitis p/w malaise, weakness, and worsening dyspnea on exertion for the past 6 days, +dry cough. . Wife noted weakness last evening when she had to support his body weight when he walked up an incline, which was a profound change even from his baseline use of crutches due to multiple b/l hip replacements. No focal muscle pain or weakness, just overall weakness. No sore throat, no rhinorrhea, no fever/chills, no sick contacts. Noted no improvement in dyspnea or cough w/mucinex, tylenol III or benadryl. Sleeps comfortably with 1 pillow. Does feel very dry and thirsty. No chest pain, no palpitations. No nausea, vomiting, diarrhea, abdominal pain. Some dysuria intermittently for ___ days; no hematuria, frequency or urgency. . No prior medical care at ___ so no prior records available for review; followed by PCP/gastroenterologist ___ at ___ and a cardiologist at ___. Not aware of any history of heart failure, but he does have history of MI (without chest pain) leading to PCE w/BMS, for which he continues to take ___ and ___ daily. Pt and wife report that he ambulates at baseline w/ crutches due to chronic multi-joint arthritis ongoing for several years. He required numerous joint replacements, R hip x4 and L hip x3 plus L total knee replacement. Over the past few years he has been unable to flex fingers ___ of his left hand. Also notes 40-lb weight loss over the past ___ years. At baseline he is minimally ambulatory with crutches. . Today in the ED his initial ED VS 98 70 171/92 20 96%. Exam notable for lack of respiratory distress despite BNP 12K, troponin 0.03. WBC and Hct wnl. ED CXR showed b/l pleural effusions, cardiomegaly and pulmovascular congestion concerning for heart failure exacerbation, cannot exclude PNA. Bedside TTE in the ED negative for pericardial effusion. Given 325 ___, 750 IV levaquin and admitted for workup of CHF. Transfer VS T 98.9 BP 131/66 HR 78 RR 16 97/RA. . Past Medical History: PMH: 1. CAD s/p MI w/PCI & BMS placement at ___ ___ 2. Arthritis, type unknown (AM stiffness), affects neck, hands, wrists, hips, knees 3. Hip replacement at ___ (R x4, L x3, c/b septic joints thought ___ bacteremia from oral flora) 4. L total knee replacement ___ 5. hypertension 6. hyperlipidemia 7. "colitis" (not UC or Crohn's), diarrhea ___ yrs, on sulfasalazine 8. atrial fibrillation 9. nephrolithiasis 10. CKD "one kidney doesn't work" 11. Peripheral vascular disease . ADDENDUM ___: RECORD REVIEW from ___: ----Most recent LVEF: 32% in ___ 43% in ___ echo C. CATH x 2: - ___ BMS to mid-LAD - ___ DES to mid-LAD stent for 70% instent restenosis; OM1 occluded at ostium with collaterals from LAD, RCA occluded proximally (known) with collaterals filling ----last stress echo ___ showed no ischemia on EKG; dense posterobasal scar, incomplete inferolateral scar ----H/O afib/flutter s/p failed cardioversion x 2 ___ and ___. refuses coumadin ----h/o Anemia of chronic disease ----h/o OSA refusing CPAP ----h/o CKD with ___ creatinine 1.3-1.4 --___ hosp at ___ in ___ for hydronephrosis in right solitary kidney (left is atrophic); tx with abx which finished on ___ ----h/o nephrolithiasis s/p ureteral stent placement and ? removal ___ Social History: ___ Family History: No history of cardiac disease, arrhythmia or sudden death. Physical Exam: ADMISSION EXAM: GEN well-appearing thin elderly male lying in bed NAD HEENT NCAT EOMI PERRL OP clear (numerous fillings) MMM NECK supple no JVD no LAD PULM CTAB, no wheeze, dull bases, poor expansion ABD soft, scaphoid, nontender nondistended +NABS, no sacral edema EXT WWP + palpable pulses, minimal non-pitting pedal edema, + intraosseous extensor muscle wasting both hands JOINT no joint effusions; +ulnar deviation all digits NEURO AOX3, CNs intact, strength ___ throughout except unable to actively flex digits ___ L hand. No focal sensory deficits. Reflexes/gait not assessed. DISCHARGE EXAM: GEN well-appearing thin elderly male lying in bed NAD NECK supple no JVD no LAD ___ RRR no m/r/g PULM CTAB, no wheeze; barrel chest, decreased BS at right base ABD soft, scaphoid, nontender nondistended +NABS, no sacral edema EXT WWP + palpable pulses, no edema, atrophy of interosseous muscles of hands bilaterally, enlarged MP joints and carpal joints, decreased mobility in right fingers - cannot flex fingers actively but can do so passively JOINT no joint effusions; +ulnar deviation all digits Pertinent Results: ADMISSION LABS: ___ 01:50PM BLOOD WBC-6.1 RBC-3.92* Hgb-13.0* Hct-39.3* MCV-100* MCH-33.3* MCHC-33.2 RDW-12.7 Plt ___ ___ 01:50PM BLOOD Neuts-61.5 ___ Monos-5.4 Eos-3.7 Baso-0.5 ___ 01:50PM BLOOD ___ PTT-37.2* ___ ___ 01:50PM BLOOD Glucose-92 UreaN-29* Creat-1.8* Na-142 K-4.9 Cl-111* HCO3-21* AnGap-15 ___ 01:50PM BLOOD ALT-24 AST-36 AlkPhos-68 TotBili-0.5 ___ 01:50PM BLOOD ___ ___ 01:50PM BLOOD Albumin-4.0 Calcium-9.0 Phos-3.6 Mg-2.1 OTHER LABS: ___ 02:04PM BLOOD Lactate-1.5 ___ 01:50PM BLOOD RheuFac-10 ___ 08:33PM BLOOD ___ ___ 01:50PM BLOOD cTropnT-0.03* ___ 09:20PM BLOOD CK-MB-4 cTropnT-0.02* ___ 09:10AM BLOOD CK-MB-3 cTropnT-0.02* DISCHARGE LABS: ___ 06:20AM BLOOD WBC-6.3 RBC-3.55* Hgb-12.0* Hct-35.7* MCV-100* MCH-33.7* MCHC-33.5 RDW-12.2 Plt ___ ___ 06:20AM BLOOD Glucose-86 UreaN-27* Creat-1.6* Na-140 K-4.1 Cl-105 HCO3-26 AnGap-13 ___ 06:20AM BLOOD Calcium-8.7 Phos-2.8 Mg-1.8 IMAGING: CXR ___: AP and lateral views of the chest. No prior. There are bibasilar opacities compatible with small effusions, larger on the right than on the left. There is engorgement of the pulmonary vasculature with indistinct vascular markings peripherally. The cardiac silhouette is enlarged. Severe degenerative changes are partially visualized at the glenohumeral joints bilaterally. Osseous and soft tissue structures are otherwise unremarkable. CXR ___: 1. Resolved pulmonary edema and vascular congestion from ___ status post diuresis. 2. Stable small bilateral pleural effusions on the right greater than the left. 3. Stable cardiomegaly. Brief Hospital Course: ___ w/multiple medical problems p/w ___ days weakness, fatigue and dry cough; ED labs/CXR consistent with acute on chronic systolic heart failure with question of underlying rheumatologic process. # acute on chronic systolic heart failure: DOE consistent with CHF exacerbation given BNP 12K, and exam/CXR w/volume overload. No e/o PNA on CXR and he was afebrile throughout admission so there was low suspicion for pneumonia as cause of DOE. CXR did show bilateral pleural effusions, R>L. TTE ___ consistent with prior echos showing infarct at least as old as ___ LVEF 40%. Trops neg x 3 (stable at 0.03 in setting of CKD). EKG showed no ischemic changes. Trigger for CHF exacerbation was thought to be UTI (see below). pt was diuresed with IV lasix and was weaned off O2 within 24 hours of admission. He reported feeling much better s/p diuresis and appeared euvolemic at the time of discharge and was ambulating with ___, who recommended home with ___. Pt refused home ___ services despite our recommendation. In house he was continued on ___, and lisinopril stopped for ___. On the day of discharge, repeat CXR was obtained due to persistence of decreased breath sounds at right lung base despite diuresis. CXR showed continued stable pleural effusions, R>L. Primary team found this concerning, especially in setting of a chronically ill appearing man with history of weight loss and possibly undiagnosed rheumatologic disease. Recommended pt stay for diagnostic tap of pleural effusion but he refused and insisted on leaving. Explains the risks of going home, including missed diagnosis of cancer, but pt chose to leave despite this information. discharged pt on small dose of maintenance lasix with cards follow up. He agreed to pursue evaluation of the right pleural effusion as an outpatient, and this was discussed with his cardiologist at ___. # rheumatologic disease/gout: Story of AM stiffness which improves w/use throughout the day, w/minimal relief from glucosamine chondroitin and tylenol arthritis are suggestive of an inflammatory joint disease rather than degenerative disease. Pattern of ulnar deviatiation in all digits and hx numerous joint replacements is concerning. Additionally, atrophy of interosseous muscles of hand bilaterally would be unusual for OA and is more consistent with RA. However, ___, RF, CCP all negative. Pt had completely lost ability to flex his right fingers and could only move them passively. He stated the immobility was due to weakness, not tightness of skin, but his fingers were somewhat shiny and sausage-like, which could be suggestive of scleroderma. However, muscle atrophy can occur in RA and could also cause these sx. Lastly, the night before discharge pt developed acute gouty flare in left first MTP joint and was treated with colchicine. He had never had gout before. Ultimately, the picture for rheumatologic disease was suspicious enough to warrant recommendation of outpatient rheum follow up, which has to be set up by PCP at ___, where most of patient's care takes place. # Weakness/fatigue: Likely multifactorial etiology including CHF as discussed above, UTI, and possibly undiagnosed rheumatologic disease. Pt was treated for UTI and CHF exacerbation and his symptoms were improved by the time of discharge. He ambulated well with ___ as above and, though they recommended home with ___, he refused this. # UTI: UA positive and pt c/o dysuria so he was treated empirically with one dose of IV levaquin 750mg in ED and continued on cipro 500mg po q12h on the floor. Planned for 7 day course. UCx grew only diphtheroids, so no sensitivities were ever obtained. # acute on chronic renal failure: per ___ records his baseline is 1.3-1.4. Recently admitted to ___ with hydronephrosis of solitary right functioning kidney with Cr elevated to 1.6 on admission, down to 1.3 on discharge. Cr fluctuating between 1.7-1.8 here at ___ (1.8 on admission). FeUrea 41% which is c/w ATN. u/a was bland on admission. improved to 1.6 on day of discharge. stopped lisinopril. continued lasix due to need for diuresis in setting of heart failure and continued ___ in setting of CAD history. continued home PO bicarb. recommended outpatient follow up. # HTN: continued carvedilol, stopped lisinopril given ARF as noted above # Hx colitis: presumed IBD since pt takes sulfasalazine at home, but pt/wife deny hx of Crohn's or ulcerative colitis. continued sulfasalazine. # CAD: s/p BMS x 1 to LAD in ___ with instent restenosis and ___ 1 to LAD stent in ___ ___E neg x 3 at ___ and echo findings c/w with prior records from ___ so no evidence of ACS being cause of fatigue. cont home meds of ___, carvedilol. held lisinopril in setting of ___. continued crestor # bradycardia/aflutter: pt in aflutter throughout admission. no RVR but occasion episodes of bradycardia to ___ overnight. consulted cards who were unconcerned as bradycardia occurs only during night when pt sleeping and never during day. cards did rec DCCV for aflutter but patient can get this with home cardiologist. He will follow up with his usual cardiologist re: anticoagulation and DCCV. Offered to provide script for coumadin or pradaxa to begin anticoag but pt could not decide which he would prefer so no prescription given and cards f/u appt made. continued carvedilol Medications on Admission: Carvedilol 6.25 BID Sulfasalazine 1000 mg BID Aspirin 325 QD ___ 75 QD Lisinopril 5 QD Sodium Bicarb 650 mg BID crestor 5mg daily MV QD OTC Tylenol arthritis PRN OTC Glucosamine chondroitin QD Discharge Medications: 1. carvedilol 6.25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 2. sulfasalazine 500 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 3. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 4. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. sodium bicarbonate 650 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 6. rosuvastatin 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q8H (every 8 hours) as needed for pain. 9. glucosamine-chondroitin Oral 10. furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp:*30 Tablet(s)* Refills:*0* 11. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) for 7 doses: last dose ___. Disp:*7 Tablet(s)* Refills:*0* 12. colchicine 0.6 mg Tablet Sig: One (1) Tablet PO once a day. Disp:*10 Tablet(s)* Refills:*0* Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis: acute on chronic systolic heart failure acute on chronic renal failure urinary tract infection pleural effusions, R>L acute gouty arthritis Secondary Diagnosis: inflammatory arthritis NOS colitis NOS Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: You came to the hospital because you had shortness of breath with exertion. You were volume overloaded and found to have an exacerbation of your heart failure. You were also found to have a urinary tract infection (UTI). You were given antibiotics to treat your UTI and a diuretic to reduce the extra fluid on your body. You had an echocardiogram that did not show any new cardiac problems. You were, however, found to have fluid in your thorax (pleural effusion) and were recommended to stay and have that evaluated, but you declined. You were also recommended home physical therapy but you refused it. While you were here you developed gout and were started on colchicine to treat this. The following changes were made to your medications: STOPPED lisinopril due to your kidney problems (please ask your doctor when it is safe to restart this) STARTED furosemide 20mg daily to prevent reaccumulation of fluid STARTED ciprofloxacin 500mg twice a day (last dose ___ for UTI STARTED colchicine 0.6mg daily for gout Followup Instructions: ___
10771213-DS-15
10,771,213
25,469,071
DS
15
2173-07-09 00:00:00
2173-07-10 14:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: LLE wound Major Surgical or Invasive Procedure: I&D ___ punch biopsy ___ History of Present Illness: Mr. ___ is a ___ with CKD, DM, CHF (unknown EF) who was recently discharged to rehabilitation after OSH admission now presenting with ___ pressure ulcer. Reportedly admitted to ___ on ___ with COPD/CHF exacerbation and was treated with nebulizers, steroids and Lasix (per notes from ___ pt says he had PNA). Found to have large ___ wound with tissue edema and hematoma at nursing home, transferred back to ___ on ___ and underwent debridement. After transfer to nursing home, he was felt to need further care for his ___ edema and leg wounds, and transferred to ___ (___). Sent to the ___ ED ___ for concerns for new LUE swelling as well as increased erythema and pain of LLE ulcer site. Pt says the swelling and pain in the leg has gotten worse over the past week, only painful when touched (___). He does not recall having a PICC in place this past month. In the ED, vitals stable, heparin gtt started for LUE US showing L basilic clot, vanc/zosyn started for presumed superinfection ___ ulcer. ACS consulted and recommended admission to medicine. This AM, pt reports being hungry and having loose stools yesterday, only having pain when LLE site touched but not otherwise. Past Medical History: LLE wound s/p debridement COPD HTN Hyperlipidemia CHF (EF not mentioned in notes) Type 2 DM Stage 3 kidney disease (no documentation of baseline Cr) Anemia, recent transfusion Obesity PVD s/p amputation of L toes esophageal CA (cared for at ___, doing periodic surveillence, no treatment yet) prior hip surgery Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: VS - 98.2, 97.8, 146-150/61-70, 79-92, 96-99% 2L, fs 150 GENERAL - chronically ill-appearing elderly man in NAD, comfortable, appropriate HEENT - NC/AT, sclerae anicteric, MMM, OP clear LUNGS - scattered rhonchi with loud expiratory breath sounds HEART - regular rhythm, no MRG, nl S1-S2 ABDOMEN - NABS, obese, soft/NT/ND EXTREMITIES - 2+ BLE edema to knees, 1+ BUE edema in forearms. LLE posterolateral calf ulceration approximately 8x5cm with surrounding eschar, surrounded by 2x2 cm fluctuant area with erythema and tenderness. NEURO - awake, A&Ox3, CNs II-XII grossly intact DISCHARGE PHYSICAL EXAM: Pertinent Results: ADMISSION LABS: ___ 06:50PM BLOOD WBC-7.2 RBC-3.46* Hgb-10.4* Hct-32.4* MCV-94 MCH-30.1 MCHC-32.1 RDW-14.5 Plt ___ ___ 06:50PM BLOOD Glucose-166* UreaN-30* Creat-2.0* Na-138 K-4.9 Cl-95* HCO3-35* AnGap-13 ___ 06:50PM BLOOD CK-MB-2 cTropnT-0.04* ___ 09:20AM BLOOD CK-MB-3 cTropnT-0.04* ___ 01:58PM BLOOD Albumin-2.5* Calcium-7.6* Phos-3.9 Mg-1.8 MICRO: Wound culture ___: ___________ STUDIES: CXR ___: Small to moderate bilateral effusions. Please note that basilar consolidation cannot be completely excluded. BLE ultrasound ___: Bilateral calf veins not visualized due to significant superficial soft tissue edema. No DVT noted in all visualized veins bilaterally. LUE ultrasound ___: Thrombus in the left basilic vein with intermittent patchy flow. ABI/PVRs ___: No evidence of peripheral vascular disease in either lower extremity. Biopsy of LLE wound ___: ___________ Brief Hospital Course: ___ with HTN, HLD, CHF with unknown EF, COPD, CKD, and LLE wound s/p recent debridement who presents with worsening erythema of the LLE wound and new LUE DVT. # LLE wound: Initially appeared necrotic on admission, and he was started on vanc/zosyn (soon changed to vanc/cipro/flagyl) given extensive history of recent hospitalization/rehabilitation exposure. Despite recent debridement two weeks ago at OSH, a new area of fluctuance was debrided again by general surgery on ___, which showed no pus, and wound cultures were obtained. Vascular surgery was consulted and found no indication for revascularization or angiography as arterial flow seems intact on exam and noninvasive testing. The violaceous appearance after debridement made the surgeons concerned for pyoderma gangrenosum, and dermatology was consulted to obtain a biopsy, which is highly suggestive of pyoderma gangrenosum. At the time of discharge the final stains are still pending and will need to be followed up by the rehabilitation physician. Patient was started on minocycline. A G6PD level is pending and will need to be follow up. If this returns normal he will need to be started on dapsone. . # LUE basilic vein thrombosis: OSH records show ___ placed ___, unclear when it was removed. Heparin gtt started on admission on ___, but he bled actively out of the despite tight wrapping and eventually required suturing and 2U pRBC transfusion after Hct dropped from 33 to 25 (asymptomatic, hemodynamically stable). Heparin gtt was discontinued on ___ when it was clear that the risks of anticoagulation exceeded the risk. His HCT remained stable for the remainder of his stay. # Elevated troponin: 0.04 on admission, Likely ___ renal failure given MB not elevated. ECG was not concerning for ACS. He was continued on aspirin 325 mg. # Presumed acute on chronic CHF, unknown EF: There was a concern for mild volume overload on admission. He was continued on his home furosemide and beta-blocker, and was given nebulizers as needed. # Acute on chronic renal failure: Admission Cr 2.0, baseline possibly between 1.3-1.5 based on OSH. # Normocytic anemia: Chronic per notes, unknown baseline, likely related to CKD. # type II DM: Glucose control will be important for wound healing. His finger stinks have remained less than 150 without insulin support but will need ___ monitored closely during rehab stay. ****Transitional issues***** - Follow up final biopsy results- Page On Call Dermatology resident ___, PAGER ___ On ___ for update. - Follow up G6PD level as well. If normal will need to start dapsone per dermatology recs. - Continue BID dressing changes with adaptec and dry gauze ocvering. DO NOT DEBRIDE further. - Patient has pendign conective tissue disease work up: tests negative or WNL including: Will need to follow up ___, ANCA, Anti-Phospholipid Antibody, RPR, SPEP and UPEP Medications on Admission: The Preadmission Medication list is accurate and complete. 1. NovoLOG *NF* (insulin aspart) 100 unit/mL Subcutaneous sliding scale 2. Aspirin EC 325 mg PO DAILY 3. Potassium Chloride (Powder) 10 mEq PO DAILY Hold for K > 4. Furosemide 20 mg PO DAILY 5. Metoprolol Tartrate 50 mg PO BID 6. Omeprazole 20 mg PO DAILY 7. traZODONE 75 mg PO HS 8. DiCYCLOmine 10 mg PO DAILY 9. Sulfameth/Trimethoprim DS 1 TAB PO DAILY 10. FoLIC Acid 1 mg PO DAILY 11. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 12. Acetaminophen 650 mg PO Q6H:PRN pain 13. Calcium 500 With D *NF* (calcium carbonate-vitamin D3) 500 mg(1,250mg) -400 unit Oral daily 14. Atorvastatin 10 mg PO DAILY 15. Docusate Sodium 100 mg PO BID 16. Fondaparinux 2.5 mg SC DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Aspirin EC 325 mg PO DAILY 3. Atorvastatin 10 mg PO DAILY 4. DiCYCLOmine 10 mg PO DAILY 5. Docusate Sodium 100 mg PO BID 6. FoLIC Acid 1 mg PO DAILY 7. Furosemide 20 mg PO DAILY 8. Metoprolol Tartrate 50 mg PO BID 9. Omeprazole 20 mg PO DAILY 10. traZODONE 75 mg PO HS 11. Calcium 500 With D *NF* (calcium carbonate-vitamin D3) 500 mg(1,250mg) -400 unit Oral daily 12. Fondaparinux 2.5 mg SC DAILY 13. NovoLOG *NF* (insulin aspart) 100 unit/mL Subcutaneous sliding scale 14. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain 15. Potassium Chloride (Powder) 10 mEq PO DAILY Hold for K > 16. Minocycline 100 mg PO BID Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: pyoderma gangrenosum Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure participating in your care at ___. You were diagnosed with an inflammatory process in your leg called pyoderma gangrenosum. This is not an infection. You were also found to have a clot in your left forearm that you should continue to treat with warm compresses. Followup Instructions: ___
10771301-DS-7
10,771,301
28,550,538
DS
7
2165-08-22 00:00:00
2165-08-22 16:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: N/V/D, dehydration. Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ man with head and neck cancer 5d s/p chemoXRT admitted for N/V/D, severe throat pain, and dehydration. His symptoms have been steadily worsening over the week and for ~2 days, he has not been able to eat or drink anything. PO intake causes chest pain/burning. He also has had worsening productive cough and sputum production, which he suctions. He has been confused, talking to people that are not present; the family states this happens when he becomes dehydrated. He feels dizzy at times and short of breath. He also notes occasional shaking chills, but no fever, headache. There has been blood and coffee grounds in his vomit. He has been using Aquaphor for the skin breakdown on his neck. . ROS: He denies fever, sweats, visual changes, abdominal pain, back pain, constipation, hematochezia, melena, hematuria, other urinary symptoms, or paresthesias. All other ROS were negative. Past Medical History: Oncologic history: Mr. ___ was undergoing treatment for renal calculi and at the time of his elective intubation for this procedure, a right hypopharyngeal mass was discovered. He was seen by Dr. ___ and in his office was noted to have a right hypopharyngeal mass encroaching on the arytenoid, as well as right vocal cord immobility. He underwent a CT scan which was performed on ___, on which was noted a mass which appeared to be centered in the right piriform sinus with possible involvement of the supraglottis and posterior hypopharyngeal wall and extensive right-sided metastatic adenopathy. He then went on to undergo a direct laryngoscopy with biopsy, and esophagoscopy in the OR. The pathology of this came back invasive squamous cell carcinoma, poorly differentiated. He also had a GE junction biopsy at that time that was unremarkable. He started cisplatin on ___ and finished chemoXRT ___. . OTHER PMHx: 1. Hypertension. 2. History of pain in the knees, particularly on the left side. 3. Kidney stones. 4. Prior back trouble. Social History: ___ Family History: His father died of some sort of cancer; however, he also had renal failure needing dialysis. Physical Exam: Admission Physical Examination: VS: T 99.0F, BP 121/87, HR 103, RR 18, O2 sat 99% RA, I/O . GEN: A&Ox2 (wrong day, date, and year), NAD. HEENT: Sclerae non-icteric, PEARLA, EOM intact, oropharyngeal erythema, dry MM, copious secretions. Neck: Supple, no JVD, no thyromegaly, no cervical LAD. CV: S1S2, RRR, no MRG. RESP: Good air movement bilaterally, no rhonchi or wheezing. BACK: No spine, rib, or iliac tenderness. ABD: Soft, non-tender, non-distended, no HSM, bowel sounds present. EXTR: No edema or calf tenderness. DERM: Erythema/darkened skin at neck with skin breakdown on the right side (~4x2cm). Neuro: Strength ___, no focal deficits. PSYCH: Appropriate and calm. Pertinent Results: ADMISSION LABS: ___ 11:30PM BLOOD WBC-2.2* RBC-3.29* Hgb-9.8* Hct-28.3* MCV-86 MCH-29.6 MCHC-34.5 RDW-14.8 Plt ___ ___ 11:30PM BLOOD Neuts-82.2* Lymphs-7.2* Monos-8.7 Eos-1.5 Baso-0.4 ___ 12:22AM BLOOD ___ PTT-25.8 ___ ___ 11:30PM BLOOD Glucose-90 UreaN-26* Creat-1.6* Na-141 K-3.4 Cl-95* HCO3-29 AnGap-20 ___ 11:30PM BLOOD Albumin-4.4 Calcium-10.0 Phos-3.7 Mg-2.2 ___ 11:30PM BLOOD ALT-15 AST-13 AlkPhos-71 TotBili-0.5 ___ 11:30PM BLOOD Lipase-16 ___ 11:30PM BLOOD cTropnT-<0.01 . ___ CT NECK: IMPRESSION: 1. Stable appearance of hypopharyngeal mass since ___. Interval decrease in bilateral cervical adenopathy. 2. No abscess or fluid collection. ATTENDING NOTE: The hypopharyngeal lesion appears smaller than prior study. . ___ CTA CHEST: IMPRESSION: No pulmonary embolism or other acute process in the chest. . ___ CXR: IMPRESSION: Lung volumes are slightly low, exaggerating heart size top normal. Lungs grossly clear. No pleural abnormalities. . DISCHARGE LABS: Brief Hospital Course: Assessment/Plan: ___ year old male with head and neck cancer s/p chemoXRT amitted with nausea, vomiting, diarrhea, throat pain, and dehydration. He had severe pain and symptom, which medication regimens were optimized. Increased dose of fentanyl patch helped to control pain better. Pt reports staying in ___ with friends for ___ weeks before returning to home in ___ area. Arrangements for patient to see PCP and ___ ONc and Med Onc teams have been made. Coordination of care plans as an outpatient should need to be well executed for this patient. At time of discharge, patient symptoms better controlled, but he can have episodes of pain after cough/clearing through which can precipitate nausea and vomiting. He has been instructed to take medications preventatively and with breakthru pain. Other details below: # Nausea/vomiting/nutrition: Initially nausea/vomiting chemo-related, then difficulty swallowing secretions and po intake poor due to pain. Now tolerating full liquids. - drinking 4 shakes daily currently - Diet full liquid with Nepro/Ensure, nutrition service followed. - Likely will be able to avoid PEG tube placement - Frequent suctioning of oral secretions - Preemptive medication for pain and nausea control. - Will need guidance for pain med titration, to be done with PCP and onc teams. # Head and neck cancer: Completed chemoXRT ___. - Dr. ___ is primary oncologist. Next appt pending. # Hx Febrile neutropenia: On 7day course of cipro for Klebsiella UTI and no fevers recently. Finished on cipro on ___. - blood cultures no growth. - WBC count improving since neupogen started on ___. Neupo given for 2 days only. Though on ___ labs, WBC dropped to 2.8. Monitor for now. Likely IVF fluid related given ___ ___. # Pancytopenia: Chemo-induced. Overall, improving. - Neupogen use as above. # Throat and chest pain (throat/chest): Due to mucositis and radiation esophagitis. - was on morphine PCA, now on Fentanyl 100mcg patch and increase prn oral morphine solution - Appreciate palliative care consult - Magic Mouthwash solution prn - Nystatin suspension in case of oral/esophageal candidiasis unseen - Per case management, will need to call physician closer to home to set up appropriate outpatient free medication services. Will have this done with PCP if needed. # Radiation skin ulceration: Grade 2 skin breakdown. Wound Care consulted. Aquaphor. Improved. # Acute on CKD: Resolved with IV fluids. - Holding HCTZ and ACE-I. # HTN: Holding HCTZ and ACE-I given dehydration and creatinine elevation. Currently normotensive. - ___ not need meds if BP remains normotensive. Will hold off on these medications for now. Should follow up with PCP for future need. # Elevated INR: Improved with vitamin K supplementation # Anxiety: Improved, standing ativan dc'd. PRN ativan. # Hematemesis: Resolved. - lansoprazole dissolving tabs Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ondansetron 8 mg PO Q8H:PRN Nausea 2. Dexamethasone 4 mg PO Q12H Take for 3 days following chemotherapy. 3. Enalapril Maleate 20 mg PO DAILY 4. Benzonatate 100 mg PO TID:PRN Cough 5. Lorazepam ___ mg PO Q4H:PRN Nausea, anxiety, insomnia 6. Guaifenesin 10 mL PO Q6H:PRN Thickened mucus 7. Fentanyl Patch 25 mcg/h TP Q72H 8. OxycoDONE-Acetaminophen Elixir ___ mL PO Q4H:PRN Pain 9. Ibuprofen 600 mg PO Q8H 10. Metoclopramide 10 mg PO QID:PRN Nausea 11. Hydrochlorothiazide 25 mg PO DAILY 12. Maalox/Diphenhydramine/Lidocaine ___ mL PO Q4H:PRN Throat/mouth pain Discharge Medications: 1. Benzonatate 100 mg PO TID:PRN Cough RX *benzonatate 100 mg 1 capsule(s) by mouth three times a day Disp #*90 Capsule Refills:*1 2. Aquaphor Ointment 1 Appl TP TID:PRN Rash RX *white petrolatum [Aquaphor with Natural Healing] 41 % Apply to skin three times a day Disp #*1 Bottle Refills:*11 3. Lansoprazole Oral Disintegrating Tab 30 mg PO BID RX *lansoprazole 15 mg 2 tablet(s) by mouth twice a day Disp #*120 Tablet Refills:*1 4. Fentanyl Patch 100 mcg/h TP Q72H RX *fentanyl 75 mcg/hour 1 patch every 72 hrs Disp #*1 Box Refills:*0 5. Lorazepam 0.5-1 mg PO Q6H:PRN anxiety, nausea RX *lorazepam 0.5 mg ___ tab by mouth every six (6) hours Disp #*60 Tablet Refills:*0 6. Ondansetron 8 mg PO Q8H:PRN Nausea RX *ondansetron 8 mg 1 tablet(s) by mouth every eight (8) hours Disp #*60 Tablet Refills:*11 7. Guaifenesin 10 mL PO Q6H:PRN Thickened mucus RX *guaifenesin 100 mg/5 mL 10 ml by mouth q 6 h Disp #*1 Bottle Refills:*1 8. Morphine Sulfate (Oral Soln.) ___ mg PO Q1H:PRN pain RX *morphine 10 mg/5 mL ___ mg by mouth every four (4) hours Disp #*1 Bottle Refills:*11 9. Nystatin Oral Suspension 5 mL PO TID RX *nystatin 100,000 unit/mL 5 ml by mouth three times a day Disp #*1 Bottle Refills:*3 10. Docusate Sodium (Liquid) 100 mg PO BID RX *docusate sodium 60 mg/15 mL 15 ml by mouth twice a day Disp #*1 Bottle Refills:*11 11. Senna 5 ML PO BID RX *sennosides [senna] 8.8 mg/5 mL 5 ml by mouth twice a day Disp #*1 Bottle Refills:*5 12. Maalox/Diphenhydramine/Lidocaine 15 mL PO QID:PRN throat pain Discharge Disposition: Home Discharge Diagnosis: 1. Nausea/vomiting. 2. Diarrhea. 3. Mucositis (inflammation in mouth/throat). 4. Esophagitis (inflammation in esophagus). 5. Dehydration. 6. Altered mental status (confusion). 7. Head and neck cancer. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital for nausea, vomiting, diarrhea, and dehydration. You had not been able to eat or drink because of mucositis/esophagitis (inflammation in the mouth/throat/esophagus) due to radiation therapy but your pain improved and you were able to start eating again. It is very important that you continue to take your nutrition shakes after discharge. You will be given a 1 week supply when you leave, but you may need to purchase additional cans for future use if needed. You were also given IV fluids and pain medication. Your blood counts were also very low and you were given neupogen to stimulate your blood counts. You were also treated for a UTI with ciprofloxacin, which you have completed. PATIENT INSTRUCTIONS: 1. You have many medications. Be sure you know how to use each one. 2. For pain, you have been instructed on how to use "breakthru" medication. Try to use medications before you cough when you remove mucous, or when you eat. Preventative treatment will lessen pain. 3. Follow up with your multiple appointments. CALL YOUR PCP or any of your doctors ___ have questions. Remember to ASK if you have ANY questions. There are always translators available. If not, find someone who speaks ___ to help you. 4. For pain medications, these can make you constipated. Be sure you take bowel regimen medications. 5. Your first appointment with Dr ___ is on ___. See below. Followup Instructions: ___
10771901-DS-6
10,771,901
24,977,017
DS
6
2166-06-11 00:00:00
2166-06-11 18:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Headache, Fever Major Surgical or Invasive Procedure: Lumbar Puncture, ___ History of Present Illness: Patient is a ___ y/o F with an unremarkable PMH who presents with fever x1 week and HA/arthralgias x2 days. Patient reports that she was in her USOH until this past ___ (___), when she developed fever to 100.9. The following day, she developed severe headache (___), which she describes as a pressure behind her eyes and associated with photophobia. Headache persisted all week and did not improve with ibuprofen. She additionally endorses pressure sensation behind her eyes and sensitivity to light. She saw her PCP on ___, who recommended continuing ibuprofen alternating with tylenol for pain. Patient vomited on ___, so went for an urgent care appointment and was referred to the ED. Patient also reports pain/weakness in her legs, particularly in her knees (left weaker than right). This started 2 days PTA, and she has never had any sort of joint or muscle problems in the past. Additionally, she reports that her arms have occasionally felt "numb" on standing. She does not endorse focal weakness however and feels that she has diffuse weakness in her legs currently more secondary to pain in her joints and legs. Also of note, she complains of trouble sleeping secondary to aching in her legs particularly her knees and ankles bilaterally. Patient reports no recent illness and denies any sore throat, congestion, rhinorrhea, or rash. With regards to sick contacts, patient reports that her roommate recently had a sore throat. She denies any recent travel, insect bites, or rash. She is otherwise healthy with immunizations up-to-date. Denies changes in vision, neck stiffness, and confusion. Also denies diarrhea, SOB, abdominal pain, dysuria. LP from the ED notable for WBC 61 with 55 lymphocytes, protein/glucose WNL (___), gram stain negative for microorganisms. Patient given ceftriaxone and acyclovir for meningitis and ketorlac, acetaminophen, and oxycodone for pain. In the ED, initial vitals were: T 98.4, HR 72, BP 113/63, RR 16, O2 98%RA Vitals prior to transfer were: T 98.5, HR 74, BP 114/75, RR 16, O2 99% RA Review of systems: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies sinus tenderness, rhinorrhea or congestion. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Past Medical History: Urinary Tract Infection Vaginitis Egg retrieval Bilateral ___ Social History: ___ Family History: Father Alive ___ ___ Grandfather ___ CAD/PVD - Early Maternal Grandmother Alive Cancer - ___ Mother Alive ___ - ___ gastric bypass Paternal Grandfather Alive ___ ___ Grandmother Alive CAD/PVD Sister Alive(2) Healthy Physical Exam: PHYSICAL EXAM ON ADMISSION: ======================== Vitals: T 98.3, BP 133/79, HR 71, RR 18, O2 100RA. General: Alert, oriented, no acute distress but appears slightly drowsy HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRLA Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema MSK: ___ knee pain on active > passive motion, also endorses pain in ankles Neuro: CNII-XII intact, full strenth ___ in UE (very slight weakness in L>R though effort dependent and somewhat limited by pain), ___ ___ weakness, grossly normal sensation, impaired gait ___ leg pain. PHYSICAL EXAM ON DISCHARGE: ====================== VS: T 97.8, BP 97/44, HR 61, RR 18, O2 99% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRLA. No pain with leftward and rightward gaze. Neck: Supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema MSK: L knee stiffness, improved. No swelling appreciated. Neuro: CN II-XII intact, ___ strength in upper and lower extremities Pertinent Results: LABS ON ADMISSION: ============== ___ 05:40AM BLOOD WBC-8.3 RBC-3.99* Hgb-12.7 Hct-36.2 MCV-91 MCH-31.8 MCHC-35.1* RDW-12.6 Plt ___ ___ 05:40AM BLOOD Plt ___ ___ 05:40AM BLOOD Glucose-113* UreaN-13 Creat-0.7 Na-139 K-4.0 Cl-104 HCO3-24 AnGap-15 CSF: 61 WBC (55%L, 13%N, 29% M), 1 RBC. TProt 26, Gluc 58 (serum = 113). ___ neg; Cx neg. (___) ========================= ___ 7:00 pm SEROLOGY/BLOOD RAPID PLASMA REAGIN TEST (Final ___: NONREACTIVE. LYME SEROLOGY (Final ___: NO ANTIBODY TO B. ___ DETECTED BY EIA. ___ 6:49 am CSF;SPINAL FLUID GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): POLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. FLUID CULTURE (Preliminary): NO GROWTH. Blood Parasite Smear: neg (___) HSV PCR: neg (___) Enterovirus PCR: neg (___) Varicella PCR: neg (___) HIV viral load negative (___) PENDING RESULTS: ============= ___ 19:04 BORRELIA BURGDORFERI ANTIBODY INDEX FOR CNS INFECTION Results Pending ___ 07:00PM BLOOD ANAPLASMA PHAGOCYTOPHILUM AND EHRLICHIA CHAFFEENSIS ANTIBODY PANEL (IGM AND IGG) -PND Brief Hospital Course: Patient is a ___ y/o F with an unremarkable PMH who presents with fever x1 week and HA with ___ arthralgiasx2 days, found to have CSF notable for 61 WBCs with 55 lymphocytes, concerning for viral meningitis. # Meningitis w/arthralgias The patient presented initially with a week long history of headache and fevers that worsened in nature the day of admission. On admission lumbar puncture was obtained which was notable for: protein/glucose WNL (___), WBC 61 with 55 lymphocytes, supportive of potential viral etiology. The patient was subsequently started on acyclovir for empiric coverage of HSV encephalitis. Bacterial meningitis ruled out with negative gram stain and culture. Infectious work-up ultimately revlealed negative viral studies in the CSF (negative HSV, VZV, enteroviral panel). HIV viral load also noted to be negative. As such acyclovir was discontinued. Given patient's headache with associated arthralgias and stiffness in her lower extremeties particularly her knees L > R there was some concern for lyme and anaplasma as causative agents of meningitis. Infectious disease consulted and recommended empiric coverage of these agents with ceftriaxone and doxycycline. Lyme serologies were negative, however she was presumptively treated for CNS lyme disease and anaplasma with high-dose doxycycline (200mg BID) given Lyme Ab in the CSF and anaplasma serologies were pending at the time of discharge (anticipate they will result within 10 days) and that it is plausible that these studies would be negative early in the course of disease. If CSF Lyme (borrelia studies) or anaplasma serologies should return positive then patient should be referred to ___ clinic and continued on doxycyline until that time. #Headache The patient was noted to have an ongoing headache throughout the course of her hospital stay noted to be exacerbated by standing. The patient's headache was attributed to ongoing meningitis as well some degree of post-LP headache given it's worsening with standing. The patient's headache was initially managed with Toradol and morphine alternating and the patient was transitioned to ibuprofen 800 mg Q8 hours and Oxycodone 5 mg Q4 hours PRN pain prior to discharge. The patient was instructed to call her primary care physician should her headache not worsen or not improve within the next 5 days. TRANSITIONAL ISSUES: ===================== -F/u anaplasma and borrelia CSF studies. If positive please refer patient immediately to ___ clinic. Also continued patient on doxycycline 200 mg BID. -If studies are negative then discontinue doxycyline 200 mg BID treatment course Medications on Admission: None Discharge Medications: 1. Ibuprofen 800 mg PO Q8H fever or pain RX *ibuprofen 800 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 2. OxycoDONE (Immediate Release) 5 mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 capsule(s) by mouth four times a day Disp #*28 Capsule Refills:*0 3. Doxycycline Hyclate 200 mg PO Q12H Duration: 20 Days RX *doxycycline hyclate 100 mg 2 tablet(s) by mouth twice a day Disp #*80 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnosis Meningitis (possible Lyme Meningitis) Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, You were admitted to ___ with fever, headache, and leg pain/weakness. We did a lumbar puncture (also called spinal tap) in the emergency department, which involved taking a sample of the fluid that surrounds the spinal cord. Based on the cells that we saw in the fluid, we diagnosed you with meningitis, an infection and inflammation of the lining of the brain and spinal cord. We sent off many tests to see what type of bacteria or virus was causing the meningitis. Most of those tests came back negative including those for viral causes. As of this time, it is not entirely clear what caused your meningitis. One possibility is that the meningitis was caused by lyme disease (a common tick-borne illness), which is treated with a medication called doxycycline. We were not able to confirm this possibility, because the test for lyme meningitis (which involves looking for antibodies in the fluid surrounding your brain) will not be available for another 10 days. Due to the possibility of lyme meningitis, you should take doxycycline 200mg twice a day until you see your primary care doctor. By the time that you see your primary care doctor, we should have results of the lab tests which will either confirm or rule out lyme meningitis; if the results are negative, you can stop taking doxycycline. If the results are positive, continue taking it for a total of 20 days and have your primary care doctor set you up with an infectious disease specialist. Your headache should improve within the next 5 days. Take ibuprofen 800mg three times a day and oxycodone 5mg four times a day as needed for headache. Seek medical attention sooner than your scheduled PCP appointment if your headache worsens, does not improve within 5 days, or if you have a fever or other concerning symptoms. Sincerely, Your ___ team Followup Instructions: ___
10772044-DS-21
10,772,044
23,541,536
DS
21
2119-07-09 00:00:00
2119-07-09 19:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: R ulna fracture R radius fracture Major Surgical or Invasive Procedure: ___: ORIF R ulna History of Present Illness: ___ RHD s/p fall this AM, slipped on ice, landed on R elbow, no other injuries, no preceding symptoms; + R elbow pain, unable to move arm secondary to pain; seen at ___ had films showed comminuted R ulnar fracture and txf here for further evaluation. Past Medical History: ___/PSH: Pre-HTN Social History: ___ Family History: N/C Physical Exam: PHYSICAL EXAMINATION: GEN: NAD, A&Ox3 AVSS RIGHT UPPER EXTREMITY: C/D/I dressing in sling and splint. EPL/FPL/DIO (index) fire. SILT axillary/radial/median/ulnar nerve distributions. 2+ radial pulse Pertinent Results: ADMISSION LABS: ___ 02:40PM BLOOD WBC-13.6* RBC-6.51* Hgb-13.4* Hct-44.4 MCV-68* MCH-20.6* MCHC-30.2* RDW-17.5* RDWSD-36.9 Plt ___ ___ 02:40PM BLOOD Neuts-86.6* Lymphs-7.0* Monos-5.4 Eos-0.1* Baso-0.4 Im ___ AbsNeut-11.79* AbsLymp-0.96* AbsMono-0.73 AbsEos-0.01* AbsBaso-0.06 ___ 02:40PM BLOOD ___ PTT-26.1 ___ ___ 02:40PM BLOOD Glucose-102* UreaN-14 Creat-1.2 Na-136 K-5.0 Cl-100 HCO3-25 AnGap-16 IMAGING: R HUMERUS/ELBOW X-RAY ___: Comminuted, displaced and angulated fractures to the proximal right radius and ulna. Intra-articular extension of the radius fracture. Please see same-day CT report for full details. CT R UPPER EXTREMITY ___: Comminuted fractures involving the right radial head, radial neck, coronoid and olecranon processes of the ulna, and proximal ulnar diametaphysis with intra-articular extension, as described above. R ELBOW X-RAY ___: Fine bony detail is obscured by an overlying back slab. There has been prior surgery with open reduction internal fixation of a comminuted proximal ulnar fracture. The hardware is unchanged in appearance when compared to the prior study. Alignment of the fracture is also unchanged compared the prior study. The fracture of the radial head is less well visualized and there appears to have been resection of the radial head. Please see the operative report for further details. Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a R ulna and radius fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for a R ulna ORIF, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with OT who determined that discharge to home with OT was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is non-weightbearing in a sling and splint to the right upper extremity, and will be discharged on Aspirin for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: None Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H RX *acetaminophen 500 mg 2 tablet(s) by mouth q 8 hours Disp #*40 Tablet Refills:*1 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*30 Capsule Refills:*1 3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth q 4 hours Disp #*60 Tablet Refills:*0 4. Aspirin 325 mg PO BID RX *aspirin 325 mg 1 tablet(s) by mouth twice a day Disp #*56 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: R radial fracture R ulna fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Non-weightbearing to the right upper extremity in splint and sling. Please keep sling intact and dry until your first follow up appointment. MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take Aspirin 325mg twice a day for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns FOLLOW UP: Please follow up with Dr. ___ in the ___ Trauma Clinic ___ days post-operation for evaluation. Someone from our office should call you to schedule this, but if you do not hear from us within a few days after discharge, please call ___ to schedule appointment. Please follow up with your primary care doctor regarding this admission within ___ weeks and for and any new medications/refills. Physical Therapy: Activity: Activity: Activity as tolerated Right lower extremity: Full weight bearing Right upper extremity: Non weight bearing Encourage turn, cough and deep breathe q2h when awake Treatments Frequency: Wound care: Site: R arm Type: Surgical Dressing: Gauze - dry Followup Instructions: ___
10772100-DS-13
10,772,100
29,595,808
DS
13
2183-02-25 00:00:00
2183-02-28 22:11:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: N/V, DKA Major Surgical or Invasive Procedure: None History of Present Illness: ___ with type I DM, frequent syncope with 4 episodes per day (wears helmet) related to dysautonomia, living related donor renal transplant in ___ with transplant surgery, presenting to ___ today for syncope, found to be in DKA. Patient states that he has not been feeling well for ___ days and has been vomiting "a lot" and "every 20 minutes". Patient vomiting red-tinged emesis (no hx of cirrhosis or varices). Patient last vomited ___ hours before initial presentation, approximately a cupful each time. No melena/hematochezia. Has had abd pain for a few days last about a week ago before which stopped a day or two after he started vomiting. Per patient, in touch with his o/p doctors for ___ of 600 or higher; taking 40U lantus, 40U Humalog with meals. Took home anti-rejection meds at ___ and ___ held them down, but feels likely mostly at home he has been able to keep down most. Sore throat started after vomiting. Negative head and neck CT scan at OSH. OSH labs: glucose 946, K=6.1, creat 3.9, GAP29. Patient was given 1L NS at OSH, started on 0.1u/kg bolus and 0.1u/kg insulin gtt at OSH. In the emergency department, patient had HTN to 210's SBP responded well to IV labetolol otherwise blood pressure remained stable. In the ED, initial vitals: 97.7 85 137/52 18 98% RA. In the ED patient received: ___ 16:25 IV DRIP Insulin Started 6 UNIT/HR ___ 16:28 IVF 1000 mL NS 4000 mL ___ 16:28 IV Lorazepam 1 mg ___ 17:34 IV DRIP Insulin Rate Changed to 8 UNIT/HR ___ 18:30 PO Potassium Chloride 40 mEq ___ 19:00 IV DRIP Insulin Rate Changed to 7 UNIT/HR ___ 19:57 IV DRIP Insulin Rate Changed to 4 UNIT/HR ___ 20:55 IV Potassium Chloride 40 mEq ___ 21:14 IV DRIP Insulin Rate Changed to 3 UNIT/HR ___ 21:37 IV Labetalol 10 mg ___ 22:06 IV DRIP Insulin Rate Changed to 2 UNIT/HR ___ 23:49 IV DRIP Insulin rate continued at 2 UNIT/HR Patient was seen and examined by surgical team in the ED, no acute surgical intervention was required, transplant nephrology was consulted and agreed with admission to the MICU. On arrival to the MICU, insulin gtt was continued, IVF was transitioned to ___ for glu <250 and corrected Na > 135. Past Medical History: Type I DM Chronic kidney disease s/p living related donor renal transplant in ___ Autonomic neuropathy with orthostatic hypotension causing ___ syncopal episodes per day (wears helmet) Hyperlipidemia Past Surgical History: repair of right leg fracture Social History: ___ Family History: DM, Parkinsons (father), ___ CA (grandmother age ___ Physical Exam: ON ADMISSION: ================= Vitals: Wt-, T:97.7, HR: 85, BP: 153/79, RR: 17, 98 (RA) GENERAL: Alert, oriented, no acute distress. hand tremors bilaterally (at baseline per patient) HEENT: Sclera anicteric, MM dry, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: no rash appreciated, multiple, well-dressed lacerations b/l arms which per nurse are not erythematous nor purulent NEURO: alert and oriented ON DISCHARGE: ============== General: Alert, oriented, in no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL NECK: supple, JVP not elevated, no LAD CV: Irregular, but not tachycardic, normal S1 + S2, no murmurs, rubs, gallops. Lungs: CTAB, no wheezes, rales, rhonchi Abdomen: Soft, NT, ND, BS+, No HSM, no rebound or guarding Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Skin: Abrasions with dried blood on forearms bilaterally, no surrounding erythema, induration, fluctuance or discharge Neuro: CNII-XII intact, strength and sensation intact. Pertinent Results: LABS ON ADMISSION: ====================== ___ 10:21PM ___ PH-7.36 ___ 10:21PM GLUCOSE-168* NA+-141 K+-4.1 CL--109* TCO2-25 ___ 10:21PM O2 SAT-47 ___ 10:00PM GLUCOSE-183* UREA N-54* CREAT-2.6* SODIUM-142 POTASSIUM-4.3 CHLORIDE-108 TOTAL CO2-20* ANION GAP-18 ___ 07:57PM ___ PH-7.38 ___ 07:57PM GLUCOSE-264* NA+-141 K+-4.0 CL--103 TCO2-25 ___ 07:57PM O2 SAT-63 ___ 07:45PM URINE HOURS-RANDOM ___ 07:45PM URINE HOURS-RANDOM ___ 07:45PM URINE UHOLD-HOLD ___ 07:45PM URINE UHOLD-HOLD ___ 07:45PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 07:45PM URINE BLOOD-SM NITRITE-NEG PROTEIN-30 GLUCOSE-1000 KETONE-40 BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-NEG ___ 07:45PM URINE RBC-3* WBC-<1 BACTERIA-FEW YEAST-NONE EPI-0 ___ 04:15PM ___ PH-7.34* ___ 04:15PM GLUCOSE-GREATER TH NA+-137 K+-4.3 CL--95* TCO2-19* ___ 04:15PM O2 SAT-75 ___ 04:00PM GLUCOSE-695* UREA N-69* CREAT-3.4*# SODIUM-137 POTASSIUM-4.4 CHLORIDE-89* TOTAL CO2-20* ANION GAP-32* ___ 04:00PM estGFR-Using this ___ 04:00PM CK-MB-5 cTropnT-0.02* ___ 04:00PM PHOSPHATE-4.1 MAGNESIUM-2.8* ___ 04:00PM WBC-12.6*# RBC-4.55* HGB-9.8* HCT-32.5* MCV-71* MCH-21.5* MCHC-30.2* RDW-16.6* RDWSD-41.1 ___ 04:00PM NEUTS-89.0* LYMPHS-3.9* MONOS-6.4 EOS-0.0* BASOS-0.1 IM ___ AbsNeut-11.25* AbsLymp-0.49* AbsMono-0.81* AbsEos-0.00* AbsBaso-0.01 ___ 04:00PM PLT COUNT-339 PERTINENT LABS: ================== CHEM 10: ___ 10:00PM Gluc 183* UreaN 54* Cr 2.6* Na 142 K 4.3 Cl-108 HCO3 20 ___ 01:13AM Gluc 141* UreaN 54* Cr 2.7* Na 142 K 4.3 Cl-107 HCO3 24 ___ 06:09AM Gluc 206* UreaN 45* Cr 2.3* Na-141 K-3.7 Cl-107 HCO3-24 ___ 09:47AM Gluc 130* UreaN-41* Cr 2.1* Na-140 K-3.6 Cl-105 HCO3-24 ___ 03:18PM Gluc 279* UreaN-34* Cr 1.9* Na-136 K-4.2 Cl-103 HCO3-23 ___ 12:45AM Gluc 239* UreaN-30* Cr-1.8* Na-136 K-4.0 Cl-101 HCO3-26 ___ 05:55AM Gluc 203* UreaN-26* Cr-1.6* Na-137 K-3.9 Cl-101 HCO3-25 ___ 06:20AM Gluc 136* UreaN-19 Cr-1.4* Na-138 K-3.7 Cl-102 HCO3-26 ___ 05:55AM BLOOD %HbA1c-11.4* eAG-280* ___ 05:55AM BLOOD T4-4.3* ___ 05:55AM BLOOD TSH-1.6 ___ 05:55AM BLOOD TSH-1.6 BLOOD GASES: ___ 04:15PM BLOOD ___ pH-7.34* ___ 07:57PM BLOOD ___ pH-7.38 ___ 10:21PM BLOOD ___ pH-7.36 MICRO: ======= ___ 6:09 am BLOOD CULTURE BCx: Pending URINE CULTURE (Final ___: < 10,000 CFU/mL. IMAGING: ========= ___ Renal US 1. Slightly elevated resistive indices ranging from 0.75 to 0.84, unchanged from ___. 2. No hydronephrosis. ___ CXR AP The lungs are clear. The hila and pulmonary vasculature are normal. No pleural abnormalities or pneumothorax. The cardiomediastinal silhouette is normal. No fractures. IMPRESSION: No pneumonia or pulmonary edema. Brief Hospital Course: ============================ SUMMARY ============================ ___ yo M with history significant for DM type 1, ESRD ___ ___ s/p preemptive living related kidney transplant from his sister in ___, and daily episodes of syncope due to dysautonomia who presents from OSH with DKA. BG was 900 with gap of 29 on first presentation. Resolved with insulin gtt, IV fluids. Cause of DKA was likely inadequate insulin administration given HgbA1c 11.4%. Infection work-up was unremarkable, LFTs, lipase, and troponins were normal. ___ endocrinologists were consulted who recommended an adjusted regimen including finger sticks before every meal as well as bedtime, and sliding scale Humalog to correct these sugars at each of the finger sticks. His blood sugars were been better controlled on this regimen. During the hospitalization, patient had ___ which was treated with fluids and Cr was back to baseline at discharge. patient had an episode of syncope, due to his dysautonomia. The autonomic neurologists were consulted and recommended increasing the dose of midodrine to be taken during the day at specific times of 8am, 12 pm, 4pm in addion to his home dose of fludracortisone. They also recommended lifestyle modifications, and the patient was educated on these. On ___, patient had a tilt table test. The results were pending at the time of discharge, but patient was adamant about going home despite education about the risks of falling from dysautonomia and going back into DKA without adequate blood glucose control. ========================= TRANSITIONAL ISSUES ========================= - Please repeat thyroid function tests as outpatient - Initiate work-up for iron deficiency anemia given labs from ___: Fe 20, ferritin 18: should have colonoscopy. - Follow up tilt table results done on ___ at ___ and recommendations from autonomic neurologist - Follow up on recommendations from ___ - Recommended that patient move into assisted living given frequent episodes of syncope or at least move in with someone to assist him but he refused. He was set up with ___. # Communication: HCP is friend ___ ___. Sister ___ ___. Also has sister ___. # Code: Full =============================== ACTIVE ISSUES TREATED =============================== # Dysautonomia: Long hx of severe dysautonomia with orthostatic hypotension and supine hypertension, difficult to control, on midodrine and fludrocortisone at home. OSH records indicate "extensive work-up" for this, felt to be from diabetes. Records obtained from ___ and PCP. No mention of tilt table test. Autonomic neurology consulted who recommended tilt table test done ___. Also recommended continuing Fludrocortisone Acetate 0.1 mg PO BID, increasing Midodrine 10 mg PO TID (8AM, 12PM, 4PM when sitting upright) during the day, and lifestyle modifications including at night, elevating head of bed 30 degrees to prevent supine hypertension and sitting in chair with feet dangling during the day # DKA: BG 900 with gap of 29 on first presentation. Now resolved s/p insulin gtt, IVF. Cause of DKA is likely non-compliance given HgbA1c 11.4%. Otherwise, initially elevated WBC count that has now normalized. CXR is normal. Bld, ___ cx negative. LFTs, lipase normal. Troponins negative. Gap remained closed throughout the remainder of hospitalization. ___ consulted for DM management. Blood glucoses better controlled on 20u Lantus qAM, 3u Humalog prandial, Humalog SS QACHS + bedtime. # Acute on CKD: Baseline Cr mostly in 1.4-1.6 range, S/p living donor transplant in ___. ___ likely hypoperfusion/pre-renal is setting of DKA, now resolved. Cylcosporine levels remained in appropriate range. Continued mycophenolate and cyclosporine at home doses as well as Bactrim ppx. # Anemia: Chronic anemia in ___ 2.2 ?CKD. Also some component of iron deficiency anemia based on ferritin of 18 in ___. Does not look to have been treated. Gave PO Iron Sulfate 325mg daily. # Hematemesis: Originally presented with hematemesis x3-4d of up to a cup full in the setting of recurrent vomiting ___ DKA. Likely ___ tear. Treated with pantoprazole 40 mg BID. Resolved. Hgb remained stable after initial drop. Patient still with some epigastric pain. Patient may need EGD as outpatient if pain persists. # Arrythmia- EKG shows normal rate, but with irregular rhythm, multiple p wave morphologies. Wandering pacemaker vs PVCs. Pt asymptomatic. # Urinary retention: Likely from dysautonomia with contribution from BPH. Foley catheter placed and home tamsulosin continued. Foley removed a couple days later with good UOP. Continued home tamsulosin. # Cognitive Disorder- Concern for underlying cognitive disorder given patient's relative apathy about recurrent syncope and falls at home, not wearing helmet outside on street, uncontrolled DM1 with HgbA1c 11, weeks of high blood sugars in 500-600s without presenting for medical care, and multiple days of hematemesis before presenting. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Fludrocortisone Acetate 0.1 mg PO BID 2. Midodrine 10 mg PO BID 3. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 4. Mycophenolate Mofetil 500 mg PO TID 5. Vitamin D 1000 UNIT PO DAILY 6. CycloSPORINE (Neoral) MODIFIED 125 mg PO Q12H 7. Glargine 40 Units Breakfast Discharge Medications: 1. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 2. Pantoprazole 40 mg PO Q12H RX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 3. Glargine 16 Units Breakfast Humalog 3 Units Breakfast Humalog 3 Units Lunch Humalog 3 Units Dinner Insulin SC Sliding Scale using HUM Insulin 4. Midodrine 10 mg PO TID 5. CycloSPORINE (Neoral) MODIFIED 125 mg PO Q12H 6. Fludrocortisone Acetate 0.1 mg PO BID 7. Mycophenolate Mofetil 500 mg PO TID 8. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 9. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Diabetic ketoacidosis Secondary: Autonomic Dysfunction (Dysautonomia) Hematemesis Anemia Cardiac arrhythmia Acute on Chronic kidney disease Urinary retention Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory, in need of assistance due to recurrent syncope. Have counciled patient on need for wheel chair or with helmet given recurrent syncope. Discharge Instructions: Dear Mr. ___, You came to the hospital because you were vomiting blood for several days. It was realized that this was because your blood sugar was high and your blood was acidotic, a syndrome called diabetic ketoacidosis. This can happen when you are not taking enough insulin to keep your blood sugars in the normal range. You improved with insulin and intravenous fluids. We consulted the diabetes specialists at ___, who recommended some changes to your insulin regimen. We made these adjustments (see recommendations below), and your blood sugars were improved. The blood in your vomit before coming to the hospital was likely due to a tear in the tube to your stomach (esophagus) that can happen with lots of vomiting. It was treated with an acid suppressing drug to help it heal (pantoprazole). You should continue taking this until your primary care doctor tells you to stop. While you were in the hospital, you had an episode of fainting, which you said happens a lot at home due to problems with the nerves that control your blood pressure (autonomic dysfunction). The neurologists who specialize in this problem came to see you and recommended a tilt table test to help clarify the diagnosis. They did this and the results are pending. As you wanted to leave the hospital, we arranged an appointment with your primary care doctor on ___ (see below). You will also follow up with the autonomic neurologist for recommendations about your autonomic dysfunction. They will call you with an appointment. You were found to have low iron and started on iron supplementation. This may make your stool black and may make you constipated. We recommend that you have a work up for this with your PCP including ___ colonoscopy. We recommended that you move to an assisted living facility or at least live with someone to assist you given your frequent episodes of fainting from low blood pressure. We recommend that you obtain a life alert. We wanted to you stay in the hospital longer so we could make a safe discharge plan but you insisted on going home. We wish you the best! -Your ___ Care Team Diabetes Management: - Please take 20 units of lantus in the morning before breakfast - Please take 3 units of Humalog with each meal. - Take a blood sugar measurement before every meal and before going to bed - Use a sliding scale Humalog to correct meal-time sugars Management of Fainting Spells due to Autonomic Nerve Problem: - Wear a helmet at all times when walking - Get up from sitting/lying very slowly - At night, elevate head of bed to 30 degrees - During the day, try to spend the majority of your time in a chair with feet dangling - Take Fludrocortisone Acetate 0.1 mg PO twice a day - Take Midodrine 10 mg PO three times a day at 8AM, 12PM, 4PM when sitting upright - Keep a blood pressure log - Follow up with the autonomic neurologist for more recommendations Followup Instructions: ___
10772285-DS-2
10,772,285
20,569,292
DS
2
2151-08-24 00:00:00
2151-08-24 15:40:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: Percocet Attending: ___. Chief Complaint: L radius/ulna fracture Major Surgical or Invasive Procedure: ORIF of L radius/ulna History of Present Illness: ___ right-hand dominant gentleman who presents with a left both-bone forearm fracture. He was at a concert at the ___ ___ at ___ on ___ evening when he was pushed, tripped and fell on to his left arm. He had immediate pain and swelling as well as deformity. He was taken to an outside hospital where he was found to have a both-bone forearm fracture. It was deemed too complicated for the institution at the time and he was referred to our clinic today for further evaluation and treatment and surgical fixation. He presented and stated that his pain has improved with icing and elevation and he denies any numbness, tingling or weakness in the left upper extremity. Past Medical History: Past medical history is notable for depression and anxiety as well as hyperlipidemia. Past surgical histories include a left foot surgery arch implant complicated by infection, status post I and D and plastics coverage. Social History: ___ Family History: NC Physical Exam: Physical Examination: General: No acute distress, A and O x 3. Skin: Intact with no evidence of discoloration. No evidence of an open fracture. Extremities: Left upper extremity splint in place, clean, dry and intact. Sensation is intact to median, ulnar and radial nerve distributions. Fingers are warm and well perfused with good cap refill. He is able to fire the EPL, FPL and DIO of the left hand. Limited flexion and extension of the wrist secondary to pain. No movement of the elbow secondary to pain. Pertinent Results: ___ 06:36PM GLUCOSE-85 UREA N-16 CREAT-1.0 SODIUM-143 POTASSIUM-4.1 CHLORIDE-102 TOTAL CO2-33* ANION GAP-12 ___ 06:36PM estGFR-Using this ___ 06:36PM WBC-6.3 RBC-4.45* HGB-14.1 HCT-43.6 MCV-98 MCH-31.7 MCHC-32.3 RDW-12.7 RDWSD-45.6 ___ 06:36PM NEUTS-56.5 ___ MONOS-9.5 EOS-4.3 BASOS-0.5 IM ___ AbsNeut-3.56 AbsLymp-1.81 AbsMono-0.60 AbsEos-0.27 AbsBaso-0.03 ___ 06:36PM PLT COUNT-204 ___ 06:36PM ___ PTT-31.5 ___ Brief Hospital Course: The patient presented to outpatient clinic and was evaluated by the orthopedic surgery team. The patient was found to have left both bone radius/ulna fractures. The patient was reduced and splinted on the left side and taken to the OR for ORIF. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is non weightbearing on the left upper extremity, weight bearing as tolerated on the left lower extremity, and will be discharged on Aspirin for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: Simvastatin 40 mg daily, Lexapro 5 mg daily and hydromorphone 2 mg ___. p.r.n. Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H RX *acetaminophen [Acetaminophen Extra Strength] 500 mg 2 tablet(s) by mouth every 8 hours Disp #*120 Tablet Refills:*0 2. Aspirin 325 mg PO DAILY RX *aspirin 325 mg 1 tablet(s) by mouth once daily Disp #*30 Tablet Refills:*0 3. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain RX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every ___ hours Disp #*50 Tablet Refills:*0 5. Senna 8.6 mg PO BID RX *sennosides [Evac-U-Gen (sennosides)] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Left radial/ulna fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory, independent Discharge Instructions: Mr. ___, - ___ were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Non weightbearing in the left upper extremity, range of motion as tolerated MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so ___ should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take aspirin 325 mg daily for 2 weeks WOUND CARE: - ___ may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if ___ experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns Followup Instructions: ___